<SEC-DOCUMENT>0001571049-15-006546.txt : 20150810
<SEC-HEADER>0001571049-15-006546.hdr.sgml : 20150810
<ACCEPTANCE-DATETIME>20150810160532
ACCESSION NUMBER:		0001571049-15-006546
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20150630
FILED AS OF DATE:		20150810
DATE AS OF CHANGE:		20150810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		151040739

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>t82897_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>UNITED
STATES</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECURITIES
AND EXCHANGE COMMISSION</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FORM
10-Q</B>&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding-right: 0.8pt; font-size: 11pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; padding-right: 0.8pt; font-size: 11pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center; font-size: 11pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&#9746;</B></FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify; font-size: 11pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>QUARTERLY
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>For
the quarterly period ended June 30, 2015</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>OR</B>&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 11pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&#9744;</B></FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>For
the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Commission
File Number: 001-36745</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Applied
DNA Sciences, Inc.</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 11pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Delaware</B></FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>59-2262718</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(State or other
    jurisdiction of</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">incorporation
    or organization)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Identification
    No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 11pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>50
    Health Sciences Drive</B></FONT></TD>
    <TD STYLE="width: 50%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Stony Brook,
    New York</B></FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>11790</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address of principal
    executive offices)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>631-240-
8800</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Registrant&rsquo;s
telephone number, including area code)&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9746;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;No</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&sect;232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9746;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;No</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller
reporting company. See the definitions of &ldquo;large accelerated filer&rdquo;, &ldquo;accelerated filer&rdquo;, and &ldquo;smaller
reporting company&rdquo; in Rule 12b-2 of the Exchange Act. (Check one):&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 11pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Large accelerated
    filer &#9744;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accelerated filer
    &#9746;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Non-accelerated
    filer &#9744;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Smaller reporting
    company &#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Do not check
    if a smaller reporting company)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;
&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;No</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At
August 6, 2015, the registrant had 21,487,202 shares of common stock outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Applied
DNA Sciences, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form
10-Q for the Quarter Ended June 30, 2015&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Table
of Contents&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 11pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 92%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Page</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a001_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PART I - FINANCIAL INFORMATION</B></FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a002_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 1 - Financial Statements (unaudited)</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a003_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 2 - Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">15</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a004_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 3 - Quantitative and Qualitative Disclosures About Market Risk</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">22</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a005_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 4 - Controls and Procedures</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a006_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PART II - OTHER INFORMATION</B></FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a007_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 1 &ndash; Legal Proceedings</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">24</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a008_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 1A &ndash; Risk Factors</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">24</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a009_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 2 &ndash; Unregistered Sales of Equity Securities and Use of Proceeds</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">24</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a010_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 3 &ndash; Defaults Under Senior Securities</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">24</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a011_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 4 &ndash; Mine Safety Disclosures</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">24</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a012_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 5 &ndash; Other Information</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">24</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="#t82897a013_v1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 6 - Exhibits</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">25</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><A NAME="t82897a001_v1"></A>Part
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><A NAME="t82897a002_v1"></A>Item
1 - Financial Statements.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>APPLIED
DNA SCIENCES, INC.</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CONDENSED
CONSOLIDATED BALANCE SHEETS</B>&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 2px solid; text-align: center">June 30,&nbsp; <BR>2015</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 2px solid; text-align: center">September 30,&nbsp; <BR>2014</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">(unaudited)</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="width: 70%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">10,730,144</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">1,393,132</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts receivable, net of allowance of $30,228 and $9,634 at June 30, 2015 and September 30, 2014, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,077,756</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">834,818</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">209,831</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">135,365</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,017,731</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,363,315</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Property, plant and equipment, net of accumulated depreciation of $743,914 at June 30, 2015 and $759,087 at September 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">526,816</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">576,128</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,988</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,638</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Deferred offering costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">181,104</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Intangible assets, net of accumulated amortization and impairment of $325,555 and $256,208 at June 30, 2015 and September 30, 2014, respectively</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">525,902</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">327,872</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">14,123,437</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">3,506,057</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: center">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY (DEFICIT)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable and accrued liabilities, including related party accrued interest of $6,597 at September 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,418,615</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,494,759</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left">Promissory notes payable, including $1,000,000 with a related party at September 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,800,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Deferred revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">204,863</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">583,362</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,623,478</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,878,121</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Warrant liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">1,096,412</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">1,623,478</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">4,974,533</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left">Commitments and contingencies (Note I)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left">Stockholders&rsquo; Equity (Deficit)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2015 and September 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>Series A Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2015 and September 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Series B Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2015 and September 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>Common stock, par value $0.001 per share; 500,000,000 and 1,350,000,000 shares authorized at June 30, 2015 and September 30, 2014, respectively; 21,482,202 and 13,935,954 shares issued and outstanding as of June 30, 2015 and September 30, 2014, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,483</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,937</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Additional paid in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">223,623,850</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">198,277,859</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">(211,145,374</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">(199,760,272</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; equity (deficit)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">12,499,959</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">(1,468,476</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total Liabilities and Stockholders&rsquo; Equity (Deficit)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">14,123,437</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">3,506,057</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
the accompanying notes to the unaudited condensed consolidated financial statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>APPLIED
    DNA SCIENCES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CONDENSED
    CONSOLIDATED STATEMENTS OF OPERATIONS</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;(Unaudited)</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Three Months Ended June
    30,</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Nine Months Ended June 30,</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2015</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2014</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2015</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2014</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="width: 40%">Revenues</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">2,267,671</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">841,197</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">5,028,234</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">2,075,698</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Selling, general and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,508,455</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,948,452</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,078,405</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,093,631</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">310,093</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">266,331</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">961,745</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,085,416</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Depreciation and amortization</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">121,339</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">113,424</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">354,144</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">325,448</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">3,939,887</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">3,328,207</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">12,394,294</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">11,504,495</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">LOSS FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,672,216</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,487,010</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,366,060</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,428,797</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left">Interest income (expense), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,052</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">111</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(26,807</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">784</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other (expense) income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,718</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,299</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,853</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">130,186</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left">Loss on conversion of promissory notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(980,842</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Gain (loss) on change in fair value of warrant liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">515,543</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">(2,994,540</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">(1,663,316</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net loss before provision for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,670,882</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,919,057</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,385,102</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,961,143</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">NET LOSS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">(1,670,882</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">(1,919,057</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">(11,385,102</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">(10,961,143</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share-basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">(0.08</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">(0.14</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">(0.63</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">(0.82</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted average shares outstanding-</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;&nbsp;&nbsp;&nbsp;Basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">21,444,335</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">13,569,262</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">18,075,506</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">13,400,540</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
                                         the accompanying notes to the unaudited condensed consolidated financial statements</FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>APPLIED
DNA SCIENCES, INC</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(Unaudited)</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center">Nine Months Ended &nbsp; <BR>June 30,</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: center">2015</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: center">2014</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Cash flows from operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; font-size: 10pt; text-align: left">Net loss</TD><TD STYLE="width: 3%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(11,385,102</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 3%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(10,961,143</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">354,144</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">325,448</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Stock based compensation expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,531,205</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,717,837</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Change in fair value of warrant liability</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,994,540</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,663,316</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Loss on conversion of promissory notes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">980,842</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Common stock issued for consulting services</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">64,426</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">337,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Bad debt expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">21,750</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,878</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-style: italic; text-align: left">Change in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Accounts receivable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,275,189</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">137,486</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Prepaid expenses and other current assets and deposits</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(59,315</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(924</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Accounts payable and accrued liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(75,515</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">292,462</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Deferred revenue</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">(378,499</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">200,121</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">(5,226,713</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">(6,271,019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Cash flows used in investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Purchase of property plant and equipment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(221,659</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(209,522</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Purchase of intangible assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">(238,082</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">(459,741</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">(209,522</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Cash flows from financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Net proceeds from sale of common stock and warrants</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,114,418</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,145,956</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Purchase and cancelation of previously issued warrants</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">(4,090,952</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">15,023,466</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">2,145,956</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Net increase (decrease) in cash and cash equivalents</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,337,012</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(4,334,585</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of period</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">1,393,132</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; font-size: 10pt; text-align: right">6,360,301</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of period</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">10,730,144</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">2,025,716</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Supplemental Disclosures of Cash Flow Information:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid during period for interest</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid during period for taxes</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Non-cash investing and financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Common stock issued for cashless exercise of options and warrants</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">19,570</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Reclassification of deferred offering costs to additional paid in capital</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">181,104</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Reclassification of warrants from liability to equity upon exercise</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">2,455,042</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Offering costs incurred, and included in accounts payable and accrued liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">68,489</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Property, plant and equipment acquired, and included in accounts payable</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">13,825</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4px double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Intangible assets acquired, and included in accounts payable</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">29,296</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 11pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 11pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 11pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Common stock issued upon conversion of promissory notes payable</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 10pt; text-align: right">1,843,750</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 11pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; font-size: 11pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4px double; font-size: 11pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
the accompanying notes to the unaudited condensed consolidated financial statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>APPLIED
DNA SCIENCES, INC.&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>June
30, 2015</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>NOTE
A &mdash; SUMMARY OF ACCOUNTING POLICIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>General</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
accompanying condensed consolidated financial statements as of June 30, 2015 and for the three and nine month periods ended June
30, 2015 and 2014 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance
with accounting principles generally accepted in the United States (&ldquo;GAAP&rdquo;) for interim financial information and
are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
and with the instructions to Form 10-Q.  Accordingly, they do not include all the information and footnotes required by generally
accepted accounting principles for complete financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation
have been included. Operating results for the three and nine month periods ended June 30, 2015 are not necessarily indicative
of the results that may be expected for the fiscal year ending September 30, 2015. The unaudited condensed consolidated financial
statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended September
30, 2014 and footnotes thereto included in the Annual Report on Form 10-K, as amended, of Applied DNA Sciences, Inc. (the &ldquo;Company&rdquo;)
filed with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
condensed consolidated balance sheet as of September 30, 2014 contained herein has been derived from the audited consolidated
financial statements as of September 30, 2014, but does not include all disclosures required by GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
warrant, option, share, and per share information in the condensed consolidated financial statements gives retroactive effect
to the one-for-60 reverse stock split of the Company&rsquo;s common stock, par value $.001 per share, that was effected on October
29, 2014. See Note G.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Business
and Basis of Presentation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
September 16, 2002, the Company was incorporated under the laws of the State of Nevada. Effective December 17, 2008, the Company
reincorporated from the State of Nevada to the State of Delaware. The Company is principally devoted to developing DNA embedded
biotechnology security solutions in the United States and Europe. To date, the Company has had a limited operating history, and
as a result, its operations have produced limited recurring revenues from its services and products; it has incurred expenses
and has sustained losses. Consequently, its operations are subject to all the risks inherent in the establishment of a biotechnology
company. For the period from inception through June 30, 2015, the Company has accumulated losses of $211,145,374.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, APDN
(B.V.I.) Inc. and Applied DNA Sciences Europe Limited, which currently have no operations or activity. Significant inter-company
transactions and balances have been eliminated in consolidation.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Revenue
Recognition</U>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company recognizes revenue in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;) 605, Revenue Recognition (&ldquo;ASC
605&rdquo;). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of
an arrangement exists; (2) delivery has occurred and/or service has been performed; (3) the selling price is fixed and determinable;
and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&rsquo;s judgments
regarding the fixed nature of the selling prices of the products delivered or services provided and the collectability of those
amounts. Provisions for allowances and other adjustments are provided for in the same period the related sales are recorded. The
Company defers any revenue for which the product has not been delivered, service has not been provided, or is subject to refund
until such time that the Company and the customer jointly determine that the product has been delivered, the service has been
provided, or no refund will be required. At June 30, 2015 and September 30, 2014, the Company recorded deferred revenue of $204,863
and $583,362, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>APPLIED
DNA SCIENCES, INC.</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>June
30, 2015</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>NOTE
A &mdash; SUMMARY OF ACCOUNTING POLICIES (continued)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Revenue
Recognition</U>, continued</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Revenue
arrangements with multiple components are divided into separate units of accounting if certain criteria are met, including whether
the delivered component has stand-alone value to the customer. Consideration received is allocated among the separate units of
accounting based on their respective selling prices. The selling price for each unit is based on vendor-specific objective evidence,
or VSOE, if available, third party evidence if VSOE is not available, or estimated selling price if neither VSOE nor third party
is available. The applicable revenue recognition criteria are then applied to each of the units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Revenue
for government contract awards, which supports the Company&rsquo;s development efforts on specific projects, is recognized as
milestones are achieved as per the contract. The Company recognized revenue of approximately $657,708 and $1,919,031 from these
contract awards during the three and nine month periods ended June 30, 2015 and $0 and $50,000 for the three and nine month periods
ended June 30, 2014, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Net
Loss Per Share</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company presents loss per share utilizing a dual presentation of basic and diluted loss per share. Basic loss per share includes
no dilution and has been calculated based upon the weighted average number of common shares outstanding during the period. Dilutive
common stock equivalents consist of shares issuable upon the exercise of the Company&rsquo;s stock options and warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
the three and nine month periods ended June 30, 2015 and 2014, common stock equivalent shares are excluded from the computation
of the diluted loss per share as their effect would be anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>APPLIED
DNA SCIENCES, INC.</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>June
30, 2015</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>NOTE
A &mdash; SUMMARY OF ACCOUNTING POLICIES (continued)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Net
Loss Per Share</U>, continued</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Securities
that could potentially dilute basic net income per share in the future that were not included in the computation of diluted net
loss per share because including those securities would have been anti-dilutive for the three and nine month periods ended
June 30, 2015 and 2014 are as follows:&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>2015</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>2014</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="width: 50%">Warrants</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">6,062,487</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">240,439</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Employee options</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">3,456,989</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2px solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2px solid; text-align: right">2,073,043</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(247,255,255)">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">9,519,476</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4px double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4px double; text-align: right">2,313,482</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Stock
Based Compensation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (&ldquo;ASC
718&rdquo;). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized
in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are
measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee&rsquo;s requisite
service period (generally the vesting period of the equity grant). The fair value of the Company&rsquo;s common stock options
are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate,
risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method.
In accordance with ASC 718, excess tax benefits realized from the exercise of stock-based awards are classified in cash flows
from financing activities. The future realization of the reserved deferred tax assets related to these tax benefits associated
with the exercise of stock options will result in a credit to additional paid in capital if the related tax deduction reduces
taxes payable. The Company has elected the &ldquo;with and without approach&rdquo; regarding ordering of windfall tax benefits
to determine whether the windfall tax benefit did reduce taxes payable in the current year. Under this approach, the windfall
tax benefit would be recognized in additional paid-in-capital only if an incremental tax benefit is realized after considering
all other benefits presently available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company accounts for stock based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either
the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable,
using the measurement date guidelines enumerated in&nbsp;ASC 505-50.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Concentrations</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Financial
instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash,
cash equivalents and trade receivables. The Company places its cash and temporary cash investments with high credit quality institutions.
At times, such investments may be in excess of the FDIC insurance limit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company&rsquo;s revenues earned from sale of products and services for the three and nine month periods ended June 30, 2015 included
an aggregate of 87% and 73%, respectively, from two customers of the Company&rsquo;s total revenues. These two customers accounted
for approximately 89% of the Company&rsquo;s total accounts receivable at June 30, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company&rsquo;s revenues earned from sale of products and services for the three month period ended June 30, 2014 included an
aggregate of 10% from one customer of the Company&rsquo;s total revenues. During the nine month period ended June 30, 2014 no
customers represented 10% or greater of the Company&rsquo;s total revenues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>APPLIED
DNA SCIENCES, INC.</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>June
30, 2015</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>NOTE
A &mdash; SUMMARY OF ACCOUNTING POLICIES (continued)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Recent
Accounting Pronouncements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
August 2014, the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) issued ASU 2014-15, &ldquo;Disclosure of Uncertainties
about an Entity&rsquo;s Ability to Continue as a Going Concern&rdquo; (&ldquo;ASU 2014-15&rdquo;). ASU 2014-15 provides guidance
on management&rsquo;s responsibility in evaluating whether there is substantial doubt about a company&rsquo;s ability to continue
as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate
whether there are conditions or events that raise substantial doubt about a company&rsquo;s ability to continue as a going concern
within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting
periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. The Company
will adopt the methodologies prescribed by ASU 2014-15 by the date required, and does not anticipate that the adoption of ASU
2014-15 will have a material effect on its condensed consolidated financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
June 2014, the FASB issued Accounting Standards Update 2014-12, &ldquo;Accounting for share-based payments when the terms of an
award provide that a performance target could be achieved after the requisite service period,&rdquo; (&ldquo;ASU 2014-12&rdquo;)
which requires performance-based awards with a performance target that affects vesting and that could be achieved after an employee
completes the requisite service period to be accounted for as a performance condition. If performance targets are clearly defined
and it is probable that the performance condition will be achieved, stock-based expense should be recognized over the remaining
requisite service period. This guidance will be effective for fiscal years (and interim reporting periods within those years)
beginning after December 15, 2015. Early adoption is permitted. The Company is in the process of evaluating the provisions of
the ASU and assessing the potential effect on the Company&rsquo;s condensed consolidated financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
May 2014, the FASB issued Accounting Standards Update 2014-09, &ldquo;Revenue from Contracts with Customers,&rdquo; (&ldquo;ASU
2014-09&rdquo;) which provides updated, comprehensive revenue recognition guidance for contracts with customers, including a new
principles-based five step framework that eliminates much of the industry-specific guidance in current accounting literature.
Under ASU 2014-09, revenue recognition is based on a core principle that companies recognize revenue in an amount consistent with
the consideration it expects to be entitled to in exchange for the transfer of goods or services. The standards update also requires
enhanced disclosures regarding the nature, amount, timing and uncertainty of recognized revenue. This guidance will be effective
for fiscal years (and interim reporting periods within those years) beginning after December 15, 2017. The Company is in the process
of evaluating the provisions of the ASU and assessing the potential effect on the Company&rsquo;s condensed consolidated financial
position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>APPLIED DNA SCIENCES,
INC.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>June 30, 2015</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt"><B>NOTE B &ndash; LIQUIDITY AND MANAGEMENT&rsquo;S
PLAN</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company has recurring
net losses, which have resulted in an accumulated deficit of $211,145,374 as of June 30, 2015. The Company incurred a net loss
of $11,385,102 and generated negative operating cash flow of $5,226,713 for the nine month period ended June 30, 2015.&nbsp;&nbsp;However,
the Company also has attained positive working capital of $11,394,253 as of June 30, 2015. At June 30, 2015 the Company had cash
and cash equivalents of $10,730,144. The Company&rsquo;s current capital resources include cash and cash equivalents, accounts
receivable and prepaid expenses. Historically, the Company has financed its operations principally from the sale of equity securities.
As discussed in Note G, on April 1, 2015, the Company closed its underwritten public offering of common stock and warrants for
gross proceeds of approximately $12.0 million, before deducting underwriting discounts and offering expenses.<B> </B>Subsequently
on April 30, 2015,<SUP> </SUP>the Company closed on the over-allotment option of the underwritten public offering for additional
gross proceeds of $263,950. In addition, on November 20, 2014 the Company closed its underwritten public offering of common stock
and warrants for gross proceeds of $9.3 million before deducting underwriting discounts and offering expenses. The Company utilized
approximately $4,091,000 of the gross proceeds to repurchase the remaining Series B Warrants from Crede, as discussed in Note
E.&nbsp;&nbsp;The Company raised $2,156,264 in a private placement of common stock and warrants and $1,800,000 in promissory notes
during the fiscal year ended September 30, 2014, including $1,000,000 from a related party. See Notes D and G.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company expects
to finance operations primarily through cash flows provided by operating activities provided that it will achieve a sufficient
level of future revenues. The Company estimates that its cash and cash equivalents are sufficient to fund operations for the next
twelve months.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company will require
additional funds to complete the continued development of its products, product manufacturing, and to fund expected additional
losses from operations, until revenues are sufficient to cover the Company&rsquo;s operating expenses.&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>NOTE C &ndash; ACCOUNTS
PAYABLE AND ACCRUED LIABILITIES</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Accounts payable and
accrued liabilities at June 30, 2015 and September 30, 2014 are as follows:</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid"><P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">June
        30,</FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">2015</FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">(unaudited)</FONT></P></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid"><P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">September
        30,<BR>2014</FONT></P></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 48%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Accounts payable</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="width: 13%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">770,395</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="width: 12%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">1,059,623</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Accrued consulting fees</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">110,500</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">102,500</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Accrued salaries payable</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">428,098</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">245,761</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Accrued interest payable</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">-</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">11,875</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Other
    accrued expenses</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">109,622</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">75,000</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Total</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman">1,418,615</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">1,494,759</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt"><B>NOTE D &ndash; PROMISSORY NOTES PAYABLE</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">On September 11, 2014,
the Company issued and sold promissory notes (the &ldquo;Notes&rdquo;) in the aggregate principal amount of $1,800,000 and bearing
interest at a rate of 12.5% per annum to Dr. James A. Hayward, the Company&rsquo;s President, Chairman and Chief Executive Officer,
in the amount of $1,000,000, and to another individual, in the amount of $800,000, both of whom are &ldquo;accredited investors&rdquo;
as defined in regulations promulgated under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;).</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Notes had a ten
month maturity. Interest was payable in cash or in shares of common stock at the option of the holders of the Notes. Interest
to be paid in shares was to be paid in shares of common stock equal to (i) the amount of interest payable, divided by (ii) the
average of the closing prices for the five consecutive trading days immediately preceding the applicable interest date. The Notes
were permitted to be prepaid in whole or in part, at any time, subject to certain prepayment penalties. Upon an event of default,
the Notes and all accrued interest thereon were to automatically convert into common stock at the closing price of the common
stock on the date of issuance of the Notes. In the event of a consolidation or merger with another corporation in which the Company
does not survive, the Notes were to be paid in full. On November 11, 2014, Dr. Hayward and the other individual agreed to exchange
for cancellation their respective Notes (including principal and accrued interest thereon) for 315,171 shares of common
stock and warrants to purchase 315,171 shares of common stock, in the case of Dr. Hayward, and 252,137 shares of common stock
and warrants to purchase 252,137 shares of common stock, in the case of the other individual, at $3.25 ($3.24 for one share of
common stock and $0.01 for one warrant) (&ldquo;combined price&rdquo;) , the aggregate public offering per share price of common
stock and warrants issued in the Company&rsquo;s underwritten public offering, which closed on November 20, 2014.&nbsp;&nbsp;The
conversion of the Notes resulted in a loss on conversion of approximately $981,000, which was recorded on the condensed consolidated
statement of operations for the nine month period ended June 30, 2015.&nbsp;&nbsp;The loss was calculated as the difference between
the carrying amount of the promissory note and accrued interest on the conversion date compared to the fair value of the common
stock and warrant issued as settlement of the Notes.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Interest expense for
these Notes was $31,875 for the nine month period ended June 30, 2015.&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>APPLIED
DNA SCIENCES, INC.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>June 30, 2015</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt"><B>NOTE E &ndash; WARRANT LIABILITY</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">On December 16, 2013,
Crede CG III, Ltd (&ldquo;Crede&rdquo;) effected the cashless exercise of 178,253 Series A Warrants and 116,667 Series B Warrants.
At December 16, 2013 (date of exercise), the Company determined the fair value of the Warrants to be $2,455,042 using the Binomial
Lattice model with the following assumptions: fair value of the Company&rsquo;s common stock $10.80 per share; dividend yield
0%; expected term: 4.55 years; risk free interest rate: 1.55%; expected volatility of: 118.89%; and an exercise price of $14.59.
The change in fair value of the warrant liability on the day of exercise amounted to a loss of $1,288,752 and was included in
the other income (expense). Upon exercise, the fair value of the Series A Warrants and 116,667 of the Series B Warrants were reclassified
to equity.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Series A and Series
B Warrants were classified as liabilities on the issuance date due to certain provisions contained in the warrant agreements,
which may cause an adjustment to the conversion rate or the number of warrants outstanding.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The change in fair
value of the warrant liability resulted in a gain of $515,543 and a loss of $1,663,316 for the three and nine month periods ended
June 30, 2014, respectively.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">On October 28, 2014,
the Company entered into a warrant repurchase option agreement with Crede, pursuant to which it had the option to purchase between
50% and 100% of Crede&rsquo;s Series B Warrant (then exercisable for 387,621 shares of common stock) at a purchase price
of $10.55 per share underlying such Series B Warrant (up to an aggregate purchase price of $4,091,000 for all of the Series B
Warrant). On November 21, 2014, the Company exercised its option and repurchased 100% of Crede&rsquo;s Series B Warrant for an
aggregate purchase price of approximately $4,091,000.&nbsp;&nbsp;The change in fair value of the warrant liability on the day
of repurchase amounted to a loss of $2,994,540 and was included in other income (expense) for the nine month period ended June
30, 2015.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt"><B>NOTE F &ndash; RELATED PARTY TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">As discussed in Note
D, on September 11, 2014, the Company issued and sold a promissory note in the aggregate principal amount of $1,000,000 and bearing
interest at a rate of 12.5% per annum to Dr. James A. Hayward, the Company&rsquo;s President, Chairman and Chief Executive Officer.
On November 11, 2014, Dr. Hayward agreed to exchange for cancellation of his Note (including principal and accrued interest thereon)
for 315,171 shares of common stock and warrants to purchase 315,171 shares of common stock, at a combined price of $3.25, the
aggregate public offering price of common stock and warrants issued in the Company&rsquo;s underwritten public offering which
closed on November 20, 2014.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">As discussed in Note
G, the Company&rsquo;s Chief Executive Officer and an affiliated company of a member of the Company&rsquo;s board of directors
participated in the Company&rsquo;s November 20, 2014 underwritten public offering.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>APPLIED DNA SCIENCES,
INC.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>June 30, 2015</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt"><B>NOTE G - CAPITAL STOCK</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">On October 24, 2014,
the Company filed a Third Certificate of Amendment of its Certificate of Incorporation with the Secretary of State of the State
of Delaware that effected a one-for-60 (1:60) reverse stock split of its common stock, par value $.001 per share, and a decrease
in its authorized common stock, from 1,350,000,000 to 500,000,000 shares, effective October 29, 2014. All warrant, option, share,
and per share information in the condensed consolidated financial statements gives retroactive effect to the one-for-60 reverse
stock split that was effected on October 29, 2014. <I>&nbsp;</I> In addition, the Company is authorized to issue 10,000,000 shares
of preferred stock with a $0.001 par value per share. As of June 30, 2015 and September 30, 2014, there were 21,482,202 and 13,935,954
shares of common stock issued and outstanding, respectively.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">On November 20, 2014,
the Company closed its underwritten public offering of 2,800,000 shares of common stock and warrants to purchase up to an aggregate
of 2,800,000 shares of common stock for gross proceeds of $9.1 million before deducting underwriting discounts and offering expenses.
The Company utilized $4,091,000 of the gross proceeds to repurchase the remaining Series B Warrants from Crede, as discussed in
Note E. The combined price for each share of common stock and warrant was $3.25. The warrants may be exercised for a period of
five years and have an exercise price of $3.50 per share. In connection with the offering, the Company granted to the underwriters
a 45-day option to purchase up to 420,000 additional shares of common stock at $3.24 per share and/or up to 420,000 additional
warrants at $0.01 per share to cover over-allotments, if any. The Company&rsquo;s Chief Executive Officer and an affiliated company
of a member of the Company&rsquo;s board of directors participated in this underwritten public offering. The Company&rsquo;s common
stock and warrants are listed on the Nasdaq Capital Market under the symbols &ldquo;APDN&rdquo; and &ldquo;APDNW&rdquo;, respectively.
On December 19, 2014, the Company closed on the underwriters&rsquo; exercise of its over-allotment option of 416,850 warrants
for gross proceeds of $4,169 and on December 30, 2014, the Company closed on the underwriters&rsquo; additional exercise of its
over-allotment option of 52,000 shares of common stock for gross proceeds of $168,400.&nbsp;&nbsp;The total number of common stock
and warrants issued under this offering, including the exercise of the over-allotment option was 2,852,000 and 3,216,850, respectively.&nbsp;&nbsp;The
gross proceeds to the Company was $9.3 million and net proceeds after deducting underwriting discounts, offering expenses and
the repurchase of the remaining Series B Warrants from Crede was approximately $3.69 million.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">In connection with
the closing of this underwritten public offering, on November 20, 2014, the Company granted 128,800 warrants to purchase common
stock to its underwriters as partial compensation. These warrants have an exercise price of $3.73 (115% of the public offering
price) and expire on November 14, 2019.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">During the three and
nine month periods ended June 30, 2015, the Company granted 15,000 and 22,500 shares of common stock to a consultant for a total
expense of approximately $47,750 and $64,426, respectively.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt/normal Calibri; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman">On April 1, 2015,
the Company closed its underwritten public offering of 4,011,000 shares of common stock and warrants to purchase up to an aggregate
of 1,604,400 shares of common stock, at $3.00 ($2.99 for one share of common stock and $0.01 for one warrant) (&ldquo;combined
offering price&rdquo;), including 191,000 shares and 76,400 warrants sold pursuant to the partial exercise of the underwriters&rsquo;
over-allotment option. The warrants have a per share exercise price of $3.50, are exercisable immediately, and expire on November
20, 2019. The gross proceeds to the Company from this offering, including the partial exercise of the over-allotment option but
before deducting the underwriting discount and offering expenses, is $12.0 million</FONT><FONT STYLE="font-size: 10pt">.<FONT STYLE="font-family: Times New Roman">
In connection with the offering, the Company granted to the underwriters a 45-day option to purchase up to 573,000 additional
shares of common stock and up to 229,200 additional warrants to cover over-allotments, if any. On April 30, 2015, the Company
closed on the underwriters&rsquo; exercise of its over-allotment option of 87,000 shares of common stock and 152,800 warrants
for gross proceeds of $263,950 .</FONT></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">In connection with
the closing of this underwritten public offering, as partial compensation, on April 1, 2015, the Company granted up to 163,720
warrants to purchase common stock to its underwriters. These warrants have an exercise price of $3.44 (115% of the public offering
price) and expire on March 27, 2020.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">See Note D for the
common stock and warrants issued in connection with the conversion of the promissory notes.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>NOTE H - STOCK OPTIONS
AND WARRANTS</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Warrants</U></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The following table
summarizes the changes in warrants outstanding and the related prices for the shares of common stock issued to non-employees of
the Company. These warrants were granted in lieu of cash for services performed or financing expenses in connection with the sale
of common stock.</FONT></P>

<P STYLE="font: 12pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Transactions involving
warrants (see Notes D, E and G) are summarized as follows:</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid; padding-right: 1.8pt; text-align: center; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Number
    of</FONT><FONT STYLE="font-size: 10pt"><BR>
    <FONT STYLE="font-family: Arial">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman">Shares</FONT></FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid; padding-right: 1.8pt; text-align: center; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Weighted</FONT><FONT STYLE="font-size: 10pt"><BR>
    <FONT STYLE="font-family: Arial">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman">Average <BR> Exercise</FONT><BR>
    <FONT STYLE="font-family: Arial">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman">Price Per <BR> Share</FONT></FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: azure">
    <TD STYLE="width: 48%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Balance at October
    1, 2014</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 14%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">945,166</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="width: 11%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">9.59</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Granted</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">5,833,878</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">3.50</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Exercised</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">(&mdash;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">(&mdash;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Cancelled
    or expired</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">(716,557</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">)</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">(11.30</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Balance at June 30, 2015</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">6,062,487</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">3.53</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 12pt 0 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>APPLIED DNA SCIENCES,
INC.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>June 30, 2015</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>NOTE H - STOCK OPTIONS
AND WARRANTS (continued)</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Employee Stock Options</U></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">In 2005, the Board
of Directors and the holders of a majority of the outstanding shares of common stock approved the 2005 Incentive Stock Plan (the
&ldquo;Incentive Plan&rdquo;). In 2007, 2008 and 2012, the Board of Directors and holders of a majority of the outstanding shares
of common stock approved various increases in the number of shares of common stock that can be issued as stock awards and stock
options thereunder to an aggregate of 5,833,334 shares and the number of shares of common stock that can be covered by awards
made to any participant in any calendar year to 833,334 shares.&nbsp;&nbsp;On January 21, 2015, the Board of Directors approved
an amendment to the Incentive Plan, which was approved by shareholders on June 16, 2015.&nbsp;&nbsp;The amendment increases the
number of shares of common stock that can be issued as stock awards and stock options thereunder to an aggregate of 8,333,333.&nbsp;&nbsp;The
amendment also extends the Incentive Plan&rsquo;s expiration date to January 25, 2025.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Incentive Plan
is designed to retain directors, executives, and selected employees and consultants by rewarding them for making contributions
to our success with an award of options to purchase shares of common stock and an award of shares of common stock. As of June
30, 2015 a total of 233,752 shares have been issued and options to purchase 4,132,475 shares have been granted under the 2005
Incentive Stock Plan.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Transactions involving
stock options issued to employees are summarized as follows:</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 33%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 13%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid; padding-right: 1.8pt; text-align: center; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Number
    of</FONT><FONT STYLE="font-size: 10pt"><BR>
    <FONT STYLE="font-family: Times New Roman">Shares</FONT></FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid"><P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Weighted
        <BR>Average</FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Exercise</FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Price
        Per</FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Share</FONT></P></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid"><P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Aggregate</FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Intrinsic</FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman; margin: 0 1.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Value</FONT></P></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Outstanding at October 1, 2014</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">2,909,046</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">4.74</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Granted</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">950,094</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">2.85</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Exercised</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&mdash;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&mdash;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Cancelled or expired</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">(402,151)</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">(3.01)</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Outstanding at June 30, 2015</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">3,456,989</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">4.42</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Vested at June 30, 2015</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">2,494,098</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">4.13</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">0.18</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Non-vested at June 30, 2015</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">962,891</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">0.12</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal inherit; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;For
the three and nine-month periods ended June 30, 2015, the Company issued 49,585 and 950,094, options to employees, consultants
and non-employee board of director members, respectively. Included in these grants for the nine month period was 450,000 options
granted to executives.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0pt 0 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>APPLIED DNA SCIENCES,
INC.</B><BR>
<B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>June 30, 2015</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>NOTE H - STOCK OPTIONS
AND WARRANTS (continued)</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Employee Stock Options</U>,
continued</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The fair value of options
granted during the three and nine month periods ended June 30, 2015 was determined using the Black Scholes Option Pricing Model
with the following weighted average assumptions:</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; border-collapse: collapse; font-size: 12pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 45%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 13%; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 13%; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 2px solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2px solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Three<BR>
    Months<BR>
    Ended<BR>
    June 30, <BR>
2015</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Nine<BR>
    Months<BR>
    Ended<BR>
    June 30, <BR>
2015</FONT></TD>
    <TD STYLE="border-bottom: Black 2px solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Stock price</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.60</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.85</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Exercise price</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.60</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.85</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Expected term, years</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.75</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.85</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dividend yield</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&mdash;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">%</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&mdash;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Volatility</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">118</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">%</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">132</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Risk free rate</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.13</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">%</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.56</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">%</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company recorded
$1,015,361(including $544,113 for stock option modifications) and $404,507 as stock compensation expense for the three month periods
ended June 30, 2015 and 2014, respectively, and $3,531,205 (including $673,176 for stock option modifications) and $1,717,837
for the nine month periods ended June 30, 2015 and 2014, respectively for the vesting portion of all options. As of June 30, 2015,
unrecorded compensation cost related to non-vested awards was $2,749,586 which is expected to be recognized over a weighted average
period of approximately 2.21 years.&nbsp;&nbsp;The weighted average grant date fair value for options granted during the three
and nine month periods ended June 30, 2015 was $69,430 and $1,076,502, respectively.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>APPLIED DNA SCIENCES,
INC.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>June 30, 2015</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>NOTE I - COMMITMENTS
AND CONTINGENCIES</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Operating Leases</U></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company leases
office space under an operating lease in Stony Brook, New York for its corporate headquarters. The lease is for a 30,000 square
foot building. The term of the lease commenced on June 15, 2013 and expires on May 31, 2016, with the option to extend the lease
for two additional three-year periods. The base rent during the initial lease term is $449,142 per annum. The Company also has
operating leases for a laboratory in Huddersfield, England, which is currently inactive and Calverton, New York. The Huddersfield
lease was terminated effective July 31, 2015. The Calverton lease was from February 1, 2014 through October 31, 2014<B>,</B> with
the option to renew for additional one year periods.&nbsp;&nbsp;The Calverton lease is currently on a month to month basis.&nbsp;&nbsp;Total rent expense for the three and nine month periods ended June
30, 2015 was $124,504 and $373,772, respectively. Total rent expense for the three and nine month periods ended June 30, 2014
were $125,268 and $380,251, respectively.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Employment Agreement</U></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company has an
employment agreement with the Chief Executive Officer. Effective June 21, 2014, the Chief Executive Officer&rsquo;s annual salary
was voluntarily reduced by $50,000. This salary reduction will be accrued and repaid when the Company reaches $3,000,000 in sales
for two consecutive quarters or the Company has net income at the end of any fiscal year.&nbsp;&nbsp;Effective January 1, 2015,
the Chief Executive Officer&rsquo;s annual salary was voluntarily reduced by an additional $50,000.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Litigation</U></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">From time to time,
the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. When
the Company is aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. If it is probable that
a loss will result and the amount of the loss can be reasonably estimated, the Company will record a liability for the loss. In
addition to the estimated loss, the recorded liability includes probable and estimable legal costs associated with the claim or
potential claim. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from
time to time that may harm the Company&rsquo;s business.&nbsp;There is no pending litigation involving the Company at this time.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 6; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>APPLIED DNA SCIENCES,
INC.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>June 30, 2015</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>NOTE J - FAIR VALUE</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The carrying value
of cash, accounts receivable, accounts payable and accrued liabilities approximate estimated fair values because of their short
maturities.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The carrying value
of the warrant liability is determined using the Binomial Lattice option pricing model as described in Note A. Certain assumptions
used in the calculation of the warrant liability represent Level-3 unobservable inputs. The Company did not have any assets or
liabilities categorized as Level 1, 2 or 3 as of June 30, 2015.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The following table
summarizes the activity of Level 3 inputs measured on a recurring basis:</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 90%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Fair Value Measurements of Common
    Stock Warrants Using Significant Unobservable Inputs (Level 3)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6"><P STYLE="font: 10pt/normal Times New Roman; margin: 0 5.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Nine
        Months Ended</B></FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman; margin: 0 5.8pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>June
        30,</B></FONT></P></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid; padding-right: 1.8pt; text-align: center; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman"><B>2015</B></FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid; padding-right: 1.8pt; text-align: center; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman"><B>2014</B></FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 58%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Balance
    at October 1, 2014 and 2013</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="width: 13%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">1,096,412</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="width: 13%; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">2,643,449</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Adjustment
    resulting from change in fair value (a)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">2,994,540</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">1,663,316</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Removal of warrant upon repurchase</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">(4,090,952</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&mdash;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Reclassification to equity upon
    exercise</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">(2,455,042</FONT></TD>
    <TD STYLE="border-bottom: black 2px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Balance
    at June 30,</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">$</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; text-align: right; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">1,851,723</FONT></TD>
    <TD STYLE="border-bottom: black 4px double; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">(a) <I>Adjustment resulting
from change in fair value</I> is the amount of total gains or losses for the period attributable to the change in unrealized gains
or losses relating to warrant liabilities held at the reporting date and realized gains or losses at the date of exercise. The
gain or loss is recorded in change in fair value of warrant liability in the accompanying condensed consolidated statements of
operations.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a003_v1"></A>Item 2. - Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The following discussion
should be read in conjunction with our Unaudited Condensed Consolidated Financial Statements and Notes thereto, included elsewhere
within this report. The Quarterly Report contains forward-looking statements, including statements using terminology such as &ldquo;can&rdquo;,
&ldquo;may&rdquo;, &ldquo;believe&rdquo;, &ldquo;designed to&rdquo;, &ldquo;will&rdquo;, &ldquo;expect&rdquo;, &ldquo;plan&rdquo;,
&ldquo;anticipate&rdquo;, &ldquo;estimate&rdquo;, &ldquo;potential&rdquo; or &ldquo;continue&rdquo;, or the negative thereof or
other comparable terminology regarding beliefs, plans, expectations or intentions regarding the future. You should read statements
that contain these words carefully because they:</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&#9679;</FONT></TD>
    <TD STYLE="width: 97%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">discuss our future
    expectations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&#9679;</FONT></TD>
    <TD STYLE="width: 97%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">contain projections
    of our future results of operations or of our financial condition; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&#9679;</FONT></TD>
    <TD STYLE="width: 97%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">state other &ldquo;forward-looking&rdquo;
    information.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">We believe it is important
to communicate our expectations. However, forward looking statements involve risks and uncertainties and our actual results and
the timing of certain events could differ materially from those discussed in forward-looking statements as a result of certain
factors, including those set forth under &ldquo;Risk Factors,&rdquo; &ldquo;Business&rdquo; and elsewhere in our Annual Report
on Form 10-K, as amended, for the fiscal year ended September 30, 2014. All forward-looking statements and risk factors included
in this document are made as of the date hereof, based on information available to us as of the date thereof, and we assume no
obligations to update any forward-looking statement or risk factor, unless we are required to do so by law.</FONT></P>

<P STYLE="font: 12pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Introduction</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Using biotechnology
as a forensic foundation, we provide botanical-DNA based security and authentication solutions and services that can help protect
products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting,
fraud, and diversion. Whether working in supply chain security, brand protection or law enforcement applications, it is our goal
to help establish secure flourishing environments that foster quality, integrity and success.&nbsp;With secure taggants, high-resolution
DNA authentication, and comprehensive reporting, our botanical DNA-based technologies are designed to deliver what we believe
to be the greatest levels of security, deterrence and legal recourse strength.&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>SigNature</I></B>&reg;
<B><I>DNA</I></B>. SigNature DNA is our platform ingredient, at the core of all our security solutions. From application to application,
the vehicle which carries SigNature DNA is custom designed to suit the application. Exhaustive development efforts have yielded
a flexible and durable marker with all the accuracy provided by nature.&nbsp;SigNature DNA is based on full, double stranded plant
DNA, and provides forensic power and protection for a wide array of applications. Highly secure, robust, and durable, SigNature
DNA markers are an ingredient that can be used to fortify brand protection efforts; mark, track and convict criminals; and strengthen
supply chain security.&nbsp;Custom DNA sequences can be embedded into a wide range of host carriers including ink, varnish, thread,
laminates and metal coatings. These items can then be tested for the presence of SigNature DNA markers through optical screening
or a forensic level authentication. Hundreds of millions of SigNature DNA marks now exist in the public domain on items ranging
from consumer product packaging to microcircuits to guitars. We believe that no marks have ever been copied.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">SigNature DNA, SigNature&reg;
T DNA, fiberTyping&reg;, DNAnet&reg;, Sentry, digitalDNA&reg;, and SmokeCloak&reg; DNA, our principal anti-counterfeiting
and product authentication solutions and our Counterfeit Prevention Authentication Program can be used in numerous industries,
including, but not limited to microcircuits and other electronics, cyber security, cash-in-transit (transport and storage
of banknotes), textiles and apparel, automotive, printing and packaging, homeland security,&nbsp;&nbsp;law enforcement and home
asset marking, identity cards and other secure documents, industrial materials,&nbsp;&nbsp;agrochemicals, pharmaceuticals, consumer
products, food and beverage, sports memorabilia, fine wine, and art and collectibles.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>SigNature T DNA
and fiberTyping</I></B>.&nbsp;There is one common thread that runs through the global textile industry: success breeds counterfeiting
and diversion. SigNature T botanical DNA markers are used for brand protection efforts and raw material source compliance programs.
In situations where natural fibers like cotton or wool are utilized, we can isolate and type inherent DNA, making it possible
to verify the presence of specified materials. This fiberTyping process provides DNA verification to help manufacturers, retailers
and brand owners ensure quality, safety and compliance of their products.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>DNAnet.</I></B>
Recognizing that DNA-based evidence is the cornerstone of the modern era of law enforcement, we have created what we believe to
be an effective crime fighting tool: DNAnet, a botanical DNA marker that can be used to definitively link evidence and offenders
to specific crime scenes and help return stolen or lost property to its rightful owner. As the crime is investigated, the fluorescing
DNA mark can assist police in linking the offender and stolen items to a specific crime scene, creating a greater ability to identify
and convict.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 11pt/115% Calibri; margin: 0 0 10pt; background-color: white; text-align: justify"><FONT STYLE="font: 10pt Times New Roman"><B><I>Sentry.
</I></B>Sentry intruder tagging systems help to expand and strengthen any security effort by providing a means of directly linking
criminals to crimes. Each unit is designed to be unique to each store, warehouse, or sting operation, allowing the police and
prosecutors to link criminals to the crimes. In the event of a crime, the fleeing offender is sprayed with an indelible,
fluorescing DNA taggant. As the crime is investigated, the fluorescing DNA mark can assist police in linking the offender and
stolen items to a specific crime scene, creating a greater ability to identify and convict.</FONT><FONT STYLE="font: 10pt Arial">
</FONT><FONT STYLE="font: 10pt Times New Roman">Whether deployed as an offender spray or fog in a retail location or a degradation
dye in cash handling boxes, DNA markers facilitate conviction, and establish a heightened level of deterrence. While any commercial/retail
establishment could benefit from the addition of a Sentry system, ideal areas of use include: banks, ATMs, pharmacies, jewelry
stores, convenience stores, pawn brokers and gun shops.&nbsp;</FONT></P>

<P STYLE="font: 10pt/115% Times New Roman; margin: 0 0 10pt; background-color: white; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>digitalDNA.
</I></B>digitalDNA is a security solution that utilizes the flexibility of mobile communications, the instant accessibility
of secure, cloud-based data, and the certainty of DNA to make item tracking and authentication fast, easy and definitive, while
providing the opportunity to create a new customer interface. digitalDNA begins with a DNA-secured form of the QR (&ldquo;quick
read&rdquo;) code or other two dimensional code. A unique identification code is created for each article, and represented in
an easy-to-read QR style barcode. The product uses forensic authentication of a botanical DNA marker, embedded within a secure
QR code, and physically included within the ink used to digitally print the code. Should there ever be a question about the validity
of a digitalDNA code, a laboratory-based analysis can be conducted to determine authenticity. Scanning bar code item numbers on
marked goods enables individuals to post or access information about a product such as its geo-location, original image or associated
documentation. Consumers may take advantage of marketing information supplied by brand owners.&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; background-color: white; text-align: justify"><FONT STYLE="font-size: 10pt">The
secure cloud application also offers back-end features including DNA custody management, forensic sample submission, CODA (certificate
of DNA authentication) issuance, customer account administration, order placement, status tracking and reporting, and online training.
The cloud-based platform is designed to be customizable for the particular attributes of each customer&rsquo;s business and conforms
to strict security standards for ISO, PCI, and Federal Information Processing Standards. This digitalDNA platform is designed
as the data management and reporting hub for devices for DNA on-site authentication and optical mark in-field validation. Market-specific
configurations have been demonstrated to businesses in textiles supply chain, printing/publishing, art and collectibles and law
enforcement.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>SmokeCloak DNA</I></B>.
&nbsp;When deployed in pharmacies, banks, commercial or retail locations, SmokeCloak DNA helps protect staff, customers and assets.
A thick and disorienting fog wards off offenders and deposits a unique, location-specific DNA marker on skin, clothing and stolen
items. The combination of fog and DNA technologies has no negative side effects and provides a strong crime fighting and loss
prevention tool.</FONT></P>

<P STYLE="font: 12pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Counterfeit Prevention
Authentication Program.</I></B> Our turnkey&nbsp;program for electronics, military, commercial, and aerospace contractors called
the Counterfeit Prevention Authentication Program&nbsp;(&ldquo;CPA&rdquo; Program) empowers&nbsp;end-users to verify the originality
or provenance of parts which have been marked by their suppliers with our SigNature DNA Markers.</FONT></P>

<P STYLE="font: 12pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri; margin: 0 0 0pt; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Plan of Operations</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>General</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">To date, the
substantial portion of our revenues have been generated from sales of our SigNature DNA platform and fiberTyping, our
principal anti-counterfeiting and product authentication solutions. We expect to continue to grow revenues from sales of our
SigNature DNA platform ingredient, including our Signature T DNA, fibertyping, DNAnet, Sentry, digitalDNA, and SmokeCloakDNA
offerings and the Counterfeit Prevention Authentication Program. We have limited sources of liquidity. We have developed or
are currently attempting to develop business in the following target markets: microcircuits and other electronics,
cash-in-transit (transport and storage of banknotes), textiles and apparel, automotive, printing and packaging, homeland
security, law enforcement and home asset marking, identity cards and other secure documents, industrial materials,
agrochemical, pharmaceuticals, consumer products, food and beverage, sports memorabilia, fine wine, and art and collectibles.
Our developments in the textile and apparel authentication, semiconductor authentication, and cash-in-transit have
contributed to the increase in our revenues. We intend to pursue both domestic and international sales opportunities in each
of these vertical markets.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Critical Accounting
Policies</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Financial Reporting
Release No. 60, published by the SEC, recommends that all companies include a discussion of critical accounting policies used
in the preparation of their financial statements. While all these significant accounting policies impact our financial condition
and results of operations, we view certain of these policies as critical. Policies determined to be critical are those policies
that have the most significant impact on our consolidated financial statements and require management to use a greater degree
of judgment and estimates. Actual results may differ from those estimates.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">We believe that given
current facts and circumstances, it is unlikely that applying any other reasonable judgments or estimate methodologies would cause
a material effect on our condensed consolidated results of operations, financial position or liquidity for the periods presented
in this report.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The accounting policies
identified as critical are as follows:</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&#9679;</FONT></TD>
    <TD STYLE="width: 97%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Revenue recognition;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&#9679;</FONT></TD>
    <TD STYLE="width: 97%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Equity based compensation;
    and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">&#9679;</FONT></TD>
    <TD STYLE="width: 97%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Fair value of financial
    instruments</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Revenue Recognition</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">We recognize revenue
in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;) 605, Revenue Recognition (&ldquo;ASC 605&rdquo;). ASC
605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement
exists; (2) delivery has occurred and/or service has been performed; (3) the selling price is fixed and determinable; and (4)
collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&rsquo;s judgments regarding
the fixed nature of the selling prices of the products delivered or services provided and the collectability of those amounts.
Provisions for allowances and other adjustments are provided for in the same period the related sales are recorded. We defer any
revenue for which the product has not been delivered, service has not been provided, or is subject to refund until such time that
we and the customer jointly determine that the product has been delivered, the service has been provided, or no refund will be
required. At June 30, 2015 and September 30, 2014, we recorded deferred revenue of $204,863 and $583,362, respectively.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 9; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Revenue arrangements
with multiple components are divided into separate units of accounting if certain criteria are met, including whether the delivered
component has stand-alone value to the customer. Consideration received is allocated among the separate units of accounting based
on their respective selling prices. The selling price for each unit is based on vendor-specific objective evidence, or VSOE, if
available, third party evidence if VSOE is not available, or estimated selling price if neither VSOE nor third party is available.
The applicable revenue recognition criteria are then applied to each of the units.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Revenue for government
contract awards, which supports our development efforts on specific projects, is recognized as milestones are achieved as per
the contract. We recognized revenue of approximately $657,708 and $1,919,031 from these contract awards during the three
and nine month periods ended June 30, 2015, respectively, and $0 and $50,000 for the three and nine month periods ended June 30,
2014, respectively.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt"><B><I>Equity Based Compensation</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">We follow ASC subtopic
718, Compensation (&ldquo;ASC 718&rdquo;) which requires all share-based payments to employees, including grants of employee stock
options, to be recognized in the statement of operations based on their fair values.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">We account for stock
based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services
rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement
date guidelines enumerated in&nbsp;ASC 505-50.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Fair Value of
Financial Instruments</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The valuation techniques
utilized are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources,
while unobservable inputs reflect internal market assumptions. These two types of inputs create the following fair value hierarchy:</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Level 1 &ndash; Quoted
prices in active markets for identical assets or liabilities.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Level 2 &ndash; Observable
inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not
active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of
the related asset or liabilities.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Level 3 &ndash; Unobservable
inputs that are supported by little or no market activity and that are significant to the fair value of assets or liabilities.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company utilizes
observable market inputs (quoted market prices) when measuring fair value whenever possible.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">For fair value measurements
categorized within Level 3 of the fair value hierarchy, the Company&rsquo;s accounting and finance department, who report to the
Chief Financial Officer, determine its valuation policies and procedures. The development and determination of the unobservable
inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company&rsquo;s accounting
and finance department and are approved by the Chief Financial Officer.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Use of Estimates</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">In preparing financial
statements in conformity with accounting principles generally accepted in the United States of America, management is required
to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent
assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results
could differ from those estimates.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt"><B>Comparison of Results of Operations for
the Three Month Periods Ended June 30, 2015 and 2014</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Revenues</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">For the three month
periods ended June 30, 2015 and 2014, we generated $2,267,671 and $841,197, respectively, in revenues. The increase in revenues
in the three month period ended June 30, 2015 of $1,426,474 or 170% was primarily from an increase in revenue related to sales
to the textile industry for protecting cotton supply chains of $1,200,000 and revenue from government contract awards of approximately
$658,000.&nbsp;&nbsp;&nbsp;These increases were offset by a decrease in revenue from suppliers of the United States Defense</FONT>
<FONT STYLE="font-size: 10pt">Logistics Agency (&ldquo;DLA&rdquo;) due to the consolidation of these individual contracts to one
contract with DLA.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Costs and Expenses</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Selling, General
and Administrative</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Selling, general and
administrative expenses for the three month period ended June 30, 2015 increased by $560,003 or 19% from $2,948,452 for the three
month period ended June 30, 2014 to $3,508,455 for the three month period ended June 30, 2015. The increase is attributable to
an increase in stock based compensation expense of $610,855, primarily associated with stock option modifications resulting from
the extension of certain stock options offset by a decrease of approximately $210,000 in legal fees as a result of the court&rsquo;s
dismissal of the SmartWater Limited litigation against us.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Research and
Development</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Research and development
expenses increased to $310,093 for the three month period ended June 30, 2015 from $266,331 for the three month period ended June
30, 2014, an increase of $43,762 or 16%.&nbsp; This increase is due to development costs incurred in relation to the two government
contracts offset by capitalized costs for the development of infield readers.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Depreciation
and Amortization</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">In the three month
period ended June 30, 2015, depreciation and amortization increased by $7,915 from $113,424 for the three month period ended June
30, 2014 to $121,339 for the three month period ended June 30, 2014.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Gain on Change
in Fair Value of Warrant Liability</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Gain from change in
fair value of warrant liability during the three month period ended June 30, 2014 was $515,543. This change in fair value related
to warrants containing certain reset provisions which required us to classify them as liabilities and mark the warrants to market
and record the change in fair value at each reporting period, and upon exercise as a non cash adjustment to our current period
operations. As discussed in Note E of the accompanying condensed consolidated financial statements, on November 21, 2014, we repurchased
the remaining outstanding Series B Warrants.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Comparison of Results
of Operations for the Nine Month Periods Ended June 30, 2015 and 2014</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Revenues</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt">For the nine month periods ended June, 30,
2015 and 2014, we generated $5,028,234 and $2,075,698, respectively, in revenues.&nbsp;&nbsp;The increase in revenues of $2,952,536
or 142% was primarily due to an increase in sales from two government contract awards of approximately $1.9 million as well as
revenues related to the set up, marking, and authentication of cotton of $1,372,500. These increases were
offset by a decrease in revenue from suppliers of the United States Defense Logistics Agency (&ldquo;DLA&rdquo;) due to the consolidation
of these individual contracts to one contract with DLA.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Costs and Expenses</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Selling, General
and Administrative</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Selling, general and
administrative expenses for the nine month period ended June 30, 2015 increased by $984,774 or 10% from $10,093,631 for the nine
month period ended June 30, 2014 to $11,078,405 for the nine month period ended June 30, 2015. The increase is primarily attributable
to an increase in stock based compensation expense of approximately $1,813,000, attributable to grants to employees that vested
immediately, as well as stock based compensation expense associated with stock option modifications resulting from the extension
of certain stock options, and to a lesser extent, the acceleration of vesting terms.&nbsp; This increase was primarily offset
by decreases in legal and consulting expenses. Legal expenses decreased by $783,000 due to the court&rsquo;s dismissal of the
SmartWater Limited litigation against us. Consulting fees decreased by $238,000 primarily due to shares of common stock issued
to a business strategy consultant in settlement of their fees during the nine month period ended June 30, 2014. The remaining
variance is due to increases in payroll offset by decreases in filing fees during the nine month period ended June 30, 2015.</FONT></P>

<P STYLE="font: 12pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Research and
Development</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Research and development
expenses decreased to $961,745 for the nine month period ended June 30, 2015 from $1,085,416 for the nine month period ended June
30, 2014.&nbsp;&nbsp;The decrease of $123,671 or 11% is attributable to purchases for laboratory equipment associated with the
corporate headquarters in the prior year as well as components purchased relating to a pilot program for the marking of cotton
during the prior period, which we did not incur during the nine month period ended June 30, 2015. Also, during the nine month
period ended June 30, 2015, we started capitalizing the costs for the development of infield readers, which were being expensed
during the same period in the prior year.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 12; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt/0.05pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Depreciation
and Amortization</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Depreciation and amortization
increased by $28,696 from $325,448 for the nine month period ended June 30, 2014 to $354,144 for the nine month period ended June
30, 2015. This increase is related to the depreciation incurred on the fixed asset additions during the period.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Loss from Change
in Fair Value of Warrant Liability</I></B></FONT></P>

<P STYLE="font: 12pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Loss from change in
fair value of warrant liability during the nine month periods ended June 30, 2015 and 2014 was $2,994,540 and $1,663,316, respectively.&nbsp;&nbsp;These
losses relate to warrants containing certain reset provisions which required us to classify them as liabilities and mark the warrants
to market and record the change in fair value at each reporting period as a non-cash adjustment to our current period operations.&nbsp;&nbsp;As
discussed in Note E of the accompanying condensed consolidated financial statements, on November 21, 2014, we repurchased the
remaining outstanding Series B Warrants.</FONT></P>

<P STYLE="font: 12pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Liquidity and Capital
Resources</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Our liquidity needs
consist of our working capital requirements and research and development expenditure funding. As of June 30, 2015, we had working
capital of $11,394,253. For the nine month period ended June 30, 2015, we generated a net cash flow deficit from operating activities
of $5,226,713 consisting primarily of our loss of $11,385,102 net with non-cash adjustments of $354,144 in depreciation
and amortization charges, $3,531,205 for stock-based compensation, $2,994,540 change in fair value of warrant liability, $980,842
in loss on the conversion of promissory notes, $64,426 in common stock issued for consulting services and $21,750 of bad
debt expense. Additionally, we had a net increase in operating assets of $1,334,504 and a net decrease in operating liabilities
of $454,014. Cash used in investing activities was $459,471 for the purchase of property, plant and equipment and intangible assets.
Cash provided by financing activities was $15,023,466 in net proceeds from the sale of common stock and warrants related
to the underwritten public offering offset by the repurchase and cancellation of the remaining Series B Warrants.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 13; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company has recurring
net losses, which have resulted in an accumulated deficit of $211,145,374 as of June 30, 2015. At June 30, 2015 the Company had
cash and cash equivalents of $10,730,144. The Company&rsquo;s current capital resources include cash and cash equivalents, accounts
receivable and prepaid expenses. Historically, the Company has financed its operations principally from the sale of equity securities.
On April 1, 2015, the Company closed on an underwritten public offering of common stock and warrants for gross proceeds of $12.0
million, before deducting underwriting discounts and offering expenses. Subsequently on April 30, 2015,<SUP> </SUP>the Company
closed on the over-allotment option of the underwritten public offering for additional gross proceeds of $263,950. In addition,
on November 20, 2014 the Company closed its underwritten public offering of common stock and warrants for gross proceeds of $9.3
million before deducting underwriting discounts and offering expenses. The Company utilized approximately $4,091,000 of the gross
proceeds to repurchase the remaining Series B Warrants from Crede, as discussed in Note E.&nbsp;&nbsp;The Company also raised
$2,156,264 in a private placement of common stock and warrants and $1,800,000 in promissory notes during the fiscal year ended
September 30, 2014, including $1,000,000 from a related party.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company expects
to finance operations primarily through cash flows provided by operating activities provided that it will achieve a sufficient
level of future revenues. The Company estimates that its cash and cash equivalents are sufficient to fund operations for the next
twelve months.&nbsp;The Company will require additional funds to complete the continued development of its products, product manufacturing,
and to fund expected additional losses from operations, until revenues are sufficient to cover the Company&rsquo;s operating expenses.&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">We expect capital expenditures
to be less than $980,000 in fiscal 2015. Our primary investments will be in laboratory equipment to support prototyping, manufacturing,
our authentication services, and outside services for our detector and reader development.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">All of the real property
used in our business is leased under operating lease agreements.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Subsequent Events</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Product Research
and Development</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">We anticipate spending
approximately $1,500,000 for product research and development activities during the next twelve months.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Acquisition of Plant
and Equipment and Other Assets</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">We do not anticipate
the sale of any material property, plant or equipment during the next twelve months.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 14; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Number of Employees</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/115% Times New Roman; margin: 0 0 10pt"><FONT STYLE="font-size: 10pt">We currently have forty-nine full-time
employees and nine part-time employees, including four in management, eleven in research and development, one in Life Sciences,
two in forensics, six in quality assurance/compliance, four in finance and accounting, five in operations, thirteen in sales and
marketing, one in human resources, five in shared services, three in information services, one in investor relations, one legal
(Intellectual Property) and one in product development. We expect to increase our staffing dedicated to sales, production and
formulation. Marketing, salaries, and general overhead will be increased as necessary. However, cost containment measures have
been put in place to monitor expenses. In order for us to attract and retain quality personnel, we anticipate we will continue
to offer competitive salaries and benefits to future employees. We anticipate that it may become desirable to add additional full
and or part time employees to discharge certain critical functions during the next twelve months. This projected increase in personnel
is dependent upon our ability to generate revenues and obtain sources of financing. There is no guarantee that we will be successful
in raising the funds required or generating revenues sufficient to fund the projected increase in the number of employees. As
we continue to expand, we will incur additional costs for personnel. We continue to work with Insperity Inc. to help us manage
many of our back-end administrative human resources and payroll responsibilities.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Off-Balance Sheet
Arrangements</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">We do not have any
off-balance sheet arrangements.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Inflation</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The effect of inflation
on our revenue and operating results was not significant.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a004_v1"></A>Item 3</B>. <B>-
Quantitative and Qualitative Disclosures About Market Risk</B>.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">There&nbsp;&nbsp;have
been no material changes in our market risk as previously disclosed under Part I, Item 3 of our Annual Report on Form 10-K, for
the fiscal year ended September 30, 2014.&nbsp;&nbsp;Please refer to the Company&rsquo;s Annual Report on Form 10-K (filed with
the SEC on December 15, 2014, as amended on March 6, 2015) for the fiscal year ended September 30, 2014.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 15; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a005_v1"></A>Item 4. - Controls and</B> <B>Procedures</B>.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Evaluation of
Disclosure Controls and Procedures</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">As of the end of the
period covered by this Quarterly Report on Form 10-Q, we conducted an evaluation, under the supervision and with the participation
of our management, including our Chief Executive Officer and Chief Financial Officer, of our disclosure controls and procedures
(as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on the evaluation of these disclosure controls and
procedures,&nbsp;the Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2015, our disclosure controls
and procedures were&nbsp;effective to ensure that the information required to be disclosed by us in reports that we file or submit
under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&rsquo;s rules
and forms.</FONT></P>

<P STYLE="font: 12pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Changes in Internal
Control over Financial Reporting</I></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">During the fiscal quarter
ended June 30, 2015, there were no changes in our internal control over financial reporting that have materially affected, or
are reasonably likely to materially affect, our internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a006_v1"></A>Part II - Other Information</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a007_v1"></A>Item 1. - Legal
Proceedings.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a008_v1"></A>Item 1A. &ndash;
Risk Factors.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Before deciding to
invest in us or to maintain or increase your investment, you should carefully consider the risks and uncertainties described in
the first two paragraphs under &ldquo;Item 2. Management&rsquo;s Discussion and Analysis of Financial Condition and Results of
Operations&rdquo;&nbsp;of this report and our other filings with the SEC, for the period ended September 30, 2014 and thereafter.
The risks and uncertainties described in this report are not the only ones facing us. Additional risks and uncertainties not presently
known to us or that we currently deem immaterial may also affect us. If any of these risks actually materialize, our business,
financial position, results of operations and cash flows could be adversely impacted. In that event, the market price of our common
stock could decline and you may lose all or part of your investment.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">During the&nbsp;three
month period ended June 30, 2015, there have been no material changes in our risk factors previously disclosed in our Annual Report
on Form 10-K (as amended March 6, 2015) for the fiscal year ended September 30, 2014.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a009_v1"></A>Item 2. - Unregistered
Sales of Equity Securities and Use of Proceeds.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">On February 27,
2015, we issued 2,500 shares of our common stock, and on each of March 31, 2015, April 30, 2015, May 29, 2015 and June 30, 2015
we issued 5,000 shares of our common stock, aggregating 22,500 shares, to a consultant for services provided pursuant to our 2005
Incentive Stock Plan. The shares were issued pursuant to an exemption from registration under the Securities Act of 1933, as amended,
by virtue of Section 4(a)(2) and/or Regulation D promulgated thereunder as a transaction not involving a public offering.</FONT></P>

<P STYLE="font: 12pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a010_v1"></A>Item 3. &ndash;
Defaults Upon Senior Securities.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a011_v1"></A>Item 4. &ndash;
Mine Safety Disclosures.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a012_v1"></A>Item 5. &ndash;
Other Information.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">None.&nbsp;</FONT></P>

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 17; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="t82897a013_v1"></A>Item 6. &ndash;
Exhibits.</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">31.1*</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Certification
    of Chief Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of
    1934, as amended</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">31.2*</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Certification
    of Chief Financial Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of
    1934, as amended</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">32.1**</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Certification
    pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive
    Officer)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">32.2**</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Certification
    pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Financial
    Officer)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">101 INS*</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">XBRL Instance Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">101 SCH*</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">XBRL Taxonomy Extension Schema
    Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">101 CAL*</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">XBRL Taxonomy Extension Calculation
    Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">101 LAB*</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">XBRL Extension Label Linkbase
    Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">101 PRE*</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">XBRL Taxonomy Extension Presentation
    Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">* Filed herewith.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">** Furnished herewith.</FONT></P>

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 18; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Signatures</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">In accordance with
the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 48%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman"><B>Applied DNA Sciences, Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Dated: August 10, 2015</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">/s/
    JAMES A. HAYWARD, Ph. D.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">James A. Hayward, Ph. D.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman"><I>Chief Executive Officer</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman"><I>(Duly authorized officer and
    principal executive officer)</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1px solid; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">/s/
    BETH JANTZEN</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman">Beth Jantzen, CPA</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman"><I>Chief Financial Officer</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman"><I>(Duly authorized officer and</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman"><I>principal financial and accounting
    officer)</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 19; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>t82897_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 8.5pt 0 0; text-align: right"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 1pt Times New Roman,serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; border-top: Black 2px solid"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit 31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>CERTIFICATION PURSUANT
TO RULE 13 a -14(a) OR 15 d -14(a) OF THE SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SARBANES-OXLEY ACT
OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="font-size: 10pt">I, James A. Hayward, certify that:</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">1.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">I
    have reviewed this quarterly report on Form 10-Q of Applied DNA Sciences, Inc.;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">2.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
    to the period covered by this report;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">3.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
    material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
    presented in this report;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">4.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">The
    registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
    procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
    in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">a.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to
    us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">b.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
    our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
    statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">c.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
    on such evaluation; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">d.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
    affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting;
    and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">5.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">The
    registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
    over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors
    (or persons performing the equivalent functions):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">a.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">all significant
    deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
    likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">b.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">any fraud,
    whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dated:
    August 10, 2015</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">By:&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1px solid; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">/s/
    JAMES A. HAYWARD</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">James
    A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Chief Executive
    Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Applied DNA
    Sciences, Inc.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>t82897_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 1pt Times New Roman,serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; border-top: Black 2px solid"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit 31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>CERTIFICATION PURSUANT
TO RULE 13 a -14(a) OR 15 d -14(a) OF THE SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SARBANES-OXLEY ACT
OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="font-size: 10pt">I, Beth Jantzen, certify that:</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">1.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">I
    have reviewed this quarterly report on Form 10-Q of Applied DNA Sciences, Inc.;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">2.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
    to the period covered by this report;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">3.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
    material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
    presented in this report;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">4.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">The
    registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
    procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
    in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">a.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to
    us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">b.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
    our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
    statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">c.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
    on such evaluation; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">d.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter&nbsp; (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
    affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting;
    and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">5.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">The
    registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
    over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors
    (or persons performing the equivalent functions):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">a.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">all significant
    deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
    likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">b.</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">any fraud,
    whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dated:
    August 10, 2015</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">By:&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1px solid; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">/s/
    BETH JANTZEN</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Beth
    Jantzen, CPA</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Chief Financial
    Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Applied DNA
    Sciences, Inc.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>t82897_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 1pt Times New Roman,serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; border-top: Black 2px solid"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit 32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>CERTIFICATION PURSUANT
TO 18 U.S.C. 1350, AS ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.35in"><FONT STYLE="font-size: 10pt">The
undersigned, James A. Hayward, Chief Executive Officer of Applied DNA Sciences, Inc. (the &ldquo;Company&rdquo;), in connection
with the Company&rsquo;s Quarterly Report on Form 10-Q for the period ended June 30, 2015 (the &ldquo;Report&rdquo;), as filed
with the Securities and Exchange Commission on the date hereof, hereby certifies pursuant to the requirements of 18 U.S.C. 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; text-align: justify; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">the
    Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934,
    as amended, and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; text-align: justify; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">the
    information in the Report fairly presents, in all material respects, the financial condition and results of operations of
    the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.35in"><FONT STYLE="font-size: 10pt">This
certification is being provided pursuant to 18 U.S.C. 1350 and is not to be deemed a part of the Report, nor is it to be deemed
to be &ldquo;filed&rdquo; for any purpose whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">By:&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">/s/
    JAMES A. HAYWARD</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">James
    A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Chief Executive
    Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Applied DNA
    Sciences, Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Dated: August
    10, 2015</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>t82897_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 1pt Times New Roman,serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; border-top: Black 2px solid"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit 32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>CERTIFICATION PURSUANT
TO 18 U.S.C. 1350, AS ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.35in"><FONT STYLE="font-size: 10pt">The
undersigned, Beth Jantzen, Chief Financial Officer of Applied DNA Sciences, Inc. (the &ldquo;Company&rdquo;), in connection with
the Company&rsquo;s Quarterly Report on Form 10-Q for the period ended June 30, 2015 (the &ldquo;Report&rdquo;), as filed with
the Securities and Exchange Commission on the date hereof, hereby certifies pursuant to the requirements of 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">&#9679;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 2.4pt; text-align: justify; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">the
    Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934,
    as amended, and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; text-align: justify; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">the
    information in the Report fairly presents, in all material respects, the financial condition and results of operations of
    the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.35in"><FONT STYLE="font-size: 10pt">This
certification is being provided pursuant to 18 U.S.C. 1350 and is not to be deemed a part of the Report, nor is it to be deemed
to be &ldquo;filed&rdquo; for any purpose whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">By:&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1px solid; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">/s/
    BETH JANTZEN</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Beth
    Jantzen, CPA</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Chief Financial
    Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Applied DNA
    Sciences, Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-family: Calibri,sans-serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 2.4pt; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Dated: August
    10, 2015</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>apdn-20150630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated using Ez-XBRL version 7.3.0.6 [08/05/2015 09:13:05 PM] -->
<!-- Based on XBRL 2.1 -->
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.4 on Saturday, August 08, 2015 03:40:14 AM -->
<xbrli:xbrl xmlns:apdn="http://www.adnas.com/20150630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2015-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr">
<link:schemaRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:type="simple" xlink:href="apdn-20150630.xsd"/>
<!-- Context Section  -->
<xbrli:context id="Context_Custom_01_Jun_2013T00_00_00_TO_15_Jun_2013T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-06-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-15
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_16_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:CredeCgIIILtdMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-16
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:CredeCgIIILtdMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-12-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-16
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:CredeCgIIILtdMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">apdn:SeriesWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-12-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-16
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_LegalEntityAxis_CredeCgIIILtdMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">apdn:SeriesBWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:CredeCgIIILtdMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-12-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-16
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_21_Jun_2014T00_00_00_TO_21_Jun_2014T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember_AgreementAxis_EmploymentAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="apdn:AgreementAxis">apdn:EmploymentAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-06-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-04-01
</xbrli:startDate>
<xbrli:endDate>
2014-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-10-01
</xbrli:startDate>
<xbrli:endDate>
2014-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-10-01
</xbrli:startDate>
<xbrli:endDate>
2014-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_11_Sep_2014T00_00_00_TO_11_Sep_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-11
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_11_Sep_2014T00_00_00_TO_11_Sep_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_PresidentChairmanAndChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">apdn:PresidentChairmanAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-11
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_11_Sep_2014T00_00_00_TO_11_Sep_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_AnotherIndividualMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">apdn:AnotherIndividualMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-11
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Oct_2013T00_00_00_TO_30_Sep_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-10-01
</xbrli:startDate>
<xbrli:endDate>
2014-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_24_Oct_2014T00_00_00_TO_24_Oct_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-10-24
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Oct_2014T00_00_00_TO_24_Oct_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-01
</xbrli:startDate>
<xbrli:endDate>
2014-10-24
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_28_Oct_2014T00_00_00_TO_28_Oct_2014T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_AgreementAxis_WarrantRepurchaseOptionAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:CredeCgIIILtdMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">apdn:SeriesBWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="apdn:AgreementAxis">apdn:WarrantRepurchaseOptionAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-10-28
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Oct_2014T00_00_00_TO_28_Oct_2014T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_AgreementAxis_WarrantRepurchaseOptionAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:CredeCgIIILtdMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">apdn:SeriesBWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="apdn:AgreementAxis">apdn:WarrantRepurchaseOptionAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-01
</xbrli:startDate>
<xbrli:endDate>
2014-10-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Oct_2014T00_00_00_TO_28_Oct_2014T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_AgreementAxis_WarrantRepurchaseOptionAgreementMember_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:CredeCgIIILtdMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">apdn:SeriesBWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="apdn:AgreementAxis">apdn:WarrantRepurchaseOptionAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-01
</xbrli:startDate>
<xbrli:endDate>
2014-10-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Oct_2014T00_00_00_TO_28_Oct_2014T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_AgreementAxis_WarrantRepurchaseOptionAgreementMember_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:CredeCgIIILtdMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">apdn:SeriesBWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="apdn:AgreementAxis">apdn:WarrantRepurchaseOptionAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-01
</xbrli:startDate>
<xbrli:endDate>
2014-10-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="Context_As_Of_11_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-11-11
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_11_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_PresidentChairmanAndChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">apdn:PresidentChairmanAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-11-11
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_11_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_AnotherIndividualMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">apdn:AnotherIndividualMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-11-11
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_PresidentChairmanAndChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">apdn:PresidentChairmanAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-11-01
</xbrli:startDate>
<xbrli:endDate>
2014-11-11
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_AnotherIndividualMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">apdn:AnotherIndividualMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-11-01
</xbrli:startDate>
<xbrli:endDate>
2014-11-11
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_20_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-11-20
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-11-01
</xbrli:startDate>
<xbrli:endDate>
2014-11-20
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Dec_2014T00_00_00_TO_19_Dec_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-12-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-19
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Dec_2014T00_00_00_TO_30_Dec_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-12-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_21_Jan_2015T00_00_00_TO_21_Jan_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">apdn:IncentiveStockPlan2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-01-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_01_Apr_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">apdn:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-04-01
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_01_Apr_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember_LegalEntityAxis_UnderwritersMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">apdn:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:UnderwritersMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-04-01
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-03-31
</xbrli:startDate>
<xbrli:endDate>
2015-04-01
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">apdn:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-03-31
</xbrli:startDate>
<xbrli:endDate>
2015-04-01
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember_LegalEntityAxis_UnderwritersMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">apdn:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:UnderwritersMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-03-31
</xbrli:startDate>
<xbrli:endDate>
2015-04-01
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_02_Apr_2015T00_00_00_TO_30_Apr_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-04-02
</xbrli:startDate>
<xbrli:endDate>
2015-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_02_Apr_2015T00_00_00_TO_30_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">apdn:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-04-02
</xbrli:startDate>
<xbrli:endDate>
2015-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-04-02
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_EmployeesConsultantsAndNon-EmployeeBoardOfDirectorMembersMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">apdn:EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-04-02
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_SalesMember_MajorCustomersAxis_TwoCustomersConcentrationRiskMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">apdn:TwoCustomersConcentrationRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-04-02
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">apdn:IncentiveStockPlan2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_EmployeesConsultantsAndNon-EmployeeBoardOfDirectorMembersMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">apdn:EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_SalesMember_MajorCustomersAxis_TwoCustomersConcentrationRiskMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">apdn:TwoCustomersConcentrationRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_TwoCustomersConcentrationRiskMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">apdn:TwoCustomersConcentrationRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_01-Jan-2015T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember_AgreementAxis_EmploymentAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>

<xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="apdn:AgreementAxis">apdn:EmploymentAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2015-01-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">apdn:IncentiveStockPlan2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_06_Aug_2015T00_00_00_TO_06_Aug_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-08-06
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_01_Oct_2013T00_00_00_TO_30_Sep_2013T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_01_Oct_2013T00_00_00_TO_30_Sep_2013T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_01_Oct_2014T00_00_00_TO_30_Sep_2014T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_01_Oct_2014T00_00_00_TO_30_Sep_2014T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">apdn:IncentiveStockPlan2005Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<!-- Unit Section  -->
<!--
I~1\FVPHexeD5678YReqi>MrlsywiI~\FVP6459c444c555cT{h>EF847:;;1665818J981=E=H17<86=<G=F4=: -->
<xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="Customer"><xbrli:measure>apdn:Customer</xbrli:measure></xbrli:unit>
<xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit>
<!-- Element Section  --><dei:EntityRegistrantName contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">APPLIED DNA SCIENCES INC</dei:EntityRegistrantName>
<dei:EntityCentralIndexKey contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">0000744452</dei:EntityCentralIndexKey>
<dei:TradingSymbol contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">apdn</dei:TradingSymbol>
<dei:CurrentFiscalYearEndDate contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">--09-30</dei:CurrentFiscalYearEndDate>
<dei:EntityFilerCategory contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">Accelerated Filer</dei:EntityFilerCategory>
<dei:EntityCommonStockSharesOutstanding contextRef="Context_As_Of_06_Aug_2015T00_00_00_TO_06_Aug_2015T00_00_00" unitRef="shares" decimals="INF">21487202</dei:EntityCommonStockSharesOutstanding>
<dei:DocumentType contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">10-Q</dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">2015-06-30</dei:DocumentPeriodEndDate>
<dei:AmendmentFlag contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">false</dei:AmendmentFlag>
<dei:DocumentFiscalYearFocus contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">2015</dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">Q3</dei:DocumentFiscalPeriodFocus>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1393132</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">10730144</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_01_Oct_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">6360301</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">2025716</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">834818</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">2077756</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">135365</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">209831</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">2363315</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">13017731</us-gaap:AssetsCurrent>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">576128</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">526816</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:DepositsAssetsNoncurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">57638</us-gaap:DepositsAssetsNoncurrent>
<us-gaap:DepositsAssetsNoncurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">52988</us-gaap:DepositsAssetsNoncurrent>
<us-gaap:DeferredCosts contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">181104</us-gaap:DeferredCosts>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">327872</us-gaap:FiniteLivedIntangibleAssetsNet>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">525902</us-gaap:FiniteLivedIntangibleAssetsNet>
<us-gaap:Assets contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">3506057</us-gaap:Assets>
<us-gaap:Assets contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">14123437</us-gaap:Assets>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1494759</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1418615</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1800000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">583362</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">204863</us-gaap:DeferredRevenueCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">3878121</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1623478</us-gaap:LiabilitiesCurrent>
<apdn:WarrantLiabilityNoncurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1096412</apdn:WarrantLiabilityNoncurrent>
<us-gaap:Liabilities contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">4974533</us-gaap:Liabilities>
<us-gaap:Liabilities contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1623478</us-gaap:Liabilities>
<us-gaap:CommitmentsAndContingencies contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:CommitmentsAndContingencies contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:CommonStockValue contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">13937</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">21483</us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">198277859</us-gaap:AdditionalPaidInCapitalCommonStock>
<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">223623850</us-gaap:AdditionalPaidInCapitalCommonStock>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">-199760272</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-211145374</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">-1468476</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">12499959</us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">3506057</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">14123437</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">9634</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">30228</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">759087</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">743914</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">256208</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">325555</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">6597</us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent>
<us-gaap:DebtInstrumentFaceAmount contextRef="Context_As_Of_11_Sep_2014T00_00_00_TO_11_Sep_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember" unitRef="USD" decimals="0">1800000</us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentFaceAmount contextRef="Context_As_Of_11_Sep_2014T00_00_00_TO_11_Sep_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_PresidentChairmanAndChiefExecutiveOfficerMember" unitRef="USD" decimals="0">1000000</us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentFaceAmount contextRef="Context_As_Of_11_Sep_2014T00_00_00_TO_11_Sep_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_AnotherIndividualMember" unitRef="USD" decimals="0">800000</us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentFaceAmount contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1000000</us-gaap:DebtInstrumentFaceAmount>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_24_Oct_2014T00_00_00_TO_24_Oct_2014T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="shares" decimals="INF">1350000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="shares" decimals="INF">13935954</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">21482202</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="shares" decimals="INF">13935954</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">21482202</us-gaap:CommonStockSharesOutstanding>
<us-gaap:SalesRevenueNet contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">841197</us-gaap:SalesRevenueNet>
<us-gaap:SalesRevenueNet contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">2075698</us-gaap:SalesRevenueNet>
<us-gaap:SalesRevenueNet contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">2267671</us-gaap:SalesRevenueNet>
<us-gaap:SalesRevenueNet contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">5028234</us-gaap:SalesRevenueNet>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">2948452</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">10093631</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">3508455</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">11078405</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">266331</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">1085416</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">310093</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">961745</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:DepreciationAndAmortization contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">113424</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">325448</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">121339</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">354144</us-gaap:DepreciationAndAmortization>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">3328207</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">11504495</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">3939887</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">12394294</us-gaap:OperatingExpenses>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-2487010</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-9428797</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-1672216</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-7366060</us-gaap:OperatingIncomeLoss>
<us-gaap:InterestIncomeExpenseNet contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">111</us-gaap:InterestIncomeExpenseNet>
<us-gaap:InterestIncomeExpenseNet contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">784</us-gaap:InterestIncomeExpenseNet>
<us-gaap:InterestIncomeExpenseNet contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">5052</us-gaap:InterestIncomeExpenseNet>
<us-gaap:InterestIncomeExpenseNet contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-26807</us-gaap:InterestIncomeExpenseNet>
<us-gaap:OtherNonoperatingIncomeExpense contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">52299</us-gaap:OtherNonoperatingIncomeExpense>
<us-gaap:OtherNonoperatingIncomeExpense contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">130186</us-gaap:OtherNonoperatingIncomeExpense>
<us-gaap:OtherNonoperatingIncomeExpense contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-3718</us-gaap:OtherNonoperatingIncomeExpense>
<us-gaap:OtherNonoperatingIncomeExpense contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-16853</us-gaap:OtherNonoperatingIncomeExpense>
<apdn:LossOnConversionOfPromissoryNotes contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-980842</apdn:LossOnConversionOfPromissoryNotes>
<apdn:IncomeLossFromChangeInFairValueOfWarrantLiability contextRef="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember" unitRef="USD" decimals="0">-1288752</apdn:IncomeLossFromChangeInFairValueOfWarrantLiability>
<apdn:IncomeLossFromChangeInFairValueOfWarrantLiability contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">515543</apdn:IncomeLossFromChangeInFairValueOfWarrantLiability>
<apdn:IncomeLossFromChangeInFairValueOfWarrantLiability contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-1663316</apdn:IncomeLossFromChangeInFairValueOfWarrantLiability>
<apdn:IncomeLossFromChangeInFairValueOfWarrantLiability contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-2994540</apdn:IncomeLossFromChangeInFairValueOfWarrantLiability>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-1919057</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-10961143</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-1670882</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-11385102</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-1919057</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-10961143</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-1670882</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-11385102</us-gaap:NetIncomeLoss>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD_per_Share" decimals="2">-0.14</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD_per_Share" decimals="2">-0.82</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">-0.08</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">-0.63</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="shares" decimals="0">13569262</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="shares" decimals="0">13400540</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="0">21444335</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="0">18075506</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:DepreciationDepletionAndAmortization contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">325448</us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">354144</us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">404507</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">1717837</us-gaap:ShareBasedCompensation>

<us-gaap:ShareBasedCompensation contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1015361</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">3531205</us-gaap:ShareBasedCompensation>
<apdn:CommonStockIssuedForConsultingServices contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">337500</apdn:CommonStockIssuedForConsultingServices>
<apdn:CommonStockIssuedForConsultingServices contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">64426</apdn:CommonStockIssuedForConsultingServices>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">16878</us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">21750</us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-137486</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1275189</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">924</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">59315</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">292462</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-75515</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">200121</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-378499</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-6271019</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-5226713</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">209522</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">221659</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquireIntangibleAssets contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">238082</us-gaap:PaymentsToAcquireIntangibleAssets>
<us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-209522</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-459741</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
<apdn:NetProceedsFromSaleOfCommonStockAndWarrants contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">2145956</apdn:NetProceedsFromSaleOfCommonStockAndWarrants>
<apdn:NetProceedsFromSaleOfCommonStockAndWarrants contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="USD" decimals="-4">3690000</apdn:NetProceedsFromSaleOfCommonStockAndWarrants>
<apdn:NetProceedsFromSaleOfCommonStockAndWarrants contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">19114418</apdn:NetProceedsFromSaleOfCommonStockAndWarrants>
<apdn:PurchaseAndCancelationOfPreviouslyIssuedWarrants contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">4090952</apdn:PurchaseAndCancelationOfPreviouslyIssuedWarrants>
<us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">2145956</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">15023466</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-4334585</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">9337012</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:InterestPaid contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:InterestPaid contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxesPaid contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxesPaid contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<apdn:CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">19570</apdn:CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants>
<apdn:ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">181104</apdn:ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital>
<apdn:DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">68489</apdn:DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities>
<apdn:PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">13825</apdn:PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable>
<apdn:IntangibleAssetsAcquiredIncludedInAccountsPayable contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">29296</apdn:IntangibleAssetsAcquiredIncludedInAccountsPayable>
<us-gaap:StockIssued1 contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1843750</us-gaap:StockIssued1>
<us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;b&gt;NOTE A &amp;#8212; SUMMARY OF ACCOUNTING POLICIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;General&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The accompanying condensed consolidated financial statements as of June 30, 2015 and for the three and nine month periods ended June 30, 2015 and 2014 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&amp;#8220;GAAP&amp;#8221;) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month periods ended June 30, 2015 are not necessarily indicative of the results that may be expected for the fiscal year ending September 30, 2015. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended September 30, 2014 and footnotes thereto included in the Annual Report on Form 10-K, as amended, of Applied DNA Sciences, Inc. (the &amp;#8220;Company&amp;#8221;) filed with the SEC.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The condensed consolidated balance sheet as of September 30, 2014 contained herein has been derived from the audited consolidated financial statements as of September 30, 2014, but does not include all disclosures required by GAAP.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;All warrant, option, share, and per share information in the condensed consolidated financial statements gives retroactive effect to the one-for-60 reverse stock split of the Company&amp;#8217;s common stock, par value $.001 per share, that was effected on October 29, 2014. See Note G.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Business and Basis of Presentation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;On September 16, 2002, the Company was incorporated under the laws of the State of Nevada. Effective December 17, 2008, the Company reincorporated from the State of Nevada to the State of Delaware. The Company is principally devoted to developing DNA embedded biotechnology security solutions in the United States and Europe. To date, the Company has had a limited operating history, and as a result, its operations have produced limited recurring revenues from its services and products; it has incurred expenses and has sustained losses. Consequently, its operations are subject to all the risks inherent in the establishment of a biotechnology company. For the period from inception through June 30, 2015, the Company has accumulated losses of $211,145,374.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, APDN (B.V.I.) Inc. and Applied DNA Sciences Europe Limited, which currently have no operations or activity. Significant inter-company transactions and balances have been eliminated in consolidation.&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company recognizes revenue in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 605, Revenue Recognition (&amp;#8220;ASC 605&amp;#8221;). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred and/or service has been performed; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&amp;#8217;s judgments regarding the fixed nature of the selling prices of the products delivered or services provided and the collectability of those amounts. Provisions for allowances and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered, service has not been provided, or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered, the service has been provided, or no refund will be required. At June 30, 2015 and September 30, 2014, the Company recorded deferred revenue of $204,863 and $583,362, respectively.&lt;/font&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Revenue arrangements with multiple components are divided into separate units of accounting if certain criteria are met, including whether the delivered component has stand-alone value to the customer. Consideration received is allocated among the separate units of accounting based on their respective selling prices. The selling price for each unit is based on vendor-specific objective evidence, or VSOE, if available, third party evidence if VSOE is not available, or estimated selling price if neither VSOE nor third party is available. The applicable revenue recognition criteria are then applied to each of the units.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Revenue for government contract awards, which supports the Company&amp;#8217;s development efforts on specific projects, is recognized as milestones are achieved as per the contract. The Company recognized revenue of approximately $657,708 and $1,919,031 from these contract awards during the three and nine month periods ended June 30, 2015 and $0 and $50,000 for the three and nine month periods ended June 30, 2014, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Net Loss Per Share&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company presents loss per share utilizing a dual presentation of basic and diluted loss per share. Basic loss per share includes no dilution and has been calculated based upon the weighted average number of common shares outstanding during the period. Dilutive common stock equivalents consist of shares issuable upon the exercise of the Company&amp;#8217;s stock options and warrants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;For the three and nine month periods ended June 30, 2015 and 2014, common stock equivalent shares are excluded from the computation of the diluted loss per share as their effect would be anti-dilutive.&lt;/font&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;/p&gt;
&lt;p style="text-align: center; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Securities that could potentially dilute basic net income per share in the future that were not included in the computation of diluted net loss per share because including those securities would have been anti-dilutive for the three and nine month periods ended&amp;#160;June 30, 2015 and 2014 are as follows:&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="3"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="3"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f7ffff; vertical-align: bottom;"&gt;
&lt;td style="width: 785px;"&gt;Warrants&lt;/td&gt;
&lt;td style="width: 46px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 15px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 157px;"&gt;6,062,487&lt;/td&gt;
&lt;td style="text-align: left; width: 15px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 46px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 15px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 158px;"&gt;240,439&lt;/td&gt;
&lt;td style="text-align: left; width: 16px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;Employee options&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;"&gt;3,456,989&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;"&gt;2,073,043&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f7ffff; vertical-align: bottom;"&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;"&gt;9,519,476&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;"&gt;2,313,482&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Stock Based Compensation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (&amp;#8220;ASC 718&amp;#8221;). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee&amp;#8217;s requisite service period (generally the vesting period of the equity grant). The fair value of the Company&amp;#8217;s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718, excess tax benefits realized from the exercise of stock-based awards are classified in cash flows from financing activities. The future realization of the reserved deferred tax assets related to these tax benefits associated with the exercise of stock options will result in a credit to additional paid in capital if the related tax deduction reduces taxes payable. The Company has elected the &amp;#8220;with and without approach&amp;#8221; regarding ordering of windfall tax benefits to determine whether the windfall tax benefit did reduce taxes payable in the current year. Under this approach, the windfall tax benefit would be recognized in additional paid-in-capital only if an incremental tax benefit is realized after considering all other benefits presently available.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company accounts for stock based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in&amp;#160;ASC 505-50.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Concentrations&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company&amp;#8217;s revenues earned from sale of products and services for the three and nine month periods ended June 30, 2015 included an aggregate of 87% and 73%, respectively, from two customers of the Company&amp;#8217;s total revenues. These two customers accounted for approximately 89% of the Company&amp;#8217;s total accounts receivable at June 30, 2015.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company&amp;#8217;s revenues earned from sale of products and services for the three month period ended June 30, 2014 included an aggregate of 10% from one customer of the Company&amp;#8217;s total revenues. During the nine month period ended June 30, 2014 no customers represented 10% or greater of the Company&amp;#8217;s total revenues.&lt;/font&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;/p&gt;
&lt;p style="text-align: center; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Recent Accounting Pronouncements&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;In August 2014, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued ASU 2014-15, &amp;#8220;Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going Concern&amp;#8221; (&amp;#8220;ASU 2014-15&amp;#8221;). ASU 2014-15 provides guidance on management&amp;#8217;s responsibility in evaluating whether there is substantial doubt about a company&amp;#8217;s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company&amp;#8217;s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. The Company will adopt the methodologies prescribed by ASU 2014-15 by the date required, and does not anticipate that the adoption of ASU 2014-15 will have a material effect on its condensed consolidated financial position or results of operations.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;In June 2014, the FASB issued Accounting Standards Update 2014-12, &amp;#8220;Accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period,&amp;#8221; (&amp;#8220;ASU 2014-12&amp;#8221;) which requires performance-based awards with a performance target that affects vesting and that could be achieved after an employee completes the requisite service period to be accounted for as a performance condition. If performance targets are clearly defined and it is probable that the performance condition will be achieved, stock-based expense should be recognized over the remaining requisite service period. This guidance will be effective for fiscal years (and interim reporting periods within those years) beginning after December 15, 2015. Early adoption is permitted. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company&amp;#8217;s condensed consolidated financial position or results of operations.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;In May 2014, the FASB issued Accounting Standards Update 2014-09, &amp;#8220;Revenue from Contracts with Customers,&amp;#8221; (&amp;#8220;ASU 2014-09&amp;#8221;) which provides updated, comprehensive revenue recognition guidance for contracts with customers, including a new principles-based five step framework that eliminates much of the industry-specific guidance in current accounting literature. Under ASU 2014-09, revenue recognition is based on a core principle that companies recognize revenue in an amount consistent with the consideration it expects to be entitled to in exchange for the transfer of goods or services. The standards update also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of recognized revenue. This guidance will be effective for fiscal years (and interim reporting periods within those years) beginning after December 15, 2017. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company&amp;#8217;s condensed consolidated financial position or results of operations.&lt;/font&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
<apdn:LiquidityAndManagementPlanTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;NOTE B &amp;#8211; LIQUIDITY AND MANAGEMENT&amp;#8217;S PLAN&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company has recurring net losses, which have resulted in an accumulated deficit of $211,145,374 as of June 30, 2015. The Company incurred a net loss of $11,385,102 and generated negative operating cash flow of $5,226,713 for the nine month period ended June 30, 2015.&amp;#160;&amp;#160;However, the Company also has attained positive working capital of $11,394,253 as of June 30, 2015. At June 30, 2015 the Company had cash and cash equivalents of $10,730,144. The Company&amp;#8217;s current capital resources include cash and cash equivalents, accounts receivable and prepaid expenses. Historically, the Company has financed its operations principally from the sale of equity securities. As discussed in Note G, on April 1, 2015, the Company closed its underwritten public offering of common stock and warrants for gross proceeds of approximately $12.0 million, before deducting underwriting discounts and offering expenses.&lt;b&gt;&amp;#160;&lt;/b&gt;Subsequently on April 30, 2015,&lt;sup&gt;&amp;#160;&lt;/sup&gt;the Company closed on the over-allotment option of the underwritten public offering for additional gross proceeds of $263,950. In addition, on November 20, 2014 the Company closed its underwritten public offering of common stock and warrants for gross proceeds of $9.3 million before deducting underwriting discounts and offering expenses. The Company utilized approximately $4,091,000 of the gross proceeds to repurchase the remaining Series B Warrants from Crede, as discussed in Note E.&amp;#160;&amp;#160;The Company raised $2,156,264 in a private placement of common stock and warrants and $1,800,000 in promissory notes during the fiscal year ended September 30, 2014, including $1,000,000 from a related party. See Notes D and G.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company expects to finance operations primarily through cash flows provided by operating activities provided that it will achieve a sufficient level of future revenues. The Company estimates that its cash and cash equivalents are sufficient to fund operations for the next twelve months.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company will require additional funds to complete the continued development of its products, product manufacturing, and to fund expected additional losses from operations, until revenues are sufficient to cover the Company&amp;#8217;s operating expenses.&lt;/font&gt;&lt;/p&gt;</apdn:LiquidityAndManagementPlanTextBlock>
<us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;NOTE C &amp;#8211; ACCOUNTS PAYABLE AND ACCRUED LIABILITIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Accounts payable and accrued liabilities at June 30, 2015 and September 30, 2014 are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;June 30,&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;(unaudited)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;September 30,&lt;br /&gt;2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; width: 752px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 201px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;770,395&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 187px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,059,623&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Accrued consulting fees&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;110,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;102,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Accrued salaries payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;428,098&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px;
 padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;245,761&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Accrued interest payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;11,875&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Other accrued expenses&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;109,622&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;75,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 15px; padding-right: 0.8pt; font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,418,615&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,494,759&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
<us-gaap:DebtDisclosureTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;NOTE D &amp;#8211; PROMISSORY NOTES PAYABLE&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;On September 11, 2014, the Company issued and sold promissory notes (the &amp;#8220;Notes&amp;#8221;) in the aggregate principal amount of $1,800,000 and bearing interest at a rate of 12.5% per annum to Dr. James A. Hayward, the Company&amp;#8217;s President, Chairman and Chief Executive Officer, in the amount of $1,000,000, and to another individual, in the amount of $800,000, both of whom are &amp;#8220;accredited investors&amp;#8221; as defined in regulations promulgated under the Securities Act of 1933, as amended (the &amp;#8220;Securities Act&amp;#8221;).&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The Notes had a ten month maturity. Interest was payable in cash or in shares of common stock at the option of the holders of the Notes. Interest to be paid in shares was to be paid in shares of common stock equal to (i) the amount of interest payable, divided by (ii) the average of the closing prices for the five consecutive trading days immediately preceding the applicable interest date. The Notes were permitted to be prepaid in whole or in part, at any time, subject to certain prepayment penalties. Upon an event of default, the Notes and all accrued interest thereon were to automatically convert into common stock at the closing price of the common stock on the date of issuance of the Notes. In the event of a consolidation or merger with another corporation in which the Company does not survive, the Notes were to be paid in full. On November 11, 2014, Dr. Hayward and the other individual agreed to exchange for cancellation their respective Notes (including principal and accrued interest thereon) for 315,171 shares of common stock and warrants to purchase 315,171 shares of common stock, in the case of Dr. Hayward, and 252,137 shares of common stock and warrants to purchase 252,137 shares of common stock, in the case of the other individual, at $3.25 ($3.24 for one share of common stock and $0.01 for one warrant) (&amp;#8220;combined price&amp;#8221;) , the aggregate public offering per share price of common stock and warrants issued in the Company&amp;#8217;s underwritten public offering, which closed on November 20, 2014.&amp;#160;&amp;#160;The conversion of the Notes resulted in a loss on conversion of approximately $981,000, which was recorded on the condensed consolidated statement of operations for the nine month period ended June 30, 2015.&amp;#160;&amp;#160;The loss was calculated as the difference between the carrying amount of the promissory note and accrued interest on the conversion date compared to the fair value of the common stock and warrant issued as settlement of the Notes.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Interest expense for these Notes was $31,875 for the nine month period ended June 30, 2015.&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
<apdn:WarrantLiabilityTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;NOTE E &amp;#8211; WARRANT LIABILITY&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;On December 16, 2013, Crede CG III, Ltd (&amp;#8220;Crede&amp;#8221;) effected the cashless exercise of 178,253 Series A Warrants and 116,667 Series B Warrants. At December 16, 2013 (date of exercise), the Company determined the fair value of the Warrants to be $2,455,042 using the Binomial Lattice model with the following assumptions: fair value of the Company&amp;#8217;s common stock $10.80 per share; dividend yield 0%; expected term: 4.55 years; risk free interest rate: 1.55%; expected volatility of: 118.89%; and an exercise price of $14.59. The change in fair value of the warrant liability on the day of exercise amounted to a loss of $1,288,752 and was included in the other income (expense). Upon exercise, the fair value of the Series A Warrants and 116,667 of the Series B Warrants were reclassified to equity.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The Series A and Series B Warrants were classified as liabilities on the issuance date due to certain provisions contained in the warrant agreements, which may cause an adjustment to the conversion rate or the number of warrants outstanding.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The change in fair value of the warrant liability resulted in a gain of $515,543 and a loss of $1,663,316 for the three and nine month periods ended June 30, 2014, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;On October 28, 2014, the Company entered into a warrant repurchase option agreement with Crede, pursuant to which it had the option to purchase between 50% and 100% of Crede&amp;#8217;s Series B Warrant (then exercisable for 387,621 shares of common stock) at a purchase price of $10.55 per share underlying such Series B Warrant (up to an aggregate purchase price of $4,091,000 for all of the Series B Warrant). On November 21, 2014, the Company exercised its option and repurchased 100% of Crede&amp;#8217;s Series B Warrant for an aggregate purchase price of approximately $4,091,000.&amp;#160;&amp;#160;The change in fair value of the warrant liability on the day of repurchase amounted to a loss of $2,994,540 and was included in other income (expense) for the nine month period ended June 30, 2015.&lt;/font&gt;&lt;/p&gt;</apdn:WarrantLiabilityTextBlock>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;NOTE F &amp;#8211; RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;As discussed in Note D, on September 11, 2014, the Company issued and sold a promissory note in the aggregate principal amount of $1,000,000 and bearing interest at a rate of 12.5% per annum to Dr. James A. Hayward, the Company&amp;#8217;s President, Chairman and Chief Executive Officer. On November 11, 2014, Dr. Hayward agreed to exchange for cancellation of his Note (including principal and accrued interest thereon) for 315,171 shares of common stock and warrants to purchase 315,171 shares of common stock, at a combined price of $3.25, the aggregate public offering price of common stock and warrants issued in the Company&amp;#8217;s underwritten public offering which closed on November 20, 2014.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;As discussed in Note G, the Company&amp;#8217;s Chief Executive Officer and an affiliated company of a member of the Company&amp;#8217;s board of directors participated in the Company&amp;#8217;s November 20, 2014 underwritten public offering.&lt;/font&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;NOTE G - CAPITAL STOCK&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;On October 24, 2014, the Company filed a Third Certificate of Amendment of its Certificate of Incorporation with the Secretary of State of the State of Delaware that effected a one-for-60 (1:60) reverse stock split of its common stock, par value $.001 per share, and a decrease in its authorized common stock, from 1,350,000,000 to 500,000,000 shares, effective October 29, 2014. All warrant, option, share, and per share information in the condensed consolidated financial statements gives retroactive effect to the one-for-60 reverse stock split that was effected on October 29, 2014.&amp;#160;&lt;i&gt;&amp;#160;&lt;/i&gt;&amp;#160;In addition, the Company is authorized to issue 10,000,000 shares of preferred stock with a $0.001 par value per share. As of June 30, 2015 and September 30, 2014, there were 21,482,202 and 13,935,954 shares of common stock issued and outstanding, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;On November 20, 2014, the Company closed its underwritten public offering of 2,800,000 shares of common stock and warrants to purchase up to an aggregate of 2,800,000 shares of common stock for gross proceeds of $9.1 million before deducting underwriting discounts and offering expenses. The Company utilized $4,091,000 of the gross proceeds to repurchase the remaining Series B Warrants from Crede, as discussed in Note E. The combined price for each share of common stock and warrant was $3.25. The warrants may be exercised for a period of five years and have an exercise price of $3.50 per share. In connection with the offering, the Company granted to the underwriters a 45-day option to purchase up to 420,000 additional shares of common stock at $3.24 per share and/or up to 420,000 additional warrants at $0.01 per share to cover over-allotments, if any. The Company&amp;#8217;s Chief Executive Officer and an affiliated company of a member of the Company&amp;#8217;s board of directors participated in this underwritten public offering. The Company&amp;#8217;s common stock and warrants are listed on the Nasdaq Capital Market under the symbols &amp;#8220;APDN&amp;#8221; and &amp;#8220;APDNW&amp;#8221;, respectively. On December 19, 2014, the Company closed on the underwriters&amp;#8217; exercise of its over-allotment option of 416,850 warrants for gross proceeds of $4,169 and on December 30, 2014, the Company closed on the underwriters&amp;#8217; additional exercise of its over-allotment option of 52,000 shares of common stock for gross proceeds of $168,400.&amp;#160;&amp;#160;The total number of common stock and warrants issued under this offering, including the exercise of the over-allotment option was 2,852,000 and 3,216,850, respectively.&amp;#160;&amp;#160;The gross proceeds to the Company was $9.3 million and net proceeds after deducting underwriting discounts, offering expenses and the repurchase of the remaining Series B Warrants from Crede was approximately $3.69 million.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;In connection with the closing of this underwritten public offering, on November 20, 2014, the Company granted 128,800 warrants to purchase common stock to its underwriters as partial compensation. These warrants have an exercise price of $3.73 (115% of the public offering price) and expire on November 14, 2019.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;During the three and nine month periods ended June 30, 2015, the Company granted 15,000 and 22,500 shares of common stock to a consultant for a total expense of approximately $47,750 and $64,426, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 11pt calibri; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;On April 1, 2015, the Company closed its underwritten public offering of 4,011,000 shares of common stock and warrants to purchase up to an aggregate of 1,604,400 shares of common stock, at $3.00 ($2.99 for one share of common stock and $0.01 for one warrant) (&amp;#8220;combined offering price&amp;#8221;), including 191,000 shares and 76,400 warrants sold pursuant to the partial exercise of the underwriters&amp;#8217; over-allotment option. The warrants have a per share exercise price of $3.50, are exercisable immediately, and expire on November 20, 2019. The gross proceeds to the Company from this offering, including the partial exercise of the over-allotment option but before deducting the underwriting discount and offering expenses, is $12.0 million&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;.&lt;font style="font-family: 'times new roman';"&gt;&amp;#160;In connection with the offering, the Company granted to the underwriters a 45-day option to purchase up to 573,000 additional shares of common stock and up to 229,200 additional warrants to cover over-allotments, if any. On April 30, 2015, the Company closed on the underwriters&amp;#8217; exercise of its over-allotment option of 87,000 shares of common stock and 152,800 warrants for gross proceeds of $263,950 .&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;In connection with the closing of this underwritten public offering, as partial compensation, on April 1, 2015, the Company granted up to 163,720 warrants to purchase common stock to its underwriters. These warrants have an exercise price of $3.44 (115% of the public offering price) and expire on March 27, 2020.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;See Note D for the common stock and warrants issued in connection with the conversion of the promissory notes.&lt;/font&gt;&lt;/p&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;NOTE H - STOCK OPTIONS AND WARRANTS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Warrants&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The following table summarizes the changes in warrants outstanding and the related prices for the shares of common stock issued to non-employees of the Company. These warrants were granted in lieu of cash for services performed or financing expenses in connection with the sale of common stock.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 12pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Transactions involving warrants (see Notes D, E and G) are summarized as follows:&lt;/font&gt;&lt;/p&gt;
&lt;table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Number of&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;&lt;br  /&gt;&lt;font style="font-family: arial;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family: 'times new roman';"&gt;Shares&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Weighted&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;&lt;br  /&gt;&lt;font style="font-family: arial;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family: 'times new roman';"&gt;Average&amp;#160;&lt;br  /&gt;Exercise&lt;/font&gt;&lt;br  /&gt;&lt;font style="font-family: arial;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family: 'times new roman';"&gt;Price Per&amp;#160;&lt;br  /&gt;Share&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; width: 752px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Balance at October 1, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 217px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;945,166&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 171px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;9.59&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Granted&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;5,833,878&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;3.50&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Exercised&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Cancelled or expired&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(716,557&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(11.30&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Balance at June 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;6,062,487&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;3.53&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="widows: 1; text-transform: none; text-indent: 0.5in; margin: 12pt 0px 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Employee Stock Options&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;In 2005, the Board of Directors and the holders of a majority of the outstanding shares of common stock approved the 2005 Incentive Stock Plan (the &amp;#8220;Incentive Plan&amp;#8221;). In 2007, 2008 and 2012, the Board of Directors and holders of a majority of the outstanding shares of common stock approved various increases in the number of shares of common stock that can be issued as stock awards and stock options thereunder to an aggregate of 5,833,334 shares and the number of shares of common stock that can be covered by awards made to any participant in any calendar year to 833,334 shares.&amp;#160;&amp;#160;On January 21, 2015, the Board of Directors approved an amendment to the Incentive Plan, which was approved by shareholders on June 16, 2015.&amp;#160;&amp;#160;The amendment increases the number of shares of common stock that can be issued as stock awards and stock options thereunder to an aggregate of 8,333,333.&amp;#160;&amp;#160;The amendment also extends the Incentive Plan&amp;#8217;s expiration date to January 25, 2025.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The Incentive Plan is designed to retain directors, executives, and selected employees and consultants by rewarding them for making contributions to our success with an award of options to purchase shares of common stock and an award of shares of common stock. As of June 30, 2015 a total of 233,752 shares have been issued and options to purchase 4,132,475 shares have been granted under the 2005 Incentive Stock Plan.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Transactions involving stock options issued to employees are summarized as follows:&lt;/font&gt;&lt;/p&gt;
&lt;table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; width: 516px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 201px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 44px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 155px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 61px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 157px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Number of&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;&lt;br  /&gt;&lt;font style="font-family: 'times new roman';"&gt;Shares&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Weighted&amp;#160;&lt;br  /&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Price Per&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Outstanding at October 1, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;2,909,046&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;4.74&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Granted&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;950,094&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;2.85&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Exercised&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Cancelled or expired&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(402,151)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(3.01)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Outstanding at June 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;3,456,989&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;4.42&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Vested at June 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;2,494,098&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;4.13&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;0.18&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Non-vested at June 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;962,891&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;0.12&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;For the three and nine-month periods ended June 30, 2015, the Company issued 49,585 and 950,094, options to employees, consultants and non-employee board of director members, respectively. Included in these grants for the nine month period was 450,000 options granted to executives.&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;/p&gt;
&lt;p style="text-align: center; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The fair value of options granted during the three and nine month periods ended June 30, 2015 was determined using the Black Scholes Option Pricing Model with the following weighted average assumptions:&lt;/font&gt;&lt;/p&gt;
&lt;table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 12pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="width: 707px;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 46px;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 15px;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 203px;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 46px;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 15px;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 205px;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 16px;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; font-size: 10pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Three&lt;br  /&gt;Months&lt;br  /&gt;Ended&lt;br  /&gt;June 30,&amp;#160;&lt;br  /&gt;2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; font-size: 10pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Nine&lt;br  /&gt;Months&lt;br  /&gt;Ended&lt;br  /&gt;June 30,&amp;#160;&lt;br  /&gt;2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Stock price&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;2.60&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;2.85&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;2.60&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;2.85&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Expected term, years&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;3.75&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;4.85&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Volatility&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;118&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;132&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Risk free rate&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;1.13&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;1.56&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company recorded $1,015,361(including $544,113 for stock option modifications) and $404,507 as stock compensation expense for the three month periods ended June 30, 2015 and 2014, respectively, and $3,531,205 (including $673,176 for stock option modifications) and $1,717,837 for the nine month periods ended June 30, 2015 and 2014, respectively for the vesting portion of all options. As of June 30, 2015, unrecorded compensation cost related to non-vested awards was $2,749,586 which is expected to be recognized over a weighted average period of approximately 2.21 years.&amp;#160;&amp;#160;The weighted average grant date fair value for options granted during the three and nine month periods ended June 30, 2015 was $69,430 and $1,076,502, respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;NOTE I - COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Operating Leases&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company leases office space under an operating lease in Stony Brook, New York for its corporate headquarters. The lease is for a 30,000 square foot building. The term of the lease commenced on June 15, 2013 and expires on May 31, 2016, with the option to extend the lease for two additional three-year periods. The base rent during the initial lease term is $449,142 per annum. The Company also has operating leases for a laboratory in Huddersfield, England, which is currently inactive and Calverton, New York. The Huddersfield lease was terminated effective July 31, 2015. The Calverton lease was from February 1, 2014 through October 31, 2014&lt;b&gt;,&lt;/b&gt;&amp;#160;with the option to renew for additional one year periods.&amp;#160;&amp;#160;The Calverton lease is currently on a month to month basis.&amp;#160;&amp;#160;Total rent expense for the three and nine month periods ended June 30, 2015 was $124,504 and $373,772, respectively. Total rent expense for the three and nine month periods ended June 30, 2014 were $125,268 and $380,251, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Employment Agreement&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company has an employment agreement with the Chief Executive Officer. Effective June 21, 2014, the Chief Executive Officer&amp;#8217;s annual salary was voluntarily reduced by $50,000. This salary reduction will be accrued and repaid when the Company reaches $3,000,000 in sales for two consecutive quarters or the Company has net income at the end of any fiscal year.&amp;#160;&amp;#160;Effective January 1, 2015, the Chief Executive Officer&amp;#8217;s annual salary was voluntarily reduced by an additional $50,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Litigation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;From time to time, the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. When the Company is aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, the Company will record a liability for the loss. In addition to the estimated loss, the recorded liability includes probable and estimable legal costs associated with the claim or potential claim. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm the Company&amp;#8217;s business.&amp;#160;There is no pending litigation involving the Company at this time.&lt;/font&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
<us-gaap:FairValueDisclosuresTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;NOTE J - FAIR VALUE&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The carrying value of cash, accounts receivable, accounts payable and accrued liabilities approximate estimated fair values because of their short maturities.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The carrying value of the warrant liability is determined using the Binomial Lattice option pricing model as described in Note A. Certain assumptions used in the calculation of the warrant liability represent Level-3 unobservable inputs. The Company did not have any assets or liabilities categorized as Level 1, 2 or 3 as of June 30, 2015.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;The following table summarizes the activity of Level 3 inputs measured on a recurring basis:&lt;/font&gt;&lt;/p&gt;
&lt;table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Fair Value Measurements of Common Stock Warrants Using Significant Unobservable Inputs (Level 3)&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td colspan="6"&gt;
&lt;p style="text-align: center; margin: 0px 5.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 5.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; width: 907px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Balance at October 1, 2014 and 2013&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 202px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,096,412&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 204px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman';
 font-stretch: normal;"&gt;2,643,449&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Adjustment resulting from change in fair value (a)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;2,994,540&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,663,316&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Removal of warrant upon repurchase&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(4,090,952&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Reclassification to equity upon exercise&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(2,455,042&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Balance at June 30,&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,851,723&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;(a)&amp;#160;&lt;i&gt;Adjustment resulting from change in fair value&lt;/i&gt;&amp;#160;is the amount of total gains or losses for the period attributable to the change in unrealized gains or losses relating to warrant liabilities held at the reporting date and realized gains or losses at the date of exercise. The gain or loss is recorded in change in fair value of warrant liability in the accompanying condensed consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
<us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Business and Basis of Presentation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;On September 16, 2002, the Company was incorporated under the laws of the State of Nevada. Effective December 17, 2008, the Company reincorporated from the State of Nevada to the State of Delaware. The Company is principally devoted to developing DNA embedded biotechnology security solutions in the United States and Europe. To date, the Company has had a limited operating history, and as a result, its operations have produced limited recurring revenues from its services and products; it has incurred expenses and has sustained losses. Consequently, its operations are subject to all the risks inherent in the establishment of a biotechnology company. For the period from inception through June 30, 2015, the Company has accumulated losses of $211,145,374.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, APDN (B.V.I.) Inc. and Applied DNA Sciences Europe Limited, which currently have no operations or activity. Significant inter-company transactions and balances have been eliminated in consolidation.&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
<us-gaap:RevenueRecognitionPolicyTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company recognizes revenue in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 605, Revenue Recognition (&amp;#8220;ASC 605&amp;#8221;). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred and/or service has been performed; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&amp;#8217;s judgments regarding the fixed nature of the selling prices of the products delivered or services provided and the collectability of those amounts. Provisions for allowances and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered, service has not been provided, or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered, the service has been provided, or no refund will be required. At June 30, 2015 and September 30, 2014, the Company recorded deferred revenue of $204,863 and $583,362, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&amp;#160;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Revenue arrangements with multiple components are divided into separate units of accounting if certain criteria are met, including whether the delivered component has stand-alone value to the customer. Consideration received is allocated among the separate units of accounting based on their respective selling prices. The selling price for each unit is based on vendor-specific objective evidence, or VSOE, if available, third party evidence if VSOE is not available, or estimated selling price if neither VSOE nor third party is available. The applicable revenue recognition criteria are then applied to each of the units.&lt;/font&gt;&lt;/div&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Revenue for government contract awards, which supports the Company&amp;#8217;s development efforts on specific projects, is recognized as milestones are achieved as per the contract. The Company recognized revenue of approximately $657,708 and $1,919,031 from these contract awards during the three and nine month periods ended June 30, 2015 and $0 and $50,000 for the three and nine month periods ended June 30, 2014, respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Net Loss Per Share&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;The Company presents loss per share utilizing a dual presentation of basic and diluted loss per share. Basic loss per share includes no dilution and has been calculated based upon the weighted average number of common shares outstanding during the period. Dilutive common stock equivalents consist of shares issuable upon the exercise of the Company&amp;#8217;s stock options and warrants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;For the three and nine month periods ended June 30, 2015 and 2014, common stock equivalent shares are excluded from the computation of the diluted loss per share as their effect would be anti-dilutive.&lt;/font&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;Securities that could potentially dilute basic net income per share in the future that were not included in the computation of diluted net loss per share because including those securities would have been anti-dilutive&amp;#160;for the three and nine month periods ended&amp;#160;June 30, 2015 and 2014 are as follows:&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="3"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="3"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #f7ffff;"&gt;
&lt;td style="width: 785px;"&gt;Warrants&lt;/td&gt;
&lt;td style="width: 46px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 15px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 157px; text-align: right;"&gt;6,062,487&lt;/td&gt;
&lt;td style="width: 15px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 46px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 15px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 158px; text-align: right;"&gt;240,439&lt;/td&gt;
&lt;td style="width: 16px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;Employee options&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"&gt;3,456,989&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"&gt;2,073,043&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #f7ffff;"&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"&gt;9,519,476&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"&gt;2,313,482&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Stock Based Compensation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (&amp;#8220;ASC 718&amp;#8221;). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee&amp;#8217;s requisite service period (generally the vesting period of the equity grant). The fair value of the Company&amp;#8217;s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718, excess tax benefits realized from the exercise of stock-based awards are classified in cash flows from financing activities. The future realization of the reserved deferred tax assets related to these tax benefits associated with the exercise of stock options will result in a credit to additional paid in capital if the related tax deduction reduces taxes payable. The Company has elected the &amp;#8220;with and without approach&amp;#8221; regarding ordering of windfall tax benefits to determine whether the windfall tax benefit did reduce taxes payable in the current year. Under this approach, the windfall tax benefit would be recognized in additional paid-in-capital only if an incremental tax benefit is realized after considering all other benefits presently available.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company accounts for stock based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in&amp;#160;ASC 505-50.&lt;/font&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
<us-gaap:ConcentrationRiskCreditRisk contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Concentrations&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company&amp;#8217;s revenues earned from sale of products and services for the three and nine month periods ended June 30, 2015 included an aggregate of 87% and 73%, respectively, from two customers of the Company&amp;#8217;s total revenues. These two customers accounted for approximately 89% of the Company&amp;#8217;s total accounts receivable at June 30, 2015.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;The Company&amp;#8217;s revenues earned from sale of products and services for the three month period ended June 30, 2014 included an aggregate of 10% from one customer of the Company&amp;#8217;s total revenues. During the nine month period ended June 30, 2014 no customers represented 10% or greater of the Company&amp;#8217;s total revenues.&lt;/font&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Recent Accounting Pronouncements&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;In August 2014, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued ASU 2014-15, &amp;#8220;Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going Concern&amp;#8221; (&amp;#8220;ASU 2014-15&amp;#8221;). ASU 2014-15 provides guidance on management&amp;#8217;s responsibility in evaluating whether there is substantial doubt about a company&amp;#8217;s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company&amp;#8217;s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. The Company will adopt the methodologies prescribed by ASU 2014-15 by the date required, and does not anticipate that the adoption of ASU 2014-15 will have a material effect on its condensed consolidated financial position or results of operations.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;In June 2014, the FASB issued Accounting Standards Update 2014-12, &amp;#8220;Accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period,&amp;#8221; (&amp;#8220;ASU 2014-12&amp;#8221;) which requires performance-based awards with a performance target that affects vesting and that could be achieved after an employee completes the requisite service period to be accounted for as a performance condition. If performance targets are clearly defined and it is probable that the performance condition will be achieved, stock-based expense should be recognized over the remaining requisite service period. This guidance will be effective for fiscal years (and interim reporting periods within those years) beginning after December 15, 2015. Early adoption is permitted. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company&amp;#8217;s condensed consolidated financial position or results of operations.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;In May 2014, the FASB issued Accounting Standards Update 2014-09, &amp;#8220;Revenue from Contracts with Customers,&amp;#8221; (&amp;#8220;ASU 2014-09&amp;#8221;) which provides updated, comprehensive revenue recognition guidance for contracts with customers, including a new principles-based five step framework that eliminates much of the industry-specific guidance in current accounting literature. Under ASU 2014-09, revenue recognition is based on a core principle that companies recognize revenue in an amount consistent with the consideration it expects to be entitled to in exchange for the transfer of goods or services. The standards update also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of recognized revenue. This guidance will be effective for fiscal years (and interim reporting periods within those years) beginning after December 15, 2017. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company&amp;#8217;s condensed consolidated financial position or results of operations.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="3"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="3"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;"&gt;&lt;font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f7ffff; vertical-align: bottom;"&gt;
&lt;td style="width: 785px;"&gt;Warrants&lt;/td&gt;
&lt;td style="width: 46px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 15px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 157px;"&gt;6,062,487&lt;/td&gt;
&lt;td style="text-align: left; width: 15px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 46px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 15px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 158px;"&gt;240,439&lt;/td&gt;
&lt;td style="text-align: left; width: 16px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;Employee options&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;"&gt;3,456,989&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;"&gt;2,073,043&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f7ffff; vertical-align: bottom;"&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;"&gt;9,519,476&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;"&gt;2,313,482&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
<us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;June 30,&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;2015&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;(unaudited)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;September 30,&lt;br /&gt;2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; width: 752px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 201px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;770,395&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 187px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,059,623&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Accrued consulting fees&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;110,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;102,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Accrued salaries payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;428,098&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;245,761&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Accrued interest payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right:
 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;11,875&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Other accrued expenses&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;109,622&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;75,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 15px; padding-right: 0.8pt; font-size: 10pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,418,615&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,494,759&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
<apdn:ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;table align="center" style="width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 11pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Number of&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;&lt;br  /&gt;&lt;font style="font-family: arial;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family: 'times new roman';"&gt;Shares&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Weighted&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;&lt;br  /&gt;&lt;font style="font-family: arial;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family: 'times new roman';"&gt;Average&amp;#160;&lt;br  /&gt;Exercise&lt;/font&gt;&lt;br  /&gt;&lt;font style="font-family: arial;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family: 'times new roman';"&gt;Price Per&amp;#160;&lt;br  /&gt;Share&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; width: 752px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Balance at October 1, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 217px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;945,166&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 171px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;9.59&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Granted&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;5,833,878&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;3.50&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Exercised&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Cancelled or expired&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(716,557&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(11.30&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Balance at June 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;6,062,487&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;3.53&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</apdn:ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock>
<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; width: 516px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 201px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 44px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 155px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 61px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 157px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Number of&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;&lt;br /&gt;&lt;font style="font-family: 'times new roman';"&gt;Shares&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Weighted&amp;#160;&lt;br /&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Price Per&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Outstanding at October 1, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;2,909,046&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;4.74&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Granted&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;950,094&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;2.85&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px;
 padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Exercised&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Cancelled or expired&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(402,151)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(3.01)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Outstanding at June 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;3,456,989&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;4.42&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Vested at June 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;2,494,098&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;4.13&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;0.18&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font
 style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Non-vested at June 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;962,891&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;0.12&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;table align="center" style="width: 100%; border-collapse: collapse; font-size: 12pt;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="width: 45%;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 3%;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 13%;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 3%;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; width: 13%;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 2px solid;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; font-size: 10pt;" colspan="2"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;Three&lt;br  /&gt;Months&lt;br  /&gt;Ended&lt;br  /&gt;June 30, &lt;br  /&gt;2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; font-size: 10pt;" colspan="2"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;Nine&lt;br  /&gt;Months&lt;br  /&gt;Ended&lt;br  /&gt;June 30, &lt;br  /&gt;2015&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: azure; vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;Stock price&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;2.60&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;2.85&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;2.60&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;2.85&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: azure; vertical-align: bottom;"&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;Expected term, years&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;3.75&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;4.85&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: azure; vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;Volatility&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;118&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;132&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;Risk free rate&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;1.13&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;1.56&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-size: 10pt;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
<us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">&lt;table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Fair Value Measurements of Common Stock Warrants Using Significant Unobservable Inputs (Level 3)&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td colspan="6"&gt;
&lt;p style="text-align: center; margin: 0px 5.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: center; margin: 0px 5.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; width: 907px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Balance at October 1, 2014 and 2013&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 202px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,096,412&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; width: 204px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;2,643,449&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Adjustment resulting from change in fair value (a)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;2,994,540&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,663,316&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Removal of warrant upon repurchase&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(4,090,952&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new
 roman'; font-stretch: normal;"&gt;Reclassification to equity upon exercise&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;(2,455,042&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #f0ffff; vertical-align: bottom;"&gt;
&lt;td style="line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;Balance at June 30,&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font: 10pt 'times new roman'; font-stretch: normal;"&gt;1,851,723&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>












<us-gaap:StockholdersEquityReverseStockSplit contextRef="Context_Custom_01_Oct_2014T00_00_00_TO_24_Oct_2014T00_00_00">one-for-60 (1:60)</us-gaap:StockholdersEquityReverseStockSplit>
<us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
<us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">50000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
<us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">657708</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
<us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1919031</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_SalesMember_MajorCustomersAxis_TwoCustomersConcentrationRiskMember" unitRef="pure" decimals="2">0.87</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_SalesMember_MajorCustomersAxis_TwoCustomersConcentrationRiskMember" unitRef="pure" decimals="2">0.73</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_TwoCustomersConcentrationRiskMember" unitRef="pure" decimals="2">0.89</us-gaap:ConcentrationRiskPercentage1>

<apdn:ConcentrationRiskNumberOfCustomers contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_SalesMember_MajorCustomersAxis_TwoCustomersConcentrationRiskMember" unitRef="Customer" decimals="INF">2</apdn:ConcentrationRiskNumberOfCustomers>
<apdn:ConcentrationRiskNumberOfCustomers contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_SalesMember_MajorCustomersAxis_TwoCustomersConcentrationRiskMember" unitRef="Customer" decimals="INF">2</apdn:ConcentrationRiskNumberOfCustomers>
<apdn:ConcentrationRiskNumberOfCustomers contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_TwoCustomersConcentrationRiskMember" unitRef="Customer" decimals="INF">2</apdn:ConcentrationRiskNumberOfCustomers>
<apdn:WorkingCapitalSurplusDeficit contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">11394253</apdn:WorkingCapitalSurplusDeficit>
<apdn:GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="USD" decimals="-5">9300000</apdn:GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants>
<apdn:GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants contextRef="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00" unitRef="USD" decimals="-5">12000000</apdn:GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants>
<apdn:GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants contextRef="Context_Custom_02_Apr_2015T00_00_00_TO_30_Apr_2015T00_00_00" unitRef="USD" decimals="0">263950</apdn:GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants>
<apdn:GrossProceedsToRepurchaseRemainingSeriesBWarrants contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="USD" decimals="0">4091000</apdn:GrossProceedsToRepurchaseRemainingSeriesBWarrants>
<us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="Context_FYE_01_Oct_2013T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">2156264</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
<apdn:ProceedsFromPromissoryNotes contextRef="Context_FYE_01_Oct_2013T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1800000</apdn:ProceedsFromPromissoryNotes>
<apdn:ProceedsFromPromissoryNotesFromRelatedParty contextRef="Context_FYE_01_Oct_2013T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1000000</apdn:ProceedsFromPromissoryNotesFromRelatedParty>
<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1059623</us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">770395</us-gaap:AccountsPayableCurrent>
<us-gaap:AccruedProfessionalFeesCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">102500</us-gaap:AccruedProfessionalFeesCurrent>
<us-gaap:AccruedProfessionalFeesCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">110500</us-gaap:AccruedProfessionalFeesCurrent>
<us-gaap:AccruedSalariesCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">245761</us-gaap:AccruedSalariesCurrent>
<us-gaap:AccruedSalariesCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">428098</us-gaap:AccruedSalariesCurrent>
<us-gaap:InterestPayableCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">11875</us-gaap:InterestPayableCurrent>
<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">75000</us-gaap:OtherAccruedLiabilitiesCurrent>
<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">109622</us-gaap:OtherAccruedLiabilitiesCurrent>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="Context_As_Of_11_Sep_2014T00_00_00_TO_11_Sep_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember" unitRef="pure" decimals="3">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>

<us-gaap:DebtInstrumentTerm contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">P10M</us-gaap:DebtInstrumentTerm>
<us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">P5D</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_PresidentChairmanAndChiefExecutiveOfficerMember" unitRef="shares" decimals="INF">315171</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_AnotherIndividualMember" unitRef="shares" decimals="INF">252137</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<apdn:NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest contextRef="Context_As_Of_11_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_PresidentChairmanAndChiefExecutiveOfficerMember" unitRef="shares" decimals="INF">315171</apdn:NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest>
<apdn:NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest contextRef="Context_As_Of_11_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_AnotherIndividualMember" unitRef="shares" decimals="INF">252137</apdn:NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="Context_As_Of_11_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_PresidentChairmanAndChiefExecutiveOfficerMember" unitRef="USD_per_Share" decimals="2">3.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="Context_As_Of_11_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_AnotherIndividualMember" unitRef="USD_per_Share" decimals="2">3.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="Context_As_Of_20_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="USD_per_Share" decimals="2">3.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
<apdn:DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice contextRef="Context_As_Of_11_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00" unitRef="USD_per_Share" decimals="2">3.24</apdn:DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice>
<apdn:DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice contextRef="Context_As_Of_11_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00" unitRef="USD_per_Share" decimals="2">0.01</apdn:DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice>

<apdn:ClassOfWarrantOrRightExercised contextRef="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesWarrantsMember" unitRef="shares" decimals="INF">178253</apdn:ClassOfWarrantOrRightExercised>
<apdn:ClassOfWarrantOrRightExercised contextRef="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_LegalEntityAxis_CredeCgIIILtdMember" unitRef="shares" decimals="INF">116667</apdn:ClassOfWarrantOrRightExercised>
<apdn:ClassOfWarrantOrRightExercised contextRef="Context_Custom_01_Oct_2014T00_00_00_TO_28_Oct_2014T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_AgreementAxis_WarrantRepurchaseOptionAgreementMember" unitRef="shares" decimals="INF">387621</apdn:ClassOfWarrantOrRightExercised>
<apdn:ClassOfWarrantOrRightExercised contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" xsi:nil="true"/>
<us-gaap:FairValueAdjustmentOfWarrants contextRef="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember" unitRef="USD" decimals="0">2455042</us-gaap:FairValueAdjustmentOfWarrants>
<us-gaap:FairValueMeasurementsValuationTechniques contextRef="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember">Binomial Lattice model</us-gaap:FairValueMeasurementsValuationTechniques>
<us-gaap:SharePrice contextRef="Context_As_Of_16_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">10.80</us-gaap:SharePrice>
<us-gaap:SharePrice contextRef="Context_As_Of_01_Apr_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="USD_per_Share" decimals="2">3.00</us-gaap:SharePrice>
<us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember" unitRef="pure" decimals="2">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember">P4Y6M18D</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember" unitRef="pure" decimals="4">0.0155</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="Context_Custom_01_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember" unitRef="pure" decimals="4">1.1889</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of_16_Dec_2013T00_00_00_TO_16_Dec_2013T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">14.59</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of_28_Oct_2014T00_00_00_TO_28_Oct_2014T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_AgreementAxis_WarrantRepurchaseOptionAgreementMember" unitRef="USD_per_Share" decimals="2">10.55</us-gaap:FairValueAssumptionsExercisePrice>
<apdn:PercentageOfOptionToPurchaseWarrant contextRef="Context_Custom_01_Oct_2014T00_00_00_TO_28_Oct_2014T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_AgreementAxis_WarrantRepurchaseOptionAgreementMember_RangeAxis_MinimumMember" unitRef="pure" decimals="2">0.50</apdn:PercentageOfOptionToPurchaseWarrant>
<apdn:PercentageOfOptionToPurchaseWarrant contextRef="Context_Custom_01_Oct_2014T00_00_00_TO_28_Oct_2014T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_AgreementAxis_WarrantRepurchaseOptionAgreementMember_RangeAxis_MaximumMember" unitRef="pure" decimals="2">1.00</apdn:PercentageOfOptionToPurchaseWarrant>
<apdn:AggregatePurchasePriceOfWarrantExercise contextRef="Context_Custom_01_Oct_2014T00_00_00_TO_28_Oct_2014T00_00_00_LegalEntityAxis_CredeCgIIILtdMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_AgreementAxis_WarrantRepurchaseOptionAgreementMember" unitRef="USD" decimals="0">4091000</apdn:AggregatePurchasePriceOfWarrantExercise>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="shares" decimals="INF">2800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>


<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="Context_As_Of_20_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="shares" decimals="INF">2800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="Context_As_Of_01_Apr_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="shares" decimals="INF">1604400</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<apdn:TermPeriodOfWarrantsOrRightsExercised contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00">P5Y</apdn:TermPeriodOfWarrantsOrRightsExercised>
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="Context_As_Of_20_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="USD_per_Share" decimals="2">3.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="Context_As_Of_01_Apr_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="USD_per_Share" decimals="2">3.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="Context_As_Of_01_Apr_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember_LegalEntityAxis_UnderwritersMember" unitRef="USD_per_Share" decimals="2">3.44</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
<apdn:NumberOfDaysOptionGivenToUnderwriters contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00">P45D</apdn:NumberOfDaysOptionGivenToUnderwriters>
<apdn:AdditionalSharesOfCommonStockPurchaseLimit contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="shares" decimals="INF">420000</apdn:AdditionalSharesOfCommonStockPurchaseLimit>
<apdn:AdditionalPerSharesOfCommonStockPurchaseLimit contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="USD_per_Share" decimals="2">3.24</apdn:AdditionalPerSharesOfCommonStockPurchaseLimit>
<apdn:AdditionalSharesOfWarrantsPurchaseLimit contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="shares" decimals="INF">420000</apdn:AdditionalSharesOfWarrantsPurchaseLimit>
<apdn:AdditionalPerSharesOfWarrantsPurchaseLimit contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="USD_per_Share" decimals="2">0.01</apdn:AdditionalPerSharesOfWarrantsPurchaseLimit>
<apdn:ClassOfWarrantOrRightClosedOnUnderwritersExercise contextRef="Context_Custom_01_Dec_2014T00_00_00_TO_19_Dec_2014T00_00_00" unitRef="shares" decimals="INF">416850</apdn:ClassOfWarrantOrRightClosedOnUnderwritersExercise>
<apdn:GrossProceedsFromClosedOnUnderwritersExercise contextRef="Context_Custom_01_Dec_2014T00_00_00_TO_19_Dec_2014T00_00_00" unitRef="USD" decimals="0">4169</apdn:GrossProceedsFromClosedOnUnderwritersExercise>
<apdn:ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise contextRef="Context_Custom_01_Dec_2014T00_00_00_TO_30_Dec_2014T00_00_00" unitRef="shares" decimals="INF">52000</apdn:ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise>
<apdn:GrossProceedsFromAdditionalClosedOnUnderwritersExercise contextRef="Context_Custom_01_Dec_2014T00_00_00_TO_30_Dec_2014T00_00_00" unitRef="USD" decimals="0">168400</apdn:GrossProceedsFromAdditionalClosedOnUnderwritersExercise>
<apdn:NumberOfCommonStockIssued contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="shares" decimals="INF">2852000</apdn:NumberOfCommonStockIssued>
<apdn:NumberOfWarrantsIssued contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="shares" decimals="INF">3216850</apdn:NumberOfWarrantsIssued>
<apdn:GrossProceedsFromSaleOfCommonStockAndWarrants contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="USD" decimals="0">9272649</apdn:GrossProceedsFromSaleOfCommonStockAndWarrants>
<apdn:AdditionalNumberOfSecuritiesCalledByWarrantsOrRights contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="shares" decimals="INF">128800</apdn:AdditionalNumberOfSecuritiesCalledByWarrantsOrRights>
<apdn:AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="USD_per_Share" decimals="2">3.73</apdn:AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="pure" decimals="2">1.15</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember_LegalEntityAxis_UnderwritersMember" unitRef="pure" decimals="2">1.15</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">22500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<apdn:ShareBasedCompensationOfferingToConsultant contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">47750</apdn:ShareBasedCompensationOfferingToConsultant>
<apdn:ShareBasedCompensationOfferingToConsultant contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">64426</apdn:ShareBasedCompensationOfferingToConsultant>
<us-gaap:CommonStockSharesSubscribedButUnissued contextRef="Context_As_Of_01_Apr_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="shares" decimals="INF">4011000</us-gaap:CommonStockSharesSubscribedButUnissued>
<apdn:SharePriceForCommonStock contextRef="Context_As_Of_01_Apr_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="USD_per_Share" decimals="2">2.99</apdn:SharePriceForCommonStock>
<apdn:SharePriceForWarrant contextRef="Context_As_Of_01_Apr_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="USD_per_Share" decimals="2">0.01</apdn:SharePriceForWarrant>
<apdn:NumberOfCommonStockSoldPursuantToOverAllotmentOfOption contextRef="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="shares" decimals="INF">191000</apdn:NumberOfCommonStockSoldPursuantToOverAllotmentOfOption>
<apdn:NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption contextRef="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="shares" decimals="INF">76400</apdn:NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption>
<us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="USD" decimals="-5">12000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
<apdn:NumberOfDaysForOptionToPurchaseAdditionalShares contextRef="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember">P45D</apdn:NumberOfDaysForOptionToPurchaseAdditionalShares>
<apdn:NumberOfAdditionalSharesOfCommonStock contextRef="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="shares" decimals="INF">573000</apdn:NumberOfAdditionalSharesOfCommonStock>
<apdn:NumberOfAdditionalWarrantsToCoverOverAllotments contextRef="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="shares" decimals="INF">229200</apdn:NumberOfAdditionalWarrantsToCoverOverAllotments>
<apdn:NumberOfCommonStockExerciseInOverAllotmentOption contextRef="Context_Custom_02_Apr_2015T00_00_00_TO_30_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="shares" decimals="INF">87000</apdn:NumberOfCommonStockExerciseInOverAllotmentOption>
<apdn:NumberOfWarrantsExerciseInOverAllotmentOption contextRef="Context_Custom_02_Apr_2015T00_00_00_TO_30_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="shares" decimals="INF">152800</apdn:NumberOfWarrantsExerciseInOverAllotmentOption>
<apdn:GrossProceedsFromExerciseOfOverAllotmentOption contextRef="Context_Custom_02_Apr_2015T00_00_00_TO_30_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember" unitRef="USD" decimals="0">263950</apdn:GrossProceedsFromExerciseOfOverAllotmentOption>
<apdn:NumberOfWarrantsGrantedAsPartialCompensation contextRef="Context_Custom_31_Mar_2015T00_00_00_TO_01_Apr_2015T00_00_00_SubsidiarySaleOfStockAxis_UnderwrittenPublicOfferingMember_LegalEntityAxis_UnderwritersMember" unitRef="shares" decimals="INF">163720</apdn:NumberOfWarrantsGrantedAsPartialCompensation>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="shares" decimals="INF">945166</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">6062487</us-gaap:ClassOfWarrantOrRightOutstanding>
<apdn:ClassOfWarrantOrRightGranted contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">5833878</apdn:ClassOfWarrantOrRightGranted>
<apdn:ClassOfWarrantOrRightForfeituresAndExpirations contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">716557</apdn:ClassOfWarrantOrRightForfeituresAndExpirations>
<apdn:WeightedAveragePricePerShareWarrantOutstanding contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD_per_Share" decimals="2">9.59</apdn:WeightedAveragePricePerShareWarrantOutstanding>
<apdn:WeightedAveragePricePerShareWarrantOutstanding contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">3.53</apdn:WeightedAveragePricePerShareWarrantOutstanding>
<apdn:WeightedAveragePricePerShareWarrantGranted contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">3.50</apdn:WeightedAveragePricePerShareWarrantGranted>
<apdn:WeightedAveragePricePerShareWarrantExercised contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" xsi:nil="true"/>
<apdn:WeightedAveragePricePerShareWarrantCancelledOrExpired contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">11.30</apdn:WeightedAveragePricePerShareWarrantCancelledOrExpired>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">3456989</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of_01_Oct_2014T00_00_00_TO_30_Sep_2014T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">2909046</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">950094</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_EmployeesConsultantsAndNon-EmployeeBoardOfDirectorMembersMember_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="INF">950094</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">402151</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">2494098</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">962891</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="USD_per_Share" decimals="2">4.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of_01_Oct_2014T00_00_00_TO_30_Sep_2014T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="USD_per_Share" decimals="2">4.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="USD_per_Share" decimals="2">2.85</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="USD_per_Share" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="USD_per_Share" decimals="2">3.01</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
<apdn:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="USD_per_Share" decimals="2">4.13</apdn:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice>
<apdn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="USD_per_Share" decimals="2">0.18</apdn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue>
<apdn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="USD_per_Share" decimals="2">0.12</apdn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue>
<apdn:SharePriceTwo contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">2.60</apdn:SharePriceTwo>
<apdn:SharePriceTwo contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">2.85</apdn:SharePriceTwo>
<apdn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">2.60</apdn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo>
<apdn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">2.85</apdn:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00">P3Y9M0D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">P4Y10M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="pure" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="pure" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="pure" decimals="2">1.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="pure" decimals="2">1.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="pure" decimals="4">0.0113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="pure" decimals="4">0.0156</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="Context_As_Of_21_Jan_2015T00_00_00_TO_21_Jan_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">8333333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">5833334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">833334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">233752</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_IncentiveStockPlan2005Member" unitRef="shares" decimals="INF">4132475</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
<us-gaap:StockOptionPlanExpense contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">544113</us-gaap:StockOptionPlanExpense>
<us-gaap:StockOptionPlanExpense contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">673176</us-gaap:StockOptionPlanExpense>
<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">2749586</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00">P2Y2M16D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
<apdn:ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">69430</apdn:ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted>
<apdn:ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1076502</apdn:ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted>
<apdn:AreaOfPropertyUnderOperatingLease contextRef="Context_Custom_01_Jun_2013T00_00_00_TO_15_Jun_2013T00_00_00" unitRef="sqft" decimals="0">30000</apdn:AreaOfPropertyUnderOperatingLease>
<us-gaap:LesseeLeasingArrangementsOperatingLeasesRenewalTerm contextRef="Context_Custom_01_Jun_2013T00_00_00_TO_15_Jun_2013T00_00_00">P3Y</us-gaap:LesseeLeasingArrangementsOperatingLeasesRenewalTerm>
<apdn:BaseRentDuringInitialLeaseTerm contextRef="Context_Custom_01_Jun_2013T00_00_00_TO_15_Jun_2013T00_00_00" unitRef="USD" decimals="0">449142</apdn:BaseRentDuringInitialLeaseTerm>

<us-gaap:OperatingLeasesRentExpenseNet contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">125268</us-gaap:OperatingLeasesRentExpenseNet>
<us-gaap:OperatingLeasesRentExpenseNet contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">380251</us-gaap:OperatingLeasesRentExpenseNet>
<us-gaap:OperatingLeasesRentExpenseNet contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">124504</us-gaap:OperatingLeasesRentExpenseNet>
<us-gaap:OperatingLeasesRentExpenseNet contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">373772</us-gaap:OperatingLeasesRentExpenseNet>
<apdn:ReducedAmountOfSalary contextRef="Context_As_Of_21_Jun_2014T00_00_00_TO_21_Jun_2014T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember_AgreementAxis_EmploymentAgreementMember" unitRef="USD" decimals="0">50000</apdn:ReducedAmountOfSalary>
<apdn:ReducedAmountOfSalary contextRef="Context_As_Of_01-Jan-2015T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember_AgreementAxis_EmploymentAgreementMember" unitRef="USD" decimals="0">50000</apdn:ReducedAmountOfSalary>
<apdn:ThresholdAmountOfSales contextRef="Context_As_Of_21_Jun_2014T00_00_00_TO_21_Jun_2014T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember_AgreementAxis_EmploymentAgreementMember" unitRef="USD" decimals="0">3000000</apdn:ThresholdAmountOfSales>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="Context_As_Of_01_Oct_2013T00_00_00_TO_30_Sep_2013T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="USD" decimals="0">2643449</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="Context_As_Of_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="USD" decimals="0">1851723</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="Context_As_Of_01_Oct_2014T00_00_00_TO_30_Sep_2014T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="USD" decimals="0">1096412</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="USD" decimals="0" id="Footnote-1_2">1663316</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="USD" decimals="0" id="Footnote-1_1">2994540</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
<apdn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="USD" xsi:nil="true"/>
<apdn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="USD" decimals="0">4090952</apdn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase>
<apdn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="USD" decimals="0">2455042</apdn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise>
<apdn:ReclassificationOfWarrantsFromLiabilityToEquityUponExercise contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">2455042</apdn:ReclassificationOfWarrantsFromLiabilityToEquityUponExercise>

<!-- Footnote Section -->
<link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<link:footnote xlink:type="resource" xlink:label="Footnote-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Adjustment resulting from change in fair value is the amount of total gains or losses for the period attributable to the change in unrealized gains or losses relating to warrant liabilities held at the reporting date and realized gains or losses at the date of exercise. The gain or loss is recorded in change in fair value of warrant liability in the accompanying condensed consolidated statements of operations.</link:footnote>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_1" xlink:label="lab_Footnote-1_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Footnote-1_1" xlink:to="Footnote-1" order="1.0"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_2" xlink:label="lab_Footnote-1_2"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Footnote-1_2" xlink:to="Footnote-1" order="1.0"/>
</link:footnoteLink>
<us-gaap:DeferredCosts contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">0</us-gaap:DeferredCosts>
<xbrli:context id="Context_3ME_01-Apr-2014T00_00_00_TO_30-Jun-2014T00_00_00_MajorCustomersAxis_CustomerOneConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_SalesMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">apdn:CustomerOneConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-04-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_3ME_01-Apr-2014T00_00_00_TO_30-Jun-2014T00_00_00_MajorCustomersAxis_CustomerOneConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_SalesMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember" unitRef="pure" decimals="2">0.10</us-gaap:ConcentrationRiskPercentage1>
<apdn:ConcentrationRiskNumberOfCustomers contextRef="Context_3ME_01-Apr-2014T00_00_00_TO_30-Jun-2014T00_00_00_MajorCustomersAxis_CustomerOneConcentrationRiskMember_ConcentrationRiskByBenchmarkAxis_SalesMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember" unitRef="Customer" decimals="INF">1</apdn:ConcentrationRiskNumberOfCustomers>
<xbrli:context id="Context_9ME_01-Oct-2013T00_00_00_TO_30-Jun-2014T00_00_00_ConcentrationRiskByBenchmarkAxis_SalesMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-10-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:ConcentrationRiskBenchmarkDescription contextRef="Context_9ME_01-Oct-2013T00_00_00_TO_30-Jun-2014T00_00_00_ConcentrationRiskByBenchmarkAxis_SalesMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember">no customers represented 10% or greater</us-gaap:ConcentrationRiskBenchmarkDescription>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="Context_As_Of_11_Nov_2014T00_00_00_TO_11_Nov_2014T00_00_00" unitRef="USD_per_Share" decimals="2">3.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
<xbrli:context id="Context_0ME_01-Nov-2014T00_00_00_TO_21-Nov-2014T00_00_00_AgreementAxis_WarrantRepurchaseOptionAgreementMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_LegalEntityAxis_CredeCgIIILtdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="apdn:AgreementAxis">apdn:WarrantRepurchaseOptionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">apdn:SeriesBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">apdn:CredeCgIIILtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-11-01</xbrli:startDate><xbrli:endDate>2014-11-21</xbrli:endDate></xbrli:period></xbrli:context>
	<apdn:PercentageOfOptionToPurchaseWarrant contextRef="Context_0ME_01-Nov-2014T00_00_00_TO_21-Nov-2014T00_00_00_AgreementAxis_WarrantRepurchaseOptionAgreementMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_LegalEntityAxis_CredeCgIIILtdMember" unitRef="pure" decimals="2">1.00</apdn:PercentageOfOptionToPurchaseWarrant>
<apdn:AggregatePurchasePriceOfWarrantExercise contextRef="Context_0ME_01-Nov-2014T00_00_00_TO_21-Nov-2014T00_00_00_AgreementAxis_WarrantRepurchaseOptionAgreementMember_ClassOfWarrantOrRightAxis_SeriesBWarrantsMember_LegalEntityAxis_CredeCgIIILtdMember" unitRef="USD" decimals="0">4091000</apdn:AggregatePurchasePriceOfWarrantExercise>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="Context_As_Of_11_Sep_2014T00_00_00_TO_11_Sep_2014T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember_RelatedPartyTransactionsByRelatedPartyAxis_PresidentChairmanAndChiefExecutiveOfficerMember" unitRef="pure" decimals="3">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_EmployeesConsultantsAndNon-EmployeeBoardOfDirectorMembersMember_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="INF">49585</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<xbrli:context id="Context_9ME_01-Oct-2014T00_00_00_TO_30-Jun-2015T00_00_00_TitleOfIndividualAxis_ExecutiveOfficerMember_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-10-01</xbrli:startDate><xbrli:endDate>2015-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_9ME_01-Oct-2014T00_00_00_TO_30-Jun-2015T00_00_00_TitleOfIndividualAxis_ExecutiveOfficerMember_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="INF">450000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>



<xbrli:context id="Context_9ME_01-Oct-2014T00_00_00_TO_30-Jun-2015T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-10-01</xbrli:startDate><xbrli:endDate>2015-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<apdn:LossOnConversionOfPromissoryNotes contextRef="Context_9ME_01-Oct-2014T00_00_00_TO_30-Jun-2015T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember" unitRef="USD" decimals="0">-981000</apdn:LossOnConversionOfPromissoryNotes>
<us-gaap:InterestExpenseDebt contextRef="Context_9ME_01-Oct-2014T00_00_00_TO_30-Jun-2015T00_00_00_ShortTermDebtTypeAxis_ConvertibleNotesPayableMember" unitRef="USD" decimals="0">31875</us-gaap:InterestExpenseDebt>
<xbrli:context id="Context_9ME_01-Oct-2014T00_00_00_TO_30-Jun-2015T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity><xbrli:period><xbrli:startDate>2014-10-01</xbrli:startDate><xbrli:endDate>2015-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_9ME_01-Oct-2014T00_00_00_TO_30-Jun-2015T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="shares" decimals="0">6062487</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<xbrli:context id="Context_9ME_01-Oct-2013T00_00_00_TO_30-Jun-2014T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity><xbrli:period><xbrli:startDate>2013-10-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_9ME_01-Oct-2013T00_00_00_TO_30-Jun-2014T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="shares" decimals="0">240439</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_9ME_01_Oct_2014T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="0">9519476</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<xbrli:context id="Context_9ME_01-Oct-2014T00_00_00_TO_30-Jun-2015T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-10-01</xbrli:startDate><xbrli:endDate>2015-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_9ME_01-Oct-2014T00_00_00_TO_30-Jun-2015T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">3456989</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<xbrli:context id="Context_9ME_01-Oct-2013T00_00_00_TO_30-Jun-2014T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-10-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_9ME_01-Oct-2013T00_00_00_TO_30-Jun-2014T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">2073043</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_9ME_01_Oct_2013T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="shares" decimals="0">2313482</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<xbrli:context id="Context_3ME_02-Apr-2015T00_00_00_TO_30-Jun-2015T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity><xbrli:period><xbrli:startDate>2015-04-02</xbrli:startDate><xbrli:endDate>2015-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_3ME_02-Apr-2015T00_00_00_TO_30-Jun-2015T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="shares" decimals="0">6062487</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>


<xbrli:context id="Context_3ME_02-Apr-2015T00_00_00_TO_30-Jun-2015T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity><xbrli:period><xbrli:startDate>2015-04-02</xbrli:startDate><xbrli:endDate>2015-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_3ME_02-Apr-2015T00_00_00_TO_30-Jun-2015T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">3456989</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<xbrli:context id="Context_3ME_01-Apr-2014T00_00_00_TO_30-Jun-2014T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-04-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_3ME_01-Apr-2014T00_00_00_TO_30-Jun-2014T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">2073043</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_3ME_02_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="0">9519476</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="shares" decimals="0">2313482</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<xbrli:context id="Context_3ME_01-Apr-2014T00_00_00_TO_30-Jun-2014T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity><xbrli:period><xbrli:startDate>2014-04-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_3ME_01-Apr-2014T00_00_00_TO_30-Jun-2014T00_00_00_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="shares" decimals="0">240439</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<apdn:GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo contextRef="Context_Custom_01_Nov_2014T00_00_00_TO_20_Nov_2014T00_00_00" unitRef="USD" decimals="-5">9100000</apdn:GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>apdn-20150630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.4 on Saturday, August 08, 2015 03:40:14 AM -->
<schema targetNamespace="http://www.adnas.com/20150630" elementFormDefault="qualified" xmlns:apdn="http://www.adnas.com/20150630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2015-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric">
<annotation><appinfo>
<link:roleType roleURI="http://www.adnas.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition>001 - Document - Document and Entity Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" id="CONDENSEDCONSOLIDATEDBALANCESHEETS">
<link:definition>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" id="CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals">
<link:definition>003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" id="CondensedConsolidatedStatementsOfOperationsUnaudited">
<link:definition>004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" id="CondensedConsolidatedStatementsOfCashFlowsUnaudited">
<link:definition>005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIES" id="SUMMARYOFACCOUNTINGPOLICIES">
<link:definition>006 - Disclosure - SUMMARY OF ACCOUNTING POLICIES</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/LiquidityAndManagementSPlan" id="LiquidityAndManagementSPlan">
<link:definition>007 - Disclosure - LIQUIDITY AND MANAGEMENT'S PLAN</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIES" id="ACCOUNTSPAYABLEANDACCRUEDLIABILITIES">
<link:definition>008 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/PromissoryNotesPayable" id="PromissoryNotesPayable">
<link:definition>009 - Disclosure - PROMISSORY NOTES PAYABLE</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/WARRANTLIABILITY" id="WARRANTLIABILITY">
<link:definition>010 - Disclosure - WARRANT LIABILITY</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition>011 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/CAPITALSTOCK" id="CAPITALSTOCK">
<link:definition>012 - Disclosure - CAPITAL STOCK</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/STOCKOPTIONSANDWARRANTS" id="STOCKOPTIONSANDWARRANTS">
<link:definition>013 - Disclosure - STOCK OPTIONS AND WARRANTS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIES" id="COMMITMENTSANDCONTINGENCIES">
<link:definition>014 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/FAIRVALUE" id="FAIRVALUE">
<link:definition>015 - Disclosure - FAIR VALUE</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESPolicies" id="SUMMARYOFACCOUNTINGPOLICIESPolicies">
<link:definition>016 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESTables" id="SUMMARYOFACCOUNTINGPOLICIESTables">
<link:definition>017 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESTables" id="ACCOUNTSPAYABLEANDACCRUEDLIABILITIESTables">
<link:definition>018 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/STOCKOPTIONSANDWARRANTSTables" id="STOCKOPTIONSANDWARRANTSTables">
<link:definition>019 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/FAIRVALUETables" id="FAIRVALUETables">
<link:definition>020 - Disclosure - FAIR VALUE (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails" id="SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails">
<link:definition>021 - Disclosure - SUMMARY OF ACCOUNTING POLICIES - Summary of potential stock issuances under various options, and warrants (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/SummaryOfAccountingPoliciesDetailTextuals" id="SummaryOfAccountingPoliciesDetailTextuals">
<link:definition>022 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailTextuals1" id="SUMMARYOFACCOUNTINGPOLICIESDetailTextuals1">
<link:definition>023 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Detail Textuals 1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/LiquidityAndManagementSPlanDetailTextuals" id="LiquidityAndManagementSPlanDetailTextuals">
<link:definition>024 - Disclosure - LIQUIDITY AND MANAGEMENT'S PLAN (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESSummaryOfAccountsPayableAndAccruedLiabilitiesDetails" id="ACCOUNTSPAYABLEANDACCRUEDLIABILITIESSummaryOfAccountsPayableAndAccruedLiabilitiesDetails">
<link:definition>025 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES - Summary of accounts payable and accrued liabilities (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/PromissoryNotesPayableDetailTextuals" id="PromissoryNotesPayableDetailTextuals">
<link:definition>026 - Disclosure - PROMISSORY NOTES PAYABLE (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/WarrantLiabilityDetailTextuals" id="WarrantLiabilityDetailTextuals">
<link:definition>027 - Disclosure - WARRANT LIABILITY (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/RELATEDPARTYTRANSACTIONSDetailTextuals" id="RELATEDPARTYTRANSACTIONSDetailTextuals">
<link:definition>028 - Disclosure - RELATED PARTY TRANSACTIONS (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/CAPITALSTOCKDetailTextuals" id="CAPITALSTOCKDetailTextuals">
<link:definition>029 - Disclosure - CAPITAL STOCK (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/CAPITALSTOCKDetailTextuals1" id="CAPITALSTOCKDetailTextuals1">
<link:definition>030 - Disclosure - CAPITAL STOCK (Detail Textuals 1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/CapitalStockDetailTextuals2" id="CapitalStockDetailTextuals2">
<link:definition>031 - Disclosure - CAPITAL STOCK (Detail Textuals 2)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/CapitalStockDetailTextuals3" id="CapitalStockDetailTextuals3">
<link:definition>032 - Disclosure - CAPITAL STOCK (Detail Textuals 3)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsTransactionsInvolvingWarrantsDetails" id="StockOptionsAndWarrantsTransactionsInvolvingWarrantsDetails">
<link:definition>033 - Disclosure - STOCK OPTIONS AND WARRANTS - Transactions involving warrants (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsTransactionsInvolvingStockOptionsIssuedToEmployeesDetails1" id="StockOptionsAndWarrantsTransactionsInvolvingStockOptionsIssuedToEmployeesDetails1">
<link:definition>034 - Disclosure - STOCK OPTIONS AND WARRANTS - Transactions involving stock options issued to employees (Details 1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsSummaryOfValueOfOptionsGrantedUsingBlackScholesOptionPricingModelWithWeightedAverageAssumptionsDetails" id="StockOptionsAndWarrantsSummaryOfValueOfOptionsGrantedUsingBlackScholesOptionPricingModelWithWeightedAverageAssumptionsDetails">
<link:definition>035 - Disclosure - STOCK OPTIONS AND WARRANTS - Summary of value of options granted using Black Scholes Option Pricing Model with weighted average assumptions (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals" id="StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals">
<link:definition>036 - Disclosure - STOCK OPTIONS AND WARRANTS - Employee Stock Options (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals1" id="StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals1">
<link:definition>037 - Disclosure - STOCK OPTIONS AND WARRANTS - Employee Stock Options (Detail Textuals 1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIESDetailTextuals" id="COMMITMENTSANDCONTINGENCIESDetailTextuals">
<link:definition>038 - Disclosure - COMMITMENTS AND CONTINGENCIES (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.adnas.com/role/FairValueFairValueMeasurementsOfCommonStockWarrantsUsingSignificantUnobservableInputsLevel3Details" id="FairValueFairValueMeasurementsOfCommonStockWarrantsUsingSignificantUnobservableInputsLevel3Details">
<link:definition>039 - Disclosure - FAIR VALUE - Fair Value Measurements of Common Stock Warrants Using Significant Unobservable Inputs (Level 3) (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="apdn-20150630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="apdn-20150630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="apdn-20150630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="apdn-20150630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
</appinfo></annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://fasb.org/us-gaap/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/currency/2014-01-31" schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/exch/2015-01-31" schemaLocation="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://fasb.org/us-types/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-types-2015-01-31.xsd"/>
<element name="DocumentAndEntityInformationAbstract" id="apdn_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantLiabilityNoncurrent" id="apdn_WarrantLiabilityNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LossOnConversionOfPromissoryNotes" id="apdn_LossOnConversionOfPromissoryNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncomeLossFromChangeInFairValueOfWarrantLiability" id="apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommonStockIssuedForConsultingServices" id="apdn_CommonStockIssuedForConsultingServices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NetProceedsFromSaleOfCommonStockAndWarrants" id="apdn_NetProceedsFromSaleOfCommonStockAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PurchaseAndCancelationOfPreviouslyIssuedWarrants" id="apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants" id="apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital" id="apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReclassificationOfWarrantsFromLiabilityToEquityUponExercise" id="apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities" id="apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable" id="apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IntangibleAssetsAcquiredIncludedInAccountsPayable" id="apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LiquidityAndManagementPlanAbstract" id="apdn_LiquidityAndManagementPlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LiquidityAndManagementPlanTextBlock" id="apdn_LiquidityAndManagementPlanTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantLiabilityAbstract" id="apdn_WarrantLiabilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantLiabilityTextBlock" id="apdn_WarrantLiabilityTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock" id="apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CustomerOneConcentrationRiskMember" id="apdn_CustomerOneConcentrationRiskMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TwoCustomersConcentrationRiskMember" id="apdn_TwoCustomersConcentrationRiskMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConcentrationRiskNumberOfCustomers" id="apdn_ConcentrationRiskNumberOfCustomers" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>


<element name="WorkingCapitalSurplusDeficit" id="apdn_WorkingCapitalSurplusDeficit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants" id="apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GrossProceedsToRepurchaseRemainingSeriesBWarrants" id="apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProceedsFromPromissoryNotes" id="apdn_ProceedsFromPromissoryNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProceedsFromPromissoryNotesFromRelatedParty" id="apdn_ProceedsFromPromissoryNotesFromRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PresidentChairmanAndChiefExecutiveOfficerMember" id="apdn_PresidentChairmanAndChiefExecutiveOfficerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AnotherIndividualMember" id="apdn_AnotherIndividualMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" id="apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice" id="apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice" id="apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CredeCgIIILtdMember" id="apdn_CredeCgIIILtdMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesWarrantsMember" id="apdn_SeriesWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesBWarrantsMember" id="apdn_SeriesBWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgreementAxis" id="apdn_AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
<element name="AgreementDomain" id="apdn_AgreementDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantRepurchaseOptionAgreementMember" id="apdn_WarrantRepurchaseOptionAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClassOfWarrantOrRightExercised" id="apdn_ClassOfWarrantOrRightExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PercentageOfOptionToPurchaseWarrant" id="apdn_PercentageOfOptionToPurchaseWarrant" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AggregatePurchasePriceOfWarrantExercise" id="apdn_AggregatePurchasePriceOfWarrantExercise" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TermPeriodOfWarrantsOrRightsExercised" id="apdn_TermPeriodOfWarrantsOrRightsExercised" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfDaysOptionGivenToUnderwriters" id="apdn_NumberOfDaysOptionGivenToUnderwriters" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdditionalSharesOfCommonStockPurchaseLimit" id="apdn_AdditionalSharesOfCommonStockPurchaseLimit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdditionalPerSharesOfCommonStockPurchaseLimit" id="apdn_AdditionalPerSharesOfCommonStockPurchaseLimit" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdditionalSharesOfWarrantsPurchaseLimit" id="apdn_AdditionalSharesOfWarrantsPurchaseLimit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdditionalPerSharesOfWarrantsPurchaseLimit" id="apdn_AdditionalPerSharesOfWarrantsPurchaseLimit" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClassOfWarrantOrRightClosedOnUnderwritersExercise" id="apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GrossProceedsFromClosedOnUnderwritersExercise" id="apdn_GrossProceedsFromClosedOnUnderwritersExercise" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise" id="apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GrossProceedsFromAdditionalClosedOnUnderwritersExercise" id="apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfCommonStockIssued" id="apdn_NumberOfCommonStockIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfWarrantsIssued" id="apdn_NumberOfWarrantsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GrossProceedsFromSaleOfCommonStockAndWarrants" id="apdn_GrossProceedsFromSaleOfCommonStockAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdditionalNumberOfSecuritiesCalledByWarrantsOrRights" id="apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights" id="apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationOfferingToConsultant" id="apdn_ShareBasedCompensationOfferingToConsultant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UnderwrittenPublicOfferingMember" id="apdn_UnderwrittenPublicOfferingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharePriceForCommonStock" id="apdn_SharePriceForCommonStock" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharePriceForWarrant" id="apdn_SharePriceForWarrant" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfCommonStockSoldPursuantToOverAllotmentOfOption" id="apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption" id="apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfDaysForOptionToPurchaseAdditionalShares" id="apdn_NumberOfDaysForOptionToPurchaseAdditionalShares" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfAdditionalSharesOfCommonStock" id="apdn_NumberOfAdditionalSharesOfCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfAdditionalWarrantsToCoverOverAllotments" id="apdn_NumberOfAdditionalWarrantsToCoverOverAllotments" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfCommonStockExerciseInOverAllotmentOption" id="apdn_NumberOfCommonStockExerciseInOverAllotmentOption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfWarrantsExerciseInOverAllotmentOption" id="apdn_NumberOfWarrantsExerciseInOverAllotmentOption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GrossProceedsFromExerciseOfOverAllotmentOption" id="apdn_GrossProceedsFromExerciseOfOverAllotmentOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UnderwritersMember" id="apdn_UnderwritersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfWarrantsGrantedAsPartialCompensation" id="apdn_NumberOfWarrantsGrantedAsPartialCompensation" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClassOfWarrantOrRightNumberOfSharesRollForward" id="apdn_ClassOfWarrantOrRightNumberOfSharesRollForward" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClassOfWarrantOrRightGranted" id="apdn_ClassOfWarrantOrRightGranted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClassOfWarrantOrRightForfeituresAndExpirations" id="apdn_ClassOfWarrantOrRightForfeituresAndExpirations" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward" id="apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WeightedAveragePricePerShareWarrantOutstanding" id="apdn_WeightedAveragePricePerShareWarrantOutstanding" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WeightedAveragePricePerShareWarrantGranted" id="apdn_WeightedAveragePricePerShareWarrantGranted" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WeightedAveragePricePerShareWarrantExercised" id="apdn_WeightedAveragePricePerShareWarrantExercised" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WeightedAveragePricePerShareWarrantCancelledOrExpired" id="apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncentiveStockPlan2005Member" id="apdn_IncentiveStockPlan2005Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" id="apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue" id="apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue" id="apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharePriceTwo" id="apdn_SharePriceTwo" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo" id="apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>








<element name="ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted" id="apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommitmentsAndContingenciesTable" id="apdn_CommitmentsAndContingenciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
<element name="EmploymentAgreementMember" id="apdn_EmploymentAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommitmentsAndContingenciesLineItems" id="apdn_CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AreaOfPropertyUnderOperatingLease" id="apdn_AreaOfPropertyUnderOperatingLease" type="num:areaItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="BaseRentDuringInitialLeaseTerm" id="apdn_BaseRentDuringInitialLeaseTerm" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReducedAmountOfSalary" id="apdn_ReducedAmountOfSalary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ThresholdAmountOfSales" id="apdn_ThresholdAmountOfSales" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase" id="apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise" id="apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember" id="apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" abstract="true" nillable="true"/>
<element name="GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo" id="apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" abstract="false" nillable="true" xbrli:balance="debit"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>apdn-20150630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.4 on Saturday, August 08, 2015 03:40:15 AM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
<calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_DeferredCosts" order="40" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet" order="50" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_DeferredRevenueCurrent" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantLiabilityNoncurrent" xlink:label="loc_apdn_WarrantLiabilityNoncurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_apdn_WarrantLiabilityNoncurrent" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_PreferredStockValue" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" order="40" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_Liabilities" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_CommitmentsAndContingencies" order="20" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquity" order="30" use="optional" weight="1"/></calculationLink>





<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" roleURI="http://www.adnas.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"/>
<calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_DepreciationAndAmortization" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_SalesRevenueNet" order="10" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_OperatingExpenses" order="20" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_OperatingIncomeLoss" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_InterestIncomeExpenseNet" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LossOnConversionOfPromissoryNotes" xlink:label="loc_apdn_LossOnConversionOfPromissoryNotes"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_apdn_LossOnConversionOfPromissoryNotes" order="40" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xlink:label="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" order="50" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit" order="20" use="optional" weight="-1"/></calculationLink>



<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" roleURI="http://www.adnas.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"/>
<calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_NetIncomeLoss" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_ShareBasedCompensation" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xlink:label="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" order="40" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LossOnConversionOfPromissoryNotes" xlink:label="loc_apdn_LossOnConversionOfPromissoryNotes"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_apdn_LossOnConversionOfPromissoryNotes" order="50" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommonStockIssuedForConsultingServices" xlink:label="loc_apdn_CommonStockIssuedForConsultingServices"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_apdn_CommonStockIssuedForConsultingServices" order="60" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts" order="70" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" order="80" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="90" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="100" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" order="110" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="10" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets" order="20" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/><loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NetProceedsFromSaleOfCommonStockAndWarrants" xlink:label="loc_apdn_NetProceedsFromSaleOfCommonStockAndWarrants"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_apdn_NetProceedsFromSaleOfCommonStockAndWarrants" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants" xlink:label="loc_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants" order="20" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="10" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="20" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="30" use="optional" weight="1"/></calculationLink>



<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails" roleURI="http://www.adnas.com/role/SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails">





</calculationLink>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#ACCOUNTSPAYABLEANDACCRUEDLIABILITIESSummaryOfAccountsPayableAndAccruedLiabilitiesDetails" roleURI="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESSummaryOfAccountsPayableAndAccruedLiabilitiesDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESSummaryOfAccountsPayableAndAccruedLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableCurrent" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaap_AccruedSalariesCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedSalariesCurrent" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaap_InterestPayableCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_InterestPayableCurrent" order="40" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent" order="50" use="optional" weight="1"/>
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>apdn-20150630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.4 on Saturday, August 08, 2015 03:40:14 AM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" roleURI="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailTextuals1" roleURI="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailTextuals1"/>

<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#PromissoryNotesPayableDetailTextuals" roleURI="http://www.adnas.com/role/PromissoryNotesPayableDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#WarrantLiabilityDetailTextuals" roleURI="http://www.adnas.com/role/WarrantLiabilityDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#RELATEDPARTYTRANSACTIONSDetailTextuals" roleURI="http://www.adnas.com/role/RELATEDPARTYTRANSACTIONSDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CapitalStockDetailTextuals2" roleURI="http://www.adnas.com/role/CapitalStockDetailTextuals2"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CapitalStockDetailTextuals3" roleURI="http://www.adnas.com/role/CapitalStockDetailTextuals3"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#StockOptionsAndWarrantsTransactionsInvolvingStockOptionsIssuedToEmployeesDetails1" roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsTransactionsInvolvingStockOptionsIssuedToEmployeesDetails1"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals" roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals1" roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals1"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#COMMITMENTSANDCONTINGENCIESDetailTextuals" roleURI="http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIESDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#FairValueFairValueMeasurementsOfCommonStockWarrantsUsingSignificantUnobservableInputsLevel3Details" roleURI="http://www.adnas.com/role/FairValueFairValueMeasurementsOfCommonStockWarrantsUsingSignificantUnobservableInputsLevel3Details"/>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AssetsAbstract_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_10" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7" xlink:to="loc_us-gaap_AssetsCurrent_11" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_12" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_13" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_13" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_14" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_13" xlink:to="loc_us-gaap_DeferredCosts_15" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_16" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6" xlink:to="loc_us-gaap_Assets_17" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_19" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_19" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_20" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_19" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_21" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_19" xlink:to="loc_us-gaap_DeferredRevenueCurrent_22" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_19" xlink:to="loc_us-gaap_LiabilitiesCurrent_23" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantLiabilityNoncurrent" xlink:label="loc_apdn_WarrantLiabilityNoncurrent_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_apdn_WarrantLiabilityNoncurrent_24" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_us-gaap_Liabilities_25" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_us-gaap_CommitmentsAndContingencies_26" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_us-gaap_StockholdersEquityAbstract_27" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_27" xlink:to="loc_us-gaap_PreferredStockValue_28" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_27" xlink:to="loc_us-gaap_CommonStockValue_29" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_27" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_30" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_27" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_31" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_27" xlink:to="loc_us-gaap_StockholdersEquity_32" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_33"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_33" order="50" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:label="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_9" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_10" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_11" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_12" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_13" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_14" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_15" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_16" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_17" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_18" order="130" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailTextuals1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0" xlink:to="loc_us-gaap_ConcentrationRiskTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6" xlink:to="loc_us-gaap_SalesMember_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6" xlink:to="loc_us-gaap_AccountsReceivableMember_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaap_MajorCustomersAxis_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_MajorCustomersAxis_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaap_NameOfMajorCustomerDomain_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MajorCustomersAxis_9" xlink:to="loc_us-gaap_NameOfMajorCustomerDomain_10" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaap_NameOfMajorCustomerDomain_10_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MajorCustomersAxis_9" xlink:to="loc_us-gaap_NameOfMajorCustomerDomain_10_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CustomerOneConcentrationRiskMember" xlink:label="loc_apdn_CustomerOneConcentrationRiskMember_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_10" xlink:to="loc_apdn_CustomerOneConcentrationRiskMember_11" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_TwoCustomersConcentrationRiskMember" xlink:label="loc_apdn_TwoCustomersConcentrationRiskMember_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_10" xlink:to="loc_apdn_TwoCustomersConcentrationRiskMember_12" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_13" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDescription" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDescription_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDescription_14" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ConcentrationRiskNumberOfCustomers" xlink:label="loc_apdn_ConcentrationRiskNumberOfCustomers_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0" xlink:to="loc_apdn_ConcentrationRiskNumberOfCustomers_15" order="30" use="optional"/>
</definitionLink>

<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/PromissoryNotesPayableDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaap_ShortTermDebtLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_3" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" xlink:to="loc_us-gaap_RelatedPartyDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" xlink:to="loc_us-gaap_RelatedPartyDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PresidentChairmanAndChiefExecutiveOfficerMember" xlink:label="loc_apdn_PresidentChairmanAndChiefExecutiveOfficerMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_6" xlink:to="loc_apdn_PresidentChairmanAndChiefExecutiveOfficerMember_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AnotherIndividualMember" xlink:label="loc_apdn_AnotherIndividualMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_6" xlink:to="loc_apdn_AnotherIndividualMember_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_10" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentTerm_11" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_12" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_13" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" xlink:label="loc_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest_14" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_15" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice" xlink:label="loc_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice_16" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice" xlink:label="loc_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice_17" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LossOnConversionOfPromissoryNotes" xlink:label="loc_apdn_LossOnConversionOfPromissoryNotes_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_apdn_LossOnConversionOfPromissoryNotes_18" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_InterestExpenseDebt_19" order="110" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/WarrantLiabilityDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_dei_LegalEntityAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2" xlink:to="loc_dei_EntityDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2" xlink:to="loc_dei_EntityDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CredeCgIIILtdMember" xlink:label="loc_apdn_CredeCgIIILtdMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_apdn_CredeCgIIILtdMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SeriesWarrantsMember" xlink:label="loc_apdn_SeriesWarrantsMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_6" xlink:to="loc_apdn_SeriesWarrantsMember_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SeriesBWarrantsMember" xlink:label="loc_apdn_SeriesBWarrantsMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_6" xlink:to="loc_apdn_SeriesBWarrantsMember_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementAxis" xlink:label="loc_apdn_AgreementAxis_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_apdn_AgreementAxis_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementDomain" xlink:label="loc_apdn_AgreementDomain_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_apdn_AgreementAxis_9" xlink:to="loc_apdn_AgreementDomain_10" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementDomain" xlink:label="loc_apdn_AgreementDomain_10_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_apdn_AgreementAxis_9" xlink:to="loc_apdn_AgreementDomain_10_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantRepurchaseOptionAgreementMember" xlink:label="loc_apdn_WarrantRepurchaseOptionAgreementMember_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_apdn_AgreementDomain_10" xlink:to="loc_apdn_WarrantRepurchaseOptionAgreementMember_11" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_12" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_12" xlink:to="loc_us-gaap_EquityComponentDomain_13" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_13_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_12" xlink:to="loc_us-gaap_EquityComponentDomain_13_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_13" xlink:to="loc_us-gaap_WarrantMember_14" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_us-gaap_RangeAxis_15" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_15" xlink:to="loc_us-gaap_RangeMember_16" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_16_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_15" xlink:to="loc_us-gaap_RangeMember_16_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_16" xlink:to="loc_us-gaap_MinimumMember_17" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_16" xlink:to="loc_us-gaap_MaximumMember_18" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightExercised" xlink:label="loc_apdn_ClassOfWarrantOrRightExercised_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_apdn_ClassOfWarrantOrRightExercised_19" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_20" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsValuationTechniques" xlink:label="loc_us-gaap_FairValueMeasurementsValuationTechniques_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_FairValueMeasurementsValuationTechniques_21" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_SharePrice_22" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_23" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedTerm_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedTerm_24" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_25" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_26" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_FairValueAssumptionsExercisePrice_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_FairValueAssumptionsExercisePrice_27" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xlink:label="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability_28" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PercentageOfOptionToPurchaseWarrant" xlink:label="loc_apdn_PercentageOfOptionToPurchaseWarrant_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_apdn_PercentageOfOptionToPurchaseWarrant_29" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AggregatePurchasePriceOfWarrantExercise" xlink:label="loc_apdn_AggregatePurchasePriceOfWarrantExercise_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_apdn_AggregatePurchasePriceOfWarrantExercise_30" order="120" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/RELATEDPARTYTRANSACTIONSDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaap_ShortTermDebtLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_3" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" xlink:to="loc_us-gaap_RelatedPartyDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" xlink:to="loc_us-gaap_RelatedPartyDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PresidentChairmanAndChiefExecutiveOfficerMember" xlink:label="loc_apdn_PresidentChairmanAndChiefExecutiveOfficerMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_6" xlink:to="loc_apdn_PresidentChairmanAndChiefExecutiveOfficerMember_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_10" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" xlink:label="loc_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest_11" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_12" order="50" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CapitalStockDetailTextuals2">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_UnderwrittenPublicOfferingMember" xlink:label="loc_apdn_UnderwrittenPublicOfferingMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" xlink:to="loc_apdn_UnderwrittenPublicOfferingMember_4" order="0" use="optional"/>








<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_us-gaap_CommonStockSharesSubscribedButUnissued_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesSubscribedButUnissued_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharePrice_10" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SharePriceForCommonStock" xlink:label="loc_apdn_SharePriceForCommonStock_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_SharePriceForCommonStock_11" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SharePriceForWarrant" xlink:label="loc_apdn_SharePriceForWarrant_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_SharePriceForWarrant_12" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption" xlink:label="loc_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption_13" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption" xlink:label="loc_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption_14" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_15" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_16" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfDaysForOptionToPurchaseAdditionalShares" xlink:label="loc_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares_17" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfAdditionalSharesOfCommonStock" xlink:label="loc_apdn_NumberOfAdditionalSharesOfCommonStock_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_NumberOfAdditionalSharesOfCommonStock_18" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfAdditionalWarrantsToCoverOverAllotments" xlink:label="loc_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments_19" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfCommonStockExerciseInOverAllotmentOption" xlink:label="loc_apdn_NumberOfCommonStockExerciseInOverAllotmentOption_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_NumberOfCommonStockExerciseInOverAllotmentOption_20" order="130" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsExerciseInOverAllotmentOption" xlink:label="loc_apdn_NumberOfWarrantsExerciseInOverAllotmentOption_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_NumberOfWarrantsExerciseInOverAllotmentOption_21" order="140" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromExerciseOfOverAllotmentOption" xlink:label="loc_apdn_GrossProceedsFromExerciseOfOverAllotmentOption_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_GrossProceedsFromExerciseOfOverAllotmentOption_22" order="150" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CapitalStockDetailTextuals3">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_UnderwrittenPublicOfferingMember" xlink:label="loc_apdn_UnderwrittenPublicOfferingMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" xlink:to="loc_apdn_UnderwrittenPublicOfferingMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_dei_LegalEntityAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_5" xlink:to="loc_dei_EntityDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_5" xlink:to="loc_dei_EntityDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_UnderwritersMember" xlink:label="loc_apdn_UnderwritersMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_6" xlink:to="loc_apdn_UnderwritersMember_7" order="0" use="optional"/>








<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsGrantedAsPartialCompensation" xlink:label="loc_apdn_NumberOfWarrantsGrantedAsPartialCompensation_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_NumberOfWarrantsGrantedAsPartialCompensation_11" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_12" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_13" order="30" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StockOptionsAndWarrantsTransactionsInvolvingStockOptionsIssuedToEmployeesDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_PlanNameAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5" xlink:to="loc_us-gaap_PlanNameDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5" xlink:to="loc_us-gaap_PlanNameDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncentiveStockPlan2005Member" xlink:label="loc_apdn_IncentiveStockPlan2005Member_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6" xlink:to="loc_apdn_IncentiveStockPlan2005Member_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_10" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_11" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_12" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_13" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_14" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_15" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_17" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_18" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_19" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_15" xlink:to="loc_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice_20" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue" xlink:label="loc_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue_21" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue" xlink:label="loc_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue_22" order="40" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_PlanNameAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5" xlink:to="loc_us-gaap_PlanNameDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5" xlink:to="loc_us-gaap_PlanNameDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncentiveStockPlan2005Member" xlink:label="loc_apdn_IncentiveStockPlan2005Member_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6" xlink:to="loc_apdn_IncentiveStockPlan2005Member_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_10" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_11" order="40" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional"/>












<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_10" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_10" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_11" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_11_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_10" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_11_Default" order="0" use="optional"/>










<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember" xlink:label="loc_apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_11" xlink:to="loc_apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember_17" order="50" use="optional"/>










<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_22" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensation_23" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_StockOptionPlanExpense_24" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_25" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_26" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted" xlink:label="loc_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted_27" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="loc_us-gaap_ExecutiveOfficerMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_11" xlink:to="loc_us-gaap_ExecutiveOfficerMember" order="60" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIESDetailTextuals">
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommitmentsAndContingenciesLineItems" xlink:label="loc_apdn_CommitmentsAndContingenciesLineItems_0"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommitmentsAndContingenciesTable" xlink:label="loc_apdn_CommitmentsAndContingenciesTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_apdn_CommitmentsAndContingenciesTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_apdn_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaap_ChiefExecutiveOfficerMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_ChiefExecutiveOfficerMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementAxis" xlink:label="loc_apdn_AgreementAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_apdn_CommitmentsAndContingenciesTable_1" xlink:to="loc_apdn_AgreementAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementDomain" xlink:label="loc_apdn_AgreementDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_apdn_AgreementAxis_5" xlink:to="loc_apdn_AgreementDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementDomain" xlink:label="loc_apdn_AgreementDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_apdn_AgreementAxis_5" xlink:to="loc_apdn_AgreementDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_EmploymentAgreementMember" xlink:label="loc_apdn_EmploymentAgreementMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_apdn_AgreementDomain_6" xlink:to="loc_apdn_EmploymentAgreementMember_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AreaOfPropertyUnderOperatingLease" xlink:label="loc_apdn_AreaOfPropertyUnderOperatingLease_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_apdn_AreaOfPropertyUnderOperatingLease_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm" xlink:label="loc_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_BaseRentDuringInitialLeaseTerm" xlink:label="loc_apdn_BaseRentDuringInitialLeaseTerm_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_apdn_BaseRentDuringInitialLeaseTerm_10" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_11" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ReducedAmountOfSalary" xlink:label="loc_apdn_ReducedAmountOfSalary_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_apdn_ReducedAmountOfSalary_12" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ThresholdAmountOfSales" xlink:label="loc_apdn_ThresholdAmountOfSales_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_apdn_ThresholdAmountOfSales_13" order="60" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/FairValueFairValueMeasurementsOfCommonStockWarrantsUsingSignificantUnobservableInputsLevel3Details">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase" xlink:label="loc_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5" xlink:to="loc_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase_8" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise" xlink:label="loc_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5" xlink:to="loc_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise_9" order="30" use="optional"/>
</definitionLink>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails" roleURI="http://www.adnas.com/role/SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails"/>
<definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails"><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaap_WarrantMember" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" order="1" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_Default" order="1"/>
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>apdn-20150630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.4 on Saturday, August 08, 2015 03:40:15 AM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_DocumentAndEntityInformationAbstract" xlink:label="loc_839743H4G541_apdn_DocumentAndEntityInformationAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document and Entity Information [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document and Entity Information [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_DocumentAndEntityInformationAbstract" xlink:to="lab_051965J6I763_apdn_DocumentAndEntityInformationAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_FG95812277699K094F4I_dei_EntityRegistrantName"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_dei_EntityRegistrantName" xlink:to="lab_HI17034499811M216H6K_dei_EntityRegistrantName"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_839743H4G541_dei_EntityCentralIndexKey"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_dei_EntityCentralIndexKey" xlink:to="lab_051965J6I763_dei_EntityCentralIndexKey"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_FG95812277699K094F4I_dei_TradingSymbol"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_dei_TradingSymbol" xml:lang="en-US">Trading Symbol</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_dei_TradingSymbol" xml:lang="en-US">Trading Symbol</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_dei_TradingSymbol" xlink:to="lab_HI17034499811M216H6K_dei_TradingSymbol"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_839743H4G541_dei_CurrentFiscalYearEndDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_dei_CurrentFiscalYearEndDate" xlink:to="lab_051965J6I763_dei_CurrentFiscalYearEndDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_FG95812277699K094F4I_dei_EntityFilerCategory"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_dei_EntityFilerCategory" xlink:to="lab_HI17034499811M216H6K_dei_EntityFilerCategory"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_839743H4G541_dei_EntityCommonStockSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_051965J6I763_dei_EntityCommonStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_FG95812277699K094F4I_dei_DocumentType"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_dei_DocumentType" xml:lang="en-US">Document Type</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_dei_DocumentType" xlink:to="lab_HI17034499811M216H6K_dei_DocumentType"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_839743H4G541_dei_DocumentPeriodEndDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_dei_DocumentPeriodEndDate" xlink:to="lab_051965J6I763_dei_DocumentPeriodEndDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_FG95812277699K094F4I_dei_AmendmentFlag"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_dei_AmendmentFlag" xlink:to="lab_HI17034499811M216H6K_dei_AmendmentFlag"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_839743H4G541_dei_DocumentFiscalYearFocus"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_dei_DocumentFiscalYearFocus" xlink:to="lab_051965J6I763_dei_DocumentFiscalYearFocus"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_FG95812277699K094F4I_dei_DocumentFiscalPeriodFocus"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_dei_DocumentFiscalPeriodFocus" xlink:to="lab_HI17034499811M216H6K_dei_DocumentFiscalPeriodFocus"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_839743H4G541_us-gaap_StatementOfFinancialPositionAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement Of Financial Position [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_051965J6I763_us-gaap_StatementOfFinancialPositionAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_FG95812277699K094F4I_us-gaap_StatementTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_StatementTable" xlink:to="lab_HI17034499811M216H6K_us-gaap_StatementTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_839743H4G541_us-gaap_StatementClassOfStockAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class Of Stock [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_StatementClassOfStockAxis" xlink:to="lab_051965J6I763_us-gaap_StatementClassOfStockAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_FG95812277699K094F4I_us-gaap_ClassOfStockDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class Of Stock [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ClassOfStockDomain" xlink:to="lab_HI17034499811M216H6K_us-gaap_ClassOfStockDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_839743H4G541_us-gaap_SeriesAPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series A Preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_051965J6I763_us-gaap_SeriesAPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_FG95812277699K094F4I_us-gaap_SeriesBPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SeriesBPreferredStockMember" xml:lang="en-US">Series B Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SeriesBPreferredStockMember" xml:lang="en-US">Series B Preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_HI17034499811M216H6K_us-gaap_SeriesBPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_839743H4G541_us-gaap_StatementLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_StatementLineItems" xlink:to="lab_051965J6I763_us-gaap_StatementLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_FG95812277699K094F4I_us-gaap_AssetsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_AssetsAbstract" xml:lang="en-US">Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_AssetsAbstract" xml:lang="en-US">ASSETS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_AssetsAbstract" xlink:to="lab_HI17034499811M216H6K_us-gaap_AssetsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_839743H4G541_us-gaap_AssetsCurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Assets, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_AssetsCurrentAbstract" xlink:to="lab_051965J6I763_us-gaap_AssetsCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_FG95812277699K094F4I_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents, At Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents at end of period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_HI17034499811M216H6K_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_839743H4G541_us-gaap_AccountsReceivableNetCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts Receivable, Net, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts receivable, net of allowance of $30,228 and $9,634 at June 30, 2015 and September 30, 2014, respectively</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_051965J6I763_us-gaap_AccountsReceivableNetCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_FG95812277699K094F4I_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid expenses and other current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_HI17034499811M216H6K_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_839743H4G541_us-gaap_AssetsCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_AssetsCurrent" xlink:to="lab_051965J6I763_us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_FG95812277699K094F4I_us-gaap_PropertyPlantAndEquipmentNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, Plant and Equipment, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, plant and equipment, net of accumulated depreciation of $743,914 at June 30, 2015 and $759,087 at September 30, 2014</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property plant and equipment, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, Plant and Equipment, Net, Beginning Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, Plant and Equipment, Net, Ending Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_HI17034499811M216H6K_us-gaap_PropertyPlantAndEquipmentNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract" xlink:label="loc_839743H4G541_us-gaap_OtherAssetsNoncurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_OtherAssetsNoncurrentAbstract" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_OtherAssetsNoncurrentAbstract" xml:lang="en-US">Other assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_051965J6I763_us-gaap_OtherAssetsNoncurrentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_FG95812277699K094F4I_us-gaap_DepositsAssetsNoncurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_DepositsAssetsNoncurrent" xml:lang="en-US">Deposits Assets, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DepositsAssetsNoncurrent" xml:lang="en-US">Deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_DepositsAssetsNoncurrent" xlink:to="lab_HI17034499811M216H6K_us-gaap_DepositsAssetsNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCosts" xlink:label="loc_839743H4G541_us-gaap_DeferredCosts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_DeferredCosts" xml:lang="en-US">Deferred Costs, Noncurrent, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_DeferredCosts" xml:lang="en-US">Deferred offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_DeferredCosts" xlink:to="lab_051965J6I763_us-gaap_DeferredCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_FG95812277699K094F4I_us-gaap_FiniteLivedIntangibleAssetsNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Amortization on intangible assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Intangible assets, net of accumulated amortization and impairment of $325,555 and $256,208 at June 30, 2015 and September 30, 2014, respectively</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_HI17034499811M216H6K_us-gaap_FiniteLivedIntangibleAssetsNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_839743H4G541_us-gaap_Assets"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_Assets" xml:lang="en-US">Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_Assets" xml:lang="en-US">Total Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_Assets" xml:lang="en-US">Total Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_Assets" xlink:to="lab_051965J6I763_us-gaap_Assets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_FG95812277699K094F4I_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_HI17034499811M216H6K_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_839743H4G541_us-gaap_LiabilitiesCurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Liabilities, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_051965J6I763_us-gaap_LiabilitiesCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_FG95812277699K094F4I_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xml:lang="en-US">Accounts payable and accrued liabilities, including related party accrued interest of $6,597 at September 30, 2014</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xml:lang="en-US">Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_HI17034499811M216H6K_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_839743H4G541_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xml:lang="en-US">Notes Payable, Related Parties, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xml:lang="en-US">Promissory notes payable, including $1,000,000 with a related party at September 30, 2014</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="lab_051965J6I763_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_FG95812277699K094F4I_us-gaap_DeferredRevenueCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Deferred revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Deferred revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Deferred revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_DeferredRevenueCurrent" xlink:to="lab_HI17034499811M216H6K_us-gaap_DeferredRevenueCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_839743H4G541_us-gaap_LiabilitiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_LiabilitiesCurrent" xlink:to="lab_051965J6I763_us-gaap_LiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantLiabilityNoncurrent" xlink:label="loc_FG95812277699K094F4I_apdn_WarrantLiabilityNoncurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_WarrantLiabilityNoncurrent" xml:lang="en-US">Warrant Liability Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_WarrantLiabilityNoncurrent" xml:lang="en-US">Warrant liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_WarrantLiabilityNoncurrent" xml:lang="en-US">This element represents amount of warrant liability as on the balance sheet date.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_WarrantLiabilityNoncurrent" xlink:to="lab_HI17034499811M216H6K_apdn_WarrantLiabilityNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_839743H4G541_us-gaap_Liabilities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_Liabilities" xml:lang="en-US">Total liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_Liabilities" xlink:to="lab_051965J6I763_us-gaap_Liabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_FG95812277699K094F4I_us-gaap_CommitmentsAndContingencies"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and Contingencies</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and contingencies (Note I)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_CommitmentsAndContingencies" xlink:to="lab_HI17034499811M216H6K_us-gaap_CommitmentsAndContingencies"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_839743H4G541_us-gaap_StockholdersEquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders Equity Attributable To Parent [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' Equity (Deficit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_StockholdersEquityAbstract" xlink:to="lab_051965J6I763_us-gaap_StockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_FG95812277699K094F4I_us-gaap_PreferredStockValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2015 and September 30, 2014</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2014 and September 30, 2013</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued, Beginning Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued, Ending Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_PreferredStockValue" xlink:to="lab_HI17034499811M216H6K_us-gaap_PreferredStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_839743H4G541_us-gaap_CommonStockValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_CommonStockValue" xml:lang="en-US">Common stock, par value $0.001 per share; 500,000,000 and 1,350,000,000 shares authorized at June 30, 2015 and September 30, 2014, respectively; 21,482,202 and 13,935,954 shares issued and outstanding as of June 30, 2015 and September 30, 2014, respectively</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_051965J6I763_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued, Beginning Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_051965J6I763_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued, Ending Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_CommonStockValue" xlink:to="lab_051965J6I763_us-gaap_CommonStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_FG95812277699K094F4I_us-gaap_AdditionalPaidInCapitalCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US">Additional Paid in Capital, Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US">Additional paid in capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_HI17034499811M216H6K_us-gaap_AdditionalPaidInCapitalCommonStock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_839743H4G541_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated losses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_051965J6I763_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit), Beginning Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_051965J6I763_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit), Ending Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_051965J6I763_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_FG95812277699K094F4I_us-gaap_StockholdersEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders' Equity Attributable To Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockholdersEquity" xml:lang="en-US">Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockholdersEquity" xml:lang="en-US">Total stockholders' equity (deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockholdersEquity" xml:lang="en-US">Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockholdersEquity" xml:lang="en-US">Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_StockholdersEquity" xlink:to="lab_HI17034499811M216H6K_us-gaap_StockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_839743H4G541_us-gaap_LiabilitiesAndStockholdersEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total Liabilities and Stockholders' Equity (Deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total Liabilities and Stockholders' Equity (Deficit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_051965J6I763_us-gaap_LiabilitiesAndStockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_FG95812277699K094F4I_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xml:lang="en-US">Allowance on accounts receivable (in dollars)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_HI17034499811M216H6K_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_839743H4G541_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated depreciation on property, plant and equipment (in dollars)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_051965J6I763_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_FG95812277699K094F4I_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xml:lang="en-US">Accumulated amortization and impairment on intangible assets (in dollars)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_HI17034499811M216H6K_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:label="loc_839743H4G541_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xml:lang="en-US">Related Party Transaction, Due from (to) Related Party, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xml:lang="en-US">Related party accrued interest (in dollars)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:to="lab_051965J6I763_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_FG95812277699K094F4I_us-gaap_DebtInstrumentFaceAmount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Debt Instrument, Face Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Convertible promissory note issued to related party in advance for working capital purposes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Promissory note issued to related party (in dollars)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Promissory note issued to related party (in dollars)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentFaceAmount"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_839743H4G541_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, Par Or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock, par value (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_051965J6I763_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_FG95812277699K094F4I_us-gaap_PreferredStockSharesAuthorized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock, shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_HI17034499811M216H6K_us-gaap_PreferredStockSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_839743H4G541_us-gaap_PreferredStockSharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred stock, shares issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued, Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_PreferredStockSharesIssued" xlink:to="lab_051965J6I763_us-gaap_PreferredStockSharesIssued"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_FG95812277699K094F4I_us-gaap_PreferredStockSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred stock, shares outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding, Beginning Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding, Ending Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_HI17034499811M216H6K_us-gaap_PreferredStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_839743H4G541_us-gaap_CommonStockParOrStatedValuePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, Par Or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock, par value (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_051965J6I763_us-gaap_CommonStockParOrStatedValuePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_FG95812277699K094F4I_us-gaap_CommonStockSharesAuthorized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock, shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_839743H4G541_us-gaap_CommonStockSharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock, shares issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued, Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_CommonStockSharesIssued" xlink:to="lab_051965J6I763_us-gaap_CommonStockSharesIssued"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_FG95812277699K094F4I_us-gaap_CommonStockSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common stock, shares outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Balance (in shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Balance (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_839743H4G541_us-gaap_IncomeStatementAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_IncomeStatementAbstract" xlink:to="lab_051965J6I763_us-gaap_IncomeStatementAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_FG95812277699K094F4I_us-gaap_SalesRevenueNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SalesRevenueNet" xml:lang="en-US">Revenue, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SalesRevenueNet" xml:lang="en-US">Revenues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SalesRevenueNet" xml:lang="en-US">Sales</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SalesRevenueNet" xlink:to="lab_HI17034499811M216H6K_us-gaap_SalesRevenueNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_839743H4G541_us-gaap_OperatingExpensesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating Expenses [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating expenses:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_OperatingExpensesAbstract" xlink:to="lab_051965J6I763_us-gaap_OperatingExpensesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_FG95812277699K094F4I_us-gaap_SellingGeneralAndAdministrativeExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SellingGeneralAndAdministrativeExpense" xml:lang="en-US">Selling, General and Administrative Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SellingGeneralAndAdministrativeExpense" xml:lang="en-US">Selling, general and administrative</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SellingGeneralAndAdministrativeExpense" xml:lang="en-US">Selling, general and administrative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_HI17034499811M216H6K_us-gaap_SellingGeneralAndAdministrativeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_839743H4G541_us-gaap_ResearchAndDevelopmentExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and Development Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_051965J6I763_us-gaap_ResearchAndDevelopmentExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_FG95812277699K094F4I_us-gaap_DepreciationAndAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation and amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation and amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_DepreciationAndAmortization" xlink:to="lab_HI17034499811M216H6K_us-gaap_DepreciationAndAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_839743H4G541_us-gaap_OperatingExpenses"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_OperatingExpenses" xml:lang="en-US">Total operating expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_OperatingExpenses" xml:lang="en-US">Total operating expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_OperatingExpenses" xlink:to="lab_051965J6I763_us-gaap_OperatingExpenses"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_FG95812277699K094F4I_us-gaap_OperatingIncomeLoss"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_OperatingIncomeLoss" xml:lang="en-US">NET LOSS FROM OPERATIONS</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_OperatingIncomeLoss" xml:lang="en-US">LOSS FROM OPERATIONS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_OperatingIncomeLoss" xlink:to="lab_HI17034499811M216H6K_us-gaap_OperatingIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_839743H4G541_us-gaap_NonoperatingIncomeExpenseAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Other income (expense):</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_051965J6I763_us-gaap_NonoperatingIncomeExpenseAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_FG95812277699K094F4I_us-gaap_InterestIncomeExpenseNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_InterestIncomeExpenseNet" xml:lang="en-US">Interest Income (Expense), Net, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_InterestIncomeExpenseNet" xml:lang="en-US">Interest income (expense), net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_InterestIncomeExpenseNet" xml:lang="en-US">Interest expense, net (Note C)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_InterestIncomeExpenseNet" xml:lang="en-US">Interest income (expense), net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_HI17034499811M216H6K_us-gaap_InterestIncomeExpenseNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_839743H4G541_us-gaap_OtherNonoperatingIncomeExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US">Other (expense) income, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US">Other (expense) income, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_051965J6I763_us-gaap_OtherNonoperatingIncomeExpense"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LossOnConversionOfPromissoryNotes" xlink:label="loc_FG95812277699K094F4I_apdn_LossOnConversionOfPromissoryNotes"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_LossOnConversionOfPromissoryNotes" xml:lang="en-US">Loss On Conversion Of Promissory Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_LossOnConversionOfPromissoryNotes" xml:lang="en-US">Loss on conversion of promissory notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_LossOnConversionOfPromissoryNotes" xml:lang="en-US">Represent loss on conversion of promissory notes.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_HI17034499811M216H6K_apdn_LossOnConversionOfPromissoryNotes" xml:lang="en-US">Loss on conversion of promissory notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_LossOnConversionOfPromissoryNotes" xml:lang="en-US">Loss on conversion of promissory notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_LossOnConversionOfPromissoryNotes" xlink:to="lab_HI17034499811M216H6K_apdn_LossOnConversionOfPromissoryNotes"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xlink:label="loc_839743H4G541_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xml:lang="en-US">Income Loss From Change In Fair Value Of Warrant Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xml:lang="en-US">Gain (loss) on change in fair value of warrant liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xml:lang="en-US">Gain (loss) on change in fair value of warrant liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xml:lang="en-US">Represent income (loss) from change in fair value of warrant liability.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xml:lang="en-US">Change in fair value of warrant liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xlink:to="lab_051965J6I763_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_FG95812277699K094F4I_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Income (Loss) From Continuing Operations Before Income Taxes, Extraordinary Items, Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Loss before provision for income taxes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Net loss before provision for income taxes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Net loss before provision for income taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_HI17034499811M216H6K_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_839743H4G541_us-gaap_IncomeTaxExpenseBenefit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Provision for income taxes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income taxes (benefit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_051965J6I763_us-gaap_IncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_FG95812277699K094F4I_us-gaap_NetIncomeLoss"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss) Attributable To Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetIncomeLoss" xml:lang="en-US">NET LOSS</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetIncomeLoss" xml:lang="en-US">NET LOSS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_NetIncomeLoss" xlink:to="lab_HI17034499811M216H6K_us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_839743H4G541_us-gaap_EarningsPerShareBasicAndDiluted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Earnings Per Share, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Net Loss per share - basic and diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Net loss per share-basic and diluted (in dollars per share)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Net (loss) per share-basic and fully diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Net loss per share-basic and diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_051965J6I763_us-gaap_EarningsPerShareBasicAndDiluted"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_FG95812277699K094F4I_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US">Weighted average shares outstanding-</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_HI17034499811M216H6K_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_839743H4G541_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted Average Number Of Shares Outstanding, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Basic and diluted (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_051965J6I763_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_FG95812277699K094F4I_us-gaap_StatementOfCashFlowsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement Of Cash Flows [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_HI17034499811M216H6K_us-gaap_StatementOfCashFlowsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_839743H4G541_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Net Cash Provided By (Used In) Operating Activities, Continuing Operations [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Cash flows from operating activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_051965J6I763_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_FG95812277699K094F4I_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments To Reconcile Net Income (Loss) To Cash Provided By (Used In) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_HI17034499811M216H6K_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_839743H4G541_us-gaap_DepreciationDepletionAndAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US">Depreciation and amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US">Depreciation and amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_051965J6I763_us-gaap_DepreciationDepletionAndAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensation" xml:lang="en-US">Stock based compensation expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensation" xml:lang="en-US">Stock-based compensation expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensation" xml:lang="en-US">Stock based compensation expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensation" xml:lang="en-US">Equity based compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensation" xml:lang="en-US">Fair value of vested warrants issued for services</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensation" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensation"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommonStockIssuedForConsultingServices" xlink:label="loc_839743H4G541_apdn_CommonStockIssuedForConsultingServices"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_CommonStockIssuedForConsultingServices" xml:lang="en-US">Common Stock Issued For Consulting Services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_CommonStockIssuedForConsultingServices" xml:lang="en-US">Common stock issued for consulting services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_CommonStockIssuedForConsultingServices" xml:lang="en-US">This element represents amount of common stock issued for consulting services during the period.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_CommonStockIssuedForConsultingServices" xlink:to="lab_051965J6I763_apdn_CommonStockIssuedForConsultingServices"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_FG95812277699K094F4I_us-gaap_ProvisionForDoubtfulAccounts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ProvisionForDoubtfulAccounts" xml:lang="en-US">Provision for Doubtful Accounts</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ProvisionForDoubtfulAccounts" xml:lang="en-US">Bad debt expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_HI17034499811M216H6K_us-gaap_ProvisionForDoubtfulAccounts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_839743H4G541_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Increase (Decrease) In Operating Capital [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Change in operating assets and liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_051965J6I763_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_FG95812277699K094F4I_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Increase (Decrease) In Accounts Receivable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">(Increase) decrease in accounts receivable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Accounts receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_HI17034499811M216H6K_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_839743H4G541_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Increase (Decrease) In Prepaid Expense and Other Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Decrease in prepaid expenses and deposits</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Decrease in prepaid expenses and deposits</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Prepaid expenses and other current assets and deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_051965J6I763_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_FG95812277699K094F4I_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Increase (Decrease) In Accounts Payable and Accrued Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Accounts payable and accrued liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">(Decrease) increase in accounts payable and accrued liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_HI17034499811M216H6K_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_839743H4G541_us-gaap_IncreaseDecreaseInDeferredRevenue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_IncreaseDecreaseInDeferredRevenue" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_IncreaseDecreaseInDeferredRevenue" xml:lang="en-US">Deferred revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_051965J6I763_us-gaap_IncreaseDecreaseInDeferredRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_FG95812277699K094F4I_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US">Net Cash Used In Operating Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US">Operating cash flow</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US">Net cash used in operating activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US">Net cash used in operating activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_839743H4G541_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Net Cash Provided By (Used In) Investing Activities, Continuing Operations [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Cash flows used in investing activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_051965J6I763_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_FG95812277699K094F4I_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Payments To Acquire Property, Plant, and Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Purchase of property and equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Purchase of property plant and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_HI17034499811M216H6K_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_839743H4G541_us-gaap_PaymentsToAcquireIntangibleAssets"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_PaymentsToAcquireIntangibleAssets" xml:lang="en-US">Payments to Acquire Intangible Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_us-gaap_PaymentsToAcquireIntangibleAssets" xml:lang="en-US">Purchase of intangible assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_051965J6I763_us-gaap_PaymentsToAcquireIntangibleAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_FG95812277699K094F4I_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xml:lang="en-US">Net Cash Provided By (Used In) Investing Activities, Continuing Operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xml:lang="en-US">Cash flows from investing activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xml:lang="en-US">Net cash used in investing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_839743H4G541_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Net Cash Provided By (Used In) Financing Activities, Continuing Operations [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Cash flows from financing activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_051965J6I763_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NetProceedsFromSaleOfCommonStockAndWarrants" xlink:label="loc_FG95812277699K094F4I_apdn_NetProceedsFromSaleOfCommonStockAndWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_NetProceedsFromSaleOfCommonStockAndWarrants" xml:lang="en-US">Net Proceeds From Sale Of Common Stock And Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_NetProceedsFromSaleOfCommonStockAndWarrants" xml:lang="en-US">Net proceeds from sale of common stock and warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_NetProceedsFromSaleOfCommonStockAndWarrants" xml:lang="en-US">The cash inflow from common stock and warrants after deducting after deducting underwriting discounts, offering expenses and the repurchase the remaining Series B Warrants from Crede to the entity.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_HI17034499811M216H6K_apdn_NetProceedsFromSaleOfCommonStockAndWarrants" xml:lang="en-US">Net proceeds from sale of common stock and warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_NetProceedsFromSaleOfCommonStockAndWarrants" xlink:to="lab_HI17034499811M216H6K_apdn_NetProceedsFromSaleOfCommonStockAndWarrants"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants" xlink:label="loc_839743H4G541_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants" xml:lang="en-US">Purchase And Cancelation Of Previously Issued Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants" xml:lang="en-US">This element represents purchase and cancelation of previously issued warrants.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants" xml:lang="en-US">Purchase and cancelation of previously issued warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants" xlink:to="lab_051965J6I763_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_FG95812277699K094F4I_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xml:lang="en-US">Net Cash Provided By (Used In) Financing Activities, Continuing Operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xml:lang="en-US">Net cash provided by financing activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xml:lang="en-US">Net cash provided by financing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="lab_HI17034499811M216H6K_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_839743H4G541_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_051965J6I763_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="lab_051965J6I763_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_FG95812277699K094F4I_us-gaap_SupplementalCashFlowInformationAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental Disclosures of Cash Flow Information:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_HI17034499811M216H6K_us-gaap_SupplementalCashFlowInformationAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_839743H4G541_us-gaap_InterestPaid"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_InterestPaid" xml:lang="en-US">Interest Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_InterestPaid" xml:lang="en-US">Cash paid during period for interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_InterestPaid" xlink:to="lab_051965J6I763_us-gaap_InterestPaid"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_FG95812277699K094F4I_us-gaap_IncomeTaxesPaid"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncomeTaxesPaid" xml:lang="en-US">Income Taxes Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_IncomeTaxesPaid" xml:lang="en-US">Cash paid during period for taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_IncomeTaxesPaid" xlink:to="lab_HI17034499811M216H6K_us-gaap_IncomeTaxesPaid"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_839743H4G541_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Non-cash investing and financing activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_051965J6I763_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants" xlink:label="loc_FG95812277699K094F4I_apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants" xml:lang="en-US">Common Stock Issued For Cashless Exercise Of Options And Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants" xml:lang="en-US">Common stock issued for cashless exercise of options and warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants" xml:lang="en-US">This element represents the amount of common stock issued for cashless exercise of options and warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants" xlink:to="lab_HI17034499811M216H6K_apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital" xlink:label="loc_839743H4G541_apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital" xml:lang="en-US">Reclassification Of Deferred Offering Costs To Additional Paid In Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital" xml:lang="en-US">Reclassification of deferred offering costs to additional paid in capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital" xml:lang="en-US">Represents Reclassification of deferred offering costs to additional paid in capital.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital" xlink:to="lab_051965J6I763_apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise" xlink:label="loc_FG95812277699K094F4I_apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise" xml:lang="en-US">Reclassification Of Warrants From Liability To Equity Upon Exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise" xml:lang="en-US">Reclassification of warrants from liability to equity upon exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise" xml:lang="en-US">Represents reclassification of warrants from liability to equity upon exercise in noncash investing and financing activities.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise" xlink:to="lab_HI17034499811M216H6K_apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities" xlink:label="loc_839743H4G541_apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Deferred Offering Costs Included In Accounts Payable And Accrued Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Offering costs incurred, and included in accounts payable and accrued liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Represents value of deferred offering costs incurred, and included in accounts payable and accrued liabilities.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities" xlink:to="lab_051965J6I763_apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable" xlink:label="loc_FG95812277699K094F4I_apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable" xml:lang="en-US">Property Plant And Equipment Acquired Included In Accounts Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable" xml:lang="en-US">Property, plant and equipment acquired, and included in accounts payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable" xml:lang="en-US">It represents property, plant and equipment acquired, included in accounts payable.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable" xlink:to="lab_HI17034499811M216H6K_apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable" xlink:label="loc_839743H4G541_apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable" xml:lang="en-US">Intangible Assets Acquired Included In Accounts Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable" xml:lang="en-US">Intangible assets acquired, and included in accounts payable</label>

<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable" xlink:to="lab_051965J6I763_apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable"/><label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable" xml:lang="en-US">Represents value of intangible assets acquired, and included in accounts payable.</label>

<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_FG95812277699K094F4I_us-gaap_StockIssued1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssued1" xml:lang="en-US">Stock Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssued1" xml:lang="en-US">Common stock issued upon conversion of promissory notes payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_StockIssued1" xlink:to="lab_HI17034499811M216H6K_us-gaap_StockIssued1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_839743H4G541_us-gaap_AccountingPoliciesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_051965J6I763_us-gaap_AccountingPoliciesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xml:lang="en-US">Organization, Consolidation, Basis Of Presentation, Business Description and Accounting Policies [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xml:lang="en-US">Business and Basis of Presentation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xml:lang="en-US">SUMMARY OF ACCOUNTING POLICIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LiquidityAndManagementPlanAbstract" xlink:label="loc_839743H4G541_apdn_LiquidityAndManagementPlanAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_LiquidityAndManagementPlanAbstract" xml:lang="en-US">Liquidity And Management Plan [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_LiquidityAndManagementPlanAbstract" xlink:to="lab_051965J6I763_apdn_LiquidityAndManagementPlanAbstract"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LiquidityAndManagementPlanTextBlock" xlink:label="loc_FG95812277699K094F4I_apdn_LiquidityAndManagementPlanTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_LiquidityAndManagementPlanTextBlock" xml:lang="en-US">Liquidity And Management Plan [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_LiquidityAndManagementPlanTextBlock" xml:lang="en-US">LIQUIDITY AND MANAGEMENT'S PLAN</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_LiquidityAndManagementPlanTextBlock" xml:lang="en-US">The entire disclosure about liquidity and management plan.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_LiquidityAndManagementPlanTextBlock" xlink:to="lab_HI17034499811M216H6K_apdn_LiquidityAndManagementPlanTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_839743H4G541_us-gaap_PayablesAndAccrualsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_PayablesAndAccrualsAbstract" xml:lang="en-US">Payables and Accruals [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_PayablesAndAccrualsAbstract" xml:lang="en-US">Payables and Accruals [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_051965J6I763_us-gaap_PayablesAndAccrualsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:label="loc_839743H4G541_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xml:lang="en-US">Convertible Notes Payable [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="lab_051965J6I763_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_DebtDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtDisclosureTextBlock" xml:lang="en-US">Debt Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtDisclosureTextBlock" xml:lang="en-US">PROMISSORY NOTES PAYABLE</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_DebtDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantLiabilityAbstract" xlink:label="loc_839743H4G541_apdn_WarrantLiabilityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_WarrantLiabilityAbstract" xml:lang="en-US">Warrant Liability [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_WarrantLiabilityAbstract" xml:lang="en-US">Warrant Liability [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_WarrantLiabilityAbstract" xlink:to="lab_051965J6I763_apdn_WarrantLiabilityAbstract"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantLiabilityTextBlock" xlink:label="loc_FG95812277699K094F4I_apdn_WarrantLiabilityTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_WarrantLiabilityTextBlock" xml:lang="en-US">Warrant Liability [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_WarrantLiabilityTextBlock" xml:lang="en-US">WARRANT LIABILITY</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_WarrantLiabilityTextBlock" xml:lang="en-US">The entire disclosure of fair value gain (loss) on warrant liability.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_WarrantLiabilityTextBlock" xlink:to="lab_HI17034499811M216H6K_apdn_WarrantLiabilityTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_839743H4G541_us-gaap_RelatedPartyTransactionsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_051965J6I763_us-gaap_RelatedPartyTransactionsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">RELATED PARTY TRANSACTIONS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_839743H4G541_us-gaap_StockholdersEquityNoteAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US">Capital Stock [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_051965J6I763_us-gaap_StockholdersEquityNoteAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xml:lang="en-US">CAPITAL STOCK</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_839743H4G541_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US">Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_051965J6I763_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">Disclosure Of Compensation Related Costs, Share-Based Payments [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">STOCK OPTIONS AND WARRANTS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_839743H4G541_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_051965J6I763_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_839743H4G541_us-gaap_FairValueDisclosuresAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_FairValueDisclosuresAbstract" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_FairValueDisclosuresAbstract" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_051965J6I763_us-gaap_FairValueDisclosuresAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_FairValueDisclosuresTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US">FAIR VALUE</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_FairValueDisclosuresTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_839743H4G541_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xml:lang="en-US">Business and Basis of Presentation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_051965J6I763_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_RevenueRecognitionPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue Recognition</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_RevenueRecognitionPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_839743H4G541_us-gaap_EarningsPerSharePolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Net Loss Per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_051965J6I763_us-gaap_EarningsPerSharePolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Stock Based Compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_839743H4G541_us-gaap_ConcentrationRiskCreditRisk"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentrations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_051965J6I763_us-gaap_ConcentrationRiskCreditRisk"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">Recent Accounting Pronouncements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_839743H4G541_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US">Schedule of stock issuances under options and warrants that could have a dilutive effect on the shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_051965J6I763_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xml:lang="en-US">Schedule Of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xml:lang="en-US">Schedule of accounts payable and accrued liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock" xlink:label="loc_839743H4G541_apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock" xml:lang="en-US">Schedule Of Disclosure Transactions Of Warrants [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock" xml:lang="en-US">Schedule of transactions involving warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock" xml:lang="en-US">Tabular disclosure of components of transactions of warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock" xlink:to="lab_051965J6I763_apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US">Schedule of summary of transactions involving stock options issued to employees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xml:lang="en-US">Schedule of fair value of options granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_FG95812277699K094F4I_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US">Schedule of fair value measurements of common stock warrants using significant unobservable inputs (Level 3)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_HI17034499811M216H6K_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>













<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_FG95812277699K094F4I_us-gaap_StockholdersEquityReverseStockSplit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockholdersEquityReverseStockSplit" xml:lang="en-US">Stockholders' Equity, Reverse Stock Split</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockholdersEquityReverseStockSplit" xml:lang="en-US">Reverse stock split</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_StockholdersEquityReverseStockSplit" xlink:to="lab_HI17034499811M216H6K_us-gaap_StockholdersEquityReverseStockSplit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:label="loc_839743H4G541_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xml:lang="en-US">Revenue Recognition, Milestone Method, Revenue Recognized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xml:lang="en-US">Revenue for government contract awards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:to="lab_051965J6I763_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_FG95812277699K094F4I_us-gaap_ConcentrationRiskTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskTable" xml:lang="en-US">Concentration Risk [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskTable" xml:lang="en-US">Concentration Risk [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ConcentrationRiskTable" xlink:to="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_839743H4G541_us-gaap_ConcentrationRiskByTypeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ConcentrationRiskByTypeAxis" xml:lang="en-US">Concentration Risk Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_051965J6I763_us-gaap_ConcentrationRiskByTypeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_FG95812277699K094F4I_us-gaap_ConcentrationRiskTypeDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskTypeDomain" xml:lang="en-US">Concentration Risk Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskTypeDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_839743H4G541_us-gaap_CustomerConcentrationRiskMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_CustomerConcentrationRiskMember" xml:lang="en-US">Customer Concentration Risk [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_CustomerConcentrationRiskMember" xml:lang="en-US">Customer Concentration Risk</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_051965J6I763_us-gaap_CustomerConcentrationRiskMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_FG95812277699K094F4I_us-gaap_ConcentrationRiskByBenchmarkAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskByBenchmarkAxis" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskByBenchmarkAxis" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskByBenchmarkAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_839743H4G541_us-gaap_ConcentrationRiskBenchmarkDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ConcentrationRiskBenchmarkDomain" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ConcentrationRiskBenchmarkDomain" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_051965J6I763_us-gaap_ConcentrationRiskBenchmarkDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_FG95812277699K094F4I_us-gaap_SalesMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SalesMember" xml:lang="en-US">Sales [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SalesMember" xml:lang="en-US">Total Revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SalesMember" xlink:to="lab_HI17034499811M216H6K_us-gaap_SalesMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_839743H4G541_us-gaap_AccountsReceivableMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_AccountsReceivableMember" xml:lang="en-US">Accounts Receivable [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_AccountsReceivableMember" xml:lang="en-US">Accounts Receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_AccountsReceivableMember" xlink:to="lab_051965J6I763_us-gaap_AccountsReceivableMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_FG95812277699K094F4I_us-gaap_MajorCustomersAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_MajorCustomersAxis" xml:lang="en-US">Major Customers [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_MajorCustomersAxis" xml:lang="en-US">Concentration Risk Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_MajorCustomersAxis" xlink:to="lab_HI17034499811M216H6K_us-gaap_MajorCustomersAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_839743H4G541_us-gaap_NameOfMajorCustomerDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_NameOfMajorCustomerDomain" xml:lang="en-US">Name Of Major Customer [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_NameOfMajorCustomerDomain" xml:lang="en-US">Concentration Risk Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_NameOfMajorCustomerDomain" xlink:to="lab_051965J6I763_us-gaap_NameOfMajorCustomerDomain"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CustomerOneConcentrationRiskMember" xlink:label="loc_FG95812277699K094F4I_apdn_CustomerOneConcentrationRiskMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_CustomerOneConcentrationRiskMember" xml:lang="en-US">Customer One Concentration Risk [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_CustomerOneConcentrationRiskMember" xml:lang="en-US">Customer One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_CustomerOneConcentrationRiskMember" xml:lang="en-US">Reflects the percentage that revenues in the period from customer is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_CustomerOneConcentrationRiskMember" xlink:to="lab_HI17034499811M216H6K_apdn_CustomerOneConcentrationRiskMember"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_TwoCustomersConcentrationRiskMember" xlink:label="loc_839743H4G541_apdn_TwoCustomersConcentrationRiskMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_TwoCustomersConcentrationRiskMember" xml:lang="en-US">Two Customers Concentration Risk [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_TwoCustomersConcentrationRiskMember" xml:lang="en-US">Two customers</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_TwoCustomersConcentrationRiskMember" xml:lang="en-US">Reflects the percentage that revenues in the period from customer is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_TwoCustomersConcentrationRiskMember" xlink:to="lab_051965J6I763_apdn_TwoCustomersConcentrationRiskMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_FG95812277699K094F4I_us-gaap_ConcentrationRiskLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskLineItems" xml:lang="en-US">Concentration Risk [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskLineItems" xml:lang="en-US">Concentration Risk [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_839743H4G541_us-gaap_ConcentrationRiskPercentage1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Concentration Risk, Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Percentage of total revenue and accounts receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_051965J6I763_us-gaap_ConcentrationRiskPercentage1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDescription" xlink:label="loc_FG95812277699K094F4I_us-gaap_ConcentrationRiskBenchmarkDescription"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskBenchmarkDescription" xml:lang="en-US">Concentration Risk, Benchmark Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskBenchmarkDescription" xml:lang="en-US">Concentration risk benchmark description</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ConcentrationRiskBenchmarkDescription" xlink:to="lab_HI17034499811M216H6K_us-gaap_ConcentrationRiskBenchmarkDescription"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ConcentrationRiskNumberOfCustomers" xlink:label="loc_839743H4G541_apdn_ConcentrationRiskNumberOfCustomers"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ConcentrationRiskNumberOfCustomers" xml:lang="en-US">Concentration Risk Number Of Customers</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ConcentrationRiskNumberOfCustomers" xml:lang="en-US">Number of customers</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ConcentrationRiskNumberOfCustomers" xml:lang="en-US">It represents number of major customers in concentration risk.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ConcentrationRiskNumberOfCustomers" xlink:to="lab_051965J6I763_apdn_ConcentrationRiskNumberOfCustomers"/>







<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_FG95812277699K094F4I_us-gaap_SubsequentEventTypeDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_HI17034499811M216H6K_us-gaap_SubsequentEventTypeDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_839743H4G541_us-gaap_SubsequentEventMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_SubsequentEventMember" xlink:to="lab_051965J6I763_us-gaap_SubsequentEventMember"/>




<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WorkingCapitalSurplusDeficit" xlink:label="loc_839743H4G541_apdn_WorkingCapitalSurplusDeficit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_WorkingCapitalSurplusDeficit" xml:lang="en-US">Working Capital Surplus Deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_WorkingCapitalSurplusDeficit" xml:lang="en-US">Working capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_WorkingCapitalSurplusDeficit" xml:lang="en-US">It represents working capital surplus deficit.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_WorkingCapitalSurplusDeficit" xlink:to="lab_051965J6I763_apdn_WorkingCapitalSurplusDeficit"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants" xlink:label="loc_FG95812277699K094F4I_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants" xml:lang="en-US">Gross Proceeds From Underwritten Public Offering Of Common Stock And Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants" xml:lang="en-US">Gross proceeds from underwritten public offering of common stock and warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants" xml:lang="en-US">Represents gross proceeds from underwritten public offering of common stock and warrants on closure.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants" xlink:to="lab_HI17034499811M216H6K_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants" xlink:label="loc_839743H4G541_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants" xml:lang="en-US">Gross Proceeds To Repurchase Remaining Series B Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants" xml:lang="en-US">Gross proceeds to repurchase remaining Series B Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants" xml:lang="en-US">The cash inflow from gross proceeds to repurchase the remaining Series B Warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants" xlink:to="lab_051965J6I763_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_FG95812277699K094F4I_us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xml:lang="en-US">Proceeds from Issuance of Private Placement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xml:lang="en-US">Proceeds from issuance of private placement of common stock and warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xml:lang="en-US">Net proceeds from sale of common stock and warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_HI17034499811M216H6K_us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ProceedsFromPromissoryNotes" xlink:label="loc_839743H4G541_apdn_ProceedsFromPromissoryNotes"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ProceedsFromPromissoryNotes" xml:lang="en-US">Proceeds From Promissory Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ProceedsFromPromissoryNotes" xml:lang="en-US">Proceeds from promissory notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ProceedsFromPromissoryNotes" xml:lang="en-US">The cash inflow from promissory notes to the entity.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ProceedsFromPromissoryNotes" xlink:to="lab_051965J6I763_apdn_ProceedsFromPromissoryNotes"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ProceedsFromPromissoryNotesFromRelatedParty" xlink:label="loc_FG95812277699K094F4I_apdn_ProceedsFromPromissoryNotesFromRelatedParty"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_ProceedsFromPromissoryNotesFromRelatedParty" xml:lang="en-US">Proceeds From Promissory Notes From Related Party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_ProceedsFromPromissoryNotesFromRelatedParty" xml:lang="en-US">Proceeds from promissory notes from related party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_ProceedsFromPromissoryNotesFromRelatedParty" xml:lang="en-US">The cash inflow from promissory notes through related party to the entity.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_ProceedsFromPromissoryNotesFromRelatedParty" xlink:to="lab_HI17034499811M216H6K_apdn_ProceedsFromPromissoryNotesFromRelatedParty"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_839743H4G541_us-gaap_AccountsPayableCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_AccountsPayableCurrent" xlink:to="lab_051965J6I763_us-gaap_AccountsPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_FG95812277699K094F4I_us-gaap_AccruedProfessionalFeesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_AccruedProfessionalFeesCurrent" xml:lang="en-US">Accrued Professional Fees, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_AccruedProfessionalFeesCurrent" xml:lang="en-US">Accrued consulting fees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_HI17034499811M216H6K_us-gaap_AccruedProfessionalFeesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_839743H4G541_us-gaap_AccruedSalariesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_AccruedSalariesCurrent" xml:lang="en-US">Accrued Salaries, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_AccruedSalariesCurrent" xml:lang="en-US">Accrued salaries payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_AccruedSalariesCurrent" xlink:to="lab_051965J6I763_us-gaap_AccruedSalariesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_FG95812277699K094F4I_us-gaap_InterestPayableCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_InterestPayableCurrent" xml:lang="en-US">Interest Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_InterestPayableCurrent" xml:lang="en-US">Accrued interest payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_InterestPayableCurrent" xlink:to="lab_HI17034499811M216H6K_us-gaap_InterestPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_839743H4G541_us-gaap_OtherAccruedLiabilitiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_OtherAccruedLiabilitiesCurrent" xml:lang="en-US">Other Accrued Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_OtherAccruedLiabilitiesCurrent" xml:lang="en-US">Other accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_051965J6I763_us-gaap_OtherAccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_FG95812277699K094F4I_us-gaap_ScheduleOfShortTermDebtTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ScheduleOfShortTermDebtTable" xml:lang="en-US">Schedule of Short-term Debt [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_HI17034499811M216H6K_us-gaap_ScheduleOfShortTermDebtTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_839743H4G541_us-gaap_ShortTermDebtTypeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShortTermDebtTypeAxis" xml:lang="en-US">Short-term Debt, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_051965J6I763_us-gaap_ShortTermDebtTypeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShortTermDebtTypeDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShortTermDebtTypeDomain" xml:lang="en-US">Short-term Debt, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShortTermDebtTypeDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_839743H4G541_us-gaap_ConvertibleNotesPayableMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ConvertibleNotesPayableMember" xml:lang="en-US">Convertible Notes Payable [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ConvertibleNotesPayableMember" xml:lang="en-US">Promissory notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_051965J6I763_us-gaap_ConvertibleNotesPayableMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_FG95812277699K094F4I_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_HI17034499811M216H6K_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_839743H4G541_us-gaap_RelatedPartyDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_RelatedPartyDomain" xlink:to="lab_051965J6I763_us-gaap_RelatedPartyDomain"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PresidentChairmanAndChiefExecutiveOfficerMember" xlink:label="loc_FG95812277699K094F4I_apdn_PresidentChairmanAndChiefExecutiveOfficerMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_PresidentChairmanAndChiefExecutiveOfficerMember" xml:lang="en-US">President, Chairman And Chief Executive Officer [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_PresidentChairmanAndChiefExecutiveOfficerMember" xml:lang="en-US">Chief Executive Officer</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_PresidentChairmanAndChiefExecutiveOfficerMember" xml:lang="en-US">James A. Hayward</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_PresidentChairmanAndChiefExecutiveOfficerMember" xml:lang="en-US">Represents President, Chairman and Chief Executive Officer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_PresidentChairmanAndChiefExecutiveOfficerMember" xlink:to="lab_HI17034499811M216H6K_apdn_PresidentChairmanAndChiefExecutiveOfficerMember"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AnotherIndividualMember" xlink:label="loc_839743H4G541_apdn_AnotherIndividualMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_AnotherIndividualMember" xml:lang="en-US">Another Individual [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_AnotherIndividualMember" xml:lang="en-US">Another individual</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_AnotherIndividualMember" xml:lang="en-US">Represents another individual who is also "accredited investors" as defined in regulations promulgated under the Securities Act of 1933, as amended (the "Securities Act").</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_AnotherIndividualMember" xlink:to="lab_051965J6I763_apdn_AnotherIndividualMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShortTermDebtLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShortTermDebtLineItems" xml:lang="en-US">Short-term Debt [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShortTermDebtLineItems" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShortTermDebtLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_839743H4G541_us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Convertible promissory note, Interest rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Interest rate on promissory note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_051965J6I763_us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_FG95812277699K094F4I_us-gaap_DebtInstrumentTerm"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentTerm" xml:lang="en-US">Debt Instrument, Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentTerm" xml:lang="en-US">Promissory notes maturity term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_DebtInstrumentTerm" xlink:to="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentTerm"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:label="loc_839743H4G541_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xml:lang="en-US">Debt instrument, convertible, threshold consecutive trading days</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:to="lab_051965J6I763_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_FG95812277699K094F4I_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Stock Issued During Period, Shares, Conversion Of Convertible Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Common stock and warrants issued in settlement of convertible debentures and interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" xlink:label="loc_839743H4G541_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" xml:lang="en-US">Number Of Shares Issued In Settlement Of Convertible Notes And Accrued Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" xml:lang="en-US">Number of shares issued in settlement of convertible notes and accrued interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" xml:lang="en-US">Number of shares issued in settlement of convertible notes and accrued interest.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" xlink:to="lab_051965J6I763_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_FG95812277699K094F4I_us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US">Conversion price of convertible promissory note converted (in dollars per share)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US">Conversion price of convertible promissory note converted into common stock (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_HI17034499811M216H6K_us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice" xlink:label="loc_839743H4G541_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice" xml:lang="en-US">Debt Instrument Convertible For One Share Of Common Stock Conversion Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice" xml:lang="en-US">Conversion price of convertible promissory note converted into common stock (in dollars per share)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice" xml:lang="en-US">The price per share of common stock of the conversion feature embedded in the debt instrument.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice" xlink:to="lab_051965J6I763_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice" xlink:label="loc_FG95812277699K094F4I_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice" xml:lang="en-US">Debt Instrument Convertible For One Share Of Warrant Conversion Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice" xml:lang="en-US">Conversion price of convertible promissory note converted into warrant (in dollars per share)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice" xml:lang="en-US">The price per share of warrant of the conversion feature embedded in the debt instrument.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice" xlink:to="lab_HI17034499811M216H6K_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_839743H4G541_us-gaap_InterestExpenseDebt"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_InterestExpenseDebt" xml:lang="en-US">Interest Expense, Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_InterestExpenseDebt" xml:lang="en-US">Interest expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_InterestExpenseDebt" xlink:to="lab_051965J6I763_us-gaap_InterestExpenseDebt"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_FG95812277699K094F4I_us-gaap_ClassOfWarrantOrRightTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ClassOfWarrantOrRightTable" xml:lang="en-US">Class of Warrant or Right [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ClassOfWarrantOrRightTable" xml:lang="en-US">Class of Warrant or Right [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_HI17034499811M216H6K_us-gaap_ClassOfWarrantOrRightTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_839743H4G541_dei_LegalEntityAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_dei_LegalEntityAxis" xlink:to="lab_051965J6I763_dei_LegalEntityAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_FG95812277699K094F4I_dei_EntityDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_dei_EntityDomain" xlink:to="lab_HI17034499811M216H6K_dei_EntityDomain"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CredeCgIIILtdMember" xlink:label="loc_839743H4G541_apdn_CredeCgIIILtdMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_CredeCgIIILtdMember" xml:lang="en-US">Crede Cg I I I Ltd [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_CredeCgIIILtdMember" xml:lang="en-US">Crede CG III, Ltd</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_CredeCgIIILtdMember" xml:lang="en-US">Represents information about Crede CG III, Ltd.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_CredeCgIIILtdMember" xlink:to="lab_051965J6I763_apdn_CredeCgIIILtdMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_FG95812277699K094F4I_us-gaap_ClassOfWarrantOrRightAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class Of Warrant Or Right [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_HI17034499811M216H6K_us-gaap_ClassOfWarrantOrRightAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_839743H4G541_us-gaap_ClassOfWarrantOrRightDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class Of Warrant Or Right [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightDomain"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SeriesWarrantsMember" xlink:label="loc_FG95812277699K094F4I_apdn_SeriesWarrantsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_SeriesWarrantsMember" xml:lang="en-US">Series Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_SeriesWarrantsMember" xml:lang="en-US">Series A Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_SeriesWarrantsMember" xml:lang="en-US">Represents the series A warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_SeriesWarrantsMember" xlink:to="lab_HI17034499811M216H6K_apdn_SeriesWarrantsMember"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SeriesBWarrantsMember" xlink:label="loc_839743H4G541_apdn_SeriesBWarrantsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_SeriesBWarrantsMember" xml:lang="en-US">Series B Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_SeriesBWarrantsMember" xml:lang="en-US">Series B Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_SeriesBWarrantsMember" xml:lang="en-US">Represents the series B warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_SeriesBWarrantsMember" xlink:to="lab_051965J6I763_apdn_SeriesBWarrantsMember"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementAxis" xlink:label="loc_FG95812277699K094F4I_apdn_AgreementAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_AgreementAxis" xml:lang="en-US">Agreement [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_AgreementAxis" xml:lang="en-US">Agreement [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_AgreementAxis" xml:lang="en-US">Information related to an agreement which represents negotiated and usually legally enforceable understanding between two or more legally competent parties.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_AgreementAxis" xlink:to="lab_HI17034499811M216H6K_apdn_AgreementAxis"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementDomain" xlink:label="loc_839743H4G541_apdn_AgreementDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_AgreementDomain" xml:lang="en-US">Agreement [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_AgreementDomain" xml:lang="en-US">Agreement [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_AgreementDomain" xml:lang="en-US">Information related to an agreement which represents negotiated and usually legally enforceable understanding between two or more legally competent parties.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_AgreementDomain" xlink:to="lab_051965J6I763_apdn_AgreementDomain"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantRepurchaseOptionAgreementMember" xlink:label="loc_FG95812277699K094F4I_apdn_WarrantRepurchaseOptionAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_WarrantRepurchaseOptionAgreementMember" xml:lang="en-US">Warrant Repurchase Option Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_WarrantRepurchaseOptionAgreementMember" xml:lang="en-US">Warrant repurchase option agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_WarrantRepurchaseOptionAgreementMember" xml:lang="en-US">Represents warrant repurchase option agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_WarrantRepurchaseOptionAgreementMember" xlink:to="lab_HI17034499811M216H6K_apdn_WarrantRepurchaseOptionAgreementMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_839743H4G541_us-gaap_StatementEquityComponentsAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_051965J6I763_us-gaap_StatementEquityComponentsAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_FG95812277699K094F4I_us-gaap_EquityComponentDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_EquityComponentDomain" xlink:to="lab_HI17034499811M216H6K_us-gaap_EquityComponentDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_839743H4G541_us-gaap_WarrantMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_WarrantMember" xml:lang="en-US">Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_WarrantMember" xlink:to="lab_051965J6I763_us-gaap_WarrantMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_FG95812277699K094F4I_us-gaap_RangeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_RangeAxis" xml:lang="en-US">Range [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_RangeAxis" xlink:to="lab_HI17034499811M216H6K_us-gaap_RangeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_839743H4G541_us-gaap_RangeMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_RangeMember" xml:lang="en-US">Range [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_RangeMember" xlink:to="lab_051965J6I763_us-gaap_RangeMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_FG95812277699K094F4I_us-gaap_MinimumMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_MinimumMember" xml:lang="en-US">Minimum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_MinimumMember" xlink:to="lab_HI17034499811M216H6K_us-gaap_MinimumMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_839743H4G541_us-gaap_MaximumMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_MaximumMember" xml:lang="en-US">Maximum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_MaximumMember" xlink:to="lab_051965J6I763_us-gaap_MaximumMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_FG95812277699K094F4I_us-gaap_ClassOfWarrantOrRightLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ClassOfWarrantOrRightLineItems" xml:lang="en-US">Class of Warrant or Right [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ClassOfWarrantOrRightLineItems" xml:lang="en-US">Class of Warrant or Right [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_HI17034499811M216H6K_us-gaap_ClassOfWarrantOrRightLineItems"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightExercised" xlink:label="loc_839743H4G541_apdn_ClassOfWarrantOrRightExercised"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightExercised" xml:lang="en-US">Class Of Warrant Or Right Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightExercised" xml:lang="en-US">Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightExercised" xml:lang="en-US">Cashless exercise of warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightExercised" xml:lang="en-US">Represents the number of warrants exercised by participants.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightExercised" xml:lang="en-US">Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ClassOfWarrantOrRightExercised" xlink:to="lab_051965J6I763_apdn_ClassOfWarrantOrRightExercised"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_FG95812277699K094F4I_us-gaap_FairValueAdjustmentOfWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Fair value of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_HI17034499811M216H6K_us-gaap_FairValueAdjustmentOfWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsValuationTechniques" xlink:label="loc_839743H4G541_us-gaap_FairValueMeasurementsValuationTechniques"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_FairValueMeasurementsValuationTechniques" xml:lang="en-US">Fair Value Measurements, Valuation Techniques</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_FairValueMeasurementsValuationTechniques" xml:lang="en-US">Method used for determining allocated fair value of the Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_FairValueMeasurementsValuationTechniques" xlink:to="lab_051965J6I763_us-gaap_FairValueMeasurementsValuationTechniques"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_FG95812277699K094F4I_us-gaap_SharePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharePrice" xml:lang="en-US">Combined offering price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharePrice" xml:lang="en-US">Stock price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharePrice" xml:lang="en-US">Fair value of common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharePrice" xml:lang="en-US">Stock price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SharePrice" xlink:to="lab_HI17034499811M216H6K_us-gaap_SharePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_839743H4G541_us-gaap_FairValueAssumptionsExpectedDividendRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_FairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Fair Value Assumptions, Expected Dividend Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_FairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Dividend yield</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:to="lab_051965J6I763_us-gaap_FairValueAssumptionsExpectedDividendRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_FG95812277699K094F4I_us-gaap_FairValueAssumptionsExpectedTerm"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueAssumptionsExpectedTerm" xml:lang="en-US">Fair Value Assumptions, Expected Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueAssumptionsExpectedTerm" xml:lang="en-US">Expected terms</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="lab_HI17034499811M216H6K_us-gaap_FairValueAssumptionsExpectedTerm"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_839743H4G541_us-gaap_FairValueAssumptionsRiskFreeInterestRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_FairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Risk Free Rate Assumed As Per Black Scholes Option Pricing Model</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_FairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Risk free interest rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_051965J6I763_us-gaap_FairValueAssumptionsRiskFreeInterestRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_FG95812277699K094F4I_us-gaap_FairValueAssumptionsExpectedVolatilityRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Volatility Assumed As Per Black Scholes Option Pricing Model</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Expected volatility</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_HI17034499811M216H6K_us-gaap_FairValueAssumptionsExpectedVolatilityRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_839743H4G541_us-gaap_FairValueAssumptionsExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_FairValueAssumptionsExercisePrice" xml:lang="en-US">Fair Value Assumptions, Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_FairValueAssumptionsExercisePrice" xml:lang="en-US">Expected price at which holders exercise warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_FairValueAssumptionsExercisePrice" xlink:to="lab_051965J6I763_us-gaap_FairValueAssumptionsExercisePrice"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PercentageOfOptionToPurchaseWarrant" xlink:label="loc_FG95812277699K094F4I_apdn_PercentageOfOptionToPurchaseWarrant"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_PercentageOfOptionToPurchaseWarrant" xml:lang="en-US">Percentage Of Option To Purchase Warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_PercentageOfOptionToPurchaseWarrant" xml:lang="en-US">Percentage of option to purchase warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_PercentageOfOptionToPurchaseWarrant" xml:lang="en-US">Represents range of percentage of option to purchase warrant.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_PercentageOfOptionToPurchaseWarrant" xlink:to="lab_HI17034499811M216H6K_apdn_PercentageOfOptionToPurchaseWarrant"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AggregatePurchasePriceOfWarrantExercise" xlink:label="loc_839743H4G541_apdn_AggregatePurchasePriceOfWarrantExercise"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_AggregatePurchasePriceOfWarrantExercise" xml:lang="en-US">Aggregate Purchase Price Of Warrant Exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_AggregatePurchasePriceOfWarrantExercise" xml:lang="en-US">Aggregate purchase price of warrant exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_AggregatePurchasePriceOfWarrantExercise" xml:lang="en-US">Represents aggregate purchase price of warrant exercise.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_AggregatePurchasePriceOfWarrantExercise" xlink:to="lab_051965J6I763_apdn_AggregatePurchasePriceOfWarrantExercise"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_FG95812277699K094F4I_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Underwritten public offering of common stock and warrants closed</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Number of shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_839743H4G541_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Number of common stock called by warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Number of common stock called by warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/zeroLabel" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Aggregate shares of common stock issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_TermPeriodOfWarrantsOrRightsExercised" xlink:label="loc_FG95812277699K094F4I_apdn_TermPeriodOfWarrantsOrRightsExercised"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_TermPeriodOfWarrantsOrRightsExercised" xml:lang="en-US">Term Period Of Warrants Or Rights Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_TermPeriodOfWarrantsOrRightsExercised" xml:lang="en-US">Period of warrant exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_TermPeriodOfWarrantsOrRightsExercised" xml:lang="en-US">Represents term period of warrants or rights exercised.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_TermPeriodOfWarrantsOrRightsExercised" xlink:to="lab_HI17034499811M216H6K_apdn_TermPeriodOfWarrantsOrRightsExercised"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_839743H4G541_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Exercise price of warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Exercise Prices</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfDaysOptionGivenToUnderwriters" xlink:label="loc_FG95812277699K094F4I_apdn_NumberOfDaysOptionGivenToUnderwriters"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfDaysOptionGivenToUnderwriters" xml:lang="en-US">Number Of Days Option Given To Underwriters</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfDaysOptionGivenToUnderwriters" xml:lang="en-US">Number of days option given to underwriters</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfDaysOptionGivenToUnderwriters" xml:lang="en-US">Represents number of days option given to underwriters.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_NumberOfDaysOptionGivenToUnderwriters" xlink:to="lab_HI17034499811M216H6K_apdn_NumberOfDaysOptionGivenToUnderwriters"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalSharesOfCommonStockPurchaseLimit" xlink:label="loc_839743H4G541_apdn_AdditionalSharesOfCommonStockPurchaseLimit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_AdditionalSharesOfCommonStockPurchaseLimit" xml:lang="en-US">Additional Shares Of Common Stock Purchase Limit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_AdditionalSharesOfCommonStockPurchaseLimit" xml:lang="en-US">Additional common stock purchase limit given to underwriters</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_AdditionalSharesOfCommonStockPurchaseLimit" xml:lang="en-US">Represents additional shares of common stock purchase limit given to underwriters.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_AdditionalSharesOfCommonStockPurchaseLimit" xlink:to="lab_051965J6I763_apdn_AdditionalSharesOfCommonStockPurchaseLimit"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalPerSharesOfCommonStockPurchaseLimit" xlink:label="loc_FG95812277699K094F4I_apdn_AdditionalPerSharesOfCommonStockPurchaseLimit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_AdditionalPerSharesOfCommonStockPurchaseLimit" xml:lang="en-US">Additional Per Shares Of Common Stock Purchase Limit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_AdditionalPerSharesOfCommonStockPurchaseLimit" xml:lang="en-US">Additional common stock per share purchase limit given to underwriters</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_AdditionalPerSharesOfCommonStockPurchaseLimit" xml:lang="en-US">Represents additional per shares of common stock purchase limit given to underwriters.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_AdditionalPerSharesOfCommonStockPurchaseLimit" xlink:to="lab_HI17034499811M216H6K_apdn_AdditionalPerSharesOfCommonStockPurchaseLimit"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalSharesOfWarrantsPurchaseLimit" xlink:label="loc_839743H4G541_apdn_AdditionalSharesOfWarrantsPurchaseLimit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_AdditionalSharesOfWarrantsPurchaseLimit" xml:lang="en-US">Additional Shares Of Warrants Purchase Limit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_AdditionalSharesOfWarrantsPurchaseLimit" xml:lang="en-US">Additional warrants purchase limit given to underwriters</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_AdditionalSharesOfWarrantsPurchaseLimit" xml:lang="en-US">Represents additional warrants purchase limit given to underwriters.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_AdditionalSharesOfWarrantsPurchaseLimit" xlink:to="lab_051965J6I763_apdn_AdditionalSharesOfWarrantsPurchaseLimit"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalPerSharesOfWarrantsPurchaseLimit" xlink:label="loc_FG95812277699K094F4I_apdn_AdditionalPerSharesOfWarrantsPurchaseLimit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_AdditionalPerSharesOfWarrantsPurchaseLimit" xml:lang="en-US">Additional Per Shares Of Warrants Purchase Limit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_AdditionalPerSharesOfWarrantsPurchaseLimit" xml:lang="en-US">Additional per share warrants purchase limit given to underwriters</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_AdditionalPerSharesOfWarrantsPurchaseLimit" xml:lang="en-US">Represents additional per share warrants purchase limit given to underwriters.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_AdditionalPerSharesOfWarrantsPurchaseLimit" xlink:to="lab_HI17034499811M216H6K_apdn_AdditionalPerSharesOfWarrantsPurchaseLimit"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise" xlink:label="loc_839743H4G541_apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise" xml:lang="en-US">Class Of Warrant Or Right Closed On Underwriters Exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise" xml:lang="en-US">Number of warrants for which underwriters' close exercise of its over-allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise" xml:lang="en-US">Represents number of warrants for closed on the underwriters exercise of its over-allotment option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise" xlink:to="lab_051965J6I763_apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromClosedOnUnderwritersExercise" xlink:label="loc_FG95812277699K094F4I_apdn_GrossProceedsFromClosedOnUnderwritersExercise"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_GrossProceedsFromClosedOnUnderwritersExercise" xml:lang="en-US">Gross Proceeds From Closed On Underwriters Exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_GrossProceedsFromClosedOnUnderwritersExercise" xml:lang="en-US">Gross proceeds from closed on underwriters exercise of over-allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_GrossProceedsFromClosedOnUnderwritersExercise" xml:lang="en-US">Represents gross proceeds from closed on the underwriters exercise of its over-allotment option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_GrossProceedsFromClosedOnUnderwritersExercise" xlink:to="lab_HI17034499811M216H6K_apdn_GrossProceedsFromClosedOnUnderwritersExercise"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise" xlink:label="loc_839743H4G541_apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise" xml:lang="en-US">Class Of Warrant Or Right Additional Closed On Underwriters Exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise" xml:lang="en-US">Common stock closed on underwriters additional exercise of over-allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise" xml:lang="en-US">Represents number of additional common stock for closed on the underwriters exercise of its over-allotment option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise" xlink:to="lab_051965J6I763_apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise" xlink:label="loc_FG95812277699K094F4I_apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise" xml:lang="en-US">Gross Proceeds From Additional Closed On Underwriters Exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise" xml:lang="en-US">Gross proceeds from closed on underwriters additional exercise of over-allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise" xml:lang="en-US">Represents gross proceeds from additional closed on the underwriters exercise of its over-allotment option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise" xlink:to="lab_HI17034499811M216H6K_apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfCommonStockIssued" xlink:label="loc_839743H4G541_apdn_NumberOfCommonStockIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_NumberOfCommonStockIssued" xml:lang="en-US">Number Of Common Stock Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_NumberOfCommonStockIssued" xml:lang="en-US">Number of common stock including the exercise of over allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_NumberOfCommonStockIssued" xml:lang="en-US">Represents number of common stock issued under this offering, including the exercise of the over allotment option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_NumberOfCommonStockIssued" xlink:to="lab_051965J6I763_apdn_NumberOfCommonStockIssued"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsIssued" xlink:label="loc_FG95812277699K094F4I_apdn_NumberOfWarrantsIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsIssued" xml:lang="en-US">Number Of Warrants Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsIssued" xml:lang="en-US">Number of warrant issued including the exercise of over allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsIssued" xml:lang="en-US">Represents number of warrants issued under this offering, including the exercise of the over allotment option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_NumberOfWarrantsIssued" xlink:to="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsIssued"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromSaleOfCommonStockAndWarrants" xlink:label="loc_839743H4G541_apdn_GrossProceedsFromSaleOfCommonStockAndWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_GrossProceedsFromSaleOfCommonStockAndWarrants" xml:lang="en-US">Gross Proceeds From Sale Of Common Stock And Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_GrossProceedsFromSaleOfCommonStockAndWarrants" xml:lang="en-US">Gross proceeds from sale of common stock and warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_GrossProceedsFromSaleOfCommonStockAndWarrants" xml:lang="en-US">The cash inflow from common stock and warrants before deducting after deducting underwriting discounts, offering expenses and the repurchase the remaining Series B Warrants from Crede to the entity.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_GrossProceedsFromSaleOfCommonStockAndWarrants" xlink:to="lab_051965J6I763_apdn_GrossProceedsFromSaleOfCommonStockAndWarrants"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_FG95812277699K094F4I_apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Additional Number Of Securities Called By Warrants Or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Additional number of common stock called by warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Represents additional number of commons tock called by warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_HI17034499811M216H6K_apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights" xlink:label="loc_839743H4G541_apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Additional Exercise Price Securities Called By Warrants Or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Exercise price of warrants which company agreed to issue to the underwriters</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Represents additional exercise price of common s tock called by warrants which company agree to issue to underwriters.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights" xlink:to="lab_051965J6I763_apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_FG95812277699K094F4I_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xml:lang="en-US">Exercise price percentage of public offering price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_HI17034499811M216H6K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xml:lang="en-US">Number of common stock shares granted to consultant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationOfferingToConsultant" xlink:label="loc_FG95812277699K094F4I_apdn_ShareBasedCompensationOfferingToConsultant"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationOfferingToConsultant" xml:lang="en-US">Share Based Compensation Offering To Consultant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationOfferingToConsultant" xml:lang="en-US">Total expenses to consultant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationOfferingToConsultant" xml:lang="en-US">Represents share based compensation offering to consultant.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_ShareBasedCompensationOfferingToConsultant" xlink:to="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationOfferingToConsultant"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_839743H4G541_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_051965J6I763_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_FG95812277699K094F4I_us-gaap_SubsidiarySaleOfStockAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Sale of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_HI17034499811M216H6K_us-gaap_SubsidiarySaleOfStockAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_839743H4G541_us-gaap_SaleOfStockNameOfTransactionDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_051965J6I763_us-gaap_SaleOfStockNameOfTransactionDomain"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_UnderwrittenPublicOfferingMember" xlink:label="loc_FG95812277699K094F4I_apdn_UnderwrittenPublicOfferingMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_UnderwrittenPublicOfferingMember" xml:lang="en-US">Underwritten Public Offering [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_UnderwrittenPublicOfferingMember" xml:lang="en-US">Underwritten public offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_UnderwrittenPublicOfferingMember" xml:lang="en-US">Represents underwritten public offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_UnderwrittenPublicOfferingMember" xlink:to="lab_HI17034499811M216H6K_apdn_UnderwrittenPublicOfferingMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_FG95812277699K094F4I_us-gaap_CommonStockSharesSubscribedButUnissued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesSubscribedButUnissued" xml:lang="en-US">Common Stock, Shares Subscribed but Unissued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesSubscribedButUnissued" xml:lang="en-US">Common stock offered</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_CommonStockSharesSubscribedButUnissued" xlink:to="lab_HI17034499811M216H6K_us-gaap_CommonStockSharesSubscribedButUnissued"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SharePriceForCommonStock" xlink:label="loc_839743H4G541_apdn_SharePriceForCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_SharePriceForCommonStock" xml:lang="en-US">Share Price For Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_SharePriceForCommonStock" xml:lang="en-US">Offering price for common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_SharePriceForCommonStock" xml:lang="en-US">Price of a single share for common stock of a number of saleable stocks of a company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_SharePriceForCommonStock" xlink:to="lab_051965J6I763_apdn_SharePriceForCommonStock"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SharePriceForWarrant" xlink:label="loc_FG95812277699K094F4I_apdn_SharePriceForWarrant"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_SharePriceForWarrant" xml:lang="en-US">Share Price For Warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_SharePriceForWarrant" xml:lang="en-US">Offering price for warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_SharePriceForWarrant" xml:lang="en-US">Price of a single share for warrant of a number of saleable stocks of a company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_SharePriceForWarrant" xlink:to="lab_HI17034499811M216H6K_apdn_SharePriceForWarrant"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption" xlink:label="loc_839743H4G541_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption" xml:lang="en-US">Number Of Common Stock Sold Pursuant To Over Allotment Of Option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption" xml:lang="en-US">Number of common stock sold pursuant to over allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption" xml:lang="en-US">Represents number of common stock sold pursuant to over allotment of option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption" xlink:to="lab_051965J6I763_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption" xlink:label="loc_FG95812277699K094F4I_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption" xml:lang="en-US">Number Of Warrants Stock Sold Pursuant To Over Allotment Of Option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption" xml:lang="en-US">Number of warrants stock sold pursuant to over allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption" xml:lang="en-US">Represents number of warrants stock sold pursuant to over allotment of option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption" xlink:to="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_839743H4G541_us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xml:lang="en-US">Gross proceeds from offering</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_051965J6I763_us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfDaysForOptionToPurchaseAdditionalShares" xlink:label="loc_FG95812277699K094F4I_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares" xml:lang="en-US">Number Of Days For Option To Purchase Additional Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares" xml:lang="en-US">Number of days for option to purchase additional shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares" xml:lang="en-US">Represents number of days for option to purchase additional shares.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares" xlink:to="lab_HI17034499811M216H6K_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfAdditionalSharesOfCommonStock" xlink:label="loc_839743H4G541_apdn_NumberOfAdditionalSharesOfCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_NumberOfAdditionalSharesOfCommonStock" xml:lang="en-US">Number Of Additional Shares Of Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_NumberOfAdditionalSharesOfCommonStock" xml:lang="en-US">Number of additional shares of common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_NumberOfAdditionalSharesOfCommonStock" xml:lang="en-US">Represents number of additional shares of common stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_NumberOfAdditionalSharesOfCommonStock" xlink:to="lab_051965J6I763_apdn_NumberOfAdditionalSharesOfCommonStock"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfAdditionalWarrantsToCoverOverAllotments" xlink:label="loc_FG95812277699K094F4I_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments" xml:lang="en-US">Number Of Additional Warrants To Cover Over Allotments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments" xml:lang="en-US">Number of additional warrants to cover over allotments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments" xml:lang="en-US">Represents number of additional warrants to cover over allotments.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments" xlink:to="lab_HI17034499811M216H6K_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfCommonStockExerciseInOverAllotmentOption" xlink:label="loc_839743H4G541_apdn_NumberOfCommonStockExerciseInOverAllotmentOption"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_NumberOfCommonStockExerciseInOverAllotmentOption" xml:lang="en-US">Number Of Common Stock Exercise In Over Allotment Option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_NumberOfCommonStockExerciseInOverAllotmentOption" xml:lang="en-US">Number of common stock exercise in over allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_NumberOfCommonStockExerciseInOverAllotmentOption" xml:lang="en-US">Represents number of common stock exercise in over allotment option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_NumberOfCommonStockExerciseInOverAllotmentOption" xlink:to="lab_051965J6I763_apdn_NumberOfCommonStockExerciseInOverAllotmentOption"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsExerciseInOverAllotmentOption" xlink:label="loc_FG95812277699K094F4I_apdn_NumberOfWarrantsExerciseInOverAllotmentOption"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsExerciseInOverAllotmentOption" xml:lang="en-US">Number Of Warrants Exercise In Over Allotment Option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsExerciseInOverAllotmentOption" xml:lang="en-US">Number of warrants exercise in over allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsExerciseInOverAllotmentOption" xml:lang="en-US">Represents number of warrants exercise in over allotment option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_NumberOfWarrantsExerciseInOverAllotmentOption" xlink:to="lab_HI17034499811M216H6K_apdn_NumberOfWarrantsExerciseInOverAllotmentOption"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromExerciseOfOverAllotmentOption" xlink:label="loc_839743H4G541_apdn_GrossProceedsFromExerciseOfOverAllotmentOption"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_GrossProceedsFromExerciseOfOverAllotmentOption" xml:lang="en-US">Gross Proceeds From Exercise Of Over Allotment Option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_GrossProceedsFromExerciseOfOverAllotmentOption" xml:lang="en-US">Gross proceeds from exercise of over allotment option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_GrossProceedsFromExerciseOfOverAllotmentOption" xml:lang="en-US">Represents gross proceeds from exercise of over allotment option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_GrossProceedsFromExerciseOfOverAllotmentOption" xlink:to="lab_051965J6I763_apdn_GrossProceedsFromExerciseOfOverAllotmentOption"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_UnderwritersMember" xlink:label="loc_FG95812277699K094F4I_apdn_UnderwritersMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_UnderwritersMember" xml:lang="en-US">Underwriters [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_UnderwritersMember" xml:lang="en-US">Underwriters</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_UnderwritersMember" xml:lang="en-US">Represents underwriters.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_UnderwritersMember" xlink:to="lab_HI17034499811M216H6K_apdn_UnderwritersMember"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsGrantedAsPartialCompensation" xlink:label="loc_839743H4G541_apdn_NumberOfWarrantsGrantedAsPartialCompensation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_NumberOfWarrantsGrantedAsPartialCompensation" xml:lang="en-US">Number Of Warrants Granted As Partial Compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_NumberOfWarrantsGrantedAsPartialCompensation" xml:lang="en-US">Number of warrants granted as partial compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_NumberOfWarrantsGrantedAsPartialCompensation" xml:lang="en-US">Represents number of warrants granted as partial compensation.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_NumberOfWarrantsGrantedAsPartialCompensation" xlink:to="lab_051965J6I763_apdn_NumberOfWarrantsGrantedAsPartialCompensation"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightNumberOfSharesRollForward" xlink:label="loc_FG95812277699K094F4I_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward" xml:lang="en-US">Class Of Warrant Or Right, Number Of Shares [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward" xml:lang="en-US">Number of Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward" xml:lang="en-US">A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward" xlink:to="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_839743H4G541_us-gaap_ClassOfWarrantOrRightOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Number of warrants granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Number Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Number of warrants outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Balance at October 1, 2014</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Balance, June 30, 2015</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_051965J6I763_us-gaap_ClassOfWarrantOrRightOutstanding"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightGranted" xlink:label="loc_FG95812277699K094F4I_apdn_ClassOfWarrantOrRightGranted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightGranted" xml:lang="en-US">Class Of Warrant Or Right Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightGranted" xml:lang="en-US">Number of shares of common stock granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightGranted" xml:lang="en-US">Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightGranted" xml:lang="en-US">Represents number of warrants granted to participants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_ClassOfWarrantOrRightGranted" xlink:to="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightGranted"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightForfeituresAndExpirations" xlink:label="loc_839743H4G541_apdn_ClassOfWarrantOrRightForfeituresAndExpirations"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightForfeituresAndExpirations" xml:lang="en-US">Class Of Warrant Or Right Forfeitures and Expirations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightForfeituresAndExpirations" xml:lang="en-US">Cancelled or expired</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightForfeituresAndExpirations" xml:lang="en-US">Represents the number of warrants that were either cancelled or expired.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_apdn_ClassOfWarrantOrRightForfeituresAndExpirations" xml:lang="en-US">Cancelled or expired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ClassOfWarrantOrRightForfeituresAndExpirations" xlink:to="lab_051965J6I763_apdn_ClassOfWarrantOrRightForfeituresAndExpirations"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward" xlink:label="loc_FG95812277699K094F4I_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Price Per Share [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward" xml:lang="en-US">Weighted Average Exercise Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward" xml:lang="en-US">A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward" xlink:to="lab_HI17034499811M216H6K_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WeightedAveragePricePerShareWarrantOutstanding" xlink:label="loc_839743H4G541_apdn_WeightedAveragePricePerShareWarrantOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_WeightedAveragePricePerShareWarrantOutstanding" xml:lang="en-US">Weighted Average Price Per Share Warrant Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_051965J6I763_apdn_WeightedAveragePricePerShareWarrantOutstanding" xml:lang="en-US">Balance at October 1, 2014</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_051965J6I763_apdn_WeightedAveragePricePerShareWarrantOutstanding" xml:lang="en-US">Balance, June 30, 2015</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_WeightedAveragePricePerShareWarrantOutstanding" xml:lang="en-US">Represents weighted average exercise price per share or per unit of warrants or rights outstanding.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_WeightedAveragePricePerShareWarrantOutstanding" xlink:to="lab_051965J6I763_apdn_WeightedAveragePricePerShareWarrantOutstanding"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WeightedAveragePricePerShareWarrantGranted" xlink:label="loc_FG95812277699K094F4I_apdn_WeightedAveragePricePerShareWarrantGranted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_WeightedAveragePricePerShareWarrantGranted" xml:lang="en-US">Weighted Average Price Per Share Warrant Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_WeightedAveragePricePerShareWarrantGranted" xml:lang="en-US">Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_WeightedAveragePricePerShareWarrantGranted" xml:lang="en-US">Represents weighted average exercise price per share or per unit of warrants or rights granted.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_WeightedAveragePricePerShareWarrantGranted" xlink:to="lab_HI17034499811M216H6K_apdn_WeightedAveragePricePerShareWarrantGranted"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WeightedAveragePricePerShareWarrantExercised" xlink:label="loc_839743H4G541_apdn_WeightedAveragePricePerShareWarrantExercised"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_WeightedAveragePricePerShareWarrantExercised" xml:lang="en-US">Weighted Average Price Per Share Warrant Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_WeightedAveragePricePerShareWarrantExercised" xml:lang="en-US">Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_WeightedAveragePricePerShareWarrantExercised" xml:lang="en-US">Represents weighted average exercise price per share or per unit of warrants or rights exercised.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_apdn_WeightedAveragePricePerShareWarrantExercised" xml:lang="en-US">Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_WeightedAveragePricePerShareWarrantExercised" xlink:to="lab_051965J6I763_apdn_WeightedAveragePricePerShareWarrantExercised"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired" xlink:label="loc_FG95812277699K094F4I_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired" xml:lang="en-US">Weighted Average Price Per Share Warrant Cancelled Or Expired</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired" xml:lang="en-US">Cancelled or expired</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired" xml:lang="en-US">Represents weighted average exercise price per share or per unit of warrants or rights Cancelled or expired.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_HI17034499811M216H6K_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired" xml:lang="en-US">Cancelled or expired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired" xlink:to="lab_HI17034499811M216H6K_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_839743H4G541_us-gaap_AwardTypeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_AwardTypeAxis" xlink:to="lab_051965J6I763_us-gaap_AwardTypeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US">Award Type [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US">Award Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_839743H4G541_us-gaap_EmployeeStockOptionMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Employee Stock Option [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Employee Stock Options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Employee options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_EmployeeStockOptionMember" xlink:to="lab_051965J6I763_us-gaap_EmployeeStockOptionMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_FG95812277699K094F4I_us-gaap_PlanNameAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_PlanNameAxis" xlink:to="lab_HI17034499811M216H6K_us-gaap_PlanNameAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_839743H4G541_us-gaap_PlanNameDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_PlanNameDomain" xml:lang="en-US">Plan Name [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_PlanNameDomain" xml:lang="en-US">Plan Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_PlanNameDomain" xlink:to="lab_051965J6I763_us-gaap_PlanNameDomain"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncentiveStockPlan2005Member" xlink:label="loc_FG95812277699K094F4I_apdn_IncentiveStockPlan2005Member"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_IncentiveStockPlan2005Member" xml:lang="en-US">Incentive Stock Plan 2005 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_IncentiveStockPlan2005Member" xml:lang="en-US">Incentive Stock Plan 2005</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_IncentiveStockPlan2005Member" xml:lang="en-US">Incentives awarded to employees for meeting certain performance targets.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_IncentiveStockPlan2005Member" xlink:to="lab_HI17034499811M216H6K_apdn_IncentiveStockPlan2005Member"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US">Number of Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Employee stock options outstanding (in shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Options Outstanding, Number Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Outstanding at October 1, 2014</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Outstanding at June 30, 2015</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Number of options granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Number of options granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_FG95812277699K094F4I_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Number of stock options (in shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_HI17034499811M216H6K_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Cancelled or expired</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Cancelled or expired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_FG95812277699K094F4I_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US">Number of options vested</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US">Vested at June 30, 2015</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_HI17034499811M216H6K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_839743H4G541_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Non-vested at June 30, 2014</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_051965J6I763_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Non-vested at June 30, 2015</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_051965J6I763_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xml:lang="en-US">Weighted Average Exercise Price Per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Outstanding Beginning Balance, Weighted Average Exercise Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Exercise price per share (in dollars per share)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price of Options Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/zeroLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Outstanding at October 1, 2014</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Outstanding at June 30, 2015</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Exercise price per share of options granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Fair value of options, exercise price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/zeroLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Options Outstanding, Exercise Prices</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Stock option exercise price (in dollars per share)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Expirations In Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Cancelled or expired</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Cancelled or expired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_839743H4G541_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Vested at June 30, 2015</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Represents information about weighted average exercise price per share vested.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:to="lab_051965J6I763_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue" xlink:label="loc_FG95812277699K094F4I_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Grant Date Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue" xml:lang="en-US">Aggregate Intrinsic Value, Vested at June 30, 2015</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue" xml:lang="en-US">The grant-date intrinsic value of options vested during the reporting period.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue" xlink:to="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue" xlink:label="loc_839743H4G541_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Grant Date Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue" xml:lang="en-US">Aggregate Intrinsic Value, Non-vested at December 31, 2014</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_051965J6I763_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue" xml:lang="en-US">Aggregate Intrinsic Value, Non-vested at June 30, 2015</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue" xml:lang="en-US">The grant-date intrinsic value of options nonvested during the reporting period.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue" xlink:to="lab_051965J6I763_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SharePriceTwo" xlink:label="loc_FG95812277699K094F4I_apdn_SharePriceTwo"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_SharePriceTwo" xml:lang="en-US">Share Price Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_SharePriceTwo" xml:lang="en-US">Stock price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_SharePriceTwo" xml:lang="en-US">Price of a single share of a number of saleable stocks of a company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_SharePriceTwo" xlink:to="lab_HI17034499811M216H6K_apdn_SharePriceTwo"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo" xlink:label="loc_839743H4G541_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo" xml:lang="en-US">Exercise price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo" xml:lang="en-US">Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo" xlink:to="lab_051965J6I763_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_FG95812277699K094F4I_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Expected term, years</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_HI17034499811M216H6K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Fair value of options, dividend yield</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Dividend yield assumed as per black scholes option pricing model</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Dividend yield</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Fair value of options, volatility rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Volatility assumed as per black scholes option pricing model</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Volatility</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Fair value of options, risk free rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Risk free interest rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Risk free rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xml:lang="en-US">Aggregate number of shares of common stock that can be issued as stock awards and stock option</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xml:lang="en-US">Number of common stock shares that can be covered by awards made to any participant per period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xml:lang="en-US">Number of shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_HI17034499811M216H6K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xml:lang="en-US">Options to purchase shares under the 2005 Incentive Stock Plan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="lab_051965J6I763_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>



<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_839743H4G541_us-gaap_VestingDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_VestingDomain" xml:lang="en-US">Vesting [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_VestingDomain" xlink:to="lab_051965J6I763_us-gaap_VestingDomain"/>















<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_839743H4G541_us-gaap_TitleOfIndividualAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_TitleOfIndividualAxis" xml:lang="en-US">Deferred Bonus and Profit Sharing Plan by Title of Individual [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_TitleOfIndividualAxis" xlink:to="lab_051965J6I763_us-gaap_TitleOfIndividualAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_FG95812277699K094F4I_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Relationship to Entity [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Title of Individual with Relationship to Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_HI17034499811M216H6K_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>





























<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_839743H4G541_us-gaap_StockOptionPlanExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_StockOptionPlanExpense" xml:lang="en-US">Stock or Unit Option Plan Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_StockOptionPlanExpense" xml:lang="en-US">Stock option modifications</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_StockOptionPlanExpense" xlink:to="lab_051965J6I763_us-gaap_StockOptionPlanExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_FG95812277699K094F4I_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xml:lang="en-US">Unrecorded compensation cost related to non-vested awards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_HI17034499811M216H6K_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_839743H4G541_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xml:lang="en-US">Weighted average period of non-vested awards options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_051965J6I763_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted" xlink:label="loc_FG95812277699K094F4I_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted" xml:lang="en-US">Share Based Compensation Weighted Average Grant Date Fair Value For Options Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted" xml:lang="en-US">Weighted average grant date fair value for options granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted" xml:lang="en-US">Represents share based compensation weighted average grant date fair value for options granted.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted" xlink:to="lab_HI17034499811M216H6K_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommitmentsAndContingenciesTable" xlink:label="loc_839743H4G541_apdn_CommitmentsAndContingenciesTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_CommitmentsAndContingenciesTable" xml:lang="en-US">Commitments And Contingencies [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_CommitmentsAndContingenciesTable" xml:lang="en-US">Represents commitments and contingencies table.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_CommitmentsAndContingenciesTable" xlink:to="lab_051965J6I763_apdn_CommitmentsAndContingenciesTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_FG95812277699K094F4I_us-gaap_ChiefExecutiveOfficerMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_ChiefExecutiveOfficerMember" xml:lang="en-US">Chief Executive Officer [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_ChiefExecutiveOfficerMember" xml:lang="en-US">Chief Executive Officer</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_ChiefExecutiveOfficerMember" xlink:to="lab_HI17034499811M216H6K_us-gaap_ChiefExecutiveOfficerMember"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_EmploymentAgreementMember" xlink:label="loc_839743H4G541_apdn_EmploymentAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_EmploymentAgreementMember" xml:lang="en-US">Employment Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_EmploymentAgreementMember" xml:lang="en-US">Employment Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_EmploymentAgreementMember" xml:lang="en-US">Represents employment agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_EmploymentAgreementMember" xlink:to="lab_051965J6I763_apdn_EmploymentAgreementMember"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommitmentsAndContingenciesLineItems" xlink:label="loc_FG95812277699K094F4I_apdn_CommitmentsAndContingenciesLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_CommitmentsAndContingenciesLineItems" xml:lang="en-US">Commitments And Contingencies [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_CommitmentsAndContingenciesLineItems" xml:lang="en-US">Represents commitments and contingencies line items.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_CommitmentsAndContingenciesLineItems" xlink:to="lab_HI17034499811M216H6K_apdn_CommitmentsAndContingenciesLineItems"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AreaOfPropertyUnderOperatingLease" xlink:label="loc_839743H4G541_apdn_AreaOfPropertyUnderOperatingLease"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_AreaOfPropertyUnderOperatingLease" xml:lang="en-US">Area Of Property Under Operating Lease</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_AreaOfPropertyUnderOperatingLease" xml:lang="en-US">Area of property under operating lease</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_AreaOfPropertyUnderOperatingLease" xml:lang="en-US">Represents the area of property under operating lease.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_AreaOfPropertyUnderOperatingLease" xlink:to="lab_051965J6I763_apdn_AreaOfPropertyUnderOperatingLease"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm" xlink:label="loc_FG95812277699K094F4I_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm" xml:lang="en-US">Lessee Leasing Arrangements, Operating Leases, Renewal Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm" xml:lang="en-US">Extended operating lease for two additional period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm" xlink:to="lab_HI17034499811M216H6K_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_BaseRentDuringInitialLeaseTerm" xlink:label="loc_839743H4G541_apdn_BaseRentDuringInitialLeaseTerm"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_BaseRentDuringInitialLeaseTerm" xml:lang="en-US">Base Rent During Initial Lease Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_BaseRentDuringInitialLeaseTerm" xml:lang="en-US">Base rent during initial lease term per annum</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_BaseRentDuringInitialLeaseTerm" xml:lang="en-US">Represents the amount for base rent during initial lease term per annum.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_BaseRentDuringInitialLeaseTerm" xlink:to="lab_051965J6I763_apdn_BaseRentDuringInitialLeaseTerm"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_FG95812277699K094F4I_us-gaap_OperatingLeasesRentExpenseNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_OperatingLeasesRentExpenseNet" xml:lang="en-US">Operating Leases, Rent Expense, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_OperatingLeasesRentExpenseNet" xml:lang="en-US">Total lease rental expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_HI17034499811M216H6K_us-gaap_OperatingLeasesRentExpenseNet"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ReducedAmountOfSalary" xlink:label="loc_839743H4G541_apdn_ReducedAmountOfSalary"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_ReducedAmountOfSalary" xml:lang="en-US">Reduced Amount Of Salary</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_ReducedAmountOfSalary" xml:lang="en-US">Reduced amount of salary</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_ReducedAmountOfSalary" xml:lang="en-US">Represents reduced amount of salary.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_ReducedAmountOfSalary" xlink:to="lab_051965J6I763_apdn_ReducedAmountOfSalary"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ThresholdAmountOfSales" xlink:label="loc_FG95812277699K094F4I_apdn_ThresholdAmountOfSales"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_ThresholdAmountOfSales" xml:lang="en-US">Threshold Amount Of Sales</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_ThresholdAmountOfSales" xml:lang="en-US">Threshold amount of sales for two consecutive quarters</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_ThresholdAmountOfSales" xml:lang="en-US">Represents threshold amount of sale.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_ThresholdAmountOfSales" xlink:to="lab_HI17034499811M216H6K_apdn_ThresholdAmountOfSales"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_839743H4G541_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_051965J6I763_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_FG95812277699K094F4I_us-gaap_FairValueByLiabilityClassAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueByLiabilityClassAxis" xml:lang="en-US">Liability Class [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_HI17034499811M216H6K_us-gaap_FairValueByLiabilityClassAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_839743H4G541_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xml:lang="en-US">Fair Value by Liability Class [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_051965J6I763_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="loc_FG95812277699K094F4I_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xml:lang="en-US">Derivative Financial Instruments, Liabilities [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xml:lang="en-US">Common Stock Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:to="lab_HI17034499811M216H6K_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_839743H4G541_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_051965J6I763_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_FG95812277699K094F4I_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xml:lang="en-US">Fair Value Measurements of Common Stock Warrants Using Significant Unobservable Inputs (Level 3)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_HI17034499811M216H6K_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_839743H4G541_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_051965J6I763_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Balance at October 1, 2014 and 2013</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_051965J6I763_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Balance at June 30,</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_051965J6I763_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_FG95812277699K094F4I_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xml:lang="en-US">Adjustment resulting from change in fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_HI17034499811M216H6K_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase" xlink:label="loc_839743H4G541_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_051965J6I763_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Removal Of Warrant Upon Repurchase</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_051965J6I763_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase" xml:lang="en-US">Removal of warrant upon repurchase</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_051965J6I763_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase" xml:lang="en-US">Represents removal of warrant upon repurchase.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_051965J6I763_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase" xml:lang="en-US">Removal of warrant upon repurchase</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_839743H4G541_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase" xlink:to="lab_051965J6I763_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise" xlink:label="loc_FG95812277699K094F4I_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_HI17034499811M216H6K_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reclassification To Equity Upon Exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_HI17034499811M216H6K_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise" xml:lang="en-US">Reclassification to equity upon exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_HI17034499811M216H6K_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise" xml:lang="en-US">Represents the amount of reclassification to equity upon exercise of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_HI17034499811M216H6K_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise" xml:lang="en-US">Reclassification to equity upon exercise</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FG95812277699K094F4I_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise" xlink:to="lab_HI17034499811M216H6K_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise"/>




<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember" xlink:label="loc_apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember"/>
<label xlink:type="resource" xlink:label="lab_apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Employees Consultants And Non Employee Board Of Director Members [Member]</label>
<label xlink:type="resource" xlink:label="lab_apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Employees, consultants and non-employee board of director members.</label>
<label xlink:type="resource" xlink:label="lab_apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Employees, consultants and non-employee board of director members</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember" xlink:to="lab_apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="loc_us-gaap_ExecutiveOfficerMember"/>
<label xlink:type="resource" xlink:label="lab_us-gaap_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Executive Officer [Member]</label>
<label xlink:type="resource" xlink:label="lab_us-gaap_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Executives</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExecutiveOfficerMember" xlink:to="lab_us-gaap_ExecutiveOfficerMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
<label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
<label xlink:type="resource" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Antidilutive Securities [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain"/>
<label xlink:type="resource" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
<label xlink:type="resource" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
<label xlink:type="resource" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
<label xlink:type="resource" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Antidilutive securities excluded from diluted net loss per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo" xlink:label="loc_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo_1"/>
<label xlink:type="resource" xlink:label="lab_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Gross Proceeds From Underwritten Public Offering Of Common Stock And Warrants Two</label>
<label xlink:type="resource" xlink:label="lab_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US">Gross proceeds from underwritten public offering of common stock and warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo_1" xlink:to="lab_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo"/><label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo" xml:lang="en-US">Represents gross proceeds from underwritten public offering of common stock and warrants on closure.</label>

</labelLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>apdn-20150630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.4 on Saturday, August 08, 2015 03:40:14 AM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#DocumentAndEntityInformation" roleURI="http://www.adnas.com/role/DocumentAndEntityInformation"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" roleURI="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" roleURI="http://www.adnas.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" roleURI="http://www.adnas.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#SUMMARYOFACCOUNTINGPOLICIES" roleURI="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIES"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#LiquidityAndManagementSPlan" roleURI="http://www.adnas.com/role/LiquidityAndManagementSPlan"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#ACCOUNTSPAYABLEANDACCRUEDLIABILITIES" roleURI="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIES"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#PromissoryNotesPayable" roleURI="http://www.adnas.com/role/PromissoryNotesPayable"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#WARRANTLIABILITY" roleURI="http://www.adnas.com/role/WARRANTLIABILITY"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#RelatedPartyTransactions" roleURI="http://www.adnas.com/role/RelatedPartyTransactions"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CAPITALSTOCK" roleURI="http://www.adnas.com/role/CAPITALSTOCK"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#STOCKOPTIONSANDWARRANTS" roleURI="http://www.adnas.com/role/STOCKOPTIONSANDWARRANTS"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#COMMITMENTSANDCONTINGENCIES" roleURI="http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIES"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#FAIRVALUE" roleURI="http://www.adnas.com/role/FAIRVALUE"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#SUMMARYOFACCOUNTINGPOLICIESPolicies" roleURI="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESPolicies"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#SUMMARYOFACCOUNTINGPOLICIESTables" roleURI="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESTables"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#ACCOUNTSPAYABLEANDACCRUEDLIABILITIESTables" roleURI="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESTables"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#STOCKOPTIONSANDWARRANTSTables" roleURI="http://www.adnas.com/role/STOCKOPTIONSANDWARRANTSTables"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#FAIRVALUETables" roleURI="http://www.adnas.com/role/FAIRVALUETables"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails" roleURI="http://www.adnas.com/role/SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#SummaryOfAccountingPoliciesDetailTextuals" roleURI="http://www.adnas.com/role/SummaryOfAccountingPoliciesDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailTextuals1" roleURI="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailTextuals1"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#LiquidityAndManagementSPlanDetailTextuals" roleURI="http://www.adnas.com/role/LiquidityAndManagementSPlanDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#ACCOUNTSPAYABLEANDACCRUEDLIABILITIESSummaryOfAccountsPayableAndAccruedLiabilitiesDetails" roleURI="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESSummaryOfAccountsPayableAndAccruedLiabilitiesDetails"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#PromissoryNotesPayableDetailTextuals" roleURI="http://www.adnas.com/role/PromissoryNotesPayableDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#WarrantLiabilityDetailTextuals" roleURI="http://www.adnas.com/role/WarrantLiabilityDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#RELATEDPARTYTRANSACTIONSDetailTextuals" roleURI="http://www.adnas.com/role/RELATEDPARTYTRANSACTIONSDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CAPITALSTOCKDetailTextuals" roleURI="http://www.adnas.com/role/CAPITALSTOCKDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CAPITALSTOCKDetailTextuals1" roleURI="http://www.adnas.com/role/CAPITALSTOCKDetailTextuals1"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CapitalStockDetailTextuals2" roleURI="http://www.adnas.com/role/CapitalStockDetailTextuals2"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#CapitalStockDetailTextuals3" roleURI="http://www.adnas.com/role/CapitalStockDetailTextuals3"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#StockOptionsAndWarrantsTransactionsInvolvingWarrantsDetails" roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsTransactionsInvolvingWarrantsDetails"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#StockOptionsAndWarrantsTransactionsInvolvingStockOptionsIssuedToEmployeesDetails1" roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsTransactionsInvolvingStockOptionsIssuedToEmployeesDetails1"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#StockOptionsAndWarrantsSummaryOfValueOfOptionsGrantedUsingBlackScholesOptionPricingModelWithWeightedAverageAssumptionsDetails" roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsSummaryOfValueOfOptionsGrantedUsingBlackScholesOptionPricingModelWithWeightedAverageAssumptionsDetails"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals" roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals1" roleURI="http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals1"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#COMMITMENTSANDCONTINGENCIESDetailTextuals" roleURI="http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIESDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="apdn-20150630.xsd#FairValueFairValueMeasurementsOfCommonStockWarrantsUsingSignificantUnobservableInputsLevel3Details" roleURI="http://www.adnas.com/role/FairValueFairValueMeasurementsOfCommonStockWarrantsUsingSignificantUnobservableInputsLevel3Details"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/DocumentAndEntityInformation">
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_DocumentAndEntityInformationAbstract" xlink:label="loc_apdn_DocumentAndEntityInformationAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityRegistrantName_1" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_2" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_TradingSymbol_3" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_4" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityFilerCategory_5" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_6" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentType_7" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_8" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_AmendmentFlag_9" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalYearFocus_10" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_11" order="100" use="optional"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_AssetsAbstract_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7" xlink:to="loc_us-gaap_AssetsCurrentAbstract_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8" xlink:to="loc_us-gaap_AssetsCurrent_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_14" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_14" xlink:to="loc_us-gaap_DeferredCosts_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7" xlink:to="loc_us-gaap_Assets_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_20" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_20" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_20" xlink:to="loc_us-gaap_DeferredRevenueCurrent_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_20" xlink:to="loc_us-gaap_LiabilitiesCurrent_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantLiabilityNoncurrent" xlink:label="loc_apdn_WarrantLiabilityNoncurrent_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19" xlink:to="loc_apdn_WarrantLiabilityNoncurrent_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19" xlink:to="loc_us-gaap_Liabilities_26" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19" xlink:to="loc_us-gaap_CommitmentsAndContingencies_27" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19" xlink:to="loc_us-gaap_StockholdersEquityAbstract_28" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_28" xlink:to="loc_us-gaap_PreferredStockValue_29" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_28" xlink:to="loc_us-gaap_CommonStockValue_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_28" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_28" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_32" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_28" xlink:to="loc_us-gaap_StockholdersEquity_33" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_34" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:label="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_PreferredStockSharesIssued_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_17" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_CommonStockSharesIssued_18" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_19" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_SalesRevenueNet_1" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_2" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_DepreciationAndAmortization_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_OperatingExpenses_6" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>


<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LossOnConversionOfPromissoryNotes" xlink:label="loc_apdn_LossOnConversionOfPromissoryNotes_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8" xlink:to="loc_apdn_LossOnConversionOfPromissoryNotes_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xlink:label="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8" xlink:to="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_15" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_16" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_17" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_17" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingIncomeLoss" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xlink:to="loc_us-gaap_NetIncomeLoss_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_ShareBasedCompensation_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xlink:label="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LossOnConversionOfPromissoryNotes" xlink:label="loc_apdn_LossOnConversionOfPromissoryNotes_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_apdn_LossOnConversionOfPromissoryNotes_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommonStockIssuedForConsultingServices" xlink:label="loc_apdn_CommonStockIssuedForConsultingServices_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_apdn_CommonStockIssuedForConsultingServices_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_10" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_10" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_10" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_10" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_16" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_16" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_16" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NetProceedsFromSaleOfCommonStockAndWarrants" xlink:label="loc_apdn_NetProceedsFromSaleOfCommonStockAndWarrants_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_20" xlink:to="loc_apdn_NetProceedsFromSaleOfCommonStockAndWarrants_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants" xlink:label="loc_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_20" xlink:to="loc_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_27" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_27" xlink:to="loc_us-gaap_InterestPaid_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_27" xlink:to="loc_us-gaap_IncomeTaxesPaid_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants" xlink:label="loc_apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" xlink:to="loc_apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants_31" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital" xlink:label="loc_apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" xlink:to="loc_apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital_32" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise" xlink:label="loc_apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" xlink:to="loc_apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise_33" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities" xlink:label="loc_apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" xlink:to="loc_apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities_34" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable" xlink:label="loc_apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" xlink:to="loc_apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable_35" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable" xlink:label="loc_apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" xlink:to="loc_apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable_36" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaap_StockIssued1_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" xlink:to="loc_us-gaap_StockIssued1_37" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIES">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/LiquidityAndManagementSPlan">
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LiquidityAndManagementPlanAbstract" xlink:label="loc_apdn_LiquidityAndManagementPlanAbstract_0"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LiquidityAndManagementPlanTextBlock" xlink:label="loc_apdn_LiquidityAndManagementPlanTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_apdn_LiquidityAndManagementPlanTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIES">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/PromissoryNotesPayable">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract_0" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/WARRANTLIABILITY">
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantLiabilityAbstract" xlink:label="loc_apdn_WarrantLiabilityAbstract_0"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantLiabilityTextBlock" xlink:label="loc_apdn_WarrantLiabilityTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_WarrantLiabilityAbstract_0" xlink:to="loc_apdn_WarrantLiabilityTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/RelatedPartyTransactions">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CAPITALSTOCK">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/STOCKOPTIONSANDWARRANTS">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIES">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/FAIRVALUE">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/STOCKOPTIONSANDWARRANTSTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock" xlink:label="loc_apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/FAIRVALUETables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>






<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaap_WarrantMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SummaryOfAccountingPoliciesDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityReverseStockSplit_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_DeferredRevenueCurrent_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:label="loc_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailTextuals1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6" xlink:to="loc_us-gaap_SalesMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6" xlink:to="loc_us-gaap_AccountsReceivableMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaap_MajorCustomersAxis_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_MajorCustomersAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaap_NameOfMajorCustomerDomain_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorCustomersAxis_9" xlink:to="loc_us-gaap_NameOfMajorCustomerDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CustomerOneConcentrationRiskMember" xlink:label="loc_apdn_CustomerOneConcentrationRiskMember_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_10" xlink:to="loc_apdn_CustomerOneConcentrationRiskMember_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_TwoCustomersConcentrationRiskMember" xlink:label="loc_apdn_TwoCustomersConcentrationRiskMember_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_10" xlink:to="loc_apdn_TwoCustomersConcentrationRiskMember_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_13" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDescription" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDescription_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_13" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDescription_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ConcentrationRiskNumberOfCustomers" xlink:label="loc_apdn_ConcentrationRiskNumberOfCustomers_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_13" xlink:to="loc_apdn_ConcentrationRiskNumberOfCustomers_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/LiquidityAndManagementSPlanDetailTextuals">
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LiquidityAndManagementPlanAbstract" xlink:label="loc_apdn_LiquidityAndManagementPlanAbstract_0"/>






























<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WorkingCapitalSurplusDeficit" xlink:label="loc_apdn_WorkingCapitalSurplusDeficit"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_apdn_WorkingCapitalSurplusDeficit" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants" xlink:label="loc_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants" xlink:label="loc_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ProceedsFromPromissoryNotes" xlink:label="loc_apdn_ProceedsFromPromissoryNotes"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_apdn_ProceedsFromPromissoryNotes" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ProceedsFromPromissoryNotesFromRelatedParty" xlink:label="loc_apdn_ProceedsFromPromissoryNotesFromRelatedParty"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_LiquidityAndManagementPlanAbstract_0" xlink:to="loc_apdn_ProceedsFromPromissoryNotesFromRelatedParty" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESSummaryOfAccountsPayableAndAccruedLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_AccountsPayableCurrent_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaap_AccruedSalariesCurrent_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_AccruedSalariesCurrent_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaap_InterestPayableCurrent_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_InterestPayableCurrent_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/PromissoryNotesPayableDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_3" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" xlink:to="loc_us-gaap_RelatedPartyDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PresidentChairmanAndChiefExecutiveOfficerMember" xlink:label="loc_apdn_PresidentChairmanAndChiefExecutiveOfficerMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_6" xlink:to="loc_apdn_PresidentChairmanAndChiefExecutiveOfficerMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AnotherIndividualMember" xlink:label="loc_apdn_AnotherIndividualMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_6" xlink:to="loc_apdn_AnotherIndividualMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaap_ShortTermDebtLineItems_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1" xlink:to="loc_us-gaap_ShortTermDebtLineItems_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_us-gaap_DebtInstrumentTerm_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" xlink:label="loc_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_16" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice" xlink:label="loc_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice_17" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice" xlink:label="loc_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice_18" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_LossOnConversionOfPromissoryNotes" xlink:label="loc_apdn_LossOnConversionOfPromissoryNotes_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_apdn_LossOnConversionOfPromissoryNotes_19" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9" xlink:to="loc_us-gaap_InterestExpenseDebt_20" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/WarrantLiabilityDetailTextuals">
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantLiabilityAbstract" xlink:label="loc_apdn_WarrantLiabilityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_WarrantLiabilityAbstract_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_dei_LegalEntityAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2" xlink:to="loc_dei_EntityDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CredeCgIIILtdMember" xlink:label="loc_apdn_CredeCgIIILtdMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_apdn_CredeCgIIILtdMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SeriesWarrantsMember" xlink:label="loc_apdn_SeriesWarrantsMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_6" xlink:to="loc_apdn_SeriesWarrantsMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SeriesBWarrantsMember" xlink:label="loc_apdn_SeriesBWarrantsMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_6" xlink:to="loc_apdn_SeriesBWarrantsMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementAxis" xlink:label="loc_apdn_AgreementAxis_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_apdn_AgreementAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementDomain" xlink:label="loc_apdn_AgreementDomain_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_AgreementAxis_9" xlink:to="loc_apdn_AgreementDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WarrantRepurchaseOptionAgreementMember" xlink:label="loc_apdn_WarrantRepurchaseOptionAgreementMember_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_AgreementDomain_10" xlink:to="loc_apdn_WarrantRepurchaseOptionAgreementMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_12" xlink:to="loc_us-gaap_EquityComponentDomain_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_13" xlink:to="loc_us-gaap_WarrantMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_us-gaap_RangeAxis_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_15" xlink:to="loc_us-gaap_RangeMember_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_16" xlink:to="loc_us-gaap_MinimumMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_16" xlink:to="loc_us-gaap_MaximumMember_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightExercised" xlink:label="loc_apdn_ClassOfWarrantOrRightExercised_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_apdn_ClassOfWarrantOrRightExercised_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsValuationTechniques" xlink:label="loc_us-gaap_FairValueMeasurementsValuationTechniques_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_us-gaap_FairValueMeasurementsValuationTechniques_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_us-gaap_SharePrice_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_24" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedTerm_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedTerm_25" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_26" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_27" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_FairValueAssumptionsExercisePrice_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_us-gaap_FairValueAssumptionsExercisePrice_28" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncomeLossFromChangeInFairValueOfWarrantLiability" xlink:label="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability_29" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PercentageOfOptionToPurchaseWarrant" xlink:label="loc_apdn_PercentageOfOptionToPurchaseWarrant_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_apdn_PercentageOfOptionToPurchaseWarrant_30" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AggregatePurchasePriceOfWarrantExercise" xlink:label="loc_apdn_AggregatePurchasePriceOfWarrantExercise_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_19" xlink:to="loc_apdn_AggregatePurchasePriceOfWarrantExercise_31" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/RELATEDPARTYTRANSACTIONSDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_3" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" xlink:to="loc_us-gaap_RelatedPartyDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_PresidentChairmanAndChiefExecutiveOfficerMember" xlink:label="loc_apdn_PresidentChairmanAndChiefExecutiveOfficerMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_6" xlink:to="loc_apdn_PresidentChairmanAndChiefExecutiveOfficerMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaap_ShortTermDebtLineItems_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1" xlink:to="loc_us-gaap_ShortTermDebtLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest" xlink:label="loc_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_8" xlink:to="loc_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CAPITALSTOCKDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityReverseStockSplit_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CAPITALSTOCKDetailTextuals1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants" xlink:label="loc_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants_3" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants" xlink:label="loc_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants_4" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_5" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_TermPeriodOfWarrantsOrRightsExercised" xlink:label="loc_apdn_TermPeriodOfWarrantsOrRightsExercised_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_TermPeriodOfWarrantsOrRightsExercised_6" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfDaysOptionGivenToUnderwriters" xlink:label="loc_apdn_NumberOfDaysOptionGivenToUnderwriters_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_NumberOfDaysOptionGivenToUnderwriters_8" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalSharesOfCommonStockPurchaseLimit" xlink:label="loc_apdn_AdditionalSharesOfCommonStockPurchaseLimit_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_AdditionalSharesOfCommonStockPurchaseLimit_9" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalPerSharesOfCommonStockPurchaseLimit" xlink:label="loc_apdn_AdditionalPerSharesOfCommonStockPurchaseLimit_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_AdditionalPerSharesOfCommonStockPurchaseLimit_10" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalSharesOfWarrantsPurchaseLimit" xlink:label="loc_apdn_AdditionalSharesOfWarrantsPurchaseLimit_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_AdditionalSharesOfWarrantsPurchaseLimit_11" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalPerSharesOfWarrantsPurchaseLimit" xlink:label="loc_apdn_AdditionalPerSharesOfWarrantsPurchaseLimit_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_AdditionalPerSharesOfWarrantsPurchaseLimit_12" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise" xlink:label="loc_apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise_13" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromClosedOnUnderwritersExercise" xlink:label="loc_apdn_GrossProceedsFromClosedOnUnderwritersExercise_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_GrossProceedsFromClosedOnUnderwritersExercise_14" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise" xlink:label="loc_apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise_15" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise" xlink:label="loc_apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise_16" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfCommonStockIssued" xlink:label="loc_apdn_NumberOfCommonStockIssued_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_NumberOfCommonStockIssued_17" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsIssued" xlink:label="loc_apdn_NumberOfWarrantsIssued_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_NumberOfWarrantsIssued_18" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromSaleOfCommonStockAndWarrants" xlink:label="loc_apdn_GrossProceedsFromSaleOfCommonStockAndWarrants_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_GrossProceedsFromSaleOfCommonStockAndWarrants_19" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NetProceedsFromSaleOfCommonStockAndWarrants" xlink:label="loc_apdn_NetProceedsFromSaleOfCommonStockAndWarrants_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_NetProceedsFromSaleOfCommonStockAndWarrants_20" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights_21" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights" xlink:label="loc_apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights_22" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_23" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_24" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationOfferingToConsultant" xlink:label="loc_apdn_ShareBasedCompensationOfferingToConsultant_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_ShareBasedCompensationOfferingToConsultant_25" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo" xlink:label="loc_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CapitalStockDetailTextuals2">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_UnderwrittenPublicOfferingMember" xlink:label="loc_apdn_UnderwrittenPublicOfferingMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" xlink:to="loc_apdn_UnderwrittenPublicOfferingMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>






<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_us-gaap_CommonStockSharesSubscribedButUnissued_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_CommonStockSharesSubscribedButUnissued_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_SharePrice_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SharePriceForCommonStock" xlink:label="loc_apdn_SharePriceForCommonStock_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_SharePriceForCommonStock_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SharePriceForWarrant" xlink:label="loc_apdn_SharePriceForWarrant_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_SharePriceForWarrant_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption" xlink:label="loc_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption" xlink:label="loc_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_16" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_17" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfDaysForOptionToPurchaseAdditionalShares" xlink:label="loc_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares_18" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfAdditionalSharesOfCommonStock" xlink:label="loc_apdn_NumberOfAdditionalSharesOfCommonStock_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_NumberOfAdditionalSharesOfCommonStock_19" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfAdditionalWarrantsToCoverOverAllotments" xlink:label="loc_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments_20" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfCommonStockExerciseInOverAllotmentOption" xlink:label="loc_apdn_NumberOfCommonStockExerciseInOverAllotmentOption_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_NumberOfCommonStockExerciseInOverAllotmentOption_21" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsExerciseInOverAllotmentOption" xlink:label="loc_apdn_NumberOfWarrantsExerciseInOverAllotmentOption_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_NumberOfWarrantsExerciseInOverAllotmentOption_22" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_GrossProceedsFromExerciseOfOverAllotmentOption" xlink:label="loc_apdn_GrossProceedsFromExerciseOfOverAllotmentOption_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_GrossProceedsFromExerciseOfOverAllotmentOption_23" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CapitalStockDetailTextuals3">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_UnderwrittenPublicOfferingMember" xlink:label="loc_apdn_UnderwrittenPublicOfferingMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" xlink:to="loc_apdn_UnderwrittenPublicOfferingMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_dei_LegalEntityAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_5" xlink:to="loc_dei_EntityDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_UnderwritersMember" xlink:label="loc_apdn_UnderwritersMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_6" xlink:to="loc_apdn_UnderwritersMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>






<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_NumberOfWarrantsGrantedAsPartialCompensation" xlink:label="loc_apdn_NumberOfWarrantsGrantedAsPartialCompensation_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11" xlink:to="loc_apdn_NumberOfWarrantsGrantedAsPartialCompensation_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StockOptionsAndWarrantsTransactionsInvolvingWarrantsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightNumberOfSharesRollForward" xlink:label="loc_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightGranted" xlink:label="loc_apdn_ClassOfWarrantOrRightGranted_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward_1" xlink:to="loc_apdn_ClassOfWarrantOrRightGranted_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightExercised" xlink:label="loc_apdn_ClassOfWarrantOrRightExercised_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward_1" xlink:to="loc_apdn_ClassOfWarrantOrRightExercised_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightForfeituresAndExpirations" xlink:label="loc_apdn_ClassOfWarrantOrRightForfeituresAndExpirations_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward_1" xlink:to="loc_apdn_ClassOfWarrantOrRightForfeituresAndExpirations_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward" xlink:label="loc_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WeightedAveragePricePerShareWarrantOutstanding" xlink:label="loc_apdn_WeightedAveragePricePerShareWarrantOutstanding_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward_7" xlink:to="loc_apdn_WeightedAveragePricePerShareWarrantOutstanding_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WeightedAveragePricePerShareWarrantGranted" xlink:label="loc_apdn_WeightedAveragePricePerShareWarrantGranted_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward_7" xlink:to="loc_apdn_WeightedAveragePricePerShareWarrantGranted_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WeightedAveragePricePerShareWarrantExercised" xlink:label="loc_apdn_WeightedAveragePricePerShareWarrantExercised_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward_7" xlink:to="loc_apdn_WeightedAveragePricePerShareWarrantExercised_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired" xlink:label="loc_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward_7" xlink:to="loc_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_WeightedAveragePricePerShareWarrantOutstanding" xlink:label="loc_apdn_WeightedAveragePricePerShareWarrantOutstanding_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward_7" xlink:to="loc_apdn_WeightedAveragePricePerShareWarrantOutstanding_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StockOptionsAndWarrantsTransactionsInvolvingStockOptionsIssuedToEmployeesDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_PlanNameAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5" xlink:to="loc_us-gaap_PlanNameDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncentiveStockPlan2005Member" xlink:label="loc_apdn_IncentiveStockPlan2005Member_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6" xlink:to="loc_apdn_IncentiveStockPlan2005Member_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_16" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17" xlink:to="loc_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice_23" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue" xlink:label="loc_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue" xlink:label="loc_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StockOptionsAndWarrantsSummaryOfValueOfOptionsGrantedUsingBlackScholesOptionPricingModelWithWeightedAverageAssumptionsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_SharePriceTwo" xlink:label="loc_apdn_SharePriceTwo_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_apdn_SharePriceTwo_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo" xlink:label="loc_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_PlanNameAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5" xlink:to="loc_us-gaap_PlanNameDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_IncentiveStockPlan2005Member" xlink:label="loc_apdn_IncentiveStockPlan2005Member_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6" xlink:to="loc_apdn_IncentiveStockPlan2005Member_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>










<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_10" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>










<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember" xlink:label="loc_apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_11" xlink:to="loc_apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>






<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>


<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_21" xlink:to="loc_us-gaap_ShareBasedCompensation_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_21" xlink:to="loc_us-gaap_StockOptionPlanExpense_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_21" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_26" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_21" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_27" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted" xlink:label="loc_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_21" xlink:to="loc_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted_28" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="loc_us-gaap_ExecutiveOfficerMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_11" xlink:to="loc_us-gaap_ExecutiveOfficerMember" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIESDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommitmentsAndContingenciesTable" xlink:label="loc_apdn_CommitmentsAndContingenciesTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_apdn_CommitmentsAndContingenciesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaap_ChiefExecutiveOfficerMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_ChiefExecutiveOfficerMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementAxis" xlink:label="loc_apdn_AgreementAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_CommitmentsAndContingenciesTable_1" xlink:to="loc_apdn_AgreementAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AgreementDomain" xlink:label="loc_apdn_AgreementDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_AgreementAxis_5" xlink:to="loc_apdn_AgreementDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_EmploymentAgreementMember" xlink:label="loc_apdn_EmploymentAgreementMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_AgreementDomain_6" xlink:to="loc_apdn_EmploymentAgreementMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_CommitmentsAndContingenciesLineItems" xlink:label="loc_apdn_CommitmentsAndContingenciesLineItems_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_CommitmentsAndContingenciesTable_1" xlink:to="loc_apdn_CommitmentsAndContingenciesLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_AreaOfPropertyUnderOperatingLease" xlink:label="loc_apdn_AreaOfPropertyUnderOperatingLease_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_apdn_AreaOfPropertyUnderOperatingLease_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm" xlink:label="loc_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_BaseRentDuringInitialLeaseTerm" xlink:label="loc_apdn_BaseRentDuringInitialLeaseTerm_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_apdn_BaseRentDuringInitialLeaseTerm_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ReducedAmountOfSalary" xlink:label="loc_apdn_ReducedAmountOfSalary_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_apdn_ReducedAmountOfSalary_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_ThresholdAmountOfSales" xlink:label="loc_apdn_ThresholdAmountOfSales_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_apdn_ThresholdAmountOfSales_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/FairValueFairValueMeasurementsOfCommonStockWarrantsUsingSignificantUnobservableInputsLevel3Details">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase" xlink:label="loc_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6" xlink:to="loc_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="apdn-20150630.xsd#apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise" xlink:label="loc_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6" xlink:to="loc_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929241621472">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE - Fair Value Measurements of Common Stock Warrants Using Significant Unobservable Inputs (Level 3) (Details) - Common Stock Warrants - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value Measurements of Common Stock Warrants Using Significant Unobservable Inputs (Level 3)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at October 1, 2014 and 2013</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,096,412<span></span>
</td>
<td class="nump">$ 2,643,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Adjustment resulting from change in fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,994,540<span></span>
</td>
<td class="nump">$ 1,663,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase', window );">Removal of warrant upon repurchase</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (4,090,952)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise', window );">Reclassification to equity upon exercise</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,455,042)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at June 30,</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,851,723<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Adjustment resulting from change in fair value is the amount of total gains or losses for the period attributable to the change in unrealized gains or losses relating to warrant liabilities held at the reporting date and realized gains or losses at the date of exercise. The gain or loss is recorded in change in fair value of warrant liability in the accompanying condensed consolidated statements of operations.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of reclassification to equity upon exercise of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToEquityUponExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents removal of warrant upon repurchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRemovalOfWarrantUponRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0````(`&&!"D?#F.=LP@$``#@9```3````6T-O;G1E;G1?5'EP97-=
M+GAM;,V9S4[#,!"$7Z7*%36N;?Y%>P&N@`0O8))M8S6.+=N4\O;8*2"H"FJ!
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M["]'GFM__=W0>S&P_K1'2.R40X#DD"`Y#D%R'('D.`;)<0*2XQ0DQQE(#CY"
M"8)"5(Z"5(["5(X"58Y"58Z"58["58X"5HY"5H%"5H%"5H%"5H%"5H%"5H%"
M5H%"5H%"5H%"5H%"5HE"5HE"5HE"5HE"5HE"5HE"5HE"5HE"5HE"5OE!5M;_
M83)Y!5!+`P04````"`!A@0I'2'4%[L4````K`@``"P```%]R96QS+RYR96QS
MK9++;L)`#$5_)9I]<4HE%A%AQ88=0OR`.^,\E,QXY#$B_?N.V(#"0ZW$TJ][
MCZZ\#JFL#C2B]AQ2U\=43'X,J<K]VG2JL0)(MB./:<&10IXV+!XUE])"1#M@
M2[`LRQ7(K8[9K.?:Q<[51G;NTQ1'E):T-M,(9Y;AFWE89.D\^(GT%V-NFM[2
MENW)4]`'_K,-`\]YEE<>QW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V"^GH`
MA3&^.R6:E((C-Z."N[_8_`)02P,$%`````@`88$*1Q8J%YF?`0``8A@``!H`
M``!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<\79RVZ"0!3&\5<Q/$"'<X[W
MJ*MNW+9]`:*C&.429IK6MR]UT=#+?.G"Y-M`8)(S_]4/`JLZY,LG?RGBJ:E#
M>6K#Z+VZU&'9WU]G98SMTKFP*WU5A(>F]76_>FBZJHC]97=T;;$[%T?O-,^G
MKAO.R3:KG[-'V_TZZ[9[R48O17?T<9V]-=TYE-['X&XG>>@WZ)>OK?_/]LWA
M<-KYQV;W6ODZ_E'AOC;(7#I(TT%*";)TD%&"QNF@,25HD@Z:4(*FZ:`I)6B6
M#II1@N;IH#DE:)$.6E"")`<RYIPDA#5':P%<"\=K`6`+1VP!9`O';`%H"T=M
M`6P+QVT!<`M';@%T"\=N`7@+1V\%>BM';P5Z*^E=&[UL<_16H+=R]%:@MW+T
M5J"W<O16H+=R]%:@MW+T5J"W<O16H+=R]#:@MW'T-J"W<?0VH+>1OI6@CR4<
MO0WH;1R]#>AM'+T-Z&T<O0WH;1R]#>AM'+T-Z&T<O<<#O4-9='[_'+M3?0SW
MKODV'!8-\`[Q>O'W3[E-A0T#K6._DW>WX]T?';>IGR'NU^^$S0=02P,$%```
M``@`88$*1POA.(3A`@``]0H``!````!D;V-0<F]P<R]A<'`N>&ULO5;;<ILP
M$/T5C5^:/B3XDE[B<9A1@*1,N15D9_*H8#EF@H&19$_2K^\"-L6)3&H_U"^6
M5N>L=L]JA2:9Z(\#GA>,RX0)]+)*,S$&XW5O*64QUC01+]F*B@N`9+"ZR/F*
M2ICR)RU?+)*8F7F\7K%,:L-^_ZO&7B3+YFQ^7C1.>_JDW`4719K$5"9YIKM)
MS'.1+R2R7F*63K2W@(H!GB,6KWDB7_5^C6F;*DP4TY09L)>^H*E@->JOL<(8
M^:J@V:M6SYPD>Q;3@N0FE:S-VE^HO2\I9W/8=,][8ZPP/UXAS[3D&DN:/;%Y
M&_M^<:?%C'%19CH87O3AUTBPL]>^&9TGV5-`$R[TR4:.-RR6.=^6:2-/K=(\
MC\NBBQF!^$0//5+!RN%U;T-Y0C/90R+Y#=-AK]ZVME;CM!"2Z_<Y?Q9+QJ28
M:(VQ&K:Q[7%RJ8^N*@2,]I%:DYF^E6TO[])"$IDRX2\"RN5_DJ+*:2?$Z*K7
MRG[G`M%LCJQ,PG%$=E9O!<5K2]*,#-\S+2^R3`2CR'=L$Q.8W&`'>X:%3N",
MCN%$!/Y<RSN!\T7)B::NB\,'Y-\B;!C^U".V=X<"(!NV%2DICOUK:ILV>4#8
M,Y&+/7Q7AD0^12B`C)2<K6]`X`=\XU@5%8SA%`)T;"4G"'W7CB(?HO-\8C5<
M)?@>AR'V"/C"-[8#P2E1H>54D@0XA/`),")L$!O44@N*`YM@!Q3TC9]J^<H5
MY`>5CRJI;2`''/JN:Y-2K!H,=2KUMKR#8M]B.T0S[$S5:7>73WT<.SF#;\?7
M;_#]2&W0&:&/'Z1;8>"R^'Q\#L/!"9SA"1QUZW;VQ_#R>'V'ZM8]U!_HS&22
M)O_6)EMPB@A\\]='-DU%_KAS]O>`SZJZIMV<`U=K%V>D/@?=G`/GX/!9/D>$
M'\\9J<]!)R=2UZ>38ZU.B$U]!W1>7NCLHWX^1[?P$$`SFJX9<AD5:\[>O3K:
MSX<WCP5M_Y&K_P%02P,$%`````@`88$*1WWDO+@^`0``:0,``!$```!D;V-0
M<F]P<R]C;W)E+GAM;,V334_#,`R&_PKJO4NS:1-$70^`.#$)B2$0MY!X6UCS
MH<13UW]/EG4M`RZ[<:MKOX]?QTDI'!/6PY.W#CPJ"%=[79O`A)MG&T3'"`EB
M`YJ'4:PP,;FR7G.,H5\3Q\66KX&,BV)&-""7'#DY`'/7$[.JE(()#QRM[_!2
M]'BW\W6"24&@!@T&`Z$C2K+JQ6R-;4Q)!GU51L<U#[BP4JT4R-MV*/N=BIT1
MO`Y'.<B^??K[IX>4(5E7N0^JKVJ:9M1,4ET<F)*WQ>-S.IM<F8#<"(BJH!BV
M#N;9J?/KY.Y^^9!5XX).\^(ZI\62SA@MV/3F_3#9F;_!L.Z&^+>.3P;3=E%A
M#1?N-FED6F[Z3"`)07CE4%ES$2YAOHD3+.P^/D'@Y:!.F"[;%MK&>AFJ=+^&
MZ/!RXLK6UK?'U(_H[%557U!+`P04````"`!A@0I'F5R<(Q`&``"<)P``$P``
M`'AL+W1H96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEV
MV[29A.U.'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYB
MZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#`"J5,7K5::0##.'W)$Q+#W(*+
M"$MX%,O67.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+
M5(UEHP$35T$FN8BT\OELQ?S:WCYES^DZ'3*!;C`;6"!_SF^GY$Y:B.%4PL3`
M:F<_5FO'T=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q
M>#BVR]*+<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*
MC5M/TVMWW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6U
MY4#3(`!8<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0
M!0X`-\313%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=
M?3K.:Y1_::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="
M?,_V]I&E)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>4
M1B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I`DQEJ&&^+3&K!'@$WVWO@C(WXV(
M]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76
M>)7`\:V</!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,C
MIW0FS>@S&L%&KQMUAVC2/'K^!?F<-0H<D1L=`F<;LT8AA&F[\!ZO)(Z:K<(1
M*T(^8ADV&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW
M0CYBSHN0$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y`\F
MIS_I,C0'HYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z>`HWEL:\4*Z">P'_T=HW
MPJOX@L`Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'
M5*^3*=@YG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+
M5--E-XH2GD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JV
ME+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^`VVZG=PZ
M.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'N
MH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+:`'@Z]1`O)256`Q
M6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5
M'<]56_*POFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V
M$I<8O./FQW%.4[@2=K8/`C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN
M>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41`71%`B.5'`86
M%S+D4.Z2D`83`<V4R43P`H)DIAR`F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4
MBK`,!2$7<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4
MS;L:OB9@2\-Z;ITM)__;7M0]M!<]1O.CF>`>LX=SFWJXPD6L_UC6'ODRWSEP
MVSK>`U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X`Q\U*M:
MI60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F`6/,,H68XWX=%FAHSU8NL
M.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#
M!!0````(`&&!"D=S-N`83`(``'H*```-````>&PO<W1Y;&5S+GAM;,U66VO;
M,!3^*T(9HX41VRE-:6L;1B$PV,J@>>A;D6W9%NCBR7+F]-=/%U^20)8V34OS
MHJ-/1]_Y='2<H[!6:XH?2HP5:!GE=01+I:H;SZO3$C-43T6%N5[)A61(Z:DL
MO+J2&&6UV<2H-_/]N<<0X3`.><,63-4@%0U7$;P8(.#VWXD,1_#I[.N?1JC;
M+\"-DV^3B?]T?KN+G]F%<P@<QX\L@L'\$GHO)YWZ_GYBL[A#/G\E^?^X=ZBO
M#+77)2@.<\''/,V@`^*P?@8K1+5_8-Q3084$2E^$UF`1CAAV'G>(DD02`^:(
M$;IV\,P`]NXZ/T:XD#:VB[`;9^J/D6211-#O?B\/EXSL=C#'(Y1N'T\#<5@A
MI;#D"ST!G;U<5_IP7'#L1%J_`]Z%1.M@=KFQP0XZ;B)DAN40.8`]%(<4YTIO
MD*0HS:A$9:0+I0331D90(3BBAK+?T1F:-L64/I@OY3'?XFYSX'S,'?L0&!6]
MJ1/1F6,9V*1ZFVR.>Y/V.%[0YD,`O1M5%5U_IZ3@##NQ#EJ(;G:(/MA#'X>H
M9P6ED.19^YM"2#6`)00K+!5)-Y&_$E5+W*JN@KTVWZ?PV"._IZ;39VU4HTOP
MH]-S='`+W3<LP7)A_QA?+^GBZO"5V:\3[LC\V*HY0L()DF,:VZ>5-O^\TMZG
MIDY1[==O5.9UC6&C^VSUG@$%24.H(KR7@,QKX=[(IEMM8>P[FC-KQY9C5Q5*
M]$-P*XHFRW".&JI^DY50=C&"H_W3R`_F@]=RH(C@:/_"&6G8M54POC;C?U!+
M`P04````"`!A@0I'JF:2#=D#``!^#0``#P```'AL+W=O<FMB;V]K+GAM;)67
M77/:.!1`_XK&+\T^M&`)2,*4SBC@9#WU!XM-.GE40!1-99N1Y";MKZ]L2',I
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M!@B`,`#A<T$$@`@`D;\&9;G]B8,$@`8`-#@7-`2@(0`-3T'9,H[IX@&EMXA.
MI^DRR</D#LTM<1H&&>",`&=TRHG"_Y;A+,P?$$UF**8)O6LBRM]E:&ZS!$"7
M`'1Y"CJLP@ZC#_0F"EJ>[5PL;7Q1"$!7`'1U"IHOTCC,LM0&EZ1Y\!L("->`
M<'U*^$(7"YKD=E9Z$T8V-JA>'[K7/QV\"*)V2^9T89.26U!&IWEH=PM2C@QV
M*4SG84XCN['I]#,<"(WU'<JV`U`Z;V=L<WB(YFAZJ*OO]#6.P[S9QSW#RM;X
M$21_R.%#77V'K[<T7*![&BUA^GWHIG^VG/`/[$,]?8>?G2C_$J*@H/ZYAOI7
M$`45]1V.OKU+Z,*67(B"KOH.65\SW`Z57/\#"QS4%3MT[<P/]B$*.HL=SG:C
M,$0=U5V7Q9TH6'@Q5!D[5.XL4'@`45!F[)"Y4P`,BR^&AF.'X6\5*70QXX8)
MB(*&8X?A)]7JP)`HY\^FABAH.'88_G;M:ID0!0W'#L./"MCQBI@\5A0:CAV&
M=Z-@-2#0=N*PO1-%H.T$VD[^KT*?H*#M!-I.SJK9Z#W*%40=G3,<MG>B"+2=
M0-N)P_9.5`:](M!VXJKG7:B@@"AH.W'5\\X`83TGT';BL+WS)8<N(`K:3ARV
M@R+\'MTRH=`]DS5',6>Z5ARBH.WD^G`Z?CT0VV\"4?)U\[F@VVGL>7O5?$/8
MG_T!8#!LW@E-.[;?%1.O.?S;<WXMY=3VI654L?:(O">_?#5\^@502P,$%```
M``@`88$*1_"\XB%-`@``\P<``!@```!X;"]W;W)K<VAE971S+W-H965T,2YX
M;6R-E=^.HC`4QE^EX0&FI8"H01)UL]F]V&0R%[O75:N0`<JV56;??OL/!B<5
MN9'V^'WGUP.G;=8Q_BX*2B7XJ*M&;()"RG8-H3@6M";BA;6T4?^<&:^)5%-^
M@:+EE)R,J:X@1F@!:U(V09Z9V"O/,W:55=G05P[$M:X)_[>C%>LV01CT@;?R
M4D@=@'D&!]^IK&DC2M8`3L^;8!NN]V&L)4;QNZ2=&(V!7OR!L7<]^7G:!$BO
M@5;T*'4*HAXWNJ=5I3,I\E^7]).IC>-QG_V[*5<M_T`$W;/J3WF2A5HM"L")
MGLFUDF^L^T%=#8E.>&25,+_@>!62U;TE`#7YL,^R,<_._A-'SN8W8&?`@P$G
MDX;(&:+!8%\=M"LS=7TCDN099QT0+=%?.UPK.==)5&8@3#95DC#!K8[><I3!
MFT[C%'BDV%E%."B@RNT%X,!GQ\:.'P/V5A$]!T0](!I7$!E[_-P>]_9X;(^-
M/;E?WUBQLXK%<T#B!23&GMX#$J-H+,`IXCA.\'/*PDM9F!S+B3*L8O4<D'H!
MJ6T#-$%PDAFMLO0BEM:/)Q!.,J-95E[$ROKCQU]C;R4XC)<I1C.^1XB\)!-6
MJ*G.ZC4S>BL,_12W.],IBM,L9U"PGV*W:+B:HKB-CF90(C\E<F]^8JOT&C1Z
MKX\Y_AT?V@V-O_39XJX:I_G::'!TQM:47\S=(\"171MIC]@A.MQO6VS.Z$]Y
MGK7D0G\1?BD;`0Y,JI/>',MGQB15>/2BBB[4#3Q,*GJ6>IBJ,;=WDIU(UO97
M['#/Y_\!4$L#!!0````(`&&!"D?]73,OQ0,``!<1```8````>&PO=V]R:W-H
M965T<R]S:&5E=#(N>&ULE5C!CMLX#/T5(_?6(BE;TB`3H..BZ!X*%#WLGCT3
M91+4CE/;,^G^?66+29-"T:@YQ+;R2#Y:U!.5Y;'KOP];:\?L9]OLA_O%=AP/
M=WD^/&UM6P_ONX/=NU\V7=_6HWOLG_/AT-MZ/1NU38Y"E'E;[_:+U7(>^]JO
MEMW+V.SV]FN?#2]M6_?_/]BF.]XO8'$:^+9[WH[30+Y:YF>[]:ZU^V'7[;/>
M;NX7'^"N(IH@,^+?G3T.%_?91/ZQZ[Y/#_^L[Q=BXF`;^S1.+FIW>;65;9K)
MDXO\@YW^CCD97MZ?O'^:TW7T'^O!5EWSWVX];AU;L<C6=E._-..W[OC9<@[%
MY/"I:X;Y.WMZ&<:N/9DLLK;^Z:^[_7P]^E^T8+.P`;(!G@U`1@V(#>@/@]PS
MF_/Z6(_U:MEWQVPXU--LPYV#]Y,3YSD;9F\NI6$>_#"-OJY0+O/7R0]#\`+R
MP)#;B(H1Q1F2N_A!$G@B09<DT-N7;]O3R5Y>VI.W5]<4U0S9^R0\!(0B`5+>
M!E8,)$-`^#8A&20D/2%]':>X),00H90JRMNXRN,T20WZ;3I%D$[A8YD('88(
MHPDB;`I^.P65";-=!MF4LP\2$38EAQ&@5)2/!R*51)!`2`4)*4\H$N?!0PHL
M-<0FBV&J!$R8+!U<#-JS2:@]$\S&>'N*9&,X&Z,C%5J94S*4D`N(()EYV+&1
M$3:,B=1#Q1#0`$(FD($P&:]35,3(`+^;P@B,,6)?J+1*F"K`,".O?!2IJ0?&
M@`0D22K&B;T5HA2%2B!%P0($+X&4XB$L?^!%BV+ZQQB7EBXA,B/5&6BD*DP"
MI[`&@I<NBHA@Q1C08OHDA`H+''A5DC&%8PP*J<O(4JT85VBB,J7.P@H'7IAD
M3.(8`Z4K,Q73!0:25AH0$CCI,"<O=#*ZRC1OVZ9TY9\0*BR)X*5,_O&BKQH$
MQ@33OVH03LZ,DL6%RMYN><+*B%[29(*<(037*7H)DBEM5UA^T`N&3&B\,-QY
MH=<*&6N]&(,@=60"*OS=>24H#X:5![U8R)CR,`9=UX"DB]B^PU`P&I72*>J#
M8?7!@HLFQLMCWB$`N-)2D3VS.F'!&%4*3-F","Q6R`(3$RO&`$IC3!%34$:^
M`UEJJ5+J*BQ8R)T4Q.I*13;&Z])2?[<Q8EBQ4'-OD.#!A)>L25ZR%)8-$LE+
MEL)=$'&'DR!=%#ZN$:9G<>/`1N$L\HLC[*%^ME_J_GFW'[+';G2GX?GHNNFZ
MT3H?XKTKO*VMU^>'QF[&Z5:Y^]Z?V_W#V!U.?T.<_PM9_0)02P,$%`````@`
M88$*1^9PHST)`P``R`X``!@```!X;"]W;W)K<VAE971S+W-H965T,RYX;6R5
MEUMOVC`8AO]*E!_0^)A#!4AMIFF[F%3U8KL.8"!J$K/8E.[?SXD-"]2'K!?-
M@<>?'R<?K_#BS/LW<6!,1A]MTXEE?)#R^)@D8G-@;24>^)%UZI,=[]M*JLM^
MGXACSZKM.*AM$@1`FK15W<6KQ7COI5\M^$DV=<=>^DB<VK;J_SRSAI^7,8PO
M-U[K_4$.-Y+5(KF.V]8MZT3-NZAGNV7\!!]+1`9D)'[6["PFY]$@O^;\;;CX
MOEW&8'!@#=O(H42E#N^L9$TS5%(S_S9%_\TY#)R>7ZI_'9>K]->58"5O?M5;
M>5"V((ZV;%>=&OG*S]^860,="FYX(\;_T>8D)&\O0^*HK3[TL>[&XUE_DA$S
MS#X`F0'H.@#Z!V`S`-\-2+39N*XOE:Q6BYZ?(W&LAK<-'Q7>#T54Y4B,U=22
MQ'CS:;C[OJ)DD;P/=0R")LBS1I";*`U!KTBBYK=*H(L$F4H@+4%OI\A&I-,2
M&L$`H=Q-E9HJ4DS"*MBJ@K5*>CL)G:IH)".X@,2-E0:C!<BSL`VQVA!MDWD>
MC$8PHO3^^=W8$/.*4@3RL`VUVE!MDWNFT4A*BQE+3JV3I'J2PO.6-0+!^!>>
M)[/.DVE3<#M//GVT&@$/`$`W5=HHITMN=<FU"_0T73Y=,_"\`0?H-"JL1H4V
M0AXCC?A4[@FG`P16B?&VLL`>"\/X-#XA;@]H]]#YEA)/KQ@FU"Q6S.UCCTN(
MS+?,]UQ,IH)PQQ@48CJ[::`]/*'.O-27GH9!D.0(`4^#E8:$N,"TH#,2'=I#
M%.KL2S.?%9EM1?[7RAZFT*0IFE'!GI0P#4>888)M:</</O9$A5DXQ@PS(\=<
MI-O*GJTP#T>98;PZ]XC;PYZHL)@19N%,_82X?VK90Q7I-*1X1@5['"(8[CLT
M+PZMF-O'\>L1A?O.,#/ZSD6ZK>Q9B'"X[PSCU;E'W![V]$,DW'>&\7K<(]HC
MF>PYCM6>_:CZ?=V):,VEVKZ,>XT=YY*I$N!!%3RH;>7UHF$[.9QFZKS7&RU]
M(?GQLF^\;EY7?P%02P,$%`````@`88$*1^A7:P43!```:!$``!@```!X;"]W
M;W)K<VAE971S+W-H965T-"YX;6R5F,N2HS84AE^%\MZ-CFY(+K>KVIA4LDC5
MU"R2-6W+EQHN#M#MR=M'((%ICY#)QACY.Y?_6.A(K&]E]:,^*]4$/_.LJ%\7
MYZ:YKL*PWI]5GM8OY545^I=C6>5IHV^K4UA?*Y4>.J,\"S%"/,S32['8K+NQ
M;]5F77XTV:50WZJ@_LCSM/IWJ[+R]KJ`13_P_7(Z-^U`N%F'@]WADJNBOI1%
M4*GCZ^(-5@GND([XZZ)N]>A[T";_7I8_VIL_#J\+U.:@,K5O6A>IOGRJ6&59
MZTE'_L<ZO<=L#<??>^^_=7)U^N]IK>(R^_MR:,XZ6[0(#NJ8?F3-]_+VN[(:
M6.MP7V9U]QGL/^JFS'N319"G/\WU4G37F_DE0M;,;8"M`1X,ACAN`V(-R-V`
M>@VH-:!S(S!KP!XBA$9[5[E=VJ2;=57>@OJ:MO,)5AJO6B?:<U!WWG31ZF[P
MK1W]W'"Q#C];/Q;!(V1K$3F-[`P"`Q'J^,XD\,(5`7?F>#I`;(@(>7)XZB3Y
MQ<EDFJ1/DXQK18S]#)FTMZ=C>VKL'U*,.J0PE3`(QCSBHSB_<+'A!`60T32V
M,QA#6&!"I[G$AD41XU(\E\><Y6%&'GENSYWEX<;^(4\V+H]!"$.",C;-Q8;#
MDFH.3W,[PP&@2%#D<9A8$"%).)DQ`2*GPL@H]`3:&H1TD3P"#88Y)P0\^@PF
M.434IRZRZ@2CP)^+$TYQPHCC'G$&`0R$2(\XBP&AV#,9=L).!@K4@R46PXS2
M&5-;.K5)HRWR:#,(D40*X>%BRQ']2"(/MY.V5D12/8\]^BP(#%$JV7.%@)P2
MNV&M47@T6F8)/,(8//]TW).8B@@!\NCLR8APCKB'3'I2%T1$HV5O6BDXURDP
MW2J2,SQ@=ZU,)Q&>;+>68<BW`,66`O`]Q19:8BY\4R:QG%[+9B@C;F6FQPE/
M.EO++$D$GLD26XQA+#T/^Z[W!EPPSXJ76`X(`C%CC0)W"P;;.'U-P3)+*72;
MP3-",7<HTP^%;QFW#`/&J(?;66ZI2TD9]3XDK"]GVQKF%,K=C(';'89GLV*9
M=CE`XK&D7[8K`RE!(N;;L0PD$,$`>9PF`XIT@P,Z8]\![K8,IO^).8NGN_>!
M:3*"^ZHE9E=+S*Z6F%\M\;^KY>Z%8!K.8Y.37[0:9HE>D)C&XCL&=!K;W3%.
MIK'DCHD93RT>VN"7YH!-DQ$SM@H8G/7!IKT(SZ*WM0S6.Q=*B&\G:TD@>F>.
MN6_9ZDG=(QA#GN:<##XI0N/5Q"@-1\?(7%6G[@!?!_ORHVC,R6@8'5X2O.'V
M&/HPOH55#([Q':P2\PK@[GZSOJ8G]6=:G2Y%';R7C3[\=B?58UDV2B>-7K2$
MLTH/PTVFCDW[-6K_#?,BP-PTY;5_KS&\7-G\!U!+`P04````"`!A@0I'I=CG
M7V4$``!2%```&````'AL+W=O<FMS:&5E=',O<VAE970U+GAM;(U836_C-A#]
M*X;O7G-F2%$,'`.QBJ(]%%CLH3TK,1,;*UFNI,3;?U]*'#FVP="\6!+]9N;-
M2//XL3HU[<]N9VT_^U57A^YQONO[X\-RV;WL;%UVWYJC/;A_7INV+GOWV+XM
MNV-KR^UH5%=+%");UN7^,%^OQK'O[7K5O/?5_F"_M[/NO:[+]K^-K9K3XQSF
MT\"/_=NN'P:6Z]7R;+?=U_;0[9O#K+6OC_,G>"C(#)`1\??>GKJ+^]E`_KEI
M?@X/?VX?YV+@8"O[T@\N2G?YL(6MJL&3B_PO._V,.1A>WD_>?Q_3=?2?R\X6
M3?7/?MOO'%LQGVWM:_E>]3^:TQ^6<U"#PY>FZL;?V<M[US?U9#*?U>4O?]T?
MQNO)_Y,+-@L;(!O@V>`<)VQ`;$"?!G+,U#,;\_JM[,OUJFU.L^Y8#F\;'AR\
M'9PXS[-N].92ZL;!IV'T8VW$:ODQ^&$(7D`V'@)GQ-(Y#T;`><@<1W/\.D#A
M$5K<CT!3!+K,@7P."0SE9"\O[:6WOZ&H1\C!)^$A"P#*%8@(LIB0PF0`DNYS
M4L&<E.>48)\%<\I\3;-KINHR)P\A)4'*KV$%PU!)F=]GHX-LM,\F$F:CF0T!
M"A6AXW&@0>>D[_/)@WQRSR<29^,A:(Q44D3X>!QD&1%D]_F8(!\S.LDQPL=#
M3"YRB??#@`C&&8>=E]AGP9A,2HS`"H81:242.A<@3(CU1\<(>0R"BQ0CQ#J5
MY3KA.P4,MAT@ESG!`X4S8C4RL8R(10*U@CR"+!@)I&6>\'5!6.#`BQ*(2/TV
M#%HH0Q!KP`EG4"804F%"B@E!C)`'+;12<4**6Q5EEM(:8<$$KW.Q7M\P9D$Z
ME[$77##0+9P`$Z8E"*LFL-;=SC?7G#2_-L1,`\5(,3)#[0IO$FCEX1YAR1,)
MDQ.$]0X,NXC-"`Q:($*FHM6>@,*X*B2L4\+BB())Q:8%!BV0G!*GQ`KK'K)8
MB9@2,V@AE=$RTBG%!$PN0%C\$)E4PKR*8?5#UBN1Q_)BD'$+)`D19,%(!%<"
ME:!_&-8_G/0O)LH,6DAAAC(F!`MK&[*V04Q))I`22#*+S;.,3"]!6-XP8U8Q
MQ660<9.Z$ZX8*19"2215KA)8A14.6>%BP383B-S$1%%6'IA1)DBD[%?"BT-D
M?;L5TZL-P002VH6Z73]?;0@8B0*53EDAH@DW)TLF),RZ%!8X8H&#A!=&8=TB
MUJV41"BL,L0J`PDJ0V&5(1:06^VXJOL$,BII9QE6#F+E`!/Y%B90#I<3VM>A
MPKI!+`DH8DFQ&DBE1,H^@,)J0*P&&%,#!F6YS!,6"Q3N<.+FQ5B'3R#*,>73
M#+<M<4=B9`VTH6E;AR;E"PZO7HA;$2-MOYE`N:3+?8N/M;PXJJEM^S8>876S
ME^;]T/MSE//H^9CL"8>CGIOQ#3P4_K#KT\UZ=2S?[%]E^[8_=+/GIN^;>CSU
M>6V:WCINXINKR<Z6V_-#95_[X5:[^]8?>?F'OCE.)WCG8\3U_U!+`P04````
M"`!A@0I'0?%A3*(!``"Q`P``&````'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;(53VX[;(!#]%<0'+#9)=JO(L91L5;4/E5;[T#X3>VRC!<8%'&__OH`O:U61
M]L7,C,\Y<V"@&-&^N0[`DW>MC#O1SOO^R)BK.M#"/6`/)OQIT&KA0VI;YGH+
MHDXDK1C/LD>FA32T+%+MQ98%#EY)`R^6N$%K8?]>0.%XHCE="J^R[7PLL+)@
M*Z^6&HR3:(B%YD3/^?&RCX@$^"5A=)N81.]7Q+>8_*A/-(L60$'EHX((RPV>
M0:DH%!K_F34_6D;B-E[4OZ7=!O=7X>`9U6]9^RZ8S2BIH1&#\J\X?H=Y"X<H
M6*%RZ4NJP7G4"X42+=ZG59JTCM.?73[3[A/X3.`KX4N6C$^-DLVOPHNRL#@2
MUXLXN_P8X#:*!&7BDEIPZ%+Q'*NW,N>'@MVBT(SA&\QEQJP(%M3OMN#T'ITG
M.O^<OEOHNZW#W>SP\7.!_2*PWPKL[V]QB[DLF*?_FK#-F6JP;;HZCE0X&#\=
MZ5I=;^>9IYE\P,NB%RW\%+:5QI$K^C#9-(8&T4-HGST<*.G"^UD3!8V/X5.(
M[72EIL1COSR0]966_P!02P,$%`````@`88$*1Z9:/H6B`0``L0,``!@```!X
M;"]W;W)K<VAE971S+W-H965T-RYX;6R%4\MNY"`0_!7$!P2;<;+9D<?23%91
M]K!2E$/VS-AM&P7<#N!Q]N\#^!%K-5(NIKM=55W0D(]HWFP+X,B'5IT]T-:Y
M?L^8+5O0PMY@#YW_4Z/1POG4-,SV!D0525HQGB1W3`O9T2*/M6=3Y#@X)3MX
M-L0.6@OS[P0*QP--Z5)XD4WK0H$5.5MYE=3068D=,5`?Z#'=G[*`B(!7":/=
MQ"1X/R.^A>1W=:!)L``*2A<4A%\N\`!*!2'?^'W6_&H9B-MX47^,N_7NS\+"
M`ZJ_LG*M-YM04D$M!N5><'R">0NW0;!$9>.7E(-UJ!<*)5I\3*OLXCI.?[)T
MIETG\)G`5\)]$HU/C:+-7\*)(C<X$MN+,+MT[^$FB'AE8J.:=VAC\1BJER+E
M]SF[!*$9PS>8TXQ9$<RK7VW!Z34ZCW3^/7VWT'=;A[O9X<_O!;)%(-L*9->W
MN,6<9LPN^:\)VYRI!M/$JV-)B4/GIB-=J^OM//(XDR]XD?>B@3_"-+*SY(S.
M3S:.H49TX-LG-[>4M/[]K(F"VH7PAX_-=*6FQ&&_/)#UE1:?4$L#!!0````(
M`&&!"D=_SMEZH`$``+$#```8````>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
MC5/;;MP@$/T5Q`<$WY)6*Z^EW515\A`IRD/[S-IC&P48%_`Z_?L"OL2J5FI?
MS,SXG#,'!LH)S;OM`1SY4%+;(^V=&PZ,V;H'Q>T=#J#]GQ:-XLZGIF-V,,";
M2%*294GRP!07FE9EK+V:JL312:'AU1`[*L7-[S-(G(XTI6OA372]"P56E6SC
M-4*!M@(U,=`>Z2D]G(N`B(`?`B:[BTGP?D%\#\ES<Z1)L``2:A<4N%^N\`A2
M!B'?^->B^=DR$/?QJOX][M:[OW`+CRA_BL;UWFQ"20,M'Z5[P^D)EBW<!\$:
MI8U?4H_6H5HIE"C^,:]"QW6:_Q3I0KM-R!9"MA&^)M'XW"C:_,8=KTJ#$[$#
M#[-+#QYN@HA7)C:J>8<V%D^A>JW2/"W9-0@MF&R'.2^8#<&\^LT6&;U%SR(]
M^S<]7^GYWF&^./P/@6(5*/8"Q>TM[C'G%9/_U83MSE2!Z>+5L:3&4;OY2+?J
M=CM/69S))[PJ!][!"S>=T)9<T/G)QC&TB`Y\^^3NGI+>OY\MD="Z$'[QL9FO
MU)PX'-8'LKW2Z@]02P,$%`````@`88$*1S4>=_*B`0``L0,``!@```!X;"]W
M;W)K<VAE971S+W-H965T.2YX;6R%4]MNXR`0_17$!Q3'=MHJ<BPE7:UV'U:J
M^M`^$WMLHP+C!1QW_[Z`+[56D?IB9L;GG#DP4(QHWFT'X,B'DMH>:>=<?V#,
M5ATH;N^P!^W_-&@4=SXU+;.]`5Y'DI(L39)[IKC0M"QB[=F4!0Y."@W/AMA!
M*6[^G4'B>*0[NA1>1-NY4&!EP59>+11H*U`3`\V1GG:'<QX0$?`J8+2;F`3O
M%\3WD/RNCS0)%D!"Y8("]\L5GD#*(.0;_YTUOUH&XC9>U'_&W7KW%V[A">6;
MJ%WGS2:4U-#P0;H7''_!O(5]$*Q0VO@EU6`=JH5"B>(?TRIT7,?I3_8PTVX3
MTIF0KH3')!J?&D6;/[CC96%P)+;G87:[@X>;(.*5B8UJWJ&-Q5.H7LM=EA?L
M&H1F3+K!G&?,BF!>_6:+E-ZBIY&>?D_/%GJV=9C-#O??"^2+0+X5R&]O<8LY
M+YC[_YJPS9DJ,&V\.I94.&@W'>E:76_G*8TS^8*71<];^,--*[0E%W1^LG$,
M#:(#WSZYVU/2^?>S)A(:%\(''YOI2DV)PWYY(.LK+3\!4$L#!!0````(`&&!
M"D>&V).-H@$``+$#```9````>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;(53
MVV[C(!#]%<0'%(>DVS9R+"5=K78?5JKZT#X3>VRC`N,%'+=_7\"76JM(?3$S
MXW/.'!C(![1OK@7PY%TKXPZT];[;,^;*%K1P-]B!"7]JM%KXD-J&N<Z"J!))
M*\:S[`?30AI:Y*GV9(L<>Z^D@2=+7*^UL!\G4#@<Z(;.A6?9M#X66)&SA5=)
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M:DP\=O,#65YI\0E02P,$%`````@`88$*1Y\V,[>A`0``L0,``!D```!X;"]W
M;W)K<VAE971S+W-H965T,3$N>&ULC5/;;N,@$/T5Q`<4QW&V5>182EJM=A\J
M57W8?2;VV$8%Q@4<IW]?P)=:5:3=%S,S/N?,@8%\0/-F6P!'KDIJ>Z"M<]V>
M,5NVH+B]PPZT_U.C4=SYU#3,=@9X%4E*LC1)?C#%A:9%'FLOILBQ=U)H>#'$
M]DIQ\W$"B<.!;NA<>!5-ZT*!%3E;>)50H*U`30S4!WK<[$]90$3`'P&#7<4D
M>#\COH7D=W6@2;``$DH7%+A?+O`(4@8AW_A]TOQJ&8CK>%;_&7?KW9^YA4>4
M?T7E6F\VH:2"FO?2O>+P"Z8M[()@B=+&+RE[ZU#-%$H4OXZKT'$=QC_;AXEV
MFY!.A'0A/"31^-@HVGSBCA>YP8'8CH?9;?8>;H*(5R8VJGF'-A:/H7HI-EF2
MLTL0FC#I"G.:,`N">?6;+5)ZBYY&>OIO^G:F;]<.MY/#_^B?S0+96B"[O<4U
MYC1COKMDJS-58)IX=2PIL==N/-*ENMS.8QIG\@4O\HXW\,Q-([0E9W1^LG$,
M-:(#WSZYVU'2^O>S)!)J%\)['YOQ2HV)PVY^(,LK+3X!4$L#!!0````(`&&!
M"D<WPNMSH0$``+$#```9````>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;(53
MVV[C(!#]%<0'%,=VME7D6$I:K78?5JKZL/M,[+&-"HP+..[^?0%?:E61^F)F
MQN><.3!0C&A>;0?@R+N2VAYIYUQ_8,Q6'2AN[[`'[?\T:!1W/C4ML[T!7D>2
MDBQ-DA],<:%I6<3:LRD+')P4&IX-L8-2W/P_@\3Q2'=T*;R(MG.AP,J"K;Q:
M*-!6H"8&FB,][0[G/"`BX*^`T6YB$KQ?$%]#\KL^TB18``F5"PK<+U=X!"F#
MD&_\-FM^M@S$;;RH_XR[]>XOW,(CRG^B=ITWFU!20\,'Z5YP_`7S%O9!L$)I
MXY=4@W6H%@HEBK]/J]!Q':<_V?U,NTU(9T*Z$AZ2:'QJ%&T^<<?+PN!(;,_#
M['8'#S=!Q"L3&]6\0QN+IU"]EKL\*]@U",V8=(,YSY@5P;SZS18IO45/(SW]
MGIXM]&SK,)L=YM\+Y(M`OA7(;V]QBSDOF/V7)FQSI@I,&Z^.)14.VDU'NE;7
MVWE*XTP^X671\Q;^<-,*;<D%G9]L'$.#Z,"W3^[VE'3^_:R)A,:%\-['9KI2
M4^*P7Q[(^DK+#U!+`P04````"`!A@0I'.9$*@Z$!``"Q`P``&0```'AL+W=O
M<FMS:&5E=',O<VAE970Q,RYX;6R%4]MNXR`0_17$!Q3'<9LJ<BPEK:KVH5+5
MA]UG8H]M5&!<P''W[Q?PI585J2]F9GS.F0,#^8#FP[8`CGPIJ>V!MLYU>\9L
MV8+B]@8[T/Y/C49QYU/3,-L9X%4D*<G2)+ECB@M-BSS6WDR18^^DT/!FB.V5
MXN;?"20.![JA<^%=-*T+!5;D;.%50H&V`C4Q4!_H<;,_90$1`7\$#'85D^#]
MC/@1DI?J0)-@`224+BAPOUS@`:0,0K[QYZ3YW3(0U_&L_A1WZ]V?N84'E']%
MY5IO-J&D@IKWTKWC\`S3%FZ#8(G2QB\I>^M0S11*%/\:5Z'C.HQ_=ME$NTY(
M)T*Z$.Z3:'QL%&T^<L>+W.!`;,?#[#9[#S=!Q"L3&]6\0QN+QU"]%)OL+F>7
M(#1ATA7F-&$6!//J5UND]!H]C?3T=_IVIF_7#K>3P]WO`MDLD*T%LNM;7&-.
M,^;^1Q.V.E,%IHE7QY(2>^W&(UVJR^T\IG$FW_`B[W@#K]PT0EMR1N<G&\=0
M(SKP[9.;6TI:_WZ61$+M0KCSL1FOU)@X[.8'LKS2XC]02P,$%`````@`88$*
M1XL6MORB`0``L0,``!D```!X;"]W;W)K<VAE971S+W-H965T,30N>&ULA5/;
M;J,P$/T5RQ]0$P)[B0A2TM6J?5BIZL/NLP,#6+4]K&U"^_>US:6HBM07/#.<
M<^:,+\6(YL5V`(Z\*JGMD7;.]0?&;-6!XO8.>]#^3X-&<>=3TS+;&^!U)"G)
MTB3YQA07FI9%K#V9LL#!2:'AR1`[*,7-VQDDCD>ZHTOA6;2="P56%FSEU4*!
MM@(U,=`<Z6EW.&<!$0%_!8QV$Y/@_8+X$I+'^DB38`$D5"XH<+]<X1ZD#$*^
M\?]9\Z-E(&[C1?UWG-:[OW`+]RC_B=IUWFQ"20T-'Z1[QO$!YA'R(%BAM/%+
MJL$Z5`N%$L5?IU7HN([3GSR=:;<)Z4Q(5\*/)!J?&D6;O[CC96%P)+;GX>QV
M!P\W0<0K$QO5O$,;BZ=0O9:[[&?!KD%HQJ0;S'G&K`CFU6^V2.DM>AKIZ=?T
M_4+?;QWNI^YY\K5`M@AD6X'L]HA;S'G&Y)^'9)L]56#:>'4LJ7#0;MK2M;K>
MSE,\1/8!+XN>M_"'FU9H2R[H_,G&8V@0'?CVR5U.2>??SYI(:%P(O_O83%=J
M2ASVRP-97VGY#E!+`P04````"`!A@0I'L%=BS*$!``"Q`P``&0```'AL+W=O
M<FMS:&5E=',O<VAE970Q-2YX;6R%4]MNXR`0_17$!Q3'=K95Y%A*NJIV'U:J
M^K#[3.RQC0J,"SAN_[Z`+[56D?IB9L;GG#DP4(QH7FT'X,B[DMH>:>=<?V#,
M5ATH;N^P!^W_-&@4=SXU+;.]`5Y'DI(L39(?3'&A:5G$VK,I"QR<%!J>#;&#
M4MQ\G$'B>*0[NA1>1-NY4&!EP59>+11H*U`3`\V1GG:'<QX0$?!7P&@W,0G>
M+XBO(?E='VD2+("$R@4%[I<K/(*40<@W?ILUOUH&XC9>U)_B;KW["[?PB/*?
MJ%WGS2:4U-#P0;H7''_!O(5]$*Q0VO@EU6`=JH5"B>+OTRIT7,?I3Y;/M-N$
M=":D*^$AB<:G1M'F3^YX61@<B>UYF-WNX.$FB'AE8J.:=VAC\12JUW*W3PMV
M#4(S)MU@SC-F13"O?K-%2F_1TTA/OZ=G"SW;.LQFA]GW`ODBD&\%\MM;W&+.
M"R;_KPG;G*D"T\:K8TF%@W;3D:[5]7:>TCB3+WA9]+R%/]RT0EMR0><G&\?0
M(#KP[9.[/26=?S]K(J%Q(;SWL9FNU)0X[)<'LK[2\A-02P,$%`````@`88$*
M1^U>'6OG`0``J@4``!D```!X;"]W;W)K<VAE971S+W-H965T,38N>&ULC53-
MCILP$'X5RP^P)B20'Q&D9*NJ/51:[:$].S`$M#:FMA.V;U_;V"Q;H=`+]@S?
MSXRLF:P7\DW5`!J]<]:J(ZZU[@Z$J*(&3M63Z*`U?RHA.=4FE%>B.@FT="3.
M2!Q%*>&T:7&>N=R+S#-QTZQIX44B=>.<RC]G8*(_XA4.B=?F6FN;('E&1E[9
M<&A5(UHDH3KBT^IPWEN$`_QLH%>3.[*U7X1XL\'W\H@C6P(P*+15H.:XPS,P
M9H6,\6^O^6%IB=-[4/_JNC757ZB"9\%^-:6N3;$11B54],;TJ^B_@6\AL8*%
M8,I]47%36O!`P8C3]^%L6G?VPY]-[&GSA-@3XI&PBUSA@Y$K\PO5-,^DZ)'J
MJ'V[U<'`I14QRD@Y-5.A<LF3S=[S59)DY&Z%/":>8,X>,R*(49^UB/$</7;T
M>)F^#O3UM,+UX!ZGRP*;(+"9"FQ\B^GG%J>8<\!LETV269/$"^P>F`3,?MDD
MG35)!X$T>F`2,/_Q7-M9DZT7B!^8!,QZV60W:[+S`IL')@&3+)OL9TWV7N#1
MPP?,OP]/)L/$05[=SE"H$+=6#[,T9L>U='+32S[@>=;1*_R@\MJT"EV$-B/M
MYJ\20H.QCYX2C&JS.,>`0:7M=6ON<M@E0Z!%%S;CN)[SOU!+`P04````"`!A
M@0I'#Q386J4!``"Q`P``&0```'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6R%
M4]MNW"`0_17$!P0ON]FD*Z^EW515^U`IRD/[S-IC&P48%_`Z_?L"OL2-5LH+
MS`SGG)EA(!_0OKH6P),WK8P[TM;[[L"8*UO0PMUA!R:<U&BU\,&U#7.=!5$E
MDE:,9]F>:2$-+?(4>[9%CKU7TL"S):[76MB_9U`X'.F&SH$7V;0^!EB1LX57
M20W&233$0GVDI\WAO(N(!/@E87`KF\3:+XBOT?E1'6D62P`%I8\*(FQ7>`*E
MHE!(_&?2?$\9B6M[5O^6N@W57X2#)U2_9>7;4&Q&206UZ)5_P>$[3"W<1\$2
ME4LK*7OG4<\42K1X&W=ITCZ,)X_91+M-X!.!?R"P,5$J\ZOPHL@M#L1U(LYN
M<PAP&T6",G%)+53H4O`4H]=BLW_,V34*31B^PIPGS()@0?UF"DYOT7FB\\_I
MVYF^75>X';/S_><"NUE@MQ;832U^^;_%->8\81ZR#TG8ZDXUV"8]'4=*[(T?
MKW2)+J_SQ--,WN%%WHD&?@K;2./(!7V8;!I#C>@AI,_N[BEIP_]9'`6UC^9#
ML.WXI$;'8S=_D.67%O\`4$L#!!0````(`&&!"D>T?*4RI0$``+$#```9````
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;(U3RV[;,!#\%8(?$.IA)X4A"[!3
M!,FA0)!#>Z:EE42$Y*HD9:5_7Y)Z1"T,M!=Q=S4S.\M',:)YMQV`(Q]*:GND
MG7/]@3%;=:"XO<,>M/_3H%'<^=2TS/8&>!U)2K(L2>Z9XD+3LHBU5U,6.#@I
M-+P:8@>EN/EU!HGCD:9T*;R)MG.AP,J"K;Q:*-!6H"8&FB,]I8?S+B`BX+N`
MT6YB$KQ?$-]#\E(?:1(L@(3*!07NERL\@I1!R#?^.6M^M@S$;;RH/\5IO?L+
MM_"(\H>H7>?-)I34T/!!NC<<GV$>81\$*Y0V?DDU6(=JH5"B^,>T"AW7<?JS
MSV?:;4(V$[*5\"6)QJ=&T>97[GA9&!R)[7DXN_3@X2:(>&5BHYIW:&/Q%*K7
M,GU("W8-0C,FVV#.,V9%,*]^LT5&;]&S2,_^3<\7>KYUF$_=\_\0V"T"NZW`
M;AXQ^W/$+>:\8/*_FK#-GBHP;;PZEE0X:#=MZ5I=;^<IBV?R"2^+GK?PC9M6
M:$LNZ/S)QF-H$!WX]LG=GI+.OY\UD="X$#[XV$Q7:DH<]LL#65]I^1M02P,$
M%`````@`88$*1XLO/M2_`0``>P0``!D```!X;"]W;W)K<VAE971S+W-H965T
M,3DN>&ULA53-;J,P$'X5RP]0$P(D&Q&DI*NJ/:Q4]=`].S#\J#:FM@G=MZ]M
M#&4KU%RP9_S]S(BQTT'(-U4#:/3!6:N.N-:Z.Q"B\AHX57>B@]:<E$)RJDTH
M*Z(Z";1P),Y(&`0)X;1I<9:ZW+/,4M%KUK3P+)'J.:?RWQF8&(YX@Z?$2U/5
MVB9(EI*95S0<6M6(%DDHC_BT.9P3BW"`UP8&M=@C6_M%B#<;/!5''-@2@$&N
MK0(URQ7N@3$K9(S?O>:7I24N]Y/Z@^O65'^A"NX%^]L4NC;%!A@54-*>Z1<Q
M/()O(;:"N6#*?5'>*RWX1,&(TX]Q;5JW#N/)/O"T=4+H">$W`AF-7)F_J:99
M*L6`5$?MO]L<#%Q:$:.,E%,S%2J7/-GL-=OLHI1<K9#'A`O,V6-F!#'JJQ8A
M7J.'CA[>IF\G^G99X79TCW:W!:))(%H*1+[%^/\6EYCSA$ENF\2K)K$7V/U@
M,F'VMTV259/$"_SZP<1C]L$W$[*8#@ZR<I=`H5STK1Z'8\[.]^P4NNGZ@F=I
M1ROX0V75M`I=A#8SZ@:J%$*#L0_N8HQJ\Q+,`8-2V^W.[.5X.<9`BVZZZO-[
MDWT"4$L#!!0````(`&&!"D>[YJ$HH@$``+$#```9````>&PO=V]R:W-H965T
M<R]S:&5E=#(P+GAM;(53VV[C(!#]%<0'%-M)=JO(L91T574?5JKZT#X3>VRC
M`N,%'+=_7\"7NE6DOL#,<,Z9&0;R`<VK;0$<>5-2VP-MG>OVC-FR!<7M#7:@
M_4F-1G'G7=,PVQG@520IR;(D^<44%YH6>8P]FB+'WDFAX=$0VRO%S?L))`X'
MFM(Y\"2:UH4`*W*V\"JA0%N!FABH#_28[D_;@(B`9P&#7=DDU'Y&?`W.W^I`
MDU`"2"A=4.!^N\`=2!F$?.+_D^9GRD!<V[/Z?>S65W_F%NY0OHC*M;[8A)(*
M:MY+]X3#`TPM[()@B=+&E92]=:AF"B6*OXV[T'$?QI/;9*)=)V03(?M&8&.B
M6.8?[GB1&QR([7B87;KW<!-$O#*Q4<U7:&/P&**7(KU-<W8)0A,F6V%.$V9!
M,*]^-45&K]&S2,]^IF]F^F9=X6;,OMO\++"=!;9K@>W48O:UQ37F-&.^)V&K
M.U5@FOAT+"FQUVZ\TB6ZO,YC%F?R"2_RCC?PCYM&:$O.Z/QDXQAJ1`<^?7*S
MHZ3U_V=Q)-0NF+^];<8G-3H.N_F#++^T^`!02P,$%`````@`88$*1U=U9"9:
M`@``1@@``!D```!X;"]W;W)K<VAE971S+W-H965T,C$N>&ULC5;;DJ(P%/P5
MB@\8((2;A50INK7[L%53\[#['#4*-4!8$F7V[S<WD9T)R(N00W>?/JTDICWI
MWFF!,;,^ZJJA:[M@K%TY#CT6N$;TA;2XX4_.I*L1X\ONXM"VP^@D277E`-<-
MG1J5C9VELO;:92FYLJIL\&MGT6M=H^[O%E>D7]N>?2^\E9>"B8*3I<[`.Y4U
M;FA)&JO#Y[6]\59[SQ40B?A5XIZ.[BUA_D#(NUC\.*UM5WC`%3XR(8'XY89S
M7%5"B7?^HT4?/05Q?']7_R;'Y?8/B.*<5+_+$RNX6]>V3OB,KA5[(_UWK&<(
MA."15%1^6L<K9:2^4VRK1A_J6C;RVJLGL:MI9@+0!#`0ACYF@J\)_H,`9PE0
M$^#2#H$F!)\Z.&IVF=P.,92E'>DMVB+Q>_)6'-X)$:YL4:G&0Z.RN!'56^;%
M,'5N0DACP`BS59@PF8;LM,R`<+@!HPM@FSH`20?3#7*%B-P9#T]%]E]$)FWZ
M=YO^."Q?AQ4\%X!W`3@6@%H@_-]D(#&-RD)ADL!+8#2#RQ4.^)X/8S"-VRW4
MVYOU)@<,C`,&>L#HN4!HC#A<'G%D=!`MB%AA0C<$<.3T:\0*!Z`+_60FX85R
M>Z/<Y'BQ<;Q8CQ<_%TB,`2?+`_9<HP59?A:Q!ODP")-X)KQ<`X$;^3R7F927
M*NXG%-68SFB3K'%WD<<3M8[DVC#UV@_5X0C<`+')?JIOO57N&>H[<63*3?DA
MGZ4MNN"?J+N4#;4.A/&M7>[#9T(8YI[=%SY!P0_U85'A,Q.WD?@JU#&G%HRT
M]U-[^.N0_0-02P,$%`````@`88$*1R6B6@B*`@``\P@``!D```!X;"]W;W)K
M<VAE971S+W-H965T,C(N>&ULC99=<Z(P%(;_"L/]2A((H(/,M'[M7NQ,IQ?=
MZU2C,@7B)K%V__WF"Z0.H%Y(.#[O>\Y),"&[,/XACI1*[ZLJ:S'WCU*>9D$@
MMD=:$3%A)UJK7_:,5T2J6WX(Q(E3LC.BJ@P0`'%0D:+V\\S$7GB>L;,LBYJ^
M<$^<JXKP?\^T9)>Y#_TF\%H<CE('@CP+6MVNJ&@M"E9[G.[G_A.<;5)-&."M
MH!?1&7NZ]G?&/O3-K]W<![H$6M*MU`Y$73[I@I:E-E*)_SK/:THM[(X;][7I
M5E7_3@1=L/)/L9-'52SPO1W=DW,I7]GE)W4M8&VX9:4PW][V+"2K&HGO5>3+
M7HO:7"_V%SQULGX!<@+4"F`Z*@B=(+P*\*@@<H+H*HA&!=@)\*,98B>('\V0
M.$%R(PCL[)JU61))\HRSBR=.1#^P<*9PKDV4LR>,FUH688)/.OJ9PW2:!9_:
MR#&HPSP[9@J&F85EXA&;E;-IB4`5V5LI\ONJ0*X*.%*%9=`PL;1$,M+*ZJ[)
M^K[)QIG@^]V&3;=A=UU"VRV*[QM$C4'4-8C<=-WTT66>&R:\GP3W)L%VU:/O
M.5*#U#:'1<`$`#A,+1ZB5@]1FSYJL*^XMZ_83<Q-8TFW9,O\0!#""(?)"+IZ
M'-TX%$ZG20Q0@NYWD/1VD!B?Z.81Q=T&+()`E,;A,+8:QKX5;C&<AF'\0-%I
M;]&IFW8\,NV6B7&2@'086UH,C"Q*DTSM:R$<YM:6PT!];OH*.AMN1?G!'*;"
MV[)S+>W_NHVVY_43TAOV37P!9TO8$U_!V=H>QU?[/#N1`_U-^*&HA??.I#HF
MS)Z^9TQ253"8J.4[JC>0]J:D>ZF'B1IS>RC;&\E.S2M&^YZ3_P=02P,$%```
M``@`88$*1W:1`4]V`@``>0D``!D```!X;"]W;W)K<VAE971S+W-H965T,C,N
M>&ULE5;;DIL@&'X5QP=8Q6/,&&<23:>]Z,S.7K37Q)#HK(H%$K=O7T`T-L75
MWD3Y\YWX42'N,'FG!4+,^*BKAN[,@K%V:UDT+U`-Z0MN4</_N6!20\:'Y&K1
MEB!XEJ2ZLAS;#JP:EHV9Q++V2I(8WUA5-NB5&/16UY#\/J`*=SL3F$/AK;P6
M3!2L)+9&WKFL44-+W!@$77;F'FR/(!00B?A1HHY.[@T1_H3QNQA\.^],6V1`
M%<J9D(#\<D<IJBJAQ)U_*=&'IR!.[P?U+W*Z//X)4I3BZF=Y9@5/:YO&&5W@
MK6)ON/N*U!Q\(9CCBLI?([]1ANN!8AHU_.BO92.O7?_/QE8T/<%1!&<DC#YZ
M@JL([H/@?4KP%,%;Z^`K@C\2/#D'JY^[[%P&&4QB@CN#ME`\3V#+X42(<&6#
M2C7>-"J+>U&])R`*8NLNA!3&F6`./2:(YB&9DAD1%@^@3>&8.@='TIUY@[1'
MA/8G&19%CO^(S,9TAYC>M%FN:E:X+.`-`NY4P%,"FV4!7YO`5P)/:S'%''L,
M_RPLFP1:DT`)K%C.4#O-</TT-]H$&Y7`F9_F8<"X\YALP'C+02)MD$@)^'^;
M^!+3]$$BW7,W163/B-D0P-:FD&41(U@A`;1+`L#Z-0&./H6SO"KI"%KQC@#]
M6P;<Y::G"K3B$06>WL53+FL:XNM[ZO]'3_6O&@B6>YJ-H&B%3ZCW"9=[F@V@
M)Q=KLJ_4B%SECDZ-'-\:UG\IQ^IX:M@[8E]ZJA_`-@6:>B9.&7(?>\@G<0NO
MZ#LDU[*AQ@DSOAO*K>N",4,\K?W"LQ?\'#0.*G1AXC84G>A/!OV`X78XZ(RG
MK>0/4$L#!!0````(`&&!"D=&WUJ?\0(``.D+```9````>&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;(V66W.B,!B&_PKC?4L.)"$==::UJ[8S.]/IQ>XUU:A,
M@;B`M?OO-R=<ZD`:+R3$YWV_0P)F>I;U>W,0HHT^RZ)J9I-#VQ[OXKC9'$29
M-;?R*"KURT[69=:JVWH?-\=:9%LC*HL8`4#C,LNKR7QJYE[J^52>VB*OQ$L=
M-:>RS.J_#Z*0Y]D$3KJ)UWQ_:/5$/)_&%]TV+T75Y+**:K&;3>[AW3-$&C'$
MKUR<F]XXTLF_2?FN;YZVLPG0.8A";%IMD:G+AUB(HM!.*O(?9_H_IA;VQYW[
MTI2KTG_+&K&0Q>]\VQY4MF`2;<4N.Q7MJSROA:N!:,.-+!KS'6U.32O+3C*)
MRNS37O/*7,_V%Y8ZV;``.0&Z"&#B%6`GP*&"Q`F24`%Q`A(JH$Y`0P7,"5BH
M('6"-%3`G8"'"O2:VY4#5Y+8+KG9,(]9F\VGM3Q'S3'3CQ&\TWRM?91YU!A#
MM5D:,WFO9S_F"()I_*&='(-ZS$/'P'%FT3%HG'GL&#S._'#,.+&T!/,DO/K6
M9/V]R9,S(>/(<U=0<F%BU?GA]J.N_;C??F0<(.(!#KAS2/H.V#@D_&N:S""5
M[:E%;M0"PH1@EHRCJW#TR:&0<T8!8BB@@F2P@L08\:OE(OT*$A>+,I"F:#RI
M90=RR`%AXXZK#H0X)1!X+-<="3A53<$!99+!,HG;+,23E65N"$*473\F?7#M
M0(H8!#!D\]#!G*C+B7IZ;QG5*)X@XLEI-0*.Y\0&<V(V)^;9T!:!@&$`$\\>
M73HO@`B[KO'+M@\U7'L,^[UX<H:88X@]F^O9<A13H"('M"P=;%GJEM'3LX?4
MO6F`^8R#"V=&,2<>[-%B''^U&\^<#V;.7>:I)Y)E$L!A6"0(!D.9:1V+>];M
M`A&*:,AK'<+A8.ZO`0%?,`O!-+2'$`T'0RX8]+RN'03!4+"X=W8X9GOQ,ZOW
M>=5$;[)5!Q%S9-A)V0IE!&Y5#0=U[K[<%&+7ZB%3X]J>1.U-*X_=P?IRNI__
M`U!+`P04````"`!A@0I''I>4+!H"``!:!@``&0```'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6R-E<MNHS`8A5\%\0#UA8M)19!:JM',8J2JBYFUDS@!U6#&
M=D+G[<<W,K0BM)M@FW/.__T8G'(4\E4UC.GHK>.]VL:-UL,]`&K?L(ZJ.S&P
MWMPY"ME1;:;R!-0@&3TX4\<!AC`''6W[N"K=VK.L2G'6O.W9LXS4N>NH_/O(
MN!BW,8JGA9?VU&B[`*H27'V'MF.]:D4?27;<Q@_HOBZLP@E^M6Q4LW%DV7="
MO-K)C\,VAA:!<;;7-H&:RX75C',;9`K_"9G_2UKC?#RE?W/=&OH=5:P6_'=[
MT(V!A7%T8$=ZYOI%C-]9:"&S@7O!E?N-]F>E13=9XJBC;_[:]NXZ^CL%#+9E
M`PX&?#6@=-60!$/RP0`\F>OKB6I:E5*,D1JHW6QT;^32AICD2+DTTY)RBP]V
M]5)AC$MPL4%!@V>:QZ"YK:B#(KM*@`%8I,`313*GP,Z/$OQY0#(%I/.`)+21
MO(<D3M/[-KR&$)ALLMNRVLL0S#;Y+.XF3[K(DP:>]'VA;,[C-<A4@O"VK`XR
MB.>RFSC9(DX6<+(5'*])<0$WQ0I.B$HSDJ//<?)%G#S@Y"MU\O!T"O*%MXHL
MEB&A#%GIFH2G:S8;K]!X&3%;\(4]*!9IBD!3K+RB7H-25.1H[1V==)N49)L/
M0&!V#`STQ'Y2>6I[%>V$-B>*^_R/0FAF<N"=:;(Q!_UUPME1VR$Q8^G//C_1
M8IA.\NO?2?4/4$L#!!0````(`&&!"D=%\DC4`@,```L.```9````>&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;)57VV[B,!3\E2@?0'(<YU8!4J&+=A]6JOJP
M^YR"@:A)3&-3NG^_MG-"4^2`Z4-S8<[,.<Y,+M,3;]_$GC'I?=95(V;^7LK#
M0Q"(]9[5A9CP`VO4+UO>UH54A^TN$(>6%1M35%<!"<,DJ(NR\>=3<^ZYG4_Y
M459EPYY;3QSKNFC_+5C%3S,?_/[$2[G;2WTBF$^#<]VFK%DC2MYX+=O._$=X
M6)%,0PSB3\E.8K#OZ>9?.7_3![\V,S_4/;"*K:6F*-3F@RU956DFI?R.I%^:
MNG"XW[.OS+BJ_=="L"6O_I8;N5?=AKZW8=OB6,D7?OK)<(98$ZYY)<Q_;WT4
MDM=]B>_5Q6>W+1NS/76_9"&6V0L(%I!S`="K!1$61*X%%`NH:T&,!;%K08(%
MR45!T"V66>JG0A;S:<M/GC@4VH#PH."M)E',GC!L:I6%.?FHSW[,"<FGP8<F
M0@P98!:(B<)QS!(QXX@G1$`TCOF!F'@<LNJ;@3,F4,-:)R;]Q-%P8H($Y#9!
MU!/0(4%D".*+%4L-I.GFZ"`0FK_;.M2J0['1BP4;8I8]AMX6B:TB,1+$5T1Z
M3');)+&*)$B0?A?)!TNVZ##1Y/+B#T%/%M!H*ZFUE11;R;ZKZ#O15R]I+^.P
MK)E5)D.9_,K$'2:<A`Y6SJTJN6'(R+@3EQTDS\*,.A@>0JN..:W&H0Y>!K"F
M#L`]=D#L79";P5LA!C+'Y($]XA#AP#`>B]49Y#*2/>)`K5<P'EY!Q.09N$UD
MSSE@B&ETQ2P(BB!+'0(&]K`#IITZA`=2NUG2.\QB#R!D#F;)[KM-@SV%D+N8
M)7<W"[&GD/0IC,?=LD!0!#&D+H](L$MA6FER30KND[*GFO3/XVL/!P2YW?B)
M/=.DCVOJ0$&MOB34W9?$GD,2W_8E8ESO8<2>0Y*XV`5!L7HO<UD7^T.5I"YV
M2>^3LN>:9"YVR<;L$@S>D0_%COTNVEW9".^52_6Z;=Z-MYQ+IEC"B6I_K[[,
MS@<5VTJ]FZK]MOM6Z0XD/_2?7N?OO_E_4$L#!!0````(`&&!"D>#`4R[D0,`
M`*H0```9````>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;)5837.C.!#]*Q3W
M">@;4HZK8GN=W<-63<UA]TQLV:8&D`=P//OO5T!#2*8!S<4&^?5[W4BOA;RZ
MF_)[==&Z]G[F65$]^9>ZOCX&076XZ#RI'LQ5%_:7DRGSI+:WY3FHKJ5.CFU0
MG@4T#&60)VGAKU?MV-=RO3*W.DL+_;7TJEN>)^5_&YV9^Y-/_'[@6WJ^U,U`
ML%X%0]PQS751I:;P2GUZ\I_)XPOC#:1%_)/J>S6Z]IKD7XWYWMS\=7SRPR8'
MG>E#W5`D]NM-;W66-4Q6^0>0OFLV@>/KGGW?EFO3?TTJO379O^FQOMAL0]\[
MZE-RR^IOYOZGAAI$0W@P6=5^>H=;59N\#_&]//G9?:=%^WWO?HE"",,#*`30
M(6#0P0,8!+#W`#X;P"&`#P%T7D%`@'!-24*`=`U0$*`^U1!T3[>=FUU2)^M5
M:>Y>=4V:%4L>+;QL2"RS5[5L=EJJ=O"Y&7U;4QZM@K>&"#!TA-ET&!*'TY@_
M.HR,IR%[H!D0@4T2S93Z6!84,IV1V`)&S&2ZZS%DIIH.HV9H]D`SC7CYA62R
M8-87S,93PR!1NDS`>P(^)N!`P)8)!$H@6H*(?2Q2M9"B>U(=1!`A^`QLW\&^
MT#CF@H?3P!<`$BD9(W(Y<8DF+J%RODR@T&>OW)]]A&80`8&8KG4'&"Y$R!V$
M8E0H!B'Y46B,V?48M2Q"0E2E'6XH/O6)>%P/@$CX$#D($5P(&I*(9^KI0=+!
M6X3B.N!?2>9T>I##[!"&ZX"+)9O3Z4$.ZY7@7B=@=BGF='J0@[$(WA*(``HU
MMQ`Z$.$/HVF<5L(]3.1B]]D!Y@NA4:1<S$H4K@5^ERX+-T([!HG<6P;!K4QZ
MGWXJ67PHN0,1%3DU=HK[F8*?I</\4((63(E[P10W(:4.!0.(V"U!.C0PBON0
M@L5<MF/*\8+Y;Q2,NX>*Y8*W`&*1DM3E;0FW#Y7+1MT"R';LT48UK82;AX)Y
MU$PKW0P@EX>';ZD4'*9F.L(&0#R,21C.O&AL)X#32>&>I>!9Y="Z68BN*Q:Z
MKRN&[YJ,+$_!=@`Y3#7##<O`L,IA`V$3;[6_\5K+\+V.<9=J^<2""T;'I%R7
MY_8(7'D'<ROJ[E5\&!V.V<^T.69]&M^0QQU!QO?V6-X=HM_IUZMK<M9_)^4Y
M+2KOU=3V<->>Q$[&U-KF:QWH>Q>='(>;3)_JYE+9Z[([2G<WM;GV_PP,?T^L
M_P=02P,$%`````@`88$*1V%ZC$1+`@``JP@``!D```!X;"]W;W)K<VAE971S
M+W-H965T,C@N>&ULE59=CZ(P%/TKA!]@N7R(&B09'3>[#YM,YF'WN6H5,H6R
MM,KLO]^V%(8Q=>SZ8#\XY]QS;[BE6<?:-UX0(KSWBM9\[1="-"N$^*$@%>8S
MUI!:/CFQML)"+MLSXDU+\%&3*HK"()BC"I>UGV=Z[Z7-,W81M*S)2^OQ2U7A
M]N^&4-:M??"'C=?R7`BU@?(,C;QC69&:EZSV6G):^T^PVD&B(!KQJR0=G\P]
M97[/V)M:_#BN_4!Y()0<A)+`<KB2+:%4*<G(?XSH1TQ%G,X']6\Z76E_CSG9
M,OJ[/(I"N@U\[TA.^$+%*^N^$Y.#=GA@E.M_[W#A@E4#Q?<J_-Z/9:W'KG^R
M"`S-3@@-(1P)$'])B`PA<B7$AA"[$A)#2&X(J,]=5^X9"YQG+>L\WF#U/L%*
MPELE(I4]KM5DT;C>?%*[USQ,TPQ=E9#!A!/,QF"BX#YF:S`0W<<\&TQR'[(;
M0L&(03(5:S[AD$\TS2<T`N%C@6@0B*<"D19(EI]-IAI2]WGT$`CT[W&<V!HG
M-D9O"K^<!-KTF&AV6[(I:&L!W;626*TDO978(9>YM>AS]Z*G5@?IPZ+O>@@L
M'(N^L,99F$SA<Z`I9C=@'))96H,LC4#\6``":SWUMF-!`:PF`!Z7U&"<7V0(
M[:%"AZJ.()>4[)T)D9&XZ89DVC(&%$$"J<,A`O;F!-.=\?RK4/'_A;(W'R0.
M!X$!69H<30[]!I_)3]R>RYI[>R;D]T,?]B?&!)$JP4P:*>3-85Q0<A)JFBJ'
M_;>T7PC6#%>#\7Z2_P-02P,$%`````@`88$*1PIT:PY-`@``Z@<``!D```!X
M;"]W;W)K<VAE971S+W-H965T,CDN>&ULC97=CJ(P',5?A?``TA90,$CB1S:[
M%YM,YF+WNF(5,D"9MLKLVV^_0,8`ZH6TY9SS_[75-FDI^^`Y(<+YJLJ:;]Q<
MB&;M>3S+287Y@C:DEF_.E%58R"Z[>+QA!)^TJ2H]!,#2JW!1NVFBQ]Y8FM"K
M*(N:O#&'7ZL*LW\[4M)VXT*W&W@O+KE0`UZ:>+WO5%2DY@6M'4;.&W<+UP<(
ME$0K_A2DY8.VH^"/E'ZHSJ_3Q@6*@90D$RH"R\>-[$E9JB19^=.&WFLJX[#=
MI?_0TY7X1\S)GI9_BY/()2UPG1,YXVLIWFG[D]@YA"HPHR77WTYVY8)6G<5U
M*OQEGD6MGZUY$P)K&S<@:T"]`4:S!M\:_+LAF#4$UA`\&#PS%;T0!RQPFC#:
M.KS!ZN<!UU+.5(A,=KA.DVO`]>!6C=Y2M(H2[Z:"K`8--#NC@3'H-9[,'RV"
MW+$`9`/@=)&]T:!IQ<$JPN<4?D?A#Z?J&XH@>!X0=`'!,""PTWB`'&IVG<9_
M7B0<+1+J@&7PO4:D);6I821@`0"<5NU?4AW&5)/$RU'BI2$.OU<)ARQ&$@+[
MF58>C!+ZX:-T$FHU"K4R4'`&RDC@<Z8)X211-$H4&2(PLV712ULVIIIDB4=9
M8L.RG%D=(T$PB!`":&9U8KMCL1_&X0O_+0A&D?2P9%K-,%G-"U!6.4'E#4[*
MBK"+OG*XD]%K+<Q!V8_VU]H6Z9/V+D^3!E_(;\PN1<V=(Q7RO-:'ZYE2020$
M6$BD7%Z\?:<D9Z&:*]EFYBHR'4&;[F;MK_?T/U!+`P04````"`!A@0I'-#[-
M9*0#``!G$0``&0```'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6R5F-]NFS`4
MQE\%Y0&"?;`!5VFD]7\K39IVL5W3QFG0`&=`F^WM9^-#2C+C>;UH@/R^\_G8
MYB/)ZJ#:']U.RC[Z55=-=[G8]?W^(HZ[EYVLBVZI]K+1[VQ56Q>]/FU?XV[?
MRF(SB.HJ!D+2N"[*9K%>#=>^M.N5>NNKLI%?VJA[J^NB_7TE*W6X7-#%>.%K
M^;KKS85XO8J/NDU9RZ8K51.U<GNY^$0OGB`WR$!\*^6AFQQ'9O#/2OTP)X^;
MRP4Q8Y"5?.E-B4*_O,MK656FDG;^B44_/(UP>CQ6OQO:U<-_+CIYK:KOY:;?
MZ=&21;21V^*MZK^JPX/$'K@I^**J;O@?O;QUO:I'R2*JBU_VM6R&UX-])R<H
M<PL`!7`44.85)"A(0@4,!2Q4P%'`0P4I"M)008:"+%20HR`/%0@4B%"!67.[
M<N1,$MLE'S;,3=$7ZU6K#E&W+\QM1"\,WYHZNGC4#07U9NF&BY_,U?<U9&(5
MOYM*R,"$N4*&TGGF>F1@GKE!)B?SS.W(>+SN1J]DGKE'9IYX^"?Q:(G,,]PG
M+))\,+&>>_<"P+@`R70!8*A`&0NHD(P5V+1"@E-VU@H?F,9.V<@0\Q?@Q)Q.
M#*LD'B?VGT[<Z<1QB;-3IVSJ9!E!0YU2IU.*3KG'R3*,#%X!3IG3*<.]<N8D
MIDZ629;`YZ$G!S0_EMPYEAQ7B9W:3)F[D0EQ$4X7@1523\<"FPEQH<1I,UPV
M/IFGFR.4AQA1M]&83L)S`R#$('!;4G![V6``03R3AY#>"B'Q0=WY03$<!/5U
ME?QG5^X$H1@/`GQ=68@L"0UQ<B<(Q0@1GK"Z18C1-.=!7;DSA&*("#8?(K<(
M:2\1XN3.$(HA(OA\5S<(<0A<*G=$4+S_13K?U`U">OY8F)<[*"@FA<A\6W",
MD]#&P!T7@$D@<H\90@F$;@UP1P9@9`CA>;X@)""#E(7L#G!G!L"_'YM7"-'A
M3B9DGKP>RZ6)X,0W5Y832>B3&-Q!!#9C*/$]BQ%*4N$?_<-835#]X<KW>']$
M$BCC@J<AXW>'&]C<2LZ'=3I9#*<_S\/FRAUOP-&+>H)TA)99$N+D#C=(T>DL
MLD^>KD<HR,B=;8"?:PB;G[Y[A"C_:_'YR>)C3@(/FV1W!$*.(^+SN^<>(99E
MYS?)Z7:T6,H8G&^Q>/+-;5^\RL]%^UHV7?2L>OTU</C"ME6JE[H,6>HV=[+8
M'$\JN>W-8::/6_L[@#WIU7[\6>/XV\KZ#U!+`P04````"`!A@0I',KLC<[@"
M``#_"@``&0```'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6R55MN.VC`0_94H
M'T`\SHVL`&EA5;4/E5;[T#X;,!!M$M/8+-N_KQU/V(!,<'D@MCESSLS$,\SL
M+-IW>>!<!9]UU<AY>%#J^!1%<G/@-9,3<>2-_F4GVIHIO6WWD3RVG&T[H[J*
M*"%95+.R"1>S[NRU7<S$255EPU_;0)[JFK5_E[P2YWD(87_P5NX/RAQ$BUET
ML=N6-6]D*9J@Y;MY^`Q/+[2#=(A?)3_+P3HPSJ^%>#>;']MY2(P/O.(;92B8
M?GSP%:\JPZ25_R#IEZ8Q'*Y[]F]=N-K]-9-\):K?Y58=M+<D#+9\QTZ5>A/G
M[QQC2`WA1E2R^PXV)ZE$W9N$0<T^[;-LNN?9_I(7:.8VH&A`+P:0C!K$:!#[
M&B1HD-P81#:4+A$O3+'%K!7G0!Z9N1[PI.&M(=',@>S8=`YD=_AL3C\6,<EF
MT8<A0@P=8)860P'N8U8]AM['O/28^(*)M)].9VGO;#QTEJ*S^6."N"=(A@2Q
M]6`:7WN9=IC&>MECB/D\%DJ<0@F2W*2U&`I93#Q)'XND3I$4TS%]3)`Y\YGY
MYS-W>I`C07$_GTN+20B`5SZG3J'IXQ>WM!C(2)+X"!5.H<)&!.1:*!\*(>:Q
M!!"G1G=L1&X*RC2K+Q5$T4E1>"B!6PG+^[8LBRLA"R(3`AY"U"V$I0EC+PA!
M4/C=!'#7,,0HE8Q)65">>5T%<!<Q>%3Q$OZCC,%=QX"%#.G(I4,04.+9F"!S
MBV'1PTU0R57'SS!RC]8"[M8`V!L@'WM-%I3FL5]([N8`4Y2:CDEA"Z$%]9)R
MMP?H^\-(QULA:)I[!47=38)BDZ!D1`E!D)J_*P\I=Y>@V"4HW+]_*P31+"[2
M6ZEH,'D<V9[_9.V^;&2P%DH/,=W$L1-"<<U#)CJ`@YY&+YN*[Y19YGK=VOG,
M;I0X]N/F9>9=_`-02P,$%`````@`88$*1Q1G."H"`@``F08``!D```!X;"]W
M;W)K<VAE971S+W-H965T,S(N>&ULC57!CILP%/P5Q`?$V$!((H*TH5JUATJK
M/;1G)YB`UF#6=L+V[VL;0]G(6[@$^S$S;]X$V6G/^)NH")'>1T-;<?0K*;L#
M`.)2D0:+#>M(J]Z4C#=8JBV_`M%Q@@M#:BA`0;`%#:Y;/TM-[85G*;M)6K?D
MA7OBUC28_SD1ROJC#_VQ\%I?*ZD+($O!Q"OJAK2B9JW'27GTG^`AATA##.)7
M37HQ6WO:_)FQ-[WY41S]0'L@E%RDEL#J<2<YH50KJ<[O5O1?3TV<KT?U9S.N
MLG_&@N2,_JX+62FW@>\5I,0W*E]9_YW8&6(M>&%4F%_O<A.2-2/%]QK\,3SK
MUCS[X4VRMS0W`5D"F@@P^B\AM(3P@0`&9V:N;UCB+.6L]T2'];\-#PK.M8A2
M]H114R,)4WS2U7L6(I2"NQ:R&#3#G`8,@O!K3#YBP@D#E`>G$30:">=&T&`D
M2)8%PE$@F@N$@X/=]K/+O<&T@\L!$V[BY2:1LTED73[$-<?D(V9%%+&S26P%
M=LL"6V>6V_59)DX'R7*6IV1]ECMGDYW]]%;DM'>.N5\_)@R<%DQ9>X@^#QK/
M![4@N`T3%*QH!=VMX(I,+2C<1-&*1LC=""U_HZ<)]!@^F!TB';Z2GYA?ZU9X
M9R;5>60.CY(Q291(L%$Q5>J>F#:4E%(O$[7FP\DY;"3KQHM@NHVROU!+`P04
M````"`!A@0I'791.MC8"``!9!P``&0```'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6R-5<MNHS`4_17$O@&;=T20DE:CF<5(51<S:R=Q`BK&U'9"Y^_'+RBI
MK(1-L"_G!;E<EP-E[[S&6'B?I.WXQJ^%Z-=!P`\U)HBO:(\[>>=$&4%";MDY
MX#W#Z*A)I`U@&*8!04WG5Z6NO;*JI!?1-AU^91Z_$(+8OQUNZ;#Q@3\6WIIS
M+50AJ,I@XAT;@CO>T,YC^+3QMV"]`[&":,2?!@]\MO94^#VE[VKSZ[CQ0Y4!
MM_@@E`22ERM^QFVKE*3SAQ7]\E3$^7I4_Z$?5\;?(XZ?:?NW.8I:I@U][XA/
MZ-**-SK\Q/89$B5XH"W7O][AP@4E(\7W"/HTUZ;3U\'<R4-+<Q.@)<")8'P"
M8Z1COB"!JI+1P>,]4G\>6$LX4R)2V>-:32;DNKA5U6L5P:0,KDK(8N`,LS,8
M,"$"J>ZT@+Z+#C4=/J9'(SV:)XQLPO2Q0#P*Q'.!V`IDMX^8:$QG,AI,$2<@
M7>"3.'T2ZY/?\3&8)(^B/,L?&Z5.H]0:%8\%,J=`9@2B\$Y2@WG*0)HDV6.C
MW&F46R-PQ\A@TC"%<;[`J'`V26&-%G09")U1==G1)L4\JP45JV3!NP?`;03<
M?7)K9$&K9($/=/O`Y6T"(K=$Y&Z4VZ@&]`3`*EK@Y/Y&0>SNE%NG>'PIWXV"
MV>@CF)WUA.?>@5XZ82;?5)U.D2W4H_,+7I4].N/?B)V;CGM[*N0`UM/R1*G`
M,D"XDHU;RW-NVK3X)-0RDVMF)K_9"-J/!]ETFE;_`5!+`P04````"`!A@0I'
M%P8]E&L"``#R"```&0```'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6R-ELV.
MFS`4A5\%L1^PC2$X2I`F4U7MHM)H%NW:29R`!C#%3IB^??U'AHPLPB;8YMSS
M7<R],9N!]^^B9$P&'TW=BFU82MFMXU@<2M90$?&.M>K.B?<-E6K:GV/1]8P>
M35!3QPB`+&YHU8;%QJR]]L6&7V1=M>RU#\2E:6C_;\=J/FQ#&(X+;]6YE'HA
M+C;Q+>Y8-:P5%6^#GIVVX3-<[V"N)4;QNV*#F(P#G?R>\W<]^7G<AD#GP&IV
MD-J"JLN5O;"ZUDZ*_->9?C)UX'0\NG\WCZO2WU/!7GC]ISK*4F4+PN#(3O12
MRS<^_&#N&5)M>."U,+_!X2(D;\:0,&CHA[U6K;D.]DX.7)@_`+D`=`L@)F_+
M,5E^HY(6FYX/@>BH?G=PK=2]]E#&@3!F*D%A%I_UZK5(DF037[61TZ")9F<U
M".4W3:S\O1`T0I(I!%D(RAX;)*,!GAHD+DM\GV5J-*W-TFH0`03@!2#L!6&7
M:3X#LAJ2`D#P8T[JY:2.0QX;9%Z#S.T(F$G4:IXP0#"%CT$K+VCE0.D,R&EP
MFI%\P1/E7E#N0-D,R&H0)AB0!=5(O"#B0*L9D-60#.5DP<Y!X"U[LZQ):($%
M].8*H;_RR319)\+1:D$]0N0'(7_EWX.L"$5YN@#D;V68+"]]Z&]2B/W%?Y^K
M%3TE$5CR!OUM"E-_]>O__`DJ=?N/E[QH?S_#S%_^7TB9(\%D`<G?T'#LZ'R6
M9%4@@@OZ#/H[&HXM3>;>4SZ"OFY>/#G/.GIFOVA_KEH1[+E4)Z,YQTZ<2Z9<
M0*2ZMU0?(+=)S4Y2#U=JW-LCV4XD[\8OC-MG3O$?4$L#!!0````(`&&!"D<>
M8A&Y\P$``!D&```9````>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;)65WY*;
M(!C%7X7Q`8+BWV2,,QL[.^U%9W;VHKTF"8G.HKA`XO;M"PC6;8U);P0^SSG\
MOE$Q[QE_$Q4A$GPTM!5;KY*RVT`H#A5IL%BQCK3JSHGQ!DNUY&<H.D[PT9@:
M"I'O)[#!=>L5N:F]\")G%TGKEKQP("Y-@_FO':&LWWJ!YPJO];F2N@"+'(Z^
M8]V05M2L!9R<MMY3L"DSK3""'S7IQ60.-/N>L3>]^';<>KY&()0<I$[`:KB2
MDE"J@]3&[S;SSY;:.)V[]&?3K:+?8T%*1G_61UDI6-\#1W+"%RI?6?^5V!9B
M'7A@5)@K.%R$9(VS>*#!'\-8MV;LASN9;VWS!F0-:#0$Z:(AM(9P-"`#!@<R
MT]<7+'&1<]8#T6']L(.-DG,=HI*!,&FJ)6&*3[IZ+<+(S^%5!UD-FFAV@P:A
M[+:F_%<#%<,L"'(@X10$F8`@2N\'A"X@F@:$MI/@,^7::-JADT&#5LEM3>DT
M67R?))HEB2P)6B")'B")_H,DGB6)+4GX>9>I9N<TT6U-Z30/@"2S(,G02KR^
M'Y#.!J26(%GHQ&G2A4Z<YH'W-)L%R6S`>@'$:F)_`<1I@K]`X.0K[O"9?,?\
M7+<"[)E4!X+Y>D^,2:(R_%7L@4J=T^."DI/4TU3-^7!T#0O).G<0CW^#XC=0
M2P,$%`````@`88$*1X#[C$GR`0``:P4``!D```!X;"]W;W)K<VAE971S+W-H
M965T,S8N>&ULC53+CILP%/T5BP\8B`UA%!&D#%75+BJ-9M&N'7(#:&Q,;2=,
M_[Y^06A%D[+`]N6\KK!=C$*^JQ9`HP_.>K6/6JV'71RKN@5.U9,8H#=?SD)R
MJLU2-K$:)-"3(W$6XR39QIQV?506KO8JRT)<-.MZ>)5(73BG\M<+,#'NHTTT
M%=ZZIM6V$)=%//-.'8=>=:)'$L[[Z+#95;E%.,#W#D:UF".;_2C$NUU\/>VC
MQ$8`!K6V"M0,5ZB`,2MDC'\&S9NE)2[GD_IGUZU)?Z0**L%^="?=FK!)A$YP
MIA>FW\3X!4(+F16L!5/NC>J+TH)/E`AQ^N''KG?CZ+\\)X&V3L"!@&?"[+-.
M((%`;H34=>J3N;X^44W+0HH1J8':G[W9&;BT(D89*:=F6E*N>+#5:TDR7,17
M*Q0P>(%Y\9C-C(B-^JH%CM;HV-'O&%0XA""/+<AD099=$"^0Y(\%TDD@70JD
M(4'Z9\K,87K?A\=DS\0\=W"5QSD8^8^.LM5`60B4W0F4W8S2QS[;59]M\-G>
M\?$83$B^V";_],E7??+@D]_Q\9AT0W":9W\9Q8O-S4$V[M`K5(M+K_W>GJOS
MO7+`[G#<X&4QT`:^4=ETO4)'H<T1<^?A+(0&$R%Y,H%:<_/-"P9G;:>YF4M_
M&?B%%L-TM<WW:_D;4$L#!!0````(`&&!"D<VS8:>K0(``)8)```9````>&PO
M=V]R:W-H965T<R]S:&5E=#,W+GAM;)5676^;,!3]*X@?4&QC`XD2I#9TVAXF
M57W8GMW$25`!9]AING\_?T%0:B#+0\"7<\X]]V)LKRZ\?1='QF3P65>-6(='
M*4_+*!+;(ZNI>.`GUJ@G>][65*IA>XC$J65T9TAU%2$`DJBF91/F*Q-[:?,5
M/\NJ;-A+&XAS7=/V[Q.K^&4=PK`+O):'H]2!*%]%/6]7UJP1)6^"ENW7X2-<
M/D.L(0;QJV07,;@/M/DWSM_UX,=N'0+M@55L*[4$59</MF%5I954YC].])I3
M$X?WG?HW4ZZR_T8%V_#J=[F31^46A,&.[>FYDJ_\\IVY&H@6W/)*F/]@>Q:2
MUQTE#&KZ::]E8ZX7^R0#CN8G($=`/:'/XR?$CA!?"7B2@!T!]P0TG8$X`KG)
M$-G:3><**FF^:ODE$">JYQ-<*GBK191R((R::IHPP4<=_<ACDJVB#RWD,&B`
M>;*89#$.*2P$]HA(&?"Z0*$O`S)T-)Y@8Q$IF/`P*_+\16349MS9C(?-BFVS
M0#HO@#L!/!3`KMLWK4P-IK&]L!@(((D3.([;6!P&F`S\?($57<H8(D#&<<\N
M;0K3++ZC/N*MC]ADR<UK(L/Z+(9@#&$\#BLL+$ECF";S=A*OG<39@1-V+`:E
M>$&R9**/?MRHH=1K*'6&;B;I$%-TF'@^2>9-DCD!/#'),O=)XQA,U)RYJ9@F
M!*!Y.PNOG86S0^8%(/!^=B9\YW<'H=<$=.M<DDQ,!0?2;YA,S$P'6Q``%O@.
M1\CO"#E']Q3E7X[@?ZQ'T+\@03S?E\*!U$*C?C>IHL&F4[/V8+9[$6SYN9%V
M&>VC_9'B$>E-ZR;^!)<;Z(D7^@AB-KFK?+XZT0/[2=M#V8C@C4NU59I];<^Y
M9,HR>%`%'-4AJ1]4;"_U;:K;88\-=B#YJ3L%]4>Q_!]02P,$%`````@`88$*
M1RQ.OC6(`@``5`D``!D```!X;"]W;W)K<VAE971S+W-H965T,S@N>&ULC59;
MLZ(@'/\JCA_@*'BM,6>ZGO9A9\Z<A]UG*BKGJ+1`=?;;+R"8M5CVD/CW=P-!
MR*Z$?K$CQMSYKLJ:3=PCYZ>QY['M$5>(O9$3KL63/:$5XN*6'CQVHACM%*DJ
M/>C[L5>AHG;S3-4^:)Z1,R^+&G]0AYVK"M&_,UR2Z\0%KBE\%H<CEP4OS[R6
MMRLJ7+."U`[%^XD[!>,U4!"%^%7@*^NT'1E^0\B7O/FQF[B^S(!+O.52`HG+
M!<]Q64HEX?Q'B]X\);';-NHKU5T1?X,8GI/R=['C1Y'6=YT=WJ-SR3_)=8UU
M'R(IN"4E4__.]LPXJ0S%=2KTW5R+6EVOS9/(T.P$J`FP)<#P*2'0A.!&`$\)
MH2:$0PF1)D1#";$FQ$,)B28D0PFI)J0/!*]Y'>IE+A!'>4;)U6$G)*<X&`LX
ME2)"V6%*3;Q'IHI36;WD09QFWD4*:0SL8&8-!HS\?LR\P<2C?LA2R[0(3X2T
M)H6N+07429]8S#4F>9)T83#@2=0!.JL!.N\&`_LQ:X,)7@],8`8FZ+["0`N$
MKP5"(Q!V!4(M$-VGC!2F;D9?8WSQ>VT366TB;1/?VW0Q,X-)7IO$5I-8"SS,
MYZ3;EP83AB,0PM<^B=4GT3ZC?I]Y@P$PC/RP'[8PL`@^KL(N;&D<Q>#`?MA*
MPU(?1@.66FKM7&HT7@N,K%-R-'Q*`M\:095E!M#?UW<-BNYFY7^PM176'PC8
M`^DO9?ID\-<&Y/L6+Z_S?:XP/:C-FCE;<JYYL[;;:GL@F$+Y?7^HS\%X`2SU
M)1BOFOW@)I]G)W3`/Q$]%#5S-H2+745M`7M".!:9_3>QSH_BB-/>E'C/93,1
M;=IL^LT-)R=SAFD/4OD_4$L#!!0````(`&&!"D>-8+0]50(``#@'```9````
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;(U5RVZC,!3]%<2^Q1CSB@A20C2:
M68Q4=3&S=A(GH`*FMA,Z?S]^04A%0S<!7\[K6LYUUE/VQDM"A//1U"U?NZ40
MW<KS^*$D#>;/M".M_'*BK,%"+MG9XQTC^*A)3>U!`"*OP57KYIFNO;`\HQ=1
M5RUY80Z_-`UF_[:DIOW:]=VA\%J=2Z$*7IYY(^]8-:3E%6T=1DYK=^.O=CY0
M$(WX4Y&>3]X=%7Y/Z9M:_#JN7:`RD)H<A)+`\G$E!:EKI22=WZWHS5,1I^^#
M^@_=KHR_QYP4M/Y;'44ITP+7.9(3OM3BE?8_B>TA5(('6G/]ZQPN7-!FH+A.
M@S_,LVKULS=?$F!I\P1H"?"[A,`2@I$P!ILG($M`-P+26V-:T1NQPP+G&:.]
MPSNLCH>_DG"F1*2RP[6:W`.NBQM5O>9!$F3>50E9#)Q@"H/Q1X0GU6<MH#M'
MAYH.OS;8&40,EAV"P2&8-A'8)M"R`!H$T%0`68'P/F2L,:UIPV!\D$;(AU_C
M=@8'(Q0@E"X'"F<#A390=&\TQ6P'3'R/":>A#0:F*0H1>!#:X/PH"@(_6@X=
MS8:.;*#DP2X:S!,"*4A#N.P4SSK%UBE]T)+!/$$4A@!]PRF9=4J,4_IH\PS&
M3T(_AL&R4:J-1OI&K1\2?#`;39=G#L#=(1E`Z>>_KS>9%@UA9SUVN7.@EU:8
MO\E8'4?[%JII\ZE>J)$_4]^DJR*=J<M(J\+<$=[-.,\Z?":_,3M7+7?V5,CI
MIT?5B5)!9"?@61[L4EYCXZ(F)Z%>8_G.S&`W"T&[X9X:+\O\/U!+`P04````
M"`!A@0I'9\%(RA@U```(_P``%````'AL+W-H87)E9%-T<FEN9W,N>&UL[7W;
M4N38M>#SX2MV=-!AB!#9>;]TVX[(`JI,NPHP4-W3X9@'D2E`W4H)2THH''[P
M/\R\G(B9GYA/F$_QE\RZ[)NTMY0)57V.?88'NXO4ON]U7VNO]=NB*,6G59(6
MO_OJKBSOO_WFFV)Q%ZW"HI/=1RE\N<GR55C"G_GM-\5]'H7+XBZ*RE7R3;_;
M'7^S"N/T*[%.X[^LH\-LG9:_^VHPZW_U^]\6\>]_6_[^*%NL5U%:BC!=BN.T
MC,LG<9+RF'&6B@-1W(5Y5/SVF_+WO_T&^W"_F?B0I>5=`7V6T;+^]?MUVA&#
M;B#ZW=ZH_G&^ONV([MC_<=-Z_CR_+LH\7)3_O=Y3-KZ(;F-L`4.<AJO(F?S\
M_/W)\9$X.IV+R\.3X]/#XTMQ<GK8,-HA+"4/$UC",OHD_A@]U=M=Y>$R3F_%
MY=/J.DOJ7\/[95K_[7"=Y[C!MW&Q@)%_BL(<#U$<A:6SVH.#[NQ@T&U8W-LX
MB7)Q"/UNL]Q9V7RQB.`[?%URRZ8M9JL5'.QEF2U^"<0EW;8X6Y=%"5<`6VN\
MH:NG>V?!O>[!GQH[G$=YG"T;-ZN`9N??_LT+-C#&DL9YFX3.JF["I'!&U#/;
M9_T6?G3`N=Y2+M7;]D\#YTK/3H^.3R\!K.!?EV?O3X[F5_#'F_G[.<"7N/S#
M\?'5):#2Q\LCL;>[7^]^&=UK;!DV@4M8%%%9?.M\#HL[PI4%_B/ZRSI^"!-H
M[ZP:P`&QOQ!YM(B@T742!2*-2I'=B#!)LL<P743XQRZLI-^?TJ"[LV`\&(JP
M%'`YD<9H^@:K+J/5-4"@6GH`8Q?WT:*,'Z+$@<?S/+H/XZ6(/@'=*@#&<)"L
MO(,!%I4].BB6E7`C[6W.<Z"&>?D4B/LDE-0##^,>+]7L<P&WO$X()981T,I%
MS%0%MST9#H)9KV&SNY/1+.A.)_C5W7A]-6>TJX8;.XKNLR)VMW`4W42P13B3
M&_@'TI1%5KC-3E+`R]L8KD].X-U=N,KR,OXK[PXW$*_@\',"<;KC_B@8C>3>
M^J-QT.].O\PU\VW-O;>D8#F)P^LXB<LX<H]'P^E]^!32+F$1L+5\#=NR.@8B
M3A?)FHAO'O&N[T,``=TX3LL(5LH;'@>CV9:W!["TBHL"2*I(LS+2*[%GW.T%
MW6X7_R<>XQ(PL+Z&;2;2-YY'#U&Z=LA7%?"MO=<;_ACFQ/!4DX9+:1D!F4!<
M(G@P7BZ`N<,^HW0!C<7>*9R#.'$)%_*,NRQ91GGQ&W$,^`9;WX-MQ8NX=%H#
M`9#[+9C7P%$)H%;K2.QV.]UN3P`*L[CQG>AU]0&S`"+"=7F7Y?%?H^5WXJ"K
MY!(!-X673<3$,"W`#;SV;<#9=Q2`-%NL<=0UB\2Q>\%@U++LE^'7=Z+?"X;3
M/F!HGV<!,C48!;/1\(L=03M&SY?+&.D(0!`1\#@%9G,?`T1Y<->BKP0%?D@L
M*H`32<!9-@`.]WEOH)>W\2S@NP22"AWGH@:%#>W>;&JW'<O?.P\1=^^B,@:I
MHMAOE@'FA@6G2,'JO%KLP;$OLR0)\\+MW,C74G'?QAFW'K65GZ1(:JM,J77@
MBW9RW=:U1IL5Z)=9C?ZVC]%(AZQN!M$W#^"@^K8]>/G;MLZ:A?(FHK7=AJJ]
M-^[&V]R_%6_3MGWXT>KR"O[SX?@44.KLK3@[/[Z87YU``['W,0V!(\/%M^#6
M8&M=U6$&)^DB6T5`:P"V"-B;]<\+9N(.:SV[1R4,";*2?!V9YS)*$F@0"&"X
M$:J;)/,L5W%*JBR297>V`I29!<O^2Y@ZR0BC/=*F(0<TK(7)?D*;.0NNMWM_
M=GDIWEZ<?;"NPB\#QWQ^>W*D?6?K)PKKZRU)K/4/JMO(3MZF[[.B0-($DLP#
M<`@IY=_79+MZKW<A(,Q>`GWWJ?,=D+4(.=X-4#N)4S#,XR:!ZQ1$<AQ%7$<W
M61[AO`\Q+0+^5'LMPT_N"LZW;GEZ?"7P)AKGU@A_<!T6\8)!)4[62":W(PP_
M1O'M'=%_.,,03L+%X(-ZGS?>N;BC2WFVP??#^>4?Q-OW9S]NB>^D$]\`/RW$
M#=RW!=`ABCA^O4.=FBO]_+PNI&1,;`8`:A$#HTO5,<.O^&]2P-<%<;+MIB0)
M1L#=1"APKQ"F&4\E?#O[>BDTVE18L4R$+MA*L4YHF464/\0+%\C>A$A>KLO-
M:[*VS"(`@L!6FIZ1<EYL,Y!DT*]9;ZM2^D!BXZVV`)_J%@,%*C8!P_D:J#F`
M@J12)+/Y1+:V?HX8MG%'OJ5M0J>;.`5!=0MT@FTLHF@INQ5A0HM<V,"(6Y/@
MZU)"M3,V;X%LG&AK#3"UASA;%\F3@N>F4?26B00#_Q?73]XM^#H"^<TC7`+H
M)ORO?59_MC2Z-5KG4!>\CF[C-,5%X(;(X/BL_A'B0E//R_7]?4(B"W#TH[A8
M`*E:$^F^$33J6[A0V[+NMRP2]BW79([BB21;8J[]G#Y^'I:E![0W"Q!A6UN!
M6"-5@_&2"`AS]"G*%S&C1G:/FRQ:`>XB6B2`-S%HD!K0EGZK'!+]<&N]V#>P
M6@0CAR;=.+#4A]?WQ`IX#XXD5%T.`"K2PV7`RAG9J1C#PQ<2OU:+*@P`_]QJ
MOHWVR\\8RP<!=&KM0E_3<)<?/WR87_R$(L?\\/#LX^G5R>D[<0Y2R>')L2-F
M2:Z"=W">)3$9RIJU@].SJV,Q%__X^_\4[=.(=U('N+J+Z`!`T4Z?^*9!?4E9
M6$@+F'))"J_$%;*J2"VE:+3]$"+"P.5='C$H``&*Q`KU(XFL!1(6&-?MC`J2
M`#%.K)40UL%5%M8/SUKD'4B50`4C-%(`G\_-I>=+,H6P:=6<\SU`_"(&NE8H
M32DA^P$:M*@O;NUC2@LAE:T0>__X^_]Z-Y^?_^/O_WO?D*YX9:THMMR+A!PD
MK\.VTM*_(IPECPAH>2-PU!=K`.C+@_^&_\;OEQ$@I#%6'7^2J@096@N"S#UL
M!\N[/#ZDU1%I4N/'*0#2>L%$"VC"6UBB0.]:1\QI.7`>"2`GM'T"01X!6Z$.
MNG/D&-6-W619R0@@5T^\T'.2_B-GB7$%_RXC[X5V@)_0Q-D]:*Z,>ZLP!;V!
MO3"XKM`2I_<01&*F^M`TQ<4F*`T"*6/:#U2*S&;4<!GABE,0%HLB!%S&]80L
M"LOKXJT:L%*TI".,$@XM0>0M/@,3`#SPM-5"8I1!0!5:D)ZN[E]-4]X!IUZ%
M3[`@DF(7962P\(:=C4_HEHS8:.L89T>$8R_$L.(N6R=+G!OC`HA#9>G/ZY3@
MR@";-?16=,6F)&KQD<^P7`,[%-PC`&:;QN,8\S2%>Q87(+_G9$]4T/['`&<,
M5S1^@%//0:R)H2?Y[X'F`E(6`<#=HJ/QZ9!))F,\:&H65@&J\7$V'.)UF!":
M4P2%W*QG5^@="0%:E@(W%"/(%0QQ`*,`!$MFZB\Y6I]Q_GI=`HK#^=61?&G)
M=39*(\$#.@$MI)012/E'FN"8TVJUOT(HY)4\!\IN8<NX@#+/2%P#2`?I9%$B
MW2)RD$8',,'!N$N>KAP8!K/L`NZR5!BCK^W?BXJ.4/'!5%TP`:/7(QP=SXAR
M6BK.%F6&)]B?\0EVX%0C03ZL=QWQ9EW`U15,E]%80>=^;E.0L]2ZAQY%JG3[
M@;U*FA.-,SF`+)W,&LZ+,2()'PO-!O"4\(_3Z"%<AAUQ3.O$,SH"^L$33&B"
M:74"A"MK>`U0M1'5&>N?CT!+@EN/&,[5:+!)2<F)TB^CAZQDN[FT'2+M09S"
M)2U)2XJAQ>(NS9+L]DD4S,[@'UFR9J;D9;?$Z]8H.L+\,#C\6-T68LH=D*(0
M9,\5]31*]1WP`A#2&#H1[R45#42,3);;X=1$X4&J6ZX7),3R0(9Q2'^JE*VQ
MLS)O,.!3S[+X#C[1@I3T7+4SX)<"F!5C.IIZ(F!QA[``0#6`%62_M84A,A7K
MZY\E\"M&G,?%+S@+4HNT5"<'^@Y(H7%QI[SR8>W0I>S707)(/90V1;M*D5DC
MM`('R]:W=U4VY9ZZ'1[`FR''>+_7"WK#43"8##^'TRBR5$JI=2WE(GL5)-[#
MSX]W&0#A0?:(YPK'!:P]#G/RZ<_/CT[%WIO.#YV3SCZ3=>SEH_H2SL1[OOX`
MAHT7=\HNE#PQE*29?3\H,;!"":=Z&=^FI)+1E8!4>"`/7&#X6!$NC,8H^8(M
MLD8(=FDH141S0-"G(Z0O`/Z[R&`2NJ:K"G+3[W\ELLE-/7*FI6%<HK4US$$D
M.<R61H]$Z79^R>+CN`N7[IM8-L(&V!`8`_^A6(844FZR=2[84+P`5`=0"\4*
MP!^EAU54*DNV6B\<&\L5<B?+;\5>;Q]!M%C#(,@$T-PB@XJ@,7$B%@4!SP#5
M`?_V^OM`@!)HG3.09@N)B;#=;^"V)-X:!@OC(Z_"(("]P3Z!5\'>$R1P"_0(
M`H!^DN[P)8BJ.5X3:'O?T2][0Y0FDP0P5&G<,5Y"6&38Z@F54N"G(#(>J;Y*
M8]>G@A.KL1#CV8(+C8RP2USLY_7REK$CCVY#$MFEV(?K@X%A(H4CE4UHS%&4
M2AT23I,;8J9-6K@:YMJ5G=$H&5K05H20':&]"RP`Z\`OV[)JB^BA\ETL(V7Y
MX>6"3*;($8N[3%C0R,>]$##RI501->"3.04G>]*`A*,RZEH[I@M'<4=*57+W
M004@]'>UP@!/)RYL$IQ'-\"9!:(1T*LUSA*C0P4AODZ;Z`1AZ]D*3N'G+"8J
MHD#(ZF.OL;X^OLLZT-KK2_6B'F/@#]=:EX2CFF\;(5+6B`F>M+%5J:,E^MX=
M!M/Q@".]1M-!,!CWJ_$>AEQ9*%HP"5JA>P`T/N)%(,<IF%C&#!)P1AGL%R0T
M%#_6:<Q4WU(@8T"<*$<F:A`(1P"28@=4/=Y%!'RX,0/L>E9FQD@$#\($?I'R
MH!1^U*4Q=T9%D9&6'0NXS()`?:%B&20BMBY<8S6T!!73G%@-5QG`JT0(83H*
M`=AP8)Q=#P8'O011&,=",BXR@E2;7!*0_'!Y=AS@V84/89QP]%EY%^<JOD'3
M5FB";7$.1`>K.2X!=.L5XV651H*R'<5TWM0Y)?G"C(['I0;B[87(@!=D/U3`
ME5LLIG*S,&[*'5C"I(.0!(T.V@`<GM-M!G>=$EM`O0JM9P(EV&6A6'JQOD?%
ML'#4!,OOC0H`M4&U01TNX!V>+L8*%A:G0MER!8HA`$TJJ14L,8X>^-.]!$.U
MFHZ?=5?0#+:;9Y_HL(%F[(Y'DV#2E3&TO6#6FP7=04\+\454WZJRE[_8-K?;
ME1C.P6<OM&X,ZY0!G2#D23^'0Z'8\,IA2+M+4?,W"U`1DOBO9,.!G:&!W%:O
MX+Q<AW1UA(Y@-W)M7"EE(JQS1V7:TJ1V$28+*>0RSI$]&(_BL>[+3M=$5"V7
ME./<MJ^%3PWD`IKW(:HZLFS?C#1KX<A6<`PACUZ-[9NH@S6/Z/-8&%7@Q0;<
MH&G=.NXGQ]5)`XU6.Y$2K\W]$9GVWAQB$%-,:01X5"8HV$!\L)2GU[$MI,19
M%]3N'A0@:,=:*DT@826-=(R(#0\L4*U)E&)C0"3M<W4C4VT':O6I$RT!:UV$
MZR*RN!-+4859,6_*:`.5O7TA*WN(,AH*:,6W._05O^S\J/Q&XZ`+G'PXG8C^
ML!L,![.=X]5]DCU%D0:=03`<C8/9=";Z07<R"+K#P<XL&`$U&D[&\-N@-\#0
M4@ZE1(R#!1W:@0@VKFNM#G='P'/@"5T@SB?7(;WR(-HL0*\OO"H.J"*3WC2H
M3JLT%OAB-!;XPV@LJ%GKT!:*^GO2(1IZ>EN^N.5#@XM7GZMH%F#/BCZC15T=
M^T5N1*U+UN0#$Y(!6/I1&X/NC<"-UDNUW<;S8W<>"T@A:2)"2IVT`VE1L>>N
M!8.0`HX\)=#.C"KGDS8.@6R729$\$*(]=,(%<',MQ4HI?\_X";"3\M;*KW)B
MZ;FDI>XSWW17UV3H,Q0OCRS1!<UU3('?)"&TNES<9:AD<.L#E&BPP2H#L=%8
M>AES9#3*>L4C?VM,\`\9!A.@EA1(818.*Z?#16L-$+XH,B&I)"0J%4&/D<0W
M-3.;MA\UWN_UD[4A]!4B4SI(B#R`!(P,YJ0%38`PH^FR##\!L*;134S*99C0
MY6IB;3,7>R52UL#S50YI:;[8(L1#7B>36IZSP@Z0P^</MAJ"JY0^7J4?LL!>
M1-4=0*,,8Q1M4[VS!PT>I#:Q99!("DB?T3(NVUWR*//:BBK.#_27/6SP*YH2
M"XY14.[AZM6BA!$E?/'2T<#N2>FU`ZF!I4`0)8%H62H_*F>Y]'$!1"YOR"QH
M[Y_,L$K-M#4A7W,`UZ5<<'6]FM')R"CTS!A2A#*]7%[0//:C\1?9=+!VK@<Q
M1FWPN68I^K_(PD/1,C+DQ!XTMF`TO"FC7/OS",)@"6QXT.<AI46TQE35D&9>
MY`NCD^!N8L13H!>&.=U8IA3R,^&TH,E<LQ-%XMQ!#Y@S1MO$^E9<DJ8M,CER
M=6FF,6Y<:2+E=<08U"&]P;0$-$J8=9#*@UX2/+856]S"96Q9(EB],U1$,@IB
M4<@>Q.TZ1A4:=1O03U;R#2C,BUL:=4<'HRYIR@MZW,I(]=9RAYLE(W`KC`&>
ML-(JF2VF:6N+=4%PV(OJ!&1`(SQ%^AIH(1GH]XJ=J-@"Z%#@"79"RIN'R\@*
M%2RJ$'$/O`$%;12_5=`4+!C=)_F3L$*,+./&'=!>M:B_@)9"QD#8?5RRBX/L
M,6@N@FW3+=DC2)\NWR;29`D*;X].#G&4=4[DFYP3E:5*-BL]%("CJ2+=*D).
M6_UP$QJT7BQ4:D$8C;"WMTB8V%4TG7Q-XTP&7U?UOD"RDL=,FU;JQGS:14GQ
MXFHO*ABDVDVBJC0?5O7DZ>SKYF%]CV#J+ZA^A8.US].G(3<?9Z_[M8PW3BT[
MXA;'=F243.=*O4M([0/.(Q.L@DM`DPJ0C'*[N2\B1%+;U7">9RG\>R'-@""-
MS->WZ`<PED=#++PNBC<9_(>$^+?SRS?DG)"T;W[YD88Y0`<5?#>!B;C6CZFT
M%'+8S#6QU%1F`:#5STV0W"&]4%Q'["A\E^$2B*;E*;)?5B'T;$J-T#\HFVQ!
MU%(]O*H9\!$GD$PI1P'@.I)]]E9:?#J/I-49[09(%<4R6U^7:@O*D4=C6G%^
MB\H6;C,9Y(5;8-F=NBOZJ\(H;*\_VP/(P)93\(01R0-K,XZEF=0DWDI4VP@)
MAUG*_)X\9@@K*I(%Y-4B^K([15*,L=6IC"714BSQ,O:7^,(E<O7Z2UHH57J`
M@CF=N6E2)[3;G:@0QYO4CZQ003@LI!@'_8CP;ASHP!<Y`,<K<CR9&H).D0;H
MB.,P1QEFR9(K.>&1@Y=EW2U"]T/M)$='30"=P''DBB5F9]=/YJ#4U?(B=;@(
MWA)Z_4O+?Z$71!JI&8Y603:-4""%SO'(I14'E\^FK7:7,$7@T]BYCH&JZ,VD
MWQ`YL^@)D`E-(GP4Y>,][9$7VB?28;4C*<IG#'A$2S21=CCV0ODA42I4Z,^'
M$BJW(M&!,LQO(V6/NK9MPP06I8K^\VC)@4MZ^D3_6&K2Y@MKNJIJ)A^3>Y;#
M"Z7+*(0=*VT9S]S%PGZUO4/%[A6M6Y!VD!K;+FJ+TA0"KO/&LURE9$:$`?BP
M-Y5N2M8'X/BOB:,;IYIO=$VXU+:JEA-ERK##W+3:HNT;(!H#3^&X$/^>$1EC
MBQ.H6:M4PXK6*\2>C?LN(9%$C>V&U&/?BO?WTY?1,PA&K.-OZ)$%BY\6<W)-
M3_@+0B7'UA301;=3LKR%ZZZ=YHO@_0<0FE^(]MT9H;WV'"&7.)1.%(DWATHF
M<M&P.[/04+/^-8V_)),X4%F@%A2XX/-P:=B0[Z;L>;4L9AL<0Y%&CU;XK`39
M&W(@EM$][`!8UF.6_\(XH.-)0+58&X<9*.DP>OYD/(9Z)6C<4(^@S.DEZ(FC
MT`*E^UN'$'CW9OLGD863SU^N6Y$7!(4XLKQHE<"55$88**V.90YIR5E4?+)Q
M*0UHA:0T"'MEPC))73<FVHW!.#<LS=YFB%R6WBZ=KQIB^$9%F!29H;91>H<'
MMJS%2]HA&1R,$<AM!*CU*?JZUE(IJ:BN_^^?@WI,_N4)A/."]^1/'T^.3JY^
M$O/3(_%A?CI_1V]"?W,ISM_/3YWF,5SW$@7..>S@@Q%^SY.P+6\8O<QX`[3E
M?XBF&6&'/*=C$30QA\J/I&TX+$GQ5J45+:UE(*)4%?4H/-_;C=K=JG#%T'BO
M<!`88S`=!3V9*(0-]NSCNI7!Z3K64EM\J><HZ/?'P:0WT%BWC2(*R_I#]HBV
MJFI`"F$?A1R6,GB2+Q\6@/2.IY?60[GLV3#HCP;^K3M!,67E$I;-S_%X^&XP
M@:Z]X="U%BCZJ98#MY6M<S(DR7C&QK$#OX&"PDNKCU;AE"BP%5.`R"<;%1AB
M'(F6]6!2.V!7*T7*E"$]+<8E">=4$(%;%_)M)P<\!XBM<Q@K$3U?:"@21#DW
MA3`_YBANI.)^?9U@?(IZ9];V<I/C.'+RHJHWGVY01*_?Z6+<14*!Z#*<4-K@
M80(]._G=82-\N!27IA9ACK3N=9'\1)YE[1BE@5$%REK>#OM1J.]UKVE`?#"6
MJK041P$!B_4-8C$E:,)H%-RW]I%8=C&S6.G8*M2(10O\<CRQG@$WB(%CUNXT
MOD:?X/MCE#Q(M"T\&J;DB+8Y'\<K6$67+WM4Z`OJZY74$O3"F*SS;$4+="`<
M2.WK&S@TLF.Q`JJ6JIUEUIPR^MA^FT\>6`[2TQ8\=_,++=/;2.SFJW!8B7QG
M!T1\_M/\S?MCHN_PX\7'XR.@^O,W)^]/KCQO_,[9L\)0.)?/D9IY"2;J_+:X
M#Q?1[[ZZE_ZPKYC!'!*#V78=2AS>^&ISVYQ23D!!M=.>#OK>WZETWG$6LBLF
MDRX0[!'\JQ=T1[-@W!_LS.72K(P"-^ACZ0'U'76[`G@2_E>W`S)&$=]ZV&%_
M&G1G4]$')C@9]W1#[8)5#0]@S&`Z&>W()'NRG?:\]KJXHKZ8C#`0:H=3FN!2
MA[UI,.[QLH?`;R:CF7#N^^+LP\GEY=G%3P)O3=^3^_`4WY>6](KUE)XV24AY
M$6P<$6PTS5U[C=+SA8!:&<!`]EJZ+U[5VRA:+%MD688S%FS-;I0L3\PSF%H)
MSJY!%*683G4I9#O)E?V[WQE]36$T:!Y;(<(>Y1WQ/:@YA9@#%PR?."ZACL#X
M]@8=\"!W']YA5JF0[9^'0&1OQ/$GX'$D/)PA+4!A0ZW=7J=,NZ:I3YBR4Q&?
MY@$%!\3U]9NJ7M?0FART=T"4$%G@L!"V(GX*P9Z?+,>S0SQ2%HT8?<>WZT3S
MF@RDN]O:@R`KTFF^H'E[L\'`?MIFWH)6FK+5&LDX`QD_G$'NS)+9"K46>LN@
MT^C@NR3+'TP<A<.V571;G8^S^<58!/$OF59-_4FS6Y.PXJ8\[')@G-G[H3YC
MA+XV;+H7[]?NHX[M@0XTOL:<7JJ]#."3JT,)Q@J=-X\K'UCW5.!3RE2]R_`)
MY+O5"JZ6)1/,D!1I5=`*==7+067&O@@*,M.F&;5M*??!SO&%2R3/'4-JR8-,
M?M$8TQ59\>DJ-IHZD]D2Q@4FR2+=QWN*;V03O$Q'$-*+*'TMS!E()JE13+)$
MHPT-%XL8L2XS?.1'8JA\(E]R!+</(BK'JL^Z$J^3&O,S7AX&.::FK88:CN=0
M6PBKCV7PE%91?@NX(N,I9'X7^?9-ODDT+P3T4P)EX@9]_@'NUSX3M64+&&_6
M2=)!6GH*0D2-E"*9DM1)1_G4J0=0RCR2GA/;1,&)261FDK(>*L[+V3-F(8O*
M6AR]?F?\5'T`LGIOTFO$7%L"AV7=JWPI[?TT&5S(K#'6[IEZ]D?]H#>8/'O>
M]G[.O+Y3)D39'73Z()/@?X9T$.@;XM!,WUHP,6=/MY,KVR?['[2]9@44@9CX
M7E!G>S4]QX2!:L!OWKT)Z:CSM#9=2C]58]4KLV"RWU5/5J]8#+?26!CPKA@5
MI/Y?3WI14[YF4V:1<NI'MEWPNY&L]<EO4_SC,RT%N!]:*4YM16ESN##0>3P<
M>M)P'8$>$RE8R7-*?F%XA+1<5=)`>G');$L="U$JLF7F.A;-$\W3=-]:S,+W
MI&69Z%/Q\4CEFY#'5&C2!+UW!R3"/O<(G>QL\XN+^>F55AQ^:LH+_%YGE]E@
M!CLF2=09%\FFL3=RYGZ07P[A%`'JWXF3DY-`O"_9YT^_$JKI-]D2Z]VL/+W)
ME.P^.CNKCFZF3+<PU7@\$3HGZX\Z#'Y>N@L2>XH3J2GVJU*RCK%;-ES\CQ95
M`]:QVP^&(U`CAGT["#5.`?8P'VU8ED@@M@L\?488[&ZOVYEV[43#.D#U*8Y`
MNN]^_9W1JW%+WXIA9S1B2_%W3?&KWXH>-+*[FAA86!-\[DT[T]G7_$XR-*F'
M#"'<!<(TFDG:U)",#K?F)*0SHL*3?3\2JQD70\N0&?2G4U#0^A+[M#E.DUK%
M-ZHY(Z7`I(8/&JZY'=JJC0S0L5"11U;DK,[5Q$>BQV4=W-O?Z@W;LC5Y>41:
MBB)@7O(C-R,E:HN]R4$ACT0=.LDI*S91,K''4#5^T8"*E7[=J5_/&0+)JIPD
M2OIYC&9WULN8EP!!E6W=XH;(^`SBRFC(+Q0K0#`>#X)!;_S%'C.=6:DAICXU
M.B)\D:\:0[T#$,UUDCU6D_092\<CDKP`!2&\.SI8/GG*+["T%2Q;7E*,;M3E
M.+Q>MTOQ<)*"`EVH`Q'IB1K`24<A07$Z"<;])H%OG]5T/:V%SETD&]:S+11:
M$N*W%._H3K^^9]VZ(D`YXPZ#[JRGWZ%1@*\?J?:K$GG?:]Q0Z*P,Y/K1E[F7
MK<Z.`W=:5UX3FO0^/I_D63#40/3ZP6PV!$3H>HF>G^`]4X)P\M(=OZ=TJ^?S
M"V#R5\#T+^>'WFR^*F7W.;T/O;+S(VP0*=Z22-$\D]]M<41NB^>:O4)',-S6
MRM7]I[-R;:6K;J&2PI+1.TVG^D^FAX8R8M!2T>@Z4/W;J*;]6LK9-KI9DZ>M
M/D_#U2H!*X0_$W[VHC*/D'UD%2G.6Q_PFB)KZ?6B>E2'YB49X>?=J[/\UMT[
M).)P?GYR-7\O+J_.#O^X5?T/.HP-1.&=.!"5D2N\>>C#=<[D%6*L!1S!(5K?
M*0T*`8&I#25]5+7O)ZEM3C+IP#"I:XD/!*"-SJ!$7^KIE&20CM)H0CNIU5[O
MVW%WORFW%8=-;IG/BF4@E6P6[Y/>1YD:(M61R(56+3L""&C7)6'<"ZQ@%#<[
MUK]*HK`MDWV=>7#VQ3[OOG:`/)?Z>42E;<;SN])W9YV>\IU_2=<Y/]2'L[!D
M-HD"M450+A6]N;(25^GJ.AR>QV)QZ*.6Q\K"5:'^.F]&L[5/"5IL1P%.P0/I
M*]"Y%I70R&DBS3M5\@MP&!9G#GB(&K3=06=DJ>%DR0883Z-:]D1CUK-AC-[`
M&BN3OB)Z$R.&HP,2#%VE@,%FV)?RB/&:-_MOV%!JO<#GW$F-(^FSPKYD/#5]
MM9<=_^\`DZ:44I>D-WY/;@S-?PZ3B]M1UQ/JTXBTN.T$@Q:U)?0T+);A7\2A
MC`KZ$.:_1*7ET"NHV&-!8>CG1Z?D$X01Y9\_PM\>U=/8JV8M-$FNP`876'[%
M:$9:4.5V+._=L#<.I@"V&T)S`-U[XQE3"&MI_@1#[4NS`&OK58[Z+R"!O?$T
M&"I=C-\QN2D\&L7`M7D':Q#6SO#@YN3P+Q\)#U!QN06<:A#T^=3KMW[E):/V
MT1(5FW4&FK:3=</.G<_1GIMH?>`2>NW)LLT7-\^@W+2XFD8\Z`#4R+4V$D3E
M.:39-B!JX!6Q_:2TUY\B]_2SVPH`8"BQS=R)Z$HR@B7UK%?"ZM6B'K25(4P&
M(.WU1OK9HE<MX>QP<`\8:V5OK\>2[:SRY.^Y[SD;SF:DP;%/H39-R$5&!QFF
MHZTB$IUT:@C7$C())B.98F@\#(;]L8?"?9DH0Q!$>KTO*''U@G%WB(2C30^%
MJX4&>[O]SFSVA5R.59A`AXA-;WJSRA[I&>Z85JFWQI$\EDV1`$Z"<)U6U:FR
MEW;51"7YU,LP_P89*!#61PZ,,-$301.P2UR>;4,&97AK"VUNVK>?1F/&9$=*
MKAR333W]@C(E#:L$K8K_4!%PA`E[MA,!\94"]>F#%M1O$/8V2W8:A?VDY@M)
M*-/))N3NC?I5.M\@$/3'@V`&5.D+,:(&!K$I@%K=,M]`#]8TZ;^01SV/%PV'
M+^!%'ZAH7)]23O>[5F;L(VU+WL:BYCUM)UJA'H;H6)>D[>=<6H)/CY3OV3%`
M6R_%SVZJV:*4;?H04R?)"N8'G,SJ7+T$W6"/^H,X$,UK,<+15<7!6Q(M+-8K
MC"__JWQ7R798>GWC\YM94IFL5UF-6FM`BZ8<)E7UR8$?<CDJ`(45)7&TIK$I
M`KZ22E;EU17T5DFE_]'"9,.=^XHZ=:K^@3A]R)('LJRJ9>T5D0J'.`K$,9W)
MNWT9\"U/<UD)5S[5@KXL4*\KT\UE,.`Y8<9YE.^\D4G\@:TKXY"TGHO9<`1Z
MSUCLBEEG--MY)T]F%$P'@V`ZF0ID=SO'VG:PA_5:]N5_=@[9KLYGQ"@%328@
M^X]&$VS6ZW4&76AHK:`:9VURMNWB5`.A4[9Q"K8SF>((Z!F0<4EHWBA]^$CK
MPPJ(K#A-?++]<Y;KM+]1!>J:J"U*>0\R'@)G1$LIOO5Z4"NBQU,J.M5\Q)\Y
M.I67*E/8JP1V_=:5?[%5/P"D9.M"J#)=^LV;T0N;I&!ZU<@IK*VH'AY>9LE*
ME[7$4^04D7JD*V<R$`T&0UNF>_9BB$5SO*M<QPKSWM!\3\8.PEGDB2OC4Y%E
MF'/R!&A7705Q]>_#=(U6[GZ%@?EN1YTLO>A4-G4IOU1OWXXDT]U@U32MOF'Y
MU%^&Z(QJJ1JLB_O/NK4IG!6>UZ"^-'K$%GT"28&3.H@Z\/][P32`F1`GJ\C,
M4=.K3&6=K/9%P7(9%?%M&LG2Q13<H<U=F.9-6M.*0.:JD9G'JJD5C1I7X-'G
MT:-YTKHB^KX*?Y&Y-LH\OE[K<D*8Z[U8+^AAJ`R[E8D1,E,KS19=6L0UNZN_
M&7G,,J<>E=0ZT2H.=X#A/K*[5<''*FWN6=4PZ`V`GDY&;D\MEFFK72-]:V18
M54`R/-BZA>U9UHYF68J_&)[%37;F&C)/\+Y2S'OZ`SJ*=LYL"<+E:_U@UIT%
MW2%RMF%G,M2<;8:>H1DTZ$Q'%E]#?@;_:^!HPVX_Z(UZP-!`*^[MUR>OWJ+)
M,8I3#_L[/T1D2G4:]NG5#;[QP8:]`?RGV^E-=[`$X$-#GQEPR^FLQTW[#<EO
M#YYI,I'W.)P%HRF_EY*G%-@P9F41M=&,)K5$,-=:+2W;1=U`<E(-82LBE9.T
M.88#:>M09G162[.42D,E?*DVZQT^)\/T(SUYT=&332DY67PAL,8&'YHB(YU4
MS':HY,X5K>X49MIA'&6E9Q>`>-RE_UBPW/#1"HX,I+-GT`$R,<3/1]5P2D2&
MK_G_=WXP(9&]WA1^!OH"/U_HD$H*`^DA^'Z-\91C^(_M3],QU1A3`H`W&/>L
MH(O=T1`HEGQE;1,7#"+553T*UMEVA]UA,.I.#(NK)#>LQ1<+-WO9ICS0U8QO
M-.4@&`UZ01_HI+WJ\600]";C[5;="R:]"8A"DV:X?L["]"@ZX2SF2I`A[AA8
M=J]2];D<!E^4Z@NI'!YFV;5SDJ86#9*)>-`PWP\F1"7&*IROL.)NZ^F"R;82
MNK!M/(]5FVJ_T^\Q:$JS7+VC2?AK8S89';\P:N^.9\%PT%47V)V`1M.M5XEP
M2W=_^'!RQ46Z45L^/*-"EL>GOF*9AUCV4-44P:`G>F!\&Z54-M-2[C<HZB<8
M.-(VL57I[SU+EC9Z)OQ31BY*0:\QI8`0VM6=$Q5\`?0'>KW)L^R70)Q&C^(G
MS-="=5`HJD.6YQ)W4;C\"\A]VHBCAI!E5O"XR>B%C2)*Y2:NUW%B(FF14BD5
MB/NB`!517@`M18]DH+LQZ11LTWD2@Y[*46:,DMJRR&*L-38AU6,E7RX!S@$I
M$1)<>&&8&490D@0+RF+,'(,ON6DT6CL:2X>`+;UAWT3'U;*VJKP0M9-6AY2$
MUWB<:"Z"L__#>HDZQ`W2Z$`<I[<@J>DJ3W%A%7J*4QE-0I`5)OBN#>UVZL)X
M%?9X<N'T9%$6^4'A6L?(?+].])&JY!MJ7*LOF:W?1M<YB?Q*&%-I!I20-E`?
M`JGNDWXQUR'$]A%1U@R5LXOUD&JH,0DR31&#Q]8&,,%:-6C2WXM3]7$^.WJ5
MS4Y)$('7:<EY$SC9,&EWLKZ$3'DCV^<ZC[))U\7QA#)*%Y_@Z5QLAE6&"Q"#
MD.FH8"5\,QJJ4J.41M1ZOJGP2\6GVT=F%0>0KQ=E<6R.'-.9=RI')#6UJE'W
M2QQ26$F8K(_L/?QRR_SG+?D[J!!1)M^$VEOB&!;:#BLC+#4J<P<6&%S'DI(F
MH#`DRBX.*%5(#(&VA8Y_I7JQE`@7%#^VT5_+,H@=\6/]9C!5]*-T?87X8B%>
MX:&;-$#T$Q:_DXF"I/Z>Q+]$27R79?KH.;B95`LB[Y0MSI<!3L9!VZF]E?FD
M^O*+FNG:8[IJETX77ZO2R..A"$`5!U5LMA(J<#1.N"[O2]DZ3/IY;!)(BZT4
M)<PXNAZ)W@V19NJ,?_'ER)S^GB3G36=;`99J02M=1=#DI8J5F8``C^/F3'YT
MUC50:D!+"+X9)RQ"&&,8N:D#H]!%:T$K7;GQ.1IRKE3JTS3#5\M+F7],+UPK
MTO:=$()"'YS)$2K>SD\NQ`_S]Q^=E`MO400B9;A2SGZ#O/`]R`MF3`XY4T\*
MM:;$6:<]Z7RL'S?FX3"RG04\5E$(756$`3E&GRM6NY5O^'6"?7=YY9WO>4'<
MI)'5WZ=),:!:)X'T.9555,7DS3L4-XNV*$LA@[%-9+%ZN&DY>7SO?&1&8A#!
M0'0\&`"L9M?H:I"OZN_792T.$7/:XUMNZ?!Z4G4#`&SM4\9XWMM,VUIH>"+@
MV+`A?=06/AM5$Q)[\Y@#N4I3A0-C<ZQT7UB4!G15"RH_F#3LM(Q#-H"Q"JL]
M2!_IHNS2DQ_MLSGA6??D*O9W4`T&11H3^H`,9(OO5DV8%H^'U*H&G*UE-@Z&
MO3ZJR<%X.`A`7MN9F_=@3#,H=PN2!.]SE[UP7YB7*OJ-ULY%M,H>V)BG`()J
M'5G!1WMH_>D&LU%?[)/UZ4*_I9/E+/5[.NZKO9ZHF^^9QYA^!\LN-<-M3D>@
MA/8'M-;G;<_Q3W[\\&%^\9,X>ZM2]X"B(<[/WI^0KK%WGB68G:C8KW?<7&1X
MJ_0PK[6*7VL5O]8J?JU5_&O6*G:?^CDEA+=H\EK>^+6\<?I:WOBUO/%K>>/7
M\L:OY8U?RQO_*Y0W=DQ&3K7C[9)XOA9)UF'ZKT627XLD_]<LDNQ-?N`IFKQM
MN]?BRG>OQ95?BRN_%E=^+:[\6ES9.M?7XLK_\L65/>4"K%+([5]?*S&_5F)^
MK<3\_U\E9M?'TEZ8^;GM7PLYOQ9R?BWD_%K(.7LMY/Q:R/FUD/-K(>?70LZO
MA9Q?"SF_%G+^\@3BN5&T5V1%<&)H+Q=WT7*=6$9*51M#9DWR>O]L-BI%(.UR
MJN[:]61NY>W]C_4R;5TQ=)M3W/8UPU;G\%I!U%=!M"6+U#8W5+9G3MHN'.&_
M:*ZD5OI`#SJ>6HYP8RZ/%YWM:U*/ST[JT7:MK1DMZAW_Q?)&-#]]VXI26$>S
MJKT\JOA]-5]DGT9A!9)[7F69ET=;H</K\Z=_XN=/SQ3##L2E(:)&4O1+7NHI
ML@[PJ(A@>T>8T2H!8?=`2EF.6`.#:[',"G(ZKL14'5:CD4"I3NF%LXFS^_-[
M!)`3=(@Y#T`K<UAA2=6XK>80IX9JBLY>ZK+><\5?/BQQ%7TJL;P\'MK'RR.Q
MM^O@?Z^""O6O9QC+J8JG^)YLU.IIU)LX%4V<`W5>Y30]#&D/?/W,`Q(]/")E
M(Q`5]ZD@BFN^.CR"A#FYS%9'+(_4!E_5YA38<AVEBSO`H5_DZ]I[7T#8ECZC
MUJ6+OXDKV[GG%+('TH&Q`K)*MNUJ4D)_W:57'V(ZZ72[#I>:#'R_&K&H<47U
MY>O[.TN=J7M=WR1:D;@P;L@-QS"=^09Z?_*GCR='6-<4Y?,/\]/YNV-,)_,;
MT++>ST^?@Y'S^[PCNC*%A/>C$GN<(\L>.CK?O8,1T;WN.7#P7#]"U)%%#JG*
M<L[[QW$D]<_OJKF4B0YN2LO>F!5XP^#5NC$ME0<<$*XLSRXN#J+;`]4$PT@#
M%3RX]?JJX]93%#^O-?^J4_GBZX(7*_`5_KMUW@&;U3;!:&TLSW>?YMW4K*YX
M-[6KZ]T.&'NU;R_9<"[EXNS#R>7E&?`,S/)@SO89F$OXI\KJ>?&O\2/F;3B@
MI$='T779RB/.ZP`CTST\D8KATCV..'!.@>8QX4"!S+5=QO+E#)PSIERMY,O!
M,!V*S@^?G/%&WE\/30)OJ[R>GL@IKBB_H7:)Z4NS)$%]2<M/SI&_?'QZAU7!
M\/^0&94HO]UD];NN?S^I!+S2DBH='&CH=T8N\ZH7&-\(<7]S:E/ZDK-M2OA>
M+7ANG^$R`JFG7*N,QPKMFT4$Z[G'IK%Y!S;M:QK>L^UYJHJF4@SRVJ4C;J'S
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MVONRQ:!A6J+&@P9%C$GUS/_QXTM5)EE*IT6+MGLN0C+F7S\UJS3ZG5`=$ITY
M1DRY7))1+S#3-)=9)!(\!218V96PRRYGXU!-O]@Y-^\?*OO6@$B1V]M-T3B6
M?K?XF:/J*_S,<<R"/FM$<QN58DE,[^V.OV&8VZY,TS;V`E,-JE+7RAY_J[$K
MPF?#H`TE)K_TVC]GF@;<;2XPR>FBMQY5(;:6FC]K7-^A^$KYM!I2+&ANJ,.Y
MF7(UTQV5(DD]2M*E[ND$?#75-HQ]7Y$'O,6R7/EJM,'::>]6ZC56@GY3.,!O
M#=4A!ZUM-_"V?@MON[2":2N/@.=6MB*X'KN=K)DEYA1>VZ9TM/&_5C2G1BYO
M.O273G1TJ\I7&<?7+/Q[FC=(?DWW6J_#^#+4+3YK.!_&-IUUC46;C/$5\=>I
M*]@\S,82A%MU]5<B-#MO64`U&X/":WQL\,*K>/88OO-_-MG=@,F#=AFW5=S\
MF_CX/#%!D:F&JH<.)6F.:SK87._-,E(W[Z\>6^-8!1K=_.YE>0-$CIN$8E_$
M3,/L0368Q;$HU4.MFL*"OL3Y;BY/I`Z>%2!8N?%'P=\-Q><._$7@J'Q2V_VU
MAS-M:-UZJ@W11ZY%KC'HJ%F;KP5E!6++R5I&>,8Z6J_=\@<U5O7AJ)YMR_"T
M%=ZI8&D=5)IOW0JU:A?`6BUL@5\M'4@[VZS!+Z+L<-IQ(L9>%?.'5A.:1\3K
M#?J^GZOQ7*X9KS=P1^J,QLZ/K=?>@)8^@\B+,-A_C]]C';1^DR=;`_NO4:/O
M>?+URZHEHK[-4?E;.B8<>M5<%&^+$G._!@"T6K4NFW*D-+B-+AOK.KEBR`MK
M*C7R2K=2DEN/J2&VJB\)0%\;XOT$P)EKZ^)*#MGR7\[?]*V]N&!<,V"^>$FZ
M0)PC\;364')(C4,LD#VH<D02`F_*__M_O.T4&VF`5+O-L*D-$B<59M,VCO+'
M-9F8K3)4<Z<,56LP81Z%,G$!@"F&:,H7*-6:47\3OF,XIOI+T=)I[JG#Y"=2
M`S]_?%,OSN0IS*2+,?EM$-PRY\0R35$8#65Q--17*QHY7%.6QC&57+B&CK,@
M'<=0:;FA'I#C%C1QU`?BUPY0K@A-_A$;2?2OO;;M]2<=)NV:^#ZG>L*?>PX:
M;8Z3=GML%R7=LELE@7_>[O`E'CVZ-_6("(%NPYC3*\A$]>JYH^1F8<F5=_F1
MM$SHJX?'`H4R>5-]'&*E9.$U@2AVY-<=OD&0;Z[-R\.E2J;6.*[LLI2Y4M3Y
M\:M#;*S:JJRRN<P/Z3T4ZR+MLDA\4@MIO959(GSO"JU$$$V/"+\IBO+W_P]0
M2P$"%`,4````"`!A@0I'PYCG;,(!```X&0``$P``````````````@`$`````
M6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(4`Q0````(`&&!"D=(=07NQ0```"L"
M```+``````````````"``?,!``!?<F5L<R\N<F5L<U!+`0(4`Q0````(`&&!
M"D<6*A>9GP$``&(8```:``````````````"``>$"``!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+`0(4`Q0````(`&&!"D<+X3B$X0(``/4*```0````
M``````````"``;@$``!D;V-0<F]P<R]A<'`N>&UL4$L!`A0#%`````@`88$*
M1WWDO+@^`0``:0,``!$``````````````(`!QP<``&1O8U!R;W!S+V-O<F4N
M>&UL4$L!`A0#%`````@`88$*1YE<G",0!@``G"<``!,``````````````(`!
M-`D``'AL+W1H96UE+W1H96UE,2YX;6Q02P$"%`,4````"`!A@0I'<S;@&$P"
M``!Z"@``#0``````````````@`%U#P``>&PO<W1Y;&5S+GAM;%!+`0(4`Q0`
M```(`&&!"D>J9I(-V0,``'X-```/``````````````"``>P1``!X;"]W;W)K
M8F]O:RYX;6Q02P$"%`,4````"`!A@0I'\+SB(4T"``#S!P``&```````````
M````@`'R%0``>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!`A0#%`````@`
M88$*1_U=,R_%`P``%Q$``!@``````````````(`!=1@``'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+`0(4`Q0````(`&&!"D?F<*,]"0,``,@.```8````
M``````````"``7`<``!X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"%`,4
M````"`!A@0I'Z%=K!1,$``!H$0``&```````````````@`&O'P``>&PO=V]R
M:W-H965T<R]S:&5E=#0N>&UL4$L!`A0#%`````@`88$*1Z78YU]E!```4A0`
M`!@``````````````(`!^",``'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+
M`0(4`Q0````(`&&!"D=!\6%,H@$``+$#```8``````````````"``9,H``!X
M;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"%`,4````"`!A@0I'IEH^A:(!
M``"Q`P``&```````````````@`%K*@``>&PO=V]R:W-H965T<R]S:&5E=#<N
M>&UL4$L!`A0#%`````@`88$*1W_.V7J@`0``L0,``!@``````````````(`!
M0RP``'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+`0(4`Q0````(`&&!"D<U
M'G?RH@$``+$#```8``````````````"``1DN``!X;"]W;W)K<VAE971S+W-H
M965T.2YX;6Q02P$"%`,4````"`!A@0I'AMB3C:(!``"Q`P``&0``````````
M````@`'Q+P``>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+`0(4`Q0````(
M`&&!"D>?-C.WH0$``+$#```9``````````````"``<HQ``!X;"]W;W)K<VAE
M971S+W-H965T,3$N>&UL4$L!`A0#%`````@`88$*1S?"ZW.A`0``L0,``!D`
M`````````````(`!HC,``'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"
M%`,4````"`!A@0I'.9$*@Z$!``"Q`P``&0``````````````@`%Z-0``>&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+`0(4`Q0````(`&&!"D>+%K;\H@$`
M`+$#```9``````````````"``5(W``!X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L!`A0#%`````@`88$*1[!78LRA`0``L0,``!D``````````````(`!
M*SD``'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"%`,4````"`!A@0I'
M[5X=:^<!``"J!0``&0``````````````@`$#.P``>&PO=V]R:W-H965T<R]S
M:&5E=#$V+GAM;%!+`0(4`Q0````(`&&!"D</%-A:I0$``+$#```9````````
M``````"``2$]``!X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L!`A0#%```
M``@`88$*1[1\I3*E`0``L0,``!D``````````````(`!_3X``'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6Q02P$"%`,4````"`!A@0I'BR\^U+\!``![!```
M&0``````````````@`'90```>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+
M`0(4`Q0````(`&&!"D>[YJ$HH@$``+$#```9``````````````"``<]"``!X
M;"]W;W)K<VAE971S+W-H965T,C`N>&UL4$L!`A0#%`````@`88$*1U=U9"9:
M`@``1@@``!D``````````````(`!J$0``'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q02P$"%`,4````"`!A@0I'):):"(H"``#S"```&0``````````````
M@`$Y1P``>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+`0(4`Q0````(`&&!
M"D=VD0%/=@(``'D)```9``````````````"``?I)``!X;"]W;W)K<VAE971S
M+W-H965T,C,N>&UL4$L!`A0#%`````@`88$*1T;?6I_Q`@``Z0L``!D`````
M`````````(`!ITP``'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"%`,4
M````"`!A@0I''I>4+!H"``!:!@``&0``````````````@`'/3P``>&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;%!+`0(4`Q0````(`&&!"D=%\DC4`@,```L.
M```9``````````````"``2!2``!X;"]W;W)K<VAE971S+W-H965T,C8N>&UL
M4$L!`A0#%`````@`88$*1X,!3+N1`P``JA```!D``````````````(`!654`
M`'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"%`,4````"`!A@0I'87J,
M1$L"``"K"```&0``````````````@`$A60``>&PO=V]R:W-H965T<R]S:&5E
M=#(X+GAM;%!+`0(4`Q0````(`&&!"D<*=&L.30(``.H'```9````````````
M``"``:-;``!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L!`A0#%`````@`
M88$*1S0^S62D`P``9Q$``!D``````````````(`!)UX``'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6Q02P$"%`,4````"`!A@0I',KLC<[@"``#_"@``&0``
M````````````@`$"8@``>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+`0(4
M`Q0````(`&&!"D<49S@J`@(``)D&```9``````````````"``?%D``!X;"]W
M;W)K<VAE971S+W-H965T,S(N>&UL4$L!`A0#%`````@`88$*1UV43K8V`@``
M60<``!D``````````````(`!*F<``'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6Q02P$"%`,4````"`!A@0I'%P8]E&L"``#R"```&0``````````````@`&7
M:0``>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+`0(4`Q0````(`&&!"D<>
M8A&Y\P$``!D&```9``````````````"``3EL``!X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L!`A0#%`````@`88$*1X#[C$GR`0``:P4``!D`````````
M`````(`!8VX``'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"%`,4````
M"`!A@0I'-LV&GJT"``"6"0``&0``````````````@`&,<```>&PO=V]R:W-H
M965T<R]S:&5E=#,W+GAM;%!+`0(4`Q0````(`&&!"D<L3KXUB`(``%0)```9
M``````````````"``7!S``!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L!
M`A0#%`````@`88$*1XU@M#U5`@``.`<``!D``````````````(`!+W8``'AL
M+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"%`,4````"`!A@0I'9\%(RA@U
M```(_P``%```````````````@`&[>```>&PO<VAA<F5D4W1R:6YG<RYX;6Q0
52P4&`````#``,``"#0``!:X`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929247324096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS - Transactions involving warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Balance at October 1, 2014</a></td>
<td class="nump">945,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightGranted', window );">Granted</a></td>
<td class="nump">5,833,878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightExercised', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightForfeituresAndExpirations', window );">Cancelled or expired</a></td>
<td class="num">(716,557)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Balance, June 30, 2015</a></td>
<td class="nump">6,062,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward', window );"><strong>Weighted Average Exercise Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WeightedAveragePricePerShareWarrantOutstanding', window );">Balance at October 1, 2014</a></td>
<td class="nump">$ 9.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WeightedAveragePricePerShareWarrantGranted', window );">Granted</a></td>
<td class="nump">$ 3.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WeightedAveragePricePerShareWarrantExercised', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired', window );">Cancelled or expired</a></td>
<td class="num">$ (11.30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WeightedAveragePricePerShareWarrantOutstanding', window );">Balance, June 30, 2015</a></td>
<td class="nump">$ 3.53<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ClassOfWarrantOrRightForfeituresAndExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants that were either cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ClassOfWarrantOrRightForfeituresAndExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ClassOfWarrantOrRightGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ClassOfWarrantOrRightGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ClassOfWarrantOrRightNumberOfSharesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ClassOfWarrantOrRightNumberOfSharesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ClassOfWarrantOrRightWeightedAveragePricePerShareRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise price per share or per unit of warrants or rights Cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_WeightedAveragePricePerShareWarrantCancelledOrExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_WeightedAveragePricePerShareWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise price per share or per unit of warrants or rights exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_WeightedAveragePricePerShareWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_WeightedAveragePricePerShareWarrantGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise price per share or per unit of warrants or rights granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_WeightedAveragePricePerShareWarrantGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_WeightedAveragePricePerShareWarrantOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_WeightedAveragePricePerShareWarrantOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(i))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001571049-15-006546-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001571049-15-006546-xbrl.zip
M4$L#!!0````(`+.`"D>56,>JE8,``#L5!@`1`!P`87!D;BTR,#$U,#8S,"YX
M;6Q55`D``Q$$R541!,E5=7@+``$$)0X```0Y`0``[%WK;^LVLO]>H/^#-@MT
MO]2QJ+=R3K)PG*3K;EZ;Y'1;W'L1*!)M\U:67$K*HQ?8O_V2>MB2+2F61<EV
MXF*Q)R9%\C?#F>'P-?SZ]]>)S3U#["'7.3X`A_P!!QW3M9`S.C[X]G#1T0[^
M?O+]=U__TNEP/T$'8L.'%A=X))\[_[/SZ^G=95*<4P_%0_Y0X?Z+U[J\W!5X
M('.\?@3$(U[F;J_^A^MTDJI.#8]40\J$%0B'8)X7IIRY9C"!CL]=$2A#1+Y]
M0?Z8MGAN(=_%W"]QFR!L4Z)5W1M^@"WC[4>N%XP"S^=X[4<N`B$>2?P1D+C>
M5=S.ZQ.VT1']?XXPP/&.C*E%Z!_[_O2HVWUY>3DT+,?P#DUW$M+!*R+A3/2I
MC9S?,Y_2:@Y=/")?\F*79C\1\I+/::Z%9@72'RO=*'/VZ5+5+V+X+=!UO1OF
MSC[U4-Z'I%+0_?7J\MX<PXG108[G&XZ9P8)*L"]^CSQ7$H!:5B+Z(BG@N(X3
M3/*_MWS<]=^FL$L^ZI"O($;FK-S[A;(%0L;YN5R5(Z[ZR:>F&S@^?LM^ZT'S
M<.0^=^-,VLEBAP<=$<R*!1@352@J%^?2@E*VH`51?AF2D?,Y?#7'^=_3G%#Z
ML@60\PP]/[](E)=#C6,@T\LO$V;1(B!;Q$-F?@&2D?>Y/\4%WY.<G`*!UQD9
MQG169FAX3V$?QADYI),<*@Q>;IDP)Z?0JUTBO[]>II0J\''AIWJ7Y!Y0VT'5
M\,@+%>P.#KE0+8\,;&+7AN7*VYUB=PJQCPC.E)D(*Z#HCP\\-)G:L[0QAL/C
M`VJ:.HD1.GSUK(-N8D;[KN/#5Y^[AZ9/K6'&NIEQ)K*.#^(/'_O$+KJ31QX\
M_APXCU1,'GC^,?K?P\TCD)?3#^8U$H.,_+?Y;V31%&*>,1?R(TM^TOW]P3\/
M3GCRGRI)DBQ\[2X6IA5V\UL@W$*N-?]-S!/VS\@81)(B(5=(9\_+I_-GH*V%
M`D!.-YCD)BGS)KL9/I8SMN<]W@P?@?)X!LT<ON:E7\*189^'!/=>D??8Q]""
M_=%@,+CTK2LX>8+X\=XGX.A`>/Y'0+[KNY.IZY"?7ECBWP;&AN-'W[;33S&;
MX8B"2A(LTN3KU$8FBK%P%B+YD4]!K-[1`JD')U2FCW((_MK-K6^EAF*S<53*
MLX.3Y+,,\TK:[2Z1O**L1H.IGP@>$#I`F9>>Y]83O+E&[R5O+WD%5I+(7C4K
MN2"LK*QD4\+:MPW/NQG&C+W!=V@T]L.O[PE.Z,49WEY>,_):R+:XV3SF[>7U
M'7E]3Q9/L_Q<1;ZW56"KR='IRH+4FJ9\/(F-_%!AYM]+&8'-3T>^#6^&`\="
MS\@*##L2PS&"P_-7:`8^>B;90V1"'(ML;X1A.,Z%7YZ3*8O[%OY,TG=#;',)
MGP_3)1RH([NAF&8X&(MN(1\;=TXE.BL24N++RCD5K\ZI\>Q-\;(LBORR+&[S
M7),P2:JDXR%719Z]CNL15V],?WE(VC6N$D/([R97'R\,A'\Q[`">OETBXPG9
MU.6G(V%H%<\(B&>#6HX+Y!B.B0Q[0+0*A\O:7E*`#(N[82M+B9W;S(I4MS,T
M;XF`Q4M$@/B!TV5SF)M^/W:Q_P#QY`P^^0]O4Q@-S:[S3%<1GVQX[?K0NS7>
M#/+W;@A2+DFI0;>,MC8&0KT#&A@(V^G[QSMHT_VY6R+A;P_$U_:,<%W8.WU+
MYX05W6+HA7W:'Q/5GAA.S[%*/)Y/*E8KM[\ZYV-OKR+_]Z+/3O1[CNN/(9[[
M_7L1;T3$"_B\NZ)\\5NIB[@DR!_-\=8;](OR^+<3?%T6O323V%K1*DR:[^#$
MRW/WOFO^GEJ([)$A:`@QAE:8LR-&L(BHN2$LH:X=T[,C_7_ZH?L_E[I=[W]!
M2@:?A77=G/1M-I)DZ!$D]DR:;]?L)I>65APK#]$+C&6\JZ`5\#4OG<6V[>)6
M67;?(<Z\@],`FV/#@S=3ZH_NR";$EF[V,MRD*]SH6*WC6K#55%NT]LW07EWV
MZK(3ZL)F/-+8CT>[K&&/=X8SBE:TKI"#)L%DKWD?5?-6IGDF$_-I3$8X]MJ]
M@]IMO.ZU>Z_=!=J=%HZ/I]TKS"8!>+QVGW-WA);2MVJ6OCB)`,UNFZW,I/V.
M<;65Q%W;3MN^'>-/(_K['>./OF/<D"C/7=FMD>6]&?_T9GS9-P15?<.LNK"?
M^6V-NNQ-_X<S_5LK_O$V&Y\O_7GI6SXQ$AK8"7_'1FP]EYA(G]#`.:RERXX+
MQE=?3M]RQE:[DQ<6`'KKC!7YS\#8YDX.TDN-1G@Y1UZZ[+B4WGLQL#7S$J(K
M=Q"&1X2BY;_80[BU#>?:F$2?#1R3\N@Y^HYFT3!#N^$(9`B>.P"%E+,8_-/,
MBX?W,A8V/KT+`P(U<;\Q$L#Y#<>L`.:FWP=/Q/U'!GZ[-^CMT_FIO&^.!?$+
M1KX/G=O@B7""3`0(+&>T&Y)62%DL`N_1UX889&]P[J08+&UUS0I`O".7"1N4
ME'<Q%&]X+?-Q=R4R=CE$\'AEK"B2V^QR$#Z)';&"R['$6,:^7!7&[DU^JR9_
M+SK[86+WAXEMEV)>R'=VR&1VUT86PB>A(F.;F,RNP=C]R++AD65+1"<,LU,L
M-W'HDH^KD,W$ZZC*U8)`6LE*BT?J]0*;NO=>S[&N7:>39)VZ!K9NAF<(0]-W
MXXV_V2G$U5:LMEVA"X)MI2)?Y;%H%0ZQ6+%BN$JV2?.R)8I`"M+5/FQ0AMTA
M[_?3M_G&;#C,0;ST37)(=[GL*73,\<3`\>55,AXDNG%E_*^+DQJCN$L/+^XL
MH:"-;5>5$O:E=G#+^<A"*=[KBM25VWF?L&AXN5MC0[%"YWXJS<S&+"N*K[<;
M`W_E$\I;P]5])+B=B`37LH"Q%;']ON7GV+?\.$9Q/QO:SX;VBK"?#>UG0Q][
M-K37S'S-[)GAVW+>'30A\83GA\_W:KH=:EK407N=;5%G9W'M<AS('5C#6#S-
MHS08_(T'G9^-Z"7`C_)XQY+%J>U!?ZK'.Y*CK3QH1N*JJ.4^W.@&PDTV;'&8
M]O\^W.C'[O_]"N7G6*%LU>51'GO!*.>L9$[Z5ON%&N%3<W[A>Q'IM_0QYX4'
M<AN-G+RS[V4M/]2V$28M2=)^TW,[-SVW5:GV\K(#\M*:?5GA^8*]O.R$O+1C
M7U:0E_W\XQ/./VH*X%\Z'>Z;@WSN'H;A:3BNTTG2O_]N\!_PWQ>_W/X#OL(S
M65&UW^[@'^CD"MO>VPL:_(?F*9*LFZ1W35F6S8?_&Y^<7VB2>O3E"U`460/:
MS[H&CL^/_P'4KYIR_/6GXPOI^"AN)$(3T.:IZ'MC`T/"U#A]`@TOP/`D9E.8
MF5"0Y"6_:1TY-7Z[/UNJ#GFN)`#UB.15K^V1\/+QGD*9U1NNOL*3U,?7Q!AA
MPW?QFDTOE:>)9]!Q)\3DY52[*H,R572SZ,LIGP8I@K/-TJR*?$RV?Y9JC*+N
MQKD5*_7^&/I+%08^/J(9[]5%I?W<#I>Y,HKPE5Z".P_5\0Z.$!EGB&91[>=B
M%;J#PSIG47NWMY>#\S/N[+K'W?<'Y]?]\WMN<-W_VBUJF**=Y_7#S3,R`EKP
M]9_PC1&JM,$N;"L!\H`-"SFC^[?)DVLS`D#E(&HZ4WO29#_`F("Y0)YIV+]!
M`Y]'6W&,6N]$%C4"4-16MA\ND`UQGR2/7,RJ%WJF"6UJ!Z#%A?6G.R/3X(),
MN).)ZX1#46BHO)O`IR,"Y6,NM#46FCBJ.&$EL<WF+&BBB6%[QP>#ZXN#$P%(
MFBKP60$J`9:0<.::H2='!W5&?`1\YU\1C'3EBPW>AF,D6T&:KPYFV\^TE0#I
MD1R+YE[81GX_50<P)!T"H[8SU2\2/Y?N"Y+B,20_2_A"._DP(NZP!/(O,0]&
MJAT*9+9M:GAC&H^2_'/^1T#F&C:=6/3\OH'Q&Y'4<(Y2HD>57G&<ZQ'U5%)*
M1.56U$4@$@VJA(PQ*:N?22@EA5=%0K>T05HJ+1&7T:*("B_2[>9M)&5Y(;>,
M%&*?914H-4A9/D!T#?UXR&Q#1S11(E.,.0%E>-C@9J,0`J^JJJQ4!WZ+X=1`
MUOGKE,Q+(>FK&QHRM.=YT/=:Y#L095&1Y_!7@,64"E:]H&LB6)N*UKDNB(HH
M@A3;64!C9.&)2535-#-+.M\EDVC_C:Z3^(3)U-),Z;!,)+X-+LJJ`@0MW>O%
M>-C@9L-B65"TM+%>%?<9G+H>(F8\[)!KUS';DUC":S'%ZB(H]>&R8K&N588;
MG7GINYZ?[Z^R-KT:`+R4!ID"D$9V@4@E\!(]0VO@D&G6B(:ZCDEI1]-$0263
MP#G4<D2LL+,2!5GGU\(>);;"7YE7>%E=M+E5P3`:`20@B))8CB;V<N)8Z\1H
MD10<0"NU;].F%R/IDBKKRU[8"O@:(8M93VA*QDU8CZQT6/Q4R'KZ,=V7H_LW
M5IN]I=%U27Y.5@5\>1;[#CY#)X`M4B!KHJ@(RZ8[BZ0N5E:^L:0I8A6LF]%A
M45,U(*3\SG*9WI!&*L0TJMI[(--O\LWVP-MUV`"O*\20?^V^@Z6`IVU`E'15
MDD4QEYEKP6J^CS.K/^YD@OSPM`)=:B%@D#."CMD<]UX]=.0@^_C`)S;_H,L$
MS-H\*P&3/3_>Y#KK1D"L>3UD)Z#GWVQH$/I6R%_3-X-V`GK=KD_M"K:ZM9*:
MJ"Q"6!\>(]\+2)JX&KR>92%Z6L&P;PU$9J9]8XI\PTX5:86?NB:HJI:92KT+
MC"49C/@N$/=<U&1^73+NH&\@!UKG!G;(0.J1:58P"<*9"?&?Z>FO-GJC`W1=
M57@AO?3R/C*6=+#ICHX``""NGBJM2T?806/7MB#VZ/*HGW\V@SG_)463U-12
M[3*..B@9^:N"I.MZ6F7+4:;<6>(J;H:S2PM>[X%B1T!3BV15*.C9MOMB.":\
M</&9&SSYP\!>WCAL<?*M*V)*-RO!:X@N-MTD\D)ZAVA]PM+6:8I)$V&@"_*W
M#>D?="5NXF(?_1FF%^[HM-&7JJSSFII9-&2"O7U^L)$!51)U(#7+CY)-A51S
MZ6I;V6:6%8'75MKZ*$#9)(V,-%R0R7^L:"QXZO4L@!?8G3RXZ?P6S;,BZVK:
M=:H,,KL4_>3/;]I<&"8DW`A*"0$@GY#<]#4>,:ZV75!$P)83V>3#YN4KP9^/
M?T4O79<>06N'30Q7^-<`G%WC(0R[P>&ZD!4N2-Q"'![H;@1^ZL9-BA#QX(0_
MY/GLX:T5(&Z,*!9+@)^%%2LL*6XW*];T43X(41]?U%M=/6^+%=&=G%[@DS$6
M_0DM]M:\X*Y0/"+Q1:0L`FN=A-H"_6$)?T]\MXSP=>SRKI+PT82V/9O;$N$#
MSPM:M++OX([0M(JY*0G=04K7%,G6*&5H.+</\\[+X<9-(Q-*5[NFWJI17+B@
MWB[Z#8GE=M/<C(`V07-[)G.CZ#^0E&Z[&2V@.746:2L79E?`QXX<0<H/#)&7
MO@/D-+^6N#XYFULO$N6EJ5@)+B;P&5KS!#P#]"U/(>FQ65F7I1+@RZ[>6J`9
MLIL>IA6$]%7.=4!OPCE=@=WO#PF;\UI68'P!_/#UL/BB6=%U7S&*`A2_R%T4
M!6C5,"(2`.FC$@L`JF++1BBJ':1%E15=8P:NZE/F[YR85E1%!0UQ;H783J77
M+7E!$]('%,O`0=LF4O@3="`V;'J6RYH@)XR[1X]-Q"%!FI=$09>T,.Y>-6",
M2&$JN(#G=5%)AP1IE1:F<DX\#M(M\E9T2TVM`(!7-8FO1<L=]*"!31HKZHRH
MD^V&)QO;4Q*%QL%)GVPK@5,/-V.-T&0I'<*E0>!LQ3_4Y0TPO*:LZPI0)7D-
MW.D3O@L'>YL7;P!$2<A$>"D$4P<S4]$6!5F2M,8Q,Y5J(`!1U%OF<TV)%HD!
MD:K+QLV4!I(E1CZ6]?S;W4RE6!2)]\6GG.HE#-4!LK7&0.8E29>9(F1K=G51
MU[0F65C7EQ!$72(N:U6$`\=T)_#2]5J0PXX@:2H/^!R,<QCKH&0JC!W"1TW5
M\_JZ'DJF`MD!BBH(:0^F$5[6E,J.*BH*KZS>XP,"`D//CW)CR6UEX0&`E!M;
M!&-MJ$PEE$P:&H3*5$QE/CV#;IBM=8554+3T*+D*VC`LZ;7KN%FQ;FW^)0N"
MGO*;RN'4!,YVR!=YH"DM(6=K>44U'>>X19;7E6^@:+)8!7D8>8J:Z!NG'U[L
MH>_OW`QOL3M!GN?BM_".3PO(=8W7I"04UKN`9M#G8PR]5]<?&\X(#IS9\U8W
MP\6H6KFD1*^@4&K.H+DL^D#)2;^$(\..WEJ([D5A:,'^:#`87/I6?!MJMG4=
M72_ONY.IZX3QGVB)&-H*UYXZ0""NJ9RPIS+1C-G%UKX!69;$+:&,K9L)PJ4S
M92MIJSV2ZKHD2WP=VN:C<*:P2^.B!<18Q8XDO3T(ARZ&T7</QBOTSE]];+C8
M0HZ!WP9$Q\*`P:0D=L/EU61@;V'&`W2@9\)D-$C.)KG&6#5X70%`$C\\VYA/
M"7E-$SX\UQA[14#49,!OBFVD>.QQG4('#@OB.=6U2B51WZK`J*OFC&#459M&
MN%%=#DM@D&EFJRMS2^-4!D`U9$V/!36@-6QOF3&-O4TKA):$;TN.&)X:'C+I
MKARR`[_@<%@]V<L_#RD0V/QA.LS/.\CJ$E%/3,N(2(M$PT34$^@R(M)AAUKM
MB:JR7T9$.FQZ!2+^#=%H3(,,/9,!?P2O`SH'OQF&Q5('Y1I6E>7#?-%S3XHN
MI$/7KP>V(7)K*%4!N1+/AS/)K22WAOKEDBL`29)$4=Y2<FLH:G[O:KPJR[S"
MDMQ5(L)M]A!&$:H&J&CPB,,J5"1VECZ)-*'N=$O'=B1>DM,[.?DXUD3*=AM$
M!:HFK@*U!EN9G=(A7XH*:(6OM257!$+F9&4AU.BE\_EY^.@*PH6+"3`OL.G&
MR#W$S\ALXR2,**HRGZR;K@:*/0TU>:](DJ!4)B'IJ%OL/B.ZK9,3X;4%?50T
M-?L@82$8AJ!K,EP`JLQ7!TWF@Q@2C3B#T;\#9SF2;AL3?%&5TCO!J\!J@(S:
MYZ]4&6@Z2S+B-U"3YYYRWT)MOG]T02HC:A60K9!9]X:*GGG.M0E"5WG[K85+
M3*1#%6$5.2W#V0JEM0^?R7)YG]:G=.$MMC;NH/&9-];>A<0:?]U.$55-TDOM
M9`D!]"5NPQN'(YP%K=.W;QZ-$CT[5-@S??0<O>66LVO3PF"F""KQDO7,NFL-
MQ*W27K=G97H%$8A-T$X4-'P9[<'MF7\$",-J\>@9:Z!.*$VY6RMC:XRBNOZC
M`)3TZR.,*%J,WMX"(:+&:V5=LPAI!?T:.,_0VPK;LBAX]0"W2GI=TR+)NBH!
MEJ2'LU-2#:G"A-`*=_KII>2;86K*2D0]/IK4AF,&")5R,G&N`(T9.?.#CM?N
M\W*W"?QR>C%%'>G@1%3T*+K&QDAB.\?3`9`D>OAW;7IN`VR.C7#>T*?/V-BA
M1-(3K/`9N8%GOT7+).T1)?$ZM2LQ357QK6!%+I!#:MH"`SI3,#:`6R6]KN3*
MO"!*2B.TTVI"<?'&U"]X)FI`IU00(]=:=.Y;&"4E491D+37MJX*O0;KJWI\6
M194'0GVRDI-H]!'%]L]X56J;Z8FJU&&]S9!>M7DFU!<OPA.YL:'GG;]";"*/
MC%PWTU"U6_5Y@"ZKI;L=*Z"<D7D'31H#$`V1&8]:R4K"S9#\2PQ8W_7"R4#^
M2Z(MF&$-`%Z*Z:T+=T9W;C$B;W9@49.^'8MQBB;1U7%6@.<.5='4-)[Q687U
MMM#=HB;(B6.U-L[418_%U]`V3J&@"_K\!DM%>)E]XKG:@S;T4!(S6V;IYC-7
M]O#(<.*##73;TK61%?Z@!U"\T"WV2!]&28&''&*KSJ!G8C1-CD9$-!,IOR6%
M32*Z#X2<4[OH'>7*=)[\8/M?IISGO]GP^.`%6>Z+=\2!+QRMKN/35[:&+IX<
M<8[KP#@5.?1ELB..G[Y^X28&'B&'_O"CA*%+\P#]_3<?38AU<.`+1V8XAO.W
M'[DPY4?.(YH[_,*]C)$/.][4,"%M`1,6?^%LZ)-Q/DPE=,_33==V\1'WURCF
M(BGL8FO^5=AVYP4^_8X(;@K3\['[.^P0FOSQT1P;38>^.9Y5?/##R/]"V4!S
M$TY4H:*\UB?ZQ_7-PSG7XWXP)M,O?]4$('SA[K]=7?7N?N-N+KA>OW_S[?IA
M</T3=WMS.>@/SN]IR>Y34D>7-C'[,:5_??_=ON>:[+FPIX#"[_F_,<T)Z!]Q
M,+.0\<%>'W9%'T+<_]_>MSZWC>3Z?KY;M?\#;VZF*JFB%5*B7C.[J7)L9X[/
M26+?V)F]\VF*EEHV9RA2RX<3[U]_`?2#38G4RWI0,O=LG74DJHE&HP$T&OC!
M];U[8.B?:9QXHR>89[TH&UV4VP=FN.`AC"=N\"0088>85T`'1.%NP#]&/"P#
M9Y18%HW'AAL;X<@`CX`9+<LTT"TPW``>#B,C@8&3AX@Q^B0`Q\2`PU7R8$PH
M0!`;#-XS+/@Q.AT&(F&G@9O"N8,-&P90&6L?K$3D@_O(C#O&`F.""13@#QI>
M0'..AAA@!)$"JESE)<%C'@PR@5.?<<\UA_^$W[-)PG^+4_L6$"%401\;;Z15
M;EJ__'IZ>JW^:?_REKCA8=S!&VL4>@%*+4]&Q&GCC"?<F2NF$-\:,?)H^<2`
M]5]3\+%O3OX?_HW?W[!!&O'S%(YY\6-`I<X&GFR]&#.RC#?XG$;NS<59CEK\
MG7J?1ZU`>8M4(PD-.!"/0>1._F_#."7R@%_^DXG//AG#$"0K@=^0MVT`V\08
M^8F.PC`)"+5!S&9HW#T5<;IX29";**ZP!UGA@C=J[5(9[5*K_`HNRB778.'$
M"W!/@NJ`W[OWM'M,VK;N$)G/M<P;U+`>W6GBHWP@V+J@:#!R@KLT2N%8^Y94
ML3=DN*$#-H!SJ!L]T79UC9'K15*[<4V0:66A+T#+J[0,&![S<^-G&!+0IJB,
M)"$>*!:0$`ITP8N%NI2O21[<!)CP!`09[,>$#<B8B'>/O'@`,WYB;H2O0O)N
M4$%A78AZ(9FH-0U4_!"F_A#?'3&75#_\YL\T(+6;Z6)MZ*7,LFZ()?%HL:9I
M=Z:T,B83,M#U<EVDQ3L-`EAGXRN;A%%B`&72&/R/B6]TQS2^B:\^G4Q\#WYY
M_N74N!EX#&P8".9E,&C,F)\S[GGD#:;G,\T(@87:H4YOM+V@5B"U5C^T14']
M4Z)U[ER?W,CX@;%$:(<"-8#!0!?4Z]!`#>"ACHZYB@:E#EH3E`00M98NFGV;
M:=RE";B,.-LIIW$("M</XS2:<A'1L:Z=N^I(7*T&*K@HI["!OO-[23#%=`<`
MO\+2,Y/L/#A-_)^Y<YDP\:MX+?>@$7!_PI3=`3E5;#0"SPF/B>1>!NP$7G#2
ML>`AQ,D#_8-W'$8,OD$B/;`I\V]W?\&;0+R&Y4^;!IS8C4<$Z3)>8[.J;`(F
M=]N^@X;A;P9*X6=7@R1$1=/L<T73`.7##$3E,WZMM4=U!+76'E5<%!DREU>)
MI#/HJA%WK'[9N&HTO5Z_>E.]S$6Y"C3_U^Z@6;*:IF[^R(B!"QQ&<+8FDYL"
M=_G1W7>_QRJ\B^87__&%/;I#MV%<D.%#XWO.!N(%77I!+_\"].>UX94C/S6B
M--[JXW,&[P=CR^,;<C30!B(B2Q';(7L,<53X\9!W4L$@"1[^D:0AQA#N/'AB
M\!#`ZMT_`<LH3`U_A'[*@\N%876*8:>8MP+OA\'AP_RT\(3RX`X-U_"],?U2
M00D;#QYX$-$3=WLP0"'"/:;A8?`\RWVE4-0D"H?I``:0`V41KHA7@<6<:_CC
M6%:RDT=%OTSB7^`K(@@8DV)R$862J/<"/H;?Q+#%^`D+SC?P1</`E`XXXL!.
MPC#Z%&'HI<7IW9_"JY(!]<B+_\*WX"DM2"3G&`Q]YWOQ`U7L8/QGBNGBCJ>!
M<1OZ!8^?B5D%&'1'5S!YB,+T_B$?3YOENCL8I./4)VGBD\%WOF[:MFD[;;/5
M=6IGJSHJJ+8+%5R4]2/&,EJ2B,O;5%P'ZIL4=0[JD^\/(>CHD_`[JAW0)K$W
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M9^.-_1;/#W$*@V#H%TOX<+)T[VQ0_)DG%,`A",YA<#AZTWP+IT,?GH[X"2(<
MB&,2L.,=^`KB4)7=.L'X**-L"#]NO27G)N;=:?'T"4_",73D_>`CP-@P#W02
M[GP0:/SDC8,Y";X/QR?9=\+#17+C$)\"%RG&2Z9A`TZYXK>)2(A07,$7R['P
M.':'^&T89LY2)G*QZS_3X3WWT2)V[U)^E$@B0#KA!?!"Z:GE)J/\-WF<E,S"
MUT79B7,BRB6)*AZSS\V01@EC\`O'Y!8V#`7&Q=,IX!09?N?^%0X1XG5_+N&#
M)Z*)M_#<-4ZN.U9G1IX\P4]_,3;2IE^A@$1#D:^G-L@0:VWP94]*H'!4[D!J
M,Z:%Q[M`<>4H9F_F!$-]+RDTD3M>K)^3(S9*`PRA)!YXS2F^!?8UE_QI#YDX
M2$7GP(4_0X]\62E*VF]T&J?IXVLY+;PZ?8$BZKL'A_@[E<@'K#I-"G(@B^Y+
MDRFE@YSFS(TH7,%92X=PRS%[G1:-]+K=:YFM3M/$Z,>$!XO\I]FS^?X=P-IR
M5=`KKQ=E!XLB+;MF-F/N-HP1I7)"=72R-1=IVJ''U3/HJQ#&G[@8UJ5Z,Y[Z
ME7D;'A@S%F'4,3-J.`*8>5/$$?"Q[P^,#`$JF<SPJ+?RZ"4Z+B`,\(FXD171
M8JE`>3@34P"Y(8T(9A#)C,GL#,A>@&$21G$NX<K2PI->I&FO*;O)C4W>,4#[
MPEQ0_#@POET-!HP>AB@U;("NEQ&2U=!=&%+8O]U<79C(._?1]7QT*5#_>M$0
MKZ/!RBI_!Q[!9_$=:)JTQY$$V"]C;B/S?LL(Q,0C?M./`PK(9J,CN^1`?'HN
MAF0&5%$I%7VDN8&YE85Q`_X#'I(G1@CG@AA=!V:KL_5K?5S!1?FJN:GW(:C"
M0*&@12XX@7@C-HQE##1.)Y@1&Y?FLX@[,7X:&HWH6<QOD3H(7$540C`@'4_D
M(0OOK,8>^-8)K"%7^["3/?;(OYH(;2VIRCO=VC":9PA:(0I_D$X"-_=UI]TU
MNU:/^XFVV;?[IM6RU>5@S*:G;`S32)YHUJKM>6T)I]0R01C63>]V%CFS]=:I
M]5F]*+.A8&QB3?V?KD%Y$!Y]G<53Q?6J-U'U%D6WKJ*2*:;,!RVE-DT\W_L/
M546!J73]?,D3&&`><Z5PI6ARDQ^A0;EV@^EQQ7TOGC'X#V4MI0HW#5Q_(+(Q
M^%DGG?"CD_%=]+.!(P4UM#$"ZFA#44Z1:$N-<8PP:VZCVWENAAL&-;K!@Y*>
MGFNP#/C+$(5B.+(8THOCE`XMBAHF8)3FY?_RD7GN,@]2BH3F^N12H?U0*ZD*
M+LK'YQ;>FV7;6VYI5$?LAZ@,5&F$&"A*,S5'4:1"!8<G%Q[0$=4"WV7M(^QO
M[V0HE$P5X],O6U87[ND!`A=$]9:NQ?2X^*]!:M!MX(`4UB1,@'\>3W\F32=\
MNX!1,6/([TJ5_\8O@5.Z_N5E2TQ4J$^764^I4JE&<=PI57K'!FX:,RV*SV]^
MXXQBKEVS/+J<DETA_)()X1R\%A<OF/%V.?YY2:%-R#DD!?+/5UR!O)I=O7<"
M<V"Q*'(QL2WKI^6%OTQ4"T3S#N]<,7'1]]U)#.(N_\II/2Y*WG_8";]5EZ\N
M%+%%XOY*O!1!`T'%^KZ@2/U[X@Z'XM\:7R/)1?#Y$P\.!U)+WX5)$HY_T9\=
M%F@9_N'2#\RQ!Z^024`T+'"K2)_MYTWODNA9W-JYIB_F@EC\$TXG4#!)]F6*
MB@D4.T;2=^>[X%0V)S\,RM\5VW%J&6OZ%T)!HNXEJDO0'9??,U5B=BW-+XM^
M39J=8Y'F$L-R!YR^C\(T&)Y(%WC4'<%_?C&6L3F:;X^.0;?71M<`GY`0Y',8
M)7[D=.1O5C:P/ALEF7?57GN<"".1VD!=.5+'M#I-T^EU=T!0==G1DR,U'<MT
M6OVUR%EF6DL+*9WM5A/16<I*U?K%>.*'3XS)4.]:IF$9IJ^B]XCF[0S-UYO&
M;IE.NV/V>ZNM\?.X<&P\;)I6MV5:3FOK/-RN4I^FJ-EH/VM=5_U](?L=8/\P
M3"F7?M-+6S:VMK9]LVWW3:?;>=;:UIS$7=*R0=OTFCO@9&Z?O*/@SH*@<5U"
M5IFX<7T_M\M,'&KW@9?];$AWX"R(:U2=RJY:O96JMRAZ/H["0,`;#;JY/N%9
M,`-M:_&J`''FB$423L0&21C%A26;-V=&U^Z9N?TY4W$)3\Q67,*'6<4EPK;0
MA8V@:2):`E-NOB1'K\6XYZW/PI'Z.I\28^(O<_68JD1/0D3@CS4DAJE:"D)C
MI@J.N&%\4TA#DZQ0$#%\Y?1+^3G`IEFBF,2E2DI#5,O1#`1<C_YN[<TR38`2
MBTV%@)]/?Q8`.@;F8//T(<&07+X0<3H&:5=5>*)*\4T&*H\_%IUYY;>"`/QQ
M\L1)?LN3J&>I7`13F&4K14PK^T`0-9Y%]8'\M9O!0XC%DOSI$ZP&P0?&X9#Y
M&=XQOT2C++(X3L=\Y)\S8.K'$'NB8K6G*0J!@'D1,1NA@8P1WN9YHM$A?:%*
M'=48OC>:PG128$6EZWWWI$T(]J2+7N:)3U>&+'G`)+'+.=N(_4`H;B-Q?X#P
M!FSD49$LJ,G_Z)DD>H*83HE(0$?^RJ9U`@S$C1^,$=XZ\D%&LG^H!!_Q9(V0
MN'[E[\SEJF"67O2HEU,BE2[O&2[K7'FQ$U"6FP$\%`X\>D`MX,P<E'A0^2>'
MH2*58PS@91Y'=U(]]D!#>&)JO"N@)ZD4A,#[AVS(VS+`IXA;17S%\F#>V"R_
MM)@ER'R^\%/PV[SWA6CY$*8)+Q%P!P^:4M-*F>D0(I#@04*'(\*DTOE!&&"R
M?%:O*BMZ',1W*":0IU]=AG-\&<(OSU05UD<),LWRL;]GJ.JZGISB,UC<$\GG
M,$"4>*I@][!_*6I2-S^HI\FL.X)Y*M1[DC@@@1=4*WZ(#%"L-E<E7;4741DO
MHG;M*K@H\UT[H\`T">O@4?]$U$'`]Y/,UQMI"`K4K`!WY2#R[CBPN#!1)[9E
MH@<C2C.+_14%Q!!A8HQ`9\A:Y0A\+DX':!LF._`0"8A%D-%!Y6,(C8Q:9<P!
M-]RAIP$0\$K2S.@*/XL\//2NC/O4PVI=K`]C`;P\$A!9F5CCW-I6^Z1MU6JG
M.A)>JYTJ+HH,SIR%`=XHB]-3'9*IXEK5&ZAZB_)1:VZ7&4,\7<BC"\Q_K`JG
M]1Q:!=^CF7XPXX/<3N3(3'1@PH.NJ2J.X"`]YCV>\`DX$)K\6*A7)]$1.'*'
M3,!2H&V-\^>D"1S2L6H):YGPY_03\"+""#M9T4=>@%$$#:'C`0[!DJA_IRY'
MF8+9>PD'-B:`'\E`M/_Z"*+E%/<3\'`LG(R/YY=G.$H:T3F:((EK\UT=0:^U
M3P47Y;8D3J?@NYD;!3+4A*!EN-L4VAKN=>7;K]UV3B7S(PC>_3T&3CB.>J_[
M$XW3;?V4!R\P1>CK>ZA@=*:A?'.S2<*$VN_Q.<G.J/F?BS.3@&_+@S[T^C\M
M'EX=NC)5B0>CW%QK?50=T:_U404796OZ2%=#1>@HY5K(MG[BKT,(+P5[N(*V
M.<_JPF<T8B$I@:Z7(I8U.$92$%XG8FZR$@TS$K[_[?2R=TY=&5IK_7I19H)(
M7QG*O0[\?!V%`?P]X`"/=5BIBJM7;ZGJ+<IE8)RF]PA/G@$A9Z&F0F3U#R'\
M3RY7Y^/IS8<<IKJXHSF]^4;#GF"3(^WY<]6$%GV3;X$`4:6J:O>.;LH#XP+^
MG>2]E5.!PYV$"(8*9*6,-Y_Z-402*;0<!?KM>CZC2%$SG56DOI#0TC'=_E"`
MJ!R/'(^:&"23^.>!P?`ZBW?(TJ[G(R9`M!$""&-RE%><R*G*YE&YL=ULJH/<
M5.]IJ@,^59[:0\/(**#L-:YW^N5MJ0BK-*(.XUFFCJE-;@9`F[*H^)38U(0H
M5R0,^'4_M:-!'U*V>X]<S-#8RHPQ,`B<1B>;&J^KY!:ZL^-P\$6MDFD14"H%
MZ"MV5)<-?W(20%E&JO4;'?)Y<_9IUL6R8SW/5<B:Q+7)/^^8JDN\&("Z!J&[
MYHW5$,1-&J!A7+@1IC(,>4(+-8+#FTK0-5.H[[1.])RXN<0$(6Q$YK'9Z]=L
M9G=/&:/D$G,B5:MH7"WL/)=H\.R*($I<RX8C*@C^P#4P`!(ARP7R#)+/4:OF
M]UV:A#%'V0TCD;H3Y]/KZDA(=6Q%;<`KN"A@P"DJH)EOL,;*`A<9\&\34@%\
M'S=SEEE[GI(JBE)KOR,&-D5,0#O%LBL))HE(Z\EUARN;C)`936`1F41XN=/A
M=DE[\AR\XEQ3<[%%;^;<#WX%II*$-3+R"8\\0:^(3#X!TF6QRFWEB9YN^22`
M#RJK&$T<B!F+YTY-9!M/!97C*:*4H6T8EZ,"<F7J)B,#,F0C:H/)F]3Q?J+A
M'<69LY8;1:,K^R^GE<]/E@G#\4-!\I_*(H[8&%PYCUI[%L\9;9FG.5CRK7FC
M.P+W!0P$VOC8>*.;SED[+'P"CM!#OW@+`X+.",K-<WL%>^NI%JK`27F7J/EZ
MLPG>^`E*)V^/&L-/U'/R8E8SE>59T+7Y/!Y-79O/"BX*F,_/[M.ZUM/JYZRG
MPK;',PF>4!'>79B9,QFI7VS-K'Z!-5,'TY3>/R0P2?#UP1A3E["BUA5*Q:)"
M'>3I43<'>G6,2SP4[:=]%@O-/Z+.(`F;P,S@X`3+^A<W):IU:&R,TZP3!H@?
MC!X]9:U`%"68>2_RSK5^)#ZVV*#^73(176.&63@WO?$('BBIL9:@6UIIU*@>
MTW#_<UWD`M'&2V:Z\!.P*#,8Y)JM>(FH[HB%P485GOC\A#R=B4JN$6U+?O=R
M'Z*-TK)D15<5)5%\10W7C\/,:6'!`S)LJ)_CI_J>\8YGII@&R;QT4U(54Z&T
MG=F.!=4PPMUCM[/_>)?&)_>N._GY*KH'8>2E,6=ZCUT$I8ZO1M<:FO4'S$J&
MN9S329Z\D]-@F&FC:_CQ``3[%I3H!Q\\M/=__]L_W,DP^/F3!^(#WMP3//]9
M!7:N?3=0SY(B@']\9:-_OCKC?__1_WSQAV7_<35(_L!==VM9?_#_WE[]T;+^
M@!,&?MY6G[]ZO[E+N@46J>HVB.`(.?'90X2V].7J]L+XH`R$#=SY=/E_OUV>
M7][^;IQ^.3<^GWXY_?7B\\676TT<;XSK3Z=?2(1*,)MVU3OVZ!9F[P[8L7%T
MNA`N0G14RF*0D*JJ%H-'"KGR%,5B5,^8C@6T/AY;!U["FRS:MFD[;;/5=?`T
M#!_ETZ/R5B.0O4XS(%<<!,9H]=JF;37)//!Z50[W>N^2B1/Z&Z/+LM"1?MDV
MF\V.V;5;RIXODY#1UKNEJ[_^*_R.92CY%I-DZI%A;H)&&J,K9&&`)G2N.$6B
M;D[,I.^8S7:KF!LS;2Z3W+H,LXS;F<Q=&MXRN_!3VW%RC,V;2.&T2;)@(<,T
MHHQ>GA!3_@ZS..4MP'`1HW),61[;,/X+_+`P0G0?S-Y+IL2+&V1*=8[U$FSA
M^%&RL[H/D%D_H@8Y`^X%?L7D5:5QS"7Q"]Z7_&JBBW`*8_F&S?F8IP"],/'N
M%'W4[Q&&"@)CDM[YV.T.W`Q9OIDK7]:;+)!`W4>$-8PN#AO&!;VC[&;#PO94
M/LS.E`V#154JO$"]G;I)P$0X<ZGCK"1"L519HRGM1Y_=I'<Q\(?74*K92S$R
M\<$XG13\6GQ:P![A9F$\Z`3[$B:\9'ZBEP3/91]%P+(ZTEEFO6YV6F:_;?&*
M:/$D+=X7>"NYETV9(K6C]7O=;[3D@CUSO7*JC?<\0=66%Q#'M/HV=?D2')TB
MB1KU3F!_PJYA4V&Y&W@A;-L/QK_4G.BX"AJ44?W>[-:X*-1LN99H>.$WA*4Q
M[7;';'8<7H$-XO2(1QM*_I?8">7,%;W2>A;O8.91I]\Q',;#Z`FOIUBN29IV
M.!':N*BS;W:X?4T<X[W1<,:NNC.ESI`-^#FC^<;&.9'RZPZC9[7O5?M>Z_M>
M6G!"V,@I\R@J>)*'*$RQIB;#=5#=R.^>-'\H@W?('J"@BB>R!,05`6RB.!VA
MXX:;V\=FC+C%%1J$EDF?$2L@/&(Y8CS'/\&+#>T-.$%L]:W-3KEHP&8C^<[\
M1^&I[3+X76_?>ONNOWT%<@E%_G3?!T4]Y@DQ_#)1-27%[)AAKODI[#H.B<%S
MW$WY%^;WI"/8SV0X>;J'W$4*L49[)S^TB4QVM<M,`R-/6:9XP;X<J"O`HO-#
MIEIRGFEAR&S92!9&O61X303'XFN.<<+#91$PZ9/'$XM`E65I9UL-AM6ROUJ$
M["P7(3L].[OZ]N7VQK@^_?WTPZ<+"I3!AU^_79P;GRY//UQ^NKR]O+BI`V2U
MEJ\^1Z5:4MA+=%'!-9/A9ZIII@*0'IP]S\ST`IJW3O,Z`*VQ2KD.0'/:]1`C
M1BX<AY]^7GPU6[9V.CL11WJ-Q=M%?Q_Y+.+$G#Q0.U`!%*]P?B/^H=7HS>NY
ML=)F+(8:/@P:;$Y#UE"H6?.D"C2\E'5Y1GNJ94'UJ[#@1T#CC"PN40>IN1)<
MHNFO)1R+9QIZ:;Q7=YSV3;GJ=W505+])`S>%XR$;OIU+_/'NCD.@\9!V<,[9
MIA-J9+P3&\0Y+AE;H>>*M7K/E8)YR=Y:[>;JLUQGP:>/7<N*LRZ/HH-4^6SL
M5E4\.4%0L[\;[K[>"CMAF^V&_&[7,EO]`INW*K_W)`"'+:3K$%0=(;5[W=V0
M;YM6NV]VFJT-<-RIHFE9H_W=LPWFFJ:$@G68&9SZO#*.L7BSTE6%_5E1/;:#
MK69;9MNR7CKK:JG:K%19S<.0JIT?!G:GLV/7=RG9;2O'@'I[[7%[.<V>:?5[
M1\>ZO_^MEJM]RE73:9O=CEU]UAVMHZV::]5*^]@VU\E+9UHM3QL^N9F][G,"
M>573U6NYV%N_9UAG::X(*TYF.LF<SV67:O6N]978F]6]\=DO:]<[/V/XLUFS
MOO)D'P*-59'J;AOKSPZ?\T=W^KA%(/P#=PT+Q<4!<4'P59_M2>27OHA;2/Y"
MMK=+9V04LWA3MLIT[)[9*<JCJIHK6@MQU85X5_Z5Z?0=L]ON5U]F<\;F'54U
MX+\S;*4UB[_T^K%S=I?LJ#ZL+I`I+04[SY6"77^]^GQY<W/U]7<#OU4E820&
M=TI4<G)3EW[5I5_5X.A5H-5OV;;$HTAR>'<$,TGMJ$)_.(MV\0:?UB`B"9TB
MWVF!PZUDG:@4%HY$-R2$'X6I@>^Z8RZ!:*A(.X$U1[*/5;/1_@E1C@BV?HRE
MO>=1P_AO%]?CM&'\E_N$Z,EF::DO(MEYN,2F<?;@>H@R3*\]>_#8R+CXP08I
M(1U=8?4P(B/).>CT"J0.5:_L`D,PH@3"XSUZP]3UBW[7D[\"^TMHE-\?$.@C
MRC$1@U*,4L=%O]`PTGE*$"@"0AG>`&Q%@"H!I!".4_^>,$,(U(7>?Z.0A8S3
M`=%A]ULM@E*A+@/P\/0ZYG^2ZT91J[1:I565HXA9P`%R$%3,-1`]B8.BC1&*
MU$,0G4NI5+Z[6=4KHKXBLD>(&YBCRL>S4$`<FCP/%?4`>E'KVDEOUU["T5@)
M1"P;&-]<^,7T&QDV%<9'WWAOIU3)]"VD:9#>X3@I;SSY_".+W'LFJ4/OD2!1
MHUQG08+/Q?Q!J?FP53)A0;E/L>&-QZ"-.+#3!`'2%+ZK.YGXWD`P4)"#R*0<
M3H4OQ'=LQJ)@R^6T!:X:S!P4(,*@$=\1YL@D98\-H$$8S:PU=&@(P%C^8X+Z
MAW$#U^>0:=\F(2'V49<7G"^H2#?U$S-;%E[;3-@P4S>YU.0$\>616%3F*1R.
MW(3#O"%G,#R$CX>%$I%CJ^*U_J``'1L*$X9VE8/@3$D-_4M-P=7@7@6XZYA%
M]Z#6>6,`87(&881=JCD0<"#0#'4SKKJGP-'A$=97YXF<LB:,H]3W&\:5!E>6
M>0=H:86!%>T&8!)3A@^,?<1$<QX==WB`4_:YK<(?>I'6#%>0\R:#P](<!:TF
M?7K-WM+0+;MMVEV[=.?J(%Y`ED(>F_\[9<$'^"Q\J<V>&_YFNVG:K>[*[YW_
MNYGW%G&9-LKK5J/9-M[@_SC$"&P[1(,6TO+::EBV>DY0]C8'\@V_N>.`CRC,
M.5?.G/;DIG#IT"7C[U8;H9P;PK7TRD&/YV'@2<S.#--O!EJO%!*.;^=8T^%<
M]'+0GP*E,YAZ>@KFKM_CCJ"@YCM'&,4(B\(9+(%N5IV?\C#-&\#SQ"D2\4@-
M*+"!@"]U>:./H8<L9*A\[ECRG3$I:5'T1,!:RL((,&O=X2_>B=E,):=(SQ&\
MN6C2158&7&T#L;*+5:0F'>K<$1LQ^!J^8E2F*VLOM/9"J\I1Y?S)AC1B4\?*
MYH)@OVY1;LCZ&[YXL;*88TG`4"&Q"W1-&8%\JD.*^PDI7N1"BO\Z_?KU],NM
M`I+ZO8XEUBJO^AR%PT+6.J-#RJIE<LA>X^Q7X_+RTC0^)?FFK/1MSL'DC3#8
M4/J^#SZVV&`_6#3PN"-L=WN$,BXP@D\SC&!T'VQX=:?3G440)@3R&0*--_(\
M)E_Q-A_^'#+L($?><+$#\R_-MX<#U.NFZ;3;IN4TC53U^?C@!>!#P2GFDYLD
MZ!:/PR'SLT8N'"F+7"_P>L847`"QFGU9<6,0S8-Z;5N-GI6YX;^(D`!PYLEC
M_M!`7"P%J8A3^]EP&NTV;X;RBQ%Y\5_&"(YNF6N',5=89WA(_^ECB(<X:H8:
MCN!KN]?H]>$!\@Z#;,'4,>`UN./M/@\+B`,AGC-GIBC]/PD\]I0=G)_T=1)>
M*O<M70U1WVSV>F:WW13>I`)_5P<->8H"QC'CC3#0;T7X0`YOEBSW?*G+/Z3!
M5],1&\X%/BRP-_+$R9A0WVL_ME;JE>7HK2[R'.ZO4+0UP88=IX,&BMVKPEVD
M;X<IRX?S5+\D=#Q=>:^AZP,**(UYKP9^U!Z#0ABX*:H"Q-C'!1P+G->ILRB_
M-A).=DH&`.]=Y`S"-*%&5\#5>C/6F[&R'%W==.;C6?>XUZAWC-TVVTZ+&VO=
M='8Z+;-E=[(6<0_H"N!C,V?3N.!PZIA:-->O+5N]F:K+43BN7`V2D,+%O:+$
M!X+ZXC%.=##EYM)ZEHA;0&691!--WJ0$GD*+1^:(VRLOH2M)[?Y0OPZ0D=BV
M]1-W*2WX`W9E[HA$#O^T"::;>^6YTE4<W8?TNF:G67:O\98G5*C7:WZZA>>!
M+)!/,7B?`L,Q]L^<?7TZX=D/N7N!F7&S?C#4/<?WR[SEM_F+IV9A6HKTTV6?
M);X2P5!;GY5X2#3-GT%9?YOR6X9G'',T,2LYZ#3-?M\!-6X5'G2*#SFKAAK+
M`HSSHX=ZSN)7WK[F&KO7W**^P:X=X.C5>8S[#CI^S`4=OUY\.KV].#>N3[_>
M_F[<?CW]<G-Z=GMY]:4&L:_-^0%PM+!=WCEU7%LUP]&=N?)<-H'1JFP"XU*Y
M'$ND;`#IV)*9N%NQ/`WB;SYU@98%TR,6IBUL.UEAF5R%6KON5KL.O<=:OSY+
MO_Y:KI]*])"\'W#AG[Y'22D#H88IV6W,9'2N;."[$'45)O=Y$1M@7C3E#'JH
M?I+Y&W2V]>:\+5NP(4%B\A?L*WBWNE-\@RI,9(U>T"7`:3"D#S_@N>6:IS;&
MM6>\'\_X5^/$.#N]OKP]_63<W%Z=_4_M`M<N</4YJD>TG")'%U0N=2"_??!`
MA9YAN3LH9>&1GF(9B-ZE;^K[RT#/,597US=L`/2Z$>GOFT0\3-_(?YR#DOR.
MD21JI:DN^%U,0#V!Q3KI6,8;^^>.]99:]T7@ZW'_*Y[XGB(G[^R!RA?QE-<-
MR[*S<)4I@MI#I`O=1K`'^',W31["B/H4YT>B)H*VV6I;RGT'K[-M9?_D#J<I
M*"=C)MG<%[Z;<>K[TE4T133*U`G*PFE>@/*I,K7GY(?R+JF8-J`R16/C'MZ/
M&:8@/2XGAI,E;[TTGA8QDY8`8T5J&<)@=CKYO>D5;->ISW)-KO-G*YWS0".Y
MT2"T4]S%59Y$#"QO1)FQ2#%/<*>$95QAM>**E]0D?;K3?$E3,I,?0OAM9=,V
MG5[3;%H\2<!NF?U6V^RWG;)#B79$U"X+Z]N.VC8<"$>O"DZ<^9VZ0N?YIJK4
M7/4,7W!3L,QXI0WM[:TVM-]]"WN>'96/8>#DF3MXF%/3(2\3>%)QH]GF`ZDE
MP$R).Z;=F=!MAXS\8R]L-"24`D;C/;B/K"2+J]5H6[H&OJ3RB(`-\FY!5J2A
MR]@]DI-5`Z@EPN(YUW#:)W3Y,7LWQL7&:8KH6M8(N+Q*CY?#9&87IO4.)ETZ
MDN(5_I9*9++?JL;!^/]`S_AA(A)1O!'6J>7$IT*G8&_^5BXGNWPS(SM\+TZR
MXI8O;CQT_VV<N1,O`3Y^=J._6*)5'L=/X[O0C_7*XM/K\R^Y8F9XP]37_]*^
MGS*S1B[1M#]'EPD*=3'3IIE+*J5+Q-SJ:C6>CMTQ>R#VB@LE^L@Q[4Z?:QB-
MQ-8\=;N`1$U`EZ:VW5Q#E=J=GNG,N<I,$'I*RYU:&">5`N#%FB[(`L94XZC-
MB'1&X8Q0IX&!$+/"5[7,)E^0:?^KA/99I:TO!.G,?J.E+`EENX`(JQ^X(UB6
MA9;%G#4KJCI2SQD8K6`GB+BI:^=6`V1,T%J[G+7+65F.EG@&LE":-L(""V46
MWI04^Q1VLX=N9+'?F5-7>`K5O5SR/H3]!"6'EABV+YW0R43&FB<UUS/JMHPW
MMMW^255.%MTRO26M`"K"0V=.OY3C,9M^O:GK35U9CIZGD33?*^:&MDNV;5O9
M]28UHRES7"CY232X4@E;PB^1198%25I=L]OFP[_N.*;3[-1!FQ>PV6S@Z`#&
MOHN\JO-Q'5Q$.`&=@C'Q#;MH:ZT0R7%,R[8W&,FQS8[EX$%B7I8&6$IXX,WK
M9J/?WS!@1=[4ZH6%^N'#[N?FC"_I=HAJ-54.=::E\)(]%Q["],&E[/16>*"9
M"LUPAT(+-I3$7$Q#^Y+#[628/&:93R%<)E%V-_\@1,>.N0>VLOD7']SNTF0V
M*I=CEWY^*@[,F7B!\-IN-BQYY)G1+0OU4J/PJ9$+`S[]7+#OII39#@-<[6YK
MV0`7,(O_IMGLF\V24-;BN)52),5&>L-QE%YWD:JQV\V\$U\2KFAV6F8?['J!
M^:YM^9'9\N/@Z$9.PR6G5#HFSW$(I%;B&L.&O=-MKGE07NU`[#AK'(@_NT"+
MT>SB3)I6[:#7F[JR'+UA3"2:J\*:91*("Q7!#"+9--!N>37.NFF%.6QQE;%X
M-3K3=(O(<#P+XR3><89B+7^KI2W^EW'"TQ6-JVNJW#%.OYQ+-*&ZC*?6J(?`
M47@HQ3_D;1CQ,JW%MA;;*G/T-@?B1-T_C#@=PX3A00ZZR2NJ8D+G+0`>T>Z*
M.5;G%#[S_,1$\-2!Z2=L//'#)\84%+4X`<QX[90%*8\%0)'OL93&1@!L?&7,
MHD=Z_X1%N*@8!8AD1JI^Q5WBSL2N/Q/-JX0KWSP*>:MW\,9WL%:]@RT70O^1
MRO;DCGD3,PG=>6X:%[1=?WU+05FUT0G[B*N!^.>Y"\,U!"W(/U\-"&GBU3,*
M<P0?$.[@%T-T=P*6^NXDADG*OP2/2B.?)N&MQR9N?F]4OE@Z_VSL6[;Z:KT2
M5/[SE?7*P.I2\6OU;]&U"?^M<4WU\-MIJ[XC:8B\F`:;TX`"`^L!DMFL>5(%
M&E[*NI0T[*Q4G^FZ5^U,KUINOY:A>P5!7N=:_(M,3UW]DI`B*9%AO"O]A32;
M8.F58U'.UE7O&RFT5M!Z_(6(TR'06$F1_Q>]FPT/3^)/>5NB_(B*H`MQG33S
MFGV2?$U76]<L*B&:-O&1[>&EFVC_GY$U@O\\NXVV."5TV\W59[G.#OK@^H1+
MZR:J#E:@XRR[>+IB*.^6*\]HK:HXF?LE:"6F->WN;H2A[[1-N]-Y&5RMG"@V
M^[M9Y:4;9:_&SJZ](R%M/*LAMB37V;\5V6D89QU6_\I#Y)N5ERKLN(IJINVO
M:-OLM5IFK]M[Z<RKY6JC<H4YVM7GV\Z]^>TS7IX4:R5]/)M)U7;8S=WQ;QU"
MW]9"5PM=Q83N$&Y1UIGV&<<AYIDH/%U\:9V_2FRW0MNSNF'!_;)VK>W=M3MF
MN]VM#.^W:F]J@:\%WK8;K:7/)(<H[D=XFM%N(W+@"0?N9Q9*EP/2-0S3.Y\=
M")%5V=D=T^HT3:>WM"VK`G=?K&1N]8;B8&2VU6BWJB^N.8ORCK)TLW^O"YV?
M3T:G#'0+5NCX<JCKK/2ME4-=B,H.XX;*/JYXBW#B;%T<50MQI3EZ&8`+:PE,
M@@\2N/9<`=?*RB=1N2P@<-T_PXAWE^=X*UJI5!F`"$)_/3(^&+X1>Q8`@Q%X
MEV^;:W"NJ5NF#C>;/81?ZYA!A&X,`Q$4@=7C(&66W9P[DXW-XM&-O#"EKH[4
MR2"6[0(R%-8RJ#0$^1^X"(JMD.MC.3RV^N*4\@\X/$O,X?$%:NLLL!._-FVU
M'!TT:65B"(T&J+E[DG2,W2'C[WO*`(Q!GK!?,0+0N#X+AFY$V-3X7)Z*0LC7
MJ\#X;S=(L25%,P>'4;1@DMDX7]4`0Z#WY`5#=AU7D*R/?"*Q5G2/\!5T;+,[
MLH-F"29M]K)L>?>UMCW@*'*UM02UKA]C>[@$_AT7,"F'(DTQ6M[H@IJ^PZO5
MPK0)W:.TPVAMMVJ[M7>.WLZ(-Z*1#5D,/.,UM]CY!C25PF`W$0:'0[W''),M
M9CYOLY*5YN+'&8YEC#HD8KAS!3[:F`IPQ^Y?^&^$U8B\NU3LXQ`L2(1MF`<L
MCD6#E(#O>]S):K]KB#YST+;TGQ8_5M)A1<!N8NL&T!S==E/^G-"`[K"-M=XQ
MI8`JQ[1;3=/IMF=_J="*%(1\J2VOU4>M/BK+T9**XKQESNKW-051UQ0?8$VQ
MH*1=G4R.JJ9Y5XX@,&H5HZAR+')VF2V^%(?:[:I15+4U6Z><8JL$=2JWS=IK
MU!5MEZ(#J\HXAH2-0Z"QDL7'.ZFWKPOF"VB<6=(YIS,I+MI)BPO&LK>0SSP'
MJ1+UXJ)I60>^\JESW_,J+5&O/.59'?O!D5Y28J^1?;R;_A!H/"3%="HO00YO
M&UQB5#B(O<'AD?X;]O`^KAU\A'FH5SHRZ9:1,>I4Q&H50C7-OM4W+><Y,!A5
M.%)7*$VS*DOK-+I+;]ZC6-6:AB.@H48/.3:S5%&RUEGD?MLRK7ZM50]T^9J-
MWM+%557@6TU#3<-1GCB/!<?E!9&U5HQH#R`;![W5ZR4\HB6L:=@W#8=ZEJS1
M;VJR-RM1;QRK:=IM>V.8,H?`_$.@L3("TFI8QR4=-0TU#4=Y>)ZZKCTFZ*`7
M1-8Z*]\RG7;'[/>>@PA_>'O_A5S6.LT7M:HU#4=`PZ$>L']C,58=KVL]]P+$
M=:B@=X=*]WK95$[?,:W^T@TGC@,KL=HF_F"DQVG82\/FU8)S.$36THWC6`W[
M&-3B$084OH3!R6/M$=5T;R-CKM,T>WW["#9^361-Y$LFLO9BA!>S=)RNPH*S
M'/9UC:5632RU<IZV0+H6XG+MF,/K\/)CR-$`DX>(,0(6#'"OC.%7#\8$IA$.
M8X,!/X9Y?Y6#OYZ%XPDBR@K`-:=OMGMM&D4D\)LZ3J$"8S-S4(WT4O",Y=?@
MMPOX1`D!:8P98F+`[R(63^`C[Y'Y3P@D//!3)(UC^,:,PQS&A/5(P*\P%T.?
M"P'-.DB;92G2)#8BDJB0)F=1$!=S%1ZZ*Q#5.R6G.Q%:E)2#50-+5UJ_)*94
M4C<>-T<1IG;D>I'QB)7U.@RLU!;#-!+8LE/*TUBH/$D+#1E,?>PAZ&T:RY$^
MD.MR,W@(?>`?;TA@(+((/O`Y'#*?X]/BLQR_$K_X+L!@#)?#OA@NZ.,QI_>%
MP%LV)Y6'MQ2O[5K=>;:Z;`=-,V6.?*]\II%PA)V*$F:WJT98P2E)P5ZVJD9L
MO;R;7-[*$2NY6)'EW3[^804F>92T%N(ASGA'S\$]7'YRM^A2T8%*0MI]1J\J
MSGUT@:Y5[A/I9I7`XCW[IF4^L^K%7F]R7\`+KO):5V!=MW,;NKUY\782$\1$
M7+0(^V=N)@BE<9W-$_><S-D=DMEL=!:V.ZY7<-45W.J"+<;>V/^"+:W/*&ZT
M;VTF811JA7:`VZ'67P>V8$>EO];*3MNA$%S\F/!>:AB--JDE9`$`?-787PT:
MJN&AM1K=`]@PU:"A&BOF')>*JX2+=NX]>D,6#(TGC_D+03SVS]UJT+`7"[\&
MU-$.-^=/];H=X[H=6@#MM]!W$\_WDJ=#D,<JT+"7/6$O7VM3G;WPDM>KM716
M<776Z[`\L:]>_)<QPHRHJ+`-3/4DL0HT[&<WK%`(6YWM\*(7K+UT`Y'J+%A=
M!%$G^E:5H[=:&4/$!I@(,#1>VR;6.+0Z]AN/:@PPR_9UVW%,VVY1=8'><-X8
MAT-O!`:7$F[?4B+P:\=RS+;5Q4;S_-D!O(0%,3V$6*/P-U.%"CR#>''B,`Z-
MO:+RE1`F?V7+;+=LLVFU#9WJ3K=EVMW.<E3;9M?NFKU6M[R$8A7"U"A8]8S4
M3,*(WAV.#-?W94YUPSB-\:.I"I,T4`N28]X@C!-X#9R/>-%&H)55?W<CH!#S
MJU\WS2X5I'10)`</AA<3VP?B5W>,UOL^`($8&B'X3(8[FTDMRD:0WLDD"G]X
M8W@K3*S9:-H\6-[0]J3Z"Z5J9BS*'#>&,(">6HXLVG1N^>M.WW1:EEQ3J]L!
M66Q.E<^4:)!_O$OCDWO7G?Q\[L4#/XS3B%V-SK0%^,I9?P;+$%/KR`]NS(;7
M[M,8%$9\"_OT@P]R]O[O?_N''`I^/O82^OXT@%\&*`TL&'@LSMZB?HGE0;C=
MO[+1/U^=\;__Z'^^^,.R_[@:)'^@H-U:UA_\O[=7?[2L/X`)^'E;??[J?:T)
M5[,MOBA?^G)U>V%<&B?&V=7GSY>WGR^^W-X8IU_.X=]?;B^__'KQY>SRXH8D
M9L>E3;5YK\W[ZD*=XA]7H#-=LD&?&*@K?L>9UN);BV^5.:I[IS[)+;@B(VPT
M35,`%VF(?@LX5$J\Z3&LB+U)0OC5AR@,_S*-+\"#W\/H+W(WO"2&N47@C*$O
M\L#<X;]3-P(6@">&;Q1#\#I:%UT++)>-\2'T5\+$N$L]']U+_CRF#J"+E*C?
M@K\&QGZ`CE7`_1-TZ,`^M\@GX5#[,7[YV7TR6KP#:L?,BMN$CTHEN0E>ZV5C
MDT_Y/32P,@L?<GWN))V@.R9=(T[8'3X?,?2Z,H_*"^!G\",^&M$.4WWM@+-H
M.TT<`&@,TC$?0G+?]>/0>`#?:HK3DDF^>X?L#*,GY/U_I4-8F'B$=Y&F<1'<
M^S!M,W-$!VF$9/GXL$L.&?'ES/4Q=A<&V8)Q*O3Q!.'HY_$*0O*#V6C$/3M@
MMZ]8VA:3D.-JOQW!EC`^LKL(5O5)]J!%3H;I_8/J3=O2FM.2L3<UNZ^V>\&R
MP?1@!L2;;)U@_QJY52KSG:<)SK$,/G6%(PPOXG_`2GLEPX4)O)F$H/C4M:IO
M;3?Q9.>(,Q><KKK=:=?:V-Q+'3A'P*Z#M[;-9J<GWMJSS&;;7LZAKPU9;<CV
MSU'IAUT0R@.>!(W3>]@)^%?MB]4B7'V.ZMX`.@+@=;%,F%TIS)D/<_;@L9%Q
M(2%%C"ORW**&<:'9:M#T36%CS7F_4LD7W5]B\D_`OL2NC[8;K=)CZ*=!XD:>
MCV',88JNU]V3\9I#G:`7`"94/$_?DYW^[OD^!L+<P2!"`!<T+A&;N-X0%H<%
M.8R7B+F#!UC!URT<D3Q"<'1@2.$"H4N&L"Z2;NE2&L+NZ:P+6`(_!B>1(1`B
M?HLN'@;9X(&1%P]@<N@G%!ITC7MNH#DO[2WP#]98<U\D-VLM56NIRG)4&MI/
M(+7W%*^MS6LMN-7GZ$<\C^(L\%"'_YN'&!N[3V"IR&1X`6CK1P[[]0@J.TQC
M.'Y_CU-/H(GY[!ZT]20*!XQAE"(6!V]XEH=&Z*@:P5>H_@=A&L4$\7.'0#PL
MCAO&OZ:M'UA/O%NBQUQCX+O>&`W;)$Q@;3":0!^9AI<@^`[#__*0A?<7\[V'
M,%3FS0_C6+0;I%N/AG$YPI_!&X#B.P+D21[`++K\4;+1<,Y+_80FAZ.ZXQ"L
ME0JYX&,#,%5TI>7&8*ONP(SAE1O>5@WSC!3CX<4:OL)S[RC+4)U/<32$5E.&
MC]8#3;0<CQ[A@ZH+NFP<?O7(M-E0Q(=^C/_BBX-W>#&R*AQX-*;RFLIXVS`R
MC8;,BM.[/\$/0.J\X('163L-P-(GK@<_P[P%?#%9\$<642"(F*C`XO#B#?Z*
M0+82\E10QKB,C*:%D2\)/O#@1F.=H3G'0DE0+IP140`C".&8S[M)^=I,2)AE
M;$I%F]`K@M_@JQ=?U*UVNZ;?RWUTO>@WO(;,GLLN\.IKN/U?P_VW<6)\/+W\
M:OQV^NG;17WG5EORZG,4#\H#-XJ>4*LI_+R!&S^8>-)$TQ6CY6#>(UH$[<.)
M^Z0LACR32LL"RDS/P=#,499,$:.+X*;<FH,^A<_CAS!"Q9VD$8U1'][JG5-9
MCA;O''0,P/>D["'-SRJ#D/2"<(Q>TR?P:O"F4-S)3`2*Y)A0)`F`,AY$WAWW
MH[^`LV6<-HPS[C_I")(PMH+8!>K\0>J[,HFKF+2(3<"/0(?L$WMD_DD+'+/P
M+F81[7<8:I(F<?YZ;>@A"'`"WA5=A3V1%YV0HZPK@`%L^/LPHI0MF`(-3^$?
M?+"%'TVGD=7[O=[OE>7H;0[&E8.QPKZ#"<.#_`!)M\.XJ4"PN;BWQ`8RQG#6
M`X=]R"]$P:"F$5URTUWH"\%]M:N/^UJ%KA6'08/-:5@&=.[%\*0*-+R4=3G4
M+JL8Q3$HC&-\YC:!8D%H,C`T%%(NV.`OXU_<4XN-;^0MWL!LJ`(`*/BF.VB7
MW+Z\$?;F;?57+AEFPMG1%F9N"P'-KS#:2!C]M827L;$(#R8`<:Q+0^%;KAO?
MJ<RL%"[G<I.IG"Q500L<M!I]'@;M1LW1NM).8JL09$N$>+TY'\*Z'`*-E9<=
MYYAD9^?=6,5AK4_=,G;@0WUP?3<84#Z2S'V6.=&BMG'I2OD"<+'R"6(GL6I8
MAV<0M`[#GX-_7$Y]TVKNAGS;M/H=TUF^26'E1*`6TWV*J;-!\O_^MWEXJF;'
M:9F.T]\`S]<@>OL69P70F[V>TD^'&`2G%&&>B8)G<$HT&3RXP3TE)FEUX6_<
MI<_=RXE>%39O197<]A>_:?;[CMEV%F)1'SOS:KG:L!O2Z;3,EKTT*M`+.D)L
MG_M?V3A\Q+K&D;H%3R=A@!?@:01:/5X(?U9OM8/9:F\<</DML]]^CLN_?3(/
M(UI?(1JJ(E]KP.L>@#(_%._\*QOX;APK1"R"'OAWBID7I-*9:`%SX`J]NA'&
M]2*_![9A:_;7DGT`DOVF:3KMMFDY2[LZ6^?^%ERA(SR0:+<8N6OX(S-8#@C6
M,$SO?+8GR5HZ*KR0_*IL^4T9LXTNS2[DIY;[%RWWMMEKVV:WN?3M;H6EOL;9
MWG&IP]![W"17C[O8`2^T<FSU\-/5;L5H`;S\"GGQ=$T\@:_=NU[`ZX?"6,+T
MX7,"T=E-DLB[2WDAA*APS]Z(T-.PF%AF-#T.`4]3N48X4_J$)4H/"-$G4&TB
M1H#7\#"A/G-XG9)QQ4_H09B$C#?P,BE\6#Z+E5^J[AX^+KP]U"+2>FF^*"D9
M\*HK)&P0HO3%A+$=D+-.-95Q`O^CLH@%YB%"=<_N!]@$^'=6CCZWJ%RO/O\@
MJN7/J1*-JLU.@^$'+%^Y&EWS$C)Z[8&5I">+=^]TK4NU]_*RLY@_*D'0R#6G
MS4!+C0*F+S8)U8[A:NKU>T9?E'I1]K0H5X%QPR:@IRE;L8/IBHCRGT-[<6-"
M6A-@OT.!&$Q`+^[W6-;PWB3"['QAC^[0U2'JSME`O*!++^CE7Q"QW/`<.&5V
M1&EBU<?G8$814"=?!DP@.#"@-W%]_\D8LL=0M&L88BU*.$&3=?[EU$"2AF@`
M[SQX8O`0P.K=/QF(/A>AJ0-+EO+J96'TO@4>CD3OY\KG(HW`KB%6*QG=_+00
MI>[!Y0@Y8_IEAOO[X,6(\ROP96*JO43/Q21@Y<Q6\F+F211R.#DY4%:H&<&<
M`D0M(*[AC[$$QQL(`ODOD_@7A`=ZX`N)(+A#B2G+'\-O8MAB+A6"<V^B`1.!
M!_Z=$F+N#&$(9*3AYV`K#G)7O/BO.$/3$9QC,3I)7OQ`3AKA'^69+KR)AO$Q
M[V+Q604#)D"!!;3P5)>/::Z#=Y*.4U\!#1'DM?&Z:=NF[;3-5M?984EWK8(V
M8Q>V>E"JEV5F5-2I:>"F0](X)3[^R`M<4+4(A)EY^P*^2QT44G$$R*%3@=9!
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MMT;'`N>T8!]/_P@?U'_8,,2'0-J_4VIS0MB1HS"-")IE8(!Y@%7Q7&,,PH*H
MG6.&_P/"P=1\%)ZG;%'WL_'&?HNN=9S"(&"]V*,W1`/*@44-BO;=<PAR]@..
M*'!N>--\"P<G'YZ.N',=#L0)`MCQ#AL"\O,&?4?6$,9'&65#^''K+5G]F/D^
M\A`!I'A7&.^'P`J7`%0N77S@)V^<MX3W`B<+#:A*0R5%8"D@H`$'0-F]1&!)
M*:[@B^58>%+!+BX$<@,"X_(9YD`W_TR']]QYB=B]&PTE$A:G,T#H-X6CE9N,
M<FSD24LR"U\798<Q^!IY/53XJU,SI%'"6,:@X?1UC;^(R>V@%B@(\<,=#QR"
MHXZZ*O+-#V3J+=2BAY^]8G>LCE,\H,P/1AQVW8TR!-8I."TV0D!3OE>X0.&H
MW+/29LS1V+&A#RZ^FKV9$PSUO:301.[D(5@C-DH#C"XD'KB3*;Y%H:9.NX[$
M09AZ.`8N_!EZY.0I++/L-SJ-T_3QM9P67IV^0!$E4>[%?@16G28%[2NS4(IL
MO3(=Z1`Q=V)N1"=YSEHZGUJ.V>OP]D:OV[V6V>HLV7"Q/B$M,"<Y:[S3(^QN
MS\OB1%'+PS[<"VGI-3,:<S=BC)>2$Y^:FDV`M5)?PPIY_`H.]%_,)BYU4TL#
MCQ^8W<S[\,"X"5Q%9>1P!##[II&UZOW^P,@PT#6@,D3JK3S0AXX,"`-VTN(W
M??+N4BA4'OD#POA16>"L(IDQF:$!V0\P5,)(SB5<65Z.I9IILRD[RHU/WE%`
M>X,M0VA@?+L:#!@]#%%JV`!=,2,D*Z*[-*3`?[NYNC"1=^ZCZ_D<*39Y\**A
M`12#U57^#SR"SW*,[41_'$E0,+%3?LP(Q,0C?M./`XI=9J,CN^1`?'HNQBX&
M=%\L%7^DN86YE4T0/]X5P0[,)$=&"&>#&%U^CUJ?+>HH9KTL.9V,JN0>.W0'
M=+K!0%CD@F/(NWW+@&&<3C#;(BX%YQ=72/R$-!K1L[!QE1X"]Q$5$0PH,BQ$
M;W!0NV,/_.T$UI"K?MC-'GOD7TV$QI94Y1UQ;1C-6\SW$G_=:7?-KM63[;K[
M=M^T6K:Z2XO9])2?U2"<WB)Z@_.&1FOW)ESHX,X$21>&.?68Z(4;`1WW\36+
MJ,_X#B*BF>"^XY*X6'YGMG"A;IC>?LLJB++M7+!]"]6!II,*-]I"I-3YVWMI
M+BT1-/W"$N,3)CC!>ANTX*NF@M2KM_O56S%66B_1SI=(MT<"F#WFF81HNV+<
M:$::>+[W'[0I+A@7ZIZ475A1;R2*7%+0S_-3>3F?C="@9*[!]+BJ&U`0\A_B
M<#)K@8(V$E$><SGHA$#EE@0L3SG4:&7!]+OWS`A2"L]@K)##FM([P(BG"9V+
M*-$RLXS<<#6,<WKO(U._(C!4#`;!"8J8@;=^7DS)#6)(+XY3<O45-3(A<^HR
M-.=A\)'#27;A*)(PEVT[4>^.6H'52S2#;[QNOVZ!W`=^:LG6E]L=517[0:I*
MRV'#T$N:Y)I=%"L_/`?P$`EOPPZ\3_TA=58-$N]D*!30#I5`+4SU?C_8);KA
M69R>O#H=T&Y2_0#QMHBVH7!*M&["NN/![P!3NOVC8;YC(SZ,$`JG)&MJD]_G
M<H_CN%/[7+:7RH*V_.(OSBCF6S_++\II@$SXEC]R9[\I5FZ&4$"\D4C\\Y("
M/J\%R!JKF6L!L@51GM-59$:@O?^P$WZ[*E^]GJ#OH$E(@4;*EQTN?*`H(BGP
MD#68XU:1[MO/FYZ!K[Y7XU#,#%G:*>M![<4%JGNALP@N.U?**L$.J*!U^CL)
M6ZKM1/$-#?^S@'FH)[[5*-D=_K$>*GW1GJW@8M6[J=Y-N]Y-:^#T5WHWK69?
MC2*XFR[!W13"VH@E[/;:\B@@NPK-X9?XD=-1QX=E_`SI4K:GCU`^&Q77Z2\8
MISL]$`>>H)$ZIM5IFDZONSN"]LV.WAQV-!W+=%K])8;IK$7.LX64XPH6BN@,
M,4:I6;D83_SPB<DFJ?-DN-PTK>HS<YJVI#57)49@KVR'FI;IM#MFOS=/CE98
MK:4F5Z_3ZM0T3:O;,BVGM?5UVJYQFJ:HV6@_2W96_?T&I,<I72^!+[1;\5F.
MG+[9MONFT^T\2W[JU=K-:C7-E@V:N=?<P6J50%)E"4$+<GST="#Z_@/>$>/=
M*PMBBMA>R4K+RP!=<>^17?MN$/-Q:KR8`TW]PU$I\8=W+J55-_1E)WFJ46(J
MMFIUX63U%D5/_U$5_7C]1)?A)SSI9J!M+9ZZ+TY&L<CYB=@@":.XL,[RYLSH
MVCTSMS]GRB3AB=DR2?@P*Y-$&!*Z9A,T3=PG7H:!"?22'+U@XIYW,T:T-'F.
MRV7@F/C+7!&EJJN3@`=Y=+/I@H<,4"UN&-\4<LXDJ^Z#GZOIE_)S$,:B9F3,
MVS,K@#B:@8"?T=\]!>5&8`R8^2LP9R(VE9\L`&$,3)+FV4J"(;GT).)T#-*N
M2N=$:>&;>Q8`#_!F%7_\B$436"G!OQ4$"#1\(ODMSW*>I;(H*RJ7>Z&2HR*F
MU6:DL4S:^D!XFC>#AQ`K'/G3)UBR@0^,PR'SN=`1D^C&DY+6XC@=\Y%_)F8,
M<-3'$*'ZL$33%-4Z",!'S$:H&V.$5Z^$&`&4T!>J/E&-X7NC*8PB!;Y3NMYW
M3]J$8$^ZZ,Z=^'2_RY('S$F[G+.-V(\!`J0E[@\0WH"-/*IL%;"!*CE%ST?3
M*1$9XLA?V=%`0%NX\8,QPBMB/HB`_T#N<2@-3Q;RB$MS_LY<^@LF!4:/>@TD
M4@EO84FLBE-Y11)0EIL!/!0./'I`+>#,')1X4,TFAU4BE6,,X&4>1RL"/Q0?
MPB1%UQ-3FWB(^>A)*@4A\/XAPQI27@F%.$S$5ZSI=9^RTAX=?XCY?.%Q($V%
M$<V4T0=_A&G"<_C=P8.FU+3Z8_+!Z8\1_"(8C@AC2><'85K)FE>]]*OH<1#?
MH9A`GGZ5PL#14HPGYD:9JL(B)D&F63ZV2E;*Z\DI/H/%/9%\#@/0%!Z5G8,V
MYNWFW?R@GB:S[@CFR9,L!5>0!%X%K?@A$DZQ1%S57=5>1&6\B+I$JI++,M^Y
M,PJ,D[`/F.#,=37P_23S]D8:\(%)]4T1X1G=87[VDS12)[9EH@\C*BB+/1:%
MGQ!A'I,`5<`OO`#FD@J\*4Z'AQUV!)(MD8`0`AD=5.'%T+D!O3+F.!GNT--P
M`WC!9V9VA:=%/AYAZMZG'A;58@D7"^#ED8!\R@0;Y]:VVB=M:YE*IC6B$7HP
MXRRD![CC^16\D3,R</A7';0XT,VH@A:YQ8WK4$45UZH.551O43XJ1$+=1'#8
M=.[2P_S'JN)7SPA66#2:003C-LCM1`XS1`<)/`":JO`'#IBP,&A/\`DX*)G\
MN*07"='1,'*'3&`JH,6)\^>'"1Q>L7@(2XKPY_03L*UAY$9/_",OP-.U!B_Q
M`(=#2=2_4U<`M8.`)1S`EM!J)`/1*NHCC-TG=-RY]<1#HS"]'\\OSW"4-*+S
M)4'/UMYT=02]UCX57)3;DOB5@FF&LW4@0S"(P(6[34&'X5Y7'N^:!?7MK#0!
M$=WN[S&@P/&R>]V?:)QNZZ=\U;TI0D+?0X4!,PW8FIL-[XXAYT3Z"T,UN9^+
MDX3`(LNC%?3Z/RT>7AU%,E6I]R2CN=;ZJ#JB7Y_N*[DL6]-(NB(J`O8HUT.V
M]1-_'2)0*12_%?3->5:@/:,3"TD)=,T4,1$GA,>0%$2&B9B;K$3#$J?[.<=S
M_13_A7W/4$:OHS"`/P<</(P?^7<`65+OQ%T>[;\RE`L=6S:_[/5AOXJK5[O;
MU5N4R\`X3>\1`3G#6LT"`(7@S1]"^)]<9L''TYL/.=AF$4\^O?E&PYY@BQ'M
M^:PE&=J+;X'`9:3*7?>.[O4"XP+^G>0MR*F`^DU"Q%<$LE+&6[_\&B*)9"ZB
M0+\+S.<_*&JF<R#4%Q*]-J9(-1W;RR&/\0"`H8NLL1O#T#OO3Z-=)D9,X/0B
M/@I&2B@1,)%3E:U;<F.[V50'N:G>AZ)A'$Z5)R+0,#(V,PK#)`@3!$E0?=]X
M4QB"/\R:X7%C;VJ3F\'HI9P//B4V-2&ZV0X#?CE)K2#0KB>B5CQR\3YY*S/&
M<`VVX0/G!*]9LZMXNE_@B-,%'36H&IVD4N!(PL=#V6PC)P&4$Z$:+]'1*PA2
M\ESRK*.S(]VCTLUJUJ*I33Y3AZ>):`-0QPY,=/#&:@CB)@W0,"[<""]>A_SZ
MG=HPX:T*Z)HI8&E:)WI.W+)@.@.V`?+8[%51-K.[IXQ1<HDYD<.0"=A.8#SV
M?4HT!&A%$*799,,1%51B[QIX+(V0Y0)Z`\GGD#[S>YY,PI@#=X:12#18W.JP
MMA6U`:\713/@=%+3S#=88V6!BPSXMPFI`+Z/FSG+K#U/%\!%B8#?$5:73K&@
MG6+9^``OM*7UY+K#E7T,R(PFL(A,HHC<Z>B=I#UYQE!Q9IRYV*(W<^X'OYA0
M*8T:&?GT+)Y.5$0FGP#ILEAEXO&T-+=\$L`'E0.))@[$C,5SIR9R(Z="??$4
M4<K0-HS+40&Y,M&,D0$9LA$UH>,-HG@WO_".M]A5J/Y%HRO[+Z>5SZ:4Z8WQ
M0T&JDLIYC-@87#G>6*]XSFC+/,W!DF_-&]T1N"]@(-#&Q\8;W73.VF'A$W`4
M&/K%6Q@0=$90;I[;*]A;3S4P!$[*&Q[-UYM-1\5/4#IY<\(8?J*>D]=EFJDL
MS]FLS>?Q:.K:?%9P4<!\?G:?UK6>5C]G/154-IY)\(2*:-'"S)S)Z.EB:V;U
M"ZR9.IBF]/XAH>F!KP_&F!H1%:'A*Q6+"G60IT=%<_5<?I=X*)J_^BP6FG]$
MS082-H&9P<$)EO4O;DI4V[[8&*<9N#Z('XP>/67=!10EF"<LLF2U%@<^HO93
MBR"9-JLQPRR<F][+``^4U+M'T"VM-&I4CVDPXKE&58'L5B_R#_@)6"1%#W+]
M&[Q$Y*+'PF"C"D]\?D*>SIHCUXBV)8^'WX=HH[2,/M&H04D47U'#]>,P<UI8
M\(`,&^KG^*G62KRIDBFF03(OW914Q50HF6(6`+T:1KA[['8VN\M8]9(B5W,Y
M>&##U&=7HU/XN82QRP#Z+@1HYD?0.V<9C-[5:+JN<QM7(#6$70UA=UP0=I5'
MV]HM@;E2=E'ZCH@6`KO"*%K&FO[*0,C5TEQE:3AT^OT=0[CM$;NM'`;'6,;F
M[`&[;18_1(<O>Q8J2@[.;6GLMDT15%UV].1(B[';RLE99EI+"RG':%M)1*N(
MW;:*WEL1BV^5H35TOL/#5:L>#_>.>;8AI;YO%*U"]CO`?@$YM?&E+1M;6]O#
MQ".K(B<KA16V^6!42:A+5"]<<XR%TV`(GT0I&W[R>*H0O.L6O]EU4&N-*YA<
M4&M.!(I\UY$[]ORGGQ=[NF51+Q6\@C>B:ESC'F87(2OY+):#GSQ0FS&)9"M%
M-^(?6HW>O&.DG*M5(MY+'$0.@P:;TY#%R)HU3ZI`PTM9EV=$7)?U$ZNPX$=`
MXXPLSLDMD!T$LCR!'URBZ:^%&0.KWMG/3%X6&LU.?5%6Q+XI5R'<@Z+Z31JX
MZ=!+V/#M7.*/=W<<`HV'M(-OV"3A]_IB&]]%QCNQ09SCDK$5P@C6ZF&$@GG)
M<'&[N?HLUUEP>>R2V';+BG-!4+1\-G:K*IZ<!.CO[X:[K[?"3MAFNR&_V[7,
M5K_`YJW*[ST)P&$+Z3H$54=([5YW-^3;IM7NFYUF:P,<=ZIH6M:XT7FVP5S3
ME&"\CI+J4I\7E3`6;U:ZJK`_*ZK'=K#5;,ML6]9+9UTM59N5*JMY&%*U\\/`
M[G1V[/INY+$M'0/J[;7'[>4T>Z;5[[UTUM52M5&I:CIML]NQJ\^ZHW6S50^-
M6F4?V^8ZV1C3_OZW`V5;+5$;/KF9O>YS`GE5T]9KN=A;OV=89VFN"&;)%5I=
M-CI:=JE63\2LQ-ZL[HW/?EF[WOD9PY_-FO65)_L0:*R*5'?;IK5\4*BZG#^Z
M\\<MXOH>N&NX,#-[+YQ=^B)NC<3RJ1FU2V=D%+-X4[;*=.R>V2G*HZJ:*UH+
M<=6%>%?^E>GT';/;[E=?9E>IYEBYW@+K-MS),-`&R9!];[$JPJ6FG_'52):X
M[JM@8W.0(K0<2Y=HZ(M75HJQ'"))7;!Q@#2\E,*`0Z/AI:Q+7;!Q,#06Y7-O
M5)#7\72^I)35'8YF9KF80SZE@?,\\,)?2"/J(G#X0K:6_GQV0C04E9@61$U?
MB#@=`HV5%/E_T;O9\/`D_A34NGO/\B,J@BY^L&C@Q;.WPOLD^3I"6.AK%I40
M39OXR/;PT5>0?'!]@A1U$P,.<2'!??(N8IN-KQQ3FOZN:QN:]HZ2\?M.V[0[
MG9?!U<J)XF&7-=G='94U]1O/BN55J%BD\I=%OV(8L,"[.JQ(>Q5HJ$HTO&WV
M6BVSUZT3BFNYVJ1<M1KMN@1D'XR7)\5:21_/9E)]1NSF[OBW#J$%D"2UT-5"
MMU>A.X1;E'6F?89A&A^[V&#[UA\3[`>ZJ?A:1;=G=<."AY>0^:9K=\QVNUL9
MWF_5WM0"7PN\;3=:U<E`WIVE.^33C'8;(8$&C6+<OH/R,[>?Z[D+(JNRL_.]
M*UZPFW\0DKG5&XJ#D=E6H_T<A*M])R`_*W&X&#&>L@4^8%-0Q)UG,`H.<H,M
MK*]X=Y)3;&WI)4\U;OQQXL8+2MK5"?Y4]6:X<@2MA6'YLECD[/*">2D.M<O+
MQNHU6SL#8ZL$=2JWS=IKI")MEZ(#2^0XAAC/(=!8R7SEYZ?H+T[^K5/L#QR@
M7R6U3Z=9T]K+Q/$9OE2]DT5I3GOE*<\2WP^.])*<_$-NZG!4-!Z27CJ]OX_8
MO9L<X`Z^#)+("V)O<'BD_^;ZZ9'MX".\N+I*DSAQ`WS+UDMIZKN+:F5.-<V^
MU3<MYSEU,U4X4%?H7J<J2^LTNDMOWJ-8U9J&(Z"A+C<Z-K-44;+66>1^VS*M
M?JU5#W3YFHW>0:'_U324T?#WOU6!BOK,^>)+OUX066M%B?90EW/06[U>PB-:
MPIJ&?=-PJ*?)NF"N)GNS$O7&L9JFW;8W5H9V",P_!!HK(R"MAG5<TE'34--P
ME(?GJ0O;8ZHV?$%DK;/R+=-I=\Q^[P`:0M37M:M>USI+-U([BE6M:3@"&@[U
M@/T;BQ,X7:]K/?=2NWNH=?*'2O=Z^51.WUFEZ?UQP"M4V\0?C/0X#7OI2OM:
M<`Z'R%JZ<1RK81^#6JQ@0.'O?WONVGP)@Y/'VB>JZ=Y&UERG:?;Z]A%L_9K(
MFLB73&3MQP@_9NE(784%9X6.O>OB7>70LPK'.$70K7LV9D'RX2E[Y-I]PH].
MO[O14+R!$NSCR^":15XXE'7FHJ*<OCQW$_;1]2*J.MQ__]]%*%IBW9JX;CL$
MLY(0/^V?%NZ*J4TQA>ZUII82[V_M]_7VGEY?H,,4H%"](/6"[(TCVT<'V@LO
M#Y"F0O2?&4N_`LK/$I.X?8@8%>JKAIB?X?</<>ZCBV#(LQ#5)RI.D/OTV4&#
M^;RHUTR$;,!SK."2[5]GS4;BW/^D$5LN#O=\ZLDM-B:(N[.(I?N0Y.(SP[.(
M>$ZNQ1;(:38Z"['S:\YOA-&+ZRDKJ`V^/WC)SK2!+'2K%<(.Q;+>__7^WX@W
ML,6EN_@Q80.\;P-?<6P:3\R-"A`N]R>U%3F,;X'SK4:W0F)[S)QV#E-![-1!
M./<>O2$+AL:3Q_R%17XO3RXW=IY<J81Y"YOAIYK?5>)W-8,'OX6^FWB^ESQ5
M25J.1C+MY3/0:@WP'#ZWEKXAK_#.WZD?\-6+_S)&$6-&5`A37._^YTOE"NG5
M]?9_%J/;2P/*[GG_%R:^[#-51<^948^<QC%+XL_,Q;YUPZO@*QND4>0%]T""
M%W\+PCN8_B..<QE,T@2^#H,!N!%$>-U^[NC:S[V@"L-5:%BA`\Z+X4D5:'@I
MZW*HU;!H9PPR-(:P,6C28B,<&6`!QV%@\$MMV2/5^!8C]L0-S,8;P<R``MT&
M&62$8N/-)_;(?*.U-*K,7J59"6='6YBEVVJT=]A6`Q^ZPS\P!<3@:1^&2O5X
M=Z=FF)ON.LU"]C(KF:*RY&0J)TM5T`('K4:?EW:U]T9Y2I!55E6)$*\WYT-8
MET.@L?*RXQR3[.R\:E8<UOK6&DU?UUFY#ZZ/H)T%'90,-QCB'TO'GI8K=*IJ
M(^)U"%J'X1M&>%+=P9N[(=\VK7['=)8O):N<"-1BND\Q7:-U]#KD-\V.TS(=
MYSF(<Q7J=OVL2YZ]GM%/AW^F<8+G<B-B<>HG>`(?P>^,P0/&I0TO,$9XCG^D
M<_P;=^E3=T7Q#:I`0U5*CIMFO^^8;6=A7NNQ,Z^6JPT[(9U.RVS9!]#^L8*P
M.\_E_E<V#D%;8YCU.X^L&NDD#$"_3]((M'I1O_%ZJQWH5GN#L("6V6_O#N5U
M'3(/(U9?(1JJ(E\'U:?GL+SSO_]M*64^\-TXIOLPS+HPDM!@_TZ]Y(DK=28*
MP0Y<I5<WPGAX+3?6V+(U^VO)/@#)?M,TG7;;M):'M-\Z][?@#!WAD42[Q<A=
MPQ^9P:I1\2IKS*H!CO<"X&%KN=]0"*W7MLUN\QB`VQ=FQF\X(?W]W_]6]G\9
M;B1F'CZ$/O`LOJ#SU%<&9C1F],7-Q/>2PKSVLS0&_I:FMC>=V<]?O0^!\Z,P
M.NE8QAO[YX[U5BL*6$R'GKJ/7P8IPXG?!Q[.^K/G,R`I8)]9\A`.\P_\APT+
M9]'BV?FGDVA>=KXV!2.%M]$0WV[.7QE#-O!`5&/,0W]O9;-9G;PM3"Y?>M!Z
MWN3:%ORG8A.DU6O*U6LOKJV8-\%.N]NU>A6;X<K5(_-F:/?MOM6R-S5%H!'S
MNB+2.5A>=\TB_,"]9_9&ENN/F3=\>+I]FK#3'UXL]`^+9I[YS,9W+"KZ[0<6
M#![&;O07#7#CPE3%PY_=/\-(CAC3U[??0_5!R3LT9D]`3>O<;H(V:/2Z&:OG
M,>M93%U50@Z=J=W6BV/JZ6``I]TDAFW(/#+ZVQ7;_M(<!AZ[DV$P^]B7%-]T
M-5*TO#2%(!_5N7OYY>.K]\U_O%N29>^?R=UJ"7'-W<-4$9MD];_"Z"\XPYRY
M$R]Q_9LTFOAI?,Y&WJ#DD'$:_W$U*F;G6@Z0W>H[S79+4#Z/'$7SKU$8Q]=1
M.&!L&'^$\^JW`(XHWR,O25AP#2=*;W`U&C$\F\&4J9J+3BRGP5"5<\T_/WT)
M'PO.3];LY^5S.VF_>M]O6=Q%WQ39NV)!RP8I+;``V;ELF>5%%MA-ZT!Y,,<*
MKL`#$/%FI]5O;YT!M^%7E4/SE8U=+X`A;F`@%G_8G=3#=!VK;Y<L^#(TZDZB
MSJ?+.$XQ3G\UNHY`G2;LVG<'5+19.*N/O\\]:-^PR0I3:MKM3K/C9#[8<H2I
MA=(?A[_'7AR'T=.7,&'%2[)1XNV>O@'GD+(,N?C15^;#+(?7;I0\[8!\:TGR
MITG3!4G:XFOW"0WQ61I%98*C[-L,F6N2W^YWFMH!J9B4YQ*[&6/<[5J@JE:D
M-4J!X5$X8G$,WH;K?V0LWBF#FVT]"C:?HDW1OBGGQWH>[>#!NZ@]=\COIM/N
M=NP9FJ<H>2ZMF^&OT^Q9_=XJM%YB422+DSTH"KO7U;9>,2$ZJ5?)`XO$C#YY
M[AU"Z.U6%+KM7/QY/D&;(GU#.\\"K=Q<A_9S=I=<!G$2I6CBY3)]!;-SDY#M
M4=&8.?.P[>(E*/S\YB&,DEL6C?'5V?DT#"BU`H2#S)\0E(7QI!;&D^RF)FK+
MS^A][IHJ_SLD<$-H2]>V];F,/'Q-^7)H3,'^+C%>7L%G,1NDB??(;B,7[Q3/
MW:?-!!"`U/9Y&:7+T_)^^NX/74HV/$_Q%,`1M0A\*^9#HF'`LX$:_@9O(DE>
MUW'P[:+/UY"Y/W3GZQ8!L-P!88-]>-*_H8&N83((`9R</;A>-'8#.-Z</7AL
M=/%#L`<.0=Z`13/B'!,C9B(?+;MM=^VIJ\NUV?CR%N0T"%$#7@9#Q&9.77]9
MQC?;3;O5W23CR<^7`2O^.S[>97##DL2GHU7N]S1UD""AOZ4&FZ]_*\/ZK>V%
MC3'R):[*LS?$1KF_T,)D.^L:FZX47Z%5C\OKRSZX='],X&7$V:G[LE:CW+V9
MP[-C9O1B<3X`AA:%(I<+46YC9K3!2W_Q,8RN`D:OS,5QIT;:D/@L/UM':*;G
M$KXB!T1T=Z^SMQJ6O=+LBXG6[]BQ_$D]=Q5]Q5Q%V?ZJ.'LH\_W.V6`V/&IW
M"C[_Q.Y=_R)(/+&9SR(V9&?WEY>7GY*AO(XL(H7?\E)\78;7ES5C=K>7W<K-
MG^?[';-CT50_Y.>Z#/N6X(?=Z72Z.^1'<0IGK^#S38C'-,].[R-&'@H]([[,
M+F\XZK-Z:&G/M-?M-.VM,_$9&7J2\!^Q]W/@^?]\!2J"O7I7C%"MX$D4>8O.
M>YO=\Q2>P??SY%Q$[@X#1#'5%ZW(T,^&=-N6TRS*>2Z88B$O=`Q5_$`D/0\>
M`N_?Z<)C\/[8\OZ#%X1CS_6-3VZ2H$D:AT/F%[!BP0QS(0,4HH4&KFAZ>Y&&
M4H-I6XV>-841KXS_2I,MRALHRR?XXR:]@T.!YT9/F*`$AR>Z_\9)E-^5K^C.
M6@NGI:?]IV,.<B_[U\G^51@BK:QD+\@HU#FP[%R7Y4]I*+@*?'E_[?S>^6SW
MSI>;_W2\N>A9S+#Z"*90#YU7=O[E<N%P%[G=GL^9HMDN*QE9KZ?#Y9'=L'MZ
M/N[R\UW,)>[5'(/I<!KMA3S29KLIUA0ZR`?D."\PQXOVY@Q/>=*,NL"[&G$"
M;L-K09"@\.@.(W]\181`^L%G+_#&Z7@YNZ@2]99@6LU@P6#WQ[(,MAO6.@P^
MO8>7WV-NG7B`!%S-4'4</S8FKY!HN22+EK[:_,*^TU?;2!HMNSJ1F8JK$?A^
MJGRV<&'438RZ:SQS?9\-/SS)91(/%L_W60'H9:?[3,+?[X0'NS_*E47D.I;C
M;)A]M)/0Y>>"E@4]Y$/+1N^6%Y/WU^W?Q19>ZL4+5SGG`\P.M/,+EO:B)5I$
M\#9G7+7`1,VL@H"]^@&+9N\OYO/3<3;`S]Q5/B9L<5O]J_?(P&?1J=N@5G`P
MLVSY-V>NTG!(9>.NS\UD[A)/^@:?O/%"#(D-6CJGJ:7P+T]@P9Q`/>YA6DO>
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M(XM.?3\4F:1<A57`-UC"INE7K.O-L_3T=U2,ZG:<&3ZM.M&%T#\1IYMG*56+
M+7.AKY:?5.%U`Q:E3"5(3(=EJ\",LCN+)<B?F?;<2X(J3'9Q7*_;FM4<<Z<U
MAPER)Z%W`3LGMWLJL?9+N+_]YAQVS)W@/$,C0P6705ZE+-2<J\"[;94SO>Y<
M"S-W@J6VY?#98K>;O5*+LAQ39B*$\F=@<*K.E55A!.=.K51,Z!3)AJ<Q5@I[
MKJ^?:"J@5E:+W93F";6ZS3)!FL>`A:D45VD2PSD/85PV#[=4,IN^T[8[G05)
M#1IAFYO$.L!+)9/H6)VFDX-B7V(6Y3=D8A%W%,AI]UJM7K<W[\I.$#2?:G"+
M1LQ+THA`'RY^3#R.U[LA:*+%'KO=:;?G5K264IBA!U/+%M@_H'/<>WY`E'?J
M<JQM;I)YI]<^52"L0>969K<F;-F\5+'6UF>WI8VU.`5N10)7F=/62H>G9E50
M0;PLB6=X+L2KKJN(-MUN5\"V&ZT5EF"6V$V&ZC7!Y:9[0[OL#WJ)PEFY&$_\
M\(GQQD;\U<(#N?;=X(L[YH]=$JRZ]\B?PZ_@3-->NOK=:7?Z>N78QIFS+\[/
MD<)9K;X'SC?[5M]R.@?"^?S5#GGZFVEWL`?.PXG%ZCO;NO8BWAP$ZV^]!(\^
M&?Y2;@GB[,X(/:TO87`BO_H0(G6C<U"L@R04.%BJI&BY!:W>,LVKZ]'(7U!N
M4<D-,`<YY+E<U?SQC5Y>[T,Q.%;3;MN;D[@"WFPDQ44,_QN+P0W*P_D=+.^;
M3M_)X6)O@SN;Y/X71.!:<@$.PQ?L=YJ]_K3X;YY#6W((IXX%RQ;G5V91YAU_
MG(:.A+0CIE5KG2KCSL]?I^X&'99MK%.\DI.T\EI5RM+,SY?I32=0[H9M&UTM
M.?)Q+MASO-;%G%.!XZ/DW32VV"I>[89YMR!Y<H47<Y?N^-?+:=BMN8F=6^'9
M\NNTU"M))9Z["6)RP7$Z]@8$#'38*V,U[-ZR*_,<+FUL+90/OLIR')!GC&UC
M-K0@BUA5D#][^SW<0LKZ'*>E8\WDO@(-*U"VI?L9[DXMHFR=Q5F(*+;G-=C6
MG/;(N1W)R#8Y]^P0QB+XS6)(DI5E[OUUZ_?^9^M\`T&7A13OD2]K]+!R?K>M
MSYW],&9SDKDD-N\S=!4O#MQ&@/]9,WJ&#MG/C)9`@7WV*DV7<$Y'N[<[IRJP
M\-EB,<7"UB;"HA5@X=)HS1N400&M;+>VQ,)%F,S[8>`&)5!B4V\BAV.G#,S?
MQYRFR4,8>?^96^G9M/_X;[?@,%CX^1[NKGHM^L\&5J*,.?OB?&6.X26<;Q/K
M-W'ML57."SS@_#NN621Y5/VXU#S)WP3[%W%H(\O`1Y5-!P\\7Z39:G7;F_!`
MBKBR07;+"L?AQS"BCP^6XX[=:CK=56[N5N3,3$88GPG2B2YA4`)*ME&,BK;C
MY+VR0CK6I'2S$!3=EMWMK$*IDA(6/2*.4N'RJ4@L+4E\&R;Y(JBS,$Z^A,GO
M#.@:A/<!&@D]0V\7S=J;7:??[FESW\G,-I\^QHMH>#`DQ(_*LPZ^LK'K!?`Y
MLC1R!TGJ^AN-^31_;WZV-Q+SV?@4%X1CIX91-PC*K5?UYO&\^I6-JI%.WVG-
M#U6O3O5NV+!1'65;W4[;FG])]`Q&G$;,O1I=1^&$1<D3U8)>P9\P;'#_B;D+
M02S%9*::YK1G/]>-X[]'R=0L6SH\[B*2="WRB<4Q8_@Q?*O?*^=_$G]E`?O.
M-\/&9H31[VRSKT&)6@5<4?@\X9G;E\`HS_7I\8T2/!=9RNG;CA2S^?2\S[6&
MF)U>(@SG%S8'$4M5-9?MCV7Q3YOM9D>+1,XEY_VSZ,[OZ];SZ&[UK*:>K+U%
MNC>JENVFT[:</?#[F7JTU6UUN\T5Z*:-\)4-TP$HUG&8(J;.C>N[43%*3A9G
MFA8#&6>:_;RP@&5.K_:I?C?<9:-_KM#BIJVIVL+IK3UYRS[Y;S<X6:9*ISJ3
MO'V`<]1#Z.O?STV#/X`E;DF0I#DS7-1R]E]>\O`M".]B.`^X=SZ[#";@=J);
M'PP\W^/Y<U\11Q9-!!@,+_[DN7=TU[`H-6>.$A7)T-KGBK@/3^H%5%I/##IG
MD??H(AL_>H$+I+E^UH1<4>2QPB87,V@@3LMQBEKL;9(O%67\K.SNCO%VKVUW
MFZT7P?@ETO]WR'BKWW'LHB[556-\R?B_PG'W4QC'E\'`3X<8?;QP(SP`+U-)
M5J4]8'C#?[[Z&(9)$";LQ/X#KX<[G5;+[CQ_<5;F7547;(F@[MX6S,:2^+[3
M=HJ:0.]BP<C6;_B-7]DX?'1]!6+S;8*/RO:*![#%RA!#JL:G*DDV-L&T^FT9
M"]@IJ[:W0`-DE0>>-CUV&W)L4'S[W'8MU1+GO+OJM.$DOK5E6LPP[:"8?SC#
M@D,8/37FUIB^`IN>02H/>_WODQ-#JGWCA@UP$./D!'GA>\%?/X_$=Y_@'\8/
M^BAYFK!_OH*)L0"T]BOQ:13Z\.E#DDQ^?O?N^_?OC1]WD=\(H_MW3<MJO<.O
MW^&#KV:&S@T+9[L0-@^3P_KN'?-UR[3*^^0;X#=C'X8*[H'NX.3;S:OWI\,_
MTYCP#PUX9>ICZ,08`<\,V+C!/3.\P!B!#!J/Y`I[L9$\,,.E(Z<1CHP$[XJ,
M>S!AL1%&A@]V#([9(_@3GYOPFW0W22+O+DU06.$7]%4V?!I$S/4IWV1ZG(CY
M%,S!'WT7D.!^MIN,!^;CZ#1@Q"9A1`\/,<O*#89&Z;CB)_0@3(()46@8M_`I
M/BR?Q0E'L+$B6&&DM9`I,,(T<4_X"'%J,`C'$S=X$K!G0PQ%T?U"'/H>$C`T
M8ME3/L:A0A[!@@<:_WB7$Q`E,7XXR`D+_-M-PDB*Q$.$6^;_Y+R8O!C!__R1
M^_K=C#2>1OEWN-%`#@)_+I`Z\<2[D3M(3C3IXV\`Z2H@0;XMS$LYLC[ZYRN[
M86E$KLR`YGP&-/?/@.:R#'@WHX]TO_Z<C5@4X3U2/+<W\<9NG#6_./=N)`IY
MXOTLB"#/.G]7<'(ZB4X*W*03(&'J\\_NGV'$+T=8Q(VN_-=5P&!8S-_@^P83
M%&7C\>G//SQ]8,'@8>Q&'%:58F;E#ZLT$OFNDA>]>B_FR@B`5?X+D]$3L$DL
M,N+!`VSQG,3$;-"X#Q_?G5W^#[`1_M-U'`?]L^D?R^%B=H]:@O]S""_[,?&]
M@2="A\;0@V]CH.N?K^2*S'+MU7L.8KF0=YR,F;>L\/)%S'_U7EVH9ZNPE=?*
M9<S>N&`]2ZEX-[42[XJ6G5L]M6J)&]&U[7N4Z!,+_FNK<=1W2GZ&VJ.=$[PJ
MSW\C_RU?\BZWR6#7_:]_E')"M$]R[]F<0J$CVI5ST_2MAIWKS%+.JPR<=OHA
M!4(N6?#"V"J?G$62EF"Y"SDVWT[P(\,)'!E."HX,!:Q[Z1J_5KJS2K=U8EO[
M4[J*_><,6SV5`^A76-:#T!@H%0<'+3@J,LJ3LJV?\*AT#R>M!%=P)2[D_=:[
M)`N9G&%"(ASFX+S(_T1IHTK:8L/%?5J[I+5DT>?+MRQOZP[NDD3.5VH67VB@
M:=8>-(L^SU\>B\A&%EWC.6!3-\E_%'=()K$`*6;Q!QDA*6D@<`:>/#N[O[R\
M_)0,JZGT>%Z9SASAWB['H@VHO3(>"SH*.;W^:X?,^WEJF:0_/[M86_1A;7MI
M=0J/-NTUU"G-*O/!9-^KK"_2O`YQA[O!%A26JN2/)3B3Y8+>`^'WP/>IOJI3
M*.]'R\G"FQ"M5]V2_"FW5GHEY`W&\H;9\LPW5X6-'`H_OWD(HP2S-/'5F>'.
M3-"7,&'QM?N$,5;!IJ\8/<4,]"AYNH6IQ"Z%M>,/3_HW--`UT$^:^.S!]:*Q
M&YP&PSGI3'/DM,71;TJMYCQF[0.?>M4LRJKC4V/]QR8JD>;#4R][8BL[["[F
M9TD:W9)LJIBC(E>C<*[9`:EXTL]W4W)<TUY7QKYMN@[+GL3:SSZ)[4J#5$/B
M%RN&MK7%IN-2,^#__:_-*H@U3%]5]W_A5+0`R;PY'?:F)$\+LYRN@NRP3.5`
M8R^.P^B))KR9_;6.P,QS%T_Z/<U=7#@)W8N1WHZH04""JCG'EMW3"Y@+Z-ZP
MV3\%\1QZ/FF\&TQ6H1O]BQ\\!PZS-E`MI8E(YY`I<;*ETH>GX@'T8T>U=<$6
M&9!IE!PGRC0(7BKG9Y%]4BTMLB'>\8J)S6S$W<GQ/`MO%72*W`B3-GP]4^_Z
MX]KU.[U:V=6NKY0<+]CU3<=R6OTM;/I=,7U#?5HM[,QE]QT=]V/G"G#/YN+@
MPB$[489''N5X(:[0>H$/JZ"5Z$MSBVJM4`VM4+M*%=(*3:O;`L?I"/RFE<IH
MBGG1LEM.K[E3#<EOW61*Y/2M6QTN.OJ#8YL2H9N'[B-56([W%2Y:=/]3*9;5
MSM%&G*-:)1R<?%?PV+1RG42M&2JO&0ZK8FK+6J'ZLGW$QZ9GP"7N.-R\*VE<
M"ZJS6D?(JNRH^@BYCXR#VC(<Y]TCY5E11N%U%`X8&Q**"T%&?X=!$Q9<IW<@
M3U>C$4.,FZL1##P.`[)GI\%0E@N4M9+,0)8+Z\6:UJ)Z,9T1)VVP!;:.S+D9
MRK4M@?\?_OG_`5!+`P04````"`"S@`I'B3(B->H(``#(;@``%0`<`&%P9&XM
M,C`Q-3`V,S!?8V%L+GAM;%54"0`#$03)51$$R55U>`L``00E#@``!#D!``#E
M76USXC80_MZ9_@>7?BV!7*[M7:9IAP!IF>$"`\FU_72CV`MH:B0JV23TUW=E
M3(X76Y9Y,8+,S23$:*7=YY%7J]7+_?+;R]AWIB`DY>RF='E1+3G`7.Y1-KPI
M/3[<E3^4?OOUVV]^^:Y<_NNVUW8:W`W'P`+G$Y894/"<9QJ,G.9_Y:9'`RZ<
MS_.ZG,N+JXOJQ7L'/_9)$`J/S'YP:N$PE(%3_?"#\ZYZ^:-3O;I^7[W&#[5/
M3KFLVO$I^^>)2'!0+R9O2J,@F%Q7*L_/SQ<O3\*_X&)8>5>M7E46!4OSDM<O
MDJZ4?KY:E+VL_/6IW7=',"9ERF1`F/M52E63)'?Y\>/'2O0M%I7T6D;R;>Z2
M($(J4R\GM83ZJ[PH5E:/RI?ORE>7%R_2*RD,!/>A!P,G:OXZF$W@IB3I>.(K
MM:-G(P&#FQ*9>*RL<*S^=%55TM_7._>-YGV_V<`/_4Z[U:@]-!NWM7;MOM[L
M_]%L/O1+CJK]L==:,8%XC,@+EX\KZMN*0345I:A+?#?T(T3:J-:*PO`2`//`
M6ZBL*MZQS:A_<'>E&5\QPL4J,'$K$>P#(I\B[$-9'A(RJ2C`*N`'<O$D@K!<
MO8PI^#Y^_*4F)02R'@J!_7W1@$^>P(^:_9)<KE*PEG4B1S7FJ5_-?T,Z)3YJ
M(6M!G0@QP[?X,_%#T&AO)K].=TVL&DB$NV@#/VYPO?H"Q"4J,AR/H]K*-(#Q
M0GX@^%@'\*)=OHT=#A<>"'1TZ.="B4KRB5*`^"7G&>AP%.!7A5-8<UT>HK(]
M<`$5?_+A'@*#?J<3LY\PO=4Q3^]LXJDK8$*HUWR9`).`G:T3C$"8N@D3:?M9
M,\(@)N_*)O+F*F:Z<=3KR`2DOB^)&&<XLF)?#SX!$<RZ/F$!]@SEAB<J5L3W
M6OM>:,2L94-OK)GW*I*<!DRXI#@@1E;=<^9F.JQ4$6M)23?2S",52\@`4#FO
MSJ76+:V6LQCZ%7-BO-_;@_<=96A?FT[!:S&<`PXI1AQQ1]'ZIPQ!:QG),CBF
MZ$=[*&I3\D1]&E`P"*<2"A>K[2)^[9*9"EYQ#,`G(@0OEQEY:CEB5TNW*2VL
M-X+%OB#FG@>PT+T'B#1X72(BI7TB993RRF8U3RTGP6HN6&R,?N:C4P^FP$+(
M)C!%X"2X2C/6OAAHR28S3V\)`6G(']K%;29\U9,O?Q(A<!:R:'VFC>ZS).Q$
M.--.^WQ./^#N/R/NHUY2S0Z#F::/)Q0N>O(>>XU(DZRD<5+I(W:<=*@3TE>;
M9MH7A=3Y>,R9$14;14^"ATT#[7N!:YY'YSIT"<4Y5)U,:$#\)=5U<7VV\$D0
M90*"?8%%#P)"&7A-(AAE0XE3D'`<1F$K1D?4I;K8ST#X)*@S`<&^/,U2$(!S
MQUR#:*:H';&-UBQ-2&GK0$6#<;34RKPZ9P'V-&"N/J+729T@1UH0#,>U4[,Y
MJ:3A.%!9VS;RZ[???/VWR^87SCRU**D8D-RGGO)T_0!_1M1T!IT)B*A5^<A(
MB..:VIUBLAUFFXKWOT%F&RT*7F2-56##>'U8YP0VRQ:])-P''^L<_@X,-?%5
MIM(;4T9EH/2:0JR7;M9F5L%15_53*=EXHPW1L'$'30\D(#!J`U`#IN#S:"DV
MFT"]W&GPEF&[C1MI&C`1X-(YJ-C1QEP$]+_H3_UZ=*K4:5"EM=O&33.OEK48
MCD/0YM+(HR^5+CCG1GR0<=Y;OZJ[7O*((9@&Y`T?O6Z?X8S@!$Q+>(FR75>Y
MZ/G.5SONT-AYJ!^BTE]CKUL8<`'S<@_D!63S!4=0-(4R(F8MA"O:F(*2B*0?
M01.``*GKK(=L]8B]HP`P4WO9<H>T;UJ],&.N9?Q&Z!U:JLC;(C@=.?L2S-'6
M632/KW;*[+`U0_!M,9Z%XCZSTRD+L,K>#D-KXX-4G4$7K:=2<C&+=DZDK<-F
M"[X-+DU1W&>Z.H7+-:M'A`W1PCM"1;10U1FLKT*G<9N_HC?$]18HV[=?$8<5
MHWG1:KDCLIRH\.8(>L"N8&.H%9L1#QBWP&"@71],DS@-8A,L-9UGI2;N#YFT
M5P?Z[GS^O.^<?4*]Q:?L$Y0H.,.CSMRA$CC23BE:=CM[E&J_^.L\J>8&=#K?
MT9;@"?1.;Y>*B\YT;>O+CYAVW`]U&SM]5X&P,=N_G$;%SSYLGT=.%3]#9LU@
MLW&]H#\B`FY)Y$C':NS*HCA%X`Q)38-FOZL)-LZ5SH;*'2=$FLEP>0\<'S2W
M<5X<FB<P-)/8?7"VM#NS)64(WAT7*@0-?659'\24NNG$&4J?&WNFH,44_F33
M`!GAH+H<ZMS@X5,P"/W%03S-,*D5.R-^S6"*B?W9)F)Q6!"`HWL#YK];;//:
M%'VJ(EO\#(DV@RTF_,.>G/&A&(^O7%D<ZTN\>B57'S"J\$WT"C-HXW[RT?)^
M8G+R>BM?H:WP3?03,VA?<R5VCR!KYX-S=8EUV3?!_@9@"Z*MRHJEH-'"V8@\
M1";7M.*"S[&2691;?^`U]]^0"DB]J$D7%YM7<MQ%GST0OA$CYP`P.SE<^`:]
M#?77[[[)0_N&[/FSO0F7A;LP4["XHXPP]P"NSK3B';>>8.O8L@O@14E`M=FW
M,UA*2^#+%V<!4W,W>:JPKS/G)'`E?9,+O`(NY>B&PAV1:#)15S=.SU%6*4&8
M4AY*?S;/,F4QFKN>\Z(U/XP6^JODNXF[("CWUL--C7?*5<T1N\$VYB8L0^\4
MVUM^,.*`$!E'!):?3#X@1,8.:=<3S3MLC.HKF,2L,XAS#ZA9E_M4'2I__:K+
M`\2$$O]UU4*Y2/G(4.O/1"C_V(DTEDNC7T-="^%+HUU4!U=B[UNN#J[QZFGU
M!.9WX+Q6KW<>[Q_ZW=K?M=MVLW;?P">]QV:CW:K=MMJMAU:SOVZ@-B>5A^N#
M-;YWC@^FZ9'N_2_R!M&C6IC;&#ONQ<]/4\:EJ#DO!RR<,V4<CID#D#)2YPX,
M.Z).\`PXU.)BX\:Y6&><#..PEH/#=8$SX6X#!QO/W"\.2QC[S!2!4^<L#0>S
M,V`%WY,0+1=O,7AG")XZAUFXF)WI2HFS7_^K-?SC?U!+`P04````"`"S@`I'
MMJOXL3@=``!9``(`%0`<`&%P9&XM,C`Q-3`V,S!?9&5F+GAM;%54"0`#$03)
M51$$R55U>`L``00E#@``!#D!``#M75ESVSBV?K]5]S_X9E['L2TGO:0F,R7+
M<H^J;$DER>GI)Q9-0A:G*5(-D([5O_X"I"B3(C8N$"`W*U6)(F$YYWQ8SX9_
M_.MU[9^]`(B\,/CZX>KCY8<S$#BAZP7/7S\\+N[.?_KPKW_^[__\X__.S_]S
M,[L_NPV=>`V"Z.P!EUEZP#W[[D6KL^&?YT/7BT)X]BUMZ^SJX_7'RX^?SO#'
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M_#.A^6^DM8L&U.#/(""#YMP%2SOVHQ9I*[?=$J7AVO8"-82F33>B,VGB?`W6
M3P"V262AW284KC`QT(F?P/F>\1;II+7>A-H@C/JM3IE=@PE-&4&BQNV-&YR3
M9?/RA^O+I)7!9'P[',^'M_C#?'(_NNTOAK<W_?O^>#"<_WLX7,P_G!WR2&BS
MW<!&'YUP?9%P)]&,<D*G-L2[R@I$GF/[J"6R#QIMR,3\\>&A/_MM<M<?#":/
MX\5H_,L4=SL8#>>W(+(]?P%>HQAW="5%?H7F".&-2)_"<.TA%,+M.(P`FMI;
M^\D'Q6ZDB)9JJ*&<?[4AM(/HWK.?/-^+MC7(%#31D,#9\)X,M6E_MOAM,>N/
MY_W!8H3'8`U")9MJ.OWLC1?9_CP*G=^++??D9AJGOC+2KAN2=MUXOI,V)QMR
MWD/]P-V-*;3`?R/;2;X>!2^A_X+/ROFR(X1BX"["(>XDW`*`4KIDEX76>U4C
MAJR?_,\U)D#]UG6QU0A&F>8;[[4/#Z/%PW"\F/?'9&\D.\MP7-Y7)#=9V=8:
MDGUG>_";[<=@_^$!V"B&@-PVT60Y"-?K,$CDE@GS$9$YX#T'^"+JX"\>@_`)
M`?A"MJ11L(DC=`]>@'^]FPE2_!Z!C$10^#;B!1[!_QY+I2`O+%`0N,#-)$;H
M:GA\2V[6H5/HQB=WV1!2#[#)X75IHZ?D!!NC\V?;WEP0O"Z`'Z'LFP3!\\NK
MW>7U;[NOK7ED1XG`,&]@A#^BK!???@)^TK?%+FQ=IC+20?&"H"9#;5+0NCI$
MLP^+-.,;1-;:[C)1Z7:^Q.<M"7%E788"8L]"Z`+X]0.N$2-,29BL0#;I+KF@
M?''"(,+C;^@GU?#<!<_DP]OO?HB`^_5#!&.@#Z2!;R,\%Y-9V'_UI$;781VK
MIP(ZSK66`^4>'@&,%!Z8B!X;G#QMMP7E"`65<F'K6@4<+'T-!PN:C.FP4)EX
M/WA8MWF%F3)<BAH_9<#LN3$&H#F`'D#]*6X20`C<A-R'@L:.MIZQ:UF?E$!%
M4R668:)/!L9ZQN7!,(!N:@%$K65]/BF`6#QD`%UI1ZB/$(A0_PE%$%^-.:`4
M"UH_:,2AROFM1+9IHA_$D&A8I1$X*&_]J!&(LG!Y()0I-V:=&MAHU0]<\L_P
MC]A[L7UR5>U'`WP_W>*K:7*+Y6W^,O6MG[1#18&`L?]+,F0,@GW'"6-,X@PX
MP$OT!F,0[=CES2E.->OGT\%+P(<YBQ[>$#>VYPY?-_CT"O`0FT0K``O<<N"2
MJ&U=79X.;)+\9/#UM,,G"]0!"TIT/(IFTB'EF?"OM0M_"L,-@-%VZMN8D\`E
M*_.&G(/P7.=.&G8UZTJ)#J?E\X.(`W.6M]S\'8>!(WVVX]:SKM1H=MH%2<B"
M.:O8+=B$R,-,'5#+`8A5Q;K2J3(0RYR.%8\;8XYTM[NK\R!$$4\_72AG7>G4
M$-3'XX`%<U:T.R)%<.^]`'<41';P[.'#Y8Y%[K;#KVA=Z=0@R*YI8A[,.1VD
M9`G/9-;5Z6@,"*V9@#]I%W#F"D44KT&JT%N%/B8.D?-(M)78YF6;L*YTZ@JJ
MZ->J<&3.`2!'M;S^C5W)NM*I*J@$@1!%"FO&G`@R+<?.9Q)SB[^!,7#+]$OH
M?"1:L7HZE0D"5/B:($GNC,$V[PP[`SY>@=RI#1-JB=DE"9018UNA%:NG4RM1
M"]N*W)ESB,S.MS/P`H(8B'&D5[!Z.K45M2!C,V+R;EAI%[1Z.M43M5"A,]'&
M6;[LE4F^L0Z]Z;DZ!T$-JZ=3Y=#@M"'!ESE+5HY/N=E@]71J'MH]!!)>S%F?
MB,.P%R7>P\0F&0:1%SR#P.%#PZEE]70J'UJ`2L";.4J)6K=DCDAZ.I47+0#'
M9\T<74?1;TGD_D`I;?7T:C"X8F8:8VE<&'-#RL5-"/U1#HI:/9T*BEIHT%@P
MYW30=UTO[7IJ>^XHV,70Y8CF*2"$E:UKG7J'6GC),67.H6)&0HD"X`YM&.#-
M$_4=)U['R9T:W]D\Q^/M4.+*UK5.[4(M!.68,OEL4>E,85WK5";40HC.A#FG
M!M$!J8%EQ+HV1,G0PNV*R6"&Y&<ZDA?%B,>CQT`>Y(+H(B)E*>XB(KN(R"XB
MLHN(["(BNXA(Q:M9%Q'9142:#-`)1$3Z?OB=)+B\"^%M&#]%R]@OA]=(N)E4
M:>=TXBDK<F40KGEUQ@8"QTORD.+//D@$'KC]=0@C[\_D>V;,`=^SJ)4NM`9U
M5AH-[3%LCF:0X_2;XS?/%V=(5&],:YAH%?!KL6:.^C#G0+7-I8:[C<$=%LLB
MS/\N7NUKM*8UOK0*T/5X,T<M>0N>HE&`(IBDW;ZS'8`'92SP/Z-7T1M=6@4T
M'@<"/:,V.S,>01.8,.DF-K\I@/.5#>5-SZP&]$:@5H%-GI\,Q!\,`S$A$/7C
M:!5"[\\W_;,0O,.*>F-3ZX-&XR,#ZT<CP4H3GU8$*JVD-S:U*4AO/&0`_60D
M0),X(H\ND"<E*J*4JZDW5+4I5`>,9'C]K!VOG(=#C?U+HK;>D-8JN$DR\Z83
M,`F\"OL6IY;>N-::8-&8V(.D7W-3HE2X7S%JZ(U];03.&P-[8/1K2DI4RNU3
MO&JG$_DJXF*/$T/5H=:;H\+3&$<?-(&#)0P3C=#,0[_?2_ASL"MI\.LH$2/R
M[Z!7T.#GP14C<YPSB#]MOX\26S?;!>Y3X/G!J66`[P<;*DEH"]P88S,MLX5[
M%+L?L&OI]@L1R%UV'N;Y><]@&>(TTCYJYOF/#&(4A6L`2V0+710$-?7ZD?"G
M#@,Y(4/FH%8>F3<@<%9K&XI<&455U;B7''M7.V3)'*^$,K$9J=77S(.JBGQ*
MFNQR)1QD$2QQ9O#<:Q%`<W>^UI`T;P^<VSY`8I>\MU):W75DY@H=FR('QHB_
M[$TFQ()51:LK37U@..R8LW$]V/\-879&0H)31KFP&N<7I><**A/FN*V-[368
M+`M$"G<@9AU5?B[2AP>ZL.G`<+DP9EUK&Q]#S@9M`=7F.8"1A"GK<Q(`^?NM
M9$V]'D;\&5`$HP)#;2QN#"P6W\/]H*D(AD15O:Y#E=&0Y,B<S;]$Y!1ON_@+
M^QE<<98S7C6]CD2M&$8.N#$8KK>C*$`.]#8")W:I^GK=BUH!D,66PG6P1,,X
M)HQ.EOL%@;DG"6OJ=1RJ@D@%A@0!!&6K>KMV]2GFTT,HA-M\,M:#=[R/K;!8
MA3!:`+@F/M_W,MD1J!5T9$AP5L"-?;Q;%D@2YDO@5-.1/8$E3I;BA4_^:=O5
MBRR)+>K4\@;8TD4@,:!E<&/,+;1$H/`.RJBAVX;.E+0D,.99SEN$QA#=0%L8
MF6<CP&>5%P`C$O&8/P>(K>2\>EIMY)P)PCP]<UDQ!BM&^"*ZV>9_$6Q3\HT8
M8#&OMW=58M&<RVV>..&*62ZLVTI>3>IBY,RSD#<&R)#=3!521]!\3R%`GDOR
M':UL#ZYMDIAAL/+`<O@*G#CR7O!2L?0<`/F:UXK-:+6+T^<$1>U0G2EU./6#
MD+P@.`I<[\5S8]OGX\$HKM7L+2UW-O'F["UM9@[0FNVAHH:"PX2IX(R""."9
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M63"JS-LV6&TC>5`CA'>/*K:*+KU-S2DTVD>6S68;*888J-Z'"$V"_.Y_X%?"
M@DY847/^C"KX2/%B4*Z@;)<>OFX`/KP3%CD['Z6TWF?BJ^YQ#`9$>8'4IC4Y
M?#U6K^/5+OWYCJ@)G'G/*RD'+'Y%'2E-:`0)TYHP*^E(;2(2*<N,S6/"!%<L
M!)R/S^$+GE<>P?,3^4!@_)2#$7]EW8-GVQ\&D<>T95-*&>!HQ0>@"!J=@Y8M
MG;("3VE@6C0/B^ARF&+(K"S8`V)/1:J:K<,UQ7N,<"<(7#!X'HU&]Y$KB&\J
M%]7BC$0;AI23(YU<8QP>J"N:*`\'JXX![D155F@9?LPQ(5*IE'W8BE9+MS<1
M5^P5D#+/BT@!5(;X%;6-V1&VEO0MIUWW[%P9S+)Z,V;P!SQEOV&PH%J^-U4$
M?%!8;^J+FA(N\]#&5L'RM7J&(+FU,7;F<B$3<E94V(JI#"@,9=QWQ5R5:<6T
M99J@BX<GPE:32K0M1,V;60-I'F&_VLV7&=C$T%G9"$R2IO>T\!=8N=IZ7(^8
M(Y0B>GD^C#GU[1-RIX^D#\+U)@SP?T4)A[CU%/D2*;]3"9DRQW/L@$+A.9U:
M7I6C3_7WFYD"IP/%Y,:8>=46/H9<H=H&RKR`P]U"(0PP+)33ZS[%G@5T,$JD
M&R/\F1T\B^+8]V44>3(IWUT*#)CCA)J0)1SVN5*J?(_D(_H*@N0(^XU>LT9Z
M16D;L@=4%[MYJ_P#%MTZ7@L!*)33ZY)U.)+I@B\1;([([5<YD>?+Z?6RDA3Y
M(<$*=6G4_6;XBC<L#U$?ZI*HI==;JJH[B21#YIB^[FP/)B_S]=W_QBA*7=0S
M_2MG'G#K63V=,7)U78"$+)D3'K<G]0'8*(;)G0>1+Y*D:0O@K`+OCY@;?"/;
MA-73&4K7&$L)[LQ1ER2^R"R?[7(AJZ<S&*XN-$7ZS;EAO$U_A.)U0@4B3J].
M!-Q;$IL.`I<$SDHMBOPFK)[6)*>-UT<Q=^8\+<^C6A!7+*IJ];2F.E4`8\:5
M.=%G-&I)4M`["$`^G+TBC+0FK)[6/*DMPLGBSISGYWF#\%OHXUV:N/4W6&Z+
MC5@]G8%H*F9JF3]SGJZGTYU>?T2G&V%=JV><TU!M*`_84AAI-@J<<`U(J-4=
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M;Y5=<]R]CIS6^%VDK:>Q)?#T4FO"&=@;+[+]9!4JFFUZQ[?;X)EQ8R/@DE`W
M?`VQ4Y0AL1X3.=YLWXI,[6T2'__=AJZ<C:=IXYKM00+R$8O^*L:C1GUHL32U
M`*J$5:JI7$[<A!4_X1NA9\/MW$[D0=8*D1F+5<<P4U9C9!F#A\.^,=?E'&EC
M>XT_YK0X8EN+L+)VBQ@/`P9L,DS]=?`S1-&H",@CZ!D?\4D,?L<W-7PFF\9/
MON=,EDM`+GE\Q:*HGE[+F-0DH=R`)+CB0G'XY[@&SOVS%>D%C@Q*!WI/P+V)
MH\?`2^YS7$NG3`.:U8[J3E/2[)NCL*2Z[NUO\7L-S`"?4#$3VRS,<5>P<HI:
M^98UJS85#I+&<C%(-UHQ$%&SSE+A/:K`HT)=Y5M'=R',K3>L39957K=.L7TH
MA.RVH5.4047@:4\KJUOO=PPT<JP>X8G"_%8<^NXTABC&O2_"R0N`?=\/=W'[
M:52`2'M?K37=+TXJ0K.^,-H($Q7@G6V3;2%>M3W=3T\JQKR..,R)(N4F6BF&
MG>S/63Q[3JWV=#]9>>03K8PXS`E%G<+0`<!-`OF(U=(.,-$P50*DB0DYPT%<
M6?<#E^JPE^-=8<1JMD*1][#)2XT'47Y]U_72KM(;N6C=EVQ&][N6BI?["E)0
M&<^:D7/8;^$,(D*46UGW^Y>*<13RKC+RM4Q$M@DLPD&(3PV%DX-P9DHVH_O5
MS*,A*I2"*&JVY6M6MN&/@N*)L.H%B]N.WHQQQ[Q:"<6PAU>A1UPVQAIA*]6(
MWO1Q1[L_"66P1U6!ENH7&"*4/[!EU.!;FSRLU5K1FWM.&:[5A;`'UC`'N.O.
M`:YS@.L<X#H'N,X!KG.`ZQS@.@>XS@&N<X#3Z0"G[JWX@W?7*;#07F<W*[-#
MRSL9G>&VW=-D`1KFWG)GH),OHBN+`T-H9<D>$*MIV%>6JN8-H:9XC[G0`RAX
M9+E<4DM>!-H@Y"W9>6H5>"E+:AM_(7\#MX]('@?/]O-KG:RRD=?&._5]JRH"
MPYV0C^^?\=XTE8W%89BC\9-8/$^'XCE(+ILSL.S238B4B4HZ?7\>@L>1F<"Q
M6JT./2$F5>B3K`5[^VLN*]0H>`G]%WS5R9=-LR`LPN%ZXX=;`%"J@,<K6*=Y
M[S3OG>;]+Z]Y3UD19TTNE/MK:-@/639'*UN;XS>6`G?JVP'1KDDD_6V_.]V:
M^Q*VG!-%^ZQW(ZE-<1IB0]`ZI,Q+6)V=.'.G46&R:F8=S8FJU2P"]/'!DX$Q
MX&;,"`X-^6+OVY;!X-@<-9?T&GTP3C4GJSZ4)U_JYJ6BKBUV0S:U>O(_@CED
M%!"]C/>2KI.$@-[EY6>^88171VOJZ/+XI:C8!=0;,^1KW]MW*JM)'*'(#EPO
M>)Z%OG\70O*C"NT/M\-WFRA&F;C,V>Q:9#$U;!UG]*5]G6;R&>'@4#X8]])[
M-RMA8D1%HR#-5YVX_2L<B)3>3C1GCJ:QR!"@0<LB+Q%ZWFJ4V6>YNV[EQD[4
M]:'N:*HE'\.LW@WDA06T!%X4DU3LNRFA</&B]':B/A6:%B^&`-O()J;9"V/'
MX#>`(N`6WPA0X7_!Z>Y$/2^:C$@%$C3G>8:F'([)4P5''96,'D\T@92F@<D1
M8AO)Y<S8OG-"_140KSS@]E\`M)]!P7F/"'QY3`V-)#'O-^&5'EF^GW.I)/_Z
M1_.)YNUJ-LRTCOE\MC#SQSG31$E51Z@:Z^U1<:)IS;2,]W:E;I"&JBGC&6_:
MQWTE0DXT$YR10[^RX$_H:"/F?>/!I)(!X[\2*2>:.<_0&5!9]*H?#6C"3JH'
MJCF>CTW"B>8(;',<ZQ"YZN<5&L@T920YD-W:$1@%$?0"Y#G?;#^N/V*;=/I.
MTQTJEYG.15)`^UXE>>1Q)NKWG69@/(;8!$N:EG!3BF\Z*F9T[,)*N[#2+JRT
M"ROMPDJ[L-(NK+0+*SWAD61(!$X75MJ%E59:!.CCHPLK/>4S0Q=6VH65=F&E
M75AI%U9:_=Y>]-+LQ]$JA-Z?_-B6MOOJ@DDK2,J<W:TV=P_VJ[>.UT4FIP!F
MIS`58T_4YVG&E:H<@Q(2.R'G$!:7*5MI))K*2"Q:/R<:0*IRT+'$9%BD57W6
MLF2J[ET(^ZH"`QA=G6B(J?KQ1I74:9H8N]2UG8VQLS%V-L;.QMC9&#L;8V=C
M/.619(@ZMK,Q=C9&G39&UI]C@K[P(K(ECP+7>_%<?-$0G"JHY17I.TP[7C!Y
M-T==5B+Q5R]:S8"?QL6LO,TB'/+?IJO9DBH5A/3Y@`V.))AB_HQ9J76B;,C>
MK1YNN0VZ_OK-,,7NGRP:8+IP]T0[A#>C<1ADO]R$Q*5^>>M!X.!6T[U&\#AB
MLU;UQJC7F:D4BV]S$?#3W.C>R9M&9^A/N_GNHF84"\N<8P>=P<K#Q^J=9*:X
MVB.`\&N0`>SM_D*N/L-70B=75TVM8/6,OOHU`9')KSG)^?:740!?/`?0Q;$/
MQ$LX1XLP*CY5.PA1-`ZCWT`T`T[X'!`/E;QE2D8AH+)_J_=>TYP=37R&I>Q[
M$HOSB1O`C$]R9#XZ$7GVDWS%#NJ?`0(S_AX?!"-H.\2\N@!PS7O>V!PBK=Y)
MYD>3W2.-D7$V07XX5MC[`7'[&.D[VX-)>/1="//G0:HK9ZOM6[V33$W&&6JM
MBR<;)3]J7T:'K\")B4/S9+G$.P<4J^[I%4[YGB^2!7]*JW7\&4P>'D:+A^%X
M,>^/;P>3\6(T_F4X'HR&\[JY!!C+"Q[5:R]*%-UX,21K&U[B0.!X`/%<<Z3K
M5O*\J4XCRT-&JMX1O5ZJR(NV#$FP<MJ.*NV8EO0YKDBC5,5:9)!3BCXK@F97
M$B8R[9@.#/(6T0BQT7:B]K`VSXUCL/+`LO)ID%-+JRM'C<E'1Y;/H+K0ROXS
M!,GNS-C]RH4TQG;7W/*H/+01SR:2*7/9HA73%7U-EPY/@FU&7K<L0LW+>GU9
M'B&*.E7>)H1EO<M8Y2D5M,1/L\8@TY9.)USAF(7`GBRG,,0K6;1]Q+=O.,$?
M;;(^W0.;:JN2JZ@E4+GI!5*&*W."BN\!0@`0NC!Y>6>\(LUH!@+P/=7#<HXK
M-5K3$@C<`.-FK+;A&\"8AD1U.B,K1/*^XXC(TO83&AB@2=32$S';=`:*>3+'
MNE\>+='.@#T&$6>F<>OI"3QM85()N5*86GL&W-@!;G\=QD$T6<YMWX9;UK2A
M%M;SQF?3V<)DI0U;-$/6"_PK6H5^OE?J4X.<TGK>KVPJ;38O6LT@;^:T[,,#
MGH$QW&UI2\)Q&"3>"EEL]"/9^.;><^#A.SO^XC$(GQ"`+^0N.@HV<83NP0OP
MKU,SRM%S,>\9N??L)\_'8@)HQY,["6;`B2'9'?!>X:$2Z<1!`\/I>_9.NL+(
M:17=:8BE;I$-44AUVUUIB*Q6!#IC<U0@L-.V9.T%<K/-1+(=^#9"`HL6MYX!
M(=DJ@!8,*88DC-&>MRB20U:%-A;E?>LVO`E'@?+UB"F7;@`>1]"&F`7-'8GF
M&11O`?1>;&(UN_,"&W-@^Z,`X8TX.;(7)"$P,E9L2:OA\2B+#GV451>3,6.E
M1:D-;-^)4SOO[.U]^^.L7O2^U1AFCS\>CWL%8,K2'-L$31=!_`S*FH8B:Z@H
MB/TL9ST^IK0_1>;MHX].]G@1#-66A6G>FEJ1009_OV`\[T.$1H'CQR[)QCFT
M(8F"D+K)JJ9!:^;P$QS%=02LT#.G939F8!V^V/YDN=,%/VY(T<TNJR=+C7]4
M(K3F.-<P8+5(6*$UNW56''+$3TP5B5XL'/X1X^\)2]G[O4<;MV)2M&9'?S>C
M5TK.`E<`BMF-R'(&E@4XD+?>O%D[6"-['J_7-MQ.EGW'(=8_3/,T]#UB-]S_
M-`TCS#>^6R;&-I*9&U\U`4K\B+[9T`MC5,Y3G-G8S@AMC[,1-]6Q:B(N6K9-
M*B?XGT?-$XO)=#T_<7>>DY&;S*_A:WH@N,.SD80_QE$R9B?+['PP!3`)D)2Q
M1;;6Q=%SZ#8C/#6IJQ/,KGU]*W/;8Z>4J+<=^9N3_V:??+`A9_+IP5OIZ-AV
M;-7CJFT<F!<EJEE:9,L^L57N9DMO0)1W7&&ON@WF:N9YRZLC'S=3M%IT&J62
M4@NKZDU4KG[6R0V8O"Q-07UW(A9:"HOE3#L(E4?I(2('?)HB_E93?)\@+!S^
MLZU>-T0*UT5#?"\,7"!+3A=73*7,!>F`I*#"__E_4$L#!!0````(`+.`"D<Q
M*T&A16$``"J^!0`5`!P`87!D;BTR,#$U,#8S,%]L86(N>&UL550)``,1!,E5
M$03)575X"P`!!"4.```$.0$``.U]:Y/<-I+@]XNX_X#S3<3($25;LB2/-;L[
M%]4/>6JFU=7;7;)OPG'A8).H;JY99)ED=:O\ZP\/ODF``/A`EF)C8M>M;B"!
M3.8+B43FO_^?S[L`/>$X\:/P/[YZ_<VKKQ`.W<CSPX?_^.K3YL/+'[[Z/W_[
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M7Y'U:SO#GU,<>MC+]T9G2K0E`\RT+%/^D5L#%E!U&\5U/)V]%[ZDUN/5]V]>
M,4SH;W[-#=,R)&*?^NEQ%6ZC>,?4]?(^26/'37-`;.L,_*\_O'G_E[=O_O[V
MQW=O7_^J#NC;O^44J&TXQDETB%VLA3W_"/6=.?>_OGKW^OWW[_[Q_>HOW[_1
MV!DU;`0,-=\X?/GI[JN_%2;;"3W$)Z+*3/1+/O?__3O?S'BX$<?B/BK$`"**
MR[C.<D[LYALE/_;@F(WXUHV(2[%/7]8^Y3:.=H-X+-]7-(A8WRH+5H8F0S'!
M[C</T=.W'O8)JJ_?TA^HT+U]^>IUYJK\;_*K7_FZM_C!I\N%Z;6SPQU2]N''
M]^]^>/W==W_YR_?OW__SU?NW']ZN?A7.GT&X_KYZ_9=7;]Z^??_^A]>O/W[W
M^ON_?_]/\8;:#)?Q6#D.T8%SR\\\6,PA(GH,TI`,/3+,(1#G1"IC)U@12_CY
MG_C89W?$$^>V,S(4!-R3#41L)")#K5J1*1"8W4;T,E*G3>CCHJE8?A,[-%QP
M=]S=1ZWO(Y/M^D2;6K^)0I-3LK\C/@",FA^V;:MZO9-I>A5Z%\=,Q=;GAS@F
M<O3!3UPG^!=VXLO0NR#G,Q5E+IQK0Y]+$&DR3#84\;&(#B;NM(?H<.MJ?2(\
MK&CW/N82*O@>SIK6K?G@!S@^)ZL]1'&74]/CQ=6GV_?RF^@(_`,V#.7CP"C_
M$7$`X.%WLI:B@]_%5Q/[]]%N%X5W:>3^=O?HD*^^/J3T8H$:)PUG7P;%HN<O
M1T[D1;-9B$U;(#X1569:-Q]S(F?SQ*#`FGW'AWZ^G$J\\I#6AH#5,3"U>38M
M2P,!8:"2_AV,*1FR::NVHXM=>HU&!Z],S<[%=:3J`:)[H@V;($)!R"1\()QC
MP]@(6-'M4D82JG,9%TW%\DNRH$<7_1`X7;Z04);K$VWJ\"8*34XI_H[H`#!:
M?-BVK>KQ3J;I5>1='#.U)B\/WA_(;Q(=7=Z<:E.;M]$0JL-J#(4-!J/1QT3"
MJE87,%6O7N_FJ'E$@-L4D1#T>FQM(!"\]B[4^G@J<Q>LB,;L"('P]H4,J.SZ
MB[A/5W2V3G+/\#LD+Q\<9T_EY]VW.$B3_#<L4ZDB2-FO?[U+B2M&M[+>?O!#
M)W1]LI\H\772E;1@S6UM-!%M,F4Q#:VWJ)B(\IE0DI9&PS+2Q')V>V7"N)T&
MS(!K+8CEQKD/E"-0@MFV+)H0&3'[_<*&S"Y+$V_?FK62LY/43$EYR8(@G`=.
MDJRW+!J\_.SWGGCZ`5BW1!THM2Z0Z1!J>M@@HH?),&"61AF+2(Z%?4LB8C$U
M\R'@K_E$I;J!BVCG^*&NW>B`8-MV="+5)R5\("PKHH%(U(>(=7LB9C4EFR+D
MLQGM"CESX61Y0T#B.,8>V\M'O+O'L;)ED8"P9END:+4<%S8:%:-SMN,3@-@9
M$XR6%9P2.@&.L>GG.[FYZ66ZN67H3%&&Y`ZJ!)1M$R1'4\"!9V"D:EK<K$F7
M,3MI'7YZV=+"2>C*#_&*_*A_!"IG6C_[5)&0G*?I,,3&`;%&X^W?_GFGQ4AJ
M!YTF%\TG`LLDP6DB"4M+E4)CMFVSTD*F=4_.!EB,,`_<_MW=Y>8.G&GHYB$E
M:]#)0'-S?Y9XKWLWTSW9EAD0H=(M`@N4OZ,`=MNBBD:^?8>-_RL82R#E**DQ
MD+'3C!$O)WE<AA[]S^7O!__)"<ANDF5Z[L3QT0\??G*"@_;EB1I0V]9#%?46
M*Y()K#H!^Z$R=8&6*<IG(S8=E+T9C+!+?\#EU-&Q2RO5:ZQ_3*?Y,1>(U<@9
M'>M]J]:0Y>]*4;_'#WX84MRC+>([G`CQLC`4`+0Q^;T08>N>EY:V5HLC:ZCJ
M&?TTUXT.9!^WV,5D3_<!OL9I9BJ5W349#&M>FQRQEO.6#4?E^`4B,PIW#H8/
M9XA47$$JQ"QQQ@F"Z)E6]:/_^-.;5XOOOON!R>J?WB^^?_.62N@_#B%&Y"^\
M["#]VQT1)Q90RG_]=D%@)WOLIOX3#L9_YRDU4Q.1"(['JR";<L>W7S#GTS0W
M,=X[OG?Y>8_#!!--N$X?<5SSS76]7Q60MGU?-;2;;)G-0MDT)GQL(FJ<,D&Y
MO<-PQ7Q:PI"-&+)N[2P*SDG08&DE%T&=GRT%<HP".#`"-_T!&Q@6OF?/[%S4
M(Q<VK.X(VX816=*/*%FPI!$Y-:7'&T)B5L>0'"?V]+*#6'=]$RJ!9=]V2A%M
M&Q(^?('8!%[7,I_"O'E@UM(0NWV!'2ZQR]UZUSWL#@$MB8L\O"=>K<^K>5(O
MG[#^XOUK@6__I[^\>[]X]<-?Z%_;?CZ@`)0AW81D`Q=E&IWM%^BLB#&=.0$]
M]0&+,$V`\B4KO2'"%X#OV*_$%9W&7@T^GVFJ.*S7A#AFUW]R(+:\R3[4FCQ:
M/ZZ54Z#="YKA!>UV4(GQI#Z="M?-)T@7>$^?=27-#>GZ=T(XMGT["8*MM[;9
MT`YA`N70&:`$SBSU\9V22>IANCFEB*="GD=)JIR!6)]DR]PTM][FH"RIE0VH
MRL14EZ<FQD49BVA+?J#^FDM'@C$KG0PD-2-=W#,?PW_P0S_%5_X3]E9A2BCM
MWP<X$T/]X$`/--LFI!?9)K?Q"2_9#%1.*>W*!(?!M-+29F+TEKLH3OT_LO-^
MB/P2PXD"A4.LI39ZJR8ZG4$/ITH$>B[T=WO'C_-Z`7]Z\]V[Q;MW6<CCNW??
M+[Y[]<,I7':.2\L.3K?N>JCI+B4'1$EQS7V'HG=Y8OG61'A=`L*M$.Z1WS-,
MM%/3:Q'-?5J^!]&X`)E=D*Y\Y]X/_)2^*@SY`Z?'*/"(B:51K_1H^MI"&:YM
MET>#`$V6JTPMXJ7I$>J+C2&(KI9GJZO59G5YAY;7%^ANLS[_Y]_75Q>7MW=_
M1I?_^6FU^1=Z<7'Y876^VGP-S@SJ\KB20=1D<"L2;?A81`+!E@F5(B612[!O
M1[00RG$(RDEPXL3]_":U>[W,-G_F[HUSI)E]1*S);^(#]MI[U#6'.J!M6T0]
M,@C3/[/IS#)F`%"79((RDB/AOJ_@[F2X!U7<_=`-#NPV-<;\E+UWZ(UZ/M@/
M4TQPYP?L[Q?OWL-/(AA&NLX`JW7/P4`CJ#TEU58'\VG!ZRC%^<9N.7/>$-ZD
M.Z)U>_RMCSW-Y$4=D+8\##VT6]$?.CM7>0N4`4`9!%@)D<,PO2&2XR=)%!]1
MR)#>YTB7.NU/KQ>O7KVB_X>>_?01.4TMIZ+*K#DT!@(@]7#TN7_^Z[Q;_(3#
M`S;T;@10;#LR0N2$=V8Q'PGHR@(.#L/N\4?"PKI'(!<8Q;M\B;38C!.8QP<`
MQ044XP$@++&Z9UPD^E=.$0"B\>,B`"B$81BZT!!B9^^%3#1???_F%1-,^IM?
M?W9BVB(^!WW4SU/K`V/+*O>CUV2<;'`1-3A"2U,S1RF7@O&OO+VLMP2[KI\.
MD<VCGR`<\#IG,7T6D?`R!#MZL*5AB^<FJLA):`Y%^HC1/4\A1\DCQBGRB$O\
M#1A+KRB&4E.O)H-6;+V!D8=@W>5F'98I%-I`X+9/U^C-7_`IVNW\=,>J?(3>
M>12F?OB`0[>;K>752"2@;)];Y6BV+H?*T;P84'4\"#,Y#EYN=3QZ0:,J:`7O
MLEF!1]6*V_0RZ)RU9S720@1%1VTF@`@*FFID0%0'YWD>RS2-_?M#RFYZ-A$-
M]@*\:#9&\\\YGB\N\-9W_=2*K.ERDXH)`Y2L42\M;52PL`N$;0O6C59'F9)J
MB?1%7JENE20'/'[%-O,@K"XZ"4=G[\3HB0Y&?WKUS:M7KVEE-G+D(6KBW]#K
M5\45"?L-L7&']#&*_3^P]V_HY:N7^:]]1@Q>P>60)JG#'^$ZK$^(2HHU*!?@
M)"CYMIN2;P!=MH\A8%!+0HZ#&_SW^6-@"?Y)OM"\J99O$MBV>0^=42BUSYU.
M2FN>+4>W`X&NLU84SF.&39Q8=104#,:[5Z7%H(K^]>+-.XD-,7O*]&_HN]>+
MMS]\M_CNU7=\E3>+]V_>+=Z_>SN:90=7*7(8IUFT1Y-@`\`"38*7?9NCIF]5
MCH(")3UCSK'GL5;#3G#C^-XJ/'?V/A&"RKYTSX,*$&T?#Y60;B77%I,0G87\
M$&7S%JC*KZ#..T,QW6>8NGP>.`=/G7W5\F)5>7<^`;W%J>.'V+MT8JK+DV7Y
M,CJ+BZDZA`J0;+F(2D@VV32?A/)9Z$5E'A)%#:>-XXR'7A67($J2^2]3IL'%
MXZ,`N(M@43'U&*<4([C^Y+18`_4VU<V"U/]4M@DV+_MT/=`."+8]SDZDE&Z_
MNF_Y0#F92LA-I3/,8]A*V^:),TGMR^#L7M*;RL,8&L&V^D&&A:6';-WZ:42L
MNM3:_8KT%IQR'*IGC5XX`%+Z1`BJE=D`X8P;8,,56A,GO<0+"[ZZ)4PAI$5*
M!5$U5U(FA3-&&_,651^B^"(ZW*?;0]!N:61:XT`+N&V/4)<4K7-HT>UK&\4H
MAX`ZNYZ!K'0P&OZT*F"[YQ=ZX8?(BX+`B1-X69I&@J`6PC20@EE+G)3GR[*7
M!?DYP/0'6HF@4NY16`E?U0\9;3V+30_'(I@LDE6%O4`%=%X\I0)_@1J-&A;U
M3@T@O**9:%9OQA*BO:R=BW5U-*UXJ'@C(\LBB!+,%9RJ>]=U70Q6L.V_&!%%
MMWQS5=RJH$!Y,J-08JE:\+BC"+1UW3(V;^OX.\:B,^<5;E%TY;B)G3!Q7*;X
M#O@#(>$FJOY=LQ2""6A[E[PF9&A?W)2EC8ZH`H>X+0=R&"*@T(LT^KI6`^D(
MJ^["N)005&ZSK11&XU>U>RQ3.9BSUM%]N@J3-&;OXS\X+EZRQ^JZSH(0CFV7
M0()@N\[.?8K*L0M$1R,^'-##&PV,SJ.0J(*4F>5]O499GFF;1HTZ9$1"'>^I
M".(\1_%OK&$*SSI"^T.\CRSD?8Q%DAM%,L@TU?#K*-JWB'@'IX"L=5^M3T4I
MUI>2ZB=;CQN)[E_'=RG]%"S5]@;'=S017M754H1FR[M21K;WB0^9B]8QXK-Y
M\C4B\Q$#`,)_&@'7UCN-BER6CS7@.$YZO"SUE;08V9:TLCTDR^(5C*Z3U`/-
MMJO4BVROE/(YJ)P$RDL8@%\FF:UW4.",I1K#&KPS%'"K75'DKV_,C&4-`@P#
MV4!*5=P`O4DTQ*<N7OY$I0ZT\SM&_#J"=WQ`3'>7-&F8ZPY1LJL7UN73T3%L
M=!4<1"-=1U>5,2NSP)MI50SKBB2:$,-Q"SJ,]!U!O(>P@;;]!Q&#E,I0MZRM
MH*R4@A@:S5`!!:!@A,;9OOYF''X08Q"6IQ:^T.!<U??R8`(7E3T-C5K(0-GV
MAN1HRJ41=K#""+.3"5,HL*=R05`Y;UH4.;WHA&@Z`(/7<_+M$BNHE9+44`$:
MCQCGDT`+1?3(C:KIM1J$:.UC0`1""@N<P94?WKKY$&KDP0RYTXDY:.*7G::9
M&\^QF^I5L6DT87R$X'E&IG$"!34RGWY<A6ZTP^Q@M#-HOBV:;LLW$J/39#D^
M$A5#H55"GP03:ZY$#YM)70DYC\U8:L0)<)*UP;O&VHF8S>FV'88V.NV48?;'
M!2)_!N4.*&]]YE8[`S?-1H"S>P*V5ZM1T<GS\XGLFG@Q#FU%<OEYC\,$)[KV
M30S`EH63H=1DJ&(LR@=#LW)FV.!L\%_!V+=>1I-:N#XNF]'&X8#`?/@1AV1'
M`7UCZ>W\T*>[H6G1V?ZT39\:5.L6417YEN+F$Q<HF\H?0M<FYQ((RXX.1OBA
M@K!3FPS)\LZ(IGUSK27!:E9<1WSG?"B98$*Q1[*A"^)B!!%[[RU648(G9C(@
M]AX_RE%KN[M\/&/0RHS)M(Y)5=L!*'GE#!!NRUC(%)X,@#N,J3Z0Q=>C"OJA
MYYUHOW*8\T5H60:C4?U"UR&3@;+MA<G1;#\-52U%<QV%^SCR#BZXDA#F&'.'
M9,I2%^9>UX1867>R%$11\?%CGQQ:C)48QTC@Q$:48B(@/`J5K?,2E5$K#`+`
M>1AS^W"".&;!&WN2RV]*KJ)$N\%X%PC;CD`W6F)YSN[!7M"!X]^'#S'P:IA<
M7V[0U?KN#GVX77]$ZYO+V^5FM;Z^`V33U1!10<*Z"9<(C9+I%DO,?()/7-JH
MOHU,!^E><_0#LF7255!L"5)E3J$5LFE?0[L!,4%PG3[B&/D99ID=_1K.;8@R
M7TH-JRI3SIDLPZMEU79CD`H@A&/;Y$H0;&>=9)7#F@+&T@6FZHXYQ`J;(->4
ML04*)\B%,#?()CAEN#!4T(MK6G[H?$1_Z3W'*<0/]+$-K"]EW>OHTR!*KD>/
M^ICQX$'MD%!-*\</Y%"L!1/ZD.NVRE+G`X3'88A8(5F9J(VL"M74QNP(V0M&
M*,F6/#*A(E@JVL+9>R'3`:^^?_.*:0#ZFU_IF6<=\E*&B1^%ZVU9UHZ:%>4H
MA"(T6]Z1,K*M@S"9@]8A*F>A]195:O^QB0`J6`[#D*#EEAA&VV9%R_$Q]"*7
ME0OLO/P:'<E;&J5/Z'5MH(3N-R"<J9/YIG4<-]"9UYH/J:=SI9ZDEL(=8"'*
MV!@MK'S^2*B/5^$'QX_9(_SU]F<GCITPS5M/]7:,,X0ZMP]IC+S@;0?C5`H%
M<3#$L4044%:J@AB5#%;1P&S\CG/J*3^C8?^CXX?H!56Z7S,YY;B3WVTI[KR4
M!9'8YPSW8#+<==SL+P_[/FL[#?JEU<V/]IP4K&:_,C%FM\73$./<].//?GX9
MIO<[SS.#E/[<3RF+'48A.7(=R*DKNRF*PN0,;Z,8\W$;YS-.+C^GL1/%GA\Z
M\7&5XEU"CFN$VBDA>\`.;#S2HQ]@GFXK]F/44Y)98(#YI7)F@HLE4;DFXHOF
M$1^V[`+5%D9L99:(5ED;Y8L#BY7/263FWMQS`A+W^\EGOCAM<I"I_I0N`"KL
M/B=YKG%V\IR11(U#V1=/*0`W`Y-;#\7+A:E-Q]P6F>PQ"WF>X1!O?<WB!NWI
M=HL;=*$CL%ID:)[EB%YDHV'<0:BC<@/$'HSS1=C&T8M[P;>P7)]!*"D*]1E$
M8C)C-A1.S1,@ZY-M^[A-5+KL7-TS7:9I[-\?4M;,>A/1BJ93/)8R;XZE@A(U
MW:#<X-Y-9RF;@%Q3TRU;=X`ZQ5?)9>F2W?G4SJ43T[+>25Y1]LQ)?)>^&/.#
M0ZI>9;(/C"VGHQ^])H?E,\H*R@O$9O'7J7P>@!>I^IA1'<7.JD7-9/02W1>H
M>1.A9N)@F2$7U)![V4)-L7"T!4_,#-\LI-R%\?80!,?Q/^F`-)=I/BD8%U11
MCTI=434E.I]M^!G[#X^TH3018><!7Q]V]SA>;UME_R3Y^E*;J0W?MF-K0)`F
M4^<@4`8#<2#T-J2K`47VZ2VF_<]&$"<C2+O@Z4MPWIZI9"@YA(9B`4,O5/9G
MZ$H:0K?E81H30U4SK+LUP_0^J8GC-AHUSCJ=-XO5=<?D515G8)`8S%AR+2]L
MNMZ>.\GCAR!ZEI4IE!=_DL&R;?M[$&T5WRKJV1+YI1,0FP'5D!MC%REB9]UD
MJS"J6CVQ?BZ=-6I,-\&N&3SLG1T_)=A;A<7SWJ6;^D]^ZN.DZRY,^Z'M.*M9
M>XT[%K&Z3JI,"G+0Z.R(7E#H:!5^C8H%4+G"0I"(`>U][U0D8^3:,J7!4N+*
M5T=.`1+0D^!1Q4S^;GA,&9M/$2V]_SHD*56+R2:ZQ93(?H!KL>U-I(B8J?\P
MR1YL^QT3$;8ICY5EZ`5<L1!J7]:1/VLJ.ZA>CP7:IA&*"]J&>823_);^[%*R
M'B@ER5D'C$:<7^9TW+$)A=Y.<<2B"F!_E<1.6Z4$RY8+IHBH:9U$$#[3"#A:
MKHQH#2UK#IZ.`$K=-PWIFS%(D]TF8>\\VM$L)Z.RJP(HMATD(7+MH$7D_D8O
MO(E]=2M#\Y(B@-*-]'!Z.2-.@X),<+^4>75^59PN?S_XZ;$#J0ENY\W:^"FC
M\J'VB.L))S0\G[WERMN:LGS7!,=/O@LP75VN$-7"@#)M..#1<:6_'F\Z^B&*
MR4D_.0345[W+*-KG#.J`LO*\6!E-6>O/K/,L(G-1.1G="=AN5F]P%"Q9#]"J
M1+DEEB+A&HRE_H-98S0WCWZ"<,"O$N+\R6Q"?<0#OUQPU0F!O$-,_YT^8L3[
M?[:>S]IY3ZHGTN)'I%KR/)]W6;QQ(-NYB`[WZ?80+%V7?D'M1'8I+-N>9@^B
M\K<?^024SP#EFFFB=N;0IAGWJ<@ALV[@57A2R<PK,.2L+\)B3%R."\S_6PEB
MG3M[G_BP!AUP52%:?#>FCG3'PR4V";W(IW]-JX^40>H,!+1[MT%(E^46*C'D
M),'4L(9>46T!U`V;/FOWO>K2XVN;0ISKDUOL8O^)OH'2-9M*,&V;3T7$%44X
MGXO*R:`LJB&V+_)Y7Q,#FR%.!-G)L8TGP':4FK=&V"[[T;+N2NC(J^H;=55A
MM:F5;LAYS/&]"[S%<8R]O'IYZ+'"G$MF3\S=#"7H<%P.16(HZJX,6O&ZG5IE
M7M650P+J@A@2X:*BQ_89YGGWG*S]WCY*_`G0-GH2?[)(#WB<-1K:-UVH1HRU
MW4-,'W57/5$1#0!YH3I:4-,CU5"!$+S3&^=(+1.]RW3=^$`XK#Q'C.>O2E>!
MZ\'V$$?7I\W`\?P&#A!5()Z(HZM)E`+[?05[)\,^F!#[096TQL&]P@=^6%H.
MQY`D@)UF%34RT(U6T"$V%6JN\&_Q$PX/RHTF^@'!<9?;**IH0,+P^424S03J
M"??C5R`2=R,"R,41\*.F-]/-C*?R$D;7@1FXFFU'9C"QA"]@LCSPSC1P0`E6
MHQ.@Q-?-7[:`\M(F^>*]^>J`7#48!+#NF(VC)E4+6PW7D=8-R"JD"6YS/:74
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M7N!'DH;Q22V2I$(`ZP[,.+IE2"1)3[%8U[H?_-`)W;DB2;JK`8LDZ1-+4_L6
M"WPQD:3A)&LJXFU!HQ,*(QF*F4D8R4S&!CP.)OL@>W`Q]EA_JSLGP.MMY5D@
M.=]EC23UNM?KP+7:QUZ/`%TJ(9_.NR%2`*Q"9_55,0&2=R2&X7F-A/H^1YT)
M=T)1;[ZPI3&3YZE0-^][/PSWS2/F_I4?4N66]>`5H8V<;8IC1,3\X'(?K/'O
M0^CA^#GVV3\\/^%)1PM"RRUF#Y!KR:_T-7*,]_DQF/]SY_AA]E*=ED<[*]B-
M[^T\QAZF\0`ZFA#,1B=@P(QHMX>]@0[N[V:OKX`'6)$\)D.`GA/[A0,FD.OM
M38R?_.B0!$?^O%QB2MJ/W+6!6BD[88"Z,*)%S40%"#4C)9B\-,5D=D2_2L,(
MN(OJ-13JC8JM6Z$)B\H7-,GJ-^1R#:"[^9C\H(6[=2]ZD"80UZ@P5`.G<C@?
M*22JNAK0D*@ZL:8[E(-PS">E$W-9]SF=[H^=QW'X<5$+1(`:&]54,D-BHWH:
M9C[U2_?*;$/R2&^BGXBC2U]LL')-S:1RU0BH%DQ;<4Y-Q#M#<P[S.,D/%0@+
MQ&&@CA<5(**5`Q&G2J!X$O7"JSX6<7.:L!]P"1S`0V(`6%L+S)K(N#3\:B#@
M,Q;7/>SW_$3D!'E#F%6XC>(=4['&S9`4P=IV$=71;U5YK<PLFPBARF2H?0-&
MPOG"3]P@2@ZLW>&VFP3P*OYK\KM:,54M9I_S\6:*R==);QQ?N7]A;8Z])YFU
MC;=?7_(_(_IW$%Y"SX:9;+#*$EF13U[@DU56]+.I8.Q?%]?TO*9LL<RL#Y2C
M'=XXGW$B8/.^E]ZUZ;;M41N=CJ?'M)L-&V)%``;N7R8+*9T'SF0(6$SUF7\'
M?\U[8*7FZ)K@3WXL<XY"K^.,79ITW32>P>O8/-@.)%`GAU.8"Y1!K21+TJ-/
M5YRPXDY!2]B9@$0$U,OL3KM*&-@9.V/)4N]A<01!&KN$/]E*@)/D\C..73_!
MZ^UZSY.##%-VC!>QFK\S@#3*C0`R<"B'1R]F,XA`4WO&ITJ[7GY.%9Q3A9PX
MHXPJ0+-^1B2+Z.*:)M@H-!M0)9Z5A@,3Z`CEO)6!6FB`DKW%;N`DB;_UW>R*
M.:]`L\[RL,ZCA+W%\3R?#G`"ZC^NPJS^LU)2R^!%K"2YC$":IOPT05*=6I0X
MRJ$B!I:]N"T`LP,6+0B3P;;?DV4.ZA#UX.74*=("74:=-$).21UVC&-!_6FH
MHY\E-`EY"GT[&J6`M'892PN)$VI&4D&C:MI<B]-4Q;RVWG$3\19GG_91F*M^
M+8]VR#I6G=IA!%)1M45Z,$M:+R!259OUE:-`"X\7CF<[,6F(]GBN94X'!6F(
M]L"<-(<]ZQPX$6G,W=NQ:5,HV7@XF:BF#;/02W^$`9C;.X+"ZO=\AVNK`2JY
MTP2L0C<X>#3YQ[!D<]N\C;&.%1=X'`()BWHV/-X<<&<-Y^5,-9REQ1#GHM"Z
M[L+Y(:OZ[O%2.WY.I@&5C2UXQ--0JJ*OBU:J(D]X.!F!N,LCZBVQQSR>TAKR
MQD94=B<K#>()-Z3E,P]8QJK+/(@\'8T6>=TG!HTIW`)>7E+'DRII.`[S)(19
M=%7$(FJ"0^S7*H"<YE'ILZH_8E*DEHQ2P#SAX5JHWQ$>K((&:-EF@243Y=JV
M4OI0K?BX)LAW)(+5"XW!U)>3(Y\W)3)0B78]*F,)$/M/)NQOS3D?@P^Z7/%6
MK3H-WOBFSAPSIJ*7]W"OM?/-JW-M)_$U$&EE45?N_$&X;HK[[KJ<9V$W(O9D
MV:1X-1SMR%^C^(C"*,5"-\QZ7E\7OZGE>[>9;3XIR10".1G>1('ODN.>;JZ>
M!(*M+#PI4H).6S3`D(^&EC(W(3[6TM_Z&4^:V-;+=?.)T#I^<$+_#V:FSZ,P
M(?OQV#_.G,1/V&O_)#?C9X?$#W&27.#$C7V6"<)C+@UD-OAS>D;V_)NNY9IV
M,[9-X=2D;D5P*^NQI_?EB@O$ULP*G12KDE]GZZ+*PGGOPK9@TM416WY\56/>
M$6AN.A<THW3B=(WJ=`7EV<Q-GKM/'S\N;_^%UA_0\OQ\_>EZL[K^$=VLKU;G
MJ\L[<)[0+`I1R;6:0QL.B-A<^>04Y?GID2STT0F=!Y:226-'JDZ8*A@K,1DE
M])J\7DQBH>MR&HMG0W)D-+^@.,2@_/DFX31M3T,9GM4[%36$-9EO2F-M?$EB
MB.GJ/S^M+E:;?Z'E]07ZN+Q>_GCY\?)Z\^<[='.UO`9TR6&&WR8K%AEC5I4R
M>PKEW$>'%`7%5Z;NQJ[\RO2J`]BEA8;@]M].J$OMK(U0:#@GR:^>G4`[`B$#
M8;'YB02MCK8G;'39XYR,AQ:%F!8EF^U.^ABPK]%)#_?-'LV3IG.4C_R,@PRF
MR]@.'YB31Q!D*Q/;G.[$MMH[7&CNPP1DX:=3XD,L_[4\N[IDS@7YY>VGRPMT
MM5J>K:Y6&XA'UH&"HW08'28U,S[R9_<O*;WNNXK"AQ3'NVMZ\Y+M^YQFW['D
M!OJH./N'[OO^`4M8>]H_B"SMVZ\"&F)@"DT"T$2.P!'R5^J#V6$^Z;C`]^D(
M)E0$QK:)%*/7SO^^3T_"O*FC='.[_KBZNUO?_@M=KS>7A1D#9ZYZF%#)',DY
M<$"L*7OZ4;SZT(IE"B=;B6!*4&GR3C:T\AX-R/%M2D3L!%W[&$P<:NWAKA&9
MWBRL*H9B-9@J0TZ!?:`9!GV<EK>WR^M-<8+Y%Z#PJ`X>W4'1:(NVCA]GZ7X/
MCA^B%^1/R=<H"O.GDN4C26#QT5ZYZX^*]@G=?+[E+>T0@;T;)R:[('M*Z*M2
M@RZ(O7!LG:$4$&SGH[(IB,U!U4E0#.S<R%D[!JJRI_2LI\B;]H5NA$.>#FC;
M!S\],F@P\BD<$0<B?WFUW%Q>D-/B[>9?:$-<A;OE^6:UOH87YS1@=J7#I#ZG
MS_P0X#$*/!PGO/X`#2[IVM0>*+8L:B]RG<\%L@E_S@NFT#G0S*DV9EF-GZP(
M(D#[J<:(4NNIQ(4SBM:C$^/:=I:AQWYYYB14'1SIH<8\FUD;OFTK:D"0EH!6
M0!0"2J\7V1]>,C@H!P37I(Y`B?/ES6JSO$)WF_7Y/\&94E/>5WL39,;X,UZ#
M%(:=M6:E/7Y9[")S!%B9";;?^^I^=8WNP%5L&>7!Q&G=M90^-._/78!$N>?-
M@"X$2@*699^2/)$*>>Y5R6/-51A'O*2NQ"BR!5#AC.-Y#%W.MB,RG%QCZR"H
MCLKXE&+^"EK?L!``2X'*+A#@Q0-&DBJU"^=11&K./*C=SD^YU@L]WC#T`8?N
ML,XF6D#MY3KIH=[UMC^;S_MT5B%`[DUB'V^+25X&[-Z3UJ7/Z\#$V]A_T(1N
MVUW0)H8YYT/U`X:38/WQXVI#'U%QHW^^9N]T+Z]!/M(U8W\E0V_$^_,)_@?'
MCW^BN0Z5EJ.Z9EP*PY;5[D&LR:]T.&+C:\U7@9GDJ9&R9F]5V%!J7A5XT*Y0
M&1M/.3#;MK(/5566A&H(M?%;KF[13\NK3_#RI)6X4LFFJ;#D?-+67:NBHZB%
M3`0[M9(!9%OFSH@(PLHSS6H]G55HK`KM#$10+K]CS6J:<[[4EAJS_9QY:D\X
M/.!;[$8/(6MNQ"K2Z&>:JP.T;6E54&YGHK$YJ#)IP>MM'=$OV7^A6MZ1\`5G
MAI595S'73(UOYQ/-2R<.R1$WN<$Q"V#W"V:G;NL#8\O0]J/79,I\!B)3^'40
M)!D<"<EKG**K**D@"<9**C*DU"2J<>/,N6;L:JAZ>;3.;?6*4"E,_2=,R]DD
M?+-&Z6::2]BVD69DZ4PZR_(BJG`66;-HYAD6L%@YK`201,]!(995>M:B$#AC
M.T!.U%/3C(1DUA(6=!<QOU_VD]_.8^SY*?U)_:)6#,)B"0H)6ATE)LK1B`Y:
M(#XA^P<<^1T;VU:G-)NE,_HXL:\T1@\;SB=5U_BY4@XUCD+RH\M*R&5R/O!`
MJ@W?MNTU($C;B7RN%8:N`8$DHE,3@ASG>(<R`2W`V5E3:5`RLH:B,*,W[CYB
M[Q#@]79)]NCYP8':_#OL'F)6R.KR,V\)0_N_4C_AD&:-89O'"NU3\@0K6WN\
M-0416XYKM@@-Z5:70>4Z*%^(-T2N+$4GM0_SZ)<-*U4%S6.8G9YE\QJ'B&>"
M#J%':!3M^<M7>F8J6DVGCTZ*B$0''GIT"/4=5'P(O-UB-Z75%M)'C!*Z@01%
MAS1)"02R+3#.S'1"+W_T-I7$6U&7"E4`F729/YH;LI9MEVH@H83"NMZVFU&+
M:G;:UVY62$3TF6DC:NO.V!CRI1;]&"Y<`ZI,E:M7$NDJS^W7VZR83;\*:9?5
M,@9NI33;`%+(E$0E4[56Q8+\*8<'0#_,0PZB$-(J#?SP*0J>Z-$L]VH`-*0?
M$7$RX!`X<:,VEDL\BBADB<U-@I!_YY0`TE-^J((0E\X;J!ULN%K=D6H6R.?A
MZF1)]OY$2WZ-Y'`9KPC'[1I`-)DB$5\P\8N5#/8"Y=`!:%F[%$L.NYT3'R5:
MF)\^\]-FUD(UC1#>[8/HB$&[:4-E4]-9&RB8MF^YEU2S\FXM9\?6&\DE,4)>
MAL:/3`6O0G+D]2/O9^P_/*;86Q).=QXP^^.%D^(BFU7/382Q26O1.LN?1O7.
M'E6VA.Z/734/$-O7HM2Z?&^T?S??W0+E^T/9!OD01+>(*AGM]K7T:7RKBF*O
M%%LE_\K5]P,%VN[@;2_6!T$1R<."`+20A0<VRR3!:?(1.]0#]];A+8V#QL0?
M8-G*G\+H/L'Q$]WL*MP?4IHF&;I^X/>^!U![23'2\K8=WO')*7[V0YQ:M@C*
M5T&L9D:V#D^X7Z#J4HBMA>J+`="UEDDJT*([OM(N/Z.3$_N.D(N[Q\4%#,WP
M)SZS_Q#Z6]^EMNQ0I;A/MY*@%U?XB=#QS=?@?.>)%(#>ZZ<1I5_\/[O%06EZ
M>9Q@]H>[?>!WO0F6'W(40-I6?VIHJ]0.7:!L9G:09W-!Z24S7'.LN!9)NK"R
MKA(TF%?MO*S,N3:?/7WT`TR^2H@_XO0Q\NH#_L">ZBG6`+*]NOD&1%!Z&57`
M01P0%^?*L#_:9Q(K)[I12;"-8O00D6V$[#1,9)"]FD<./1[`21XUY_V>$OR&
MC&\Q@9NYOKJ66`#%MO$5(M>?P9V=`6`Y_A/@8]VTRAE0L0R.A/LLBM+9<4/6
M7'[V$^.W$!408-Y"U-!2X#PZ&OU"Q\.I":/PK?1>"[0^E$T53E:\B':.W[K8
MUQ?&$A0\95Y%4YD/^8Q3T(.MKVBH#)N?<$;./!!?9X?CUIX^XMT]CI6U8@\8
M:YJQ%[T65V8S4)>!YK-@7.N,BAH<K:_&CW+-K\2,5KV.,QRZCSLG_DW@>NCI
MH28\<':@C;"",2BF"#P36'[^)"C",WD"UC6S>]U\:U,P\^T(?3-%5[4!!\[!
MH(6@'I<*7#,[!G`FY`"=@+K94_,8U,F;,]XR.0%.A-ZE/,9?F6K;QM71:-T.
MT;]:\Q<';'P3T;9Q6=`3G#GJX!VURYP6X\S'[_G;&/JHVV?7P7I'*^%\6T9%
M@E"3FXIG9N586(>H8;B`L11]/":U$#T,-I^D?'3^*XKSPUMB<C+J@&#;3G0B
MU>0M-@@5HR`>>)3P@!=:UF47':LBY+89R]`X.[S>UC:B=W01`[!E7F0HM2K&
MD+'T.6)=?F`=4W3P@1@2UV0;%8O3QW0#7@7G\-8A5@]I=RH)57"V#(PZNL(X
M,)D%*<P](9JS/\X=&9=;O`VPRTJG8+3',9U&'Z*P2BHQ/ZVQ)RO9W_THJU_C
MYD3P$_H<+L3E\`5R$N3AK1]BC[Z-H5-IN4*:QY@<W$?ZYY0=!^NS]G'D'=P4
M$91QY=<)?F`)1/EOOD$;`C"F#.7S?>^<E.S,"8(C<CR>4<C+O;!,Y8"6CZ5U
M%VIYR?G^K;PI'J075#P)/1TS0"UNGJ/"43&\ZE.&8Z4$@AJ"K6C'<U3QN@&I
MPC$1S$4(0H4",RS^6_M9=_QTM8BX>(*Z"K%X$71%ONXJQ;OA=[,E)-N1""F2
M*NF)=#QB$V"XAG,@9CU&T<^:9G>O3;ZT*&PWA49_;7SC6H4!YK:UCIA*3>IR
M!HC8A29&Y5]9I0YF/3.#F%=/XR'T&%X(784K]2Y:VRP)(K.A[.HT/.^H"R@X
M,R=`744<R^2`RES8ML\(6^:GWA?(>F)DX=E#&6<;IB6)V7I(9+*YS/6!^KKK
M;>$-*YW`%<!8.8`KH:?@C/%I-*A_/MFY5?OP;81<A@E]A`_H!&Z$RHH>;/>\
M]5^"P@*Q';MW*="C1W"WI5B`'%[5Y4]\=E44/HM/^`_W"?[]0/9X2=RNU/R9
MB1B0;?LN0[&5AE6,16RP_=LT0Z+KV+.^3V>-&_7RGKHG6RMX)D"EE^-`1)"'
M8F%=@RMQE+Q"EI"=]/2TP+O[.8I_\\.'<V?ODU/OW2'>!X?D`F]]M[-H2ML\
M20%8\>AZ4&KR3#8<9>-1-@%E,^P[<8;XN'P\`-=-$X&ZT_9<1P<EV>?Q^'P@
M3IJ*&(G=,P49&B#B/\91DMS$D8NQE]#^&I]HAY/GV$]3'-X<[@/?76^WF%:`
M(@XAJ[O%:L4L0R\O!ZV5>S+&>E:34\8A6).M&524@T44+JH"1APRRD&SHR2O
M@L:K,A'P1?UZ$+&<R8FUSXG%+D4/56+M.;&BG%C-DG'5OCV`DFBFH=9MJ2X?
MQB0<K7&8E8D'EL<RHD[K3W093Z&-I<4W$?GDA&L?G03?8GI&(FO?D1W@Y$RB
ML]MV2Q^J%9?.!/D>_;N)4`D&%7`0!X3.K*G:*;$O]$(:41\KQSZ>$7M]]W$,
M]&E2B^LDC\@/MT'TS/7B@XPF-/5%0A<@?J>Q5A`[HZ8J8;[P3%45K[*^?>OM
M3>P_.2EM6<V;;.I&#A6AV@XC*B/?NN2N^03Y5&K_L\FHF`W"NQP98;^"\#Y#
M>)_/GLE]?,^I$>('LKHW+S6N<=IP"Q,GP%J(6X\SZPF^4M!92^H'N&_5=<C/
M.\*.47R\CE*LYJC)YEMQR>0("661'7O+\8A-L.]B&6+#Y&A?8A-.@HV^RZ2'
M3J=SU,2*ND=EKC$0]T=!JL2.3K](32/O]%>W.*`FX,:)TZ-6<$T'KM4@FAX!
M]/0%_VT&`C$8(%R6,1'O%D+VVSA#?#\)XN;!K6&8*VJAQS@Z/#S6:0!`-XTC
ML<HA*7TU,'_AD*RI[ODACKN/8]*2$(W9MHN&M)`1EMG(1BY0-A;$!;H^&EGW
M:.MV7HVKE`J%=++4K')!6TL3<=WB)"'*U0D^8)R(Y4-Z%NJ!9CM,T8ML!^.Q
M#N75&8A.L29(T^!'>#\Y!"D-*FXAMO=4XU*EL[42B\XN?W=.X-#XI;Y=ZIIM
MT2YU(R/BNWPD.+NDAT:2C81HGR3<U6>?Q*PUGWRLPA23[Y[V^FU2_2&`8ML>
M"9%K91]E`ZW[<>.@D\N-GZ-E46Y,^$;'WDA9;SXY6I.C:)S1_<IW[OW`3_7M
M30\46W:G%[DF`[()*&?#RA18AL@0+R?#"W^FS6OMN',F[*-BEI0X<,:D_$HC
M^"A.-SC>7>#[U*BIE!26;5/5@ZBLH2J;\))HP1VB4\!V9E+YEFIO1OH_Y(P<
M6MO"4:\_4_=D:\]&!*BT^]?7&&YANVRF!FE55*#LHUCD*\.G<0(PUO6=$#U%
M;@/[+$[^W=04G/2CS5J8@;A5J4_T*KMER'QLS6Y+4B`6RY](4>MX_)V/SZXC
MLQFPWLSIHG43R],8;%8XZ6>]OA(GO7PW9S?D\G)N$SMAXKCTJC4Y.U;_8E)&
M7`.R;:6O183V>X?*S3_$HN.38V?=MNDSL9*YT^9@.V*K5ZN\8Z:])N0=2/0P
M(*2BY"/NWYH]$S-23\=O`1<-RE+#B>_A,#U_=/QXYX3+T#M_]/'V\C-V#ZG_
M1`[66]_%L4$)<EW8EK/5=`G1=I\R"`N4PV`O-AD45(!!&9SI?,64EFC5LEHC
M44"`*0C#/!**_W!VQ-U??H/^[AR?G=@#E7PW%+G**](N9G;$S`PNX\Y(JZED
MW9FHM`'Z>4E.8H\X7H6>_^1[!R?0*'DNFFOEM8`8D=:%)1^)RJ$PCM6&:/C%
M4`#/`M2W7]$%3@L3]/P8T>K@3I!$Z"MZ!88]/V67S$\X(;Q-?/Y*D7(_1#%^
M.`1LG^R]Y>X0L!=0_&4Z2]V](P(4L_LEM'39>ZS7[]^\8<7.B<XEPSST@H[[
MJC[PJZ^!O$3HD53Q*P2YF%H*,E^9EA$70+$=;1`BUQ-AAEUB6_[)],/+S>\U
M'_/1U5=ADL9,H>5Y'+=$1]RE[-!3E"16/7-K0+1U%M="NLFHC#O+V0M4Y"U1
M``O$04Q9EUMZSA@?X6K4O?$JI()\3."`"%0,PK6&#BW"TD#8NLDSEUMIB$-;
M:&UI**HQ=4UC!P3;9K$3J5Y-0\>!.-1KH=&\WJ)];:@C>41I!S[6;;N8WY3L
MNI#9;$E,17UOR"K)8Q1XY'=)=F[>Q([GAP\7SE$Y8<88/@Q[KT607IFL0","
MFL-#%8`H@X@H2(`F<C@]_`H]W"H]TH(>;H4>:48/KX,>0`RJOM!HF%=MB9GQ
M+$I+D=!J'-B[.-"R:C>L-]K=HT/VR?=-GQ/18FL%#F5<0/O,.FPUVT9\,+%:
M9V!6"(9#1!PDXC#)L8)!S?4-A<O+5):^>0D:E(\P.I7.A443?4XYG_P1IVE0
M*3!44LG#]^2W![(VFYN_S@#GAHPCB6JAB#'$<$"L/6^)P!?D&UF%=\4GK"W,
MTHB6H9>EQ^='%:7`_"@+68GBCT0B0<.1]393+[GN686HA-W4,SSSCMZPYF]+
M5@(AFO^:8%HZ$562<#JI:!I^V,FZF-6>@@&XD#@-0@&Y8AA308GO(T;43@#.
MFJ7=N(E]M[-/H\8Q7`;8MANH0P*]XV3%UV,0`&2LC(%T!:T]'=/4!XV8:_XW
M>A%)](@7!8$3)[1K,U<R7X-R=^T0ABC,J%Y.4HU4UMU<;?UA$(3K5QX#G%?A
M4A^B>!UBILQKM<D;6U!R7`<O8L5I'8$T/?JRYI<2J(B`Y:YLJX?#Y+I4VU>=
M@#SS*Q`+KNL$=*,5\#C!"DQ;]7EI?^+'G&2,Q%M,+S(PHFDCGL>]7#K$J\=$
M@3BQ8RDJL0,[DI::7!EGY=/[%;$XT7'00E;SK0>2:)!"SJ!"]&NGH,U`;9R%
M-:$HXMG()E#&.3E.2P]/I$)4G.&Q%-7\=;`N>4T7NG?5.^FNJ;:NF[O1$*8:
M9<,6+.\1Q/VP)@)9"1[K;HX"&TEO:<4\-.-K_\!)DD(@U_&M__!H5FE'`LEV
MQ$R*9,N*TL%4Z^?>`_$JV`11C1VKX9]I4;,>KNEG3Z7X3"]OZ@I<@MUO'J*G
M;SWL4UE[2W^@(O:V(F+D5[]>X0<GN&3%RE5*!'5-F=NJ=&^[R4IL!.)#++W+
MGV;7LUL1"9MT6@\QCTS%Q'PAO5)$K7FV;$`'`DVNR/G!TO/WB;9M37>+6$:J
MJ07\,B`V<QYC#Y\_K%:KJ]33>$W9-<]*.+L;@99-IZ/0^0-:L?^1H8!>46JA
M\",BXQ84`P!!7[6=5QY/^N$VBG=L`>3<1X<4M=`"$IB5"(8XUBJ6"LMG%9/J
M26)`($\J`F>&>_.5,.>Z\.;AU4G21ZSSF`*S1%(O8YH?4JP40.K<B5XE)!D(
M:^7_I&AIB!>D.DDF2'6*%K3B20I,*"\%V,N!`YQ+WA@Y[XML4#.I$X#5BSH!
M2JTW`[P_=C[.FK,Y%B)+>PW0!Z-0<3_I_5.28Y0_4`!V`R43FOZ;)8G$#!;D
MLUY);KO1W3.MG!1%2`A8_LR^](Z(`X##HNK>N^7US*Z\JG)V[Q%1)A!#*F,]
MQ)CEH^N<]#IF6C6N321:1:3ROT,ZN\'8N;D5[=OZJA*RR;O,IA&B%?`*I)X?
M?9?VH"T$-\0/4>JSL?0%R2$Y.$%P1`&-R)/_8@K3Q:Q(.*MYE:1D&'U8>8_3
M9XQ#E#Y'U.O>13$N9KG1;H]3NA[M<DND")CE[I3!?I/=)8!C:`*UHVCG'#LU
M\5H;ET@1A,,EG%T;E+[KW?9_RWV?!R"0-$EMNTXQ&R#KF1=!/";",8].@M=[
M^KV*=0R.W(H@K?H)RF@W>3J/YY0S$9^**D(*[J@^&-VX1#?BZ!8B#,@1,4:S
M<F!X[L<8F-.@)\+]WH26_,Y9PH08!;K^Y>\'/SV>$Y4>A?23:?4$DP*QUANL
M![561@(;ALIQ4')LM+Z5O$^8PH>:C_<:FS#K%M8-Q/9-J`BU/IZ#EP^C]+&4
M;@AE7VH^ILOTL%Y#L/HD6PJMN7616P$B+*JY:3BES3H91*I5N[ACQGX_A)JB
M#I[RUDC%1-O:LHI"RXFD?X.:.M&BO5KSJ`;A9^85/=57G6*M&U1MVP(.@98!
MT$%K>=^D%J'GXXN/?NCO#CN]L$3W9-NZI(E*DUNRO\,*)VAN'IP>[.0?)5W8
MQ3PS\KWS6<KWG8)=GV1+)S:WWF(5_G=8SJ#BIL'H\$[^D&KQ+N:PG/IX9=HD
MI0>:;4W?BZQ&^N"5N'V*58,P$X[6#8@:XYHG(C>Y=LC+G"[XEY]Q[/H)]I2N
M=7M`V'FOTX>6>H9Q,<MB+Q<SG*;;N?[C(^WOX22/`2:?!&>#*F5``%QL:^/3
M2#<+BUJI10'K'%$/W1_Y%;3K[SLST<SQ?<_Q#3%K!&>#]2P]LU+2<I(75RHJ
M;C['Z(/CQS\YP0$OO?\Z)"DO$)N''G7](CDPVVY1'ZI-QJ/C$9N`RAD5#P)6
M?7PC[)X8=A75`<[_4>)/)?='A3DMR-U'["2'F-T])O07S'!LL/L8^K\?.GMA
M=![(E.'9.I9K("P1Q.KD!2JFHW(^B./\`&0_XO0QHHEHQ'IOR1G%P[2]E1_2
MG#,G8!Q)_U*37NH&@+LNTN5P:?1`D[WG[+KJQ%BK\&/'3-N6L89$1Y^4>]8&
M.-IN,>LELP=2;%%I^[QL[S1;'M3/1K;ING&NUH\='8=]E/BT7=2LE+?N5K3%
M5K';;D-F;3CJ27+8L12YA%:8<XDYN*"=IW'HT4:;V@Y#'SSK#D,_PC+/O9R\
M0/ETE,]GO79A>0SZV!;(''T<V#\EFS*LFOU7XU888FG29+87GFU?00%A;7$$
MUY#6`,D"&>JN0SY'R_E4\R@M95*[4GCK)[]]B#&N=J$>8AP[X4$RC@*$6^%C
M,@S1<<SX<8DD;+M,:(](=!8XQ&F[<Q_)EI+\K0GU>*CC_S'R<`#67.K@OZ7X
M^[*F\Z#LIHR7M>VFA)%AV,V?HH`<ZP,_/0IDUEC3-2!#MJ4M(C3YN!P`7X:G
MHT)A=I^*D2=E>[MY?;`5[F1TV]+-[[B4VE6I`X)D@9LHJCO"V<6T_9920]`K
M9)&WW7#RY]:T,3F.*_?O-F^;#-G,_)#:9M8!.39$O;LTN^`!K[=<L6^BF^S=
M9'8#H&HOE>%9?3FMAG"3$\M9-`\GLX";".4S\]L2$'9P'#RC;?YP.(U0\9;8
M5IK+V(A6<EYB]JJ!H+M71![8^VD-$>Y_/*TNOX,*M#S$+,TGA\R467%YGJLX
MI0P_55B6"KJH(MHNF9+-+%4,FUM-`\RGVT^A&P//0LJ*GF1Y*0,\%9XF16-,
M$:TH'$<#9S"%7K0D5E8`1D=<YZS.$+F_\=[F%P=Z*4T4H1]YO.?Y-7YF?]+.
M7U.$:CMLH(Q\]XTLGXGX5,3G+GAW17(6(?/YB/$S:0;<\)MB_(G6;'J._33%
M(1'?^\!WRSR&9FM66@"JR*%U@\A"NO,T5+@N4H19&\0$^0P(&+_(3*K5;NQU
M1-KR>R3^F=;;.^R2K=*Z8>=.$&#O[)@G=V4#E;,"ARX#JJ2[%GF4G_\0C5=(
M1PD9<=`T?[XHJIO/F%DQSD2@D@HUG>@6=!`%;:R$I[XD_/_`<609^=*MSPQ$
MDPSV#,8D>DTEFC>.[AQP[*8WZ=Q:E7GJ.739LSIQZ$$-HM5XGRK2K6[/9%[F
MRU;.W$GQ]BZ9\/&=<=#/%-D,SX[SY_P]ML;'KOJ^C7[5?1-;9HIC_E4+Q(%%
M^;2$MS_.IR.YEKW8VHU'>[>O!_FNO<!!>:P*I-#P4^NWA-6':/!=4P-*%.@V
M@VV`/=`A:+(Y<*Y$!\FVOF.E*-@#W*G<=;MPC@F_*OG1?\+A)BIB1(35M=PI
M-8A6W2E5I`6G(>))T9GY#2J;2^]1J[/AN%,#D24:QJ/(9C>)#PS9-.)UWZ="
MUMR],L6VXEZ%ZH@#<Z^TA+G?O=*1Y"$7J9[G4^!.P../Z^TY.V2S(&5^PW+E
M[_RN)(Z.6QYU<':N4W70;84DBLG9U0151GP^XO<8Q4TK`P'@5G4D=&N!E^+*
M,:`3@2BED7&OWK669!!$HE0(`N465EO<)1>QNK(^BIHB1TX#325I.*0%V6YK
M+TTB2`2:YF2#U&&S8%^77D(*)M@P%=MT!.G6<04Y3DC/C27=RLZ9B=(8U4G+
M#Z-C>&C=L("X9R)$E7RS(A@%WR\SP+,(/8/46V,BW:VIM/`'ZW]))5G'^9*)
M\=B>EZKZT53,UC21IJ8W$-:ZPP5$,4V/=NE<P=96$U&BQ\4Z`14VB@0/\ZLF
M4FR=,?]SEF*Y#JM!-JW'!/I0X500[D%>O:@P!X3682TJ#^BUP1CH7[>+W-+B
M>/Q]855N_\P3=VNU?GUZ0TJV_9+6S\NJ>+(@+P`_;0SB=$;T:W3BR<R(OH]Z
MQ#5ZJ1$*B$-GK$4TR_$JJ)`!NO#'.$J2FSAR,?:2#P1=33THMA)ZD*VZ>KI$
M:/(\FX]R`(A"@*8)IT9^GR-/1:8BXD+QAJ$#IR-+10\^2"ET0DIP+&%7]@I-
M=,C8CF'IF4[C(BK"A^,L*A-$W6VLG!N!Z<W):5++[^]6FY4#)#P-.C6!.OU)
M1W"C\Z6[EWJZ2-/1U%)$8[J<QAI6PQ[!T;(:ULY8:+H<4K@Z=CZ**'FIH-7M
M'+3J<5VKRO<4=>WX6L/<GYU+Y^8YA96;:OX.6<EO%<^VXI7*D!'G#M=275:=
M3PCG=R8-4&F]A@S=X.#1$@)4!IL:"UG76,.0[G3_.EZ#<N5#2.`G14V%A80V
M]-^=]`'B_O4*K-BYZY/6$=1(?C$CU"']R=(-$"`>)K30$FN3XA[7CB89#Y?*
MN\U,DJ`KE!%PEU]2?`D:15L`E7T8J0"/>2R\<P)<TV++T),T`VSK4#V(5EP9
M7:15#GH41,OA(6"LM0J<"NWZL22A:,NJ*`'P?(;BO2$ZQG621Z*&MD'TG!UC
MA66C[O$VBC'RL'=P4]:S;4N.%95_%R<V^@_/3]SHP'K9%56I\.<]#A.<,+A4
MP\6X2%CA_]PYO!W<'9E`QIV5EI%M[CS&'J;Y+$Q=AJF?'H%X6$;Z1NQUF2B;
M49+S!A5J4DGR@56B226%:%CYF3*\4;I[[6),9\>.NAYPW,#QB2$X?LU0DVB,
M%+Y!5.A.YFL2)$$"@@!S`(>H#IU$OCG+$Y6KUM[N#R]>-Q"ZY;<4^L20*(!&
MR0^@*G%:<HCK@&3I?T05[)WPB)R'&-/^6Q$_3>8>$-B'&<-)TZTD<8M@N?40
M:<LN0M;H:#TS>DP%T>M7#M4],W<?OB<G`X\XO?38P/AP27?UP'HDGQW+(3?.
MD?YJ2;ZZURCG7'U-QRO*JSJN,^S$>KGE*8G<*M%,(;UDH%!U.519CXIN=5RV
M)F*++IH5Z*-Z6&*!LL5!.,Y6:-RP*/4^$LTBT8#[%T\J^.K]D*>4^IE5Z5D_
M*F=-5'B]F.1''ID->96^/A]WHE5M5;\;G7@3J,5UWFWKQ^S*(2QJWU_CE(K^
MARC>8C\]Q!/4OC<I,3<Y5077VUE%@@<ZG3O41%4EAR!UVE;#6GVZ:>156KAN
M$F$=<`+OWL\ZLUR;Z+SX:EIA2`VP5H./6NAW*A1TUE8H^7Q:YNY<R/;VHHR#
ML-Y$*3L@9C<,4LFV&$,<A&/E4,S?_7)KX%8_<N'=U2@`+&BH+][]H4)MV9[1
M`7,?L7>@%SB]>C81*=J-<Q\H]Q8=;T%K;M>()&LIR`PVZXNAX'TE4O<+_<+6
M^7\P_*J3)YL]KVML(94[7"-+Z(S*['"?^)[OQ$=^)\UOHS_[^BW)A("LA\4D
M*+:D(DL4X8DQO]!15GC:D-1:(9&>#S8C#Y;K7SL[\N.&2$OBN%1R+B*:1*)L
M*?LA63.!*DCVL",?!TC)*G\XN?94_6H#CJ#5_GHW+'*:^Y(?,8TM:!T\>X%9
M/6XJH"KM/LCGE.?+7_BTV5VBZ3!LA,X!'2@-,*L<(P\2)(&=&57EL?^DJ"B,
M)Q"@O_)#O$KQ3KEKX@@KG5P@ODJDT8/OZ!<*'C'X0(Z`IT>GTXNTMP1OFNAZ
M4^IF[']57EOR^GG4^7=C_QY[9X?T4^AKO=72A&K[_*>,O*#^1I:-D-7I+">C
M^T.*\ND@G*.Q,.:W:\QS`-A\68^9E<["6IP\]"*,I1)\B.+*HDJ9IL+)5A))
M):AT7V'Q)!\RN);E8S\%5`.1=2W7AE>4J4@,@*1-#62*I"L')02G(&NIV\**
M#RD3VNE;*AJJY']-^)^SC$P@*9=]8B;.J.R1L;%$/\O'U+_M;@*P?Z_=1JE/
M_+.1("RF#AX=TO\\$2H#;Z3[<9$)?_[D&[K<:XJ*WM5SMZ"-6V7E+@IH?F%R
M(`MLHC7AWV7^/'R]Y:DX2HZ!(6@H]5G4R*!8O(4"0SDTFAI#X:$"(!V_GJ8T
MP1CU70:1HI4=1TFQSTF11D!*-$Q(B/Z",+TTV8(O]:*A-;3JP*BKC!&+Q`S0
M@^I5+"!I1/7:&:/HQN+-'7#M."=9J@_S0&O*68@B+W=S"EIS`D6@["L.5#7S
M18"KU2=H51Z'D'0=\YOWR]\/?GI4O712@&3K4DD)R?91J%HI)I^&R$$HS[[@
M4T%<!QEAV%411W3W;>WR1IU!I9<SRMPY@A-#FW"3(R*7Z$V4/Q5K-F$S\EU4
M88-P6=0)(?94*`P6'N)0J'-2O`]MM7&$YYX,)D'>VYY&8++^]L30%@656OVF
M`7HCYC3H=$*TR`'4\]!4$>H.AYY^&$'92?MZ:X6IY)"L1J7ZD!2KK\Y.L[`N
MN@8B66^MD#V];,17``63=+'LZR71C3"P,)&2D/9'A50D=%25DA^?Z+LNPM>U
M(Y.9_Z0*&X3_I$X()054!'W8RU!Z5*^'>0"Z3X,I4!?6(G[!GDU2Y.L1"XC>
MDSD)^E17+S6`.D^:^D'=>=)3#N->^N4U759A/3`TZ+I/#A3*15\?ZHI7?$55
MG%78BE_#O=HS1+YY@5743/-#(%'J2;#OO\GK)00PUTQ7!6C=W:G(_XBW=KHZ
M3#U";UV1J8?ZS;59X9^!TV238U^]6X*GRJ9#7W[+!E.7C26UQI=I$VNU5E7V
M?+WUUM0UTP0)HZU$']HJ?24*348S""!HLLGPKE^CP>N`,P'B/3W_>FD`Q!,S
MDW>-K@XJPC[&$W8<)T,>K9?383Q3KZ(C?+9-VT8"?HBNB@,@ET9I[UV/RVV5
MUM9B;66G0R@6(YZ7?N0%*I?)C1.GOA-4WXUJA7R4`%H-]RBBK'`XRB"@)?$U
M.(S:6V7[#L4X*%?/`7DA4X>8V`QE=TJ4S4,[ACC+CT$]Z`-Q(TR$NS^8HR'9
M`Q139V_WHA<+N^N[C8+@0Q33]^I:[H4F:*NNAS896N^D*8"*MBI:FBRJ?:'X
MC?$O%!3*8`'R7083H51@$R5EF?LV@W%;HIA^M2T?@/P$.2C&5%?X@9^79F7O
MWYCVX`<AVL3E'C_X(6MZQ_Z^9Q64RQYW7O77P+PH,^70[V$9:889:V-T;6]]
M2)/4"6DSUSX'31F.K:QH!035?9/1A9SZW7HYT.;X5`:!R.8>Y\M$$V+%%=5=
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M924.BAIIJK&5[<^8_G_L+8DP.P^\(-`-CEG`8M0@J>I"\!Q4=1)I!%!SH"B#
MFE4.(W!YG/&T`JKF)&K1H=%CNR`(=&?2G`3_'84UTT6&SJN>(AJ@;V4+Y5M2
M#\":@+3BW&JCW:L2FJJQT*:`0H+CH`XV.C@J>CV!0@L._&#,*@[\<\Z^3L:^
MN-7?.BM#21Q<^H]#Z*?U4'>,8M;`OAKT!I(78*;4Q$ZPD4:;5BF;Q%PUP%IU
M<+70-U;,4\7_C)W606C#BV8.0F<B594%18'YF?KBWN]5:LOZM.HJ/S#U-KG7
M!PC5?ZRB;*RD"B#VXZ(#49X.DTD\*1DJ$RFG?"J$".E4'QNL/]A24(.\P:9V
MFE:Y%M'H=7S)8]%CNX4=*T#W$#N)8JR'RX#_.D:7$]WI3.DY*I$#Q,W5]&A.
MI+^[J#>[*H?!).#]:;'*',6U%NK+^7)I>2-SLHJ@@WAG%EI]DJTLV>;66W<1
M[`J"#A"T!9_5.1YMU]9R#SM919IHV,4G@+JZ)J*VC^6^0^^&?!W:XUK8UES>
M^'V*/=ANSS@18662(.BC;L67@D<&ZPT>IQ0UI7:0$\K9?`KK<K</HB/&K$`4
MKT$@K!K0J:'%`&S9:!E*K6A`-C8K&I=5%9^LA(#^,Y;!R-A-6QR$1M2-@#5G
MI%=6I(Y)GZ#,V.4C4SD"]UNJ=6MS;3L%#41:/3O(OQ#]NR5??,J]6S>_74RD
M9#8[.&A^UA=ZUMU=1V;WA;N[EO2Y;16FL>2\3K5O>PUGI/ZA"KJ#P^PKLNLP
M]9^XY:#0"5;O#&H[20%9#9KWH-CDEV)XYNDP_J$S`!9_&@LU0,%N4Y02Y-"#
M#W_YA3-WB#=OV6&<TD1<%\<I$1H:SR:_WK%DOM2)'S"XYV$J4MD?L%4024#!
M*]%Y-CMI5!+-Y$\?.C7M1*O;,M:3$;.S<?I+!J96^@I5UD)G1U0=EZV'V(*+
M_*2XJ&8$6WY`89>F?45KK+DCTXJHU*V95#Y/4LEQ+AD]/*^]`=O'\"E(VJWE
M[N5:[C[7<O>J6BZOQ`6@$L*<U"Q";+Q>0A9HJZ;+HQ?$"^/E%;X&X4S/29YL
M:!>CV'XT8Y\V%1Z!\,P&&D&LU_"9V?B,>F-F:/I.QWM@B>W)*KQA;,UJ@\]U
M/NI:^E0/1]UDG-)GX"O2UAM\3?H;LBJ`&\)Y:%F>B')GP5*1)8LTF.HATSY*
M?!H#`HBR\F<_V1.Q1"-/>AP6J^,9K1GU_E=)<L#>Q2$F5I5OAL<\*O?4B>R-
ME-S?T%_!^FG6A"A3FIY\G8KU@71<'8-<E8I^M0,IV$/H&$A/\.QL0"+^/*C9
M/P`9JSRU$XZIOCN=(TREPE9NO>8ZPG0M?:I'F&XR3GFY4RUMN)K,DMAPW]5H
M.>T3,H/GK/#0/UDO7J*4)O7BQ1II9H5^WX_#O0"'GW!".+;>:L'H4FOL/5@_
M"4Q#V"G/"GS)XK)BNJXK`^^WIJ=J.W+QQ";".D?,0PL^[$1N)R;29.H7%-.H
ML=.Q!]=1^*1F$L2F?(+EK3KZDY!S2D-0K#J#+3!V^6>A*AGY\JE3`=HN"@F)
M%G#:S4RLOOJ/`Y/IKM.)\50NVALE)?*X%2LM0?/XMGH%SBWN$,1Q8NZ/,E.V
M<$=!]D8A<H#UV$%]&.-"[C"\=BO*9NZD(SU-\\6I>PLO.:3;.=70OSJY9;F&
M9T7W@J(LN+UF$/.G+9D3\5)41XW>-GM$C)TX*7\[^\4S,&KU\10Y5G:D2X].
MM#]P')T(Q3JSQWO(:+W_`@"R`4LLATT>P&?W^1R1N=ZK*7@A@)P]8=FISLQ#
M38=OHI)<^EL#?YH?]3.8A(H3\]SVN:W5A*_E)OT,0E?2?IX\8*K9RJ,'3)(/
MCA^C)R<X5%EGT2CY/*M3#9A8G0YV74-9>;$/QC:.&AX;W6:?D*M4I-X;>DMF
M3O*XNP(;)1N;^)/Z2!V/,("Y24`_0N4]1[.#P2G'VZ:F&YPV-7:5Z;`C_A2:
M]*3,5]'^'.1Q7W=_)W_FU_\@)O?WB>H%?F4[Y8N0^<V:U9/L\$\"X5W)ET"C
MTS^B&>K;><YI9LIV0-W:P3OFV=1C'+UFWX^5SI_S$KS3,B%5RX0Z+%-QD9R]
M5RA,$C2+!(WTBN\[!I-%OYVI7;I4NNGY(:LGS!C2N8\.J49_/9[2"Z2!O`6M
M*NXW.K]*G=(>*>V5A3LOB"^V"M/8#Q/?_8F&[57/3C/LQ&HE]ZF);&)UM(P.
M6QK1M5&Q.&*K@SCW6"'R\N$A9N>/)DGR!Z?V30\<8FT>,;_S?>E1BOD%Q9K7
M>YE=01XK%()2,B_&^RAFA?!Y>A*PFO>S:-#^HOESJ$^+=J9X1*1N:@S<A*&;
M@'G"&4[:Z0Q,L3@@&P."Q!+S4G^P>(%=UAD#O8&1%0J>8"=W'!R?5NKF."SD
M$YI%MJ#>AQ_]QC$P0^TP.SMNGB/]\UDQT_YYJH)$MWGB3S'("&!G%-G&66+`
M-'EM`P\+DET7;UX<E!"E$.`RW]-!85G%T@FP<Q]D_142_F>7R(D3'B'Z]$TI
M4?3!&R)BPV>FB9-,7RR3Y+"KW^I+9']$C:JT@]/REA6).KZKS-)@V<JHLG3S
MR9D%/6>?N/54\U/VY0P)L"0^+_9>'O:$H7B$GC8.I#X:_NP^TD6IFJ7_/H0>
MCH,C>RF5)#@E3ES@,!\NC=B`I)+PM\\8D+4F/'7O3D<;3N#:::C"$RB'U8W-
M'KO$:=W@>/?:*%]JFIV`R(R:BL@3U,GJ-C0L(XHMC>C:()QI*Q0NR)"2`0MT
MQ$X,]$7%I((];<U`5:D&E'"JI_@Y*A?^D^_AT+LE1_S1GD@,W@C85Q$CD-B&
MOLRW@.@>3N'APP1T%CSB\W+2''T<G'C!]0'4N:B1@7KFY,!!_\LR;>X#Q_T-
M)>XC02G)WXM0-Y^Z[;O(P\&)MUT:C7+6CRBS6XMIRCQHFHH3M\(_1?0('/CI
M46"'IRGQIK$E$$>8R<ENPS:7F[!@G0'27&"GGTHRQ5.0R4J)RD&$JC`.?',-
MFGXP#\_S&)EIJW1J6Y@3->2W?O+;AQC36W),Q">U=ISNW,@7<9P6D'A&DTUW
M@.@64+Z'+_(\K4AH@9V.*9&VE$@VS#08ZMP69/!S7IF$'O:/R=H$Z:+#EW%,
MEEF!^8[)$A-P`M:UWIMA>4@?H]C_PZ"W\>@;.-DCL(2D$S0@R!K:K/.&-JA<
M\,LXM&F0LTP%KF2?<:J0G]QHMR.DY4V5TT<G1:X3HGMB,EB+6GJ:XW]CV0\)
M<D*OUH'YRSFV]`G]M(>4'HD_`:7YT?GL[PZ[.B(W.+[<[8/HB*<_BO1NX.2.
M(`HDG>#HD:W:Z@K&F@/D2Y^V4VU`V)(:-969:=*JYG0C@@LA*Z%RIC1WCH=I
M9ID3'M'>B5/?]??T?0^-D^T[FRR?GB^J*O[3^*"*LG\":I1OG3>(EW1/G\8&
M=BY^LCZG@)03J,Q,0?*EROJ/7X:OJ4C&ZZ9WR3W(+\=!E$GFM,ZA1"Q/1J/=
M$%Y_I'_Z$,7LUY/[@Z)U3\X-%!-P.E56K,9RZ-G?3MOE4R=B_AJ;.&S[;'BN
MTMB[`?9`@&#Q#JV(%@IIY!/QMVHW!,[I>W(]\CJ-`R<35OZ_.74=K?_@AP\7
MT<[Q6V]=1`2O3[*E99I;[ZH$1J_@?^$C6GTVK?%K)\VES-8FN/Q_<W+0QD\#
MO-ZN0I;;>7""Y6=?N4%Z]V1;'"5"I?6.GHZC_E\Y$OU"Q\[>RW40&A=XBV-Z
M?C^+P@,/>-[$T=9/F6FDHD/5/+6BZ@A;$RHI&TJ%2\:#%L7H9S]]O&6/]8B)
M?O3WF^B26.#T*%35TK.`+GC;1V%]<K0+'I:#J8?#APNM@=43ZW!LNR3TF0!!
MFF2P?F@UE`.E8ZF)$)C_;]8C*_7*N3M/=39-^@H3]8N([MG6CH\B9`0--6+T
M*21&B\_@-BN;`\(<ZZ+#T=A%GK_U7<Z:8*RLG,_D!R89D\TG*7F<_`['3[Z+
MNX]Q14$>=C1+-E'J!-6_GT=)>AVE_\+I+7:CAY#>7U;PZW)_I4IOGDW9MNES
MD;[U@C=;%V4+(U'P:%&I2\>77]2#2V1A=,0I*I=>9`&1;'507H4M>G\*8S(T
M]@@5W2KUW"C)ZD_0U]01+3)6U&=CBX-S1F95%DHNS)R:X@3J4M2JF"Y#KW@S
M'M%?B=L6WV+JX)'?GT=A&CMN2IQ!41T+<<P1QHZM1OEAD&"2^X&B-5!>USGT
MRG=D1'W17R]Z.ML76T:5/5LIJ'%ZG_#G9E,"GD!"#[DMRY%GQ,-QE"%15O$V
M`\9V)ZJ?UUB_J+19Y'1_B.)J%U?U'.AQ%[5?87,<TBD7Q&OIS$I%Z,K;(+)&
M43UZJJ;9(S<A&(5N+2W("O@B5L!W6SX*HG?74W=9'[OOP"CTJ?2U85?7B-OR
MVL&CU=Y&F880"Y2.J-I,^PL8Z[4!:IVLO_-3RG\)L3/4;!#K@4/7Q\F&UI?M
M\]S5@%@I3JJ`6JN)8#D%D3FH-@G]PJ:-?\>A7QG3`+6*1+L5+*G[[=:P3"D`
M(&4J5;E37&E2D37G.Y2?/_IX>_D9NP>:^+/>;GT7QQ]9TP'=^*8,E.VHI!S-
MEMS1T:@8CK+QZ!<^`]:UXBBH@;&`&GRI%$KK9\H!UHK'Z=@QB=;JI3\(1:>M
M3<2SK=@G&3+=P78>1\D'6Y..\5$!8%)U4*C84EQBX^3S@!C/7F$16\T^29G&
MX;SR0[Q*\4[YHD\=H-7SOR+*FLXHG8K8W/D]TM%Q5?9.`XJU3Z$`.T3J\'7_
M`5&#J0?(XC+&SGI[$T=['*?'3S0Y?4U^9)7LK[#3G^JB",6*>55!KO76G<RA
MK_[S68A-0\4\Q";:M[?&N$5;M,]QXX\1H@*W8!+<]"VQ"7(5_4%?5SA*N`*Q
MT\I2*+;7JB(XWS'W"B<)QG1MLH5JN^;ZOI);'.)G?DFA>_PU6<+VL=B,+$UN
MYU!0!J9Z^9HLFLJ*UOSBP.!U'!B'&I>?4QS2M)B&>//N+<\1<CS/I]J'D,#>
M:_G165GG4&XN*@.\"QK?)@#3"];K<!62;^`$;!V!M+=58P\(*WY%+UI-_J03
MJ`RFB$]!V1PNG_;3%@9@%5.LLEZ6?H85ESW:UH/5IW#"\#`^?OI>A3:"39=B
M%QT(LE2GW.N@#L3)4!-&L8>A)(GSN1=MO95FJ<_7.-5U).3`;+L,?:BVGQ]W
MV/\TS]U?(#(+E!.@BQ_+N\Q$C0HA^0?FX^%ENBJQJ9(%5^'1`;;Z%GL'%WM+
MIN36VSLG<.*CDHGNGFG%,HN0:&MV-@[Q@:S*'QMJWPKK8I`9)=X/=@H,].VL
M.@J%>8T%V``QG5+9$%M,F6`,D-0-^6OR&`55P%@O8BX`835&+D2KW6T]&U@7
MW[;RMV+43'&IL3Y.BJ,K8=8DOSG^_>#$M*PVH&B_,J8U9[H;:6#Q?+F<]4?P
MI4(VGZ-<Y(Y=^<X];53@X^0C<2$.1.FNPUO"6S%UZ(E[[R>?PN@^P?$3S8M9
MA?L#>\<2NF06XPRE?+#)UK7U'F,"`G96H6=K+%!E%90O@Z(0%0LAMM("5=="
M;#%47TV4KF8M>7\J5I2FX$_$AQ8$^.R8HW`\#YPD$12$D9Y'Y,!LGW3[4&V%
MP?-!B(VR6#ME`-%U#H$JG^\D34L3'[W"6=-OY`LP/D(2BZT1?<G7DC%H9;]F
MX\*YS(R4!>>3[@L<^T\./7A\\$.';,\)5F&2QNRDD-30-,E=U@5OVS;IDZ-=
M%RR'@`H0J`*C[ON!S'P>3H1S7ON<5W?XV:$WD2F\L*TA[RO9<#/&/TFK?B7)
MYYQ:EU_-F?HYM4FXDF1.3G5XO!*GEWX)MK[%FW.9]R9CGJ1DGSN!>^`%WFZC
M(/@0Q8**W&H'H\DV9-MKF(/D\RB$!:IL`/U"MX"R/<#R4>R2/*<R3U^/MJC3
MX4&?6-[>G?\0LFIT8=KQ`1+TX@H_$6J^^1J<@S2;*M$+BTRL1RRHZ@H[T:J:
MK=TG]>TG=62+@R2#I>V%C;JX=3=L9%+*U&YE*5XNMDNZ&\LMVDJYC+TPN./W
M767)L'>I$Z=**0ISD_3,(?]T,7)2M';3B':'>;U`1&3>LH=!Y(<W$]'D,O2@
M4^0?!^*?OWFU@.><3Z&SU+SS"106?)TO0.)'QP^OHB19A6YP\&C?GTLGIJ6A
MS"^-)M\8&'=]AD\PLOV0F8\%HCLA[B39R]<HWPUM,Y;O!Z8';^$K++W_.B3L
MW24B:!\"ED=+%1]R'^FC"4JTLK817+]\+AVBYY_/I$`&9->-O-5;O(L(IZRW
MV<GOTYX.S;M"*>77SKLC*WF[<Q-=[?B.?E;3O$W%6W';LYW0%,5L+XAN!I6[
ML9]R;)OX.8VB+7K.:'2@-(JGHY%^4K-](E62I?OHU4JD-"?8>TZPD/5_5SL2
M`:&7+E/922VW8F[$*>LV;`TD8^W2?(NB/\@FNOS]0'Y/MWWY&<>NWVFRQ2G$
M-O9G-8G?S@=1/4DIVG/Y2:JY)[2)$-\5-^WYOD"<J`!]E!;=T@AA3C>FF?%4
M=#-_W`"%<%W/D(EABQ4I2L=NBX0CO\@U0?ET^O(J00X*"K]UEU\5'M@]U:$J
M,SZ7F?31H4?D;8#=E&T,LQ9??TY0]!P2>,EAQSLN.??1@8\H?YF@G1/_AE.T
M=^+4=_T]NQ1[C@X!79(=LO<Q^7WX,+LO`Y\=S.3([F,:BY:Z_Z6.+3.MU]%.
M6A$3X^2<B-4A2!U>,>R:K)7]Y2RB#06V%SY1&`0J3RL39VV.`571":F(W8BX
MZ+@VHIY6":IL@17?NZ:V/>]XQ;9!3_7Y1E"V$[.T37MT:!I'(3T6["5B3A!Z
M^T:;A>"<(/>,(,30>#E!=GQ+>OK;'B$:WM7H=+"ACD<D8:Y$QU,.,[8F5*VU
MW3-!7ZFI[6"0OAJG8O8D>^X3J7P!*[*AAF;.]DJ<,6-?-_<1>P?:<W=)G&[/
M#]B>[J@[PG*?+C_SBY$/!%W:7^+`]?MZF]^3W."8=:`0O>B=:"%S"9H&XR&2
ME^^(*OOJGE"Y*93OBE\@5O9%)^4[0V1KO%^:S0>[TQ*Z*4>3\-5\\C=PTV?'
M;@""![USK&HNF3/08HB8BD33WE/A&0G7%+OI.<BV#%X[.RQ\.ZP\=6QI:.]J
M`I9>(+J,U?>YNE10X\_6A['-9,H"<R5Y_S;Z$M94>`O+*?2UMBMU9??YVE2T
M'5FE-]GG9$2+%U6:3JXR^-:$JHX?`(E:9.76AL859J=+3QBB1IZD)`^ND8>-
M(/\(<8J"*$E8>5_6&/.$E4N=EB-KEIH`#;C?^#$FY+Z)(Q=C+Z&KLN8&SV0W
M*0YO#O>![ZZW6TRO8=9;_MB.O;5;AE[^VF[S'(GN.<:!_JMRM_AF@'M<[(:H
M";83E&\%T;V@ZF80WPW*MT-O/VIO&^DE2?&^D6QJ4.!_?KK0PHI")<&)L\^)
MPU3"H4J</2=.E!.'J%"7$R=AQ*$7!<\6JUV,R^Q=EP(C?;%O_S93VL>X;"9)
MVG@8DW?HVVV7&*!#7,WR))S$?R;NW&]_(S^3_]`:]>1/_Q]02P,$%`````@`
MLX`*1XLW*3?W,P``C:4#`!4`'`!A<&1N+3(P,34P-C,P7W!R92YX;6Q55`D`
M`Q$$R541!,E5=7@+``$$)0X```0Y`0``[%UMD]HZLOY^J^Y_F#O[=2<S0,[9
MD]1FMSS`9*G#``5,LOGD\M@"M#$V1[)GAO/KK^07,&#)DE\0]DZE*B'@EOOI
M;DFM5JOU]W^^K>VK%X`P=)TOUZT/=]=7P#%="SK++]=/\X>;WZ[_^8___9^_
M_]_-S;_OI\.KGFOZ:^!X5X_DF04$UM4K]%97_3]O^A;T7'3U+6SKJO6A\^'N
MP\<K\G%F>#ZRC.U?KS1_Z6/OZNZWOUZU[UJ_7-UU/G^\^]SZ>*4]7MW<T/?8
MT/GY;&!P1?AR\)?KE>=M/M_>OKZ^?GA[1O8'%RUOVW=WG=OXP>OPR<]O&!X\
M_=J)GVW=_OMQ.#-78&W<0`=[AF/NJ6@S:72M3Y\^W0:_DD<Q_(P#^J%K&EX@
MJ4R^KIA/T/_=Q(_=T*]N6NV;3NO#&[:NJ0R0:X,I6%P%K__L;3?@RS6&ZXU-
MV0Z^6R&P^')M;"SGALKQ[M?.':7^2ZP=S;'ZC@>][<!9N&@=\'Q]1=M]F@X.
MF#<LQ\`?3'=]2W^]Y39P6XRY[GC4ZX]F_1[Y,!L/!SUMWN_=:T-MU.W/_M7O
MSV="+`HT4SFC$P,1(:V`!TW#QB6Q?=1H41"N8P$'`XM\P*X-+<,#ULPC?U/]
MXO%BO`$HT"M^<@R?=%Y@B0')TW#58+H&7CW8[FO96%+:+0AE]O3XJ$U_C!^T
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M!82SC(U[]].$3&SD%\.>>:[Y<X"Q3Q=DQ,&R`/IF(.CZ>+P)!G?B1GPW$!GM
M/=P#G@$%/>W*F:A.2.$;YN#-\T77%>*M53>Z'+ZH5728.6ZN.K<VA[S%6SO#
M,'FL_-AA)+R1;Y`/K"$TGJ$-O9TYE#>HYGIY):YU#C4*-534[0['C5@*VQQL
M9C11U"7O#VD48J)-YS_F9":::=U@:LK!J&!3);KK.9CDD%?&F-AHR*,ORIJQ
M@5XTT1TVW19CC4-?&6N=@JQU"L]VM,U3%R"Y]APX+Z[]0N;;7$Y*@?;/""WY
M+/62@#5W^^0E[A;LQG3!^;[TMU8CAMVL]LVP?4"CF<$37^F/P'K"A+U[VS!_
MSLP5>77D)4X0<;B<Y:-K`?L[]%;?`5RNR./:"T#$0]`(AG783@DV<B8.JQ%O
MK,;DSWF\WMRMJX)5J)>(-%]=Y"?/3"O<6M%%KP%1T`]V'QZ!@7VT"^"[Z[7K
M!'*+A1GTD!E<.G`!3?+%D^,^8X!>J`,X<#:^AX?@!=@=F:YZ!C:D!)6V^6@C
M%#+K@"4-IM*MQT]TZ['U:R#*Z.NA\0SL=-#)?<Q/!VV%1+?_N#H'AQ-`%NA6
MW\G'ZA'U67F>>0;R"G"=H#\3WW.7.%BY.$Y0GHG7$<@GVQW=N60*$`;Y9+JG
M+)%7[Y1/:4'N)4A&J0T"F(Q[P2;PD+!QP"`9^(%CT0W:\%O:0.Z4A"!EQ#4/
M7F#3)`T79<T<]!N=U[CVC#U$7-.X(9LB#)K7A6GUNW#<%N(QDD$@7PS,#TOW
MY=8"D,BY]9%^H/Q_O+EK1;DB?R%?Z>&;IV`)Z0L=;V2L00K#K$?UR&](:DQ#
MA[P:R(Q;)!]/U'68W!(]<;L)DAENS!6T=YI>('<M+[^8%S<3R96++("^7!,:
M'Q,FW<!1,NRSJ*!+D"##'A#3?OL=;+DZ.'I6;]=7":=08BVTSJP&LI*D66NS
M[?K9M1GB/WA&[]11[,<08G&WSRSNKH\HR@>(3</^`0Q$/*H>F:,8DF<]KG^L
MHQ(X:&)]=)2,0@_0!JA+.%FZB#\&'3RI_U)'+:0#B17P4<TTL%_HS58$/!Z3
MA9QG.+3/\N<$#J'^:WW5DX$KUM8O9]96#&M.FF7H)?F(_K<Z:N`(02SK7Q7)
M>K?RYLP3J<_JO]59^L=08C7\[<QJT`@S%F7HP3988]'!,_JG.HK]&$(L[M\4
M6?W>27@@W^`,NS]Z6F_=U5$''#2Q.CXI54?8)\45DGA>;]5RS<S%LU^SI6OE
M]CBB<XR_<)1'X%1'+O-8&/@YD+2/;Y:&L:$V\LLML#T<?Q-$A1+&$GVM[XX!
MC!</T#$<$Q*QN1AFA(9DR'-'ATI`-0]STK/Y#QY4%">2%.:1V3.A,`-%5P3?
M`I"U7;@YP.$_8-Z.8IZ*5-BU#8S'B\"WUMY@VDB62:,H]L16388*4_BOMS:3
M@'KNVH`.1XVG#RL*8@GI)5V5J1CJK<,9F4T!UB8QJP&V1[!^!HC7)]E4BJ)B
M?!4Q>B8715EZ?0'HV=UO?:E0[WTN]:92*0JWY5<O"P4[UE\K_<:#&/%BP8!\
M%)I)=P\KBL[EGD*3C)>F0#4#KX8Q\+"`-W[XH*)H'E\3Z5H[8;P1(VJ(*MI%
M$5;?T?.*HH)LS?`T>,I[(Q1)S\=KCD7_Z?_APQ?#IOENFM<U$-I"9QFDPO$<
M6A%Z17'(3`4R_%M!2(W0?WST9PI,`(/4Q1'P(E'Q^C.'3%7(,Z>ZLZ`TPT4B
M_M_&@%;_;4/+91#S'GLK@`Y$Q5&W`+6JJ&I.K0LB8B=GU$GYHFH^@J\VLB3;
MC8]Y9^=Q2*K.2^;!GKO7NAN`O"T]G!IL&9#Y:$,=3S)$<;LKFTQOJ0TXB7I=
M61B:,2PG1IV1ZYC"_C273F^IC3Z)JC@31#-&WQ[8T)T.?(R4HUX6B=Y2&WC*
MUEBZIGEX&N%&]R).NR[V>,&G@^?TEMK`4WYM'H%HQEC\`!WH@2%\`=:`*,-9
M0EH+(10/=[KE$^HMM<$JT=$X&T5I'M4%.,.97K#>JE-TBG++SINMC\.;*#A"
M?+Y@KV+EV@06IOZ?MQ5PC42;T%MJHU(R06093,T8C!.(Q:/,;"*]K38F):7`
M3!M(`=<(+TJD#I%X;%*@%;VM-FB5H5-^P%(07R,L(UGC*5%*E"*E>^%!(?-L
MRY!H16^KC7[EL@Q)?,V8*>+5R!2\`,<'V5:03J"WU<;%<BF<#:6TT(F7/+&N
MV@>0FOOUMMHP6"Z-IL-0&\MF'+T_+FW'C6QE4.AMM8&M`OZ9`+)F#+0)&8GU
M0[VM-KY5KM--T90WJJI;8M/SG-`+RAK1+`<WJ#@+').O5@Z5WE8;X"I!S1GH
MFA'XRA5-X8BSK39`5H+:^>!*BZ>I3OQ()/YFI7.E/*VW5<?)N$IBIG>DX2AK
M+:S0*4X<Q\_,S3MZ5.^H#8+ETF0:B&;X4YIEP9#MB0&M@1,5PTT`Y@6Y,HGU
MCNHC?SFT+0:K&7D!4UH7T@%6WT`.<3>P9IK^V@^B-F1=#TW(FY>SB?6.ZI.!
M.?0O!JNI_IB4'Z9W5)\<S*'?=!C_#3N7!78L]<[%!+)*6$<S(;(K"16T@DLH
M?G!T-^1[*83W4@COI1#>2R&\ET)X+X5P63I\+X7P7@KAO11"??7[7@JAKJ40
M;-M]I9=8/KBHY_K/WL*W3\^F"J2_R;13IT(*DK@:,5P?Q+\(WV2Q0%&0SS8(
M=.58VMI%'OPS^)YY:(Z?+EG**Q17<Y`RI?(@-V/6X)S]2,@J*1..0<DWIK@^
MA(SIY`+7E/V*74;I-G'K7\\'#T2D<S?Y>_8TE:,UU84E9.PD)[QF[&STP+,W
M<+"'PH*UA@E(A_`SDG+32527E9#1.0]#$Y-)B/&.42`@*]B:GP`4W!`@G%_"
M:D!UZ0D9I8LC*FU_XX),(+P10O.]E8O@G_L-DTS5'Q.J+DN17^5I2-@7-=1=
MU>%MOI)J#HE4EZ4HJN(]"O8%$'57+_^R&T%*U54JBBKZ"`K[_HDZ:3N10I5C
MWA:@5EW-0D;K@G#85UW45/,2TS6'2G5%BYR:3H/!N3>CUBK.G*89%*JK7A12
M[1["3JWU#LM)WD4G0E:GJA=9.'9:KB"N=H:<,9<\[6!:1LG!K@TM.@7MQ(/'
MB_$&H.!5^,DQ?`N2G\^=-S9P"+M@QY1`JAB#0D5VF&$#'!V,YM=O.GI2<7X8
M6X*LS=`3]INQ*1'9O[.,BK2*E(EGTBC.#9-6*@](,[839L`F;2Z_`H<@M>F6
MF[6&3G`AN`=?0(2;FY0BTH#BI#*N'EEI*H*X&K'#/25J(2*E%==[9`RSW6!G
M-5O[7#K%.6<YE)X%I[0A7>'1Q>1>^]$6.W=GB$FE./<LAYKY8)HQL)^(16:^
M5IR`ED.E:1"JJM="_YRW[);CQO!"%R8NF)_MBF72*DX8DG;)1``U8YMWX)!9
M`F#O`"5_#<4B49S:(Z2S='5S$#7"\0JJ/S/EPQNSN82JDW0*:#P;F.J%-:,2
MU]#%>.QT78<TBPD_X\6$R`5B[*)M4!,P19MBA*K3;W)H4QR8VAIY#%V&*"G_
M-%&LNS*<)1@X#P9$P?;4>'%<:HRE6^F&5&?=Y-5U+J#-2+0[@A[4K?*)^/:A
MXWNP<!$(GYL;;P#WWX@L"7CH&&@;!.!IK3I"2=#8@>3#:2\SQEO)6U6G`4D[
MA17+HK(S\6<W4@(]ZL[WP`$+;G$3!H7J!**<QI&*HQD98L0=WG<`WEHP^9SJ
M]"#YA=\Q]Z7E?RGLE7&%G3C?Y=[`T*311VC['C=U((-2=1Z0M'H%\#0C!>P[
M@,L5/9U"N#"68.33DZ_CQ<G>ND!P1[8IU2E#TD:1!V`STL5XR!/`Q<>+?`VJ
MSD3*90#RML070#,"38>+N@Q7(>WI6HT<J7"KJM]^`6E*])[L!]M]59>EE*BH
MM&-&KJK5"9F"?"5ZZS1A8X+<%TCT<[]]PO2,Z<Z<--.#+^'%`"FK3)$-F5)>
M<#G5L]*4QO;@RX'>B`$YWZI-<7"P-`V*K/'**\2E,-U"L_[CX["H/3UO;+J.
M"8/+[?=`YZZ@4`6&ERI>ISAYJVJCJTADJG>IRL\68E7F$$P;8I$K3A.K2OW9
MJ4<<@31BAHOC.-1K7=/0:Y:UI!,HSB\[KWTP1:!Z.+F\C5*U`<[SF$5NT13?
M5?\4FHL#EG2M>?DY$HKO]SZ?.8B(HGBHHQ+U)\Z2A<<$'UQ$(QJ^324P`^@%
MFFP;$*-6G-!X1D,0ED<S\B$#@5&#3RD]R'$J>&2*\R+/ZUID"*(9A7&(Y!`@
M[E,/A/\F9!7=8B-V?%*P$=5YEN>U(#FY-".YXA3S:;E3*5,Z)5>=WBFI5E';
M2`=:>&5;S#&IRB@F"&P,:,570<<YDXX5I#.'I2FES$2D0=6YHA49CBCTXDOB
MR[2EN.-$=\C3Z)!I(N+?B=W]FZ_!"\CYK'(0RH+>C$-_I_B/[J:7,ILCV@M(
M_*S"0E)0-B,MO=B^265;V*H33\^PAUE0.DVXWYPAA8'S`G"5>122+U"=)EMJ
M(D4.[*IW%4J*#!G;:`FLF7_X$($\-S"(-Z(ZC;9$]3,B15*B:,2*[@3R\;T"
M,I9S3*LZB_;\!I,F@68LUXK)LK()375%P<I-K+AX&NQ615>85N=62;Y`;U_(
M'2%EN%4YL*N.)C"V7PE``LX$P`HR"6C)0B*@_2XBF=FC5`+F'JQ$$WI;<=6"
M\M29LODJ*0C%"5T,@YCXR%P906RU2R]ULP/L-*$`O$#7Q_8VW%C.L@K9=O3V
M1>8QEV0:>:31:.=(4*Z534MZ^R(SF(N;6WGB:8)S1$40]#F\H@O4%S(DT\@_
M0-"UCN.^'%N3:49O7\AM*E*.CBS"R@[.*3<.C?0;A+:D.P2IE-)6<42OMR_D
MSI42S"$%6FEY9)O`U`BWR&NT-=0QN"P,K;2$L=`:^HXBIV7F;S9V("?#CN4T
M<!8N6H<*$SC#*M:"WKZ0&UND[$$"7%,ROL+*3Q,#\@HJ)!_3VXHO;)'0$6M?
M_!!-(PX@)<I]92KSX$F]K?A^EA+T>0*H&7M]L3AHM3;R<1__=:R4Y4X/8M-V
ML8]$:B47;5KOU#'J609JU5<QRAPW(1AM@''_#2`38D!O^`F7V=G!S[SMZ1VU
MD=!25)P2Z"HBC\L,B$Z!:1L8PP4THZ!=G!XV7I!_::J9BX-]3LN"(<-T>!TX
M408:RW**MJMWU`9,J[*@,N2B>EX3-J78_.E^P>ZLYMREJRQO^[1QG;C/B%N1
M<)-Z1VT(]'P&)"62"]VH2^T$Q*6S?8O&=7,FB)?5M-Y1&_2LRI9*$DUYT=(2
M"YHS,[BBA!V+B9.YYY>[1;VC-DI:E?T4DXCJ0[K,`@^'F5RY[46Z(;VC-GQ:
ME9GD$D0S3N<FE@JM%#M)>TSOJ`V:5F`%+)@5AD^KKU`Y>WI\U*8_Q@]:MSM^
M&LT'HZ^3\7#0'?1GYZY$&74?HIB):T-3L'`:DTA!%<HQ6AI.5`UJ7_&3_(=6
MI\5!)LE.<_<^A@Y9</<`-A'<Q/6D3N#,B4;O"<\_.4*H]+V*:U9R%<SHH57+
MH[H@2/4=?@C)M$46Y5N"\M%PC&40>IQ1YT>\P[/*!*6V39OF]&1!2JGN+,T?
MKY>)DBKJ*.+R2_-JQ'#5V>"CB6TVT7YH]\.^-NJ1;Z9/_=YPH-T/AH.Y@JDN
M\A!QO!@U;)&YCD.E8+(365?O_2J1:2QGBXHG*+Y6&#-4?JAU[HI'!<_BE>>Y
MMR*#$FP>7<D-76?I`;1.LM/U$54[40E=.T3_$=B%S-^J@L[;`\^>7.=D4"CN
M?,6DSNB<;*AU[GS?M>E4&\WC6>]'86_ON'QEEH_'>KX,S^ZX[4Q_CDF@THOC
M2"C-=^-AJ+.E3NG1"V!-#$0P$828B"`X:'#F09+%A\!LD$6J8,AGL20W#4BT
MHGAJ$%`!8_R7PUCGGM;5)H.Y-IS-Q]W?SW_Q#)'?RK6)\'"XRTMG;J&K9WB$
M"GI64/S[@"'B<.PK@N].V0MT+]FFE%\HDZ$*5@A='F:=NUG0O\:3^6`\FFFC
M7N2)G3WJL!^_@B.ONS+UT7@7[)L'2GA.*D&@1Q9K6,7R1Y1AZ0Y<L&7%_;FP
M(EDKJL)2J7/W[XX?'P?SQS[I\J3W=\?!+EM_I&*/C:9^PK#P,#TL%)PJ70+'
ME,ZYEFE'00<7XD^D/\LUI#P:(J<51F^5QESGSOF@#:;?M.%3_]Q=<7<1R%ZF
M(G,MCTQ!1TMC1Z1?<>D4=Z,,$3-Z31:B.G<23I9(O#_^GBTBBR`]\R`E14&D
M/\DW5L.\CEP@&W$D,JIR3*^*6#K!B8I`:MPXMS"MXMM)\UB""";5!TS*T7S?
M0`X1#2WS$:R0Q/6>0:GX>M`\6L]&I/I@2(D!Q9/;!,?Q@#=P3")@^`)HF@X.
MA9`54Y1K3?7=GCEL(Q_*9I2,)TLTBBZL"S6%^&>7L`T]^HF?L<"B4GUW9P[]
M\]&H/J515IVVUX1HD.N0CV:0L!=9M/CD(-N4ZFL[<UA$#H@5'M=0NDB;!QEJ
M[TLTZ8G87`'+IR5"-<*2!6V?3B$S8/HH2-'KOX5G?X(+7LFTXWO1:=9C3T5H
M[Z_TE]5PB5>)$.H<>A%)7U;3O9N0Q)PP-X&,W$#.DEU9NMDZIC,7Q%OG_LG8
MVU?3)9NPP\_(\-R;6&(/*I&<M:\@D=E+"[77L!WZHK)H1'1UCS\]BA"D.<7U
MD,)#P]L<<T'>QA7'9ZM*"BE%,,T(\J8+0*-]+CR0=[\]28_17@UD1>+Y&G3.
M@1/6@OX.X')%-*,13,82!#_VB*IV.Y3BMJN2+\4!ZLK,7K%,*PR1GS%;0XU_
MU;"<C;"0R2,P*$?6F)@V/2-%5M'!ENJ3XSYC@((KP`<.66G'%]5#X5WIDM]4
M[[R0TF10Z^62OUX;:+M;*":"0[N?)JY']VH,>U=IA5['0B1$4'\S$+V+Y;0X
M90]X!K0;$N-,_JEGO)-14JJB%_WW1CE#.;,&A+/7!"B&YGZ;WH#V!GFW#%7Y
M5J6G:RKIC2>E"*K4V64;YLA8@YZ[-J`C;5T)4J6#3_4=3LQ>DJ*\%*5'KL$C
M6#\#Q-'PX7.7I\Y3,SW6R1'2)L3D^NN-[6X!2$2!,A7)IJFC4CD2B(->=59P
MP:&+K$3`P`/K"AV#_2O>O0!Q;;!LLV;VI:VI5U^=<47M7][`E+\'EFQ3L0::
M&>T(XQ4TK$.WV)L1ME!;/H*>"4`XG"YG&QO*U9`XH:YC\I00JD:XAXD[;"8&
M&J/@$B4KB+/&XP<W]3F3NH:'8L10-6/'=$J'3P=8\:1!Y.6O_6!GK@<61&#\
MZDQ9Q#4\'",$JKS[HO-<<E%6[<*0S^@,6%3CCY>\E$I0PS,N3"!J[RZIZHCC
M([0!]EP'/`)OY5J'#_RY]\*$SCQF-5;#(R^Y0%9X$D;I$8=#?[KU[E#+>U1'
M!ZBR]O#2"6KH-C.!E.4IVY=Q*O!^.R?OS-A,XU`I=HG9:A)4ZP&2ANF6(LO<
MRN)0*79X,W0EVF^3<&JN8)_,XVN`3C!F;H)D4"IV>S-TQE!T)J2&Q#1..L$]
M<,S5VD`_Y4?M`U+%WFT)0_<QG-+"&!<R@._PR8_B1Z2*CVJ+Z$Y4ZR?`ZCVH
MSPRR/,L<P!-/Z8HOT1-0"",2?8"A$:-S?+*1K*8!#-)T,S7)(M%_JZE:.8":
M$59^-/[CHMC=R,H[/'U8_W19BLV89E,!E!8B5C/&TKR:\>(`6>:,RJ316W=*
M%9JNH'1E<D&HFC<9AWEC!L<.$%_@"%+J+;41*+X>#G4G`4EU93.&)N>O[LX^
M)54I0*JWU(:<I'4IB*D9D^4)P*%`3AZ;2&]=6`Q*=I%Z@*2AE>4F`-$OC"7@
MW03.(]-;%Q:!.E2;H*Z/`#5BA<-9%^P+[N8+3.SI]=:%A:)RJ9^%3/7`SO*W
MCOD?^70J&B]VDQ73W\JDU%L7%F_B*50"4ZW/R7-N^<Z;>*KNSN\B?QJ4DU:O
MV\5EA-((;W@$O(%#.B`8NICG`!\^5TN='D%M0$XA0=0U\&J"W!=(AMG[[1,&
MUL`9;P"=)9QE5'\(`AQ>A^.3[Z(?Z<6D7&T7:;BNYE%(F$J3&5D7#+OH)V&S
M:VR@9]@S'VUL'[-']6R:6FE60`2*"VPSU/85D1&*&*()@(7IB:.@B,@K@A[Q
MIR;^LPW-\8)P1RUPD<B?3Q0686FWC*;K9P2E"#2RE5]K/=_3(8Y>CT;^H6=M
M7@P;T/I?9.A#:$O@!^<N>*ME(?I:68BD:*HKME[:D#%WIV#C(W-E8#`%-/)+
MV/__]JZMMW$;"_^C%N-V=]M'QW$&QF;BP/:TV"=#L6E'N[*4ZI*9]-<O*5FR
M9/$JD3ZD1BA09!*1TKGPD#R7[ZRQ>J/D3LE`2$WDE+"[,NLL]7\YO?CK%K`$
MJ"(MJ+"NIZ3%2-%G@+/Z)2=P2B-4F7/6A-_L6O_UK\<_G_PDB>*\KS5SI?.&
M."5!,0/.,OO=&9F17YTA.Y^].*4U2E*>8E`R;3.H<L>XZ/F4Z9=P79;/1:L'
M`A8<0G>%*_:**S7I`USLB,"D9!"1PO,JP9;D@)(D__X'A!(I`7,&`A<8=14T
MGZ)A>+?/9*Z]P"/G>6E)7PT`+C/J(^$V)=`I67HDNPA3A*612AMI^@#@NJ).
MDF52,HSDG67ZBN+V@48L8?Y`X%JB3I(64@3MOS9RX**>9Y5/8;Q9@&N-=!S-
M!.1I\U*F4>H%-[T*75WTSO3"`H_-HA"OD-3''_(8A4=L?T_UCSOS'<OD*0IW
MYW^(KST]9@5M.K=^C>)T@[_V'KVD\ICI[6'`5Z1^_&>L4P&]CI<"-D@2PS)0
MGP>^+XD$Q!`K@Y*!R5-8=,08`7Q#8DI'4IA#@5^X&+2Z(1.#+_#&`5^1.+)B
MA'$%Q`S"E55W?==['MY]U/\BL,[RDP!?GKJ9;"7R'`=FJ%,DM.'MAX$O1&J2
M$DL;''B!&?!#B;_'#)F]>GY\\D*2;O+JH\/\.]KE@-/+P\'?H9A?@J@X#3`<
M`UTPU&B?*EG`IIPAY6D8$;_-(MS[[_X>7U?YTF0\#HRV("TU]N</(X30V'$>
M)4I%Z0.`,18T7'KJI#B.MD#(683X)I^11(0';R?NF\`:`HVUP!817:0\.@9Q
M,FX26,9*5MB8%<#BEQ)8:6GS)H'&;>@G?Q%EPS#A39H)LZ1%3QZ&AG/H)^*2
M@F&$?9NTU:[Z&_R6A#21P+]+SL=%?)78^^'QWOO@[===IX0&?NBG%FIT#B.R
M7#7F1?O[C-1Z%,W(\Q832<$0D@I#*D`JYEPZ`/&.?+TFAH:64%6D_M1"AZT9
M%[>RH+Z@I*!P$:Y1F@9YQFJ#HMRW>(G"ECLIZY:G8VYH$`I91=%*,'2]C>%]
MZ[)>GF-_QX6GD9X#&MM"V\Y$(TQ;&9[..ELF!0\1`4C+UT"CL/"*,I;5Z#OO
M]A.L[T_)8N@@%KI.JY=^G*O-M.H&?<[M)UCOH@&]8!.JK6)+I\4@&!3+L'Y:
MDJS:$@[<?@)V-:K(5HJ:_N5;OQ<"#-&1^#@V<(@=Y<EF_OT-X<L689%$SG+M
MZ>W$+7\C@P2WJ[7.MJ;,O/S0#$YU/;T(DHKU/$0[IL##"[HTQLMXY1]?A2F"
M[$%`"8(BKK(R3WATV)!9E*#=3\?H_><]\HE(?R4_$$G^6I,D_M7V$=O)8!ZF
M/C.%A/(4=)\E+O.;`J-_/5-"9IE=?`,S:>/Z$:!,.P;+VGR]^E8-3&6A0^(5
M@V;'Q6+QF.X%\-OM1X&RVF@<HAR+Z!\\B/@<=9V*^@2QQD`W"%*P.3*T.)Z$
M1B5-W!B(/0JZ)Q!/5`K2M34=K0"Y*3%N^":4]BQTGQ\^KREFE4&$G6ED5Q!$
M,N*Y>ABZ84]'^;2I@$Y#8"7Z'6.4QS(8VU?[(>A..PK[%?7CP?*^1!)@[C*T
MQZ!RMN@LY;'=VE8X9Q6Z(*<M\^^I/IQOK>1&0Z56,45`D90\)8,XO.<Y8H0N
M`I"8?LRBTUL4(H*2**@#Y(V#SJ_J<HH7$J0M8P;F*']%EO`03WT>/$-**"2Z
M<)G$V.##ZR[3LX(+JP$;ST$G)[%E09==Z^,'87=77G@4U5I7ST"G"76QIXV/
MUY8>!E2+1V@1KK+:4]#Y.DWF<P1T^5RW+>$7/_1/V4DHH\9ST+DTUQ*@RZGU
MR8.P?U^\[W("JS\'G>0B*;#K3X9V=ACT!3_*=%KD#H1.;M'F\6]0I"W'5=/M
MGOK%\^\HWOG))4NB%67CCH).7)&0`BT0)Z1I$/;UP?/CO+W!=/_?+$F+_&Q.
MIP"I<=L),+R3JL2EJ1J&B:[(_(*\)(OSFW)"?I$+:H-VKZ'_5\8M?)&=8CNQ
MT,6CI`H2!`ZCPBY/IV4E'K<?VDZ`VQ]WE6R3A&$4N%T,5Y)DIYR"A"1>[DC;
M0@+/@,(]*?65LNC\*;83X'[(_8V[F$#H.C7S6B$HAA8-W4XL=#7UU8*2L&%4
MGM$H)=V#'V*$ZN7_BEI`FV([L3!?IZLVL`@<1ALXGO[_$058<B3EN<=>T9QD
M.[$P5:BOG6B3"%U]9E(WBBNOZ&`H'+N=6)B4U%T3KBBSM#G8I>TQ:9LT>R6.
MR458452QHZIU8+EXE"?:3BSTUPF]/IW(U-9D3&>9X07.9WDH4E,VT?,Y5>5,
M!$O6$D.WO[CHTY,DS&2)6K^<MV.<US&6WYQ;GXH+I4UBY\))#=_^XICS3I6X
M2KP&G'CF*Q!7\\?I9G[_/%UM_K-939_6T]EFL7Q:P[9)8.&X2O1"$`T=&QX8
MQ-D=NQJ,70W&K@9C5P,[Q3EV-9`@9A!AZ+&KP=C58.QJ("3*LEJ@L:O!H+H:
M&#B#/7:'S0?&*=,)F_\;7/FD"1#+?K#Y5F*4_<:2*(>,0:S6FX/F6PEB)BE^
M$67#R`ZT%BS;RGX+3-7I3RUT6J&S8-E6=FUH*8I6@H>1QGACL&R+G'S*>Y&`
M,&T)C-<Q:?,1KMGT>;&9/JXWR]F_8:-:N0DG_3$P#XIR9+(")6):_($0$:W6
M!ZT0T1F4_V']%OAJY+1&`\>WA`SG;=)"R@9QTJ_!IS][\3(N#K!Y6@L^F>3[
M#]>E+AP-'0?KJ`)RE`WC:%^CM3AP3+,4[T+^W]3:/HE1T'&R_C*G4`1][M8C
MZ^?R4U7%S1\('3[K*'$A4<,X0#?)[&#GY2:`CI]I40(.<<,H_VE9N>)ZJ6+I
MBQ'`X31M5KZB9A@%/BWZEEF:I%Y(^O>I"+DV##BVIDW239(,5NY`7H<_C?=A
M(S[N)_0M_U-G7W8U@<NW8AGBM-V*.E4^&,2KJ=RRE4-^Y@4!VM]]E&@0YP>5
M`6WD9W;U/MV;:FWW+YWU-)_C*$F>XVB'T#XO#OJ*C7C\#1.#S?ES]A+XN^4!
M?QM>+8U6==-PSX%3T36U8_=PC61?E,6N*%F#NDUTP0E>(9(SA(FZPCR7T@Z9
MB1R[H7<F<AB7M-N&O-R\MZO0!WVU8Y@#$N<K3E$70*ERRQ/BJTD-=NR2KD38
M,*`7N)!RS7K%B@N\9=]I/E=O^!UIU0;,H/,L69Z&[[V/I*A#_NR_HW`352<@
M_#)1B@QW,'3V;!=C($N8I5`+T_W>+[[C[(*JGUG+JN1'_T2-M"O.`)U$VT6\
M2M1I@U0P)>,R6-!+S!*3@"?,]A.U)(76(BZT=+;<8SHN:.IP\,Q6/<N929M)
MP`7MJ[FC@$4S@">E:EO'3/(J,5N6KTP].LX"_(+],JR?+40`*LH3@6>8=A%Z
M)RHKV4.E3\AZ;;O(76D2Z+8Y>ERQ(@HK>4,YWU36^L6,:5OU<E-"]^/1M_[E
MZ:TTPS('7$O%^VE%Q^F@&_[HL0[RM%;:`.6Y$WA@:I<29G(4?P!T<Z!>KA8J
M-97,H,!,!3(K#Z!R`FL^#=T9J)>TVJ14HK+,%]:R&&N/E-+W#(OS)H%N#Z3'
ML(HHK.1MF5_L":5]I:TP!71#H6Z+6(V^*JW!6I])KQ2ISG-!MQ;JZ4=1([12
M`LL\*A=Z&A$X'9J@."%T>Z&>ZM"!VDHGW"Y4R;V)+QZ^/)`.ORA,SI*+">(V
MR?*X^[@\\NQ]D%]-OWGQ_@K?MQY5*+`X>$F[QEX*W0RI<Z:O48Y4NNIVBE;.
M@3LQD^ZNF51$L9//Q:D]+#)=1/JI[470C9IZZ:16+E1Z:)E/BDYIF?2ZB6:8
MFBQ(.5#]\C-`-VSJM%.JD5>)V3)GDX9$Y\VWR&#V.)G=.=W0Q55==;\`0"G>
MFY]Z04Y5LS)L,E:&Z<#^%^Q#"6LC4FD4T.L=KM:7::3?;83S=?:2^'O?BS\*
MAU!AH01-"%ACH`O&=$J5H3@<TAU7A`L]3]X)_UC#C18W,1`.AJX/X\F-(6H9
MFBS#PV:?0/@`V*)QT!5=4J*@'-$DZ#(&K57_SPEGP:,45';?R:$+`VZP1^C@
MD>-XW2T\#&*`=['_@O9W6?HU])6!8*@30)<A:)$T78ND&3`,;$!K,1"@RQ],
MJEA_U@P!?R/GGZB[\.4A\&()@QK1I!)L#^)YJ_.O>XCBFGWD^J8ISX.70AB0
MH)!@:'A!&9D*V@+3G@6O<+B)+&O$0H-.R.>SKJ.`1&F3#'_Y)EKB]TV#($H+
M4/DB5*:0["HQ&WCE@RE=Z,X.2\$HKA-*=>F+ZGS@]1&F-:8+0T:L"WU8%]#5
M%K>^/<@P!!810Q?,\27L2[+AO1"3&Q=^RB(0Q5$E\6#PF@Z#>B-'O:48&W6(
M$'PN*XSF)BJ3T:YKTD7[E>0TX$4CIK<I!3Y8"LQ14L(%&1&I`W<P>(&):240
M4F\K2$>;@"J_)YI%^%V-HY;0*$A.`UZ$<CM]$/+!5H`/RL6M/"$MPN8!7/4^
MS)T'O$CEAC=A(2-LA06YOJ/UT@RI2<"+56YUW15RP1FXD)(2?$&75PJU6<!+
M1TQIA3H;3***0*;C_C*FXX[IN&,ZKOUY,V,Z[IB..Z;C4D4]IN..Z;@WC3TE
M:/?3,7K_>8]\LFY_)3\0(?]:6Z[X5]M'=/2">9CB[8YAJ2E/03=",&>;Z<2R
M$\7,"J?X"*;%O'X$J(<!@V=MQEY]*W.UZ#-=^"@G::RJ)X$0_FG\X1FA^O>.
M50`WK@*`3J)TH@R@EH/9VT^EZ4AS[6G+L0[0?IH\>W'J>T&=5EF?)6^.`>1J
M?FJI2"<N6'0R<CXKQWF'9UNG>G-D,*G\`P)U<C^AE:VH9MFFK78!PI&?$W,&
M$ZJCA5RNV<DB?(^"=WQS+O]8./R36SOZ[_UD%T1)%A>2J.2X0@'I:S^+DC1I
MB3&1"`3TFU@I4*`"Y5Z51^4I*JLH"!ZBF&@EZ["C-@NP`[\WTVD''64.#/>D
M4^L*KWJHJ3>4ASD2=Q2FPC&E2:,N-7@K>H>G^%BM*4I/_?CS^5W)#IS'`'GC
MM0A4ACAM1\L;].H0]D+ECP)RS1L699T\*YNC4[\:$WI`?HIW,W**FG]_\^-<
M'LP,3+59@%SXAD7-([>_,^KW0O0A.I+SQ/!V9ICPP6UWYG_JJT$MMN9YJ*P)
M*F;@3T3^C_93O'MXQ^+:6+:3ZWJ`EYP3N-?Q[8[S\ORP]"S`(Z`DE6LB.LP"
M!(6D18H4Q5`FWMX#O@0I@N.^_`Q`&$:`6G`AW%UC(+PFJ,P!!3($J`,-V@TZ
M:PVKP8Q4KQ)XI&6<'Y5[Z4-[,J@P.:!BT)D`??.PZ=0`%!&WY-A0BX0;N7[8
M%=VI/UMTW=M$\]-;$'T@5(9\/HTQG[$XQ/[B$-V7T;%XY%H;"U+P6P0%(XWG
MAE\D<DVNVT+NSJ8+'\+]<^"%)'=?7$IBX'7`Q2<M?>#DI^BGW&WM*\\>M7,)
M,SM<.`:ZC,60@.GJQ.."+IV`!,0ZLT&P]=0?&VX)#(-:;=XNF+4OO6=<+0E8
M"+QK&?`E):ZL@4F[7X0DL=%_+\P'^5K\BG_P"W-X8X`#4VUV4QP#@N\?1):8
M[64Z8[..FS;K<%,7S_ZIFI>.'U8W^\(!]P0QQK`?VY:VN5.DS=Q&=8MW.=MG
M1*A:QE7YPD`+$@KL4.5F!^H<!\N@,E/>!E[?ZY@Z,U@(G1^A$0RLB%[=9P3M
MHZ"RR$FL1[AX217=)W.VA+BK+G;BT'B&)2RI93^7B]&@X:2\S=G:9"##R6`A
M=+Z('=H,?**UW+UOF293&0B?:0]<F']FSA\HP:NP6<T@4F;-KW.V5U`??3;`
M0^B65'8H]%,4OM]6IQEO=+9%$9!:<]BHK7&6#<9:CTBNDCL;.#1$7(=;.HDE
M/V;(S9=@N#D0-\9M>`>_%IQM-]5/24%73+VUU?#=U\QH+=4=:FJUZ/L*9WMS
M@:P8O7S_0387$=-*OH"O&J4/<;:)F94+1YGU/XC37\RW"N4$?O4H?8JSC=XL
M73_*S!\##6Y=;5SM@.?RU69BN&2W3V)U;YM1N+D[;ANW_@1G6_WI5'\(ID,'
M/;IJOQ03\OO:/=Z]%F$:^V'B[_[P@JR[OO=YZ7;B:-29X[R]#=>@[P*&5+2*
MU]Q82T7OW4X<#2>;5E09QFGKBF(5`L@Z.YV\^&-YR.E<'NKN,+3_FN!=[R[P
M=O];[U[Q+$GQ9[+%D`9JT1X%?_KIZ]5.-$V2[%3,,R+$HZYH(3S;E._QFV\1
MUY"4#PT,@X-*('`QB>Y]Y,'SXWQ!UI92XWPGDKVIEP(C=YC3)8,,&U"PH$L.
M"YU+;VB'!;9!\8G7:LG<2X'Q0(P!$YED&/1I'=COR&/1O?_N[_%Y;(6E9\+C
M*/MN8'@3HVIMF&_ZSO=1XA,(@0&I]Q\1EI\?^.D'A((WWPX,X>*4BK<XI\\G
M/APE7_G)_QYB1*[\".M4>DL5I[T;&+S&"05G\$V;RYNBWF`N&@J*U]FOLL%O
MR+S1O3*"L8Y@K",8ZPC&RE"0$8QU!&/EZH/NU*X1C'4$8QW!6$<PUA&,=01C
M'<%81S!6$YZLQQ&,=01CM407F[`$TRQ]C6+_;SZDFNYWC1"L2KSZL8WG%^^[
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M[C<K-&QQ%TE3`LW]F6`.:P5JM[$],`T-0N=$9+H&%M>[XJ=IVIQ016LZT[D*
M@=74),UJRN>7MJB>C95JRNHW`(@I50W2B@\%F!A;NZ&2RRTIS0P3KH>:.F``
MV$T<#6"2;#`&!>'G0?&[OT-T7E8@5#G;DDV4>D'][\2E_Q2E_T'I"NVB8T@R
M>>IA+!F?D<GW;R>.=O61T=";<5#;>0T^2^!%+(L7QJ&@0`[$=[`*@R0BOV)C
M<:X0N>#AW^,K7![API=!8^@RVC]R.W&^_8]@>[>&S4ZAHEX15J$35B7Q#U'<
M1.QC^7ETS;^=.-JGAZ>IVCFDK2L;[*GE.]IEY.JT/!SPGA>+0U/T`6Y["$7<
M,"=J\TE2L^67+XO-E_G39CU]NI\MGS:+I\_SI]EBOH9%F,!+\.2G1<I*N"=V
M')MS%.Y\E%P27R12H)3FT0'/R7DA*S-):AQPMI$J'VD&5H)$MZ/Y>@*T,`E$
MTA)2B;FZGAP$%W&%]1<SI:DGWNIZUL[LU4<'Y<,19Q1PYDX'^=$5@4^BG1C-
MTV.,\HL#PUBW'P*"+>AHH:G?#P9$(!("TY#2'@,"%J!SE,=U6T$%"J=F3D7Y
MJ3+9(I0!0'`"+#8S<SSHGVZG9>*L=5Z.A?18H-K^/G9,DBRP1#^6>8N1MSP\
MQ]$;BM./K_B&'B_QCQ[Y^D?D4:.!<@.!JMZ5A$&SC!)T#:)"_1$E"4*$)$Q9
M/2>H26ZR0B'Z5GBI.4?(#K-!Y?OVT)">U$*7@S-L`/$LK\@FE<7XRQ>AG_I>
MD!/`$+K$**C$W+[+7TS5,&JEVXJ:GE,;GA#/:\D=!U7%K&%%"^F"SO9@K-T5
MVF<[M)^>HBQ,EX>U%WCQ!VO)4A_>?H+QZ/1=J4QBH-,4&)+:X+\FKU%0_V+$
M/"73G]Y^@G''])45FQJ#,6_S,:I+I+7\X0NV'EE\/@N0XN=3%.9I-&61?]ZV
M;NT?0__@[_`OOH;12X+B=W*S6(1O69H\HG<4_`+4G:XBY!(ZD2GGYPT#*-:O
M/N?1]UY(CPFLHF?)[)?A"NVRF.SN>*_WDY8`2/X35NK`SW5$5+.O^U7`P32!
M(!F;IP$FN.V&KQAR]U&RY&,6>$DB"+MQQP'7[YL0LD"=&%P8B&[TY^,U?X2Q
M/N/O!HX."C7'N/UBLL5MI;U'L?_ND=#9@Q]ZF%PO6(1X6\CRDTZ#;8)8H^),
MP/''FV@&72G5&34(MZ1&CO-"$29?!PP>#[!1ZV6>XUCT&KDR\X)=5B0[K*(@
M>(AB`2ZA\7<#(^:;TCCC^LWDYK",=LW_03)UVMZ-)E>2)@^K#3*?2T;-=;X/
MN._`391-H.>:V:E+M]_R^NMUZL6I6_K-X,]G?/![C))D$>Z";$^@>.=>3*J"
MI$XJIK\!N+&"@^N@"XLMC05K9L$*G:)W+U@>SO[OKV_DT;<SI"\K^''3CP#N
MS@"@[B`\[A\V_[W0]Q`="8JLK?J^(W?[/+B37Z"B^5\9_CUAQ_P[BG?^#;5>
M_"G0D'N#47XY5O?/(>BW!L;#_N5T"@P<Z.`I1\A/;8D7Q7E_'M85G!K-_YD0
M2(KS\3_^#U!+`P04````"`"S@`I'J>:9R<H1``!PK0``$0`<`&%P9&XM,C`Q
M-3`V,S`N>'-D550)``,1!,E5$03)575X"P`!!"4.```$.0$``.T];6_;.)/?
M#[C_P,N7ZP'K.&[:O6VPW0>*X_0QSK%]MM-N/SU@)-HF*DM>4DKB^_4WI$2]
M4F]VTLKK`HNM8\X,YTWDS)`:__Z/YXV-'@GCU'4^GO7.+\X0<4S7HL[JX]G]
MXK;SV]D__OCW?_O]/SJ=/Z]G(W3CFOZ&.!ZZ`Y@E)19ZHMX:#?ZO,["HYS+T
M.:"%>N>7YQ?G[Q!\G&//9Q;>_8(,?^5S#UW\]@MZ>]%[CRXNK]Y=7/7>(>,.
M=3IB'FZNR08C#[,5\<9X0_@6F^3CV=KSME?=[M/3TSFV',S/37?3%30N?KT4
M/-M$<'7KLLT-66+?]CZ>_>5C6[)XAD!(AU_AK>544I*@*:BGRW.7K0#DHM?]
M\VXTEQPJFC9UOJ6@GQ^8K>`ONV+X`7.BP,6HY44(2>#WW6`P`K5+Z/XY`L))
MHK0$F#K<PXX9,Y%C.A2Q]^'#AZX<5:`.66&/6(7$/W29:Y-N"*:P?-Y98;R-
ML):8/TB,<$"JNW/1ZUSV,B@=['G%:##(Z(/O$:[03-=W/+9+*Y03\WSE/G;#
M03';97HVTV<,W+P(+QP5B._2B!:A>AP8T("39W.MAQ<C&C50YY%P3X\2C&FD
M<3`UN1Y'#@F47AJ%4U./``,:<#"`M]L2KC6-'-'(PKTM*Y@$1C2S,+(L=+1?
MNS`:6V'+B%GAF)B9TC>7V/0ZY'EK8P?#`K6[A;\CS;F.XV_T1"R/=85H70#J
M`!1AU(SPJI%"!+&F8<=Q/>S!JOC'[WB[I<[2%5^+Y^Q*L+@`!"0^W,^&!>N3
ME$2MO89C#1R/>KLA4&(;2?D,45!&*40TIT66U*&2'UC34"=>U!,?L6.A@`9*
M$/F]FZ6@B/J<6!/G#_D9K,.!AL00"U6(%8+H,&*"]>!-;)N^73Q!-Z7<O;3=
MGXQO!N/YX`8^S">CX8VQ&-Q<&R-CW!_,_SD8+.:!SFO`Z37_%M0]!R614/41
M(92DA$)2**#UTP`)Q4XQK-/>FG@4V.%US9'!TAOG<A_CH#=IVO]U2M9R'8LX
M0!$^<->FEEB>(PWRR7*R)4QRP.\=[$.P*.(%:;%],/56>U?/:O,%_',W&(/%
M)K=H,AW,C,40`-";:(*?IDL8H(_Y^M9VGQI;3H.H-]S[?0S7-^;_1+>CR9=3
M-=S\_N[.F'V=W!K]_N1^O!B./TU!5_WA(-R;R@#TAOA5Q`"4F[;+?4:$50(2
M0M\Q$:2HG)"R1_0OGX*+[2"XNH-8<B5]=3Z%N#)0=AF`7MG_G57V:/B_]\.;
MX>(K,L8WZ,X8&Y^DN__G'$UAHSDA;8>^-I\:7XWKT0#4`=_,[@<WHZ%Q/1P-
M%Y&/UX+4Z_^WK/X5+102DV8(R:$$O1,RQ)2Y&\HY)$YC%Q+O*=[A!YL$JB\8
MTRO[0U;9T]GD;CB?3V!Q&4\6@TCI)Z3<+\9L9HP7RK.^!FK-?:M5:.\BJ]`0
M+W+4KR>DR1FQ1?`!\;>W6S#L<,CR1<08:+1P5*_97E:SL\%(QA]38P9K\P*T
M/#?Z,F0\(17WC>EP88SFBTG_?\+X+_F-7I5OLZH,<9!$.B'M27DG4^DTL*N$
MSZJ*TPH&]3J]S,5H`AV%^'+/4A1.2,']R=W=<"&3`]``I`TB4!V,XV"X#$"O
MZ'<YYXU)2#6GB)R0KF^-X>RS,;H?!)J-_]3K\7U6CP(!28P34EI),C:%Y-FD
MA%=F;1&@7M$-LS?T1M'[F35+A2Q$_%IMA1!,;X-<4E=E@X#:*5F@3LJ6-$4#
M>+U-]D[T3M$Z!<%(ZMDH!=';()?_%4<MIZCU:`]-ZCG[I5:S;W.)8+R]GJ(F
MY_YF@]ENLC1,>0.`.BNUS45#4]<#.2FVYYYK?AMR[HL+$OS>L0C[C!EU?3[9
MRA31<*POF$'.Z/$;XF&JSIE>?1:]K7.I:<7N`@`!-\A=HJWB!W'!$***(^0+
MEM!CP!-R`Z9^D8?`3R%?Z$W(V4]?DE8.M+$@SYZ/:SA%!EQOW5RV7!4[!%21
M(GM2IBF.S]*Z[E7&<UEXO7'R:7<SXZ#>*9FGY#1$]^34!]<;)Y>J5QREG/2C
M4R>>SBYEJKH/]H%OF$^L$<4/U`;)2'IG?#7J>LOGB@NU8_O4WHA#1M`VX$3N
M?3C@!=DQ,R>Y#>H/>G3/<2U(O2%SQ8NB`Z*3?G;#,%$]'CN=$2I@].K/U2UR
MQTDGK??P"$B>`"4/@'3ZKPFKMT.N5E%\^'32!DD>/NF,4#*N5WRN0)$ZJOJI
M:ZTN>U7*+HBF+W-%BW)MGU;PW,=;ZH5E@[0ZWX;Z+@'0ZSM7.*C0]]N?^A9Z
MN*S2]V6!OLL/OO/ZOCPE?4L]YDM?R:L90^?1M1^IL])7WPX@H+=7@T-U&$Q.
MA*B:Z<1K90ULDH05=5%B+=S!9FN[.Q+E>[WFIJY'5N\`N0K"/@X0U%7#^JFL
MKT+VZ+F(*"8BSSBM#:W`B%$9X#.V?2)N^DN(3V*06/<<5'IM8_/;W%P#E;!8
M/F74A($[UR+V%^JMOQ"Z6@.X\4@87A$#E+X)Z-19,KX3"WJ?R]4N2GTN4:UX
M%,R*#\K55@&_R!<,(\DQ"EE&`<\H9!I)KH/7=I]"OA$.&$<XYOSG&A8[B5I#
MDL/:^O_>Z'K_R-_G*/,/-0V2\X1FYR>=N.QMD/+-IPZ^WJ+YVR$O8-'3VDM*
M[O%IZP"UP?46R]5C2B\!GO33=HLID]MH].&.8*$U]3J8N]FXCO1E]23)#79.
M5PY=4A.^N'?<!T[8HZ@:#YVM[_$1>23V96HK_P[SZ'TA5R)*W+2`/X`;)-E!
M27[$-AUP%#[&BB<DF4()KE"2+13PA=Y(SB!!_-OLR.)_HBO&C"R1;#=Q)=Z9
M_WC&*:QWHDV%_&XM^P&(IAT=U9[C7R#2^?/&5B""<DGC"^F462V$$RL289N`
M\G880,3=$B;.?[J*^;/N"\@#"F\J3]I&K9+&Q@]-I0$48K=.$/#KIH)D'H67
M%:>KVD;`I[B9!`R`)"[SD*-ME%/4!2;HL3-R34FF!$7\U5%X'?%5I_>V<]D[
M?^96P%B#^2.)&LZO\)K-K^^L4W-FA2"F?%]CLM+^-@5SROFTB%UB>UQ]TXE)
MU96ZI%],&2\:M/!S)R;1E`=="YXZ3"3QU!^'L*'KZ%.+CR1B]%<G)M.4DUS?
MGSI<1$CRTP$ND6\'5&?Z&"OXV(D)-&4@VUZHSO0*1WPX9.ILTZ%:<RLD^:G9
M[%6]LNHL1C9C*2RQ(GT0BV#OUT,XJ+D4)F;W#IVYO!U376Z25`8QD6;,E3;N
MJN,5"D=\:+86E#>+JJ6&+-8!AM&WN&K&A.N,]^&CO('8_GNFI*5=(<,6@9*7
M\DY9Q@/WF'1+D6R*R/!?]<"#\%*VX[N"[R"Y&WID(U*?,X1#J(]G'O-%\"FA
M(-RCKK60>);/PE9>#K5MD0$J6.X#,O5\,?J)N?Y634*!/$B'<N)E;P"-72?8
MO))"E0$E18',%?).MM,)L\0VUTH3A(V>&GK`M@@B/YZ9C%C4>PD91R[G$Z?O
M.F'[RLDR<_DL(6H-V(,ECNWW:B(/'=/=$"',+;#?7V-G189.5`69++,F3:A@
M#]QC4$FBUA.<^-VZ3+0C\FUQ^WY.V",U4ZY0%^'UA+?(P\O(/B8>N+%)B"5M
M.L<V216_$A7KA`(:81V!%J8^,]>0(`+??4$Z2,+%$TX>Q>LL]BZPLT85S5&/
M]I'`?&T3S@?/A)F4QP>=>A_9G\0Q*&A&3!MS+HNN@<%OR)+`SF=-EO`O+`-]
MEWM\X1J6)2MMV)YB:@V=\!I00E&'DSJ")RPOI+*W6$"B#6/A#O[RX=_[K>LH
M)RE550,J1Z`EK>%AU[5]BX#!Z[SID(PX7X+:$6AM&M0\=^)-'QE>@_&W,M0V
MX1,3LA;(G%S'#R!R!#H:.A!*KZBP,^?$XTU4LP?N$6A$_[J8,+\F>:L#W)[4
MK9A;<:1\;<.67$NV!'0@7-#L^LI3W^]ITI=/3C4F*P9ICZ&R/.K,4P+3,J.(
MGS6P?)$*Q`?<R4N.\6XM.PKHA-V?1,MTT?>Y![DRFS@$,D,3!@+:,\J_W9'-
M`V')4+D&<$H^R]U@ZOPHKUT\N8IC7BU<+>@629?C<>P+'B&_55*DDIQJX.1R
M0QV/K`C[?FX9_)===ESV3<2#X1L)/MO:/H=HD9HTM8*6@AU!>0^@.$\6*F3;
MC"=&/8\X4__!IJ:*C6L4/5Z$VA$$1BDY%^Z,;,,2QXR(YS*H<$%N<%VEHWJX
M1Z"1I-&+"\2E4,<MI?@JV0"UGM1YK*/0`N'4@K_[:TS9!@)\Q^JO*5D.GHD)
M=!XA-H$5D+#<1M<8LT6;GN&XWAKV)<>BC]3RL9V3KA"B15*HS7>^QF"+H.HX
M=.;$\P(PL2R+XQM/Y++21>.B!R2Y!)"2^]_+D$ME&P&EO7;)EZ@N/7A#(,?D
M.62"]UM7A)Y2S-3.%1]VB1<_2*JT="BIT&W`9T!:"=]NM80;UJ$J*2+3'G7T
M(?PB_=5P.!QY5CY5T8VV:`D(P@L57>38UP^WCO_K"@%RXRV2P%@Q(O\VGFDR
M/,I\_YV+,)9W95&873QRPTK6;Z0&=<RKD18I//2%.-8.SM0BEG,^5!>A13+V
MQ;%/M'I.V$R\=*B.=JSD^E0!>.!N_)(R38$I\5;!*CH&7;CJ-#GD/QE=UH%.
M[2("_(<)9ZS`F\1]0\6CW.<BPVC.]FIC',/Q\(*PS51.&5<L0V?D.K>M"9\4
M74GQPTRLPN,;O`O?:?X$.0ZX95072=?*:L*W2L;XR#U(`E(QK7+4$=VDZF9-
MD%JT'B6N%X0A:%-Q:^$=&.F^KG75LU??M`48;;=K?4&KD5ID4>WVW[==^3IA
M<IW1;$![X+;(RKGJ=$VI&^(=005/:\?8GP_QAKI4VNP7C36Q-X4C\)7HN"Y[
M65$3MVA@6F1GQ:5:HPO%R`*T2(:<I]6\CMP0[PC\,G[$HB(T,7TF[^3UL6T3
MZWJ7S1.TNW<3]!9Y0BR`6DYD-KBG$AK3:%%$(V>_AF#+`G?>$H>'%U^#@^:%
M&[YWD"X6-$$Z@J>A^*`]5]NJ!FU154N:23JE?($D6JVREM2"M.?$(,5COG*E
M'VX/^YK]?>[:%B0YXJ=-O(4[>23,L&W7"P[]@MI%>8!0BT"+UMML<'"`%IJ3
M:*$>1(U*G-ME"JW9]+^@NE4+LU5U+L5]:>E*(VT%?`LM&W,<W22%[1`<,^6<
M.LO6QFRAU`FKJ&!HZ*0?QQJK6@5J"^6.NNTU%+HF7HLDSN5`B7?L2D5NBGA,
M\2)A^1-TW6"+8L*L!X9=9`TNKM!1;"<#^A+'+4=KD=]JZVSIFU<SU[9A2WW"
MK/*DMP3Q.U\X:"IR:+`J`2.PMIL0]+XD0(;)6W&#YRT-)N15$I8@MEWF3`]G
MF?.HXY,&3ER;3'M<NHQE)9SOB93-`BZ3=U$:(K8G;:S!>?Z9;H+4HB)4#;9U
MMQJ:H1V7O$&S!YM8$R;7J*:"Z_!;I(&A?*^)/@;]J<7+H**182Z8*@=K45BE
MKX@:PA3!^Z[\>A?#3/%.WE04RVS8H>(SX9ZXUAW<TLD8.%5@KJS#OM*L+?*>
M2KEKB2U7PAOL0?8E-C=.3=EFJ(E^#YOG;Z31L2O[<'X/I59/U9Y-/*Y-+YY<
M;<U:?O]W<(2H35?BIT52*XA&`Z\WSX_4:-%_M32=68,C'X\;RJOB+\^'?R]'
M\@BJ,*)P2(.:J'@3SI6_94X<\4OFBTR'D6K0[YSJ6-[5>B?N4/L/I/!U@>"G
M-:3C%]ZU+X%I4714HO\1=:0&LJV]JL';DYT:C&#9KE%V^)$%P`E\Q(+M$<'I
M:^C5L/':!4\S_F$[P;5\K1J6"E_J5C3TQ[9D4=PF3XA4!?B":\E+-`JS?!/6
MPHUH*#19SF%98LGWC0O&#Y;A];L1+-:,\+5K)WE/'2$6`1R!;+I?41&_:I;_
MC909,5U8*6P:M,P0EW&$5X*/4A[UN)F1C?N([:@P)AJYQ:\K)53VG>=]O5VW
MQ:9(M]RKZ-#W0V8_@F`H^@G)^.J5V#LA5U(CUZY(H98WE!'3<\,F`?GCJT,)
ME48=Y7*5*BZ[HV=4INF?_0+]5-(IRTL1+'>G%]%1Z(E9O])Z7_#S+4$_<_CX
M_U!+`0(>`Q0````(`+.`"D>56,>JE8,``#L5!@`1`!@```````$```"D@0``
M``!A<&1N+3(P,34P-C,P+GAM;%54!0`#$03)575X"P`!!"4.```$.0$``%!+
M`0(>`Q0````(`+.`"D>),B(UZ@@``,AN```5`!@```````$```"D@>"#``!A
M<&1N+3(P,34P-C,P7V-A;"YX;6Q55`4``Q$$R55U>`L``00E#@``!#D!``!0
M2P$"'@,4````"`"S@`I'MJOXL3@=``!9``(`%0`8```````!````I($9C0``
M87!D;BTR,#$U,#8S,%]D968N>&UL550%``,1!,E5=7@+``$$)0X```0Y`0``
M4$L!`AX#%`````@`LX`*1S$K0:%%80``*KX%`!4`&````````0```*2!H*H`
M`&%P9&XM,C`Q-3`V,S!?;&%B+GAM;%54!0`#$03)575X"P`!!"4.```$.0$`
M`%!+`0(>`Q0````(`+.`"D>+-RDW]S,``(VE`P`5`!@```````$```"D@30,
M`0!A<&1N+3(P,34P-C,P7W!R92YX;6Q55`4``Q$$R55U>`L``00E#@``!#D!
M``!02P$"'@,4````"`"S@`I'J>:9R<H1``!PK0``$0`8```````!````I(%Z
M0`$`87!D;BTR,#$U,#8S,"YX<V155`4``Q$$R55U>`L``00E#@``!#D!``!0
52P4&``````8`!@`:`@``CU(!````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929241614096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES - Summary of accounts payable and accrued liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 770,395<span></span>
</td>
<td class="nump">$ 1,059,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued consulting fees</a></td>
<td class="nump">110,500<span></span>
</td>
<td class="nump">102,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries payable</a></td>
<td class="nump">428,098<span></span>
</td>
<td class="nump">245,761<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">109,622<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 1,418,615<span></span>
</td>
<td class="nump">$ 1,494,759<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929241441536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS - Employee Stock Options (Detail Textuals 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,015,361<span></span>
</td>
<td class="nump">$ 404,507<span></span>
</td>
<td class="nump">$ 3,531,205<span></span>
</td>
<td class="nump">$ 1,717,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option modifications</a></td>
<td class="nump">544,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">673,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecorded compensation cost related to non-vested awards</a></td>
<td class="nump">2,749,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,749,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average period of non-vested awards options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 16 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted', window );">Weighted average grant date fair value for options granted</a></td>
<td class="nump">$ 69,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,076,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Options | Employees, consultants and non-employee board of director members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options granted</a></td>
<td class="nump">49,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Options | Executives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents share based compensation weighted average grant date fair value for options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ShareBasedCompensationWeightedAverageGrantDateFairValueForOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (e)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=apdn_EmployeesConsultantsAndNonEmployeeBoardOfDirectorMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929445666112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROMISSORY NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">PROMISSORY NOTES PAYABLE</a></td>
<td class="text"><p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><b>NOTE D &#8211; PROMISSORY NOTES PAYABLE</b></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">On September 11, 2014, the Company issued and sold promissory notes (the &#8220;Notes&#8221;) in the aggregate principal amount of $1,800,000 and bearing interest at a rate of 12.5% per annum to Dr. James A. Hayward, the Company&#8217;s President, Chairman and Chief Executive Officer, in the amount of $1,000,000, and to another individual, in the amount of $800,000, both of whom are &#8220;accredited investors&#8221; as defined in regulations promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The Notes had a ten month maturity. Interest was payable in cash or in shares of common stock at the option of the holders of the Notes. Interest to be paid in shares was to be paid in shares of common stock equal to (i) the amount of interest payable, divided by (ii) the average of the closing prices for the five consecutive trading days immediately preceding the applicable interest date. The Notes were permitted to be prepaid in whole or in part, at any time, subject to certain prepayment penalties. Upon an event of default, the Notes and all accrued interest thereon were to automatically convert into common stock at the closing price of the common stock on the date of issuance of the Notes. In the event of a consolidation or merger with another corporation in which the Company does not survive, the Notes were to be paid in full. On November 11, 2014, Dr. Hayward and the other individual agreed to exchange for cancellation their respective Notes (including principal and accrued interest thereon) for 315,171 shares of common stock and warrants to purchase 315,171 shares of common stock, in the case of Dr. Hayward, and 252,137 shares of common stock and warrants to purchase 252,137 shares of common stock, in the case of the other individual, at $3.25 ($3.24 for one share of common stock and $0.01 for one warrant) (&#8220;combined price&#8221;) , the aggregate public offering per share price of common stock and warrants issued in the Company&#8217;s underwritten public offering, which closed on November 20, 2014.&#160;&#160;The conversion of the Notes resulted in a loss on conversion of approximately $981,000, which was recorded on the condensed consolidated statement of operations for the nine month period ended June 30, 2015.&#160;&#160;The loss was calculated as the difference between the carrying amount of the promissory note and accrued interest on the conversion date compared to the fair value of the common stock and warrant issued as settlement of the Notes.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">Interest expense for these Notes was $31,875 for the nine month period ended June 30, 2015.&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20,22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238255072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Detail Textuals) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 24, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">one-for-60 (1:60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">1,350,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,482,202<span></span>
</td>
<td class="nump">13,935,954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,482,202<span></span>
</td>
<td class="nump">13,935,954<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 4<br><br><br><br> -Subparagraph (SAB TOPIC 4.C)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section C<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238411920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Detail Textuals) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 11, 2014</div></th>
<th class="th"><div>Nov. 20, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 11, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note issued to related party (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible promissory note converted (in dollars per share)</a></td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note issued to related party (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Promissory notes | James A. Hayward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note issued to related party (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock and warrants issued in settlement of convertible debentures and interest</a></td>
<td class="nump">315,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest', window );">Number of shares issued in settlement of convertible notes and accrued interest</a></td>
<td class="nump">315,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible promissory note converted (in dollars per share)</a></td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in settlement of convertible notes and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 470<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-161870<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-30)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=apdn_PresidentChairmanAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=apdn_PresidentChairmanAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929245034304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Detail Textuals 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2015</div></th>
<th class="th"><div>Apr. 30, 2015</div></th>
<th class="th"><div>Dec. 30, 2014</div></th>
<th class="th"><div>Dec. 19, 2014</div></th>
<th class="th"><div>Nov. 20, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Nov. 11, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Underwritten public offering of common stock and warrants closed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common stock called by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo', window );">Gross proceeds from underwritten public offering of common stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants', window );">Gross proceeds to repurchase remaining Series B Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,091,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible promissory note converted into common stock (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_TermPeriodOfWarrantsOrRightsExercised', window );">Period of warrant exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfDaysOptionGivenToUnderwriters', window );">Number of days option given to underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_AdditionalSharesOfCommonStockPurchaseLimit', window );">Additional common stock purchase limit given to underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_AdditionalPerSharesOfCommonStockPurchaseLimit', window );">Additional common stock per share purchase limit given to underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_AdditionalSharesOfWarrantsPurchaseLimit', window );">Additional warrants purchase limit given to underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_AdditionalPerSharesOfWarrantsPurchaseLimit', window );">Additional per share warrants purchase limit given to underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise', window );">Number of warrants for which underwriters' close exercise of its over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">416,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_GrossProceedsFromClosedOnUnderwritersExercise', window );">Gross proceeds from closed on underwriters exercise of over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise', window );">Common stock closed on underwriters additional exercise of over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise', window );">Gross proceeds from closed on underwriters additional exercise of over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfCommonStockIssued', window );">Number of common stock including the exercise of over allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,852,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfWarrantsIssued', window );">Number of warrant issued including the exercise of over allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,216,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_GrossProceedsFromSaleOfCommonStockAndWarrants', window );">Gross proceeds from sale of common stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,272,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants', window );">Gross proceeds from underwritten public offering of common stock and warrants</a></td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="nump">$ 263,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NetProceedsFromSaleOfCommonStockAndWarrants', window );">Net proceeds from sale of common stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,114,418<span></span>
</td>
<td class="nump">$ 2,145,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights', window );">Additional number of common stock called by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights', window );">Exercise price of warrants which company agreed to issue to the underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Exercise price percentage of public offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of common stock shares granted to consultant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ShareBasedCompensationOfferingToConsultant', window );">Total expenses to consultant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,750<span></span>
</td>
<td class="nump">$ 64,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents additional exercise price of common s tock called by warrants which company agree to issue to underwriters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_AdditionalExercisePriceSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents additional number of commons tock called by warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_AdditionalNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_AdditionalPerSharesOfCommonStockPurchaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents additional per shares of common stock purchase limit given to underwriters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_AdditionalPerSharesOfCommonStockPurchaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_AdditionalPerSharesOfWarrantsPurchaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents additional per share warrants purchase limit given to underwriters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_AdditionalPerSharesOfWarrantsPurchaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_AdditionalSharesOfCommonStockPurchaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents additional shares of common stock purchase limit given to underwriters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_AdditionalSharesOfCommonStockPurchaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_AdditionalSharesOfWarrantsPurchaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents additional warrants purchase limit given to underwriters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_AdditionalSharesOfWarrantsPurchaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of additional common stock for closed on the underwriters exercise of its over-allotment option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ClassOfWarrantOrRightAdditionalClosedOnUnderwritersExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants for closed on the underwriters exercise of its over-allotment option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ClassOfWarrantOrRightClosedOnUnderwritersExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents gross proceeds from additional closed on the underwriters exercise of its over-allotment option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_GrossProceedsFromAdditionalClosedOnUnderwritersExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_GrossProceedsFromClosedOnUnderwritersExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents gross proceeds from closed on the underwriters exercise of its over-allotment option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_GrossProceedsFromClosedOnUnderwritersExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_GrossProceedsFromSaleOfCommonStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from common stock and warrants before deducting after deducting underwriting discounts, offering expenses and the repurchase the remaining Series B Warrants from Crede to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_GrossProceedsFromSaleOfCommonStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents gross proceeds from underwritten public offering of common stock and warrants on closure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents gross proceeds from underwritten public offering of common stock and warrants on closure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrantsTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from gross proceeds to repurchase the remaining Series B Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NetProceedsFromSaleOfCommonStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from common stock and warrants after deducting after deducting underwriting discounts, offering expenses and the repurchase the remaining Series B Warrants from Crede to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NetProceedsFromSaleOfCommonStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfCommonStockIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of common stock issued under this offering, including the exercise of the over allotment option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfCommonStockIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfDaysOptionGivenToUnderwriters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of days option given to underwriters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfDaysOptionGivenToUnderwriters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants issued under this offering, including the exercise of the over allotment option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ShareBasedCompensationOfferingToConsultant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents share based compensation offering to consultant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ShareBasedCompensationOfferingToConsultant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_TermPeriodOfWarrantsOrRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents term period of warrants or rights exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_TermPeriodOfWarrantsOrRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 470<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-161870<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929244805440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Detail Textuals 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2015</div></th>
<th class="th"><div>Apr. 30, 2015</div></th>
<th class="th"><div>Nov. 20, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common stock called by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=apdn_UnderwrittenPublicOfferingMember', window );">Underwritten public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscribedButUnissued', window );">Common stock offered</a></td>
<td class="nump">4,011,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common stock called by warrants</a></td>
<td class="nump">1,604,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Combined offering price</a></td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_SharePriceForCommonStock', window );">Offering price for common stock</a></td>
<td class="nump">2.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_SharePriceForWarrant', window );">Offering price for warrant</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption', window );">Number of common stock sold pursuant to over allotment option</a></td>
<td class="nump">191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption', window );">Number of warrants stock sold pursuant to over allotment option</a></td>
<td class="nump">76,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="nump">$ 3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Gross proceeds from offering</a></td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares', window );">Number of days for option to purchase additional shares</a></td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfAdditionalSharesOfCommonStock', window );">Number of additional shares of common stock</a></td>
<td class="nump">573,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments', window );">Number of additional warrants to cover over allotments</a></td>
<td class="nump">229,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfCommonStockExerciseInOverAllotmentOption', window );">Number of common stock exercise in over allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfWarrantsExerciseInOverAllotmentOption', window );">Number of warrants exercise in over allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_GrossProceedsFromExerciseOfOverAllotmentOption', window );">Gross proceeds from exercise of over allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 263,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_GrossProceedsFromExerciseOfOverAllotmentOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents gross proceeds from exercise of over allotment option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_GrossProceedsFromExerciseOfOverAllotmentOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfAdditionalSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of additional shares of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfAdditionalSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfAdditionalWarrantsToCoverOverAllotments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of additional warrants to cover over allotments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfAdditionalWarrantsToCoverOverAllotments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfCommonStockExerciseInOverAllotmentOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of common stock exercise in over allotment option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfCommonStockExerciseInOverAllotmentOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of common stock sold pursuant to over allotment of option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfCommonStockSoldPursuantToOverAllotmentOfOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfDaysForOptionToPurchaseAdditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of days for option to purchase additional shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfDaysForOptionToPurchaseAdditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfWarrantsExerciseInOverAllotmentOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants exercise in over allotment option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfWarrantsExerciseInOverAllotmentOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants stock sold pursuant to over allotment of option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfWarrantsStockSoldPursuantToOverAllotmentOfOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_SharePriceForCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share for common stock of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_SharePriceForCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_SharePriceForWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share for warrant of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_SharePriceForWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscribedButUnissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscribedButUnissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=apdn_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=apdn_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238951504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</a></td>
<td class="text"><p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><b>NOTE C &#8211; ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</b></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">Accounts payable and accrued liabilities at June 30, 2015 and September 30, 2014 are as follows:</font></p>
<table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid;" colspan="2">
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">June 30,</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">2015</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">(unaudited)</font></p>
</td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid;" colspan="2">
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">September 30,<br />2014</font></p>
</td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; width: 752px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Accounts payable</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; width: 201px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">770,395</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; width: 187px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,059,623</font></td>
<td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Accrued consulting fees</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">110,500</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">102,500</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Accrued salaries payable</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">428,098</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px;
 padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">245,761</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Accrued interest payable</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">-</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">11,875</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Other accrued expenses</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">109,622</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">75,000</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Total</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 15px; padding-right: 0.8pt; font-size: 10pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,418,615</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,494,759</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a),20,24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929247123824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Detail Textuals 3) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2015</div></th>
<th class="th"><div>Nov. 20, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Exercise price percentage of public offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=apdn_UnderwrittenPublicOfferingMember', window );">Underwritten public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="nump">$ 3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=apdn_UnderwrittenPublicOfferingMember', window );">Underwritten public offering | Underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfWarrantsGrantedAsPartialCompensation', window );">Number of warrants granted as partial compensation</a></td>
<td class="nump">163,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Exercise price percentage of public offering price</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfWarrantsGrantedAsPartialCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants granted as partial compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfWarrantsGrantedAsPartialCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=apdn_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=apdn_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=apdn_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=apdn_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238255040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 10,730,144<span></span>
</td>
<td class="nump">$ 1,393,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $30,228 and $9,634 at June 30, 2015 and September 30, 2014, respectively</a></td>
<td class="nump">2,077,756<span></span>
</td>
<td class="nump">834,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">209,831<span></span>
</td>
<td class="nump">135,365<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">13,017,731<span></span>
</td>
<td class="nump">2,363,315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net of accumulated depreciation of $743,914 at June 30, 2015 and $759,087 at September 30, 2014</a></td>
<td class="nump">526,816<span></span>
</td>
<td class="nump">576,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="nump">52,988<span></span>
</td>
<td class="nump">57,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">181,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net of accumulated amortization and impairment of $325,555 and $256,208 at June 30, 2015 and September 30, 2014, respectively</a></td>
<td class="nump">525,902<span></span>
</td>
<td class="nump">327,872<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">14,123,437<span></span>
</td>
<td class="nump">3,506,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities, including related party accrued interest of $6,597 at September 30, 2014</a></td>
<td class="nump">1,418,615<span></span>
</td>
<td class="nump">1,494,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Promissory notes payable, including $1,000,000 with a related party at September 30, 2014</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">204,863<span></span>
</td>
<td class="nump">583,362<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,623,478<span></span>
</td>
<td class="nump">3,878,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WarrantLiabilityNoncurrent', window );">Warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,096,412<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">$ 1,623,478<span></span>
</td>
<td class="nump">$ 4,974,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note I)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2015 and September 30, 2014</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share; 500,000,000 and 1,350,000,000 shares authorized at June 30, 2015 and September 30, 2014, respectively; 21,482,202 and 13,935,954 shares issued and outstanding as of June 30, 2015 and September 30, 2014, respectively</a></td>
<td class="nump">$ 21,483<span></span>
</td>
<td class="nump">$ 13,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid in capital</a></td>
<td class="nump">223,623,850<span></span>
</td>
<td class="nump">198,277,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(211,145,374)<span></span>
</td>
<td class="num">(199,760,272)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">12,499,959<span></span>
</td>
<td class="num">(1,468,476)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity (Deficit)</a></td>
<td class="nump">$ 14,123,437<span></span>
</td>
<td class="nump">$ 3,506,057<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2015 and September 30, 2014</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2015 and September 30, 2014</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_WarrantLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents amount of warrant liability as on the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_WarrantLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3-4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of deferred costs that are expected to be recognized as a charge against earnings in periods after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.10)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a)(5))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929387661616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">SUMMARY OF ACCOUNTING POLICIES</a></td>
<td class="text"><p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>NOTE A &#8212; SUMMARY OF ACCOUNTING POLICIES</b></font></p>
<p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>General</u></font></p>
<p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The accompanying condensed consolidated financial statements as of June 30, 2015 and for the three and nine month periods ended June 30, 2015 and 2014 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month periods ended June 30, 2015 are not necessarily indicative of the results that may be expected for the fiscal year ending September 30, 2015. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended September 30, 2014 and footnotes thereto included in the Annual Report on Form 10-K, as amended, of Applied DNA Sciences, Inc. (the &#8220;Company&#8221;) filed with the SEC.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The condensed consolidated balance sheet as of September 30, 2014 contained herein has been derived from the audited consolidated financial statements as of September 30, 2014, but does not include all disclosures required by GAAP.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">All warrant, option, share, and per share information in the condensed consolidated financial statements gives retroactive effect to the one-for-60 reverse stock split of the Company&#8217;s common stock, par value $.001 per share, that was effected on October 29, 2014. See Note G.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Business and Basis of Presentation</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">On September 16, 2002, the Company was incorporated under the laws of the State of Nevada. Effective December 17, 2008, the Company reincorporated from the State of Nevada to the State of Delaware. The Company is principally devoted to developing DNA embedded biotechnology security solutions in the United States and Europe. To date, the Company has had a limited operating history, and as a result, its operations have produced limited recurring revenues from its services and products; it has incurred expenses and has sustained losses. Consequently, its operations are subject to all the risks inherent in the establishment of a biotechnology company. For the period from inception through June 30, 2015, the Company has accumulated losses of $211,145,374.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, APDN (B.V.I.) Inc. and Applied DNA Sciences Europe Limited, which currently have no operations or activity. Significant inter-company transactions and balances have been eliminated in consolidation.&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Revenue Recognition</u>&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company recognizes revenue in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 605, Revenue Recognition (&#8220;ASC 605&#8221;). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred and/or service has been performed; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&#8217;s judgments regarding the fixed nature of the selling prices of the products delivered or services provided and the collectability of those amounts. Provisions for allowances and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered, service has not been provided, or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered, the service has been provided, or no refund will be required. At June 30, 2015 and September 30, 2014, the Company recorded deferred revenue of $204,863 and $583,362, respectively.</font><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Revenue arrangements with multiple components are divided into separate units of accounting if certain criteria are met, including whether the delivered component has stand-alone value to the customer. Consideration received is allocated among the separate units of accounting based on their respective selling prices. The selling price for each unit is based on vendor-specific objective evidence, or VSOE, if available, third party evidence if VSOE is not available, or estimated selling price if neither VSOE nor third party is available. The applicable revenue recognition criteria are then applied to each of the units.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Revenue for government contract awards, which supports the Company&#8217;s development efforts on specific projects, is recognized as milestones are achieved as per the contract. The Company recognized revenue of approximately $657,708 and $1,919,031 from these contract awards during the three and nine month periods ended June 30, 2015 and $0 and $50,000 for the three and nine month periods ended June 30, 2014, respectively.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Net Loss Per Share</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company presents loss per share utilizing a dual presentation of basic and diluted loss per share. Basic loss per share includes no dilution and has been calculated based upon the weighted average number of common shares outstanding during the period. Dilutive common stock equivalents consist of shares issuable upon the exercise of the Company&#8217;s stock options and warrants.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">For the three and nine month periods ended June 30, 2015 and 2014, common stock equivalent shares are excluded from the computation of the diluted loss per share as their effect would be anti-dilutive.</font><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"></p>
<p style="text-align: center; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Securities that could potentially dilute basic net income per share in the future that were not included in the computation of diluted net loss per share because including those securities would have been anti-dilutive for the three and nine month periods ended&#160;June 30, 2015 and 2014 are as follows:&#160;</font></p>
<table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td>&#160;</td>
<td>&#160;</td>
<td style="text-align: center;" colspan="3">&#160;</td>
<td>&#160;</td>
<td style="text-align: center;" colspan="3">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="padding-bottom: 1pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>2015</b></font></td>
<td style="text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="padding-bottom: 1pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>2014</b></font></td>
<td style="text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
</tr>
<tr style="background-color: #f7ffff; vertical-align: bottom;">
<td style="width: 785px;">Warrants</td>
<td style="width: 46px;">&#160;</td>
<td style="text-align: left; width: 15px;">&#160;</td>
<td style="text-align: right; width: 157px;">6,062,487</td>
<td style="text-align: left; width: 15px;">&#160;</td>
<td style="width: 46px;">&#160;</td>
<td style="text-align: left; width: 15px;">&#160;</td>
<td style="text-align: right; width: 158px;">240,439</td>
<td style="text-align: left; width: 16px;">&#160;</td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="text-align: left; padding-bottom: 1pt;">Employee options</td>
<td style="padding-bottom: 1pt;">&#160;</td>
<td style="border-bottom: black 2px solid; text-align: left;">&#160;</td>
<td style="border-bottom: black 2px solid; text-align: right;">3,456,989</td>
<td style="text-align: left; padding-bottom: 1pt;">&#160;</td>
<td style="padding-bottom: 1pt;">&#160;</td>
<td style="border-bottom: black 2px solid; text-align: left;">&#160;</td>
<td style="border-bottom: black 2px solid; text-align: right;">2,073,043</td>
<td style="text-align: left; padding-bottom: 1pt;">&#160;</td>
</tr>
<tr style="background-color: #f7ffff; vertical-align: bottom;">
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="border-bottom: black 4px double; text-align: left;">&#160;</td>
<td style="border-bottom: black 4px double; text-align: right;">9,519,476</td>
<td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td>
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="border-bottom: black 4px double; text-align: left;">&#160;</td>
<td style="border-bottom: black 4px double; text-align: right;">2,313,482</td>
<td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td>
</tr>
</table>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Stock Based Compensation</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (&#8220;ASC 718&#8221;). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee&#8217;s requisite service period (generally the vesting period of the equity grant). The fair value of the Company&#8217;s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718, excess tax benefits realized from the exercise of stock-based awards are classified in cash flows from financing activities. The future realization of the reserved deferred tax assets related to these tax benefits associated with the exercise of stock options will result in a credit to additional paid in capital if the related tax deduction reduces taxes payable. The Company has elected the &#8220;with and without approach&#8221; regarding ordering of windfall tax benefits to determine whether the windfall tax benefit did reduce taxes payable in the current year. Under this approach, the windfall tax benefit would be recognized in additional paid-in-capital only if an incremental tax benefit is realized after considering all other benefits presently available.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company accounts for stock based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in&#160;ASC 505-50.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Concentrations</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company&#8217;s revenues earned from sale of products and services for the three and nine month periods ended June 30, 2015 included an aggregate of 87% and 73%, respectively, from two customers of the Company&#8217;s total revenues. These two customers accounted for approximately 89% of the Company&#8217;s total accounts receivable at June 30, 2015.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company&#8217;s revenues earned from sale of products and services for the three month period ended June 30, 2014 included an aggregate of 10% from one customer of the Company&#8217;s total revenues. During the nine month period ended June 30, 2014 no customers represented 10% or greater of the Company&#8217;s total revenues.</font><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"></p>
<p style="text-align: center; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Recent Accounting Pronouncements</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">In August 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2014-15, &#8220;Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern&#8221; (&#8220;ASU 2014-15&#8221;). ASU 2014-15 provides guidance on management&#8217;s responsibility in evaluating whether there is substantial doubt about a company&#8217;s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company&#8217;s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. The Company will adopt the methodologies prescribed by ASU 2014-15 by the date required, and does not anticipate that the adoption of ASU 2014-15 will have a material effect on its condensed consolidated financial position or results of operations.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">In June 2014, the FASB issued Accounting Standards Update 2014-12, &#8220;Accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period,&#8221; (&#8220;ASU 2014-12&#8221;) which requires performance-based awards with a performance target that affects vesting and that could be achieved after an employee completes the requisite service period to be accounted for as a performance condition. If performance targets are clearly defined and it is probable that the performance condition will be achieved, stock-based expense should be recognized over the remaining requisite service period. This guidance will be effective for fiscal years (and interim reporting periods within those years) beginning after December 15, 2015. Early adoption is permitted. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company&#8217;s condensed consolidated financial position or results of operations.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">In May 2014, the FASB issued Accounting Standards Update 2014-09, &#8220;Revenue from Contracts with Customers,&#8221; (&#8220;ASU 2014-09&#8221;) which provides updated, comprehensive revenue recognition guidance for contracts with customers, including a new principles-based five step framework that eliminates much of the industry-specific guidance in current accounting literature. Under ASU 2014-09, revenue recognition is based on a core principle that companies recognize revenue in an amount consistent with the consideration it expects to be entitled to in exchange for the transfer of goods or services. The standards update also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of recognized revenue. This guidance will be effective for fiscal years (and interim reporting periods within those years) beginning after December 15, 2017. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company&#8217;s condensed consolidated financial position or results of operations.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238865184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS - Summary of value of options granted using Black Scholes Option Pricing Model with weighted average assumptions (Details) - Jun. 30, 2015 - $ / shares<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_SharePriceTwo', window );">Stock price</a></td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="nump">$ 2.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo', window );">Exercise price</a></td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="nump">$ 2.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term, years</a></td>
<td class="text">3 years 9 months<span></span>
</td>
<td class="text">4 years 10 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">118.00%<span></span>
</td>
<td class="nump">132.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free rate</a></td>
<td class="nump">1.13%<span></span>
</td>
<td class="nump">1.56%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_SharePriceTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_SharePriceTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (f)(2)(iii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (f)(2)(ii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (f)(2)(iv)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (f)(2)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 14<br><br><br><br> -Section D<br><br><br><br> -Subsection 2<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929247067040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES (Detail Textuals) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 24, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">one-for-60 (1:60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (211,145,374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (211,145,374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (199,760,272)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 583,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Revenue for government contract awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 657,708<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,919,031<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration recognized during the period for the milestone or milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 28<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51671726&amp;loc=SL6892177-166501<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 4<br><br><br><br> -Subparagraph (SAB TOPIC 4.C)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section C<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929245124672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS - Employee Stock Options (Detail Textuals) - Employee Stock Options - Incentive Stock Plan 2005 - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jan. 21, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Aggregate number of shares of common stock that can be issued as stock awards and stock option</a></td>
<td class="nump">5,833,334<span></span>
</td>
<td class="nump">8,333,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Number of common stock shares that can be covered by awards made to any participant per period</a></td>
<td class="nump">833,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares issued</a></td>
<td class="nump">233,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Options to purchase shares under the 2005 Incentive Stock Plan</a></td>
<td class="nump">4,132,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share instruments newly issued under a share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares purchased on the open market during the period for issuance to employees under the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=apdn_IncentiveStockPlan2005Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=apdn_IncentiveStockPlan2005Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238540896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LIQUIDITY AND MANAGEMENT'S PLAN (Detail Textuals) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2015</div></th>
<th class="th"><div>Apr. 30, 2015</div></th>
<th class="th"><div>Nov. 20, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_LiquidityAndManagementPlanAbstract', window );"><strong>Liquidity And Management Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (211,145,374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (211,145,374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (199,760,272)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,670,882)<span></span>
</td>
<td class="num">$ (1,919,057)<span></span>
</td>
<td class="num">(11,385,102)<span></span>
</td>
<td class="num">$ (10,961,143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Operating cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,226,713)<span></span>
</td>
<td class="num">(6,271,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WorkingCapitalSurplusDeficit', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,394,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,394,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,730,144<span></span>
</td>
<td class="nump">$ 2,025,716<span></span>
</td>
<td class="nump">$ 10,730,144<span></span>
</td>
<td class="nump">$ 2,025,716<span></span>
</td>
<td class="nump">1,393,132<span></span>
</td>
<td class="nump">$ 6,360,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants', window );">Gross proceeds from underwritten public offering of common stock and warrants</a></td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="nump">$ 263,950<span></span>
</td>
<td class="nump">$ 9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants', window );">Gross proceeds to repurchase remaining Series B Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,091,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement of common stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,156,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ProceedsFromPromissoryNotes', window );">Proceeds from promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ProceedsFromPromissoryNotesFromRelatedParty', window );">Proceeds from promissory notes from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents gross proceeds from underwritten public offering of common stock and warrants on closure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_GrossProceedsFromUnderwrittenPublicOfferingOfCommonStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from gross proceeds to repurchase the remaining Series B Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_GrossProceedsToRepurchaseRemainingSeriesBWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_LiquidityAndManagementPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_LiquidityAndManagementPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ProceedsFromPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from promissory notes to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ProceedsFromPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ProceedsFromPromissoryNotesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from promissory notes through related party to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ProceedsFromPromissoryNotesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_WorkingCapitalSurplusDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents working capital surplus deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_WorkingCapitalSurplusDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929244107088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LIQUIDITY AND MANAGEMENT'S PLAN<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_LiquidityAndManagementPlanAbstract', window );"><strong>Liquidity And Management Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_LiquidityAndManagementPlanTextBlock', window );">LIQUIDITY AND MANAGEMENT'S PLAN</a></td>
<td class="text"><p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><b>NOTE B &#8211; LIQUIDITY AND MANAGEMENT&#8217;S PLAN</b></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The Company has recurring net losses, which have resulted in an accumulated deficit of $211,145,374 as of June 30, 2015. The Company incurred a net loss of $11,385,102 and generated negative operating cash flow of $5,226,713 for the nine month period ended June 30, 2015.&#160;&#160;However, the Company also has attained positive working capital of $11,394,253 as of June 30, 2015. At June 30, 2015 the Company had cash and cash equivalents of $10,730,144. The Company&#8217;s current capital resources include cash and cash equivalents, accounts receivable and prepaid expenses. Historically, the Company has financed its operations principally from the sale of equity securities. As discussed in Note G, on April 1, 2015, the Company closed its underwritten public offering of common stock and warrants for gross proceeds of approximately $12.0 million, before deducting underwriting discounts and offering expenses.<b>&#160;</b>Subsequently on April 30, 2015,<sup>&#160;</sup>the Company closed on the over-allotment option of the underwritten public offering for additional gross proceeds of $263,950. In addition, on November 20, 2014 the Company closed its underwritten public offering of common stock and warrants for gross proceeds of $9.3 million before deducting underwriting discounts and offering expenses. The Company utilized approximately $4,091,000 of the gross proceeds to repurchase the remaining Series B Warrants from Crede, as discussed in Note E.&#160;&#160;The Company raised $2,156,264 in a private placement of common stock and warrants and $1,800,000 in promissory notes during the fiscal year ended September 30, 2014, including $1,000,000 from a related party. See Notes D and G.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The Company expects to finance operations primarily through cash flows provided by operating activities provided that it will achieve a sufficient level of future revenues. The Company estimates that its cash and cash equivalents are sufficient to fund operations for the next twelve months.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The Company will require additional funds to complete the continued development of its products, product manufacturing, and to fund expected additional losses from operations, until revenues are sufficient to cover the Company&#8217;s operating expenses.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_LiquidityAndManagementPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_LiquidityAndManagementPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_LiquidityAndManagementPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure about liquidity and management plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_LiquidityAndManagementPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929177979152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance on accounts receivable (in dollars)</a></td>
<td class="nump">$ 30,228<span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation on property, plant and equipment (in dollars)</a></td>
<td class="nump">743,914<span></span>
</td>
<td class="nump">759,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization and impairment on intangible assets (in dollars)</a></td>
<td class="nump">$ 325,555<span></span>
</td>
<td class="nump">256,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent', window );">Related party accrued interest (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note issued to related party (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">1,350,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">21,482,202<span></span>
</td>
<td class="nump">13,935,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">21,482,202<span></span>
</td>
<td class="nump">13,935,954<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.14)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e5074-111524<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date within one year where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929247380304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of stock issuances under options and warrants that could have a dilutive effect on the shares outstanding</a></td>
<td class="text"><table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td>&#160;</td>
<td>&#160;</td>
<td style="text-align: center;" colspan="3">&#160;</td>
<td>&#160;</td>
<td style="text-align: center;" colspan="3">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="padding-bottom: 1pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>2015</b></font></td>
<td style="text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="padding-bottom: 1pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>2014</b></font></td>
<td style="text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
</tr>
<tr style="background-color: #f7ffff; vertical-align: bottom;">
<td style="width: 785px;">Warrants</td>
<td style="width: 46px;">&#160;</td>
<td style="text-align: left; width: 15px;">&#160;</td>
<td style="text-align: right; width: 157px;">6,062,487</td>
<td style="text-align: left; width: 15px;">&#160;</td>
<td style="width: 46px;">&#160;</td>
<td style="text-align: left; width: 15px;">&#160;</td>
<td style="text-align: right; width: 158px;">240,439</td>
<td style="text-align: left; width: 16px;">&#160;</td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="text-align: left; padding-bottom: 1pt;">Employee options</td>
<td style="padding-bottom: 1pt;">&#160;</td>
<td style="border-bottom: black 2px solid; text-align: left;">&#160;</td>
<td style="border-bottom: black 2px solid; text-align: right;">3,456,989</td>
<td style="text-align: left; padding-bottom: 1pt;">&#160;</td>
<td style="padding-bottom: 1pt;">&#160;</td>
<td style="border-bottom: black 2px solid; text-align: left;">&#160;</td>
<td style="border-bottom: black 2px solid; text-align: right;">2,073,043</td>
<td style="text-align: left; padding-bottom: 1pt;">&#160;</td>
</tr>
<tr style="background-color: #f7ffff; vertical-align: bottom;">
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="border-bottom: black 4px double; text-align: left;">&#160;</td>
<td style="border-bottom: black 4px double; text-align: right;">9,519,476</td>
<td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td>
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="border-bottom: black 4px double; text-align: left;">&#160;</td>
<td style="border-bottom: black 4px double; text-align: right;">2,313,482</td>
<td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238966416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Aug. 06, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">APPLIED DNA SCIENCES INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000744452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">apdn<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,487,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation 12B<br><br><br><br> -Number 240<br><br><br><br> -Section 12b<br><br><br><br> -Subsection 1<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation 12B<br><br><br><br> -Number 240<br><br><br><br> -Section 12b<br><br><br><br> -Subsection 1<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929440638912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accounts payable and accrued liabilities</a></td>
<td class="text"><table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid;" colspan="2">
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">June 30,</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">2015</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">(unaudited)</font></p>
</td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid;" colspan="2">
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">September 30,<br />2014</font></p>
</td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; width: 752px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Accounts payable</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; width: 201px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">770,395</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; width: 187px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,059,623</font></td>
<td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Accrued consulting fees</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">110,500</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">102,500</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Accrued salaries payable</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">428,098</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">245,761</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Accrued interest payable</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">-</font></td>
<td style="line-height: 16px; padding-right:
 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">11,875</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Other accrued expenses</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">109,622</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">75,000</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Total</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 15px; padding-right: 0.8pt; font-size: 10pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,418,615</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,494,759</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238410240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Revenues</a></td>
<td class="nump">$ 2,267,671<span></span>
</td>
<td class="nump">$ 841,197<span></span>
</td>
<td class="nump">$ 5,028,234<span></span>
</td>
<td class="nump">$ 2,075,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">3,508,455<span></span>
</td>
<td class="nump">2,948,452<span></span>
</td>
<td class="nump">11,078,405<span></span>
</td>
<td class="nump">10,093,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">310,093<span></span>
</td>
<td class="nump">266,331<span></span>
</td>
<td class="nump">961,745<span></span>
</td>
<td class="nump">1,085,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">121,339<span></span>
</td>
<td class="nump">113,424<span></span>
</td>
<td class="nump">354,144<span></span>
</td>
<td class="nump">325,448<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">3,939,887<span></span>
</td>
<td class="nump">3,328,207<span></span>
</td>
<td class="nump">12,394,294<span></span>
</td>
<td class="nump">11,504,495<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">LOSS FROM OPERATIONS</a></td>
<td class="num">(1,672,216)<span></span>
</td>
<td class="num">(2,487,010)<span></span>
</td>
<td class="num">(7,366,060)<span></span>
</td>
<td class="num">(9,428,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income (expense), net</a></td>
<td class="nump">5,052<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="num">(26,807)<span></span>
</td>
<td class="nump">784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(3,718)<span></span>
</td>
<td class="nump">52,299<span></span>
</td>
<td class="num">(16,853)<span></span>
</td>
<td class="nump">130,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_LossOnConversionOfPromissoryNotes', window );">Loss on conversion of promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(980,842)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability', window );">Gain (loss) on change in fair value of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,543<span></span>
</td>
<td class="num">(2,994,540)<span></span>
</td>
<td class="num">(1,663,316)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before provision for income taxes</a></td>
<td class="num">$ (1,670,882)<span></span>
</td>
<td class="num">$ (1,919,057)<span></span>
</td>
<td class="num">$ (11,385,102)<span></span>
</td>
<td class="num">$ (10,961,143)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS</a></td>
<td class="num">$ (1,670,882)<span></span>
</td>
<td class="num">$ (1,919,057)<span></span>
</td>
<td class="num">$ (11,385,102)<span></span>
</td>
<td class="num">$ (10,961,143)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share-basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.14)<span></span>
</td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding-</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted (in shares)</a></td>
<td class="nump">21,444,335<span></span>
</td>
<td class="nump">13,569,262<span></span>
</td>
<td class="nump">18,075,506<span></span>
</td>
<td class="nump">13,400,540<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent income (loss) from change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_IncomeLossFromChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_LossOnConversionOfPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent loss on conversion of promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_LossOnConversionOfPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 940<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51673353&amp;loc=d3e41242-110953<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 10<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Income Tax Expense (or Benefit)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.10)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 330<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51677171&amp;loc=d3e3636-108311<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929250613392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">CAPITAL STOCK</a></td>
<td class="text"><p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><b>NOTE G - CAPITAL STOCK</b></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">On October 24, 2014, the Company filed a Third Certificate of Amendment of its Certificate of Incorporation with the Secretary of State of the State of Delaware that effected a one-for-60 (1:60) reverse stock split of its common stock, par value $.001 per share, and a decrease in its authorized common stock, from 1,350,000,000 to 500,000,000 shares, effective October 29, 2014. All warrant, option, share, and per share information in the condensed consolidated financial statements gives retroactive effect to the one-for-60 reverse stock split that was effected on October 29, 2014.&#160;<i>&#160;</i>&#160;In addition, the Company is authorized to issue 10,000,000 shares of preferred stock with a $0.001 par value per share. As of June 30, 2015 and September 30, 2014, there were 21,482,202 and 13,935,954 shares of common stock issued and outstanding, respectively.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">On November 20, 2014, the Company closed its underwritten public offering of 2,800,000 shares of common stock and warrants to purchase up to an aggregate of 2,800,000 shares of common stock for gross proceeds of $9.1 million before deducting underwriting discounts and offering expenses. The Company utilized $4,091,000 of the gross proceeds to repurchase the remaining Series B Warrants from Crede, as discussed in Note E. The combined price for each share of common stock and warrant was $3.25. The warrants may be exercised for a period of five years and have an exercise price of $3.50 per share. In connection with the offering, the Company granted to the underwriters a 45-day option to purchase up to 420,000 additional shares of common stock at $3.24 per share and/or up to 420,000 additional warrants at $0.01 per share to cover over-allotments, if any. The Company&#8217;s Chief Executive Officer and an affiliated company of a member of the Company&#8217;s board of directors participated in this underwritten public offering. The Company&#8217;s common stock and warrants are listed on the Nasdaq Capital Market under the symbols &#8220;APDN&#8221; and &#8220;APDNW&#8221;, respectively. On December 19, 2014, the Company closed on the underwriters&#8217; exercise of its over-allotment option of 416,850 warrants for gross proceeds of $4,169 and on December 30, 2014, the Company closed on the underwriters&#8217; additional exercise of its over-allotment option of 52,000 shares of common stock for gross proceeds of $168,400.&#160;&#160;The total number of common stock and warrants issued under this offering, including the exercise of the over-allotment option was 2,852,000 and 3,216,850, respectively.&#160;&#160;The gross proceeds to the Company was $9.3 million and net proceeds after deducting underwriting discounts, offering expenses and the repurchase of the remaining Series B Warrants from Crede was approximately $3.69 million.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">In connection with the closing of this underwritten public offering, on November 20, 2014, the Company granted 128,800 warrants to purchase common stock to its underwriters as partial compensation. These warrants have an exercise price of $3.73 (115% of the public offering price) and expire on November 14, 2019.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">During the three and nine month periods ended June 30, 2015, the Company granted 15,000 and 22,500 shares of common stock to a consultant for a total expense of approximately $47,750 and $64,426, respectively.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 11pt calibri; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">On April 1, 2015, the Company closed its underwritten public offering of 4,011,000 shares of common stock and warrants to purchase up to an aggregate of 1,604,400 shares of common stock, at $3.00 ($2.99 for one share of common stock and $0.01 for one warrant) (&#8220;combined offering price&#8221;), including 191,000 shares and 76,400 warrants sold pursuant to the partial exercise of the underwriters&#8217; over-allotment option. The warrants have a per share exercise price of $3.50, are exercisable immediately, and expire on November 20, 2019. The gross proceeds to the Company from this offering, including the partial exercise of the over-allotment option but before deducting the underwriting discount and offering expenses, is $12.0 million</font><font style="font-size: 10pt;">.<font style="font-family: 'times new roman';">&#160;In connection with the offering, the Company granted to the underwriters a 45-day option to purchase up to 573,000 additional shares of common stock and up to 229,200 additional warrants to cover over-allotments, if any. On April 30, 2015, the Company closed on the underwriters&#8217; exercise of its over-allotment option of 87,000 shares of common stock and 152,800 warrants for gross proceeds of $263,950 .</font></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">In connection with the closing of this underwritten public offering, as partial compensation, on April 1, 2015, the Company granted up to 163,720 warrants to purchase common stock to its underwriters. These warrants have an exercise price of $3.44 (115% of the public offering price) and expire on March 27, 2020.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">See Note D for the common stock and warrants issued in connection with the conversion of the promissory notes.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929250641760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><b>NOTE F &#8211; RELATED PARTY TRANSACTIONS</b></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">As discussed in Note D, on September 11, 2014, the Company issued and sold a promissory note in the aggregate principal amount of $1,000,000 and bearing interest at a rate of 12.5% per annum to Dr. James A. Hayward, the Company&#8217;s President, Chairman and Chief Executive Officer. On November 11, 2014, Dr. Hayward agreed to exchange for cancellation of his Note (including principal and accrued interest thereon) for 315,171 shares of common stock and warrants to purchase 315,171 shares of common stock, at a combined price of $3.25, the aggregate public offering price of common stock and warrants issued in the Company&#8217;s underwritten public offering which closed on November 20, 2014.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">As discussed in Note G, the Company&#8217;s Chief Executive Officer and an affiliated company of a member of the Company&#8217;s board of directors participated in the Company&#8217;s November 20, 2014 underwritten public offering.</font></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph b<br><br><br><br> -Article 3A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929177999680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES (Detail Textuals 1) - Customer Concentration Risk - Customer<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Total Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskBenchmarkDescription', window );">Concentration risk benchmark description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">no customers represented 10% or greater<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Total Revenue | Two customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total revenue and accounts receivable</a></td>
<td class="nump">87.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ConcentrationRiskNumberOfCustomers', window );">Number of customers</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Total Revenue | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total revenue and accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ConcentrationRiskNumberOfCustomers', window );">Number of customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Accounts Receivable | Two customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total revenue and accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ConcentrationRiskNumberOfCustomers', window );">Number of customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ConcentrationRiskNumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents number of major customers in concentration risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ConcentrationRiskNumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskBenchmarkDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identifies or describes the benchmark that serves as the denominator in the calculation of the percentage of concentration risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 21<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 18<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6351-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 20<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6404-108592<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 20<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskBenchmarkDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 18<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6351-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 20<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 20<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6404-108592<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 21<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=apdn_TwoCustomersConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=apdn_TwoCustomersConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=apdn_CustomerOneConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=apdn_CustomerOneConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238424816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock', window );">Schedule of transactions involving warrants</a></td>
<td class="text"><table align="center" style="width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 11pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Number of</font><font style="font-size: 10pt;"><br  /><font style="font-family: arial;">&#160;</font><font style="font-family: 'times new roman';">Shares</font></font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Weighted</font><font style="font-size: 10pt;"><br  /><font style="font-family: arial;">&#160;</font><font style="font-family: 'times new roman';">Average&#160;<br  />Exercise</font><br  /><font style="font-family: arial;">&#160;</font><font style="font-family: 'times new roman';">Price Per&#160;<br  />Share</font></font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; width: 752px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Balance at October 1, 2014</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; width: 217px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">945,166</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; width: 171px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">9.59</font></td>
<td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Granted</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">5,833,878</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">3.50</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Exercised</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(&#8212;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(&#8212;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Cancelled or expired</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(716,557</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(11.30</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Balance at June 30, 2015</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">6,062,487</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">3.53</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of summary of transactions involving stock options issued to employees</a></td>
<td class="text"><table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; width: 516px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 201px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 44px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 155px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 61px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 157px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Number of</font><font style="font-size: 10pt;"><br /><font style="font-family: 'times new roman';">Shares</font></font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid;" colspan="2">
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Weighted&#160;<br />Average</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Exercise</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Price Per</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Share</font></p>
</td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid;" colspan="2">
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Aggregate</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Intrinsic</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Value</font></p>
</td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Outstanding at October 1, 2014</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">2,909,046</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">4.74</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Granted</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">950,094</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">2.85</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px;
 padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Exercised</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">&#8212;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">&#8212;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Cancelled or expired</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(402,151)</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(3.01)</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Outstanding at June 30, 2015</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">3,456,989</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">4.42</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Vested at June 30, 2015</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">2,494,098</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">4.13</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">0.18</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font
 style="font: 10pt 'times new roman'; font-stretch: normal;">Non-vested at June 30, 2015</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">962,891</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">0.12</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of fair value of options granted</a></td>
<td class="text"><table align="center" style="width: 100%; border-collapse: collapse; font-size: 12pt;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="width: 45%;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="width: 3%;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="width: 1%;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="text-align: right; width: 13%;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="width: 3%;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="width: 1%;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="text-align: right; width: 13%;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="width: 1%;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 2px solid;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="border-bottom: black 2px solid;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; font-size: 10pt;" colspan="2"><font style="font: 10pt times new roman, times, serif;">Three<br  />Months<br  />Ended<br  />June 30, <br  />2015</font></td>
<td style="border-bottom: black 2px solid; text-align: center;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; font-size: 10pt;" colspan="2"><font style="font: 10pt times new roman, times, serif;">Nine<br  />Months<br  />Ended<br  />June 30, <br  />2015</font></td>
<td style="border-bottom: black 2px solid;"><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
</tr>
<tr style="background-color: azure; vertical-align: bottom;">
<td><font style="font: 10pt times new roman, times, serif;">Stock price</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">$</font></td>
<td style="text-align: right; font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">2.60</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">$</font></td>
<td style="text-align: right;"><font style="font: 10pt times new roman, times, serif;">2.85</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td><font style="font: 10pt times new roman, times, serif;">Exercise price</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">$</font></td>
<td style="text-align: right;"><font style="font: 10pt times new roman, times, serif;">2.60</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">$</font></td>
<td style="text-align: right;"><font style="font: 10pt times new roman, times, serif;">2.85</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
</tr>
<tr style="background-color: azure; vertical-align: bottom;">
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">Expected term, years</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="text-align: right; font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">3.75</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="text-align: right; font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">4.85</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td><font style="font: 10pt times new roman, times, serif;">Dividend yield</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt times new roman, times, serif;">&#8212;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">%</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt times new roman, times, serif;">&#8212;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">%</font></td>
</tr>
<tr style="background-color: azure; vertical-align: bottom;">
<td><font style="font: 10pt times new roman, times, serif;">Volatility</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt times new roman, times, serif;">118</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">%</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt times new roman, times, serif;">132</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">%</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td><font style="font: 10pt times new roman, times, serif;">Risk free rate</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt times new roman, times, serif;">1.13</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">%</font></td>
<td><font style="font: 10pt times new roman, times, serif;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt times new roman, times, serif;">1.56</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt times new roman, times, serif;">%</font></td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of transactions of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ScheduleOfDisclosureTransactionsOfWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (d)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929250641760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE</a></td>
<td class="text"><p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><b>NOTE J - FAIR VALUE</b></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The carrying value of cash, accounts receivable, accounts payable and accrued liabilities approximate estimated fair values because of their short maturities.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The carrying value of the warrant liability is determined using the Binomial Lattice option pricing model as described in Note A. Certain assumptions used in the calculation of the warrant liability represent Level-3 unobservable inputs. The Company did not have any assets or liabilities categorized as Level 1, 2 or 3 as of June 30, 2015.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The following table summarizes the activity of Level 3 inputs measured on a recurring basis:</font></p>
<table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Fair Value Measurements of Common Stock Warrants Using Significant Unobservable Inputs (Level 3)</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td colspan="6">
<p style="text-align: center; margin: 0px 5.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;"><b>Nine Months Ended</b></font></p>
<p style="text-align: center; margin: 0px 5.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;"><b>June 30,</b></font></p>
</td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font: 10pt 'times new roman'; font-stretch: normal;"><b>2015</b></font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font: 10pt 'times new roman'; font-stretch: normal;"><b>2014</b></font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; width: 907px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Balance at October 1, 2014 and 2013</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; width: 202px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,096,412</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; width: 204px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman';
 font-stretch: normal;">2,643,449</font></td>
<td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Adjustment resulting from change in fair value (a)</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">2,994,540</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,663,316</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Removal of warrant upon repurchase</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(4,090,952</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">&#8212;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Reclassification to equity upon exercise</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">&#8212;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(2,455,042</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Balance at June 30,</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">&#8212;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,851,723</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
</table>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">(a)&#160;<i>Adjustment resulting from change in fair value</i>&#160;is the amount of total gains or losses for the period attributable to the change in unrealized gains or losses relating to warrant liabilities held at the reporting date and realized gains or losses at the date of exercise. The gain or loss is recorded in change in fair value of warrant liability in the accompanying condensed consolidated statements of operations.</font></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 30<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 21<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 16<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13504-108611<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13433-108611<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929387587536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK OPTIONS AND WARRANTS</a></td>
<td class="text"><p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><b>NOTE H - STOCK OPTIONS AND WARRANTS</b></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><u>Warrants</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The following table summarizes the changes in warrants outstanding and the related prices for the shares of common stock issued to non-employees of the Company. These warrants were granted in lieu of cash for services performed or financing expenses in connection with the sale of common stock.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 12pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">Transactions involving warrants (see Notes D, E and G) are summarized as follows:</font></p>
<table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Number of</font><font style="font-size: 10pt;"><br  /><font style="font-family: arial;">&#160;</font><font style="font-family: 'times new roman';">Shares</font></font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Weighted</font><font style="font-size: 10pt;"><br  /><font style="font-family: arial;">&#160;</font><font style="font-family: 'times new roman';">Average&#160;<br  />Exercise</font><br  /><font style="font-family: arial;">&#160;</font><font style="font-family: 'times new roman';">Price Per&#160;<br  />Share</font></font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; width: 752px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Balance at October 1, 2014</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; width: 217px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">945,166</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; width: 171px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">9.59</font></td>
<td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Granted</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">5,833,878</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">3.50</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Exercised</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(&#8212;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(&#8212;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Cancelled or expired</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(716,557</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(11.30</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Balance at June 30, 2015</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">6,062,487</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">3.53</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
</table>
<p style="widows: 1; text-transform: none; text-indent: 0.5in; margin: 12pt 0px 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><u>Employee Stock Options</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">In 2005, the Board of Directors and the holders of a majority of the outstanding shares of common stock approved the 2005 Incentive Stock Plan (the &#8220;Incentive Plan&#8221;). In 2007, 2008 and 2012, the Board of Directors and holders of a majority of the outstanding shares of common stock approved various increases in the number of shares of common stock that can be issued as stock awards and stock options thereunder to an aggregate of 5,833,334 shares and the number of shares of common stock that can be covered by awards made to any participant in any calendar year to 833,334 shares.&#160;&#160;On January 21, 2015, the Board of Directors approved an amendment to the Incentive Plan, which was approved by shareholders on June 16, 2015.&#160;&#160;The amendment increases the number of shares of common stock that can be issued as stock awards and stock options thereunder to an aggregate of 8,333,333.&#160;&#160;The amendment also extends the Incentive Plan&#8217;s expiration date to January 25, 2025.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The Incentive Plan is designed to retain directors, executives, and selected employees and consultants by rewarding them for making contributions to our success with an award of options to purchase shares of common stock and an award of shares of common stock. As of June 30, 2015 a total of 233,752 shares have been issued and options to purchase 4,132,475 shares have been granted under the 2005 Incentive Stock Plan.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">Transactions involving stock options issued to employees are summarized as follows:</font></p>
<table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; width: 516px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 201px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 44px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 155px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 29px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 61px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 157px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Number of</font><font style="font-size: 10pt;"><br  /><font style="font-family: 'times new roman';">Shares</font></font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid;" colspan="2">
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Weighted&#160;<br  />Average</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Exercise</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Price Per</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Share</font></p>
</td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid;" colspan="2">
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Aggregate</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Intrinsic</font></p>
<p style="text-align: center; margin: 0px 1.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;">Value</font></p>
</td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Outstanding at October 1, 2014</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">2,909,046</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">4.74</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Granted</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">950,094</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">2.85</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Exercised</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">&#8212;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">&#8212;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Cancelled or expired</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(402,151)</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(3.01)</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Outstanding at June 30, 2015</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">3,456,989</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">4.42</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Vested at June 30, 2015</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">2,494,098</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">4.13</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">0.18</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Non-vested at June 30, 2015</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">962,891</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">0.12</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
</table>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-size: 10pt;">&#160;For the three and nine-month periods ended June 30, 2015, the Company issued 49,585 and 950,094, options to employees, consultants and non-employee board of director members, respectively. Included in these grants for the nine month period was 450,000 options granted to executives.</font><font style="font-size: 10pt;"><b>&#160;</b></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"></p>
<p style="text-align: center; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The fair value of options granted during the three and nine month periods ended June 30, 2015 was determined using the Black Scholes Option Pricing Model with the following weighted average assumptions:</font></p>
<table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 12pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="width: 707px;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="width: 46px;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="width: 15px;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: right; width: 203px;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="width: 46px;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="width: 15px;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: right; width: 205px;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="width: 16px;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 2px solid;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; font-size: 10pt;" colspan="2"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Three<br  />Months<br  />Ended<br  />June 30,&#160;<br  />2015</font></td>
<td style="border-bottom: black 2px solid; text-align: center;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; font-size: 10pt;" colspan="2"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Nine<br  />Months<br  />Ended<br  />June 30,&#160;<br  />2015</font></td>
<td style="border-bottom: black 2px solid;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Stock price</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">$</font></td>
<td style="text-align: right; font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">2.60</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">$</font></td>
<td style="text-align: right;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">2.85</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Exercise price</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">$</font></td>
<td style="text-align: right;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">2.60</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">$</font></td>
<td style="text-align: right;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">2.85</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Expected term, years</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: right; font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">3.75</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: right; font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">4.85</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Dividend yield</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#8212;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">%</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#8212;</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">%</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Volatility</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">118</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">%</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">132</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">%</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Risk free rate</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">1.13</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">%</font></td>
<td><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: right;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">1.56</font></td>
<td style="font-size: 10pt;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">%</font></td>
</tr>
</table>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The Company recorded $1,015,361(including $544,113 for stock option modifications) and $404,507 as stock compensation expense for the three month periods ended June 30, 2015 and 2014, respectively, and $3,531,205 (including $673,176 for stock option modifications) and $1,717,837 for the nine month periods ended June 30, 2015 and 2014, respectively for the vesting portion of all options. As of June 30, 2015, unrecorded compensation cost related to non-vested awards was $2,749,586 which is expected to be recognized over a weighted average period of approximately 2.21 years.&#160;&#160;The weighted average grant date fair value for options granted during the three and nine month periods ended June 30, 2015 was $69,430 and $1,076,502, respectively.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 40<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 50<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51659978&amp;loc=d3e25284-112666<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 14<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929250649936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><b>NOTE I - COMMITMENTS AND CONTINGENCIES</b></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><u>Operating Leases</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The Company leases office space under an operating lease in Stony Brook, New York for its corporate headquarters. The lease is for a 30,000 square foot building. The term of the lease commenced on June 15, 2013 and expires on May 31, 2016, with the option to extend the lease for two additional three-year periods. The base rent during the initial lease term is $449,142 per annum. The Company also has operating leases for a laboratory in Huddersfield, England, which is currently inactive and Calverton, New York. The Huddersfield lease was terminated effective July 31, 2015. The Calverton lease was from February 1, 2014 through October 31, 2014<b>,</b>&#160;with the option to renew for additional one year periods.&#160;&#160;The Calverton lease is currently on a month to month basis.&#160;&#160;Total rent expense for the three and nine month periods ended June 30, 2015 was $124,504 and $373,772, respectively. Total rent expense for the three and nine month periods ended June 30, 2014 were $125,268 and $380,251, respectively.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><u>Employment Agreement</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The Company has an employment agreement with the Chief Executive Officer. Effective June 21, 2014, the Chief Executive Officer&#8217;s annual salary was voluntarily reduced by $50,000. This salary reduction will be accrued and repaid when the Company reaches $3,000,000 in sales for two consecutive quarters or the Company has net income at the end of any fiscal year.&#160;&#160;Effective January 1, 2015, the Chief Executive Officer&#8217;s annual salary was voluntarily reduced by an additional $50,000.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><u>Litigation</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">From time to time, the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. When the Company is aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, the Company will record a liability for the loss. In addition to the estimated loss, the recorded liability includes probable and estimable legal costs associated with the claim or potential claim. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm the Company&#8217;s business.&#160;There is no pending litigation involving the Company at this time.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 460<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51674963&amp;loc=d3e12565-110249<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 440<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238779312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Business and Basis of Presentation</a></td>
<td class="text"><p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Business and Basis of Presentation</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">On September 16, 2002, the Company was incorporated under the laws of the State of Nevada. Effective December 17, 2008, the Company reincorporated from the State of Nevada to the State of Delaware. The Company is principally devoted to developing DNA embedded biotechnology security solutions in the United States and Europe. To date, the Company has had a limited operating history, and as a result, its operations have produced limited recurring revenues from its services and products; it has incurred expenses and has sustained losses. Consequently, its operations are subject to all the risks inherent in the establishment of a biotechnology company. For the period from inception through June 30, 2015, the Company has accumulated losses of $211,145,374.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, APDN (B.V.I.) Inc. and Applied DNA Sciences Europe Limited, which currently have no operations or activity. Significant inter-company transactions and balances have been eliminated in consolidation.&#160;</font></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Revenue Recognition</u>&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company recognizes revenue in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 605, Revenue Recognition (&#8220;ASC 605&#8221;). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred and/or service has been performed; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&#8217;s judgments regarding the fixed nature of the selling prices of the products delivered or services provided and the collectability of those amounts. Provisions for allowances and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered, service has not been provided, or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered, the service has been provided, or no refund will be required. At June 30, 2015 and September 30, 2014, the Company recorded deferred revenue of $204,863 and $583,362, respectively.</font></p>
<div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;">&#160;<font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></div>
<div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Revenue arrangements with multiple components are divided into separate units of accounting if certain criteria are met, including whether the delivered component has stand-alone value to the customer. Consideration received is allocated among the separate units of accounting based on their respective selling prices. The selling price for each unit is based on vendor-specific objective evidence, or VSOE, if available, third party evidence if VSOE is not available, or estimated selling price if neither VSOE nor third party is available. The applicable revenue recognition criteria are then applied to each of the units.</font></div>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Revenue for government contract awards, which supports the Company&#8217;s development efforts on specific projects, is recognized as milestones are achieved as per the contract. The Company recognized revenue of approximately $657,708 and $1,919,031 from these contract awards during the three and nine month periods ended June 30, 2015 and $0 and $50,000 for the three and nine month periods ended June 30, 2014, respectively.</font></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Net Loss Per Share</u></font></p>
<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company presents loss per share utilizing a dual presentation of basic and diluted loss per share. Basic loss per share includes no dilution and has been calculated based upon the weighted average number of common shares outstanding during the period. Dilutive common stock equivalents consist of shares issuable upon the exercise of the Company&#8217;s stock options and warrants.</font></p>
<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">For the three and nine month periods ended June 30, 2015 and 2014, common stock equivalent shares are excluded from the computation of the diluted loss per share as their effect would be anti-dilutive.</font></p>
<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Securities that could potentially dilute basic net income per share in the future that were not included in the computation of diluted net loss per share because including those securities would have been anti-dilutive&#160;for the three and nine month periods ended&#160;June 30, 2015 and 2014 are as follows:&#160;</font></p>
<table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td>&#160;</td>
<td>&#160;</td>
<td style="text-align: center;" colspan="3">&#160;</td>
<td>&#160;</td>
<td style="text-align: center;" colspan="3">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="padding-bottom: 1pt;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: center; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: center; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>2015</b></font></td>
<td style="text-align: center;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="padding-bottom: 1pt;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: center; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
<td style="text-align: center; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>2014</b></font></td>
<td style="text-align: center;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom; background-color: #f7ffff;">
<td style="width: 785px;">Warrants</td>
<td style="width: 46px;">&#160;</td>
<td style="width: 15px; text-align: left;">&#160;</td>
<td style="width: 157px; text-align: right;">6,062,487</td>
<td style="width: 15px; text-align: left;">&#160;</td>
<td style="width: 46px;">&#160;</td>
<td style="width: 15px; text-align: left;">&#160;</td>
<td style="width: 158px; text-align: right;">240,439</td>
<td style="width: 16px; text-align: left;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left; padding-bottom: 1pt;">Employee options</td>
<td style="padding-bottom: 1pt;">&#160;</td>
<td style="text-align: left; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;">&#160;</td>
<td style="text-align: right; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;">3,456,989</td>
<td style="text-align: left; padding-bottom: 1pt;">&#160;</td>
<td style="padding-bottom: 1pt;">&#160;</td>
<td style="text-align: left; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;">&#160;</td>
<td style="text-align: right; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;">2,073,043</td>
<td style="text-align: left; padding-bottom: 1pt;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #f7ffff;">
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;">&#160;</td>
<td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;">9,519,476</td>
<td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td>
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;">&#160;</td>
<td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;">2,313,482</td>
<td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Based Compensation</a></td>
<td class="text"><p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Stock Based Compensation</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (&#8220;ASC 718&#8221;). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee&#8217;s requisite service period (generally the vesting period of the equity grant). The fair value of the Company&#8217;s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718, excess tax benefits realized from the exercise of stock-based awards are classified in cash flows from financing activities. The future realization of the reserved deferred tax assets related to these tax benefits associated with the exercise of stock options will result in a credit to additional paid in capital if the related tax deduction reduces taxes payable. The Company has elected the &#8220;with and without approach&#8221; regarding ordering of windfall tax benefits to determine whether the windfall tax benefit did reduce taxes payable in the current year. Under this approach, the windfall tax benefit would be recognized in additional paid-in-capital only if an incremental tax benefit is realized after considering all other benefits presently available.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company accounts for stock based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in&#160;ASC 505-50.</font></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations</a></td>
<td class="text"><p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Concentrations</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company&#8217;s revenues earned from sale of products and services for the three and nine month periods ended June 30, 2015 included an aggregate of 87% and 73%, respectively, from two customers of the Company&#8217;s total revenues. These two customers accounted for approximately 89% of the Company&#8217;s total accounts receivable at June 30, 2015.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<div style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">The Company&#8217;s revenues earned from sale of products and services for the three month period ended June 30, 2014 included an aggregate of 10% from one customer of the Company&#8217;s total revenues. During the nine month period ended June 30, 2014 no customers represented 10% or greater of the Company&#8217;s total revenues.</font></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;"><u>Recent Accounting Pronouncements</u></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">In August 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2014-15, &#8220;Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern&#8221; (&#8220;ASU 2014-15&#8221;). ASU 2014-15 provides guidance on management&#8217;s responsibility in evaluating whether there is substantial doubt about a company&#8217;s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company&#8217;s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. The Company will adopt the methodologies prescribed by ASU 2014-15 by the date required, and does not anticipate that the adoption of ASU 2014-15 will have a material effect on its condensed consolidated financial position or results of operations.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">In June 2014, the FASB issued Accounting Standards Update 2014-12, &#8220;Accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period,&#8221; (&#8220;ASU 2014-12&#8221;) which requires performance-based awards with a performance target that affects vesting and that could be achieved after an employee completes the requisite service period to be accounted for as a performance condition. If performance targets are clearly defined and it is probable that the performance condition will be achieved, stock-based expense should be recognized over the remaining requisite service period. This guidance will be effective for fiscal years (and interim reporting periods within those years) beginning after December 15, 2015. Early adoption is permitted. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company&#8217;s condensed consolidated financial position or results of operations.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font: 10pt 'times new roman', times, serif; font-stretch: normal;">In May 2014, the FASB issued Accounting Standards Update 2014-09, &#8220;Revenue from Contracts with Customers,&#8221; (&#8220;ASU 2014-09&#8221;) which provides updated, comprehensive revenue recognition guidance for contracts with customers, including a new principles-based five step framework that eliminates much of the industry-specific guidance in current accounting literature. Under ASU 2014-09, revenue recognition is based on a core principle that companies recognize revenue in an amount consistent with the consideration it expects to be entitled to in exchange for the transfer of goods or services. The standards update also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of recognized revenue. This guidance will be effective for fiscal years (and interim reporting periods within those years) beginning after December 15, 2017. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company&#8217;s condensed consolidated financial position or results of operations.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 825<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51676700&amp;loc=d3e61082-112788<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 825<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 21<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 20<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 825<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51676700&amp;loc=d3e61044-112788<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18823-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.B.Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section B<br><br><br><br> -Paragraph Question 1<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (b),(f)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238543840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS - Transactions involving stock options issued to employees (Details 1) - Jun. 30, 2015 - Employee Stock Options - Incentive Stock Plan 2005 - $ / shares<br></strong></div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at October 1, 2014</a></td>
<td class="nump">2,909,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">950,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled or expired</a></td>
<td class="num">(402,151)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at June 30, 2015</a></td>
<td class="nump">3,456,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Vested at June 30, 2015</a></td>
<td class="nump">2,494,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Non-vested at June 30, 2015</a></td>
<td class="nump">962,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at October 1, 2014</a></td>
<td class="nump">$ 4.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">$ 2.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled or expired</a></td>
<td class="num">$ (3.01)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at June 30, 2015</a></td>
<td class="nump">4.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice', window );">Vested at June 30, 2015</a></td>
<td class="nump">4.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue', window );">Aggregate Intrinsic Value, Vested at June 30, 2015</a></td>
<td class="nump">0.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue', window );">Aggregate Intrinsic Value, Non-vested at June 30, 2015</a></td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options nonvested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information about weighted average exercise price per share vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(i)-(ii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28,29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=apdn_IncentiveStockPlan2005Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=apdn_IncentiveStockPlan2005Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929241513616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES - Summary of potential stock issuances under various options, and warrants (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from diluted net loss per share</a></td>
<td class="nump">9,519,476<span></span>
</td>
<td class="nump">2,313,482<span></span>
</td>
<td class="nump">9,519,476<span></span>
</td>
<td class="nump">2,313,482<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from diluted net loss per share</a></td>
<td class="nump">6,062,487<span></span>
</td>
<td class="nump">240,439<span></span>
</td>
<td class="nump">6,062,487<span></span>
</td>
<td class="nump">240,439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from diluted net loss per share</a></td>
<td class="nump">3,456,989<span></span>
</td>
<td class="nump">2,073,043<span></span>
</td>
<td class="nump">3,456,989<span></span>
</td>
<td class="nump">2,073,043<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Antidilution<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Diluted Earnings Per Share<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Contingent Stock Agreement<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238342784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROMISSORY NOTES PAYABLE (Detail Textuals) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 11, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Nov. 20, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 11, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note issued to related party (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Promissory notes maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays', window );">Debt instrument, convertible, threshold consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible promissory note converted (in dollars per share)</a></td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice', window );">Conversion price of convertible promissory note converted into common stock (in dollars per share)</a></td>
<td class="nump">3.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice', window );">Conversion price of convertible promissory note converted into warrant (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_LossOnConversionOfPromissoryNotes', window );">Loss on conversion of promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 980,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note issued to related party (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_LossOnConversionOfPromissoryNotes', window );">Loss on conversion of promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Promissory notes | James A. Hayward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note issued to related party (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock and warrants issued in settlement of convertible debentures and interest</a></td>
<td class="nump">315,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest', window );">Number of shares issued in settlement of convertible notes and accrued interest</a></td>
<td class="nump">315,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible promissory note converted (in dollars per share)</a></td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Promissory notes | Another individual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note issued to related party (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock and warrants issued in settlement of convertible debentures and interest</a></td>
<td class="nump">252,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest', window );">Number of shares issued in settlement of convertible notes and accrued interest</a></td>
<td class="nump">252,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible promissory note converted (in dollars per share)</a></td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of common stock of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_DebtInstrumentConvertibleForOneShareOfCommonStockConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of warrant of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_DebtInstrumentConvertibleForOneShareOfWarrantConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_LossOnConversionOfPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent loss on conversion of promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_LossOnConversionOfPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in settlement of convertible notes and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NumberOfSharesIssuedInSettlementOfConvertibleNotesAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 470<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-161870<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instruments must exceed threshold percentage for a specified number of trading days to trigger conversion feature, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-30)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=apdn_PresidentChairmanAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=apdn_PresidentChairmanAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=apdn_AnotherIndividualMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=apdn_AnotherIndividualMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929178068848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,385,102)<span></span>
</td>
<td class="num">$ (10,961,143)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">354,144<span></span>
</td>
<td class="nump">325,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation expense</a></td>
<td class="nump">3,531,205<span></span>
</td>
<td class="nump">1,717,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability', window );">Change in fair value of warrant liability</a></td>
<td class="nump">2,994,540<span></span>
</td>
<td class="nump">1,663,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_LossOnConversionOfPromissoryNotes', window );">Loss on conversion of promissory notes</a></td>
<td class="nump">980,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_CommonStockIssuedForConsultingServices', window );">Common stock issued for consulting services</a></td>
<td class="nump">64,426<span></span>
</td>
<td class="nump">337,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">21,750<span></span>
</td>
<td class="nump">16,878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(1,275,189)<span></span>
</td>
<td class="nump">137,486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets and deposits</a></td>
<td class="num">(59,315)<span></span>
</td>
<td class="num">(924)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(75,515)<span></span>
</td>
<td class="nump">292,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(378,499)<span></span>
</td>
<td class="nump">200,121<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities</a></td>
<td class="num">(5,226,713)<span></span>
</td>
<td class="num">(6,271,019)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows used in investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property plant and equipment</a></td>
<td class="num">(221,659)<span></span>
</td>
<td class="num">(209,522)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="num">(238,082)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash used in investing activities</a></td>
<td class="num">(459,741)<span></span>
</td>
<td class="num">(209,522)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_NetProceedsFromSaleOfCommonStockAndWarrants', window );">Net proceeds from sale of common stock and warrants</a></td>
<td class="nump">19,114,418<span></span>
</td>
<td class="nump">2,145,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants', window );">Purchase and cancelation of previously issued warrants</a></td>
<td class="num">(4,090,952)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash provided by financing activities</a></td>
<td class="nump">15,023,466<span></span>
</td>
<td class="nump">2,145,956<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">9,337,012<span></span>
</td>
<td class="num">(4,334,585)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">1,393,132<span></span>
</td>
<td class="nump">6,360,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 10,730,144<span></span>
</td>
<td class="nump">$ 2,025,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosures of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid during period for interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during period for taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants', window );">Common stock issued for cashless exercise of options and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital', window );">Reclassification of deferred offering costs to additional paid in capital</a></td>
<td class="nump">$ 181,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise', window );">Reclassification of warrants from liability to equity upon exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,455,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities', window );">Offering costs incurred, and included in accounts payable and accrued liabilities</a></td>
<td class="nump">68,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable', window );">Property, plant and equipment acquired, and included in accounts payable</a></td>
<td class="nump">13,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable', window );">Intangible assets acquired, and included in accounts payable</a></td>
<td class="nump">29,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued upon conversion of promissory notes payable</a></td>
<td class="nump">$ 1,843,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of common stock issued for cashless exercise of options and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_CommonStockIssuedForCashlessExerciseOfOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_CommonStockIssuedForConsultingServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents amount of common stock issued for consulting services during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_CommonStockIssuedForConsultingServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents value of deferred offering costs incurred, and included in accounts payable and accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent income (loss) from change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_IncomeLossFromChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents value of intangible assets acquired, and included in accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_IntangibleAssetsAcquiredIncludedInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_LossOnConversionOfPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent loss on conversion of promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_LossOnConversionOfPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_NetProceedsFromSaleOfCommonStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from common stock and warrants after deducting after deducting underwriting discounts, offering expenses and the repurchase the remaining Series B Warrants from Crede to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_NetProceedsFromSaleOfCommonStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents property, plant and equipment acquired, included in accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_PropertyPlantAndEquipmentAcquiredIncludedInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents purchase and cancelation of previously issued warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_PurchaseAndCancelationOfPreviouslyIssuedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Reclassification of deferred offering costs to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ReclassificationOfDeferredOfferingCostsToAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents reclassification of warrants from liability to equity upon exercise in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ReclassificationOfWarrantsFromLiabilityToEquityUponExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 230<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -Subparagraph (f)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.5)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929250612880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WarrantLiabilityAbstract', window );"><strong>Warrant Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WarrantLiabilityTextBlock', window );">WARRANT LIABILITY</a></td>
<td class="text"><p style="widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;"><b>NOTE E &#8211; WARRANT LIABILITY</b></font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">On December 16, 2013, Crede CG III, Ltd (&#8220;Crede&#8221;) effected the cashless exercise of 178,253 Series A Warrants and 116,667 Series B Warrants. At December 16, 2013 (date of exercise), the Company determined the fair value of the Warrants to be $2,455,042 using the Binomial Lattice model with the following assumptions: fair value of the Company&#8217;s common stock $10.80 per share; dividend yield 0%; expected term: 4.55 years; risk free interest rate: 1.55%; expected volatility of: 118.89%; and an exercise price of $14.59. The change in fair value of the warrant liability on the day of exercise amounted to a loss of $1,288,752 and was included in the other income (expense). Upon exercise, the fair value of the Series A Warrants and 116,667 of the Series B Warrants were reclassified to equity.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The Series A and Series B Warrants were classified as liabilities on the issuance date due to certain provisions contained in the warrant agreements, which may cause an adjustment to the conversion rate or the number of warrants outstanding.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">The change in fair value of the warrant liability resulted in a gain of $515,543 and a loss of $1,663,316 for the three and nine month periods ended June 30, 2014, respectively.</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">&#160;</font></p>
<p style="text-align: justify; widows: 1; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman'; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;"><font style="font-size: 10pt;">On October 28, 2014, the Company entered into a warrant repurchase option agreement with Crede, pursuant to which it had the option to purchase between 50% and 100% of Crede&#8217;s Series B Warrant (then exercisable for 387,621 shares of common stock) at a purchase price of $10.55 per share underlying such Series B Warrant (up to an aggregate purchase price of $4,091,000 for all of the Series B Warrant). On November 21, 2014, the Company exercised its option and repurchased 100% of Crede&#8217;s Series B Warrant for an aggregate purchase price of approximately $4,091,000.&#160;&#160;The change in fair value of the warrant liability on the day of repurchase amounted to a loss of $2,994,540 and was included in other income (expense) for the nine month period ended June 30, 2015.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_WarrantLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_WarrantLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_WarrantLiabilityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of fair value gain (loss) on warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_WarrantLiabilityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929175033232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITY (Detail Textuals) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 21, 2014</div></th>
<th class="th"><div>Oct. 28, 2014</div></th>
<th class="th"><div>Dec. 16, 2013</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightExercised', window );">Cashless exercise of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability', window );">Gain (loss) on change in fair value of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 515,543<span></span>
</td>
<td class="num">$ (2,994,540)<span></span>
</td>
<td class="num">$ (1,663,316)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=apdn_CredeCgIIILtdMember', window );">Crede CG III, Ltd | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,455,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementsValuationTechniques', window );">Method used for determining allocated fair value of the Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Binomial Lattice model<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Expected terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118.89%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Expected price at which holders exercise warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability', window );">Gain (loss) on change in fair value of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,288,752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=apdn_CredeCgIIILtdMember', window );">Crede CG III, Ltd | Series A Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightExercised', window );">Cashless exercise of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=apdn_CredeCgIIILtdMember', window );">Crede CG III, Ltd | Series B Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightExercised', window );">Cashless exercise of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=apdn_CredeCgIIILtdMember', window );">Crede CG III, Ltd | Series B Warrants | Warrant repurchase option agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ClassOfWarrantOrRightExercised', window );">Cashless exercise of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Expected price at which holders exercise warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_PercentageOfOptionToPurchaseWarrant', window );">Percentage of option to purchase warrant</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_AggregatePurchasePriceOfWarrantExercise', window );">Aggregate purchase price of warrant exercise</a></td>
<td class="nump">$ 4,091,000<span></span>
</td>
<td class="nump">$ 4,091,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=apdn_CredeCgIIILtdMember', window );">Crede CG III, Ltd | Series B Warrants | Warrant repurchase option agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_PercentageOfOptionToPurchaseWarrant', window );">Percentage of option to purchase warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=apdn_CredeCgIIILtdMember', window );">Crede CG III, Ltd | Series B Warrants | Warrant repurchase option agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_PercentageOfOptionToPurchaseWarrant', window );">Percentage of option to purchase warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_AggregatePurchasePriceOfWarrantExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents aggregate purchase price of warrant exercise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_AggregatePurchasePriceOfWarrantExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_IncomeLossFromChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent income (loss) from change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_IncomeLossFromChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_PercentageOfOptionToPurchaseWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents range of percentage of option to purchase warrant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_PercentageOfOptionToPurchaseWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 480<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6939902&amp;loc=d3e20148-110875<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed upon price for the exchange of the underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk-free interest rate assumption used in valuing an instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementsValuationTechniques">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the inputs and valuation technique(s) used to measure fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (bbb)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementsValuationTechniques</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=apdn_CredeCgIIILtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=apdn_CredeCgIIILtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=apdn_SeriesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=apdn_SeriesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=apdn_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=apdn_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_AgreementAxis=apdn_WarrantRepurchaseOptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_AgreementAxis=apdn_WarrantRepurchaseOptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.2.0.727</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>73</ContextCount>
  <ElementCount>224</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>28</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>006 - Disclosure - SUMMARY OF ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>007 - Disclosure - LIQUIDITY AND MANAGEMENT'S PLAN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/LiquidityAndManagementSPlan</Role>
      <ShortName>LIQUIDITY AND MANAGEMENT'S PLAN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>008 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIES</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>009 - Disclosure - PROMISSORY NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.adnas.com/role/PromissoryNotesPayable</Role>
      <ShortName>PROMISSORY NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>010 - Disclosure - WARRANT LIABILITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/WARRANTLIABILITY</Role>
      <ShortName>WARRANT LIABILITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>011 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>012 - Disclosure - CAPITAL STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CAPITALSTOCK</Role>
      <ShortName>CAPITAL STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>013 - Disclosure - STOCK OPTIONS AND WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/STOCKOPTIONSANDWARRANTS</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>014 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>015 - Disclosure - FAIR VALUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/FAIRVALUE</Role>
      <ShortName>FAIR VALUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>016 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>017 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIES</ParentRole>
      <Position>17</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>018 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESTables</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIES</ParentRole>
      <Position>18</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>019 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/STOCKOPTIONSANDWARRANTSTables</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adnas.com/role/STOCKOPTIONSANDWARRANTS</ParentRole>
      <Position>19</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>020 - Disclosure - FAIR VALUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/FAIRVALUETables</Role>
      <ShortName>FAIR VALUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adnas.com/role/FAIRVALUE</ParentRole>
      <Position>20</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>021 - Disclosure - SUMMARY OF ACCOUNTING POLICIES - Summary of potential stock issuances under various options, and warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/SummaryOfAccountingPoliciesSummaryOfPotentialStockIssuancesUnderVariousOptionsAndWarrantsDetails</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES - Summary of potential stock issuances under various options, and warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>022 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/SummaryOfAccountingPoliciesDetailTextuals</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>023 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Detail Textuals 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailTextuals1</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES (Detail Textuals 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/SUMMARYOFACCOUNTINGPOLICIESTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>024 - Disclosure - LIQUIDITY AND MANAGEMENT'S PLAN (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/LiquidityAndManagementSPlanDetailTextuals</Role>
      <ShortName>LIQUIDITY AND MANAGEMENT'S PLAN (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/LiquidityAndManagementSPlan</ParentRole>
      <Position>24</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>025 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES - Summary of accounts payable and accrued liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESSummaryOfAccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES - Summary of accounts payable and accrued liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>026 - Disclosure - PROMISSORY NOTES PAYABLE (Detail Textuals)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.adnas.com/role/PromissoryNotesPayableDetailTextuals</Role>
      <ShortName>PROMISSORY NOTES PAYABLE (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/PromissoryNotesPayable</ParentRole>
      <Position>26</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>027 - Disclosure - WARRANT LIABILITY (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/WarrantLiabilityDetailTextuals</Role>
      <ShortName>WARRANT LIABILITY (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/WARRANTLIABILITY</ParentRole>
      <Position>27</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>028 - Disclosure - RELATED PARTY TRANSACTIONS (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/RELATEDPARTYTRANSACTIONSDetailTextuals</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/RelatedPartyTransactions</ParentRole>
      <Position>28</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>029 - Disclosure - CAPITAL STOCK (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CAPITALSTOCKDetailTextuals</Role>
      <ShortName>CAPITAL STOCK (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/CAPITALSTOCK</ParentRole>
      <Position>29</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>030 - Disclosure - CAPITAL STOCK (Detail Textuals 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CAPITALSTOCKDetailTextuals1</Role>
      <ShortName>CAPITAL STOCK (Detail Textuals 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/CAPITALSTOCK</ParentRole>
      <Position>30</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>031 - Disclosure - CAPITAL STOCK (Detail Textuals 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CapitalStockDetailTextuals2</Role>
      <ShortName>CAPITAL STOCK (Detail Textuals 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/CAPITALSTOCK</ParentRole>
      <Position>31</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>032 - Disclosure - CAPITAL STOCK (Detail Textuals 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CapitalStockDetailTextuals3</Role>
      <ShortName>CAPITAL STOCK (Detail Textuals 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/CAPITALSTOCK</ParentRole>
      <Position>32</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>033 - Disclosure - STOCK OPTIONS AND WARRANTS - Transactions involving warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/StockOptionsAndWarrantsTransactionsInvolvingWarrantsDetails</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS - Transactions involving warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>034 - Disclosure - STOCK OPTIONS AND WARRANTS - Transactions involving stock options issued to employees (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/StockOptionsAndWarrantsTransactionsInvolvingStockOptionsIssuedToEmployeesDetails1</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS - Transactions involving stock options issued to employees (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>035 - Disclosure - STOCK OPTIONS AND WARRANTS - Summary of value of options granted using Black Scholes Option Pricing Model with weighted average assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/StockOptionsAndWarrantsSummaryOfValueOfOptionsGrantedUsingBlackScholesOptionPricingModelWithWeightedAverageAssumptionsDetails</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS - Summary of value of options granted using Black Scholes Option Pricing Model with weighted average assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>036 - Disclosure - STOCK OPTIONS AND WARRANTS - Employee Stock Options (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS - Employee Stock Options (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>037 - Disclosure - STOCK OPTIONS AND WARRANTS - Employee Stock Options (Detail Textuals 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/StockOptionsAndWarrantsEmployeeStockOptionsDetailTextuals1</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS - Employee Stock Options (Detail Textuals 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>038 - Disclosure - COMMITMENTS AND CONTINGENCIES (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIESDetailTextuals</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adnas.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>38</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>039 - Disclosure - FAIR VALUE - Fair Value Measurements of Common Stock Warrants Using Significant Unobservable Inputs (Level 3) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/FairValueFairValueMeasurementsOfCommonStockWarrantsUsingSignificantUnobservableInputsLevel3Details</Role>
      <ShortName>FAIR VALUE - Fair Value Measurements of Common Stock Warrants Using Significant Unobservable Inputs (Level 3) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">In ''CONDENSED CONSOLIDATED BALANCE SHEETS'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression.</Log>
    <Log type="Info">In ''CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)'', column(s) 4 are contained in other reports, so were removed by flow through suppression.</Log>
    <Log type="Info">In ''CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)'', column(s) 1, 2, 3 are contained in other reports, so were removed by flow through suppression.</Log>
  </Logs>
  <InputFiles>
    <File>apdn-20150630.xml</File>
    <File>apdn-20150630_cal.xml</File>
    <File>apdn-20150630_def.xml</File>
    <File>apdn-20150630_lab.xml</File>
    <File>apdn-20150630_pre.xml</File>
    <File>apdn-20150630.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929238839312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Detail Textuals)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 15, 2013 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 21, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_AreaOfPropertyUnderOperatingLease', window );">Area of property under operating lease | ft&#178;</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm', window );">Extended operating lease for two additional period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_BaseRentDuringInitialLeaseTerm', window );">Base rent during initial lease term per annum</a></td>
<td class="nump">$ 449,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Total lease rental expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,504<span></span>
</td>
<td class="nump">$ 125,268<span></span>
</td>
<td class="nump">$ 373,772<span></span>
</td>
<td class="nump">$ 380,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | Employment Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ReducedAmountOfSalary', window );">Reduced amount of salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_ThresholdAmountOfSales', window );">Threshold amount of sales for two consecutive quarters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_AreaOfPropertyUnderOperatingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the area of property under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_AreaOfPropertyUnderOperatingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_BaseRentDuringInitialLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount for base rent during initial lease term per annum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_BaseRentDuringInitialLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents commitments and contingencies line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ReducedAmountOfSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents reduced amount of salary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ReducedAmountOfSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_ThresholdAmountOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents threshold amount of sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_ThresholdAmountOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apdn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of the lessee's leasing arrangement renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_AgreementAxis=apdn_EmploymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apdn_AgreementAxis=apdn_EmploymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139929250526992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of fair value measurements of common stock warrants using significant unobservable inputs (Level 3)</a></td>
<td class="text"><table align="center" style="widows: 1; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 11pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Fair Value Measurements of Common Stock Warrants Using Significant Unobservable Inputs (Level 3)</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td colspan="6">
<p style="text-align: center; margin: 0px 5.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;"><b>Nine Months Ended</b></font></p>
<p style="text-align: center; margin: 0px 5.8pt 0px 0px; font: 10pt 'times new roman'; font-stretch: normal;"><font style="font-size: 10pt;"><b>June 30,</b></font></p>
</td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font: 10pt 'times new roman'; font-stretch: normal;"><b>2015</b></font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: center; line-height: 16px; padding-right: 1.8pt;" colspan="2"><font style="font: 10pt 'times new roman'; font-stretch: normal;"><b>2014</b></font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; width: 907px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Balance at October 1, 2014 and 2013</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; width: 202px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,096,412</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; width: 13px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="text-align: right; line-height: 16px; width: 204px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">2,643,449</font></td>
<td style="line-height: 16px; width: 14px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Adjustment resulting from change in fair value (a)</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">2,994,540</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,663,316</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Removal of warrant upon repurchase</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(4,090,952</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">&#8212;</font></td>
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
<tr style="background-color: white; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new
 roman'; font-stretch: normal;">Reclassification to equity upon exercise</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">&#8212;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 2px solid; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">(2,455,042</font></td>
<td style="border-bottom: black 2px solid; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">)</font></td>
</tr>
<tr style="background-color: #f0ffff; vertical-align: bottom;">
<td style="line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">Balance at June 30,</font></td>
<td style="text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">&#8212;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">$</font></td>
<td style="border-bottom: black 4px double; text-align: right; line-height: 16px; padding-right: 0.8pt;"><font style="font: 10pt 'times new roman'; font-stretch: normal;">1,851,723</font></td>
<td style="border-bottom: black 4px double; line-height: 16px; padding-right: 0.8pt;"><font style="font-size: 10pt;">&#160;</font></td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19279-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
